data_1t1t_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1t1t _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 20.2 mttt . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.277 0.561 . . . . 0.0 110.232 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.475 HG21 ' O ' ' A' ' 49' ' ' LEU . 10.8 tt -120.26 165.16 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.33 -0.856 . . . . 0.0 110.051 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -143.34 144.12 31.96 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.277 -0.889 . . . . 0.0 110.136 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 173.51 -151.6 13.81 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.585 ' N ' ' CD1' ' A' ' 5' ' ' TYR . 20.0 m-85 -110.15 98.31 34.53 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.325 -1.103 . . . . 0.0 110.413 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.409 ' HG3' ' HB2' ' A' ' 46' ' ' CYS . 49.2 Cg_endo -75.77 144.2 27.55 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 124.025 1.54 . . . . 0.0 110.738 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.551 ' CG1' ' CG2' ' A' ' 15' ' ' ILE . 6.3 m -109.14 -171.97 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.199 -0.938 . . . . 0.0 110.015 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -89.2 -88.47 0.16 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.217 -0.927 . . . . 0.0 110.19 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.503 ' HB3' ' CD2' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -141.09 -42.71 0.38 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.143 -0.973 . . . . 0.0 110.239 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.522 ' HB3' ' CB ' ' A' ' 62' ' ' ARG . 6.2 m-90 -116.46 16.57 15.61 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.256 -0.902 . . . . 0.0 110.057 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 88.6 m-20 56.54 17.12 2.85 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.261 -0.9 . . . . 0.0 110.146 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 56.4 m -70.14 -11.01 60.59 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.266 -0.896 . . . . 0.0 110.197 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.454 ' HD2' ' N ' ' A' ' 13' ' ' LYS . 5.5 mptt -108.04 40.01 1.83 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.328 -0.858 . . . . 0.0 110.241 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.488 ' O ' ' HB ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER 46.17 36.22 3.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.173 -0.954 . . . . 0.0 109.997 -179.997 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.551 ' CG2' ' CG1' ' A' ' 7' ' ' VAL . 2.5 mt 62.91 7.65 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.491 -0.755 . . . . 0.0 110.65 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.465 ' O ' ' O ' ' A' ' 17' ' ' TRP . 32.8 t -148.64 111.96 4.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.054 -1.029 . . . . 0.0 109.696 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.465 ' O ' ' O ' ' A' ' 16' ' ' CYS . 5.2 t90 -43.44 -94.3 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.329 -0.857 . . . . 0.0 110.306 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -160.54 -64.0 0.06 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.771 -1.206 . . . . 0.0 110.366 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.522 ' HB2' ' CG ' ' A' ' 22' ' ' TYR . 0.8 OUTLIER -70.15 171.02 10.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.464 -0.773 . . . . 0.0 110.367 -179.937 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -75.75 -54.69 6.55 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.234 -0.916 . . . . 0.0 109.966 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -71.9 -16.99 62.13 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.363 -0.836 . . . . 0.0 110.061 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.522 ' CG ' ' HB2' ' A' ' 19' ' ' ASN . 1.4 m-30 -57.72 -26.41 61.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.195 -0.941 . . . . 0.0 110.033 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.4 t -98.19 -17.69 18.86 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.252 -0.905 . . . . 0.0 110.243 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 35' ' ' GLY . 66.9 t30 -72.0 -40.28 68.63 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.258 -0.902 . . . . 0.0 110.069 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.13 -47.45 82.68 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.012 -1.055 . . . . 0.0 109.397 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.48 -43.44 85.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.374 -0.829 . . . . 0.0 109.354 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.483 ' HB3' ' HB3' ' A' ' 32' ' ' ALA . 1.8 m -60.23 -39.59 87.21 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.407 -0.808 . . . . 0.0 109.423 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.417 ' HG3' ' HA ' ' A' ' 33' ' ' ASP . 0.0 OUTLIER -60.05 -30.74 69.4 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.261 -0.899 . . . . 0.0 109.488 179.365 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.05 -31.65 79.47 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 107.798 -2.121 . . . . 0.0 107.798 179.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.516 ' O ' ' HB3' ' A' ' 31' ' ' LYS . 1.8 mt -91.8 19.0 6.91 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.672 -0.899 . . . . 0.0 109.217 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.516 ' HB3' ' O ' ' A' ' 30' ' ' LEU . 1.5 tptt 72.76 13.38 5.15 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.805 -0.559 . . . . 0.0 111.019 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.483 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . . . -92.34 73.06 5.3 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.902 -1.124 . . . . 0.0 109.975 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.417 ' HA ' ' HG3' ' A' ' 28' ' ' LYS . 18.9 m-20 -43.96 -62.0 1.27 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.316 -0.865 . . . . 0.0 110.407 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.404 ' HB3' ' NE2' ' A' ' 47' ' ' GLN . 0.3 OUTLIER -74.05 84.18 1.79 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.363 -0.836 . . . . 0.0 110.035 179.989 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.524 ' CA ' ' SG ' ' A' ' 46' ' ' CYS . . . -124.35 116.17 2.72 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.528 ' C ' ' CD1' ' A' ' 36' ' ' TYR . 12.8 p90 -139.04 147.44 42.06 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.316 -1.108 . . . . 0.0 109.85 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.455 ' SG ' ' HA ' ' A' ' 44' ' ' CYS . 0.0 OUTLIER -100.26 139.63 35.65 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.165 -0.959 . . . . 0.0 110.492 -179.619 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.578 ' CD1' ' HB2' ' A' ' 42' ' ' LEU . 26.0 t-105 -79.65 103.71 9.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.235 -0.916 . . . . 0.0 109.626 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -67.12 65.59 0.22 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.548 ' CD1' HG22 ' A' ' 41' ' ' THR . 6.3 t-105 -160.21 -65.77 0.07 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.284 -1.127 . . . . 0.0 109.883 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.548 HG22 ' CD1' ' A' ' 40' ' ' TRP . 3.8 t 177.62 35.83 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.53 -0.731 . . . . 0.0 109.903 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.578 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 9.6 mt -119.15 20.51 12.63 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.089 -1.007 . . . . 0.0 110.458 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.476 ' HB3' ' HB ' ' A' ' 15' ' ' ILE . 3.3 m 55.58 -170.42 0.07 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.153 -0.967 . . . . 0.0 110.179 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.468 ' O ' ' CD2' ' A' ' 5' ' ' TYR . 12.2 t -79.04 163.14 25.4 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.342 -0.849 . . . . 0.0 110.307 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -148.04 100.07 3.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.29 -0.882 . . . . 0.0 109.955 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.524 ' SG ' ' CA ' ' A' ' 35' ' ' GLY . 63.7 m -123.3 148.93 45.45 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.173 -0.954 . . . . 0.0 110.357 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.426 ' N ' ' CD ' ' A' ' 47' ' ' GLN . 0.7 OUTLIER -131.64 140.19 49.3 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.352 -0.843 . . . . 0.0 109.857 179.717 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.479 ' O ' ' O ' ' A' ' 31' ' ' LYS . . . 111.26 20.39 7.09 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.514 HD12 ' CB ' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -99.49 168.31 9.77 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 121.232 -1.158 . . . . 0.0 109.65 179.472 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.471 ' O ' ' HB2' ' A' ' 53' ' ' ALA . 43.3 Cg_endo -70.5 161.2 46.88 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.619 1.326 . . . . 0.0 110.62 -179.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -62.05 -16.68 53.68 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.219 -0.926 . . . . 0.0 109.717 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -94.84 15.01 19.62 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.435 -0.791 . . . . 0.0 109.941 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.514 ' CB ' HD12 ' A' ' 49' ' ' LEU . . . -56.01 149.22 15.83 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.283 -0.886 . . . . 0.0 110.304 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.456 ' C ' HG21 ' A' ' 55' ' ' ILE . 7.7 mtm105 -92.08 88.64 6.61 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.294 -0.879 . . . . 0.0 110.261 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.456 HG21 ' C ' ' A' ' 54' ' ' ARG . 0.2 OUTLIER -131.81 156.01 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.161 -0.962 . . . . 0.0 110.006 179.671 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 55' ' ' ILE . 8.9 mttt 42.45 56.0 3.91 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.236 -0.915 . . . . 0.0 110.303 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -88.05 -5.98 58.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.265 -0.897 . . . . 0.0 110.363 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.429 ' O ' ' ND2' ' A' ' 11' ' ' ASN . 0.1 OUTLIER 57.05 173.21 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.342 -0.849 . . . . 0.0 110.111 -179.909 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 101.41 132.94 7.92 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.67 173.44 8.1 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.188 -1.183 . . . . 0.0 110.236 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 35.1 t -43.4 104.99 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.364 -0.835 . . . . 0.0 110.169 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.522 ' CB ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -87.02 49.55 1.84 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.213 -0.929 . . . . 0.0 110.179 -179.882 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.131 -0.98 . . . . 0.0 110.309 -179.989 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.247 0.546 . . . . 0.0 110.237 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.47 HG21 ' O ' ' A' ' 49' ' ' LEU . 7.7 tt -119.22 163.95 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.272 -0.893 . . . . 0.0 110.28 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 3' ' ' ASP . 1.9 p30 -141.0 138.45 33.72 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.409 -0.807 . . . . 0.0 110.14 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 45' ' ' TYR . . . -177.59 -163.29 29.19 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.512 ' HA ' ' O ' ' A' ' 44' ' ' CYS . 3.0 m-85 -105.86 102.7 40.39 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.301 -1.117 . . . . 0.0 110.262 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.502 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 47.7 Cg_endo -74.3 109.98 3.0 Favored 'Trans proline' 0 C--N 1.301 -1.945 0 O-C-N 123.994 1.523 . . . . 0.0 111.187 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.545 ' CG1' HG13 ' A' ' 15' ' ' ILE . 14.6 m -91.29 -162.48 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.291 -0.88 . . . . 0.0 109.762 179.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.525 ' OD2' ' CG ' ' A' ' 13' ' ' LYS . 11.5 t0 -77.58 -87.97 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.334 -0.854 . . . . 0.0 109.829 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.488 ' O ' ' NH1' ' A' ' 54' ' ' ARG . 1.1 m-85 -141.29 -58.97 0.49 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.328 -0.857 . . . . 0.0 109.745 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.573 ' CD2' ' CB ' ' A' ' 63' ' ' ALA . 4.8 m-90 -106.22 24.42 12.51 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.442 -0.786 . . . . 0.0 109.678 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.47 ' OD1' HG22 ' A' ' 7' ' ' VAL . 58.9 m-80 57.58 15.5 2.85 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.367 -0.833 . . . . 0.0 109.726 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 5.1 t -92.5 -42.11 9.89 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.308 -0.87 . . . . 0.0 110.417 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.525 ' CG ' ' OD2' ' A' ' 8' ' ' ASP . 5.3 mmtp -60.41 -93.18 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.42 -0.8 . . . . 0.0 110.27 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.466 ' HG2' ' O ' ' A' ' 13' ' ' LYS . 2.7 mmp_? -144.68 101.4 3.66 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.175 -0.953 . . . . 0.0 110.511 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.545 HG13 ' CG1' ' A' ' 7' ' ' VAL . 4.3 tt -44.0 -27.6 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.218 -0.926 . . . . 0.0 109.458 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.537 ' HB2' ' N ' ' A' ' 44' ' ' CYS . 30.9 t -158.91 106.25 1.82 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.597 -0.689 . . . . 0.0 110.415 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.405 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -54.58 -172.57 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.179 -0.951 . . . . 0.0 109.81 179.773 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -114.55 33.59 5.24 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.109 -0.994 . . . . 0.0 110.174 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -131.55 145.55 51.78 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.257 -0.902 . . . . 0.0 109.959 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.426 ' OD1' ' N ' ' A' ' 20' ' ' ASN . 15.5 p-10 -82.06 9.09 9.11 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.243 -0.911 . . . . 0.0 110.352 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.46 -33.77 2.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.238 -0.914 . . . . 0.0 110.313 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -52.72 -35.75 56.36 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.107 -0.996 . . . . 0.0 110.199 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.406 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 0.1 OUTLIER -88.86 -30.57 18.82 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.219 -0.925 . . . . 0.0 110.049 179.846 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -69.93 -52.43 24.61 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.347 -0.846 . . . . 0.0 110.316 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -50.12 -47.9 53.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.212 -0.93 . . . . 0.0 110.308 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.3 -41.24 66.85 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.239 -0.913 . . . . 0.0 110.15 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.481 ' HB3' ' HB3' ' A' ' 32' ' ' ALA . 8.3 m -59.91 -34.33 73.05 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.106 -0.996 . . . . 0.0 109.794 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.55 -31.79 73.06 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.391 -0.818 . . . . 0.0 109.726 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.13 -33.95 86.16 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 107.957 -2.057 . . . . 0.0 107.957 178.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.489 ' O ' ' HB3' ' A' ' 31' ' ' LYS . 1.4 mt -89.54 19.58 4.48 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.61 -0.936 . . . . 0.0 109.426 179.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.5 ' O ' ' O ' ' A' ' 48' ' ' GLY . 0.4 OUTLIER 68.27 18.42 9.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.699 -0.625 . . . . 0.0 111.02 179.749 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.481 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . . . -92.31 74.77 5.31 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.913 -1.117 . . . . 0.0 109.78 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 32' ' ' ALA . 62.9 t0 -39.99 -70.48 0.1 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.415 -0.803 . . . . 0.0 110.677 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.17 86.25 1.06 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.508 -0.745 . . . . 0.0 110.192 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.522 ' CA ' ' SG ' ' A' ' 46' ' ' CYS . . . -121.15 98.73 0.67 Allowed Glycine 0 N--CA 1.488 2.102 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.496 ' OH ' ' CD2' ' A' ' 45' ' ' TYR . 53.1 p90 -126.42 153.64 44.73 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.353 -1.087 . . . . 0.0 109.855 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.1 OUTLIER -102.2 146.33 28.14 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.139 -0.976 . . . . 0.0 110.367 -179.638 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.608 ' CD1' ' HB2' ' A' ' 42' ' ' LEU . 25.8 t-105 -79.82 148.57 31.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.139 -0.976 . . . . 0.0 109.645 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -106.36 53.19 0.64 Allowed Glycine 0 N--CA 1.491 2.335 0 C-N-CA 119.615 -1.279 . . . . 0.0 110.204 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.529 ' HB3' ' CD1' ' A' ' 38' ' ' TRP . 30.9 t-105 -160.54 -83.08 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.255 -1.144 . . . . 0.0 110.021 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.515 ' OG1' ' CD1' ' A' ' 40' ' ' TRP . 72.6 p -155.25 38.54 0.4 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.407 -0.808 . . . . 0.0 110.354 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.608 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 0.4 OUTLIER -119.46 24.03 10.89 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.093 -1.004 . . . . 0.0 110.681 -179.847 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.53 ' CB ' HG12 ' A' ' 15' ' ' ILE . 90.5 p 45.52 -174.01 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.3 -0.875 . . . . 0.0 110.363 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.537 ' N ' ' HB2' ' A' ' 16' ' ' CYS . 25.3 t -71.87 171.97 10.75 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.184 -0.948 . . . . 0.0 109.261 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.496 ' CD2' ' OH ' ' A' ' 36' ' ' TYR . 1.1 t80 -158.26 100.95 1.71 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.999 -1.063 . . . . 0.0 111.001 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.522 ' SG ' ' CA ' ' A' ' 35' ' ' GLY . 85.9 m -121.05 137.2 54.76 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.353 -0.842 . . . . 0.0 109.533 179.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.451 ' OE1' ' N ' ' A' ' 47' ' ' GLN . 9.6 mp0 -121.87 148.11 45.14 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.163 -0.961 . . . . 0.0 110.35 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.5 ' O ' ' O ' ' A' ' 31' ' ' LYS . . . 100.05 27.18 7.94 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.592 ' CD1' ' CB ' ' A' ' 53' ' ' ALA . 0.2 OUTLIER -109.32 170.9 4.9 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.191 -1.182 . . . . 0.0 109.872 179.751 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.501 ' HD2' ' HB2' ' A' ' 49' ' ' LEU . 42.0 Cg_endo -68.43 158.35 58.01 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.689 1.363 . . . . 0.0 110.717 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -60.66 -22.61 64.04 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.332 -0.855 . . . . 0.0 110.173 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -85.38 11.73 9.71 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.243 -0.91 . . . . 0.0 109.94 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.592 ' CB ' ' CD1' ' A' ' 49' ' ' LEU . . . -62.16 135.82 57.67 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.304 -0.872 . . . . 0.0 110.548 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.488 ' NH1' ' O ' ' A' ' 9' ' ' TYR . 15.7 tpp85 -77.2 131.69 38.37 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.3 -0.875 . . . . 0.0 109.869 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.508 ' C ' ' CD1' ' A' ' 55' ' ' ILE . 1.3 pp -156.85 -173.24 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.276 -0.89 . . . . 0.0 110.303 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -45.89 93.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.212 -0.93 . . . . 0.0 110.608 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.479 ' N ' ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -112.6 22.39 14.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.333 -0.854 . . . . 0.0 109.856 179.604 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.87 -178.17 0.11 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.354 -0.841 . . . . 0.0 110.373 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.458 ' O ' ' O ' ' A' ' 60' ' ' ARG . . . 92.89 101.1 1.47 Allowed Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.529 ' O ' ' N ' ' A' ' 62' ' ' ARG . 2.8 ptm85 -50.73 -175.8 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.254 -1.145 . . . . 0.0 110.212 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.413 ' C ' ' O ' ' A' ' 60' ' ' ARG . 33.9 t -42.21 93.32 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.379 -0.825 . . . . 0.0 110.389 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.54 ' CB ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -84.07 43.66 0.95 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.339 -0.851 . . . . 0.0 110.481 -179.754 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.573 ' CB ' ' CD2' ' A' ' 10' ' ' TRP . . . . . . . . 0 N--CA 1.492 1.643 0 O-C-N 121.179 -0.95 . . . . 0.0 110.184 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . 0.463 ' HG2' ' O ' ' A' ' 1' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.491 0.662 . . . . 0.0 110.34 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.517 ' CG2' ' HG ' ' A' ' 49' ' ' LEU . 8.6 tt -120.44 160.58 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.384 -0.823 . . . . 0.0 110.075 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -142.7 144.28 32.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.328 -0.858 . . . . 0.0 110.096 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 179.83 -149.46 8.61 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.618 ' N ' ' CD1' ' A' ' 5' ' ' TYR . 12.4 m-85 -122.29 110.1 32.75 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.291 -1.123 . . . . 0.0 110.266 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.482 ' HB3' HG22 ' A' ' 55' ' ' ILE . 46.6 Cg_endo -73.95 128.76 12.63 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 124.055 1.555 . . . . 0.0 110.685 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.51 HG11 ' CG2' ' A' ' 15' ' ' ILE . 14.7 m -83.15 -175.87 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.283 -0.885 . . . . 0.0 110.156 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.439 ' O ' ' NH1' ' A' ' 54' ' ' ARG . 16.2 t70 -64.37 -117.54 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.171 -0.955 . . . . 0.0 109.582 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.592 ' HB3' ' CD2' ' A' ' 10' ' ' TRP . 2.0 t80 -119.62 -50.77 2.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.828 -1.17 . . . . 0.0 109.792 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.592 ' CD2' ' HB3' ' A' ' 9' ' ' TYR . 3.3 m-90 -106.08 21.32 17.53 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.233 -0.917 . . . . 0.0 109.709 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.484 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 42.5 m-20 59.5 12.33 2.71 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.388 -0.82 . . . . 0.0 110.167 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 6.8 m -67.21 -62.85 1.22 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.255 -0.903 . . . . 0.0 109.808 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.1 mmtp -73.58 -178.37 3.07 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.591 -0.693 . . . . 0.0 109.87 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.74 -174.58 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.131 -0.981 . . . . 0.0 110.059 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.51 ' CG2' HG11 ' A' ' 7' ' ' VAL . 20.2 mt -86.76 23.75 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.129 -0.982 . . . . 0.0 110.205 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.515 ' HB2' ' N ' ' A' ' 44' ' ' CYS . 14.4 t -160.16 165.53 31.45 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.239 -0.913 . . . . 0.0 110.595 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.468 ' N ' ' SG ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -115.8 -157.39 0.64 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.371 -0.831 . . . . 0.0 109.821 179.617 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -119.61 -3.79 10.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.211 -0.931 . . . . 0.0 109.989 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.559 ' HB2' ' CG ' ' A' ' 22' ' ' TYR . 0.7 OUTLIER -100.79 133.31 45.45 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.328 -0.858 . . . . 0.0 110.083 179.87 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -60.32 -45.93 91.68 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.194 -0.941 . . . . 0.0 110.641 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.33 -13.23 59.97 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.163 -0.961 . . . . 0.0 110.37 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.559 ' CG ' ' HB2' ' A' ' 19' ' ' ASN . 1.0 OUTLIER -66.66 -11.5 54.21 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.18 -0.95 . . . . 0.0 110.385 -179.771 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.467 ' O ' ' HB2' ' A' ' 27' ' ' CYS . 0.1 OUTLIER -118.73 -31.72 4.75 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.232 -0.917 . . . . 0.0 110.078 179.857 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.529 ' CA ' ' O ' ' A' ' 35' ' ' GLY . 2.0 t-20 -82.53 -49.17 10.19 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.224 -0.922 . . . . 0.0 109.47 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -54.99 -26.91 40.09 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.028 -1.045 . . . . 0.0 109.065 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.452 ' HG ' ' N ' ' A' ' 27' ' ' CYS . 0.1 OUTLIER -90.85 -46.87 7.94 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.646 -0.659 . . . . 0.0 109.486 179.628 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.471 ' SG ' ' HG3' ' A' ' 6' ' ' PRO . 7.7 m -60.05 -34.77 73.86 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.394 -0.816 . . . . 0.0 110.149 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.9 mmmt -61.55 -32.75 72.83 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.183 -0.948 . . . . 0.0 109.319 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.82 -30.98 78.77 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 107.24 -2.344 . . . . 0.0 107.24 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.529 ' O ' ' CD ' ' A' ' 50' ' ' PRO . 11.9 mt -89.69 20.35 4.1 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.777 -0.837 . . . . 0.0 109.261 178.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.49 ' HB3' ' O ' ' A' ' 30' ' ' LEU . 1.0 OUTLIER 66.95 16.5 10.37 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.661 -0.65 . . . . 0.0 110.695 -179.872 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.529 ' HB2' ' CD2' ' A' ' 49' ' ' LEU . . . -90.71 82.76 5.73 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.996 -1.065 . . . . 0.0 110.197 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 32' ' ' ALA . 26.0 t0 -43.25 -71.46 0.08 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.287 -0.883 . . . . 0.0 110.24 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.471 ' O ' ' HA ' ' A' ' 46' ' ' CYS . 0.0 OUTLIER -76.47 86.65 3.2 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.283 -0.886 . . . . 0.0 109.954 179.877 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.529 ' O ' ' CA ' ' A' ' 24' ' ' ASN . . . -125.6 87.69 0.36 Allowed Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.574 ' OH ' ' CZ3' ' A' ' 38' ' ' TRP . 29.4 p90 -130.59 153.91 48.4 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.957 -1.319 . . . . 0.0 109.624 179.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.53 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.1 OUTLIER -83.39 155.21 23.61 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.191 -0.943 . . . . 0.0 111.464 -178.686 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.587 ' CG ' ' HB2' ' A' ' 42' ' ' LEU . 2.5 t-105 -79.45 140.26 37.4 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.3 -21.09 63.18 Favored Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.662 -1.256 . . . . 0.0 110.861 -178.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.495 ' CD1' HG21 ' A' ' 41' ' ' THR . 49.4 t-105 -79.4 -77.19 0.18 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.884 -1.363 . . . . 0.0 109.847 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.495 HG21 ' CD1' ' A' ' 40' ' ' TRP . 13.5 t -178.14 43.92 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.478 -0.764 . . . . 0.0 109.704 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.587 ' HB2' ' CG ' ' A' ' 38' ' ' TRP . 0.8 OUTLIER -109.47 36.72 2.84 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.222 -0.924 . . . . 0.0 110.578 -179.524 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.481 ' CB ' ' HB ' ' A' ' 15' ' ' ILE . 74.6 m 52.69 -174.32 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.166 -0.958 . . . . 0.0 110.323 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.53 ' HA ' ' HA ' ' A' ' 37' ' ' CYS . 15.9 t -77.97 161.09 27.78 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.218 -0.926 . . . . 0.0 110.081 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -144.1 110.38 5.47 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.088 -1.007 . . . . 0.0 111.215 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.529 ' SG ' ' CA ' ' A' ' 35' ' ' GLY . 60.0 m -130.15 134.65 47.46 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.324 -0.86 . . . . 0.0 109.263 178.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -127.42 143.7 51.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.128 -0.983 . . . . 0.0 110.508 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 31' ' ' LYS . . . 103.81 26.93 6.53 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.592 ' CD1' ' CB ' ' A' ' 53' ' ' ALA . 0.2 OUTLIER -105.62 169.39 7.06 Favored Pre-proline 0 N--CA 1.495 1.813 0 O-C-N 121.267 -1.137 . . . . 0.0 110.052 179.743 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.529 ' CD ' ' O ' ' A' ' 30' ' ' LEU . 48.2 Cg_endo -74.51 161.67 39.5 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.671 1.353 . . . . 0.0 110.397 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -59.99 -20.61 58.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.311 -0.868 . . . . 0.0 109.906 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.405 ' O ' ' CG ' ' A' ' 52' ' ' ASN . 6.1 t-20 -81.73 5.13 19.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.383 -0.823 . . . . 0.0 110.009 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.592 ' CB ' ' CD1' ' A' ' 49' ' ' LEU . . . -53.68 153.32 4.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.236 -0.915 . . . . 0.0 110.2 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.475 ' O ' HG22 ' A' ' 55' ' ' ILE . 35.2 ttp85 -105.05 91.18 3.69 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.228 -0.92 . . . . 0.0 110.312 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.555 ' CD1' ' N ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -149.17 157.87 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.259 -0.901 . . . . 0.0 110.149 179.842 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.433 ' C ' ' O ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER 41.63 53.79 3.83 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.417 -0.802 . . . . 0.0 110.283 179.843 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.408 ' O ' ' HB3' ' A' ' 58' ' ' SER . 0.0 OUTLIER -97.21 -20.48 17.9 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.33 -0.857 . . . . 0.0 109.899 179.915 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.473 ' OG ' ' N ' ' A' ' 59' ' ' GLY . 0.1 OUTLIER 60.74 -176.68 0.11 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.537 -0.727 . . . . 0.0 110.273 179.844 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.473 ' N ' ' OG ' ' A' ' 58' ' ' SER . . . 110.34 -177.89 19.77 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.9 ptm180 -107.09 -177.16 3.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.153 -1.204 . . . . 0.0 110.245 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -48.71 124.06 7.82 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.201 -0.937 . . . . 0.0 110.105 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.515 ' CB ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -81.64 47.11 1.03 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.264 -0.897 . . . . 0.0 110.463 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.642 0 O-C-N 121.258 -0.901 . . . . 0.0 110.245 179.882 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.262 0.553 . . . . 0.0 110.244 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.526 ' CG2' ' HG ' ' A' ' 49' ' ' LEU . 17.1 tt -119.97 164.32 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.205 -0.934 . . . . 0.0 110.341 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -143.79 126.39 15.98 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.327 -0.858 . . . . 0.0 109.722 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -168.93 -155.97 10.17 Favored Glycine 0 N--CA 1.492 2.396 0 C-N-CA 119.561 -1.304 . . . . 0.0 110.041 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.57 ' CD1' ' O ' ' A' ' 42' ' ' LEU . 77.2 m-85 -111.7 106.83 56.71 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.304 -1.115 . . . . 0.0 110.706 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.522 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 49.8 Cg_endo -78.91 113.37 3.24 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.957 1.504 . . . . 0.0 109.907 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.492 ' O ' ' NH1' ' A' ' 54' ' ' ARG . 15.5 m -94.04 -169.11 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.012 -1.055 . . . . 0.0 111.05 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.433 ' OD2' ' CB ' ' A' ' 14' ' ' ARG . 9.9 t0 -59.53 -152.23 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.433 -0.792 . . . . 0.0 110.53 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.45 ' HB2' ' CE2' ' A' ' 10' ' ' TRP . 22.0 m-85 -98.84 -11.8 21.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.365 -0.834 . . . . 0.0 110.582 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.535 ' HB3' ' CB ' ' A' ' 62' ' ' ARG . 0.3 OUTLIER -130.22 4.26 4.79 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.03 -1.044 . . . . 0.0 109.74 -179.872 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.509 ' N ' ' OD1' ' A' ' 11' ' ' ASN . 1.6 m120 57.13 16.12 2.8 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.253 -0.905 . . . . 0.0 109.531 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 5.5 t -70.59 -64.04 0.98 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.365 -0.835 . . . . 0.0 110.504 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.495 ' O ' ' CD ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -161.52 82.6 0.61 Allowed 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.259 -0.901 . . . . 0.0 110.502 -179.565 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.437 ' CB ' ' O ' ' A' ' 13' ' ' LYS . 2.0 mtt180 173.06 35.06 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.392 -0.818 . . . . 0.0 109.795 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.534 ' CD1' ' HB2' ' A' ' 43' ' ' SER . 46.6 pt -54.25 -30.26 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.439 -0.788 . . . . 0.0 110.69 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.492 ' N ' HG13 ' A' ' 15' ' ' ILE . 8.5 t -139.36 129.33 24.99 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.137 -0.977 . . . . 0.0 110.589 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.427 ' CE3' ' HB3' ' A' ' 22' ' ' TYR . 0.0 OUTLIER -73.24 170.17 15.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.361 -0.837 . . . . 0.0 110.067 179.785 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -88.23 55.0 3.26 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.318 -0.864 . . . . 0.0 110.075 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.608 ' ND2' ' CE1' ' A' ' 22' ' ' TYR . 2.2 t-20 -165.52 156.28 13.67 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.338 -0.852 . . . . 0.0 110.032 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.422 ' C ' ' OD1' ' A' ' 20' ' ' ASN . 49.7 p30 -87.38 -1.58 58.02 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.226 -0.921 . . . . 0.0 110.266 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.37 -6.02 4.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.19 -0.944 . . . . 0.0 110.586 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.608 ' CE1' ' ND2' ' A' ' 19' ' ' ASN . 3.1 m-30 -59.69 -69.41 0.21 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.1 -1.0 . . . . 0.0 110.247 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.4 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 6.0 p -69.37 -6.36 29.39 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.98 -1.075 . . . . 0.0 109.852 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.539 ' CB ' ' O ' ' A' ' 35' ' ' GLY . 64.3 t30 -75.71 -61.06 2.05 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.388 -0.82 . . . . 0.0 109.506 179.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -49.25 -48.56 45.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.41 -0.806 . . . . 0.0 109.733 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.52 ' HG ' ' N ' ' A' ' 27' ' ' CYS . 0.1 OUTLIER -64.52 -37.35 87.24 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.307 -0.87 . . . . 0.0 109.088 179.423 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.52 ' N ' ' HG ' ' A' ' 26' ' ' LEU . 1.3 m -61.86 -39.26 91.24 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.244 -0.91 . . . . 0.0 109.281 179.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.76 -31.49 69.71 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.466 -0.771 . . . . 0.0 109.55 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.64 -36.9 91.28 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 108.304 -1.919 . . . . 0.0 108.304 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.554 ' O ' ' CB ' ' A' ' 31' ' ' LYS . 6.9 mt -87.69 17.58 4.61 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.535 -0.979 . . . . 0.0 109.746 179.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.554 ' CB ' ' O ' ' A' ' 30' ' ' LEU . 0.7 OUTLIER 78.83 11.27 1.58 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.711 -0.618 . . . . 0.0 110.79 179.991 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.528 ' HB3' ' CD2' ' A' ' 49' ' ' LEU . . . -95.04 84.16 4.07 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.959 -1.088 . . . . 0.0 109.812 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -54.09 -73.78 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.279 -0.888 . . . . 0.0 111.143 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.483 ' HB3' ' CG ' ' A' ' 47' ' ' GLN . 23.2 t -66.87 92.37 0.23 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.386 -0.821 . . . . 0.0 110.663 -179.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.539 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -129.4 88.12 0.31 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.58 ' CZ ' ' HB3' ' A' ' 45' ' ' TYR . 11.1 p90 -99.57 -175.93 3.13 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.165 -1.197 . . . . 0.0 110.422 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.51 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.1 OUTLIER -131.91 131.45 42.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.122 -0.986 . . . . 0.0 110.73 -179.656 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.584 ' CD1' ' HB2' ' A' ' 42' ' ' LEU . 1.9 t-105 -86.87 122.33 30.58 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.299 -0.875 . . . . 0.0 109.839 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.6 -10.14 86.13 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.565 ' HB3' ' CD1' ' A' ' 38' ' ' TRP . 41.1 t-105 -79.77 -92.9 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.207 -1.172 . . . . 0.0 110.095 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.501 ' CG2' ' C ' ' A' ' 40' ' ' TRP . 14.4 p -152.94 54.47 0.77 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.037 -1.039 . . . . 0.0 110.039 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.584 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 6.0 mt -132.3 8.76 4.34 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.203 -0.936 . . . . 0.0 110.813 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.534 ' HB2' ' CD1' ' A' ' 15' ' ' ILE . 1.4 t 56.77 -174.4 0.07 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.956 -1.09 . . . . 0.0 109.869 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.51 ' HA ' ' HA ' ' A' ' 37' ' ' CYS . 15.3 t -72.26 156.53 39.03 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.106 -0.996 . . . . 0.0 109.186 179.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.58 ' HB3' ' CZ ' ' A' ' 36' ' ' TYR . 67.4 t80 -138.04 113.85 9.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.113 -0.992 . . . . 0.0 110.478 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.525 ' HA ' ' HA2' ' A' ' 35' ' ' GLY . 62.5 m -125.28 138.93 54.09 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.207 -0.933 . . . . 0.0 109.735 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.483 ' CG ' ' HB3' ' A' ' 34' ' ' SER . 0.0 OUTLIER -118.16 137.65 52.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.359 -0.838 . . . . 0.0 110.072 -179.949 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 31' ' ' LYS . . . 102.22 32.51 4.91 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.608 ' CD2' ' N ' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -101.46 -177.27 0.54 Allowed Pre-proline 0 N--CA 1.496 1.865 0 O-C-N 121.185 -1.185 . . . . 0.0 109.303 179.646 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.506 ' HD2' ' HB2' ' A' ' 49' ' ' LEU . 47.6 Cg_endo -85.12 161.11 11.55 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 O-C-N 123.619 1.326 . . . . 0.0 110.123 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -59.53 -19.95 51.99 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.1 -1.0 . . . . 0.0 109.883 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -96.25 19.54 11.74 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.372 -0.83 . . . . 0.0 109.695 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.476 ' HB2' ' O ' ' A' ' 50' ' ' PRO . . . -53.79 134.01 42.31 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.346 -0.846 . . . . 0.0 110.562 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.551 ' HB3' ' CZ ' ' A' ' 54' ' ' ARG . 1.3 ttm105 -71.71 87.49 0.96 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.298 -0.876 . . . . 0.0 109.976 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.531 ' O ' ' N ' ' A' ' 57' ' ' ARG . 1.9 pp -124.34 -166.41 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.062 -1.024 . . . . 0.0 110.626 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.468 ' O ' ' HG3' ' A' ' 56' ' ' LYS . 0.4 OUTLIER -61.39 70.41 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.486 -0.758 . . . . 0.0 110.837 -179.555 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.531 ' N ' ' O ' ' A' ' 55' ' ' ILE . 9.1 tpp85 -114.79 -16.03 11.81 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.074 -1.016 . . . . 0.0 109.799 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.9 132.02 46.24 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.419 -0.801 . . . . 0.0 109.984 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -107.77 33.42 6.32 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.428 ' HG2' ' O ' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -122.77 107.4 11.86 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.276 -1.132 . . . . 0.0 110.28 179.954 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 2.6 t -50.74 107.52 0.18 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.288 -0.882 . . . . 0.0 109.882 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.535 ' CB ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -87.32 48.61 1.67 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.324 -0.86 . . . . 0.0 110.375 179.973 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.152 -0.967 . . . . 0.0 110.228 -179.99 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 13.3 tttm . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.178 0.513 . . . . 0.0 110.219 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.508 HG21 HD13 ' A' ' 2' ' ' ILE . 4.5 tt -146.93 159.85 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.334 -0.854 . . . . 0.0 110.1 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.517 ' HB3' ' CG ' ' A' ' 47' ' ' GLN . 65.8 m-20 -131.14 136.2 48.14 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.347 -0.845 . . . . 0.0 109.873 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 178.77 -160.8 26.8 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.606 ' CE2' ' CD1' ' A' ' 45' ' ' TYR . 15.0 m-85 -109.28 109.25 60.46 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.305 -1.115 . . . . 0.0 110.256 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.51 ' CG ' ' SG ' ' A' ' 27' ' ' CYS . 49.4 Cg_endo -80.51 108.09 2.09 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.928 1.489 . . . . 0.0 110.9 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.414 HG21 ' OD1' ' A' ' 11' ' ' ASN . 17.0 m -83.49 -170.59 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.228 -0.92 . . . . 0.0 109.83 179.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -70.65 -118.23 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.111 -0.993 . . . . 0.0 109.827 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -115.94 -55.06 2.45 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.816 -1.177 . . . . 0.0 110.073 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.543 ' HB3' ' CB ' ' A' ' 62' ' ' ARG . 3.0 m-90 -99.6 15.23 27.32 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.24 -0.913 . . . . 0.0 110.121 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.475 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 5.1 m-20 59.4 12.74 2.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.219 -0.925 . . . . 0.0 110.067 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.8 t -90.89 -28.68 17.96 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.277 -0.889 . . . . 0.0 110.43 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.489 ' O ' ' CB ' ' A' ' 14' ' ' ARG . 4.5 mmtp -86.79 41.38 0.95 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.272 -0.892 . . . . 0.0 110.619 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.489 ' CB ' ' O ' ' A' ' 13' ' ' LYS . 0.1 OUTLIER 69.03 141.6 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.159 -0.963 . . . . 0.0 110.536 179.787 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.424 HG22 HD12 ' A' ' 15' ' ' ILE . 6.9 pt -74.48 -6.29 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.376 -0.828 . . . . 0.0 110.104 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.495 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 4.4 t -148.25 153.99 39.46 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.267 -0.896 . . . . 0.0 110.257 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.456 ' CE3' ' HB3' ' A' ' 22' ' ' TYR . 0.2 OUTLIER -86.56 -161.99 0.72 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.359 -0.838 . . . . 0.0 110.105 179.886 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.471 ' CD1' ' O ' ' A' ' 18' ' ' TYR . 9.3 t80 -106.61 -25.85 11.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.283 -0.886 . . . . 0.0 110.118 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -93.36 152.7 18.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.329 -0.857 . . . . 0.0 110.165 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 -81.99 -9.02 59.7 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.173 -0.954 . . . . 0.0 110.214 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.424 ' O ' ' N ' ' A' ' 24' ' ' ASN . 13.8 tttp -105.41 -39.59 6.09 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.181 -0.949 . . . . 0.0 110.07 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.456 ' HB3' ' CE3' ' A' ' 17' ' ' TRP . 1.5 m-85 -44.65 -33.63 1.89 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.296 -0.878 . . . . 0.0 110.259 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.474 ' O ' ' HB2' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -78.32 -28.53 47.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.278 -0.889 . . . . 0.0 110.008 -179.993 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.511 ' OD1' ' NZ ' ' A' ' 28' ' ' LYS . 0.3 OUTLIER -68.98 -41.31 78.05 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.399 -0.813 . . . . 0.0 109.305 179.465 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.2 -43.04 99.73 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.377 -0.827 . . . . 0.0 110.055 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.478 ' C ' ' CD1' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -74.56 -42.68 58.37 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.318 -0.864 . . . . 0.0 109.591 179.74 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.51 ' SG ' ' CG ' ' A' ' 6' ' ' PRO . 1.5 m -61.09 -30.78 70.55 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.293 -0.879 . . . . 0.0 109.303 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.545 ' CA ' ' HE3' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -65.43 -27.42 68.51 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.17 -0.956 . . . . 0.0 108.87 178.572 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.94 -34.52 89.13 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 107.197 -2.361 . . . . 0.0 107.197 178.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.533 ' O ' ' CD ' ' A' ' 50' ' ' PRO . 53.1 mt -91.01 22.03 3.9 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.763 -0.845 . . . . 0.0 109.16 178.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.488 ' O ' ' O ' ' A' ' 48' ' ' GLY . 0.0 OUTLIER 60.48 22.53 12.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.611 -0.681 . . . . 0.0 110.653 179.907 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.521 ' O ' ' CE ' ' A' ' 28' ' ' LYS . . . -86.15 86.4 7.35 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.984 -1.072 . . . . 0.0 109.995 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.533 ' O ' ' NZ ' ' A' ' 28' ' ' LYS . 6.7 t70 -40.28 -86.62 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.498 -0.751 . . . . 0.0 110.597 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.9 m -69.99 93.65 0.8 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.993 -1.067 . . . . 0.0 110.058 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.544 ' CA ' ' SG ' ' A' ' 46' ' ' CYS . . . -128.72 112.77 1.45 Allowed Glycine 0 N--CA 1.487 2.099 0 C-N-CA 119.638 -1.268 . . . . 0.0 110.018 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -148.21 159.97 43.41 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.273 -1.134 . . . . 0.0 109.985 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.48 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.1 OUTLIER -93.32 146.15 23.93 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.153 -0.967 . . . . 0.0 110.684 -179.599 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.513 ' CD1' ' HB2' ' A' ' 42' ' ' LEU . 8.7 t-105 -79.55 111.06 15.45 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.238 -0.914 . . . . 0.0 109.439 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -66.2 61.25 0.16 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 -179.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.545 ' CD1' HG22 ' A' ' 41' ' ' THR . 14.7 t-105 -160.94 -69.67 0.06 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.329 -1.1 . . . . 0.0 109.453 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.545 HG22 ' CD1' ' A' ' 40' ' ' TRP . 11.8 t -179.91 33.42 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.586 -0.696 . . . . 0.0 109.588 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.513 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 0.3 OUTLIER -109.46 30.83 6.26 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.293 -0.88 . . . . 0.0 111.013 -179.433 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.495 ' HA ' ' HB2' ' A' ' 16' ' ' CYS . 6.1 p 48.29 -175.3 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.934 -1.104 . . . . 0.0 110.235 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.5 ' O ' ' HA ' ' A' ' 5' ' ' TYR . 14.7 t -78.55 140.47 38.51 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.259 -0.901 . . . . 0.0 109.366 179.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.606 ' CD1' ' CE2' ' A' ' 5' ' ' TYR . 4.7 t80 -128.94 118.77 23.18 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.053 -1.029 . . . . 0.0 110.696 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.544 ' SG ' ' CA ' ' A' ' 35' ' ' GLY . 63.1 m -136.17 152.18 50.53 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.488 -0.758 . . . . 0.0 109.719 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.517 ' CG ' ' HB3' ' A' ' 3' ' ' ASP . 1.6 mt-30 -134.83 147.24 49.88 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.142 -0.973 . . . . 0.0 110.701 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.488 ' O ' ' O ' ' A' ' 31' ' ' LYS . . . 97.98 30.05 7.31 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.534 ' CD2' ' N ' ' A' ' 49' ' ' LEU . 0.1 OUTLIER -108.07 170.9 5.04 Favored Pre-proline 0 N--CA 1.498 1.963 0 O-C-N 121.158 -1.201 . . . . 0.0 109.77 179.66 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.533 ' CD ' ' O ' ' A' ' 30' ' ' LEU . 42.7 Cg_endo -68.93 157.85 60.25 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.692 1.364 . . . . 0.0 110.917 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -59.37 -24.02 63.06 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.379 -0.825 . . . . 0.0 110.008 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -86.46 14.18 7.17 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.335 -0.853 . . . . 0.0 109.783 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.494 ' CB ' HD13 ' A' ' 49' ' ' LEU . . . -56.86 113.69 1.77 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.459 -0.776 . . . . 0.0 110.86 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.481 ' O ' ' HA ' ' A' ' 6' ' ' PRO . 6.7 ttm-85 -59.9 116.39 4.08 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.252 -0.905 . . . . 0.0 109.645 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.509 ' HA ' ' HA ' ' A' ' 6' ' ' PRO . 1.8 pp -140.19 178.06 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.074 -1.016 . . . . 0.0 111.004 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 55' ' ' ILE . 0.1 OUTLIER -41.81 93.74 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.529 -0.732 . . . . 0.0 110.736 -179.566 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.506 ' N ' ' O ' ' A' ' 55' ' ' ILE . 11.6 ttp180 -119.73 -18.91 8.2 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.294 -0.879 . . . . 0.0 109.782 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.32 155.9 35.96 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.367 -0.833 . . . . 0.0 110.148 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -118.13 14.71 12.31 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.424 ' O ' ' C ' ' A' ' 61' ' ' CYS . 4.6 mpt_? -99.39 98.95 9.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.431 -1.04 . . . . 0.0 110.205 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.424 ' C ' ' O ' ' A' ' 60' ' ' ARG . 4.5 t -40.05 109.76 0.12 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.507 -0.746 . . . . 0.0 110.096 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.543 ' CB ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -90.52 52.0 2.12 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.279 -0.888 . . . . 0.0 110.329 -179.808 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.604 0 O-C-N 121.22 -0.925 . . . . 0.0 110.219 179.977 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 20.7 mttt . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.251 0.548 . . . . 0.0 110.235 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.469 HG12 ' N ' ' A' ' 3' ' ' ASP . 6.9 tt -134.34 165.11 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.414 -0.804 . . . . 0.0 109.943 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.469 ' N ' HG12 ' A' ' 2' ' ' ILE . 1.0 OUTLIER -135.2 128.6 32.29 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.308 -0.87 . . . . 0.0 110.107 179.895 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -167.56 -176.26 38.12 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.794 -1.323 . . . . 0.0 109.794 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.521 ' N ' ' CD1' ' A' ' 5' ' ' TYR . 6.1 m-30 -99.07 109.58 54.7 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.296 -1.12 . . . . 0.0 110.407 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.549 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 48.8 Cg_endo -78.89 129.56 9.09 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.934 1.491 . . . . 0.0 110.277 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.475 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . 30.1 m -93.46 -170.25 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.125 -0.985 . . . . 0.0 110.185 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.504 ' CB ' ' HB2' ' A' ' 13' ' ' LYS . 7.9 t70 -74.68 -89.36 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.319 -0.863 . . . . 0.0 109.792 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.657 ' CZ ' ' CH2' ' A' ' 10' ' ' TRP . 24.5 t80 -138.32 -75.11 0.39 Allowed 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.308 -0.87 . . . . 0.0 109.611 179.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.657 ' CH2' ' CZ ' ' A' ' 9' ' ' TYR . 0.0 OUTLIER -89.62 23.02 2.78 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.447 -0.783 . . . . 0.0 109.386 179.322 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.483 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 3.7 m120 61.18 24.17 14.3 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.83 -0.543 . . . . 0.0 110.834 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.505 ' HA ' ' HB2' ' A' ' 61' ' ' CYS . 48.3 t -93.25 -37.46 12.05 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.986 -1.071 . . . . 0.0 110.43 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.504 ' HB2' ' CB ' ' A' ' 8' ' ' ASP . 54.4 mmtt -85.08 44.1 1.06 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.282 -0.886 . . . . 0.0 109.894 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' A' ' 13' ' ' LYS . 1.3 tpp180 54.73 165.13 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.307 -0.871 . . . . 0.0 110.152 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.502 ' CG2' ' HB3' ' A' ' 43' ' ' SER . 7.7 tt -84.1 1.29 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.326 -0.859 . . . . 0.0 110.423 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.501 ' HB2' ' N ' ' A' ' 44' ' ' CYS . 33.7 t -142.44 127.19 18.12 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.268 -0.895 . . . . 0.0 110.424 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -69.22 -149.49 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.265 -0.897 . . . . 0.0 110.337 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -140.08 40.45 1.95 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.146 -0.971 . . . . 0.0 110.313 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -149.25 162.72 39.46 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.328 -0.858 . . . . 0.0 109.914 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 25.1 m-20 -88.7 30.25 0.93 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.13 -0.981 . . . . 0.0 109.915 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -156.09 -39.98 0.08 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.396 -0.815 . . . . 0.0 109.764 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -45.97 -27.58 0.94 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.243 -0.91 . . . . 0.0 110.008 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -100.0 -50.97 3.82 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.292 -0.88 . . . . 0.0 110.104 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.508 ' N ' ' OD1' ' A' ' 24' ' ' ASN . 1.4 m-20 -55.42 -60.07 3.93 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.376 -0.828 . . . . 0.0 109.95 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 24' ' ' ASN . 6.8 t0 -42.99 -51.54 5.6 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.223 -0.923 . . . . 0.0 110.378 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.6 mt -65.16 -42.72 93.47 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.201 -0.937 . . . . 0.0 110.46 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.465 ' SG ' ' HG3' ' A' ' 6' ' ' PRO . 2.4 m -61.18 -39.62 90.82 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.388 -0.82 . . . . 0.0 110.478 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.477 ' HD3' ' HA ' ' A' ' 33' ' ' ASP . 0.5 OUTLIER -60.82 -31.87 71.26 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.284 -0.885 . . . . 0.0 109.602 179.954 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.28 -28.27 73.38 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 107.993 -2.043 . . . . 0.0 107.993 179.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.54 ' O ' ' CD ' ' A' ' 50' ' ' PRO . 13.5 mt -92.42 19.52 7.11 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.691 -0.888 . . . . 0.0 109.127 178.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.508 ' HB3' ' O ' ' A' ' 30' ' ' LEU . 28.7 tptt 72.93 15.02 4.71 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.694 -0.629 . . . . 0.0 110.939 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.454 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . . . -99.96 55.87 0.94 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.866 -1.146 . . . . 0.0 109.667 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 34' ' ' SER . 17.9 p30 -40.29 -30.05 0.09 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.462 -0.773 . . . . 0.0 110.649 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.493 ' N ' ' OD1' ' A' ' 33' ' ' ASP . 70.2 p -91.09 62.77 4.92 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.244 -0.91 . . . . 0.0 110.368 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.458 ' HA2' ' SG ' ' A' ' 46' ' ' CYS . . . -104.64 134.44 12.0 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.539 ' CD1' ' O ' ' A' ' 36' ' ' TYR . 29.3 p90 -160.17 129.74 5.18 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.394 -1.062 . . . . 0.0 109.39 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.517 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.0 OUTLIER -89.74 136.32 33.1 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.162 -0.961 . . . . 0.0 110.994 -179.059 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.567 ' CD1' ' HB2' ' A' ' 42' ' ' LEU . 4.6 t-105 -80.35 111.05 16.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.302 -0.874 . . . . 0.0 109.448 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -61.63 -10.96 26.87 Favored Glycine 0 N--CA 1.49 2.277 0 C-N-CA 120.434 -0.888 . . . . 0.0 110.943 -178.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.522 ' HB3' ' CD1' ' A' ' 38' ' ' TRP . 16.7 t-105 -79.66 -78.43 0.16 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.793 -1.416 . . . . 0.0 110.249 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.411 HG22 ' CD1' ' A' ' 40' ' ' TRP . 5.8 t -173.46 38.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.27 -0.894 . . . . 0.0 109.714 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.567 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 0.3 OUTLIER -110.04 24.66 12.72 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.245 -0.909 . . . . 0.0 110.414 -179.679 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.502 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 7.7 m 54.53 -176.55 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.049 -1.032 . . . . 0.0 109.827 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.517 ' HA ' ' HA ' ' A' ' 37' ' ' CYS . 7.4 t -76.64 151.82 36.05 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.178 -0.951 . . . . 0.0 109.131 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.523 ' HB3' ' CZ ' ' A' ' 36' ' ' TYR . 0.8 OUTLIER -138.58 104.74 5.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.866 -1.146 . . . . 0.0 111.378 -179.632 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.458 ' SG ' ' HA2' ' A' ' 35' ' ' GLY . 63.8 m -121.02 140.66 51.62 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.397 -0.814 . . . . 0.0 109.393 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.446 ' HA ' HD22 ' A' ' 49' ' ' LEU . 14.6 mt-30 -129.92 149.43 51.66 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.107 -0.996 . . . . 0.0 110.407 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 31' ' ' LYS . . . 97.62 24.84 11.49 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.5 ' CD1' ' CB ' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -103.09 172.1 4.58 Favored Pre-proline 0 N--CA 1.499 2.019 0 O-C-N 121.279 -1.13 . . . . 0.0 109.444 179.438 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.54 ' CD ' ' O ' ' A' ' 30' ' ' LEU . 41.9 Cg_endo -68.57 154.44 71.59 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 O-C-N 123.335 1.176 . . . . 0.0 110.352 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -58.28 -21.98 50.91 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.325 -0.86 . . . . 0.0 110.191 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 16.6 t30 -86.44 11.71 11.88 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.306 -0.871 . . . . 0.0 110.085 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.5 ' CB ' ' CD1' ' A' ' 49' ' ' LEU . . . -52.71 143.89 15.31 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.446 -0.783 . . . . 0.0 110.669 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.499 ' NH1' ' O ' ' A' ' 8' ' ' ASP . 1.2 ttm105 -88.54 116.72 26.98 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.365 -0.834 . . . . 0.0 109.996 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.549 ' HA ' ' HA ' ' A' ' 6' ' ' PRO . 1.3 pp -139.24 -164.74 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.188 -0.945 . . . . 0.0 110.733 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.498 ' HG3' ' CD1' ' A' ' 15' ' ' ILE . 0.3 OUTLIER -36.24 96.12 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 121.371 0.605 . . . . 0.0 111.107 -179.414 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.456 ' N ' ' O ' ' A' ' 55' ' ' ILE . 8.3 ttm-85 -110.1 -20.02 12.84 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.376 -0.828 . . . . 0.0 109.762 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.8 m -166.32 162.59 17.32 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.412 -0.805 . . . . 0.0 110.056 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -114.61 45.75 1.27 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.439 ' O ' ' HB2' ' A' ' 11' ' ' ASN . 7.7 ptm180 -137.17 172.15 13.42 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.162 -1.199 . . . . 0.0 110.485 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.505 ' HB2' ' HA ' ' A' ' 12' ' ' CYS . 0.5 OUTLIER -116.7 103.26 10.18 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.402 -0.811 . . . . 0.0 109.695 179.993 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.624 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -85.53 28.77 0.73 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.888 -1.132 . . . . 0.0 110.547 179.766 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.124 -0.985 . . . . 0.0 110.283 -179.949 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 9.8 ptpt . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.221 0.534 . . . . 0.0 110.193 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.521 ' CG2' ' HG ' ' A' ' 49' ' ' LEU . 19.3 tt -131.18 160.56 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.322 -0.861 . . . . 0.0 110.056 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 3' ' ' ASP . 5.0 p-10 -134.52 127.5 31.48 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.381 -0.824 . . . . 0.0 109.654 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -177.32 -172.86 42.3 Favored Glycine 0 N--CA 1.49 2.286 0 C-N-CA 119.253 -1.451 . . . . 0.0 110.21 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.603 ' N ' ' CD1' ' A' ' 5' ' ' TYR . 3.2 m-30 -102.36 113.36 65.91 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.438 -1.036 . . . . 0.0 110.088 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.478 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 46.3 Cg_endo -75.15 142.48 27.47 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.815 1.429 . . . . 0.0 110.452 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.472 HG12 ' O ' ' A' ' 6' ' ' PRO . 30.0 m -141.08 -170.18 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.35 -0.843 . . . . 0.0 110.149 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.513 ' OD2' ' N ' ' A' ' 12' ' ' CYS . 21.3 p-10 -69.45 -148.29 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.234 -0.916 . . . . 0.0 109.979 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.577 ' HB3' ' CD2' ' A' ' 10' ' ' TRP . 6.3 t80 -98.82 -14.9 19.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.197 -0.939 . . . . 0.0 110.316 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.577 ' CD2' ' HB3' ' A' ' 9' ' ' TYR . 7.9 m-90 -133.32 24.04 4.12 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.227 -0.921 . . . . 0.0 110.252 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.477 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 2.4 m-20 59.41 13.78 3.4 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.192 -0.942 . . . . 0.0 110.166 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.513 ' N ' ' OD2' ' A' ' 8' ' ' ASP . 71.5 m -83.0 -77.17 0.25 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.299 -0.876 . . . . 0.0 110.82 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.437 ' O ' ' HB3' ' A' ' 14' ' ' ARG . 14.6 mttt -95.51 -167.83 1.68 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.368 -0.833 . . . . 0.0 111.076 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.542 ' O ' ' N ' ' A' ' 16' ' ' CYS . 16.8 tpp180 58.57 -106.0 0.28 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.48 -0.763 . . . . 0.0 110.45 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.518 ' CG2' ' OG ' ' A' ' 43' ' ' SER . 78.0 mt 57.19 -81.7 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.08 -1.012 . . . . 0.0 109.914 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.542 ' N ' ' O ' ' A' ' 14' ' ' ARG . 40.3 t -137.37 115.21 11.41 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.41 -0.806 . . . . 0.0 110.19 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -66.7 -149.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.214 -0.928 . . . . 0.0 109.939 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.57 59.25 1.55 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.122 -0.986 . . . . 0.0 110.14 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.53 ' CB ' ' HB2' ' A' ' 22' ' ' TYR . 1.1 m-80 -159.15 -177.86 6.79 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.276 -0.89 . . . . 0.0 110.091 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -90.74 -41.03 11.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.281 -0.887 . . . . 0.0 110.854 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.6 mtmp? -110.63 -1.12 16.95 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.132 -0.98 . . . . 0.0 110.811 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.53 ' HB2' ' CB ' ' A' ' 19' ' ' ASN . 1.2 m-85 -56.5 -52.36 65.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.057 -1.027 . . . . 0.0 109.986 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.4 t -78.03 -14.84 59.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.271 -0.893 . . . . 0.0 110.14 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.527 ' O ' ' CG ' ' A' ' 28' ' ' LYS . 9.6 t-20 -76.49 -41.45 46.97 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.259 -0.901 . . . . 0.0 110.006 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.1 -40.27 89.07 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.199 -0.938 . . . . 0.0 109.766 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -74.23 -45.06 50.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.325 -0.859 . . . . 0.0 109.954 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.464 ' SG ' ' HG3' ' A' ' 6' ' ' PRO . 1.2 m -60.85 -45.03 96.12 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.339 -0.851 . . . . 0.0 109.615 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.527 ' CG ' ' O ' ' A' ' 24' ' ' ASN . 2.2 mmmt -59.65 -31.08 69.19 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.334 -0.854 . . . . 0.0 109.323 179.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -56.57 -35.58 67.39 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 108.851 -1.699 . . . . 0.0 108.851 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.695 ' O ' ' CB ' ' A' ' 31' ' ' LYS . 10.5 mt -81.65 -28.91 33.38 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.387 -1.067 . . . . 0.0 109.617 179.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.695 ' CB ' ' O ' ' A' ' 30' ' ' LEU . 10.0 tttt 131.54 5.82 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.748 0 C-N-CA 123.528 0.731 . . . . 0.0 109.839 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.474 ' HB2' ' CD2' ' A' ' 49' ' ' LEU . . . -82.73 113.1 20.16 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.901 -1.124 . . . . 0.0 110.226 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.514 ' HA ' ' CD ' ' A' ' 28' ' ' LYS . 0.2 OUTLIER -73.66 -62.41 1.5 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.308 -0.87 . . . . 0.0 110.134 179.893 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -80.45 82.84 6.38 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.399 -0.813 . . . . 0.0 109.996 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.531 ' CA ' ' SG ' ' A' ' 46' ' ' CYS . . . -121.06 104.07 0.93 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.562 ' OH ' ' CD2' ' A' ' 45' ' ' TYR . 41.4 p90 -126.35 -177.16 3.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.178 -1.19 . . . . 0.0 109.794 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.1 OUTLIER -110.72 147.28 34.72 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.087 -1.008 . . . . 0.0 110.277 -179.916 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.585 ' CD1' ' HB2' ' A' ' 42' ' ' LEU . 15.6 t-105 -79.53 166.61 21.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.084 -1.01 . . . . 0.0 109.855 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -125.54 55.67 0.72 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.479 ' O ' ' HB ' ' A' ' 41' ' ' THR . 11.6 t-105 -160.33 -69.66 0.07 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.374 -1.074 . . . . 0.0 109.335 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.479 ' HB ' ' O ' ' A' ' 40' ' ' TRP . 5.1 t -179.06 32.37 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.67 -0.644 . . . . 0.0 109.883 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.585 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 0.8 OUTLIER -113.58 21.39 15.13 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.102 -0.999 . . . . 0.0 110.908 -179.433 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.518 ' OG ' ' CG2' ' A' ' 15' ' ' ILE . 8.2 t 57.34 -168.69 0.11 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.13 -0.981 . . . . 0.0 110.784 179.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 37' ' ' CYS . 19.4 t -71.91 171.98 10.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.391 -0.818 . . . . 0.0 110.162 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.562 ' CD2' ' OH ' ' A' ' 36' ' ' TYR . 1.1 t80 -151.5 110.21 3.83 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.994 -1.066 . . . . 0.0 110.752 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.531 ' SG ' ' CA ' ' A' ' 35' ' ' GLY . 82.9 m -125.44 137.49 53.99 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.327 -0.858 . . . . 0.0 109.824 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -119.92 131.95 55.37 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.206 -0.934 . . . . 0.0 109.931 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 107.82 41.22 1.6 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.575 ' CD2' ' N ' ' A' ' 49' ' ' LEU . 0.1 OUTLIER -119.6 172.9 3.98 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.362 -1.081 . . . . 0.0 109.83 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.494 ' HD2' ' HB2' ' A' ' 49' ' ' LEU . 42.1 Cg_endo -68.32 155.22 70.05 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 O-C-N 123.677 1.356 . . . . 0.0 110.516 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -61.12 -19.95 62.08 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.359 -0.838 . . . . 0.0 110.459 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -88.62 11.87 16.23 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.208 -0.933 . . . . 0.0 110.095 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.521 ' CB ' HD11 ' A' ' 49' ' ' LEU . . . -65.27 110.38 2.57 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.24 -0.913 . . . . 0.0 110.167 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.451 ' O ' ' HA ' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -57.71 136.08 56.83 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.234 -0.916 . . . . 0.0 110.282 179.982 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.495 ' C ' ' CD1' ' A' ' 55' ' ' ILE . 1.4 pp -154.36 -169.94 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.204 -0.935 . . . . 0.0 110.319 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.427 ' O ' ' CG ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -50.07 91.1 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.315 -0.866 . . . . 0.0 110.662 -179.523 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.471 ' N ' ' O ' ' A' ' 55' ' ' ILE . 2.4 ttt85 -119.76 -5.86 10.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.204 -0.935 . . . . 0.0 110.022 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.424 ' HB2' ' CG ' ' A' ' 11' ' ' ASN . 46.3 m -120.67 -178.53 3.74 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.309 -0.87 . . . . 0.0 110.031 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -118.94 -36.86 0.85 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.401 ' O ' ' C ' ' A' ' 61' ' ' CYS . 0.3 OUTLIER -131.74 155.32 47.9 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.19 -1.183 . . . . 0.0 110.393 -179.922 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.401 ' C ' ' O ' ' A' ' 60' ' ' ARG . 43.3 t -43.79 115.4 0.8 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.285 -0.884 . . . . 0.0 110.305 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.524 ' CB ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -90.85 48.26 1.51 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.253 -0.904 . . . . 0.0 110.262 -179.975 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.678 0 O-C-N 121.272 -0.893 . . . . 0.0 110.147 179.991 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . 0.497 ' CG ' ' O ' ' A' ' 1' ' ' LYS . 2.2 tttm . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.191 0.52 . . . . 0.0 110.167 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.496 ' CG2' ' HG ' ' A' ' 49' ' ' LEU . 10.1 tt -111.15 157.45 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.239 -0.913 . . . . 0.0 110.497 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.584 ' CB ' ' CG ' ' A' ' 47' ' ' GLN . 7.1 p30 -133.21 117.28 17.24 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.733 -0.604 . . . . 0.0 109.66 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -155.45 -150.61 5.63 Favored Glycine 0 N--CA 1.491 2.353 0 C-N-CA 119.496 -1.335 . . . . 0.0 109.846 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.492 ' HA ' ' O ' ' A' ' 44' ' ' CYS . 14.1 m-85 -122.83 114.33 29.8 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.403 -1.057 . . . . 0.0 110.29 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.466 ' HA ' ' O ' ' A' ' 54' ' ' ARG . 48.2 Cg_endo -76.04 144.8 27.33 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 124.047 1.551 . . . . 0.0 110.619 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.468 HG13 ' HA ' ' A' ' 15' ' ' ILE . 32.8 m -141.76 -171.47 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.297 -0.877 . . . . 0.0 109.894 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.531 ' HB2' ' CB ' ' A' ' 14' ' ' ARG . 3.9 t0 -67.54 -176.0 0.57 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.227 -0.92 . . . . 0.0 110.175 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.472 ' HB3' ' CE2' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -76.55 -11.02 59.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.359 -0.838 . . . . 0.0 109.68 179.739 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.548 ' HB3' ' N ' ' A' ' 62' ' ' ARG . 4.0 m-90 -132.22 8.38 4.34 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.382 -0.824 . . . . 0.0 110.115 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.472 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 18.3 m-20 60.09 33.08 21.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.162 -0.961 . . . . 0.0 110.25 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.467 ' O ' ' HD3' ' A' ' 13' ' ' LYS . 5.5 t -98.12 -67.27 0.85 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.237 -0.914 . . . . 0.0 110.683 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.481 ' O ' ' HB2' ' A' ' 14' ' ' ARG . 45.2 mmtt -131.32 86.02 2.32 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.297 -0.877 . . . . 0.0 110.587 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.531 ' CB ' ' HB2' ' A' ' 8' ' ' ASP . 1.0 OUTLIER 177.75 -22.88 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.488 -0.758 . . . . 0.0 111.008 179.739 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.545 HG12 ' CB ' ' A' ' 43' ' ' SER . 6.8 tt -30.33 -45.13 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.749 -0.595 . . . . 0.0 111.203 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.518 ' N ' ' CG2' ' A' ' 15' ' ' ILE . 43.0 t -159.18 154.3 25.21 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.226 -0.921 . . . . 0.0 109.967 179.107 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -114.84 -151.76 0.49 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.21 -0.931 . . . . 0.0 110.629 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -123.91 16.14 9.33 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.334 -0.854 . . . . 0.0 110.51 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.462 ' HB2' ' HB2' ' A' ' 22' ' ' TYR . 36.4 m-20 -119.16 148.02 43.55 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.083 -1.011 . . . . 0.0 110.395 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -88.16 26.45 1.39 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.323 -0.86 . . . . 0.0 110.165 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.4 pttm -150.29 -35.23 0.16 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.292 -0.88 . . . . 0.0 110.457 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.462 ' HB2' ' HB2' ' A' ' 19' ' ' ASN . 0.1 OUTLIER -51.51 -28.82 14.59 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -0.918 . . . . 0.0 110.691 -179.661 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.443 ' O ' ' C ' ' A' ' 24' ' ' ASN . 0.5 OUTLIER -87.18 -59.68 2.19 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.1 -1.0 . . . . 0.0 110.333 -179.905 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.443 ' C ' ' O ' ' A' ' 23' ' ' CYS . 0.1 OUTLIER -40.72 -40.41 1.3 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.488 -0.758 . . . . 0.0 110.001 179.879 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.99 -47.69 80.21 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.315 -0.866 . . . . 0.0 110.311 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.8 mt -74.84 -37.92 62.12 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.192 -0.942 . . . . 0.0 110.046 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.491 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . 15.2 m -58.38 -39.68 80.26 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.161 -0.962 . . . . 0.0 109.473 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.87 -29.9 68.62 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.329 -0.857 . . . . 0.0 109.37 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.2 -37.35 92.82 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 108.311 -1.916 . . . . 0.0 108.311 179.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.509 ' O ' ' CB ' ' A' ' 31' ' ' LYS . 39.5 mt -89.02 19.39 4.2 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.462 -1.022 . . . . 0.0 109.524 179.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.509 ' CB ' ' O ' ' A' ' 30' ' ' LEU . 0.3 OUTLIER 73.18 16.22 4.27 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.657 -0.652 . . . . 0.0 110.809 179.912 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.491 ' HB1' ' HB3' ' A' ' 27' ' ' CYS . . . -95.65 89.7 5.43 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.957 -1.089 . . . . 0.0 109.797 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -55.31 -75.15 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.22 -0.925 . . . . 0.0 111.018 -179.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.472 ' O ' ' HA ' ' A' ' 46' ' ' CYS . 8.6 t -62.34 95.42 0.07 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.389 -0.82 . . . . 0.0 110.912 -179.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.459 ' HA2' ' SG ' ' A' ' 46' ' ' CYS . . . -123.06 110.87 1.6 Allowed Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.585 ' CD1' ' O ' ' A' ' 36' ' ' TYR . 13.1 p90 -138.99 144.25 38.84 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.388 -1.066 . . . . 0.0 109.738 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.491 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.0 OUTLIER -90.97 154.56 19.36 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.038 -1.039 . . . . 0.0 110.832 -179.359 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.439 ' CG ' ' HB2' ' A' ' 42' ' ' LEU . 18.5 t-105 -79.95 -172.03 3.19 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.271 -0.893 . . . . 0.0 109.936 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -119.55 -29.3 1.76 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.567 ' CE2' HG23 ' A' ' 41' ' ' THR . 12.8 t-105 -79.38 -83.1 0.1 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.233 -1.157 . . . . 0.0 109.986 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.567 HG23 ' CE2' ' A' ' 40' ' ' TRP . 5.3 t -166.41 48.42 0.07 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.347 -0.845 . . . . 0.0 109.707 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.443 ' O ' ' HB2' ' A' ' 43' ' ' SER . 8.0 mp -106.9 23.49 14.28 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.312 -0.868 . . . . 0.0 110.745 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.545 ' CB ' HG12 ' A' ' 15' ' ' ILE . 5.1 m 58.48 -166.93 0.15 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 120.935 -1.103 . . . . 0.0 110.027 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 5' ' ' TYR . 9.3 t -83.68 156.27 22.73 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.34 -0.85 . . . . 0.0 108.88 178.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.45 ' CD2' ' OH ' ' A' ' 36' ' ' TYR . 0.8 OUTLIER -128.72 116.95 20.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.96 -1.088 . . . . 0.0 110.354 -179.629 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 34' ' ' SER . 74.0 m -137.52 137.45 38.65 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.353 -0.842 . . . . 0.0 109.848 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.584 ' CG ' ' CB ' ' A' ' 3' ' ' ASP . 1.7 mp0 -123.78 154.63 39.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.273 -0.892 . . . . 0.0 110.431 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.489 ' O ' ' O ' ' A' ' 31' ' ' LYS . . . 99.73 15.46 31.55 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.584 ' CD1' ' CB ' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -98.66 170.35 7.09 Favored Pre-proline 0 N--CA 1.497 1.891 0 O-C-N 121.133 -1.216 . . . . 0.0 109.723 179.669 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.531 ' HD2' ' HB2' ' A' ' 49' ' ' LEU . 43.3 Cg_endo -70.61 156.46 61.07 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 123.515 1.271 . . . . 0.0 110.706 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.439 ' HA ' HD11 ' A' ' 2' ' ' ILE . 48.3 t0 -58.99 -24.85 63.1 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.334 -0.854 . . . . 0.0 110.01 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -85.79 14.18 6.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.373 -0.829 . . . . 0.0 109.806 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.584 ' CB ' ' CD1' ' A' ' 49' ' ' LEU . . . -56.25 152.15 11.46 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.449 -0.782 . . . . 0.0 110.381 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.466 ' O ' ' HA ' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -92.19 110.48 21.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.309 -0.87 . . . . 0.0 109.536 179.476 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.592 ' CD1' ' N ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -148.65 -164.62 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.256 -0.903 . . . . 0.0 110.647 -179.384 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' A' ' 55' ' ' ILE . 0.1 OUTLIER -40.45 108.63 0.09 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.573 -0.705 . . . . 0.0 110.54 -179.816 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.456 ' CG ' ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -136.43 20.68 3.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.381 -0.824 . . . . 0.0 109.872 179.807 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.451 ' CB ' ' O ' ' A' ' 57' ' ' ARG . 0.5 OUTLIER 66.86 153.49 0.08 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.408 -0.807 . . . . 0.0 110.161 -179.969 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 128.73 101.57 1.03 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.709 -1.357 . . . . 0.0 109.709 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.436 ' O ' ' C ' ' A' ' 61' ' ' CYS . 1.6 mmt180 -70.13 94.85 0.92 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.257 -1.143 . . . . 0.0 109.965 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.436 ' C ' ' O ' ' A' ' 60' ' ' ARG . 41.8 t 42.54 88.95 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 0.0 109.967 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.548 ' N ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -83.11 26.48 0.62 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.357 -0.84 . . . . 0.0 110.844 -179.905 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.492 ' CB ' ' O ' ' A' ' 62' ' ' ARG . . . . . . . . 0 N--CA 1.492 1.644 0 O-C-N 121.01 -1.056 . . . . 0.0 110.244 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 5.4 mtmm . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.21 0.528 . . . . 0.0 110.152 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.474 HG23 ' HG ' ' A' ' 49' ' ' LEU . 6.0 tt -133.09 154.72 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.202 -0.936 . . . . 0.0 110.418 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -124.88 128.6 48.9 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.345 -0.847 . . . . 0.0 109.983 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -168.19 -166.07 26.64 Favored Glycine 0 N--CA 1.491 2.347 0 C-N-CA 119.554 -1.307 . . . . 0.0 110.114 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.592 ' N ' ' CD1' ' A' ' 5' ' ' TYR . 13.7 m-85 -111.05 104.3 56.01 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.318 -1.107 . . . . 0.0 109.656 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.55 ' N ' HG22 ' A' ' 55' ' ' ILE . 50.1 Cg_endo -76.98 111.44 3.23 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 123.948 1.499 . . . . 0.0 111.281 -179.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.8 m -83.4 -169.99 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.231 -0.918 . . . . 0.0 109.877 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.55 ' CB ' ' HB2' ' A' ' 13' ' ' LYS . 11.8 p-10 -71.9 -134.77 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.287 -0.883 . . . . 0.0 109.852 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.57 ' HB3' ' CD2' ' A' ' 10' ' ' TRP . 0.2 OUTLIER -92.43 -63.26 1.25 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.035 -1.041 . . . . 0.0 110.397 -179.871 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.57 ' CD2' ' HB3' ' A' ' 9' ' ' TYR . 2.8 m-90 -107.11 26.79 9.71 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.134 -0.979 . . . . 0.0 110.125 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.479 ' HA ' ' OD1' ' A' ' 8' ' ' ASP . 1.3 m-20 67.31 5.83 4.48 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.134 -0.979 . . . . 0.0 109.853 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.454 ' O ' ' C ' ' A' ' 13' ' ' LYS . 89.2 m -83.86 -66.1 0.93 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.277 -0.889 . . . . 0.0 110.733 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.55 ' HB2' ' CB ' ' A' ' 8' ' ' ASP . 6.8 mmmt -37.95 -85.68 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.726 -0.609 . . . . 0.0 110.843 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 4.6 ttm180 -165.33 109.02 0.85 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.002 -1.061 . . . . 0.0 110.673 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.454 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 46.3 pt -48.77 -24.24 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.139 -0.975 . . . . 0.0 109.348 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.46 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 34.4 t -150.15 126.39 10.69 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.714 -0.616 . . . . 0.0 109.865 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.652 ' CE3' ' CD2' ' A' ' 22' ' ' TYR . 0.0 OUTLIER -85.36 -162.05 0.67 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.184 -0.948 . . . . 0.0 110.197 -179.901 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -101.72 -54.74 2.67 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.328 -0.857 . . . . 0.0 110.181 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -60.66 113.86 2.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.449 -0.782 . . . . 0.0 110.29 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 29.4 p30 -59.65 -15.22 17.7 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.354 -0.841 . . . . 0.0 110.329 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.402 ' HG3' ' N ' ' A' ' 22' ' ' TYR . 8.2 pttp -92.98 -27.89 16.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.203 -0.936 . . . . 0.0 110.293 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.652 ' CD2' ' CE3' ' A' ' 17' ' ' TRP . 45.3 t80 -60.63 -47.9 84.18 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.245 -0.909 . . . . 0.0 110.046 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -64.6 -40.44 95.53 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.334 -0.854 . . . . 0.0 110.174 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -57.59 -35.44 70.41 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.226 -0.921 . . . . 0.0 110.133 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -58.72 -57.52 12.62 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.241 -0.912 . . . . 0.0 110.015 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.87 -39.01 93.1 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.274 -0.891 . . . . 0.0 110.149 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.495 ' HB3' ' HB2' ' A' ' 32' ' ' ALA . 11.4 m -62.65 -37.19 85.38 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.223 -0.923 . . . . 0.0 109.877 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.88 -29.4 70.58 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.181 -0.949 . . . . 0.0 109.368 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.78 -27.34 69.88 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 107.438 -2.265 . . . . 0.0 107.438 178.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.508 ' O ' ' CB ' ' A' ' 31' ' ' LYS . 9.9 mt -96.3 19.41 11.99 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.879 -0.777 . . . . 0.0 109.051 178.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.508 ' CB ' ' O ' ' A' ' 30' ' ' LEU . 0.7 OUTLIER 71.47 10.92 6.6 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.468 -0.77 . . . . 0.0 110.985 179.684 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.53 ' CB ' HD21 ' A' ' 49' ' ' LEU . . . -85.3 103.46 14.25 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.833 -1.167 . . . . 0.0 109.983 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.441 ' N ' ' OD1' ' A' ' 33' ' ' ASP . 4.4 m-20 -61.25 -80.25 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.407 -0.808 . . . . 0.0 110.885 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.461 ' O ' ' HA ' ' A' ' 46' ' ' CYS . 60.3 p -66.26 94.04 0.24 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.234 -0.916 . . . . 0.0 110.348 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.421 ' HA2' ' SG ' ' A' ' 46' ' ' CYS . . . -116.75 84.5 0.37 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.421 ' C ' ' CD1' ' A' ' 36' ' ' TYR . 31.5 p90 -114.88 151.49 33.87 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.203 -1.175 . . . . 0.0 109.841 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.517 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.1 OUTLIER -95.62 155.3 16.8 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.118 -0.989 . . . . 0.0 110.505 -179.642 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.582 ' CD1' ' HB3' ' A' ' 40' ' ' TRP . 27.6 t-105 -79.52 168.15 19.82 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.188 -0.945 . . . . 0.0 109.613 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -106.66 -26.42 5.87 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.582 ' HB3' ' CD1' ' A' ' 38' ' ' TRP . 53.8 t-105 -79.61 -92.02 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.26 -1.141 . . . . 0.0 109.726 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.553 ' OG1' ' CD1' ' A' ' 40' ' ' TRP . 70.7 p -158.07 46.37 0.35 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.357 -0.84 . . . . 0.0 109.857 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.571 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 1.1 mt -110.92 30.92 6.42 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.14 -0.975 . . . . 0.0 110.686 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.46 ' HA ' ' HB2' ' A' ' 16' ' ' CYS . 3.2 t 54.85 -172.68 0.05 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.201 -0.937 . . . . 0.0 110.386 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.517 ' HA ' ' HA ' ' A' ' 37' ' ' CYS . 17.5 t -78.77 166.63 22.24 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.335 -0.853 . . . . 0.0 109.814 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.553 ' CD2' ' CE2' ' A' ' 5' ' ' TYR . 0.8 OUTLIER -139.82 120.08 13.85 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.243 -0.911 . . . . 0.0 110.488 -179.613 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.49 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . 80.5 m -136.07 135.19 39.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.121 -0.987 . . . . 0.0 109.697 179.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.42 ' CA ' HD23 ' A' ' 49' ' ' LEU . 12.6 mt-30 -115.53 142.94 46.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.353 -0.842 . . . . 0.0 110.205 -179.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 31' ' ' LYS . . . 99.9 31.91 5.82 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.594 ' CD2' ' N ' ' A' ' 49' ' ' LEU . 0.1 OUTLIER -103.49 176.3 1.86 Allowed Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.052 -1.263 . . . . 0.0 109.327 179.38 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.503 ' HD3' ' O ' ' A' ' 30' ' ' LEU . 47.2 Cg_endo -70.56 155.93 62.3 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 123.692 1.364 . . . . 0.0 110.24 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -59.7 -19.03 47.09 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.052 -1.03 . . . . 0.0 109.597 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -102.31 24.71 9.87 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.395 -0.815 . . . . 0.0 109.472 179.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.471 ' HB2' ' O ' ' A' ' 50' ' ' PRO . . . -64.22 123.14 18.34 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.355 -0.841 . . . . 0.0 110.509 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.525 ' CZ ' ' O ' ' A' ' 9' ' ' TYR . 0.1 OUTLIER -68.64 112.31 5.32 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.217 -0.927 . . . . 0.0 110.278 179.834 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.581 ' O ' ' CD1' ' A' ' 55' ' ' ILE . 2.5 pp -143.68 128.07 14.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.44 -0.788 . . . . 0.0 110.589 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.49 ' C ' ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER 29.17 52.67 0.08 Allowed 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 121.227 0.537 . . . . 0.0 111.689 179.862 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.407 ' HD3' ' HG2' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -128.62 7.98 5.8 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.231 -0.918 . . . . 0.0 110.196 179.479 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.461 ' HB3' ' HB2' ' A' ' 11' ' ' ASN . 0.4 OUTLIER -92.32 151.92 20.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.32 -0.862 . . . . 0.0 110.114 179.87 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.15 -136.54 1.26 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.44 ' O ' ' O ' ' A' ' 61' ' ' CYS . 25.4 mmt85 -88.16 92.41 9.14 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.172 -1.193 . . . . 0.0 110.271 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 10' ' ' TRP . 0.0 OUTLIER 52.74 101.79 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.241 -0.912 . . . . 0.0 110.137 179.935 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.52 ' CB ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -82.32 46.77 1.07 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.243 -0.911 . . . . 0.0 110.293 -179.875 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.252 -0.905 . . . . 0.0 110.261 179.964 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . 0.452 ' O ' ' HG3' ' A' ' 1' ' ' LYS . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.308 0.575 . . . . 0.0 110.163 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.52 ' CG2' ' HG ' ' A' ' 49' ' ' LEU . 15.9 tt -133.62 166.31 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.242 -0.912 . . . . 0.0 109.991 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -142.24 138.11 31.2 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.297 -0.877 . . . . 0.0 110.011 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 176.78 -148.67 9.13 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.549 ' N ' ' CD1' ' A' ' 5' ' ' TYR . 18.2 m-85 -123.61 117.61 27.6 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.285 -1.127 . . . . 0.0 110.321 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.483 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 45.5 Cg_endo -74.03 134.18 19.2 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.923 1.486 . . . . 0.0 110.159 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.524 ' CG2' ' OD1' ' A' ' 11' ' ' ASN . 27.2 m -136.99 -168.79 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.142 -0.974 . . . . 0.0 110.475 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.536 ' CB ' ' HB3' ' A' ' 14' ' ' ARG . 0.7 OUTLIER -80.13 172.28 13.98 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.342 -0.849 . . . . 0.0 110.383 -179.821 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.583 ' HB3' ' CE2' ' A' ' 10' ' ' TRP . 0.4 OUTLIER -62.34 -19.56 63.48 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.306 -0.871 . . . . 0.0 109.817 179.706 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.583 ' CE2' ' HB3' ' A' ' 9' ' ' TYR . 2.9 m-90 -131.23 12.87 5.1 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.333 -0.854 . . . . 0.0 110.15 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.524 ' OD1' ' CG2' ' A' ' 7' ' ' VAL . 88.6 m-20 56.5 35.44 26.01 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.129 -0.982 . . . . 0.0 109.375 -179.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.415 ' SG ' ' HB2' ' A' ' 10' ' ' TRP . 34.8 m -90.74 -53.2 4.51 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.481 -0.762 . . . . 0.0 111.642 -179.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.489 ' O ' ' O ' ' A' ' 14' ' ' ARG . 1.2 mppt? -125.21 -56.41 1.54 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.059 -1.026 . . . . 0.0 111.885 -178.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.536 ' HB3' ' CB ' ' A' ' 8' ' ' ASP . 14.6 tpp180 -36.76 -96.02 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.371 -0.831 . . . . 0.0 111.064 -178.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.471 ' HA ' HG11 ' A' ' 7' ' ' VAL . 72.0 mt 50.4 -88.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 120.954 -1.092 . . . . 0.0 110.515 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.543 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 1.6 t -135.13 134.4 40.18 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.371 -0.831 . . . . 0.0 109.714 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.425 ' O ' ' SG ' ' A' ' 37' ' ' CYS . 0.0 OUTLIER -88.62 -156.52 0.38 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.165 -0.959 . . . . 0.0 110.631 -179.654 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -107.25 -32.32 7.84 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.224 -0.923 . . . . 0.0 110.161 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -87.45 153.52 21.36 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.289 -0.882 . . . . 0.0 110.136 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -86.24 -17.55 34.45 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.179 -0.951 . . . . 0.0 109.997 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.7 ttpp -96.15 -10.56 27.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.284 -0.885 . . . . 0.0 109.992 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -69.39 -58.75 3.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.248 -0.908 . . . . 0.0 110.094 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -65.62 -28.17 68.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.311 -0.868 . . . . 0.0 110.096 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.479 ' O ' ' HG2' ' A' ' 28' ' ' LYS . 6.9 t-20 -69.07 -40.43 78.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.344 -0.848 . . . . 0.0 109.918 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.57 -46.15 87.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.156 -0.965 . . . . 0.0 110.007 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.1 mt -74.27 -42.69 59.21 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.319 -0.863 . . . . 0.0 109.946 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.467 ' O ' ' HB1' ' A' ' 32' ' ' ALA . 5.7 m -58.95 -39.39 81.53 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.219 -0.926 . . . . 0.0 109.547 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.479 ' HG2' ' O ' ' A' ' 24' ' ' ASN . 2.6 mmmt -60.83 -28.18 68.62 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.196 -0.94 . . . . 0.0 109.443 179.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.12 -35.35 90.69 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 107.677 -2.169 . . . . 0.0 107.677 178.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.508 ' O ' ' HD3' ' A' ' 50' ' ' PRO . 13.6 mt -91.38 21.94 4.21 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.701 -0.882 . . . . 0.0 109.117 178.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.474 ' O ' ' O ' ' A' ' 48' ' ' GLY . 0.7 OUTLIER 67.72 15.43 9.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.426 -0.796 . . . . 0.0 110.95 179.868 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.506 ' HB2' ' CD2' ' A' ' 49' ' ' LEU . . . -83.99 89.44 7.25 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.859 -1.151 . . . . 0.0 109.582 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -48.03 -83.68 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.322 -0.862 . . . . 0.0 111.195 -179.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.473 ' O ' ' HA ' ' A' ' 46' ' ' CYS . 10.0 m -68.97 92.11 0.5 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.296 -0.878 . . . . 0.0 110.5 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.519 ' CA ' ' SG ' ' A' ' 46' ' ' CYS . . . -127.03 97.41 0.48 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.41 ' O ' ' SG ' ' A' ' 44' ' ' CYS . 40.6 p90 -119.73 -169.41 1.76 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.235 -1.156 . . . . 0.0 110.658 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 34.4 t -128.12 127.7 43.5 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.363 -0.836 . . . . 0.0 110.268 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.594 ' CD1' ' HB3' ' A' ' 40' ' ' TRP . 28.0 t-105 -79.77 147.25 31.92 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.994 -1.067 . . . . 0.0 110.054 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -110.91 61.11 0.31 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.594 ' HB3' ' CD1' ' A' ' 38' ' ' TRP . 14.2 t-105 -160.31 -70.38 0.07 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.235 -1.156 . . . . 0.0 110.056 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.577 HG22 ' CD1' ' A' ' 40' ' ' TRP . 7.0 t -171.47 34.99 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.443 -0.786 . . . . 0.0 110.178 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.575 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 12.5 mt -119.69 10.29 11.66 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.261 -0.899 . . . . 0.0 110.358 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.543 ' HA ' ' HB2' ' A' ' 16' ' ' CYS . 50.7 m 54.46 -170.52 0.06 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.236 -0.915 . . . . 0.0 110.317 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.465 ' O ' ' HB3' ' A' ' 5' ' ' TYR . 43.0 t -74.18 155.31 38.5 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.195 -0.941 . . . . 0.0 109.247 179.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.401 ' HB3' ' CZ ' ' A' ' 36' ' ' TYR . 1.0 OUTLIER -137.06 112.56 9.32 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.873 -1.142 . . . . 0.0 111.123 -179.35 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.519 ' SG ' ' CA ' ' A' ' 35' ' ' GLY . 68.1 m -128.8 143.86 51.02 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.296 -0.877 . . . . 0.0 109.837 178.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.462 ' HA ' HD23 ' A' ' 49' ' ' LEU . 1.5 mp0 -126.61 145.68 50.46 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.217 -0.927 . . . . 0.0 110.159 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 31' ' ' LYS . . . 95.56 33.87 6.28 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.522 ' N ' HD21 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -109.14 171.27 4.59 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.275 -1.133 . . . . 0.0 109.741 179.738 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.508 ' HD3' ' O ' ' A' ' 30' ' ' LEU . 42.4 Cg_endo -69.45 158.68 56.47 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.51 1.269 . . . . 0.0 110.774 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -62.0 -15.33 43.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.333 -0.855 . . . . 0.0 109.885 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -96.59 16.14 19.69 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.344 -0.848 . . . . 0.0 109.819 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.509 ' CB ' ' CD1' ' A' ' 49' ' ' LEU . . . -60.46 127.88 33.9 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.386 -0.821 . . . . 0.0 110.528 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.476 ' O ' ' HA ' ' A' ' 6' ' ' PRO . 0.5 OUTLIER -71.32 99.53 1.96 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.284 -0.885 . . . . 0.0 109.887 179.742 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.484 ' C ' ' CD1' ' A' ' 55' ' ' ILE . 2.3 pp -137.4 -160.81 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.181 -0.949 . . . . 0.0 110.463 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.476 ' C ' ' O ' ' A' ' 55' ' ' ILE . 12.8 mttt -29.68 96.8 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 121.382 0.61 . . . . 0.0 111.567 -179.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.437 ' O ' ' CB ' ' A' ' 58' ' ' SER . 0.3 OUTLIER -111.3 0.36 16.67 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.41 -0.806 . . . . 0.0 110.038 179.555 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.437 ' CB ' ' O ' ' A' ' 57' ' ' ARG . 0.4 OUTLIER 66.55 172.9 0.25 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.422 -0.799 . . . . 0.0 110.287 -179.985 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 60' ' ' ARG . . . 86.42 108.75 0.8 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.469 ' O ' ' N ' ' A' ' 62' ' ' ARG . 8.9 mmm-85 -49.36 -179.69 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.283 -1.128 . . . . 0.0 110.302 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 10' ' ' TRP . 16.3 t -43.4 96.51 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.248 -0.908 . . . . 0.0 110.149 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.534 ' CB ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -82.76 46.1 1.05 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.166 -0.959 . . . . 0.0 110.244 179.926 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.196 -0.94 . . . . 0.0 110.12 -179.985 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 1.4 mtpp . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.205 0.526 . . . . 0.0 110.269 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.463 HG21 ' O ' ' A' ' 49' ' ' LEU . 7.1 tt -132.94 161.8 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.324 -0.86 . . . . 0.0 110.264 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.463 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 4.5 m-20 -128.4 129.53 46.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.341 -0.85 . . . . 0.0 109.66 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -169.06 -170.03 33.16 Favored Glycine 0 N--CA 1.494 2.526 0 C-N-CA 119.372 -1.394 . . . . 0.0 110.259 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.557 ' N ' ' CD1' ' A' ' 5' ' ' TYR . 6.8 m-85 -107.69 102.4 44.74 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.431 -1.041 . . . . 0.0 110.485 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.59 138.17 26.31 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 124.004 1.528 . . . . 0.0 110.425 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.534 HG11 ' CG2' ' A' ' 15' ' ' ILE . 21.4 m -120.47 -168.97 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.239 -0.913 . . . . 0.0 110.449 -179.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.533 ' HB2' ' CB ' ' A' ' 13' ' ' LYS . 8.3 p-10 -66.94 -150.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.352 -0.843 . . . . 0.0 110.283 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.597 ' HB3' ' CD2' ' A' ' 10' ' ' TRP . 0.2 OUTLIER -87.13 -33.93 19.26 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.191 -0.943 . . . . 0.0 110.382 -179.861 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.597 ' CD2' ' HB3' ' A' ' 9' ' ' TYR . 8.7 m-90 -129.23 34.36 4.41 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.001 -1.062 . . . . 0.0 110.367 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.506 ' CA ' ' OD1' ' A' ' 8' ' ' ASP . 62.8 m-80 57.17 16.48 3.01 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.125 -0.984 . . . . 0.0 110.297 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.466 ' HB2' ' HA ' ' A' ' 61' ' ' CYS . 2.0 t -109.9 -44.19 3.86 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.208 -0.933 . . . . 0.0 110.488 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.533 ' CB ' ' HB2' ' A' ' 8' ' ' ASP . 0.0 OUTLIER -69.96 58.32 0.15 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.295 -0.878 . . . . 0.0 110.447 -179.733 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.45 ' HB2' ' O ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER 59.34 122.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.322 -0.861 . . . . 0.0 110.903 179.722 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.58 ' CG2' ' CB ' ' A' ' 43' ' ' SER . 1.3 mp -79.34 -12.81 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-O 121.747 0.784 . . . . 0.0 109.36 179.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.486 ' SG ' ' N ' ' A' ' 44' ' ' CYS . 1.5 t -146.55 158.05 43.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.458 -0.776 . . . . 0.0 109.263 179.35 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.549 ' CE2' ' CD1' ' A' ' 22' ' ' TYR . 0.0 OUTLIER -104.72 165.77 10.84 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.896 -1.128 . . . . 0.0 110.996 -179.511 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -81.17 -32.26 33.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.068 -1.02 . . . . 0.0 110.266 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -96.2 114.21 25.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.301 -0.874 . . . . 0.0 110.356 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -47.17 -27.98 1.65 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.391 -0.818 . . . . 0.0 110.348 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 29.7 tttm -76.19 -33.14 59.3 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.18 -0.95 . . . . 0.0 110.378 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.549 ' CD1' ' CE2' ' A' ' 17' ' ' TRP . 0.3 OUTLIER -55.12 -41.92 72.31 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.191 -0.943 . . . . 0.0 110.11 179.94 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.29 -52.99 7.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.222 -0.924 . . . . 0.0 110.248 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.483 ' HB2' ' O ' ' A' ' 35' ' ' GLY . 28.0 t-20 -48.19 -41.2 26.44 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.243 -0.911 . . . . 0.0 110.44 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -57.2 -52.49 65.12 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.263 -0.898 . . . . 0.0 110.556 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.41 -34.25 70.18 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.152 -0.968 . . . . 0.0 110.428 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.475 ' HB3' ' HB2' ' A' ' 32' ' ' ALA . 9.4 m -62.87 -45.69 91.38 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.084 -1.01 . . . . 0.0 109.788 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.94 -27.72 63.64 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.576 -0.85 . . . . 0.0 109.372 179.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.31 -37.99 93.93 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 108.352 -1.899 . . . . 0.0 108.352 179.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.538 ' O ' ' CB ' ' A' ' 31' ' ' LYS . 16.0 mt -90.6 21.18 4.12 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.54 -0.976 . . . . 0.0 109.342 179.099 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.538 ' CB ' ' O ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER 74.26 12.92 3.98 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.743 -0.598 . . . . 0.0 110.736 179.899 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.527 ' CB ' HD21 ' A' ' 49' ' ' LEU . . . -87.32 85.68 7.19 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.843 -1.16 . . . . 0.0 109.829 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -49.5 -87.57 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.414 -0.804 . . . . 0.0 111.186 -179.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 82.8 p -60.89 96.16 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.303 -0.873 . . . . 0.0 110.73 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.505 ' CA ' ' SG ' ' A' ' 46' ' ' CYS . . . -132.11 123.06 3.5 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.595 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 4.3 p90 -143.98 -174.91 4.4 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.173 -1.193 . . . . 0.0 109.76 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 26.3 t -124.55 138.0 54.36 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.966 -1.084 . . . . 0.0 110.961 -179.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.585 ' CD1' ' HB2' ' A' ' 42' ' ' LEU . 21.2 t-105 -88.25 99.43 12.22 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.171 -0.955 . . . . 0.0 109.653 179.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -69.36 70.3 0.49 Allowed Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.57 ' CD1' HG23 ' A' ' 41' ' ' THR . 7.5 t-105 -160.53 -65.28 0.07 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.317 -1.107 . . . . 0.0 109.648 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.57 HG23 ' CD1' ' A' ' 40' ' ' TRP . 1.7 t 175.34 36.1 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.564 -0.71 . . . . 0.0 109.885 179.357 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.585 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 1.0 OUTLIER -124.52 18.75 8.84 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.291 -0.881 . . . . 0.0 110.573 -179.781 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.58 ' CB ' ' CG2' ' A' ' 15' ' ' ILE . 28.8 t 56.22 -177.54 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.193 -0.942 . . . . 0.0 110.764 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.51 ' O ' ' HA ' ' A' ' 5' ' ' TYR . 15.8 t -70.62 173.21 7.4 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.307 -0.871 . . . . 0.0 109.334 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -154.66 106.27 2.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.945 -1.097 . . . . 0.0 110.528 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.505 ' SG ' ' CA ' ' A' ' 35' ' ' GLY . 75.2 m -127.21 137.8 52.98 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.389 -0.819 . . . . 0.0 109.736 179.442 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.463 ' HA ' ' HA ' ' A' ' 3' ' ' ASP . 16.9 mt-30 -116.66 130.83 56.97 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.152 -0.967 . . . . 0.0 109.966 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.505 ' O ' ' O ' ' A' ' 31' ' ' LYS . . . 117.88 24.38 3.36 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.551 ' CD2' ' N ' ' A' ' 49' ' ' LEU . 0.1 OUTLIER -104.04 173.42 3.4 Favored Pre-proline 0 N--CA 1.498 1.925 0 O-C-N 121.077 -1.249 . . . . 0.0 109.513 179.591 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.515 ' HD2' ' HB2' ' A' ' 49' ' ' LEU . 41.5 Cg_endo -68.87 156.86 64.05 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.443 1.233 . . . . 0.0 110.559 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -59.2 -21.58 59.69 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.259 -0.9 . . . . 0.0 110.222 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -90.48 14.03 14.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.376 -0.827 . . . . 0.0 109.987 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.468 ' O ' HG12 ' A' ' 55' ' ' ILE . . . -57.94 125.51 23.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.291 -0.881 . . . . 0.0 110.153 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.594 ' CB ' ' CZ ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -64.71 140.52 58.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.098 -1.001 . . . . 0.0 109.957 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.484 HG23 ' O ' ' A' ' 5' ' ' TYR . 26.3 mm -141.02 175.33 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.19 -0.943 . . . . 0.0 110.415 -179.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.485 ' HG2' HG11 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -60.82 82.82 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.332 -0.855 . . . . 0.0 110.074 179.486 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.442 ' N ' ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -95.56 20.81 9.06 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.1 -1.0 . . . . 0.0 110.356 -179.964 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.418 ' HB3' ' O ' ' A' ' 57' ' ' ARG . 4.7 t 63.24 -169.13 0.19 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.289 -0.882 . . . . 0.0 110.375 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 60' ' ' ARG . . . 121.03 -5.46 11.21 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.465 ' O ' ' O ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER 41.95 80.91 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.232 -1.158 . . . . 0.0 110.572 179.751 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.466 ' HA ' ' HB2' ' A' ' 12' ' ' CYS . 27.2 m 48.44 100.39 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.347 -0.846 . . . . 0.0 110.619 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.532 ' CB ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -89.75 44.26 1.2 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.241 -0.912 . . . . 0.0 110.095 179.699 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.235 -0.916 . . . . 0.0 110.181 -179.86 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 10.3 ttmt . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.25 0.548 . . . . 0.0 110.221 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.472 ' CG2' ' HG ' ' A' ' 49' ' ' LEU . 18.6 tt -127.58 158.77 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.134 -0.979 . . . . 0.0 110.285 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.465 ' HB2' ' HG3' ' A' ' 47' ' ' GLN . 2.5 p30 -133.37 139.28 46.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.366 -0.834 . . . . 0.0 110.102 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.475 ' C ' ' CD1' ' A' ' 5' ' ' TYR . . . 174.18 -164.53 35.76 Favored Glycine 0 N--CA 1.492 2.373 0 C-N-CA 119.685 -1.245 . . . . 0.0 110.057 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.581 ' N ' ' CD1' ' A' ' 5' ' ' TYR . 1.2 m-85 -112.62 98.58 44.81 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.25 -1.147 . . . . 0.0 110.51 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.501 ' CG ' ' SG ' ' A' ' 27' ' ' CYS . 44.8 Cg_endo -72.94 116.75 4.84 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.928 1.489 . . . . 0.0 110.557 179.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.534 ' CG1' HG22 ' A' ' 15' ' ' ILE . 21.3 m -79.97 -177.22 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.492 -0.755 . . . . 0.0 110.078 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.473 ' O ' ' NE ' ' A' ' 54' ' ' ARG . 77.5 m-20 -61.72 -96.67 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.131 -0.98 . . . . 0.0 110.114 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.476 ' HB3' ' CE3' ' A' ' 10' ' ' TRP . 0.2 OUTLIER -131.94 -59.02 0.95 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.102 -0.999 . . . . 0.0 109.594 179.63 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.501 ' O ' ' HB2' ' A' ' 11' ' ' ASN . 13.8 m-90 -106.99 17.13 23.46 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.468 -0.77 . . . . 0.0 109.46 179.295 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.517 ' N ' ' OD1' ' A' ' 11' ' ' ASN . 1.3 m-20 60.67 11.7 3.26 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.353 -0.842 . . . . 0.0 110.302 -179.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 63.5 m -60.38 -60.25 4.12 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.12 -0.988 . . . . 0.0 110.518 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.44 ' O ' ' CG ' ' A' ' 14' ' ' ARG . 0.8 OUTLIER -63.61 -63.49 1.16 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.365 -0.834 . . . . 0.0 110.325 -179.792 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.44 ' CG ' ' O ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER 173.1 176.78 0.1 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.276 -0.89 . . . . 0.0 110.423 179.977 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.548 ' CG2' ' OG ' ' A' ' 43' ' ' SER . 1.0 OUTLIER -77.68 -15.25 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.297 -0.877 . . . . 0.0 109.452 179.813 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.553 ' HB2' ' N ' ' A' ' 44' ' ' CYS . 10.9 t -141.49 157.99 44.43 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.413 -0.804 . . . . 0.0 109.872 179.068 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.478 ' CE3' ' CG ' ' A' ' 22' ' ' TYR . 22.9 t90 -95.67 -112.58 0.13 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.178 -0.951 . . . . 0.0 110.059 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -157.92 58.64 0.48 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.847 -1.158 . . . . 0.0 110.182 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.442 ' HB2' ' CE3' ' A' ' 17' ' ' TRP . 0.2 OUTLIER -170.91 153.58 3.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.378 -0.826 . . . . 0.0 110.086 179.97 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -84.69 -5.1 59.3 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.177 -0.952 . . . . 0.0 110.5 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -119.2 -30.69 4.89 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.066 -1.021 . . . . 0.0 110.735 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.478 ' CG ' ' CE3' ' A' ' 17' ' ' TRP . 26.3 t80 -54.1 -54.12 43.86 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.089 -1.007 . . . . 0.0 110.178 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.447 ' O ' ' HB2' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -62.04 -20.06 63.55 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.199 -0.938 . . . . 0.0 109.695 179.853 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.517 ' CB ' ' O ' ' A' ' 35' ' ' GLY . 0.2 OUTLIER -84.74 -42.71 14.97 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.266 -0.896 . . . . 0.0 110.457 -179.913 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -59.18 -43.41 92.16 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.028 -1.045 . . . . 0.0 109.759 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.408 ' O ' ' CD1' ' A' ' 30' ' ' LEU . 6.3 mt -71.55 -46.43 59.52 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.272 -0.892 . . . . 0.0 109.898 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.501 ' SG ' ' CG ' ' A' ' 6' ' ' PRO . 1.3 m -59.48 -40.13 85.99 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.301 -0.874 . . . . 0.0 110.017 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.477 ' HD2' ' ND2' ' A' ' 24' ' ' ASN . 0.1 OUTLIER -64.81 -33.31 75.7 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.268 -0.895 . . . . 0.0 109.141 179.389 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -53.43 -34.5 48.94 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 108.356 -1.898 . . . . 0.0 108.356 179.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.652 ' O ' ' CB ' ' A' ' 31' ' ' LYS . 1.8 mp -81.43 -35.51 30.55 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.469 -1.018 . . . . 0.0 109.353 179.149 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.652 ' CB ' ' O ' ' A' ' 30' ' ' LEU . 1.5 ttmm 141.8 -2.66 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.576 0 C-N-CA 123.051 0.54 . . . . 0.0 110.027 179.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.476 ' O ' ' HG3' ' A' ' 28' ' ' LYS . . . -80.7 94.82 6.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.991 -1.068 . . . . 0.0 110.345 -179.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.462 ' HA ' ' CG ' ' A' ' 28' ' ' LYS . 11.5 m-20 -65.11 -46.0 82.85 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.294 -0.878 . . . . 0.0 110.271 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.19 80.39 9.23 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.327 -0.858 . . . . 0.0 110.301 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.517 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -119.06 103.39 0.99 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -126.38 133.15 51.38 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.23 -1.159 . . . . 0.0 110.404 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.0 OUTLIER -84.67 127.48 34.11 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.207 -0.933 . . . . 0.0 110.167 179.875 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.541 ' CD1' HD11 ' A' ' 42' ' ' LEU . 0.3 OUTLIER -79.92 139.81 36.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.254 -0.904 . . . . 0.0 110.258 -179.899 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -90.83 12.16 69.7 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.529 ' CD1' HG23 ' A' ' 41' ' ' THR . 21.4 t-105 -105.03 -70.16 0.79 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.316 -1.108 . . . . 0.0 110.151 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.529 HG23 ' CD1' ' A' ' 40' ' ' TRP . 14.1 t -172.35 32.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.399 -0.813 . . . . 0.0 110.343 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.541 HD11 ' CD1' ' A' ' 38' ' ' TRP . 0.2 OUTLIER -112.16 13.65 20.57 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.201 -0.937 . . . . 0.0 110.236 179.961 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.548 ' OG ' ' CG2' ' A' ' 15' ' ' ILE . 28.0 t 44.12 -166.1 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.281 -0.887 . . . . 0.0 110.916 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.553 ' N ' ' HB2' ' A' ' 16' ' ' CYS . 21.5 t -68.57 113.67 6.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.509 -0.744 . . . . 0.0 109.669 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.424 ' CE2' ' HE1' ' A' ' 5' ' ' TYR . 2.7 t80 -99.62 123.52 43.96 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.176 -0.952 . . . . 0.0 110.145 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.423 ' SG ' ' SG ' ' A' ' 44' ' ' CYS . 59.7 m -134.94 128.13 31.94 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.295 -0.878 . . . . 0.0 110.141 179.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.465 ' HG3' ' HB2' ' A' ' 3' ' ' ASP . 0.5 OUTLIER -117.37 135.64 53.72 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.316 -0.865 . . . . 0.0 109.842 179.843 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 99.63 44.14 2.36 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.572 ' CD2' ' N ' ' A' ' 49' ' ' LEU . 0.1 OUTLIER -115.63 172.25 3.87 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.299 -1.118 . . . . 0.0 109.84 179.64 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.498 ' HD3' ' HB3' ' A' ' 31' ' ' LYS . 46.0 Cg_endo -72.04 157.82 53.63 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.832 1.438 . . . . 0.0 110.599 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -59.38 -19.96 51.1 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.208 -0.932 . . . . 0.0 109.941 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -83.84 6.68 20.58 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.281 -0.887 . . . . 0.0 110.04 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.435 ' HB1' ' O ' ' A' ' 50' ' ' PRO . . . -63.77 106.81 1.06 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.345 -0.847 . . . . 0.0 110.257 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.489 ' O ' ' HA ' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -62.42 156.45 22.61 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.244 -0.91 . . . . 0.0 109.93 179.744 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.469 HG22 ' O ' ' A' ' 5' ' ' TYR . 10.7 mm -142.77 -179.8 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.341 -0.849 . . . . 0.0 110.264 -179.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.493 ' O ' ' CG ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -60.38 84.31 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.436 -0.79 . . . . 0.0 110.124 179.277 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.497 ' NH1' ' HG2' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -106.09 -11.86 15.97 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.246 -0.909 . . . . 0.0 110.264 -179.942 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -146.1 167.04 24.38 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.335 -0.853 . . . . 0.0 110.191 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -148.62 35.64 1.11 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.526 ' O ' ' O ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER -136.98 41.72 2.47 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.111 -1.229 . . . . 0.0 110.383 179.767 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.526 ' O ' ' O ' ' A' ' 60' ' ' ARG . 49.6 t 41.06 106.54 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 121.586 0.708 . . . . 0.0 111.697 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.486 ' CB ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -83.19 40.09 0.69 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.186 -0.946 . . . . 0.0 110.688 179.56 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.658 0 O-C-N 121.086 -1.009 . . . . 0.0 110.296 179.947 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.271 0.558 . . . . 0.0 110.135 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.519 ' CG2' ' HG ' ' A' ' 49' ' ' LEU . 20.6 tt -126.01 160.58 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.295 -0.878 . . . . 0.0 110.181 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -139.75 128.9 23.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.311 -0.868 . . . . 0.0 110.007 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -177.58 -145.36 5.81 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.941 -1.263 . . . . 0.0 109.941 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.625 ' N ' ' CD1' ' A' ' 5' ' ' TYR . 12.8 m-85 -122.5 97.11 45.13 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.274 -1.133 . . . . 0.0 110.099 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.459 ' HA ' ' O ' ' A' ' 54' ' ' ARG . 42.5 Cg_endo -69.91 126.84 13.66 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.003 1.528 . . . . 0.0 110.815 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.534 HG11 ' CG2' ' A' ' 15' ' ' ILE . 15.2 m -85.38 -169.45 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.484 -0.76 . . . . 0.0 110.511 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.479 ' O ' ' NH1' ' A' ' 54' ' ' ARG . 2.6 t70 -63.15 -158.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.367 -0.833 . . . . 0.0 110.296 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.446 ' HB3' ' CE2' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -91.17 -20.3 22.13 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.296 -0.878 . . . . 0.0 110.176 179.972 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.485 ' HB3' ' N ' ' A' ' 62' ' ' ARG . 5.0 m-90 -128.25 18.24 6.5 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.176 -0.953 . . . . 0.0 110.52 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.483 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 8.3 m-20 59.88 12.7 3.19 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.343 -0.848 . . . . 0.0 110.372 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 3.5 t -79.23 -50.22 11.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.118 -0.989 . . . . 0.0 109.634 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.464 ' O ' ' O ' ' A' ' 14' ' ' ARG . 1.2 mptm? -79.97 152.38 29.54 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.464 -0.772 . . . . 0.0 109.611 179.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.464 ' O ' ' O ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -46.11 173.5 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.168 -0.958 . . . . 0.0 110.125 -179.921 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.534 ' CG2' HG11 ' A' ' 7' ' ' VAL . 3.9 mt -71.34 -1.94 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.113 -0.992 . . . . 0.0 109.853 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.56 ' HB2' ' N ' ' A' ' 44' ' ' CYS . 18.9 t -146.6 154.44 41.49 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.384 -0.823 . . . . 0.0 110.006 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.565 ' CZ3' ' CG ' ' A' ' 22' ' ' TYR . 28.3 t90 -118.39 169.54 9.66 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.118 -0.989 . . . . 0.0 109.796 179.438 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.421 ' N ' ' CG ' ' A' ' 17' ' ' TRP . 23.2 t80 -79.48 92.86 5.31 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.216 -0.928 . . . . 0.0 109.564 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.516 ' CB ' ' HB2' ' A' ' 22' ' ' TYR . 4.2 p-10 -174.3 142.47 0.79 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.289 -0.882 . . . . 0.0 110.517 -179.383 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 32.3 p30 -90.69 7.97 36.82 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.237 -0.914 . . . . 0.0 109.871 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.6 mttt -154.64 -28.69 0.11 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.145 -0.972 . . . . 0.0 111.724 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.565 ' CG ' ' CZ3' ' A' ' 17' ' ' TRP . 1.6 t80 -47.85 -21.54 0.43 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.555 -1.341 . . . . 0.0 110.576 -179.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.413 ' O ' ' HB2' ' A' ' 27' ' ' CYS . 0.1 OUTLIER -87.0 -34.9 19.09 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.05 -1.031 . . . . 0.0 110.327 -179.815 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.473 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 12.3 t-20 -72.67 -40.31 66.4 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.07 -1.018 . . . . 0.0 109.697 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -62.75 -33.87 76.05 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.323 -0.86 . . . . 0.0 109.93 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.431 ' HG ' ' N ' ' A' ' 27' ' ' CYS . 0.1 OUTLIER -83.23 -44.22 15.23 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.315 -0.866 . . . . 0.0 109.148 179.55 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.462 ' HB3' ' HB2' ' A' ' 32' ' ' ALA . 1.5 m -58.71 -40.79 84.7 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.536 -0.728 . . . . 0.0 109.562 179.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 24' ' ' ASN . 0.2 OUTLIER -64.34 -33.97 77.07 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.268 -0.895 . . . . 0.0 109.015 179.165 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.07 -37.33 45.5 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 108.589 -1.804 . . . . 0.0 108.589 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.672 ' O ' ' CB ' ' A' ' 31' ' ' LYS . 4.1 mt -79.75 -35.47 38.74 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.454 -1.027 . . . . 0.0 109.472 179.323 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.672 ' CB ' ' O ' ' A' ' 30' ' ' LEU . 21.5 tttt 139.21 2.88 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.575 0 C-N-CA 123.122 0.569 . . . . 0.0 110.131 179.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.497 ' HB3' ' HB3' ' A' ' 49' ' ' LEU . . . -88.25 109.3 19.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.781 -1.199 . . . . 0.0 110.18 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.45 ' HA ' ' HG3' ' A' ' 28' ' ' LYS . 2.6 m-20 -78.62 -44.4 24.05 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.142 -0.974 . . . . 0.0 110.402 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.463 ' O ' ' HA ' ' A' ' 46' ' ' CYS . 2.0 t -82.6 73.72 9.62 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.276 -0.89 . . . . 0.0 110.215 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.486 ' CA ' ' SG ' ' A' ' 46' ' ' CYS . . . -118.32 120.91 4.87 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.531 ' C ' ' CD1' ' A' ' 36' ' ' TYR . 14.0 p90 -143.79 153.89 42.86 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.322 -1.105 . . . . 0.0 109.742 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.0 OUTLIER -107.26 126.6 52.63 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.976 -1.077 . . . . 0.0 110.843 -179.443 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.593 ' CD1' ' HB3' ' A' ' 40' ' ' TRP . 43.7 t-105 -89.1 114.71 25.99 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.461 -0.774 . . . . 0.0 109.816 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.9 73.31 2.45 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 -179.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.593 ' HB3' ' CD1' ' A' ' 38' ' ' TRP . 0.1 OUTLIER -160.59 -73.27 0.07 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.283 -1.127 . . . . 0.0 109.8 179.395 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.504 HG23 ' CD1' ' A' ' 40' ' ' TRP . 15.0 t -169.0 39.29 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.506 -0.746 . . . . 0.0 109.908 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.575 HD11 ' CD1' ' A' ' 38' ' ' TRP . 0.4 OUTLIER -130.21 1.71 4.68 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.253 -0.904 . . . . 0.0 110.344 -179.897 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.471 ' HB3' HG21 ' A' ' 15' ' ' ILE . 48.9 m 56.12 -166.94 0.11 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.148 -0.97 . . . . 0.0 110.365 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.56 ' N ' ' HB2' ' A' ' 16' ' ' CYS . 6.8 t -77.91 151.37 33.81 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.253 -0.904 . . . . 0.0 110.171 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.539 ' CD1' ' CZ ' ' A' ' 5' ' ' TYR . 6.9 t80 -135.16 102.71 5.28 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.271 -0.893 . . . . 0.0 110.484 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.486 ' SG ' ' CA ' ' A' ' 35' ' ' GLY . 76.7 m -118.61 133.96 55.47 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.162 -0.961 . . . . 0.0 109.95 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 16.1 mt-30 -119.86 134.66 55.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.261 -0.899 . . . . 0.0 109.778 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 104.93 38.87 2.43 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.545 ' CD2' ' N ' ' A' ' 49' ' ' LEU . 0.1 OUTLIER -114.61 172.25 3.76 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.385 -1.068 . . . . 0.0 109.739 179.785 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.478 ' HD2' ' HB2' ' A' ' 49' ' ' LEU . 46.0 Cg_endo -71.94 156.31 56.52 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.676 1.356 . . . . 0.0 110.398 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.451 ' O ' ' OD1' ' A' ' 51' ' ' ASP . 21.0 t0 -60.34 -20.07 57.95 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.176 -0.952 . . . . 0.0 110.188 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -79.85 0.7 29.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.309 -0.869 . . . . 0.0 110.102 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.514 ' CB ' HD13 ' A' ' 49' ' ' LEU . . . -62.43 101.12 0.21 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.365 -0.834 . . . . 0.0 110.01 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.487 ' O ' ' CD1' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -55.33 149.85 12.33 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.079 -1.013 . . . . 0.0 110.218 -179.69 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.5 HG21 ' O ' ' A' ' 5' ' ' TYR . 35.5 mm -139.97 169.76 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.309 -0.87 . . . . 0.0 109.939 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.456 ' HD3' ' O ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -42.37 96.21 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.203 -0.936 . . . . 0.0 110.146 179.66 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.485 ' N ' ' O ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -125.51 7.6 7.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.197 -0.939 . . . . 0.0 110.092 179.923 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 58.64 160.39 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.29 -0.881 . . . . 0.0 110.494 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 148.41 -170.29 28.95 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.37 158.69 15.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.2 -1.177 . . . . 0.0 109.997 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 55.9 m -56.73 119.52 6.31 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.226 -0.921 . . . . 0.0 110.13 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.485 ' N ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -83.45 45.35 1.04 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.2 -0.937 . . . . 0.0 110.153 179.834 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.578 0 O-C-N 121.207 -0.933 . . . . 0.0 110.324 -179.758 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 1.5 tttt . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.3 0.571 . . . . 0.0 110.31 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.497 HG22 ' O ' ' A' ' 50' ' ' PRO . 5.9 tt -142.24 160.5 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.137 -0.977 . . . . 0.0 110.136 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.457 ' OD1' ' O ' ' A' ' 3' ' ' ASP . 3.6 p30 -126.9 122.65 35.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.301 -0.875 . . . . 0.0 110.383 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -165.11 -164.77 21.19 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.628 ' CE2' ' CD1' ' A' ' 45' ' ' TYR . 15.8 m-85 -117.31 107.9 44.53 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.227 -1.16 . . . . 0.0 110.487 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.531 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 49.6 Cg_endo -76.82 129.9 11.08 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 124.034 1.544 . . . . 0.0 110.649 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.482 HG12 HG23 ' A' ' 15' ' ' ILE . 32.8 m -105.63 -165.34 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.316 -0.865 . . . . 0.0 109.678 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.496 ' OD1' ' CZ3' ' A' ' 10' ' ' TRP . 5.0 t70 -60.56 -139.27 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.318 -0.864 . . . . 0.0 109.85 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.433 ' C ' ' CG ' ' A' ' 10' ' ' TRP . 3.2 m-85 -110.17 -4.11 15.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.083 -1.01 . . . . 0.0 110.079 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.562 ' CD1' ' O ' ' A' ' 62' ' ' ARG . 1.3 m-90 -143.55 8.58 1.55 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.254 -0.904 . . . . 0.0 110.165 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.533 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 7.5 m-20 66.56 2.29 2.45 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.631 -0.668 . . . . 0.0 110.894 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.429 ' O ' ' C ' ' A' ' 13' ' ' LYS . 0.6 OUTLIER -85.66 -59.09 2.41 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.165 -0.959 . . . . 0.0 110.5 -179.965 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.492 ' CB ' ' OD2' ' A' ' 8' ' ' ASP . 27.8 mmtt -41.99 -70.45 0.11 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.38 -0.825 . . . . 0.0 110.464 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.477 ' HG3' ' O ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -172.55 -178.7 2.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.272 -0.892 . . . . 0.0 110.286 -179.808 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.53 ' CG2' ' OG ' ' A' ' 43' ' ' SER . 0.6 OUTLIER -104.13 -17.85 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.273 -0.892 . . . . 0.0 109.442 179.935 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.555 ' SG ' ' CA ' ' A' ' 44' ' ' CYS . 5.3 t -158.42 174.31 15.31 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.375 -0.828 . . . . 0.0 110.462 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -100.8 -148.85 0.37 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.266 -0.896 . . . . 0.0 110.372 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -120.27 -37.28 3.08 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.152 -0.968 . . . . 0.0 110.331 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -82.3 140.64 33.47 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.351 -0.843 . . . . 0.0 110.402 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -69.24 -5.33 22.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.274 -0.891 . . . . 0.0 110.322 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.2 -31.6 7.84 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.159 -0.963 . . . . 0.0 110.4 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -63.18 -18.59 63.64 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.229 -0.92 . . . . 0.0 110.478 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.453 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 0.1 OUTLIER -90.53 -54.64 3.91 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.067 -1.02 . . . . 0.0 110.283 179.923 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.501 ' CB ' ' O ' ' A' ' 35' ' ' GLY . 52.0 t30 -48.98 -36.67 18.12 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.173 -0.954 . . . . 0.0 110.01 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.406 ' OD1' ' C ' ' A' ' 25' ' ' ASP . 13.1 t0 -57.78 -53.75 54.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.346 -0.846 . . . . 0.0 110.078 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.74 -42.75 85.74 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.201 -0.937 . . . . 0.0 110.263 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.49 ' HB3' ' HB2' ' A' ' 32' ' ' ALA . 1.3 m -58.86 -33.27 70.28 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.156 -0.965 . . . . 0.0 109.54 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.5 tptm -63.37 -30.69 71.78 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.304 -0.873 . . . . 0.0 109.083 179.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.18 -32.58 83.02 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 107.825 -2.11 . . . . 0.0 107.825 178.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.532 ' O ' ' CD ' ' A' ' 50' ' ' PRO . 2.9 mt -90.54 21.56 3.9 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.59 -0.947 . . . . 0.0 109.106 178.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.501 ' HB3' ' O ' ' A' ' 30' ' ' LEU . 13.0 tttm 65.25 20.32 11.88 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.815 -0.553 . . . . 0.0 110.78 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.49 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . . . -91.97 89.9 7.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.028 -1.045 . . . . 0.0 110.039 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -49.79 -79.66 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.371 -0.831 . . . . 0.0 110.667 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 75.2 m -71.04 91.4 0.89 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.215 -0.928 . . . . 0.0 110.438 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.521 ' CA ' ' SG ' ' A' ' 46' ' ' CYS . . . -131.56 123.72 3.81 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.418 ' C ' ' CD1' ' A' ' 36' ' ' TYR . 5.0 p90 -142.81 -175.29 4.44 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.177 -1.19 . . . . 0.0 110.594 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 6.2 t -115.91 136.35 53.12 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.217 -0.927 . . . . 0.0 110.406 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.596 ' CD1' ' HB2' ' A' ' 42' ' ' LEU . 1.9 t-105 -79.92 150.94 30.38 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.146 -0.971 . . . . 0.0 109.674 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -98.1 -13.81 41.37 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 -179.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.601 ' CD1' ' CG2' ' A' ' 41' ' ' THR . 40.8 t-105 -84.06 -73.05 0.44 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.216 -1.167 . . . . 0.0 109.936 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.601 ' CG2' ' CD1' ' A' ' 40' ' ' TRP . 7.5 t -179.66 50.52 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.554 -0.716 . . . . 0.0 109.748 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.596 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 0.5 OUTLIER -120.84 21.32 11.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.315 -0.866 . . . . 0.0 110.638 -179.554 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.53 ' OG ' ' CG2' ' A' ' 15' ' ' ILE . 28.2 t 50.99 -168.57 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.116 -0.99 . . . . 0.0 110.406 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.555 ' CA ' ' SG ' ' A' ' 16' ' ' CYS . 3.0 t -77.25 135.0 38.43 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.201 -0.937 . . . . 0.0 109.67 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.628 ' CD1' ' CE2' ' A' ' 5' ' ' TYR . 8.1 t80 -122.05 109.56 14.71 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.199 -0.938 . . . . 0.0 110.234 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.521 ' SG ' ' CA ' ' A' ' 35' ' ' GLY . 24.2 m -125.52 149.13 48.57 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.471 -0.768 . . . . 0.0 109.732 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.406 ' OE1' ' HB2' ' A' ' 3' ' ' ASP . 24.8 mt-30 -130.03 137.96 50.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.267 -0.895 . . . . 0.0 110.333 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 31' ' ' LYS . . . 112.32 22.84 5.69 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.534 HD13 ' CB ' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -99.85 170.26 6.99 Favored Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.128 -1.219 . . . . 0.0 109.999 179.645 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.532 ' CD ' ' O ' ' A' ' 30' ' ' LEU . 41.5 Cg_endo -67.31 155.06 72.1 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.978 1.515 . . . . 0.0 110.457 -179.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -56.94 -23.06 42.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.324 -0.86 . . . . 0.0 110.162 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -87.56 13.61 9.9 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.276 -0.89 . . . . 0.0 110.237 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.534 ' CB ' HD13 ' A' ' 49' ' ' LEU . . . -62.32 115.41 4.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.282 -0.887 . . . . 0.0 110.074 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.481 ' O ' ' HA ' ' A' ' 6' ' ' PRO . 0.1 OUTLIER -72.29 133.8 45.21 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.228 -0.92 . . . . 0.0 110.551 -179.811 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.531 ' HA ' ' HA ' ' A' ' 6' ' ' PRO . 1.3 pp -142.98 -167.52 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.426 -0.796 . . . . 0.0 110.209 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.453 ' HG3' HD13 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -41.05 91.74 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.342 -0.849 . . . . 0.0 111.007 -179.386 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.566 ' O ' ' C ' ' A' ' 58' ' ' SER . 10.3 mtp85 -120.48 21.81 11.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.199 -0.938 . . . . 0.0 109.323 179.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.566 ' C ' ' O ' ' A' ' 57' ' ' ARG . 0.2 OUTLIER -7.45 122.93 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.255 0 CA-C-O 121.475 0.655 . . . . 0.0 112.432 -179.571 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -142.43 -103.41 0.48 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.457 ' O ' ' O ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER -132.64 48.05 2.45 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.241 -1.153 . . . . 0.0 110.253 179.973 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.457 ' O ' ' O ' ' A' ' 60' ' ' ARG . 0.8 OUTLIER 40.24 91.46 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.505 -0.747 . . . . 0.0 109.933 179.938 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.562 ' O ' ' CD1' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -81.31 47.41 1.03 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.106 -0.997 . . . . 0.0 110.479 -179.666 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.171 -0.955 . . . . 0.0 110.332 -179.935 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 12.4 ptmt . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.255 0.55 . . . . 0.0 110.279 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.478 HG23 HD12 ' A' ' 2' ' ' ILE . 10.3 tt -125.02 163.16 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.326 -0.859 . . . . 0.0 110.159 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.457 ' OD1' ' O ' ' A' ' 2' ' ' ILE . 85.2 m-20 -135.91 136.12 40.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.343 -0.848 . . . . 0.0 109.979 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -178.39 -159.52 23.08 Favored Glycine 0 N--CA 1.492 2.388 0 C-N-CA 119.608 -1.282 . . . . 0.0 109.977 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.638 ' N ' ' CD1' ' A' ' 5' ' ' TYR . 5.4 m-85 -120.14 111.27 35.51 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.41 -1.053 . . . . 0.0 109.774 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 44' ' ' CYS . 45.4 Cg_endo -72.22 144.79 42.44 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.949 1.499 . . . . 0.0 110.877 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.535 ' CG1' HG21 ' A' ' 15' ' ' ILE . 15.7 m -99.71 -168.07 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.324 -0.86 . . . . 0.0 110.392 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -72.87 -128.04 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.4 -0.813 . . . . 0.0 110.105 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -115.55 -33.04 5.36 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.915 -1.115 . . . . 0.0 110.327 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.524 ' O ' ' HB2' ' A' ' 11' ' ' ASN . 4.1 m-90 -112.7 13.38 19.86 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.178 -0.952 . . . . 0.0 110.301 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.524 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 3.0 m-20 62.23 6.61 1.9 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.548 -0.72 . . . . 0.0 110.705 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 16.9 m -76.92 -67.02 0.75 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.062 -1.024 . . . . 0.0 110.358 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.432 ' O ' ' O ' ' A' ' 14' ' ' ARG . 2.9 mptm? -58.63 173.53 0.4 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.497 -0.752 . . . . 0.0 110.506 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.432 ' O ' ' O ' ' A' ' 13' ' ' LYS . 5.0 ttp180 -50.78 -178.54 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.352 -0.842 . . . . 0.0 110.139 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.535 HG21 ' CG1' ' A' ' 7' ' ' VAL . 4.0 mt -95.95 26.04 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.238 -0.914 . . . . 0.0 109.794 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.458 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 8.7 t -151.94 159.41 43.8 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.463 -0.773 . . . . 0.0 110.044 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.599 ' CZ3' ' CD1' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -85.75 -152.68 0.17 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.223 -0.923 . . . . 0.0 110.266 -179.967 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -120.33 44.43 2.45 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.289 -0.882 . . . . 0.0 110.357 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -176.84 158.78 1.67 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.151 -0.968 . . . . 0.0 110.321 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 34.8 t30 -82.9 -7.18 59.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.263 -0.898 . . . . 0.0 110.239 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.6 tptt -110.1 -31.32 7.4 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.256 -0.902 . . . . 0.0 109.971 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -54.64 -31.23 57.09 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.327 -0.858 . . . . 0.0 110.269 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.459 ' O ' ' HB2' ' A' ' 27' ' ' CYS . 0.1 OUTLIER -91.38 -32.77 15.53 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.223 -0.923 . . . . 0.0 110.481 -179.663 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.513 ' CB ' ' O ' ' A' ' 35' ' ' GLY . 25.1 t30 -70.63 -44.32 67.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.106 -0.996 . . . . 0.0 110.133 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -56.27 -45.57 80.07 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.232 -0.918 . . . . 0.0 110.468 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.599 ' CD1' ' CZ3' ' A' ' 17' ' ' TRP . 0.2 OUTLIER -78.1 -40.33 38.65 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.208 -0.932 . . . . 0.0 110.332 -179.9 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.516 ' HB3' ' HB2' ' A' ' 32' ' ' ALA . 1.6 m -57.45 -37.8 73.43 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.146 -0.971 . . . . 0.0 109.522 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.99 -28.12 69.88 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.427 -0.796 . . . . 0.0 109.524 179.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.62 -34.97 90.4 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 107.873 -2.091 . . . . 0.0 107.873 178.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.528 ' O ' ' CB ' ' A' ' 31' ' ' LYS . 1.3 mt -89.16 17.8 5.62 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.707 -0.878 . . . . 0.0 109.325 178.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.528 ' CB ' ' O ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER 72.54 14.79 5.16 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.64 -0.662 . . . . 0.0 111.161 179.688 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.516 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . . . -85.3 81.0 8.96 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.786 -1.196 . . . . 0.0 109.633 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 32' ' ' ALA . 0.1 OUTLIER -39.89 -80.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.373 -0.83 . . . . 0.0 110.842 -179.32 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.472 ' O ' ' HA ' ' A' ' 46' ' ' CYS . 57.9 m -69.85 90.16 0.6 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.33 -0.856 . . . . 0.0 110.514 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.513 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -122.26 89.18 0.42 Allowed Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 29.6 p90 -118.25 153.82 33.28 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.244 -1.151 . . . . 0.0 109.964 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.1 OUTLIER -107.31 134.59 50.16 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.148 -0.97 . . . . 0.0 110.632 -179.567 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.567 ' CD1' ' HB2' ' A' ' 42' ' ' LEU . 14.6 t-105 -83.67 125.57 31.99 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.396 -0.815 . . . . 0.0 109.908 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -89.15 64.25 3.33 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.559 ' CE2' HG23 ' A' ' 41' ' ' THR . 0.1 OUTLIER -155.84 -80.4 0.08 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.299 -1.118 . . . . 0.0 109.648 179.816 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.559 HG23 ' CE2' ' A' ' 40' ' ' TRP . 2.6 t -162.68 33.64 0.1 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.361 -0.837 . . . . 0.0 109.869 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.567 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 0.4 OUTLIER -117.9 4.92 12.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.333 -0.854 . . . . 0.0 110.363 -179.753 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.507 ' CB ' ' HB ' ' A' ' 15' ' ' ILE . 13.0 m 59.96 -170.93 0.13 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.218 -0.927 . . . . 0.0 110.456 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 37' ' ' CYS . 19.3 t -75.57 156.45 34.99 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.297 -0.877 . . . . 0.0 109.977 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -140.82 99.54 3.63 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.016 -1.053 . . . . 0.0 110.917 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.476 ' SG ' ' CA ' ' A' ' 35' ' ' GLY . 65.6 m -120.51 139.77 52.41 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.241 -0.912 . . . . 0.0 109.551 178.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.405 ' HA ' ' OD1' ' A' ' 3' ' ' ASP . 58.8 mt-30 -126.24 138.96 53.67 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.201 -0.937 . . . . 0.0 110.201 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 31' ' ' LYS . . . 103.8 32.61 4.38 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 -179.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.564 ' CD2' ' N ' ' A' ' 49' ' ' LEU . 0.1 OUTLIER -110.2 172.34 3.67 Favored Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 121.276 -1.132 . . . . 0.0 109.506 179.843 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.495 ' HD2' ' HB2' ' A' ' 49' ' ' LEU . 42.5 Cg_endo -67.78 162.17 40.68 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 O-C-N 123.514 1.271 . . . . 0.0 110.7 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -64.58 -19.78 65.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.354 -0.841 . . . . 0.0 110.134 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -92.68 15.57 14.14 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.265 -0.897 . . . . 0.0 109.997 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.513 ' CB ' HD11 ' A' ' 49' ' ' LEU . . . -62.29 141.79 58.08 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.183 -0.948 . . . . 0.0 110.205 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.455 ' O ' HD11 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -66.24 139.7 58.11 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.304 -0.873 . . . . 0.0 109.764 179.722 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.487 ' O ' ' N ' ' A' ' 57' ' ' ARG . 5.3 mm -139.1 -177.76 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.029 -1.045 . . . . 0.0 110.862 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.525 ' HA ' ' CG1' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -59.76 77.78 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.512 -0.742 . . . . 0.0 110.963 -179.528 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.487 ' N ' ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -107.0 17.47 23.02 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.208 -0.932 . . . . 0.0 109.539 179.117 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.438 ' C ' ' O ' ' A' ' 57' ' ' ARG . 0.8 OUTLIER -39.41 136.09 0.98 Allowed 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.25 0.548 . . . . 0.0 110.5 -179.776 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.456 ' O ' ' HD3' ' A' ' 60' ' ' ARG . . . 158.31 -34.45 0.51 Allowed Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.456 ' HD3' ' O ' ' A' ' 59' ' ' GLY . 14.8 mmt85 -114.93 68.92 0.71 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.325 -1.103 . . . . 0.0 110.348 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.423 ' C ' ' O ' ' A' ' 60' ' ' ARG . 0.1 OUTLIER -42.35 100.41 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.32 -0.862 . . . . 0.0 110.098 179.653 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.425 ' CB ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -83.84 45.89 1.12 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.132 -0.98 . . . . 0.0 110.246 -179.969 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.196 -0.94 . . . . 0.0 110.313 -179.931 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.283 0.563 . . . . 0.0 110.156 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.475 HG22 ' O ' ' A' ' 49' ' ' LEU . 4.4 tt -140.21 157.51 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.321 -0.862 . . . . 0.0 110.094 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.574 ' OD1' ' CE1' ' A' ' 45' ' ' TYR . 33.4 t0 -125.42 128.01 47.44 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.632 -0.667 . . . . 0.0 109.863 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -174.68 -160.23 22.36 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.691 ' CE2' ' CD1' ' A' ' 45' ' ' TYR . 3.6 m-85 -126.56 99.64 29.81 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.444 -1.033 . . . . 0.0 110.258 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.522 ' HD2' ' O ' ' A' ' 44' ' ' CYS . 43.4 Cg_endo -69.79 125.61 12.33 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 O-C-N 123.917 1.483 . . . . 0.0 110.659 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.565 ' CG1' ' HA ' ' A' ' 56' ' ' LYS . 17.2 m -79.65 175.49 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.418 -0.801 . . . . 0.0 110.31 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -51.35 167.85 0.08 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.272 -0.892 . . . . 0.0 110.145 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.518 ' HB3' ' CE2' ' A' ' 10' ' ' TRP . 0.3 OUTLIER -66.43 -8.48 26.22 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.244 -0.91 . . . . 0.0 110.287 179.976 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.527 ' CG ' ' HB2' ' A' ' 63' ' ' ALA . 1.7 m-90 -139.59 11.28 2.5 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.28 -0.887 . . . . 0.0 109.993 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.427 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 2.8 m120 55.54 19.06 3.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.205 -0.934 . . . . 0.0 109.572 -179.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 3.5 t -81.78 -38.64 25.29 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.55 -0.719 . . . . 0.0 110.74 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.405 ' O ' ' CB ' ' A' ' 14' ' ' ARG . 2.5 mttp -93.04 53.38 1.97 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.273 -0.892 . . . . 0.0 110.603 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.405 ' CB ' ' O ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER 62.57 -143.85 0.39 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.233 -0.917 . . . . 0.0 110.409 179.694 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.549 ' CD1' ' HB2' ' A' ' 43' ' ' SER . 31.8 pt -109.4 4.06 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.165 -0.959 . . . . 0.0 110.277 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.536 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 0.9 OUTLIER -151.36 -174.23 4.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.18 -0.95 . . . . 0.0 109.708 179.436 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.689 ' CE3' ' CG ' ' A' ' 22' ' ' TYR . 0.0 OUTLIER -118.02 -171.92 2.16 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.121 -0.987 . . . . 0.0 110.156 179.839 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -91.28 -36.59 13.79 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.11 -0.994 . . . . 0.0 110.294 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.466 ' HB2' ' HB2' ' A' ' 22' ' ' TYR . 20.8 m120 -78.87 148.58 32.73 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.326 -0.859 . . . . 0.0 110.302 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -88.66 -16.68 31.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.342 -0.849 . . . . 0.0 110.121 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.28 -14.11 24.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.287 -0.883 . . . . 0.0 110.318 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.689 ' CG ' ' CE3' ' A' ' 17' ' ' TRP . 2.8 t80 -72.62 -40.11 66.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.085 -1.009 . . . . 0.0 109.913 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.46 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 1.3 t -63.3 -34.4 77.6 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.328 -0.857 . . . . 0.0 109.659 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.538 ' CB ' ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -78.0 -51.82 9.76 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.279 -0.888 . . . . 0.0 109.776 179.76 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.476 ' N ' ' CG ' ' A' ' 24' ' ' ASN . 5.7 m-20 -51.54 -49.08 62.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.197 -0.94 . . . . 0.0 110.173 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.7 mt -71.04 -37.59 72.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.242 -0.911 . . . . 0.0 110.282 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.493 ' HB3' ' HB3' ' A' ' 32' ' ' ALA . 1.8 m -62.3 -38.66 90.25 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.159 -0.963 . . . . 0.0 109.616 179.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.515 ' CD ' ' HA ' ' A' ' 33' ' ' ASP . 8.7 mmmt -61.55 -27.07 68.36 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.291 -0.881 . . . . 0.0 109.145 179.277 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.61 -33.46 86.68 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 107.189 -2.364 . . . . 0.0 107.189 178.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.515 ' O ' ' CB ' ' A' ' 31' ' ' LYS . 12.8 mt -90.29 21.65 3.72 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.872 -0.781 . . . . 0.0 108.95 178.485 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.515 ' CB ' ' O ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER 71.81 8.54 6.09 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.452 -0.78 . . . . 0.0 110.81 179.875 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.493 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . . . -87.06 103.76 15.68 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.95 -1.094 . . . . 0.0 109.877 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.515 ' HA ' ' CD ' ' A' ' 28' ' ' LYS . 9.2 m-20 -67.05 -76.49 0.08 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -0.912 . . . . 0.0 110.723 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.473 ' O ' ' HA ' ' A' ' 46' ' ' CYS . 0.5 OUTLIER -66.28 93.68 0.23 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.361 -0.837 . . . . 0.0 110.791 -179.514 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.538 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -133.05 126.2 4.32 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.421 ' C ' ' SG ' ' A' ' 23' ' ' CYS . 40.4 p90 -145.48 151.56 38.38 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.152 -1.204 . . . . 0.0 110.261 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 42.0 t -97.1 133.16 42.12 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.185 -0.947 . . . . 0.0 110.913 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.529 ' CB ' ' HB2' ' A' ' 42' ' ' LEU . 0.7 OUTLIER -97.49 138.62 34.64 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.266 -0.896 . . . . 0.0 109.935 179.535 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -89.06 8.74 79.15 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.533 ' CD1' HG21 ' A' ' 41' ' ' THR . 20.6 t-105 -99.57 -76.46 0.54 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.166 -1.196 . . . . 0.0 110.104 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.533 HG21 ' CD1' ' A' ' 40' ' ' TRP . 11.6 t -169.08 31.63 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.393 -0.817 . . . . 0.0 109.888 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.549 ' O ' ' CD2' ' A' ' 5' ' ' TYR . 10.9 mp -107.0 14.23 26.66 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.442 -0.786 . . . . 0.0 110.215 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.549 ' HB2' ' CD1' ' A' ' 15' ' ' ILE . 8.2 t 47.56 -169.1 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.185 -0.947 . . . . 0.0 110.239 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.522 ' O ' ' HD2' ' A' ' 6' ' ' PRO . 1.8 t -81.41 97.12 7.59 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.691 ' CD1' ' CE2' ' A' ' 5' ' ' TYR . 4.8 t80 -79.81 130.54 35.41 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.12 -0.988 . . . . 0.0 111.251 -178.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 34' ' ' SER . 83.3 m -145.15 145.94 31.58 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.366 -0.834 . . . . 0.0 109.376 179.104 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.47 ' HG2' ' OD1' ' A' ' 3' ' ' ASP . 3.9 mt-30 -127.57 142.23 51.42 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.086 -1.008 . . . . 0.0 110.244 -179.618 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' A' ' 31' ' ' LYS . . . 101.94 31.03 5.54 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 179.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.526 HD22 ' N ' ' A' ' 49' ' ' LEU . 0.1 OUTLIER -108.58 171.75 4.26 Favored Pre-proline 0 N--CA 1.497 1.896 0 O-C-N 121.132 -1.216 . . . . 0.0 109.658 179.456 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.504 ' HD3' ' O ' ' A' ' 30' ' ' LEU . 44.1 Cg_endo -69.41 159.42 53.73 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 123.621 1.327 . . . . 0.0 110.738 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -61.15 -24.04 65.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.32 -0.863 . . . . 0.0 109.822 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -88.05 9.69 21.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.335 -0.853 . . . . 0.0 109.854 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.483 ' O ' HG12 ' A' ' 55' ' ' ILE . . . -59.16 126.09 26.26 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.374 -0.829 . . . . 0.0 110.233 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.546 ' O ' ' CD1' ' A' ' 55' ' ' ILE . 14.1 ttm-85 -53.82 150.08 7.94 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.317 -0.864 . . . . 0.0 110.351 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.546 ' CD1' ' O ' ' A' ' 54' ' ' ARG . 5.8 mm -146.87 175.03 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.443 -0.786 . . . . 0.0 110.013 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.565 ' HA ' ' CG1' ' A' ' 7' ' ' VAL . 0.1 OUTLIER -46.44 94.63 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.35 -0.844 . . . . 0.0 110.211 179.31 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.475 ' N ' ' O ' ' A' ' 55' ' ' ILE . 0.1 OUTLIER -116.29 -13.93 11.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.184 -0.948 . . . . 0.0 110.364 -179.904 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.0 t 49.86 -172.14 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.201 -0.937 . . . . 0.0 110.177 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 133.08 -129.43 5.43 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.33 138.47 53.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.328 -1.101 . . . . 0.0 110.265 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 32.5 t -43.61 113.75 0.55 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.233 -0.917 . . . . 0.0 110.179 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.519 ' CB ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -86.88 35.1 0.68 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.178 -0.951 . . . . 0.0 110.356 -179.961 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.527 ' HB2' ' CG ' ' A' ' 10' ' ' TRP . . . . . . . . 0 N--CA 1.492 1.654 0 O-C-N 121.281 -0.887 . . . . 0.0 110.105 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 2.8 ptmt . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.23 0.538 . . . . 0.0 110.184 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.49 ' CG2' ' HG ' ' A' ' 49' ' ' LEU . 3.3 tt -120.52 163.53 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.269 -0.894 . . . . 0.0 110.313 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.504 ' CB ' ' HG2' ' A' ' 47' ' ' GLN . 35.1 p-10 -125.26 117.19 23.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.589 -0.694 . . . . 0.0 109.675 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -153.37 -165.03 13.1 Favored Glycine 0 N--CA 1.493 2.455 0 C-N-CA 119.529 -1.32 . . . . 0.0 110.285 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.688 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 21.4 m-85 -124.9 97.84 37.66 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.424 -1.045 . . . . 0.0 110.523 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.512 ' HD2' ' O ' ' A' ' 44' ' ' CYS . 44.2 Cg_endo -70.68 130.31 18.01 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.865 1.455 . . . . 0.0 110.691 179.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.46 HG13 ' HA ' ' A' ' 15' ' ' ILE . 15.6 m -80.51 -162.53 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.303 -0.873 . . . . 0.0 110.523 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.424 ' O ' ' NH1' ' A' ' 54' ' ' ARG . 1.0 OUTLIER -74.63 -88.59 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.439 -0.788 . . . . 0.0 110.553 -179.544 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.473 ' O ' ' NH1' ' A' ' 62' ' ' ARG . 0.2 OUTLIER -142.35 -66.79 0.39 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.295 -0.878 . . . . 0.0 110.066 -179.888 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.522 ' O ' ' HB2' ' A' ' 11' ' ' ASN . 4.0 m-90 -90.2 10.38 24.8 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.307 -0.87 . . . . 0.0 109.823 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.522 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 6.2 m-20 65.75 5.44 3.36 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.627 -0.67 . . . . 0.0 110.655 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 2.7 t -73.65 -36.8 65.43 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.047 -1.033 . . . . 0.0 109.617 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.464 ' O ' ' O ' ' A' ' 14' ' ' ARG . 5.8 tttt -86.72 152.3 22.65 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.42 -0.8 . . . . 0.0 109.333 179.092 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.464 ' O ' ' O ' ' A' ' 13' ' ' LYS . 1.1 ptp180 -38.31 160.25 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.419 -0.801 . . . . 0.0 110.983 -179.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.538 ' CD1' ' OG ' ' A' ' 43' ' ' SER . 30.3 pt -70.5 0.71 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.383 -0.823 . . . . 0.0 110.84 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.502 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 1.7 t -141.74 121.86 13.8 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.174 -0.954 . . . . 0.0 109.406 179.192 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.66 ' CD2' ' CD2' ' A' ' 22' ' ' TYR . 1.1 t90 -60.94 -137.28 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.14 -0.975 . . . . 0.0 110.111 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -142.6 30.6 1.51 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.159 -0.963 . . . . 0.0 110.468 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.533 ' HB2' ' CE3' ' A' ' 17' ' ' TRP . 0.1 OUTLIER -143.63 134.47 25.27 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.152 -0.967 . . . . 0.0 110.235 179.759 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -69.17 -6.81 31.11 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.313 -0.867 . . . . 0.0 110.119 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.84 -21.84 12.89 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.32 -0.863 . . . . 0.0 110.224 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.66 ' CD2' ' CD2' ' A' ' 17' ' ' TRP . 8.5 t80 -72.53 -56.74 4.9 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.243 -0.911 . . . . 0.0 109.579 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.479 ' O ' ' HB2' ' A' ' 27' ' ' CYS . 1.6 t -56.3 -30.25 62.27 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.435 -0.791 . . . . 0.0 109.51 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.488 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 10.0 t-20 -81.14 -36.04 30.76 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.134 -0.979 . . . . 0.0 109.99 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -64.06 -48.77 74.95 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.197 -0.939 . . . . 0.0 109.711 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.64 -40.02 73.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.372 -0.83 . . . . 0.0 109.867 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.517 ' HB3' ' HB2' ' A' ' 32' ' ' ALA . 9.7 m -62.74 -41.01 98.99 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.314 -0.867 . . . . 0.0 109.747 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 24' ' ' ASN . 0.0 OUTLIER -63.79 -24.4 67.74 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.204 -0.935 . . . . 0.0 109.347 179.302 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.83 -37.03 91.89 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 107.638 -2.185 . . . . 0.0 107.638 178.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.496 ' O ' ' HB3' ' A' ' 31' ' ' LYS . 1.1 mt -93.67 20.19 7.76 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.815 -0.815 . . . . 0.0 109.245 178.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.496 ' HB3' ' O ' ' A' ' 30' ' ' LEU . 0.1 OUTLIER 69.61 15.78 8.12 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.851 -0.53 . . . . 0.0 111.365 179.557 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.517 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . . . -78.36 86.04 4.45 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.744 -1.222 . . . . 0.0 109.26 179.273 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.416 ' C ' ' O ' ' A' ' 32' ' ' ALA . 2.2 m-20 -39.38 -90.3 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.621 -0.675 . . . . 0.0 111.488 -178.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.493 ' O ' ' HA ' ' A' ' 46' ' ' CYS . 12.5 p -67.01 92.34 0.24 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.31 -0.869 . . . . 0.0 111.109 -178.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.508 ' CA ' ' SG ' ' A' ' 46' ' ' CYS . . . -122.31 108.79 1.32 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 108.91 -1.676 . . . . 0.0 108.91 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.411 ' CD1' ' C ' ' A' ' 36' ' ' TYR . 30.4 p90 -135.8 165.57 25.3 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.178 -1.19 . . . . 0.0 110.651 -179.516 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.511 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.0 OUTLIER -107.59 128.99 55.03 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.317 -0.864 . . . . 0.0 109.94 179.608 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.587 ' CD1' ' HB2' ' A' ' 42' ' ' LEU . 35.5 t-105 -79.6 166.87 21.43 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.091 -1.006 . . . . 0.0 110.005 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -98.25 -27.35 8.77 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 120.003 -1.094 . . . . 0.0 110.369 -179.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.566 ' HB3' ' CD1' ' A' ' 38' ' ' TRP . 48.6 t-105 -79.51 -91.8 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.994 -1.298 . . . . 0.0 110.074 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.487 HG21 ' CD2' ' A' ' 40' ' ' TRP . 41.6 p -150.54 34.9 0.63 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.074 -1.016 . . . . 0.0 110.346 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.587 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 0.2 OUTLIER -89.53 0.29 57.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.303 -0.873 . . . . 0.0 110.074 179.809 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.538 ' OG ' ' CD1' ' A' ' 15' ' ' ILE . 0.9 OUTLIER 60.77 -176.4 0.11 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.227 -0.921 . . . . 0.0 110.201 -179.897 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.512 ' O ' ' HD2' ' A' ' 6' ' ' PRO . 0.9 OUTLIER -80.19 94.48 6.05 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.991 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.688 ' CD1' ' CZ ' ' A' ' 5' ' ' TYR . 9.3 t80 -79.98 138.97 37.18 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.117 -0.989 . . . . 0.0 110.682 -179.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.508 ' SG ' ' CA ' ' A' ' 35' ' ' GLY . 74.2 m -149.3 144.44 26.47 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.343 -0.848 . . . . 0.0 110.228 179.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.504 ' HG2' ' CB ' ' A' ' 3' ' ' ASP . 39.1 mt-30 -126.64 149.39 49.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.387 -0.821 . . . . 0.0 110.069 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.486 ' O ' ' O ' ' A' ' 31' ' ' LYS . . . 99.59 21.73 13.97 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.503 ' HB2' ' HD2' ' A' ' 50' ' ' PRO . 0.1 OUTLIER -101.48 169.29 7.91 Favored Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 121.072 -1.252 . . . . 0.0 109.898 179.626 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.503 ' HD2' ' HB2' ' A' ' 49' ' ' LEU . 44.6 Cg_endo -71.56 159.02 52.4 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 123.717 1.377 . . . . 0.0 110.342 -179.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.442 ' HA ' HD13 ' A' ' 2' ' ' ILE . 18.9 t70 -60.47 -23.66 64.64 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.157 -0.964 . . . . 0.0 109.723 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -92.87 17.24 10.88 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.466 -0.771 . . . . 0.0 109.609 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.516 ' O ' ' CD1' ' A' ' 55' ' ' ILE . . . -47.72 143.67 3.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.372 -0.83 . . . . 0.0 110.104 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.481 ' O ' ' HA ' ' A' ' 6' ' ' PRO . 41.8 ttp85 -85.24 91.7 8.22 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.344 -0.848 . . . . 0.0 110.334 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.546 ' CD1' ' N ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -140.3 166.81 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.324 -0.86 . . . . 0.0 109.965 179.69 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 6.1 mttt 45.25 67.12 0.77 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.135 -0.978 . . . . 0.0 109.759 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.477 ' HG2' ' O ' ' A' ' 55' ' ' ILE . 34.2 mmm-85 -125.44 17.25 8.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.247 -0.908 . . . . 0.0 110.458 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 57' ' ' ARG . 0.7 OUTLIER -42.23 138.99 1.52 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.334 -0.854 . . . . 0.0 109.941 179.884 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -164.25 -128.28 0.94 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.492 ' O ' ' O ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER -117.32 46.67 1.65 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.394 -1.063 . . . . 0.0 110.242 -179.97 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.492 ' O ' ' O ' ' A' ' 60' ' ' ARG . 52.2 m 56.06 121.46 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.476 0.655 . . . . 0.0 110.643 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.475 ' NH1' ' HA ' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -87.66 39.18 0.87 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.024 -1.048 . . . . 0.0 110.235 179.747 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.234 -0.917 . . . . 0.0 110.264 -179.938 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 7.5 mttt . . . . . 0 N--CA 1.494 1.749 0 CA-C-O 121.158 0.504 . . . . 0.0 110.025 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.461 HG23 ' O ' ' A' ' 50' ' ' PRO . 13.5 tt -118.98 161.81 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.143 -0.973 . . . . 0.0 110.337 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -131.34 131.46 43.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.259 -0.901 . . . . 0.0 110.032 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.449 ' O ' ' CD1' ' A' ' 45' ' ' TYR . . . -169.95 -176.17 39.43 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.702 -1.237 . . . . 0.0 110.011 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.681 ' CE1' ' CE1' ' A' ' 45' ' ' TYR . 66.8 m-85 -106.27 100.85 31.62 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.381 -1.07 . . . . 0.0 110.15 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.477 ' O ' ' HB3' ' A' ' 44' ' ' CYS . 43.3 Cg_endo -70.59 140.98 40.76 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.845 1.445 . . . . 0.0 110.478 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.529 ' CG1' HG21 ' A' ' 15' ' ' ILE . 5.1 m -110.12 -170.99 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.194 -0.941 . . . . 0.0 110.168 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -63.99 -145.04 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.24 -0.913 . . . . 0.0 110.686 -179.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -85.97 -47.57 9.49 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.427 -0.796 . . . . 0.0 110.648 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.486 ' HB3' ' CB ' ' A' ' 62' ' ' ARG . 3.3 m-90 -120.36 21.35 11.7 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.098 -1.001 . . . . 0.0 110.546 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.49 ' N ' ' OD1' ' A' ' 11' ' ' ASN . 1.8 m-20 57.7 15.12 2.74 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.118 -0.989 . . . . 0.0 110.154 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.8 t -84.94 -52.8 5.73 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.244 -0.91 . . . . 0.0 110.46 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.426 ' O ' ' CG ' ' A' ' 14' ' ' ARG . 5.6 tptt -61.49 -51.91 66.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.33 -0.856 . . . . 0.0 110.326 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.426 ' CG ' ' O ' ' A' ' 13' ' ' LYS . 0.1 OUTLIER 176.66 -158.71 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.204 -0.935 . . . . 0.0 110.511 -179.963 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.538 ' CD1' ' N ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -119.33 -18.04 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.368 -0.832 . . . . 0.0 109.491 179.558 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.556 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 1.8 t -132.64 111.99 11.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.469 -0.769 . . . . 0.0 110.22 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.466 ' CD2' ' HB3' ' A' ' 22' ' ' TYR . 0.0 OUTLIER -50.27 163.55 0.16 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.24 -0.913 . . . . 0.0 110.157 179.868 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -79.88 -24.75 40.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.305 -0.872 . . . . 0.0 109.983 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -83.88 145.72 28.46 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.272 -0.892 . . . . 0.0 110.047 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 16.0 p30 -80.46 7.6 9.47 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.212 -0.93 . . . . 0.0 110.416 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -131.23 -18.42 2.91 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.137 -0.977 . . . . 0.0 110.954 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.466 ' HB3' ' CD2' ' A' ' 17' ' ' TRP . 0.1 OUTLIER -60.36 -14.07 16.66 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.926 -1.109 . . . . 0.0 110.286 -179.753 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.464 ' O ' ' HB2' ' A' ' 27' ' ' CYS . 0.1 OUTLIER -103.58 -29.85 10.86 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.152 -0.967 . . . . 0.0 110.204 179.926 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.461 ' O ' ' CG ' ' A' ' 28' ' ' LYS . 55.1 t-20 -72.81 -52.58 14.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.192 -0.943 . . . . 0.0 109.582 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -54.75 -42.34 71.51 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.257 -0.902 . . . . 0.0 109.91 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.434 ' CD1' ' C ' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -72.89 -41.64 64.45 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.279 -0.888 . . . . 0.0 109.431 179.749 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.504 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . 1.5 m -60.61 -39.75 89.34 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.4 -0.813 . . . . 0.0 109.638 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.461 ' CG ' ' O ' ' A' ' 24' ' ' ASN . 1.7 mmmp? -61.73 -30.17 70.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.362 -0.837 . . . . 0.0 109.6 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.82 -34.01 80.74 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 108.149 -1.981 . . . . 0.0 108.149 179.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.55 ' O ' ' CB ' ' A' ' 31' ' ' LYS . 62.4 mt -93.06 18.56 9.07 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.605 -0.938 . . . . 0.0 109.785 179.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.55 ' CB ' ' O ' ' A' ' 30' ' ' LEU . 0.1 OUTLIER 76.11 12.76 2.75 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.618 -0.676 . . . . 0.0 111.133 179.717 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.53 ' CB ' HD21 ' A' ' 49' ' ' LEU . . . -88.52 82.1 7.0 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.845 -1.159 . . . . 0.0 109.734 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.406 ' O ' ' HD3' ' A' ' 28' ' ' LYS . 72.1 m-20 -46.25 -74.91 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.576 -0.702 . . . . 0.0 111.151 -179.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.0 t -69.76 90.38 0.59 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.424 -0.798 . . . . 0.0 110.983 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.482 ' CA ' ' SG ' ' A' ' 46' ' ' CYS . . . -122.04 113.89 2.37 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 108.976 -1.65 . . . . 0.0 108.976 179.212 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.567 ' CE1' ' HB3' ' A' ' 45' ' ' TYR . 27.4 p90 -133.28 154.6 50.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.123 -1.222 . . . . 0.0 110.485 -179.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.479 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.5 OUTLIER -107.73 118.08 35.81 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.332 -0.855 . . . . 0.0 110.151 179.775 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.597 ' CD1' ' HB3' ' A' ' 40' ' ' TRP . 25.0 t-105 -85.71 99.37 11.28 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.157 -0.965 . . . . 0.0 110.248 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.71 68.03 1.02 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.597 ' HB3' ' CD1' ' A' ' 38' ' ' TRP . 57.3 t-105 -157.94 -88.61 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.251 -1.147 . . . . 0.0 110.254 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 67.0 p -144.74 23.12 1.59 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.114 -0.991 . . . . 0.0 110.281 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.583 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 0.4 OUTLIER -121.01 11.17 10.94 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.168 -0.958 . . . . 0.0 110.537 -179.82 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.556 ' HA ' ' HB2' ' A' ' 16' ' ' CYS . 25.7 m 46.81 -170.23 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.919 -1.113 . . . . 0.0 109.973 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.494 ' HB2' ' HA ' ' A' ' 16' ' ' CYS . 51.2 t -77.65 151.65 34.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.101 -1.0 . . . . 0.0 109.139 179.224 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.681 ' CE1' ' CE1' ' A' ' 5' ' ' TYR . 6.1 t80 -147.85 123.86 10.72 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.836 -1.165 . . . . 0.0 111.299 -179.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.496 ' HB3' ' HB3' ' A' ' 32' ' ' ALA . 80.0 m -130.63 142.73 50.45 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.444 -0.785 . . . . 0.0 109.453 178.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 13.2 mp0 -116.98 131.17 57.02 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.082 -1.011 . . . . 0.0 110.22 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 31' ' ' LYS . . . 105.35 42.04 1.81 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.602 ' CD2' ' N ' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -103.51 -174.79 0.35 Allowed Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.1 -1.236 . . . . 0.0 109.466 179.744 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.559 ' CD ' ' CB ' ' A' ' 49' ' ' LEU . 49.9 Cg_endo -86.23 160.33 9.88 Favored 'Trans proline' 0 C--N 1.303 -1.842 0 O-C-N 123.938 1.493 . . . . 0.0 109.764 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -59.91 -19.54 52.19 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.051 -1.031 . . . . 0.0 109.756 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -99.54 22.01 11.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.331 -0.856 . . . . 0.0 109.645 179.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.474 ' HB3' ' O ' ' A' ' 50' ' ' PRO . . . -60.1 137.9 58.0 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.374 -0.828 . . . . 0.0 110.244 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.478 ' NH2' ' HB3' ' A' ' 54' ' ' ARG . 12.2 ttp-105 -77.69 129.61 35.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.267 -0.896 . . . . 0.0 110.03 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.53 ' O ' ' N ' ' A' ' 57' ' ' ARG . 12.9 mm -134.5 177.15 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.182 -0.949 . . . . 0.0 109.616 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 2.4 ptmt -67.14 61.77 0.05 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.121 -0.987 . . . . 0.0 109.191 179.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.53 ' N ' ' O ' ' A' ' 55' ' ' ILE . 20.0 ttm-85 -86.86 -25.17 24.63 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.598 -0.689 . . . . 0.0 110.665 -179.205 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.8 m -123.19 162.0 23.4 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.14 -0.975 . . . . 0.0 110.119 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -145.17 13.97 1.88 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.515 ' O ' ' O ' ' A' ' 61' ' ' CYS . 2.4 mpp_? -106.55 41.86 1.37 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.096 -1.238 . . . . 0.0 110.211 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.515 ' O ' ' O ' ' A' ' 60' ' ' ARG . 42.7 t 42.42 104.25 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.501 0.667 . . . . 0.0 111.285 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.486 ' CB ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -81.53 45.39 0.87 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.087 -1.008 . . . . 0.0 110.412 179.588 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.069 -1.019 . . . . 0.0 110.183 179.873 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 4.0 pttp . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.265 0.555 . . . . 0.0 110.248 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.5 ' CG2' ' HG ' ' A' ' 49' ' ' LEU . 15.2 tt -131.68 161.1 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.266 -0.896 . . . . 0.0 110.136 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.409 ' OD1' ' HA ' ' A' ' 47' ' ' GLN . 48.8 m-20 -127.46 147.57 50.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.379 -0.826 . . . . 0.0 110.133 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 164.21 -179.93 38.78 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.668 ' CZ ' ' CD2' ' A' ' 45' ' ' TYR . 23.8 m-85 -98.22 109.82 53.68 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.331 -1.1 . . . . 0.0 110.241 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.495 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 48.8 Cg_endo -74.8 130.53 13.58 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 123.972 1.512 . . . . 0.0 110.576 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.424 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . 16.4 m -119.66 -168.22 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.23 -0.919 . . . . 0.0 109.767 179.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.489 ' HB2' ' HB2' ' A' ' 14' ' ' ARG . 0.7 OUTLIER -66.58 -176.84 0.51 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.332 -0.855 . . . . 0.0 110.139 179.712 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.483 ' HB3' ' CE2' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -79.1 -5.85 55.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.326 -0.859 . . . . 0.0 109.9 179.723 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.483 ' CE2' ' HB3' ' A' ' 9' ' ' TYR . 4.5 m-90 -137.98 3.62 2.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.282 -0.886 . . . . 0.0 110.513 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.478 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 2.2 m-20 59.73 12.21 2.83 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.283 -0.886 . . . . 0.0 110.524 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 4.2 t -77.78 -62.85 1.54 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.097 -1.002 . . . . 0.0 111.186 -178.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.516 ' O ' ' CB ' ' A' ' 14' ' ' ARG . 1.5 tmtt? -136.39 98.98 3.97 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.059 -1.026 . . . . 0.0 111.313 -179.089 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.566 ' O ' ' N ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER 168.04 -88.74 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.361 -0.837 . . . . 0.0 110.222 179.098 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.533 HG21 ' CB ' ' A' ' 43' ' ' SER . 5.0 mt 55.57 -81.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.142 -0.974 . . . . 0.0 110.087 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.566 ' N ' ' O ' ' A' ' 14' ' ' ARG . 37.5 t -122.77 127.91 49.78 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.428 -0.795 . . . . 0.0 109.946 179.238 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.64 ' CZ3' ' CD2' ' A' ' 22' ' ' TYR . 0.1 OUTLIER -69.8 -145.5 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.051 -1.03 . . . . 0.0 109.92 179.609 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -118.02 -9.73 10.5 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.239 -0.913 . . . . 0.0 110.21 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.437 ' CB ' ' HB2' ' A' ' 22' ' ' TYR . 0.7 OUTLIER -117.8 166.65 12.2 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.318 -0.864 . . . . 0.0 110.296 -179.896 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -88.68 -59.47 2.22 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.254 -0.904 . . . . 0.0 110.308 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.28 -26.98 66.9 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.208 -0.932 . . . . 0.0 110.24 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.64 ' CD2' ' CZ3' ' A' ' 17' ' ' TRP . 0.4 OUTLIER -58.86 -53.65 56.01 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.316 -0.865 . . . . 0.0 110.506 -179.818 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -66.77 -27.18 67.38 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.17 -0.956 . . . . 0.0 110.337 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.439 ' OD1' ' O ' ' A' ' 33' ' ' ASP . 25.0 t-20 -66.71 -55.61 14.32 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.276 -0.89 . . . . 0.0 110.272 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -44.09 -49.86 8.7 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.347 -0.846 . . . . 0.0 110.417 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.53 -42.1 95.96 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.201 -0.937 . . . . 0.0 110.154 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.462 ' HB3' ' HB2' ' A' ' 32' ' ' ALA . 0.8 OUTLIER -59.54 -39.87 85.38 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.243 -0.911 . . . . 0.0 109.419 179.474 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.1 mtmt -62.91 -33.9 76.3 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.258 -0.901 . . . . 0.0 109.154 179.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -50.87 -39.42 39.84 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.766 -1.734 . . . . 0.0 108.766 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.655 ' O ' ' CB ' ' A' ' 31' ' ' LYS . 6.9 mt -79.94 -34.07 39.14 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.248 -1.148 . . . . 0.0 109.609 179.415 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.655 ' CB ' ' O ' ' A' ' 30' ' ' LEU . 1.8 tttp 141.14 0.35 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.658 0 C-N-CA 123.015 0.526 . . . . 0.0 110.126 179.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' A' ' 48' ' ' GLY . . . -85.44 117.12 24.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.95 -1.094 . . . . 0.0 110.511 -179.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.439 ' O ' ' OD1' ' A' ' 24' ' ' ASN . 11.3 t0 -83.32 -59.15 2.55 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.272 -0.893 . . . . 0.0 110.309 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.93 88.04 2.9 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.388 -0.82 . . . . 0.0 110.117 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.482 ' CA ' ' SG ' ' A' ' 46' ' ' CYS . . . -124.03 109.68 1.33 Allowed Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.446 ' OH ' ' CD2' ' A' ' 45' ' ' TYR . 47.6 p90 -127.27 147.44 50.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.279 -1.13 . . . . 0.0 109.861 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.1 OUTLIER -91.66 140.64 29.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.284 -0.885 . . . . 0.0 110.815 -179.282 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.583 ' CD1' ' HB3' ' A' ' 40' ' ' TRP . 45.5 t-105 -79.78 104.11 10.14 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.276 -0.89 . . . . 0.0 109.407 179.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -76.4 76.09 1.53 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -179.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.583 ' HB3' ' CD1' ' A' ' 38' ' ' TRP . 5.8 t-105 -160.5 -72.21 0.07 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.41 -1.053 . . . . 0.0 109.583 179.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.471 ' HB ' ' O ' ' A' ' 40' ' ' TRP . 12.7 t -179.11 35.3 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.569 -0.707 . . . . 0.0 109.79 179.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.569 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 1.7 mt -113.12 -84.3 0.59 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.244 -0.91 . . . . 0.0 110.866 -179.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.533 ' CB ' HG21 ' A' ' 15' ' ' ILE . 3.2 t 170.36 175.76 0.06 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.411 -0.806 . . . . 0.0 109.59 -179.394 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.497 ' O ' ' CD2' ' A' ' 5' ' ' TYR . 10.3 t -63.49 159.96 17.43 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.003 -1.06 . . . . 0.0 108.923 179.415 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.668 ' CD2' ' CZ ' ' A' ' 5' ' ' TYR . 1.0 OUTLIER -147.99 116.41 6.59 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.877 -1.14 . . . . 0.0 110.935 -179.755 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.482 ' SG ' ' CA ' ' A' ' 35' ' ' GLY . 71.6 m -128.46 149.38 50.6 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.28 -0.887 . . . . 0.0 109.686 179.238 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.409 ' HA ' ' OD1' ' A' ' 3' ' ' ASP . 0.2 OUTLIER -127.96 104.51 7.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.163 -0.96 . . . . 0.0 110.074 -179.853 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 32' ' ' ALA . . . 131.51 49.86 0.1 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.525 HD13 ' CB ' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -120.37 173.47 3.69 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.351 -1.087 . . . . 0.0 110.106 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.501 ' HD2' ' HB2' ' A' ' 49' ' ' LEU . 43.0 Cg_endo -70.38 157.7 58.4 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.944 1.497 . . . . 0.0 110.362 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -60.39 -18.0 47.62 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.285 -0.884 . . . . 0.0 110.033 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -89.83 9.18 28.45 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.34 -0.85 . . . . 0.0 109.968 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.525 ' CB ' HD13 ' A' ' 49' ' ' LEU . . . -58.42 122.01 12.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.388 -0.82 . . . . 0.0 110.275 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.412 ' O ' HG21 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -78.03 130.88 37.01 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.181 -0.949 . . . . 0.0 110.297 -179.98 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.523 ' O ' ' N ' ' A' ' 57' ' ' ARG . 2.3 pp -145.0 -179.56 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.317 -0.865 . . . . 0.0 110.074 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.423 ' O ' ' HG3' ' A' ' 56' ' ' LYS . 4.1 ptpt -51.35 88.2 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.323 -0.861 . . . . 0.0 110.479 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.523 ' N ' ' O ' ' A' ' 55' ' ' ILE . 0.3 OUTLIER -110.25 -28.85 8.42 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.408 -0.808 . . . . 0.0 109.382 179.526 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -125.48 170.84 11.01 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.67 -0.644 . . . . 0.0 110.222 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -124.71 -3.8 7.61 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.402 ' O ' ' HG3' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -108.14 131.64 54.43 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.272 -1.134 . . . . 0.0 110.041 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 33.5 m -44.31 126.57 5.27 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.196 -0.94 . . . . 0.0 109.813 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.475 ' HB2' ' HA ' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -86.68 50.31 1.98 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.131 -0.98 . . . . 0.0 110.127 179.879 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.187 -0.946 . . . . 0.0 110.246 179.96 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 38.1 pttt . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.298 0.57 . . . . 0.0 110.219 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.532 ' CG2' ' O ' ' A' ' 50' ' ' PRO . 2.8 tt -154.36 166.07 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.261 -0.899 . . . . 0.0 110.056 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.497 ' N ' HG12 ' A' ' 2' ' ' ILE . 2.4 p-10 -147.87 166.04 28.81 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.369 -0.832 . . . . 0.0 109.965 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 157.36 -152.12 23.41 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.474 ' HA ' ' O ' ' A' ' 44' ' ' CYS . 6.9 m-85 -110.58 99.22 40.41 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.276 -1.131 . . . . 0.0 110.393 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.532 ' HA ' ' CG2' ' A' ' 55' ' ' ILE . 46.7 Cg_endo -73.85 126.76 10.94 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 124.066 1.561 . . . . 0.0 110.146 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.423 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . 16.0 m -79.59 -172.29 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.243 -0.911 . . . . 0.0 110.256 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.459 ' O ' ' HB2' ' A' ' 9' ' ' TYR . 6.9 p-10 -77.28 -44.63 29.06 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.155 -0.966 . . . . 0.0 109.87 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.565 ' HB3' ' CE3' ' A' ' 10' ' ' TRP . 1.7 t80 178.98 -66.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.675 -0.641 . . . . 0.0 109.444 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.565 ' CE3' ' HB3' ' A' ' 9' ' ' TYR . 2.6 m-90 -107.27 21.68 17.14 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.35 -0.844 . . . . 0.0 109.37 179.272 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.475 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 2.3 m120 59.11 14.07 3.29 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.46 -0.775 . . . . 0.0 110.307 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.9 m -68.9 -36.26 77.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.259 -0.901 . . . . 0.0 109.969 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.1 44.7 1.01 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.423 -0.798 . . . . 0.0 109.773 179.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 62.32 -179.8 0.13 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.332 -0.855 . . . . 0.0 110.081 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.449 ' HB ' ' HB3' ' A' ' 43' ' ' SER . 3.3 mt -82.11 -6.56 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.211 -0.931 . . . . 0.0 110.548 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.447 ' HB2' ' C ' ' A' ' 43' ' ' SER . 46.3 t -132.12 162.56 30.54 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.286 -0.884 . . . . 0.0 110.37 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.669 ' CE3' ' CG ' ' A' ' 22' ' ' TYR . 0.3 OUTLIER -105.77 -153.66 0.5 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.274 -0.891 . . . . 0.0 109.889 179.605 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -105.48 -20.27 13.53 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.184 -0.948 . . . . 0.0 110.113 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.457 ' HB3' ' HB2' ' A' ' 22' ' ' TYR . 0.3 OUTLIER -100.98 149.7 23.65 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.262 -0.899 . . . . 0.0 110.137 179.963 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -84.32 -25.56 29.16 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.215 -0.928 . . . . 0.0 110.276 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -90.22 -28.61 18.74 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.23 -0.919 . . . . 0.0 110.355 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.669 ' CG ' ' CE3' ' A' ' 17' ' ' TRP . 28.4 t80 -57.54 -46.36 83.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.262 -0.899 . . . . 0.0 110.179 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -64.45 -43.41 94.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.193 -0.942 . . . . 0.0 109.792 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.489 ' O ' ' CG ' ' A' ' 28' ' ' LYS . 50.0 t30 -57.92 -40.9 81.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.222 -0.924 . . . . 0.0 109.675 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.57 -56.82 17.0 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.222 -0.923 . . . . 0.0 110.066 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.72 -36.87 82.19 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.238 -0.914 . . . . 0.0 109.966 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.489 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . 5.2 m -63.02 -43.06 99.77 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.173 -0.955 . . . . 0.0 109.469 179.553 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.489 ' CG ' ' O ' ' A' ' 24' ' ' ASN . 0.3 OUTLIER -58.36 -27.78 64.52 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.294 -0.879 . . . . 0.0 109.257 179.027 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.14 -38.34 94.26 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 107.956 -2.057 . . . . 0.0 107.956 179.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.486 ' O ' ' HB3' ' A' ' 31' ' ' LYS . 5.0 mt -89.78 21.47 3.54 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.65 -0.912 . . . . 0.0 109.14 178.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.488 ' O ' ' O ' ' A' ' 48' ' ' GLY . 0.4 OUTLIER 69.65 15.92 8.06 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.647 -0.658 . . . . 0.0 110.798 179.922 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.518 ' CB ' HD21 ' A' ' 49' ' ' LEU . . . -88.38 73.6 8.76 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.933 -1.105 . . . . 0.0 109.383 179.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.425 ' C ' ' O ' ' A' ' 32' ' ' ALA . 0.1 OUTLIER -39.82 -76.94 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.565 -0.709 . . . . 0.0 110.848 -179.289 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.463 ' O ' ' HA ' ' A' ' 46' ' ' CYS . 1.8 t -65.88 93.65 0.19 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.443 -0.786 . . . . 0.0 110.454 -179.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.522 ' CA ' ' SG ' ' A' ' 46' ' ' CYS . . . -128.52 93.64 0.36 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.523 ' C ' ' CD1' ' A' ' 36' ' ' TYR . 9.4 p90 -113.47 153.35 28.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.294 -1.121 . . . . 0.0 109.859 179.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.1 OUTLIER -108.8 139.99 42.86 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.097 -1.002 . . . . 0.0 110.428 -179.863 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.639 ' CD1' ' CD1' ' A' ' 42' ' ' LEU . 49.1 t-105 -79.54 86.85 5.16 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.292 -0.88 . . . . 0.0 109.848 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -62.38 80.77 0.03 OUTLIER Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -179.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.571 ' HB3' ' CD1' ' A' ' 38' ' ' TRP . 14.0 t-105 -160.53 -73.16 0.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.435 -1.038 . . . . 0.0 109.6 179.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.554 HG22 ' CD1' ' A' ' 40' ' ' TRP . 15.0 t -179.07 40.1 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.634 -0.666 . . . . 0.0 109.588 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.639 ' CD1' ' CD1' ' A' ' 38' ' ' TRP . 0.3 OUTLIER -123.25 -80.65 0.63 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.281 -0.887 . . . . 0.0 110.818 -179.485 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.468 ' CB ' ' O ' ' A' ' 42' ' ' LEU . 1.2 p 170.01 176.09 0.05 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.263 -0.898 . . . . 0.0 109.901 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 5' ' ' TYR . 6.8 t -74.6 166.54 23.39 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.23 -0.919 . . . . 0.0 110.176 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.501 ' CD2' ' OH ' ' A' ' 36' ' ' TYR . 0.8 OUTLIER -148.98 108.47 3.98 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.191 -0.943 . . . . 0.0 110.35 -179.973 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.522 ' SG ' ' CA ' ' A' ' 35' ' ' GLY . 64.9 m -129.23 137.71 51.26 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.375 -0.828 . . . . 0.0 109.729 179.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.467 ' OE1' ' CE1' ' A' ' 45' ' ' TYR . 2.2 mt-30 -124.18 128.4 49.17 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.086 -1.009 . . . . 0.0 110.314 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.488 ' O ' ' O ' ' A' ' 31' ' ' LYS . . . 121.25 28.9 1.56 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.528 HD13 ' CB ' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -106.2 169.5 6.84 Favored Pre-proline 0 N--CA 1.497 1.883 0 O-C-N 121.135 -1.215 . . . . 0.0 109.993 179.6 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.532 ' O ' ' CG2' ' A' ' 2' ' ' ILE . 42.4 Cg_endo -67.23 157.62 60.85 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 O-C-N 123.87 1.458 . . . . 0.0 111.126 -179.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -58.46 -27.86 64.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.488 -0.758 . . . . 0.0 109.883 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.4 ' O ' ' OD1' ' A' ' 52' ' ' ASN . 15.8 t-20 -90.75 20.42 4.74 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.393 -0.817 . . . . 0.0 109.457 179.437 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.528 ' CB ' HD13 ' A' ' 49' ' ' LEU . . . -62.84 110.83 1.89 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.665 -0.647 . . . . 0.0 110.592 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.509 ' NH1' ' O ' ' A' ' 9' ' ' TYR . 1.3 tmm_? -65.02 129.36 39.43 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.324 -0.86 . . . . 0.0 110.307 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.532 ' CG2' ' HA ' ' A' ' 6' ' ' PRO . 2.7 pt -152.55 -163.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.543 -0.723 . . . . 0.0 109.907 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.474 ' O ' ' HG3' ' A' ' 56' ' ' LYS . 2.5 ptmm? -40.72 93.43 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.569 -0.707 . . . . 0.0 110.498 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.526 ' N ' ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -135.17 2.95 3.1 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.294 -0.879 . . . . 0.0 110.113 -179.935 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -153.46 -173.63 4.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.239 -0.913 . . . . 0.0 109.864 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -166.73 23.93 0.13 Allowed Glycine 0 N--CA 1.49 2.272 0 C-N-CA 119.674 -1.25 . . . . 0.0 110.049 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.485 ' O ' ' O ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER -137.16 47.47 2.11 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.959 -1.318 . . . . 0.0 110.411 179.802 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.485 ' O ' ' O ' ' A' ' 60' ' ' ARG . 0.5 OUTLIER 47.36 103.07 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.619 -0.676 . . . . 0.0 110.742 179.885 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.485 ' N ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -79.9 54.68 1.92 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.382 -0.824 . . . . 0.0 110.171 179.811 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.165 -0.959 . . . . 0.0 110.263 -179.962 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 20.2 mttt . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.277 0.561 . . . . 0.0 110.232 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.475 HG21 ' O ' ' A' ' 49' ' ' LEU . 10.8 tt -120.26 165.16 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.33 -0.856 . . . . 0.0 110.051 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -143.34 144.12 31.96 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.277 -0.889 . . . . 0.0 110.136 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 173.51 -151.6 13.81 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.585 ' N ' ' CD1' ' A' ' 5' ' ' TYR . 20.0 m-85 -110.15 98.31 34.53 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.325 -1.103 . . . . 0.0 110.413 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.409 ' HG3' ' HB2' ' A' ' 46' ' ' CYS . 49.2 Cg_endo -75.77 144.2 27.55 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 124.025 1.54 . . . . 0.0 110.738 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.551 ' CG1' ' CG2' ' A' ' 15' ' ' ILE . 6.3 m -109.14 -171.97 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.199 -0.938 . . . . 0.0 110.015 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -89.2 -88.47 0.16 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.217 -0.927 . . . . 0.0 110.19 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.503 ' HB3' ' CD2' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -141.09 -42.71 0.38 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.143 -0.973 . . . . 0.0 110.239 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.522 ' HB3' ' CB ' ' A' ' 62' ' ' ARG . 6.2 m-90 -116.46 16.57 15.61 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.256 -0.902 . . . . 0.0 110.057 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 88.6 m-20 56.54 17.12 2.85 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.261 -0.9 . . . . 0.0 110.146 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 56.4 m -70.14 -11.01 60.59 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.266 -0.896 . . . . 0.0 110.197 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.454 ' HD2' ' N ' ' A' ' 13' ' ' LYS . 5.5 mptt -108.04 40.01 1.83 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.328 -0.858 . . . . 0.0 110.241 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.488 ' O ' ' HB ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER 46.17 36.22 3.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.173 -0.954 . . . . 0.0 109.997 -179.997 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.551 ' CG2' ' CG1' ' A' ' 7' ' ' VAL . 2.5 mt 62.91 7.65 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.491 -0.755 . . . . 0.0 110.65 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.465 ' O ' ' O ' ' A' ' 17' ' ' TRP . 32.8 t -148.64 111.96 4.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.054 -1.029 . . . . 0.0 109.696 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.465 ' O ' ' O ' ' A' ' 16' ' ' CYS . 5.2 t90 -43.44 -94.3 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.329 -0.857 . . . . 0.0 110.306 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -160.54 -64.0 0.06 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.771 -1.206 . . . . 0.0 110.366 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.522 ' HB2' ' CG ' ' A' ' 22' ' ' TYR . 0.8 OUTLIER -70.15 171.02 10.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.464 -0.773 . . . . 0.0 110.367 -179.937 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -75.75 -54.69 6.55 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.234 -0.916 . . . . 0.0 109.966 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -71.9 -16.99 62.13 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.363 -0.836 . . . . 0.0 110.061 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.522 ' CG ' ' HB2' ' A' ' 19' ' ' ASN . 1.4 m-30 -57.72 -26.41 61.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.195 -0.941 . . . . 0.0 110.033 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.4 t -98.19 -17.69 18.86 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.252 -0.905 . . . . 0.0 110.243 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 35' ' ' GLY . 66.9 t30 -72.0 -40.28 68.63 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.258 -0.902 . . . . 0.0 110.069 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.13 -47.45 82.68 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.012 -1.055 . . . . 0.0 109.397 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.48 -43.44 85.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.374 -0.829 . . . . 0.0 109.354 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.483 ' HB3' ' HB3' ' A' ' 32' ' ' ALA . 1.8 m -60.23 -39.59 87.21 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.407 -0.808 . . . . 0.0 109.423 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.417 ' HG3' ' HA ' ' A' ' 33' ' ' ASP . 0.0 OUTLIER -60.05 -30.74 69.4 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.261 -0.899 . . . . 0.0 109.488 179.365 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.05 -31.65 79.47 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 107.798 -2.121 . . . . 0.0 107.798 179.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.516 ' O ' ' HB3' ' A' ' 31' ' ' LYS . 1.8 mt -91.8 19.0 6.91 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.672 -0.899 . . . . 0.0 109.217 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.516 ' HB3' ' O ' ' A' ' 30' ' ' LEU . 1.5 tptt 72.76 13.38 5.15 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.805 -0.559 . . . . 0.0 111.019 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.483 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . . . -92.34 73.06 5.3 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.902 -1.124 . . . . 0.0 109.975 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.417 ' HA ' ' HG3' ' A' ' 28' ' ' LYS . 18.9 m-20 -43.96 -62.0 1.27 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.316 -0.865 . . . . 0.0 110.407 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.404 ' HB3' ' NE2' ' A' ' 47' ' ' GLN . 0.3 OUTLIER -74.05 84.18 1.79 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.363 -0.836 . . . . 0.0 110.035 179.989 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.524 ' CA ' ' SG ' ' A' ' 46' ' ' CYS . . . -124.35 116.17 2.72 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.528 ' C ' ' CD1' ' A' ' 36' ' ' TYR . 12.8 p90 -139.04 147.44 42.06 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.316 -1.108 . . . . 0.0 109.85 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.455 ' SG ' ' HA ' ' A' ' 44' ' ' CYS . 0.0 OUTLIER -100.26 139.63 35.65 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.165 -0.959 . . . . 0.0 110.492 -179.619 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.578 ' CD1' ' HB2' ' A' ' 42' ' ' LEU . 26.0 t-105 -79.65 103.71 9.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.235 -0.916 . . . . 0.0 109.626 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -67.12 65.59 0.22 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.548 ' CD1' HG22 ' A' ' 41' ' ' THR . 6.3 t-105 -160.21 -65.77 0.07 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.284 -1.127 . . . . 0.0 109.883 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.548 HG22 ' CD1' ' A' ' 40' ' ' TRP . 3.8 t 177.62 35.83 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.53 -0.731 . . . . 0.0 109.903 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.578 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 9.6 mt -119.15 20.51 12.63 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.089 -1.007 . . . . 0.0 110.458 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.476 ' HB3' ' HB ' ' A' ' 15' ' ' ILE . 3.3 m 55.58 -170.42 0.07 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.153 -0.967 . . . . 0.0 110.179 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.468 ' O ' ' CD2' ' A' ' 5' ' ' TYR . 12.2 t -79.04 163.14 25.4 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.342 -0.849 . . . . 0.0 110.307 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -148.04 100.07 3.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.29 -0.882 . . . . 0.0 109.955 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.524 ' SG ' ' CA ' ' A' ' 35' ' ' GLY . 63.7 m -123.3 148.93 45.45 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.173 -0.954 . . . . 0.0 110.357 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.426 ' N ' ' CD ' ' A' ' 47' ' ' GLN . 0.7 OUTLIER -131.64 140.19 49.3 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.352 -0.843 . . . . 0.0 109.857 179.717 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.479 ' O ' ' O ' ' A' ' 31' ' ' LYS . . . 111.26 20.39 7.09 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.514 HD12 ' CB ' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -99.49 168.31 9.77 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 121.232 -1.158 . . . . 0.0 109.65 179.472 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.471 ' O ' ' HB2' ' A' ' 53' ' ' ALA . 43.3 Cg_endo -70.5 161.2 46.88 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.619 1.326 . . . . 0.0 110.62 -179.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -62.05 -16.68 53.68 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.219 -0.926 . . . . 0.0 109.717 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -94.84 15.01 19.62 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.435 -0.791 . . . . 0.0 109.941 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.514 ' CB ' HD12 ' A' ' 49' ' ' LEU . . . -56.01 149.22 15.83 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.283 -0.886 . . . . 0.0 110.304 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.456 ' C ' HG21 ' A' ' 55' ' ' ILE . 7.7 mtm105 -92.08 88.64 6.61 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.294 -0.879 . . . . 0.0 110.261 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.456 HG21 ' C ' ' A' ' 54' ' ' ARG . 0.2 OUTLIER -131.81 156.01 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.161 -0.962 . . . . 0.0 110.006 179.671 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 55' ' ' ILE . 8.9 mttt 42.45 56.0 3.91 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.236 -0.915 . . . . 0.0 110.303 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -88.05 -5.98 58.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.265 -0.897 . . . . 0.0 110.363 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.429 ' O ' ' ND2' ' A' ' 11' ' ' ASN . 0.1 OUTLIER 57.05 173.21 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.342 -0.849 . . . . 0.0 110.111 -179.909 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 101.41 132.94 7.92 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.67 173.44 8.1 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.188 -1.183 . . . . 0.0 110.236 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 35.1 t -43.4 104.99 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.364 -0.835 . . . . 0.0 110.169 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.522 ' CB ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -87.02 49.55 1.84 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.213 -0.929 . . . . 0.0 110.179 -179.882 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.131 -0.98 . . . . 0.0 110.309 -179.989 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.247 0.546 . . . . 0.0 110.237 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.47 HG21 ' O ' ' A' ' 49' ' ' LEU . 7.7 tt -119.22 163.95 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.272 -0.893 . . . . 0.0 110.28 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 3' ' ' ASP . 1.9 p30 -141.0 138.45 33.72 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.409 -0.807 . . . . 0.0 110.14 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 45' ' ' TYR . . . -177.59 -163.29 29.19 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.512 ' HA ' ' O ' ' A' ' 44' ' ' CYS . 3.0 m-85 -105.86 102.7 40.39 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.301 -1.117 . . . . 0.0 110.262 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.502 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 47.7 Cg_endo -74.3 109.98 3.0 Favored 'Trans proline' 0 C--N 1.301 -1.945 0 O-C-N 123.994 1.523 . . . . 0.0 111.187 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.545 ' CG1' HG13 ' A' ' 15' ' ' ILE . 14.6 m -91.29 -162.48 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.291 -0.88 . . . . 0.0 109.762 179.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.525 ' OD2' ' CG ' ' A' ' 13' ' ' LYS . 11.5 t0 -77.58 -87.97 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.334 -0.854 . . . . 0.0 109.829 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.488 ' O ' ' NH1' ' A' ' 54' ' ' ARG . 1.1 m-85 -141.29 -58.97 0.49 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.328 -0.857 . . . . 0.0 109.745 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.573 ' CD2' ' CB ' ' A' ' 63' ' ' ALA . 4.8 m-90 -106.22 24.42 12.51 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.442 -0.786 . . . . 0.0 109.678 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.47 ' OD1' HG22 ' A' ' 7' ' ' VAL . 58.9 m-80 57.58 15.5 2.85 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.367 -0.833 . . . . 0.0 109.726 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 5.1 t -92.5 -42.11 9.89 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.308 -0.87 . . . . 0.0 110.417 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.525 ' CG ' ' OD2' ' A' ' 8' ' ' ASP . 5.3 mmtp -60.41 -93.18 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.42 -0.8 . . . . 0.0 110.27 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.466 ' HG2' ' O ' ' A' ' 13' ' ' LYS . 2.7 mmp_? -144.68 101.4 3.66 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.175 -0.953 . . . . 0.0 110.511 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.545 HG13 ' CG1' ' A' ' 7' ' ' VAL . 4.3 tt -44.0 -27.6 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.218 -0.926 . . . . 0.0 109.458 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.537 ' HB2' ' N ' ' A' ' 44' ' ' CYS . 30.9 t -158.91 106.25 1.82 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.597 -0.689 . . . . 0.0 110.415 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.405 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -54.58 -172.57 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.179 -0.951 . . . . 0.0 109.81 179.773 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -114.55 33.59 5.24 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.109 -0.994 . . . . 0.0 110.174 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -131.55 145.55 51.78 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.257 -0.902 . . . . 0.0 109.959 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.426 ' OD1' ' N ' ' A' ' 20' ' ' ASN . 15.5 p-10 -82.06 9.09 9.11 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.243 -0.911 . . . . 0.0 110.352 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.46 -33.77 2.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.238 -0.914 . . . . 0.0 110.313 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -52.72 -35.75 56.36 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.107 -0.996 . . . . 0.0 110.199 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.406 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 0.1 OUTLIER -88.86 -30.57 18.82 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.219 -0.925 . . . . 0.0 110.049 179.846 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -69.93 -52.43 24.61 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.347 -0.846 . . . . 0.0 110.316 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -50.12 -47.9 53.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.212 -0.93 . . . . 0.0 110.308 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.3 -41.24 66.85 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.239 -0.913 . . . . 0.0 110.15 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.481 ' HB3' ' HB3' ' A' ' 32' ' ' ALA . 8.3 m -59.91 -34.33 73.05 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.106 -0.996 . . . . 0.0 109.794 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.55 -31.79 73.06 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.391 -0.818 . . . . 0.0 109.726 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.13 -33.95 86.16 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 107.957 -2.057 . . . . 0.0 107.957 178.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.489 ' O ' ' HB3' ' A' ' 31' ' ' LYS . 1.4 mt -89.54 19.58 4.48 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.61 -0.936 . . . . 0.0 109.426 179.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.5 ' O ' ' O ' ' A' ' 48' ' ' GLY . 0.4 OUTLIER 68.27 18.42 9.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.699 -0.625 . . . . 0.0 111.02 179.749 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.481 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . . . -92.31 74.77 5.31 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.913 -1.117 . . . . 0.0 109.78 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 32' ' ' ALA . 62.9 t0 -39.99 -70.48 0.1 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.415 -0.803 . . . . 0.0 110.677 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.17 86.25 1.06 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.508 -0.745 . . . . 0.0 110.192 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.522 ' CA ' ' SG ' ' A' ' 46' ' ' CYS . . . -121.15 98.73 0.67 Allowed Glycine 0 N--CA 1.488 2.102 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.496 ' OH ' ' CD2' ' A' ' 45' ' ' TYR . 53.1 p90 -126.42 153.64 44.73 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.353 -1.087 . . . . 0.0 109.855 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.1 OUTLIER -102.2 146.33 28.14 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.139 -0.976 . . . . 0.0 110.367 -179.638 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.608 ' CD1' ' HB2' ' A' ' 42' ' ' LEU . 25.8 t-105 -79.82 148.57 31.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.139 -0.976 . . . . 0.0 109.645 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -106.36 53.19 0.64 Allowed Glycine 0 N--CA 1.491 2.335 0 C-N-CA 119.615 -1.279 . . . . 0.0 110.204 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.529 ' HB3' ' CD1' ' A' ' 38' ' ' TRP . 30.9 t-105 -160.54 -83.08 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.255 -1.144 . . . . 0.0 110.021 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.515 ' OG1' ' CD1' ' A' ' 40' ' ' TRP . 72.6 p -155.25 38.54 0.4 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.407 -0.808 . . . . 0.0 110.354 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.608 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 0.4 OUTLIER -119.46 24.03 10.89 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.093 -1.004 . . . . 0.0 110.681 -179.847 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.53 ' CB ' HG12 ' A' ' 15' ' ' ILE . 90.5 p 45.52 -174.01 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.3 -0.875 . . . . 0.0 110.363 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.537 ' N ' ' HB2' ' A' ' 16' ' ' CYS . 25.3 t -71.87 171.97 10.75 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.184 -0.948 . . . . 0.0 109.261 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.496 ' CD2' ' OH ' ' A' ' 36' ' ' TYR . 1.1 t80 -158.26 100.95 1.71 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.999 -1.063 . . . . 0.0 111.001 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.522 ' SG ' ' CA ' ' A' ' 35' ' ' GLY . 85.9 m -121.05 137.2 54.76 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.353 -0.842 . . . . 0.0 109.533 179.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.451 ' OE1' ' N ' ' A' ' 47' ' ' GLN . 9.6 mp0 -121.87 148.11 45.14 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.163 -0.961 . . . . 0.0 110.35 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.5 ' O ' ' O ' ' A' ' 31' ' ' LYS . . . 100.05 27.18 7.94 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.592 ' CD1' ' CB ' ' A' ' 53' ' ' ALA . 0.2 OUTLIER -109.32 170.9 4.9 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.191 -1.182 . . . . 0.0 109.872 179.751 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.501 ' HD2' ' HB2' ' A' ' 49' ' ' LEU . 42.0 Cg_endo -68.43 158.35 58.01 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.689 1.363 . . . . 0.0 110.717 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -60.66 -22.61 64.04 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.332 -0.855 . . . . 0.0 110.173 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -85.38 11.73 9.71 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.243 -0.91 . . . . 0.0 109.94 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.592 ' CB ' ' CD1' ' A' ' 49' ' ' LEU . . . -62.16 135.82 57.67 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.304 -0.872 . . . . 0.0 110.548 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.488 ' NH1' ' O ' ' A' ' 9' ' ' TYR . 15.7 tpp85 -77.2 131.69 38.37 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.3 -0.875 . . . . 0.0 109.869 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.508 ' C ' ' CD1' ' A' ' 55' ' ' ILE . 1.3 pp -156.85 -173.24 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.276 -0.89 . . . . 0.0 110.303 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -45.89 93.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.212 -0.93 . . . . 0.0 110.608 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.479 ' N ' ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -112.6 22.39 14.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.333 -0.854 . . . . 0.0 109.856 179.604 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.87 -178.17 0.11 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.354 -0.841 . . . . 0.0 110.373 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.458 ' O ' ' O ' ' A' ' 60' ' ' ARG . . . 92.89 101.1 1.47 Allowed Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.529 ' O ' ' N ' ' A' ' 62' ' ' ARG . 2.8 ptm85 -50.73 -175.8 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.254 -1.145 . . . . 0.0 110.212 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.413 ' C ' ' O ' ' A' ' 60' ' ' ARG . 33.9 t -42.21 93.32 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.379 -0.825 . . . . 0.0 110.389 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.54 ' CB ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -84.07 43.66 0.95 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.339 -0.851 . . . . 0.0 110.481 -179.754 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.573 ' CB ' ' CD2' ' A' ' 10' ' ' TRP . . . . . . . . 0 N--CA 1.492 1.643 0 O-C-N 121.179 -0.95 . . . . 0.0 110.184 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.463 ' HG2' ' O ' ' A' ' 1' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.491 0.662 . . . . 0.0 110.34 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.517 ' CG2' ' HG ' ' A' ' 49' ' ' LEU . 8.6 tt -120.44 160.58 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.384 -0.823 . . . . 0.0 110.075 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -142.7 144.28 32.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.328 -0.858 . . . . 0.0 110.096 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 179.83 -149.46 8.61 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.618 ' N ' ' CD1' ' A' ' 5' ' ' TYR . 12.4 m-85 -122.29 110.1 32.75 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.291 -1.123 . . . . 0.0 110.266 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.482 ' HB3' HG22 ' A' ' 55' ' ' ILE . 46.6 Cg_endo -73.95 128.76 12.63 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 124.055 1.555 . . . . 0.0 110.685 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.51 HG11 ' CG2' ' A' ' 15' ' ' ILE . 14.7 m -83.15 -175.87 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.283 -0.885 . . . . 0.0 110.156 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.439 ' O ' ' NH1' ' A' ' 54' ' ' ARG . 16.2 t70 -64.37 -117.54 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.171 -0.955 . . . . 0.0 109.582 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.592 ' HB3' ' CD2' ' A' ' 10' ' ' TRP . 2.0 t80 -119.62 -50.77 2.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.828 -1.17 . . . . 0.0 109.792 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.592 ' CD2' ' HB3' ' A' ' 9' ' ' TYR . 3.3 m-90 -106.08 21.32 17.53 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.233 -0.917 . . . . 0.0 109.709 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.484 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 42.5 m-20 59.5 12.33 2.71 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.388 -0.82 . . . . 0.0 110.167 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 6.8 m -67.21 -62.85 1.22 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.255 -0.903 . . . . 0.0 109.808 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.1 mmtp -73.58 -178.37 3.07 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.591 -0.693 . . . . 0.0 109.87 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.74 -174.58 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.131 -0.981 . . . . 0.0 110.059 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.51 ' CG2' HG11 ' A' ' 7' ' ' VAL . 20.2 mt -86.76 23.75 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.129 -0.982 . . . . 0.0 110.205 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.515 ' HB2' ' N ' ' A' ' 44' ' ' CYS . 14.4 t -160.16 165.53 31.45 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.239 -0.913 . . . . 0.0 110.595 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.468 ' N ' ' SG ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -115.8 -157.39 0.64 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.371 -0.831 . . . . 0.0 109.821 179.617 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -119.61 -3.79 10.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.211 -0.931 . . . . 0.0 109.989 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.559 ' HB2' ' CG ' ' A' ' 22' ' ' TYR . 0.7 OUTLIER -100.79 133.31 45.45 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.328 -0.858 . . . . 0.0 110.083 179.87 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -60.32 -45.93 91.68 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.194 -0.941 . . . . 0.0 110.641 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.33 -13.23 59.97 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.163 -0.961 . . . . 0.0 110.37 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.559 ' CG ' ' HB2' ' A' ' 19' ' ' ASN . 1.0 OUTLIER -66.66 -11.5 54.21 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.18 -0.95 . . . . 0.0 110.385 -179.771 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.467 ' O ' ' HB2' ' A' ' 27' ' ' CYS . 0.1 OUTLIER -118.73 -31.72 4.75 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.232 -0.917 . . . . 0.0 110.078 179.857 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.529 ' CA ' ' O ' ' A' ' 35' ' ' GLY . 2.0 t-20 -82.53 -49.17 10.19 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.224 -0.922 . . . . 0.0 109.47 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -54.99 -26.91 40.09 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.028 -1.045 . . . . 0.0 109.065 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.452 ' HG ' ' N ' ' A' ' 27' ' ' CYS . 0.1 OUTLIER -90.85 -46.87 7.94 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.646 -0.659 . . . . 0.0 109.486 179.628 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.471 ' SG ' ' HG3' ' A' ' 6' ' ' PRO . 7.7 m -60.05 -34.77 73.86 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.394 -0.816 . . . . 0.0 110.149 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.9 mmmt -61.55 -32.75 72.83 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.183 -0.948 . . . . 0.0 109.319 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.82 -30.98 78.77 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 107.24 -2.344 . . . . 0.0 107.24 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.529 ' O ' ' CD ' ' A' ' 50' ' ' PRO . 11.9 mt -89.69 20.35 4.1 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.777 -0.837 . . . . 0.0 109.261 178.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.49 ' HB3' ' O ' ' A' ' 30' ' ' LEU . 1.0 OUTLIER 66.95 16.5 10.37 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.661 -0.65 . . . . 0.0 110.695 -179.872 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.529 ' HB2' ' CD2' ' A' ' 49' ' ' LEU . . . -90.71 82.76 5.73 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.996 -1.065 . . . . 0.0 110.197 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 32' ' ' ALA . 26.0 t0 -43.25 -71.46 0.08 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.287 -0.883 . . . . 0.0 110.24 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.471 ' O ' ' HA ' ' A' ' 46' ' ' CYS . 0.0 OUTLIER -76.47 86.65 3.2 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.283 -0.886 . . . . 0.0 109.954 179.877 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.529 ' O ' ' CA ' ' A' ' 24' ' ' ASN . . . -125.6 87.69 0.36 Allowed Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.574 ' OH ' ' CZ3' ' A' ' 38' ' ' TRP . 29.4 p90 -130.59 153.91 48.4 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.957 -1.319 . . . . 0.0 109.624 179.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.53 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.1 OUTLIER -83.39 155.21 23.61 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.191 -0.943 . . . . 0.0 111.464 -178.686 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.587 ' CG ' ' HB2' ' A' ' 42' ' ' LEU . 2.5 t-105 -79.45 140.26 37.4 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.3 -21.09 63.18 Favored Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.662 -1.256 . . . . 0.0 110.861 -178.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.495 ' CD1' HG21 ' A' ' 41' ' ' THR . 49.4 t-105 -79.4 -77.19 0.18 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.884 -1.363 . . . . 0.0 109.847 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.495 HG21 ' CD1' ' A' ' 40' ' ' TRP . 13.5 t -178.14 43.92 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.478 -0.764 . . . . 0.0 109.704 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.587 ' HB2' ' CG ' ' A' ' 38' ' ' TRP . 0.8 OUTLIER -109.47 36.72 2.84 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.222 -0.924 . . . . 0.0 110.578 -179.524 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.481 ' CB ' ' HB ' ' A' ' 15' ' ' ILE . 74.6 m 52.69 -174.32 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.166 -0.958 . . . . 0.0 110.323 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.53 ' HA ' ' HA ' ' A' ' 37' ' ' CYS . 15.9 t -77.97 161.09 27.78 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.218 -0.926 . . . . 0.0 110.081 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -144.1 110.38 5.47 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.088 -1.007 . . . . 0.0 111.215 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.529 ' SG ' ' CA ' ' A' ' 35' ' ' GLY . 60.0 m -130.15 134.65 47.46 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.324 -0.86 . . . . 0.0 109.263 178.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -127.42 143.7 51.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.128 -0.983 . . . . 0.0 110.508 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 31' ' ' LYS . . . 103.81 26.93 6.53 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.592 ' CD1' ' CB ' ' A' ' 53' ' ' ALA . 0.2 OUTLIER -105.62 169.39 7.06 Favored Pre-proline 0 N--CA 1.495 1.813 0 O-C-N 121.267 -1.137 . . . . 0.0 110.052 179.743 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.529 ' CD ' ' O ' ' A' ' 30' ' ' LEU . 48.2 Cg_endo -74.51 161.67 39.5 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.671 1.353 . . . . 0.0 110.397 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -59.99 -20.61 58.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.311 -0.868 . . . . 0.0 109.906 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.405 ' O ' ' CG ' ' A' ' 52' ' ' ASN . 6.1 t-20 -81.73 5.13 19.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.383 -0.823 . . . . 0.0 110.009 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.592 ' CB ' ' CD1' ' A' ' 49' ' ' LEU . . . -53.68 153.32 4.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.236 -0.915 . . . . 0.0 110.2 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.475 ' O ' HG22 ' A' ' 55' ' ' ILE . 35.2 ttp85 -105.05 91.18 3.69 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.228 -0.92 . . . . 0.0 110.312 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.555 ' CD1' ' N ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -149.17 157.87 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.259 -0.901 . . . . 0.0 110.149 179.842 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.433 ' C ' ' O ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER 41.63 53.79 3.83 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.417 -0.802 . . . . 0.0 110.283 179.843 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.408 ' O ' ' HB3' ' A' ' 58' ' ' SER . 0.0 OUTLIER -97.21 -20.48 17.9 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.33 -0.857 . . . . 0.0 109.899 179.915 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.473 ' OG ' ' N ' ' A' ' 59' ' ' GLY . 0.1 OUTLIER 60.74 -176.68 0.11 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.537 -0.727 . . . . 0.0 110.273 179.844 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.473 ' N ' ' OG ' ' A' ' 58' ' ' SER . . . 110.34 -177.89 19.77 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.9 ptm180 -107.09 -177.16 3.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.153 -1.204 . . . . 0.0 110.245 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -48.71 124.06 7.82 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.201 -0.937 . . . . 0.0 110.105 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.515 ' CB ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -81.64 47.11 1.03 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.264 -0.897 . . . . 0.0 110.463 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.642 0 O-C-N 121.258 -0.901 . . . . 0.0 110.245 179.882 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.262 0.553 . . . . 0.0 110.244 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.526 ' CG2' ' HG ' ' A' ' 49' ' ' LEU . 17.1 tt -119.97 164.32 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.205 -0.934 . . . . 0.0 110.341 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -143.79 126.39 15.98 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.327 -0.858 . . . . 0.0 109.722 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -168.93 -155.97 10.17 Favored Glycine 0 N--CA 1.492 2.396 0 C-N-CA 119.561 -1.304 . . . . 0.0 110.041 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.57 ' CD1' ' O ' ' A' ' 42' ' ' LEU . 77.2 m-85 -111.7 106.83 56.71 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.304 -1.115 . . . . 0.0 110.706 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.522 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 49.8 Cg_endo -78.91 113.37 3.24 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.957 1.504 . . . . 0.0 109.907 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.492 ' O ' ' NH1' ' A' ' 54' ' ' ARG . 15.5 m -94.04 -169.11 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.012 -1.055 . . . . 0.0 111.05 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.433 ' OD2' ' CB ' ' A' ' 14' ' ' ARG . 9.9 t0 -59.53 -152.23 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.433 -0.792 . . . . 0.0 110.53 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.45 ' HB2' ' CE2' ' A' ' 10' ' ' TRP . 22.0 m-85 -98.84 -11.8 21.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.365 -0.834 . . . . 0.0 110.582 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.535 ' HB3' ' CB ' ' A' ' 62' ' ' ARG . 0.3 OUTLIER -130.22 4.26 4.79 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.03 -1.044 . . . . 0.0 109.74 -179.872 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.509 ' N ' ' OD1' ' A' ' 11' ' ' ASN . 1.6 m120 57.13 16.12 2.8 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.253 -0.905 . . . . 0.0 109.531 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 5.5 t -70.59 -64.04 0.98 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.365 -0.835 . . . . 0.0 110.504 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.495 ' O ' ' CD ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -161.52 82.6 0.61 Allowed 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.259 -0.901 . . . . 0.0 110.502 -179.565 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.437 ' CB ' ' O ' ' A' ' 13' ' ' LYS . 2.0 mtt180 173.06 35.06 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.392 -0.818 . . . . 0.0 109.795 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.534 ' CD1' ' HB2' ' A' ' 43' ' ' SER . 46.6 pt -54.25 -30.26 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.439 -0.788 . . . . 0.0 110.69 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.492 ' N ' HG13 ' A' ' 15' ' ' ILE . 8.5 t -139.36 129.33 24.99 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.137 -0.977 . . . . 0.0 110.589 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.427 ' CE3' ' HB3' ' A' ' 22' ' ' TYR . 0.0 OUTLIER -73.24 170.17 15.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.361 -0.837 . . . . 0.0 110.067 179.785 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -88.23 55.0 3.26 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.318 -0.864 . . . . 0.0 110.075 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.608 ' ND2' ' CE1' ' A' ' 22' ' ' TYR . 2.2 t-20 -165.52 156.28 13.67 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.338 -0.852 . . . . 0.0 110.032 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.422 ' C ' ' OD1' ' A' ' 20' ' ' ASN . 49.7 p30 -87.38 -1.58 58.02 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.226 -0.921 . . . . 0.0 110.266 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.37 -6.02 4.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.19 -0.944 . . . . 0.0 110.586 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.608 ' CE1' ' ND2' ' A' ' 19' ' ' ASN . 3.1 m-30 -59.69 -69.41 0.21 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.1 -1.0 . . . . 0.0 110.247 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.4 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 6.0 p -69.37 -6.36 29.39 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.98 -1.075 . . . . 0.0 109.852 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.539 ' CB ' ' O ' ' A' ' 35' ' ' GLY . 64.3 t30 -75.71 -61.06 2.05 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.388 -0.82 . . . . 0.0 109.506 179.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -49.25 -48.56 45.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.41 -0.806 . . . . 0.0 109.733 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.52 ' HG ' ' N ' ' A' ' 27' ' ' CYS . 0.1 OUTLIER -64.52 -37.35 87.24 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.307 -0.87 . . . . 0.0 109.088 179.423 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.52 ' N ' ' HG ' ' A' ' 26' ' ' LEU . 1.3 m -61.86 -39.26 91.24 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.244 -0.91 . . . . 0.0 109.281 179.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.76 -31.49 69.71 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.466 -0.771 . . . . 0.0 109.55 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.64 -36.9 91.28 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 108.304 -1.919 . . . . 0.0 108.304 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.554 ' O ' ' CB ' ' A' ' 31' ' ' LYS . 6.9 mt -87.69 17.58 4.61 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.535 -0.979 . . . . 0.0 109.746 179.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.554 ' CB ' ' O ' ' A' ' 30' ' ' LEU . 0.7 OUTLIER 78.83 11.27 1.58 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.711 -0.618 . . . . 0.0 110.79 179.991 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.528 ' HB3' ' CD2' ' A' ' 49' ' ' LEU . . . -95.04 84.16 4.07 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.959 -1.088 . . . . 0.0 109.812 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -54.09 -73.78 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.279 -0.888 . . . . 0.0 111.143 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.483 ' HB3' ' CG ' ' A' ' 47' ' ' GLN . 23.2 t -66.87 92.37 0.23 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.386 -0.821 . . . . 0.0 110.663 -179.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.539 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -129.4 88.12 0.31 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.58 ' CZ ' ' HB3' ' A' ' 45' ' ' TYR . 11.1 p90 -99.57 -175.93 3.13 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.165 -1.197 . . . . 0.0 110.422 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.51 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.1 OUTLIER -131.91 131.45 42.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.122 -0.986 . . . . 0.0 110.73 -179.656 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.584 ' CD1' ' HB2' ' A' ' 42' ' ' LEU . 1.9 t-105 -86.87 122.33 30.58 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.299 -0.875 . . . . 0.0 109.839 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.6 -10.14 86.13 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.565 ' HB3' ' CD1' ' A' ' 38' ' ' TRP . 41.1 t-105 -79.77 -92.9 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.207 -1.172 . . . . 0.0 110.095 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.501 ' CG2' ' C ' ' A' ' 40' ' ' TRP . 14.4 p -152.94 54.47 0.77 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.037 -1.039 . . . . 0.0 110.039 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.584 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 6.0 mt -132.3 8.76 4.34 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.203 -0.936 . . . . 0.0 110.813 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.534 ' HB2' ' CD1' ' A' ' 15' ' ' ILE . 1.4 t 56.77 -174.4 0.07 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.956 -1.09 . . . . 0.0 109.869 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.51 ' HA ' ' HA ' ' A' ' 37' ' ' CYS . 15.3 t -72.26 156.53 39.03 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.106 -0.996 . . . . 0.0 109.186 179.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.58 ' HB3' ' CZ ' ' A' ' 36' ' ' TYR . 67.4 t80 -138.04 113.85 9.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.113 -0.992 . . . . 0.0 110.478 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.525 ' HA ' ' HA2' ' A' ' 35' ' ' GLY . 62.5 m -125.28 138.93 54.09 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.207 -0.933 . . . . 0.0 109.735 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.483 ' CG ' ' HB3' ' A' ' 34' ' ' SER . 0.0 OUTLIER -118.16 137.65 52.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.359 -0.838 . . . . 0.0 110.072 -179.949 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 31' ' ' LYS . . . 102.22 32.51 4.91 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.608 ' CD2' ' N ' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -101.46 -177.27 0.54 Allowed Pre-proline 0 N--CA 1.496 1.865 0 O-C-N 121.185 -1.185 . . . . 0.0 109.303 179.646 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.506 ' HD2' ' HB2' ' A' ' 49' ' ' LEU . 47.6 Cg_endo -85.12 161.11 11.55 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 O-C-N 123.619 1.326 . . . . 0.0 110.123 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -59.53 -19.95 51.99 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.1 -1.0 . . . . 0.0 109.883 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -96.25 19.54 11.74 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.372 -0.83 . . . . 0.0 109.695 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.476 ' HB2' ' O ' ' A' ' 50' ' ' PRO . . . -53.79 134.01 42.31 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.346 -0.846 . . . . 0.0 110.562 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.551 ' HB3' ' CZ ' ' A' ' 54' ' ' ARG . 1.3 ttm105 -71.71 87.49 0.96 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.298 -0.876 . . . . 0.0 109.976 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.531 ' O ' ' N ' ' A' ' 57' ' ' ARG . 1.9 pp -124.34 -166.41 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.062 -1.024 . . . . 0.0 110.626 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.468 ' O ' ' HG3' ' A' ' 56' ' ' LYS . 0.4 OUTLIER -61.39 70.41 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.486 -0.758 . . . . 0.0 110.837 -179.555 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.531 ' N ' ' O ' ' A' ' 55' ' ' ILE . 9.1 tpp85 -114.79 -16.03 11.81 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.074 -1.016 . . . . 0.0 109.799 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.9 132.02 46.24 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.419 -0.801 . . . . 0.0 109.984 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -107.77 33.42 6.32 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.428 ' HG2' ' O ' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -122.77 107.4 11.86 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.276 -1.132 . . . . 0.0 110.28 179.954 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 2.6 t -50.74 107.52 0.18 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.288 -0.882 . . . . 0.0 109.882 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.535 ' CB ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -87.32 48.61 1.67 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.324 -0.86 . . . . 0.0 110.375 179.973 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.152 -0.967 . . . . 0.0 110.228 -179.99 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 13.3 tttm . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.178 0.513 . . . . 0.0 110.219 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.508 HG21 HD13 ' A' ' 2' ' ' ILE . 4.5 tt -146.93 159.85 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.334 -0.854 . . . . 0.0 110.1 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.517 ' HB3' ' CG ' ' A' ' 47' ' ' GLN . 65.8 m-20 -131.14 136.2 48.14 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.347 -0.845 . . . . 0.0 109.873 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 178.77 -160.8 26.8 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.606 ' CE2' ' CD1' ' A' ' 45' ' ' TYR . 15.0 m-85 -109.28 109.25 60.46 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.305 -1.115 . . . . 0.0 110.256 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.51 ' CG ' ' SG ' ' A' ' 27' ' ' CYS . 49.4 Cg_endo -80.51 108.09 2.09 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.928 1.489 . . . . 0.0 110.9 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.414 HG21 ' OD1' ' A' ' 11' ' ' ASN . 17.0 m -83.49 -170.59 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.228 -0.92 . . . . 0.0 109.83 179.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -70.65 -118.23 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.111 -0.993 . . . . 0.0 109.827 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -115.94 -55.06 2.45 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.816 -1.177 . . . . 0.0 110.073 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.543 ' HB3' ' CB ' ' A' ' 62' ' ' ARG . 3.0 m-90 -99.6 15.23 27.32 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.24 -0.913 . . . . 0.0 110.121 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.475 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 5.1 m-20 59.4 12.74 2.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.219 -0.925 . . . . 0.0 110.067 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.8 t -90.89 -28.68 17.96 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.277 -0.889 . . . . 0.0 110.43 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.489 ' O ' ' CB ' ' A' ' 14' ' ' ARG . 4.5 mmtp -86.79 41.38 0.95 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.272 -0.892 . . . . 0.0 110.619 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.489 ' CB ' ' O ' ' A' ' 13' ' ' LYS . 0.1 OUTLIER 69.03 141.6 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.159 -0.963 . . . . 0.0 110.536 179.787 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.424 HG22 HD12 ' A' ' 15' ' ' ILE . 6.9 pt -74.48 -6.29 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.376 -0.828 . . . . 0.0 110.104 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.495 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 4.4 t -148.25 153.99 39.46 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.267 -0.896 . . . . 0.0 110.257 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.456 ' CE3' ' HB3' ' A' ' 22' ' ' TYR . 0.2 OUTLIER -86.56 -161.99 0.72 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.359 -0.838 . . . . 0.0 110.105 179.886 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.471 ' CD1' ' O ' ' A' ' 18' ' ' TYR . 9.3 t80 -106.61 -25.85 11.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.283 -0.886 . . . . 0.0 110.118 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -93.36 152.7 18.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.329 -0.857 . . . . 0.0 110.165 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 -81.99 -9.02 59.7 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.173 -0.954 . . . . 0.0 110.214 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.424 ' O ' ' N ' ' A' ' 24' ' ' ASN . 13.8 tttp -105.41 -39.59 6.09 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.181 -0.949 . . . . 0.0 110.07 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.456 ' HB3' ' CE3' ' A' ' 17' ' ' TRP . 1.5 m-85 -44.65 -33.63 1.89 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.296 -0.878 . . . . 0.0 110.259 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.474 ' O ' ' HB2' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -78.32 -28.53 47.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.278 -0.889 . . . . 0.0 110.008 -179.993 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.511 ' OD1' ' NZ ' ' A' ' 28' ' ' LYS . 0.3 OUTLIER -68.98 -41.31 78.05 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.399 -0.813 . . . . 0.0 109.305 179.465 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.2 -43.04 99.73 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.377 -0.827 . . . . 0.0 110.055 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.478 ' C ' ' CD1' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -74.56 -42.68 58.37 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.318 -0.864 . . . . 0.0 109.591 179.74 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.51 ' SG ' ' CG ' ' A' ' 6' ' ' PRO . 1.5 m -61.09 -30.78 70.55 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.293 -0.879 . . . . 0.0 109.303 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.545 ' CA ' ' HE3' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -65.43 -27.42 68.51 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.17 -0.956 . . . . 0.0 108.87 178.572 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.94 -34.52 89.13 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 107.197 -2.361 . . . . 0.0 107.197 178.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.533 ' O ' ' CD ' ' A' ' 50' ' ' PRO . 53.1 mt -91.01 22.03 3.9 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.763 -0.845 . . . . 0.0 109.16 178.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.488 ' O ' ' O ' ' A' ' 48' ' ' GLY . 0.0 OUTLIER 60.48 22.53 12.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.611 -0.681 . . . . 0.0 110.653 179.907 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.521 ' O ' ' CE ' ' A' ' 28' ' ' LYS . . . -86.15 86.4 7.35 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.984 -1.072 . . . . 0.0 109.995 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.533 ' O ' ' NZ ' ' A' ' 28' ' ' LYS . 6.7 t70 -40.28 -86.62 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.498 -0.751 . . . . 0.0 110.597 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.9 m -69.99 93.65 0.8 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.993 -1.067 . . . . 0.0 110.058 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.544 ' CA ' ' SG ' ' A' ' 46' ' ' CYS . . . -128.72 112.77 1.45 Allowed Glycine 0 N--CA 1.487 2.099 0 C-N-CA 119.638 -1.268 . . . . 0.0 110.018 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -148.21 159.97 43.41 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.273 -1.134 . . . . 0.0 109.985 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.48 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.1 OUTLIER -93.32 146.15 23.93 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.153 -0.967 . . . . 0.0 110.684 -179.599 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.513 ' CD1' ' HB2' ' A' ' 42' ' ' LEU . 8.7 t-105 -79.55 111.06 15.45 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.238 -0.914 . . . . 0.0 109.439 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -66.2 61.25 0.16 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 -179.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.545 ' CD1' HG22 ' A' ' 41' ' ' THR . 14.7 t-105 -160.94 -69.67 0.06 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.329 -1.1 . . . . 0.0 109.453 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.545 HG22 ' CD1' ' A' ' 40' ' ' TRP . 11.8 t -179.91 33.42 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.586 -0.696 . . . . 0.0 109.588 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.513 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 0.3 OUTLIER -109.46 30.83 6.26 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.293 -0.88 . . . . 0.0 111.013 -179.433 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.495 ' HA ' ' HB2' ' A' ' 16' ' ' CYS . 6.1 p 48.29 -175.3 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.934 -1.104 . . . . 0.0 110.235 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.5 ' O ' ' HA ' ' A' ' 5' ' ' TYR . 14.7 t -78.55 140.47 38.51 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.259 -0.901 . . . . 0.0 109.366 179.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.606 ' CD1' ' CE2' ' A' ' 5' ' ' TYR . 4.7 t80 -128.94 118.77 23.18 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.053 -1.029 . . . . 0.0 110.696 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.544 ' SG ' ' CA ' ' A' ' 35' ' ' GLY . 63.1 m -136.17 152.18 50.53 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.488 -0.758 . . . . 0.0 109.719 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.517 ' CG ' ' HB3' ' A' ' 3' ' ' ASP . 1.6 mt-30 -134.83 147.24 49.88 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.142 -0.973 . . . . 0.0 110.701 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.488 ' O ' ' O ' ' A' ' 31' ' ' LYS . . . 97.98 30.05 7.31 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.534 ' CD2' ' N ' ' A' ' 49' ' ' LEU . 0.1 OUTLIER -108.07 170.9 5.04 Favored Pre-proline 0 N--CA 1.498 1.963 0 O-C-N 121.158 -1.201 . . . . 0.0 109.77 179.66 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.533 ' CD ' ' O ' ' A' ' 30' ' ' LEU . 42.7 Cg_endo -68.93 157.85 60.25 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.692 1.364 . . . . 0.0 110.917 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -59.37 -24.02 63.06 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.379 -0.825 . . . . 0.0 110.008 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -86.46 14.18 7.17 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.335 -0.853 . . . . 0.0 109.783 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.494 ' CB ' HD13 ' A' ' 49' ' ' LEU . . . -56.86 113.69 1.77 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.459 -0.776 . . . . 0.0 110.86 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.481 ' O ' ' HA ' ' A' ' 6' ' ' PRO . 6.7 ttm-85 -59.9 116.39 4.08 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.252 -0.905 . . . . 0.0 109.645 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.509 ' HA ' ' HA ' ' A' ' 6' ' ' PRO . 1.8 pp -140.19 178.06 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.074 -1.016 . . . . 0.0 111.004 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 55' ' ' ILE . 0.1 OUTLIER -41.81 93.74 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.529 -0.732 . . . . 0.0 110.736 -179.566 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.506 ' N ' ' O ' ' A' ' 55' ' ' ILE . 11.6 ttp180 -119.73 -18.91 8.2 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.294 -0.879 . . . . 0.0 109.782 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.32 155.9 35.96 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.367 -0.833 . . . . 0.0 110.148 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -118.13 14.71 12.31 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.424 ' O ' ' C ' ' A' ' 61' ' ' CYS . 4.6 mpt_? -99.39 98.95 9.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.431 -1.04 . . . . 0.0 110.205 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.424 ' C ' ' O ' ' A' ' 60' ' ' ARG . 4.5 t -40.05 109.76 0.12 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.507 -0.746 . . . . 0.0 110.096 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.543 ' CB ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -90.52 52.0 2.12 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.279 -0.888 . . . . 0.0 110.329 -179.808 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.604 0 O-C-N 121.22 -0.925 . . . . 0.0 110.219 179.977 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 20.7 mttt . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.251 0.548 . . . . 0.0 110.235 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.469 HG12 ' N ' ' A' ' 3' ' ' ASP . 6.9 tt -134.34 165.11 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.414 -0.804 . . . . 0.0 109.943 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.469 ' N ' HG12 ' A' ' 2' ' ' ILE . 1.0 OUTLIER -135.2 128.6 32.29 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.308 -0.87 . . . . 0.0 110.107 179.895 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -167.56 -176.26 38.12 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.794 -1.323 . . . . 0.0 109.794 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.521 ' N ' ' CD1' ' A' ' 5' ' ' TYR . 6.1 m-30 -99.07 109.58 54.7 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.296 -1.12 . . . . 0.0 110.407 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.549 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 48.8 Cg_endo -78.89 129.56 9.09 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.934 1.491 . . . . 0.0 110.277 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.475 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . 30.1 m -93.46 -170.25 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.125 -0.985 . . . . 0.0 110.185 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.504 ' CB ' ' HB2' ' A' ' 13' ' ' LYS . 7.9 t70 -74.68 -89.36 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.319 -0.863 . . . . 0.0 109.792 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.657 ' CZ ' ' CH2' ' A' ' 10' ' ' TRP . 24.5 t80 -138.32 -75.11 0.39 Allowed 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.308 -0.87 . . . . 0.0 109.611 179.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.657 ' CH2' ' CZ ' ' A' ' 9' ' ' TYR . 0.0 OUTLIER -89.62 23.02 2.78 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.447 -0.783 . . . . 0.0 109.386 179.322 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.483 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 3.7 m120 61.18 24.17 14.3 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.83 -0.543 . . . . 0.0 110.834 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.505 ' HA ' ' HB2' ' A' ' 61' ' ' CYS . 48.3 t -93.25 -37.46 12.05 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.986 -1.071 . . . . 0.0 110.43 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.504 ' HB2' ' CB ' ' A' ' 8' ' ' ASP . 54.4 mmtt -85.08 44.1 1.06 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.282 -0.886 . . . . 0.0 109.894 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' A' ' 13' ' ' LYS . 1.3 tpp180 54.73 165.13 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.307 -0.871 . . . . 0.0 110.152 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.502 ' CG2' ' HB3' ' A' ' 43' ' ' SER . 7.7 tt -84.1 1.29 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.326 -0.859 . . . . 0.0 110.423 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.501 ' HB2' ' N ' ' A' ' 44' ' ' CYS . 33.7 t -142.44 127.19 18.12 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.268 -0.895 . . . . 0.0 110.424 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -69.22 -149.49 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.265 -0.897 . . . . 0.0 110.337 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -140.08 40.45 1.95 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.146 -0.971 . . . . 0.0 110.313 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -149.25 162.72 39.46 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.328 -0.858 . . . . 0.0 109.914 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 25.1 m-20 -88.7 30.25 0.93 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.13 -0.981 . . . . 0.0 109.915 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -156.09 -39.98 0.08 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.396 -0.815 . . . . 0.0 109.764 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -45.97 -27.58 0.94 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.243 -0.91 . . . . 0.0 110.008 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -100.0 -50.97 3.82 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.292 -0.88 . . . . 0.0 110.104 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.508 ' N ' ' OD1' ' A' ' 24' ' ' ASN . 1.4 m-20 -55.42 -60.07 3.93 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.376 -0.828 . . . . 0.0 109.95 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 24' ' ' ASN . 6.8 t0 -42.99 -51.54 5.6 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.223 -0.923 . . . . 0.0 110.378 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.6 mt -65.16 -42.72 93.47 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.201 -0.937 . . . . 0.0 110.46 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.465 ' SG ' ' HG3' ' A' ' 6' ' ' PRO . 2.4 m -61.18 -39.62 90.82 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.388 -0.82 . . . . 0.0 110.478 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.477 ' HD3' ' HA ' ' A' ' 33' ' ' ASP . 0.5 OUTLIER -60.82 -31.87 71.26 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.284 -0.885 . . . . 0.0 109.602 179.954 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.28 -28.27 73.38 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 107.993 -2.043 . . . . 0.0 107.993 179.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.54 ' O ' ' CD ' ' A' ' 50' ' ' PRO . 13.5 mt -92.42 19.52 7.11 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.691 -0.888 . . . . 0.0 109.127 178.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.508 ' HB3' ' O ' ' A' ' 30' ' ' LEU . 28.7 tptt 72.93 15.02 4.71 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.694 -0.629 . . . . 0.0 110.939 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.454 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . . . -99.96 55.87 0.94 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.866 -1.146 . . . . 0.0 109.667 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 34' ' ' SER . 17.9 p30 -40.29 -30.05 0.09 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.462 -0.773 . . . . 0.0 110.649 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.493 ' N ' ' OD1' ' A' ' 33' ' ' ASP . 70.2 p -91.09 62.77 4.92 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.244 -0.91 . . . . 0.0 110.368 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.458 ' HA2' ' SG ' ' A' ' 46' ' ' CYS . . . -104.64 134.44 12.0 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.539 ' CD1' ' O ' ' A' ' 36' ' ' TYR . 29.3 p90 -160.17 129.74 5.18 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.394 -1.062 . . . . 0.0 109.39 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.517 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.0 OUTLIER -89.74 136.32 33.1 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.162 -0.961 . . . . 0.0 110.994 -179.059 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.567 ' CD1' ' HB2' ' A' ' 42' ' ' LEU . 4.6 t-105 -80.35 111.05 16.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.302 -0.874 . . . . 0.0 109.448 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -61.63 -10.96 26.87 Favored Glycine 0 N--CA 1.49 2.277 0 C-N-CA 120.434 -0.888 . . . . 0.0 110.943 -178.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.522 ' HB3' ' CD1' ' A' ' 38' ' ' TRP . 16.7 t-105 -79.66 -78.43 0.16 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.793 -1.416 . . . . 0.0 110.249 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.411 HG22 ' CD1' ' A' ' 40' ' ' TRP . 5.8 t -173.46 38.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.27 -0.894 . . . . 0.0 109.714 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.567 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 0.3 OUTLIER -110.04 24.66 12.72 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.245 -0.909 . . . . 0.0 110.414 -179.679 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.502 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 7.7 m 54.53 -176.55 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.049 -1.032 . . . . 0.0 109.827 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.517 ' HA ' ' HA ' ' A' ' 37' ' ' CYS . 7.4 t -76.64 151.82 36.05 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.178 -0.951 . . . . 0.0 109.131 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.523 ' HB3' ' CZ ' ' A' ' 36' ' ' TYR . 0.8 OUTLIER -138.58 104.74 5.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.866 -1.146 . . . . 0.0 111.378 -179.632 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.458 ' SG ' ' HA2' ' A' ' 35' ' ' GLY . 63.8 m -121.02 140.66 51.62 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.397 -0.814 . . . . 0.0 109.393 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.446 ' HA ' HD22 ' A' ' 49' ' ' LEU . 14.6 mt-30 -129.92 149.43 51.66 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.107 -0.996 . . . . 0.0 110.407 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 31' ' ' LYS . . . 97.62 24.84 11.49 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.5 ' CD1' ' CB ' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -103.09 172.1 4.58 Favored Pre-proline 0 N--CA 1.499 2.019 0 O-C-N 121.279 -1.13 . . . . 0.0 109.444 179.438 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.54 ' CD ' ' O ' ' A' ' 30' ' ' LEU . 41.9 Cg_endo -68.57 154.44 71.59 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 O-C-N 123.335 1.176 . . . . 0.0 110.352 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -58.28 -21.98 50.91 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.325 -0.86 . . . . 0.0 110.191 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 16.6 t30 -86.44 11.71 11.88 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.306 -0.871 . . . . 0.0 110.085 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.5 ' CB ' ' CD1' ' A' ' 49' ' ' LEU . . . -52.71 143.89 15.31 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.446 -0.783 . . . . 0.0 110.669 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.499 ' NH1' ' O ' ' A' ' 8' ' ' ASP . 1.2 ttm105 -88.54 116.72 26.98 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.365 -0.834 . . . . 0.0 109.996 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.549 ' HA ' ' HA ' ' A' ' 6' ' ' PRO . 1.3 pp -139.24 -164.74 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.188 -0.945 . . . . 0.0 110.733 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.498 ' HG3' ' CD1' ' A' ' 15' ' ' ILE . 0.3 OUTLIER -36.24 96.12 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 121.371 0.605 . . . . 0.0 111.107 -179.414 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.456 ' N ' ' O ' ' A' ' 55' ' ' ILE . 8.3 ttm-85 -110.1 -20.02 12.84 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.376 -0.828 . . . . 0.0 109.762 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.8 m -166.32 162.59 17.32 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.412 -0.805 . . . . 0.0 110.056 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -114.61 45.75 1.27 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.439 ' O ' ' HB2' ' A' ' 11' ' ' ASN . 7.7 ptm180 -137.17 172.15 13.42 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.162 -1.199 . . . . 0.0 110.485 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.505 ' HB2' ' HA ' ' A' ' 12' ' ' CYS . 0.5 OUTLIER -116.7 103.26 10.18 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.402 -0.811 . . . . 0.0 109.695 179.993 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.624 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -85.53 28.77 0.73 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.888 -1.132 . . . . 0.0 110.547 179.766 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.124 -0.985 . . . . 0.0 110.283 -179.949 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 9.8 ptpt . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.221 0.534 . . . . 0.0 110.193 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.521 ' CG2' ' HG ' ' A' ' 49' ' ' LEU . 19.3 tt -131.18 160.56 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.322 -0.861 . . . . 0.0 110.056 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 3' ' ' ASP . 5.0 p-10 -134.52 127.5 31.48 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.381 -0.824 . . . . 0.0 109.654 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -177.32 -172.86 42.3 Favored Glycine 0 N--CA 1.49 2.286 0 C-N-CA 119.253 -1.451 . . . . 0.0 110.21 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.603 ' N ' ' CD1' ' A' ' 5' ' ' TYR . 3.2 m-30 -102.36 113.36 65.91 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.438 -1.036 . . . . 0.0 110.088 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.478 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 46.3 Cg_endo -75.15 142.48 27.47 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.815 1.429 . . . . 0.0 110.452 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.472 HG12 ' O ' ' A' ' 6' ' ' PRO . 30.0 m -141.08 -170.18 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.35 -0.843 . . . . 0.0 110.149 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.513 ' OD2' ' N ' ' A' ' 12' ' ' CYS . 21.3 p-10 -69.45 -148.29 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.234 -0.916 . . . . 0.0 109.979 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.577 ' HB3' ' CD2' ' A' ' 10' ' ' TRP . 6.3 t80 -98.82 -14.9 19.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.197 -0.939 . . . . 0.0 110.316 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.577 ' CD2' ' HB3' ' A' ' 9' ' ' TYR . 7.9 m-90 -133.32 24.04 4.12 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.227 -0.921 . . . . 0.0 110.252 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.477 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 2.4 m-20 59.41 13.78 3.4 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.192 -0.942 . . . . 0.0 110.166 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.513 ' N ' ' OD2' ' A' ' 8' ' ' ASP . 71.5 m -83.0 -77.17 0.25 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.299 -0.876 . . . . 0.0 110.82 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.437 ' O ' ' HB3' ' A' ' 14' ' ' ARG . 14.6 mttt -95.51 -167.83 1.68 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.368 -0.833 . . . . 0.0 111.076 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.542 ' O ' ' N ' ' A' ' 16' ' ' CYS . 16.8 tpp180 58.57 -106.0 0.28 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.48 -0.763 . . . . 0.0 110.45 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.518 ' CG2' ' OG ' ' A' ' 43' ' ' SER . 78.0 mt 57.19 -81.7 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.08 -1.012 . . . . 0.0 109.914 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.542 ' N ' ' O ' ' A' ' 14' ' ' ARG . 40.3 t -137.37 115.21 11.41 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.41 -0.806 . . . . 0.0 110.19 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -66.7 -149.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.214 -0.928 . . . . 0.0 109.939 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.57 59.25 1.55 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.122 -0.986 . . . . 0.0 110.14 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.53 ' CB ' ' HB2' ' A' ' 22' ' ' TYR . 1.1 m-80 -159.15 -177.86 6.79 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.276 -0.89 . . . . 0.0 110.091 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -90.74 -41.03 11.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.281 -0.887 . . . . 0.0 110.854 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.6 mtmp? -110.63 -1.12 16.95 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.132 -0.98 . . . . 0.0 110.811 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.53 ' HB2' ' CB ' ' A' ' 19' ' ' ASN . 1.2 m-85 -56.5 -52.36 65.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.057 -1.027 . . . . 0.0 109.986 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.4 t -78.03 -14.84 59.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.271 -0.893 . . . . 0.0 110.14 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.527 ' O ' ' CG ' ' A' ' 28' ' ' LYS . 9.6 t-20 -76.49 -41.45 46.97 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.259 -0.901 . . . . 0.0 110.006 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.1 -40.27 89.07 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.199 -0.938 . . . . 0.0 109.766 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -74.23 -45.06 50.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.325 -0.859 . . . . 0.0 109.954 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.464 ' SG ' ' HG3' ' A' ' 6' ' ' PRO . 1.2 m -60.85 -45.03 96.12 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.339 -0.851 . . . . 0.0 109.615 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.527 ' CG ' ' O ' ' A' ' 24' ' ' ASN . 2.2 mmmt -59.65 -31.08 69.19 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.334 -0.854 . . . . 0.0 109.323 179.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -56.57 -35.58 67.39 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 108.851 -1.699 . . . . 0.0 108.851 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.695 ' O ' ' CB ' ' A' ' 31' ' ' LYS . 10.5 mt -81.65 -28.91 33.38 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.387 -1.067 . . . . 0.0 109.617 179.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.695 ' CB ' ' O ' ' A' ' 30' ' ' LEU . 10.0 tttt 131.54 5.82 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.748 0 C-N-CA 123.528 0.731 . . . . 0.0 109.839 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.474 ' HB2' ' CD2' ' A' ' 49' ' ' LEU . . . -82.73 113.1 20.16 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.901 -1.124 . . . . 0.0 110.226 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.514 ' HA ' ' CD ' ' A' ' 28' ' ' LYS . 0.2 OUTLIER -73.66 -62.41 1.5 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.308 -0.87 . . . . 0.0 110.134 179.893 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -80.45 82.84 6.38 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.399 -0.813 . . . . 0.0 109.996 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.531 ' CA ' ' SG ' ' A' ' 46' ' ' CYS . . . -121.06 104.07 0.93 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.562 ' OH ' ' CD2' ' A' ' 45' ' ' TYR . 41.4 p90 -126.35 -177.16 3.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.178 -1.19 . . . . 0.0 109.794 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.1 OUTLIER -110.72 147.28 34.72 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.087 -1.008 . . . . 0.0 110.277 -179.916 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.585 ' CD1' ' HB2' ' A' ' 42' ' ' LEU . 15.6 t-105 -79.53 166.61 21.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.084 -1.01 . . . . 0.0 109.855 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -125.54 55.67 0.72 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.479 ' O ' ' HB ' ' A' ' 41' ' ' THR . 11.6 t-105 -160.33 -69.66 0.07 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.374 -1.074 . . . . 0.0 109.335 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.479 ' HB ' ' O ' ' A' ' 40' ' ' TRP . 5.1 t -179.06 32.37 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.67 -0.644 . . . . 0.0 109.883 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.585 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 0.8 OUTLIER -113.58 21.39 15.13 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.102 -0.999 . . . . 0.0 110.908 -179.433 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.518 ' OG ' ' CG2' ' A' ' 15' ' ' ILE . 8.2 t 57.34 -168.69 0.11 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.13 -0.981 . . . . 0.0 110.784 179.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 37' ' ' CYS . 19.4 t -71.91 171.98 10.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.391 -0.818 . . . . 0.0 110.162 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.562 ' CD2' ' OH ' ' A' ' 36' ' ' TYR . 1.1 t80 -151.5 110.21 3.83 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.994 -1.066 . . . . 0.0 110.752 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.531 ' SG ' ' CA ' ' A' ' 35' ' ' GLY . 82.9 m -125.44 137.49 53.99 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.327 -0.858 . . . . 0.0 109.824 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -119.92 131.95 55.37 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.206 -0.934 . . . . 0.0 109.931 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 107.82 41.22 1.6 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.575 ' CD2' ' N ' ' A' ' 49' ' ' LEU . 0.1 OUTLIER -119.6 172.9 3.98 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.362 -1.081 . . . . 0.0 109.83 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.494 ' HD2' ' HB2' ' A' ' 49' ' ' LEU . 42.1 Cg_endo -68.32 155.22 70.05 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 O-C-N 123.677 1.356 . . . . 0.0 110.516 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -61.12 -19.95 62.08 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.359 -0.838 . . . . 0.0 110.459 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -88.62 11.87 16.23 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.208 -0.933 . . . . 0.0 110.095 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.521 ' CB ' HD11 ' A' ' 49' ' ' LEU . . . -65.27 110.38 2.57 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.24 -0.913 . . . . 0.0 110.167 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.451 ' O ' ' HA ' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -57.71 136.08 56.83 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.234 -0.916 . . . . 0.0 110.282 179.982 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.495 ' C ' ' CD1' ' A' ' 55' ' ' ILE . 1.4 pp -154.36 -169.94 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.204 -0.935 . . . . 0.0 110.319 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.427 ' O ' ' CG ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -50.07 91.1 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.315 -0.866 . . . . 0.0 110.662 -179.523 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.471 ' N ' ' O ' ' A' ' 55' ' ' ILE . 2.4 ttt85 -119.76 -5.86 10.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.204 -0.935 . . . . 0.0 110.022 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.424 ' HB2' ' CG ' ' A' ' 11' ' ' ASN . 46.3 m -120.67 -178.53 3.74 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.309 -0.87 . . . . 0.0 110.031 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -118.94 -36.86 0.85 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.401 ' O ' ' C ' ' A' ' 61' ' ' CYS . 0.3 OUTLIER -131.74 155.32 47.9 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.19 -1.183 . . . . 0.0 110.393 -179.922 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.401 ' C ' ' O ' ' A' ' 60' ' ' ARG . 43.3 t -43.79 115.4 0.8 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.285 -0.884 . . . . 0.0 110.305 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.524 ' CB ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -90.85 48.26 1.51 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.253 -0.904 . . . . 0.0 110.262 -179.975 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.678 0 O-C-N 121.272 -0.893 . . . . 0.0 110.147 179.991 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.497 ' CG ' ' O ' ' A' ' 1' ' ' LYS . 2.2 tttm . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.191 0.52 . . . . 0.0 110.167 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.496 ' CG2' ' HG ' ' A' ' 49' ' ' LEU . 10.1 tt -111.15 157.45 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.239 -0.913 . . . . 0.0 110.497 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.584 ' CB ' ' CG ' ' A' ' 47' ' ' GLN . 7.1 p30 -133.21 117.28 17.24 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.733 -0.604 . . . . 0.0 109.66 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -155.45 -150.61 5.63 Favored Glycine 0 N--CA 1.491 2.353 0 C-N-CA 119.496 -1.335 . . . . 0.0 109.846 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.492 ' HA ' ' O ' ' A' ' 44' ' ' CYS . 14.1 m-85 -122.83 114.33 29.8 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.403 -1.057 . . . . 0.0 110.29 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.466 ' HA ' ' O ' ' A' ' 54' ' ' ARG . 48.2 Cg_endo -76.04 144.8 27.33 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 124.047 1.551 . . . . 0.0 110.619 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.468 HG13 ' HA ' ' A' ' 15' ' ' ILE . 32.8 m -141.76 -171.47 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.297 -0.877 . . . . 0.0 109.894 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.531 ' HB2' ' CB ' ' A' ' 14' ' ' ARG . 3.9 t0 -67.54 -176.0 0.57 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.227 -0.92 . . . . 0.0 110.175 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.472 ' HB3' ' CE2' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -76.55 -11.02 59.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.359 -0.838 . . . . 0.0 109.68 179.739 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.548 ' HB3' ' N ' ' A' ' 62' ' ' ARG . 4.0 m-90 -132.22 8.38 4.34 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.382 -0.824 . . . . 0.0 110.115 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.472 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 18.3 m-20 60.09 33.08 21.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.162 -0.961 . . . . 0.0 110.25 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.467 ' O ' ' HD3' ' A' ' 13' ' ' LYS . 5.5 t -98.12 -67.27 0.85 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.237 -0.914 . . . . 0.0 110.683 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.481 ' O ' ' HB2' ' A' ' 14' ' ' ARG . 45.2 mmtt -131.32 86.02 2.32 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.297 -0.877 . . . . 0.0 110.587 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.531 ' CB ' ' HB2' ' A' ' 8' ' ' ASP . 1.0 OUTLIER 177.75 -22.88 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.488 -0.758 . . . . 0.0 111.008 179.739 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.545 HG12 ' CB ' ' A' ' 43' ' ' SER . 6.8 tt -30.33 -45.13 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.749 -0.595 . . . . 0.0 111.203 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.518 ' N ' ' CG2' ' A' ' 15' ' ' ILE . 43.0 t -159.18 154.3 25.21 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.226 -0.921 . . . . 0.0 109.967 179.107 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -114.84 -151.76 0.49 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.21 -0.931 . . . . 0.0 110.629 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -123.91 16.14 9.33 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.334 -0.854 . . . . 0.0 110.51 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.462 ' HB2' ' HB2' ' A' ' 22' ' ' TYR . 36.4 m-20 -119.16 148.02 43.55 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.083 -1.011 . . . . 0.0 110.395 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -88.16 26.45 1.39 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.323 -0.86 . . . . 0.0 110.165 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.4 pttm -150.29 -35.23 0.16 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.292 -0.88 . . . . 0.0 110.457 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.462 ' HB2' ' HB2' ' A' ' 19' ' ' ASN . 0.1 OUTLIER -51.51 -28.82 14.59 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -0.918 . . . . 0.0 110.691 -179.661 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.443 ' O ' ' C ' ' A' ' 24' ' ' ASN . 0.5 OUTLIER -87.18 -59.68 2.19 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.1 -1.0 . . . . 0.0 110.333 -179.905 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.443 ' C ' ' O ' ' A' ' 23' ' ' CYS . 0.1 OUTLIER -40.72 -40.41 1.3 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.488 -0.758 . . . . 0.0 110.001 179.879 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.99 -47.69 80.21 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.315 -0.866 . . . . 0.0 110.311 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.8 mt -74.84 -37.92 62.12 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.192 -0.942 . . . . 0.0 110.046 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.491 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . 15.2 m -58.38 -39.68 80.26 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.161 -0.962 . . . . 0.0 109.473 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.87 -29.9 68.62 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.329 -0.857 . . . . 0.0 109.37 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.2 -37.35 92.82 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 108.311 -1.916 . . . . 0.0 108.311 179.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.509 ' O ' ' CB ' ' A' ' 31' ' ' LYS . 39.5 mt -89.02 19.39 4.2 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.462 -1.022 . . . . 0.0 109.524 179.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.509 ' CB ' ' O ' ' A' ' 30' ' ' LEU . 0.3 OUTLIER 73.18 16.22 4.27 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.657 -0.652 . . . . 0.0 110.809 179.912 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.491 ' HB1' ' HB3' ' A' ' 27' ' ' CYS . . . -95.65 89.7 5.43 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.957 -1.089 . . . . 0.0 109.797 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -55.31 -75.15 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.22 -0.925 . . . . 0.0 111.018 -179.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.472 ' O ' ' HA ' ' A' ' 46' ' ' CYS . 8.6 t -62.34 95.42 0.07 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.389 -0.82 . . . . 0.0 110.912 -179.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.459 ' HA2' ' SG ' ' A' ' 46' ' ' CYS . . . -123.06 110.87 1.6 Allowed Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.585 ' CD1' ' O ' ' A' ' 36' ' ' TYR . 13.1 p90 -138.99 144.25 38.84 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.388 -1.066 . . . . 0.0 109.738 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.491 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.0 OUTLIER -90.97 154.56 19.36 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.038 -1.039 . . . . 0.0 110.832 -179.359 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.439 ' CG ' ' HB2' ' A' ' 42' ' ' LEU . 18.5 t-105 -79.95 -172.03 3.19 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.271 -0.893 . . . . 0.0 109.936 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -119.55 -29.3 1.76 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.567 ' CE2' HG23 ' A' ' 41' ' ' THR . 12.8 t-105 -79.38 -83.1 0.1 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.233 -1.157 . . . . 0.0 109.986 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.567 HG23 ' CE2' ' A' ' 40' ' ' TRP . 5.3 t -166.41 48.42 0.07 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.347 -0.845 . . . . 0.0 109.707 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.443 ' O ' ' HB2' ' A' ' 43' ' ' SER . 8.0 mp -106.9 23.49 14.28 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.312 -0.868 . . . . 0.0 110.745 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.545 ' CB ' HG12 ' A' ' 15' ' ' ILE . 5.1 m 58.48 -166.93 0.15 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 120.935 -1.103 . . . . 0.0 110.027 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 5' ' ' TYR . 9.3 t -83.68 156.27 22.73 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.34 -0.85 . . . . 0.0 108.88 178.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.45 ' CD2' ' OH ' ' A' ' 36' ' ' TYR . 0.8 OUTLIER -128.72 116.95 20.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.96 -1.088 . . . . 0.0 110.354 -179.629 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 34' ' ' SER . 74.0 m -137.52 137.45 38.65 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.353 -0.842 . . . . 0.0 109.848 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.584 ' CG ' ' CB ' ' A' ' 3' ' ' ASP . 1.7 mp0 -123.78 154.63 39.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.273 -0.892 . . . . 0.0 110.431 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.489 ' O ' ' O ' ' A' ' 31' ' ' LYS . . . 99.73 15.46 31.55 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.584 ' CD1' ' CB ' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -98.66 170.35 7.09 Favored Pre-proline 0 N--CA 1.497 1.891 0 O-C-N 121.133 -1.216 . . . . 0.0 109.723 179.669 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.531 ' HD2' ' HB2' ' A' ' 49' ' ' LEU . 43.3 Cg_endo -70.61 156.46 61.07 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 123.515 1.271 . . . . 0.0 110.706 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.439 ' HA ' HD11 ' A' ' 2' ' ' ILE . 48.3 t0 -58.99 -24.85 63.1 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.334 -0.854 . . . . 0.0 110.01 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -85.79 14.18 6.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.373 -0.829 . . . . 0.0 109.806 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.584 ' CB ' ' CD1' ' A' ' 49' ' ' LEU . . . -56.25 152.15 11.46 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.449 -0.782 . . . . 0.0 110.381 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.466 ' O ' ' HA ' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -92.19 110.48 21.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.309 -0.87 . . . . 0.0 109.536 179.476 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.592 ' CD1' ' N ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -148.65 -164.62 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.256 -0.903 . . . . 0.0 110.647 -179.384 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' A' ' 55' ' ' ILE . 0.1 OUTLIER -40.45 108.63 0.09 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.573 -0.705 . . . . 0.0 110.54 -179.816 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.456 ' CG ' ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -136.43 20.68 3.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.381 -0.824 . . . . 0.0 109.872 179.807 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.451 ' CB ' ' O ' ' A' ' 57' ' ' ARG . 0.5 OUTLIER 66.86 153.49 0.08 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.408 -0.807 . . . . 0.0 110.161 -179.969 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 128.73 101.57 1.03 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.709 -1.357 . . . . 0.0 109.709 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.436 ' O ' ' C ' ' A' ' 61' ' ' CYS . 1.6 mmt180 -70.13 94.85 0.92 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.257 -1.143 . . . . 0.0 109.965 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.436 ' C ' ' O ' ' A' ' 60' ' ' ARG . 41.8 t 42.54 88.95 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 0.0 109.967 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.548 ' N ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -83.11 26.48 0.62 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.357 -0.84 . . . . 0.0 110.844 -179.905 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.492 ' CB ' ' O ' ' A' ' 62' ' ' ARG . . . . . . . . 0 N--CA 1.492 1.644 0 O-C-N 121.01 -1.056 . . . . 0.0 110.244 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 5.4 mtmm . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.21 0.528 . . . . 0.0 110.152 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.474 HG23 ' HG ' ' A' ' 49' ' ' LEU . 6.0 tt -133.09 154.72 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.202 -0.936 . . . . 0.0 110.418 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -124.88 128.6 48.9 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.345 -0.847 . . . . 0.0 109.983 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -168.19 -166.07 26.64 Favored Glycine 0 N--CA 1.491 2.347 0 C-N-CA 119.554 -1.307 . . . . 0.0 110.114 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.592 ' N ' ' CD1' ' A' ' 5' ' ' TYR . 13.7 m-85 -111.05 104.3 56.01 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.318 -1.107 . . . . 0.0 109.656 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.55 ' N ' HG22 ' A' ' 55' ' ' ILE . 50.1 Cg_endo -76.98 111.44 3.23 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 123.948 1.499 . . . . 0.0 111.281 -179.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.8 m -83.4 -169.99 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.231 -0.918 . . . . 0.0 109.877 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.55 ' CB ' ' HB2' ' A' ' 13' ' ' LYS . 11.8 p-10 -71.9 -134.77 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.287 -0.883 . . . . 0.0 109.852 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.57 ' HB3' ' CD2' ' A' ' 10' ' ' TRP . 0.2 OUTLIER -92.43 -63.26 1.25 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.035 -1.041 . . . . 0.0 110.397 -179.871 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.57 ' CD2' ' HB3' ' A' ' 9' ' ' TYR . 2.8 m-90 -107.11 26.79 9.71 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.134 -0.979 . . . . 0.0 110.125 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.479 ' HA ' ' OD1' ' A' ' 8' ' ' ASP . 1.3 m-20 67.31 5.83 4.48 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.134 -0.979 . . . . 0.0 109.853 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.454 ' O ' ' C ' ' A' ' 13' ' ' LYS . 89.2 m -83.86 -66.1 0.93 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.277 -0.889 . . . . 0.0 110.733 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.55 ' HB2' ' CB ' ' A' ' 8' ' ' ASP . 6.8 mmmt -37.95 -85.68 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.726 -0.609 . . . . 0.0 110.843 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 4.6 ttm180 -165.33 109.02 0.85 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.002 -1.061 . . . . 0.0 110.673 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.454 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 46.3 pt -48.77 -24.24 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.139 -0.975 . . . . 0.0 109.348 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.46 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 34.4 t -150.15 126.39 10.69 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.714 -0.616 . . . . 0.0 109.865 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.652 ' CE3' ' CD2' ' A' ' 22' ' ' TYR . 0.0 OUTLIER -85.36 -162.05 0.67 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.184 -0.948 . . . . 0.0 110.197 -179.901 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -101.72 -54.74 2.67 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.328 -0.857 . . . . 0.0 110.181 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -60.66 113.86 2.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.449 -0.782 . . . . 0.0 110.29 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 29.4 p30 -59.65 -15.22 17.7 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.354 -0.841 . . . . 0.0 110.329 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.402 ' HG3' ' N ' ' A' ' 22' ' ' TYR . 8.2 pttp -92.98 -27.89 16.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.203 -0.936 . . . . 0.0 110.293 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.652 ' CD2' ' CE3' ' A' ' 17' ' ' TRP . 45.3 t80 -60.63 -47.9 84.18 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.245 -0.909 . . . . 0.0 110.046 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -64.6 -40.44 95.53 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.334 -0.854 . . . . 0.0 110.174 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -57.59 -35.44 70.41 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.226 -0.921 . . . . 0.0 110.133 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -58.72 -57.52 12.62 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.241 -0.912 . . . . 0.0 110.015 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.87 -39.01 93.1 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.274 -0.891 . . . . 0.0 110.149 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.495 ' HB3' ' HB2' ' A' ' 32' ' ' ALA . 11.4 m -62.65 -37.19 85.38 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.223 -0.923 . . . . 0.0 109.877 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.88 -29.4 70.58 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.181 -0.949 . . . . 0.0 109.368 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.78 -27.34 69.88 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 107.438 -2.265 . . . . 0.0 107.438 178.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.508 ' O ' ' CB ' ' A' ' 31' ' ' LYS . 9.9 mt -96.3 19.41 11.99 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.879 -0.777 . . . . 0.0 109.051 178.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.508 ' CB ' ' O ' ' A' ' 30' ' ' LEU . 0.7 OUTLIER 71.47 10.92 6.6 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.468 -0.77 . . . . 0.0 110.985 179.684 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.53 ' CB ' HD21 ' A' ' 49' ' ' LEU . . . -85.3 103.46 14.25 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.833 -1.167 . . . . 0.0 109.983 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.441 ' N ' ' OD1' ' A' ' 33' ' ' ASP . 4.4 m-20 -61.25 -80.25 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.407 -0.808 . . . . 0.0 110.885 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.461 ' O ' ' HA ' ' A' ' 46' ' ' CYS . 60.3 p -66.26 94.04 0.24 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.234 -0.916 . . . . 0.0 110.348 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.421 ' HA2' ' SG ' ' A' ' 46' ' ' CYS . . . -116.75 84.5 0.37 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.421 ' C ' ' CD1' ' A' ' 36' ' ' TYR . 31.5 p90 -114.88 151.49 33.87 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.203 -1.175 . . . . 0.0 109.841 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.517 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.1 OUTLIER -95.62 155.3 16.8 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.118 -0.989 . . . . 0.0 110.505 -179.642 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.582 ' CD1' ' HB3' ' A' ' 40' ' ' TRP . 27.6 t-105 -79.52 168.15 19.82 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.188 -0.945 . . . . 0.0 109.613 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -106.66 -26.42 5.87 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.582 ' HB3' ' CD1' ' A' ' 38' ' ' TRP . 53.8 t-105 -79.61 -92.02 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.26 -1.141 . . . . 0.0 109.726 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.553 ' OG1' ' CD1' ' A' ' 40' ' ' TRP . 70.7 p -158.07 46.37 0.35 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.357 -0.84 . . . . 0.0 109.857 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.571 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 1.1 mt -110.92 30.92 6.42 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.14 -0.975 . . . . 0.0 110.686 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.46 ' HA ' ' HB2' ' A' ' 16' ' ' CYS . 3.2 t 54.85 -172.68 0.05 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.201 -0.937 . . . . 0.0 110.386 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.517 ' HA ' ' HA ' ' A' ' 37' ' ' CYS . 17.5 t -78.77 166.63 22.24 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.335 -0.853 . . . . 0.0 109.814 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.553 ' CD2' ' CE2' ' A' ' 5' ' ' TYR . 0.8 OUTLIER -139.82 120.08 13.85 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.243 -0.911 . . . . 0.0 110.488 -179.613 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.49 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . 80.5 m -136.07 135.19 39.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.121 -0.987 . . . . 0.0 109.697 179.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.42 ' CA ' HD23 ' A' ' 49' ' ' LEU . 12.6 mt-30 -115.53 142.94 46.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.353 -0.842 . . . . 0.0 110.205 -179.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 31' ' ' LYS . . . 99.9 31.91 5.82 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.594 ' CD2' ' N ' ' A' ' 49' ' ' LEU . 0.1 OUTLIER -103.49 176.3 1.86 Allowed Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.052 -1.263 . . . . 0.0 109.327 179.38 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.503 ' HD3' ' O ' ' A' ' 30' ' ' LEU . 47.2 Cg_endo -70.56 155.93 62.3 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 123.692 1.364 . . . . 0.0 110.24 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -59.7 -19.03 47.09 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.052 -1.03 . . . . 0.0 109.597 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -102.31 24.71 9.87 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.395 -0.815 . . . . 0.0 109.472 179.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.471 ' HB2' ' O ' ' A' ' 50' ' ' PRO . . . -64.22 123.14 18.34 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.355 -0.841 . . . . 0.0 110.509 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.525 ' CZ ' ' O ' ' A' ' 9' ' ' TYR . 0.1 OUTLIER -68.64 112.31 5.32 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.217 -0.927 . . . . 0.0 110.278 179.834 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.581 ' O ' ' CD1' ' A' ' 55' ' ' ILE . 2.5 pp -143.68 128.07 14.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.44 -0.788 . . . . 0.0 110.589 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.49 ' C ' ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER 29.17 52.67 0.08 Allowed 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 121.227 0.537 . . . . 0.0 111.689 179.862 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.407 ' HD3' ' HG2' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -128.62 7.98 5.8 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.231 -0.918 . . . . 0.0 110.196 179.479 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.461 ' HB3' ' HB2' ' A' ' 11' ' ' ASN . 0.4 OUTLIER -92.32 151.92 20.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.32 -0.862 . . . . 0.0 110.114 179.87 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.15 -136.54 1.26 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.44 ' O ' ' O ' ' A' ' 61' ' ' CYS . 25.4 mmt85 -88.16 92.41 9.14 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.172 -1.193 . . . . 0.0 110.271 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 10' ' ' TRP . 0.0 OUTLIER 52.74 101.79 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.241 -0.912 . . . . 0.0 110.137 179.935 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.52 ' CB ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -82.32 46.77 1.07 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.243 -0.911 . . . . 0.0 110.293 -179.875 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.252 -0.905 . . . . 0.0 110.261 179.964 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.452 ' O ' ' HG3' ' A' ' 1' ' ' LYS . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.308 0.575 . . . . 0.0 110.163 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.52 ' CG2' ' HG ' ' A' ' 49' ' ' LEU . 15.9 tt -133.62 166.31 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.242 -0.912 . . . . 0.0 109.991 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -142.24 138.11 31.2 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.297 -0.877 . . . . 0.0 110.011 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 176.78 -148.67 9.13 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.549 ' N ' ' CD1' ' A' ' 5' ' ' TYR . 18.2 m-85 -123.61 117.61 27.6 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.285 -1.127 . . . . 0.0 110.321 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.483 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 45.5 Cg_endo -74.03 134.18 19.2 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.923 1.486 . . . . 0.0 110.159 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.524 ' CG2' ' OD1' ' A' ' 11' ' ' ASN . 27.2 m -136.99 -168.79 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.142 -0.974 . . . . 0.0 110.475 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.536 ' CB ' ' HB3' ' A' ' 14' ' ' ARG . 0.7 OUTLIER -80.13 172.28 13.98 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.342 -0.849 . . . . 0.0 110.383 -179.821 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.583 ' HB3' ' CE2' ' A' ' 10' ' ' TRP . 0.4 OUTLIER -62.34 -19.56 63.48 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.306 -0.871 . . . . 0.0 109.817 179.706 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.583 ' CE2' ' HB3' ' A' ' 9' ' ' TYR . 2.9 m-90 -131.23 12.87 5.1 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.333 -0.854 . . . . 0.0 110.15 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.524 ' OD1' ' CG2' ' A' ' 7' ' ' VAL . 88.6 m-20 56.5 35.44 26.01 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.129 -0.982 . . . . 0.0 109.375 -179.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.415 ' SG ' ' HB2' ' A' ' 10' ' ' TRP . 34.8 m -90.74 -53.2 4.51 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.481 -0.762 . . . . 0.0 111.642 -179.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.489 ' O ' ' O ' ' A' ' 14' ' ' ARG . 1.2 mppt? -125.21 -56.41 1.54 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.059 -1.026 . . . . 0.0 111.885 -178.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.536 ' HB3' ' CB ' ' A' ' 8' ' ' ASP . 14.6 tpp180 -36.76 -96.02 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.371 -0.831 . . . . 0.0 111.064 -178.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.471 ' HA ' HG11 ' A' ' 7' ' ' VAL . 72.0 mt 50.4 -88.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 120.954 -1.092 . . . . 0.0 110.515 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.543 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 1.6 t -135.13 134.4 40.18 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.371 -0.831 . . . . 0.0 109.714 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.425 ' O ' ' SG ' ' A' ' 37' ' ' CYS . 0.0 OUTLIER -88.62 -156.52 0.38 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.165 -0.959 . . . . 0.0 110.631 -179.654 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -107.25 -32.32 7.84 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.224 -0.923 . . . . 0.0 110.161 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -87.45 153.52 21.36 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.289 -0.882 . . . . 0.0 110.136 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -86.24 -17.55 34.45 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.179 -0.951 . . . . 0.0 109.997 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.7 ttpp -96.15 -10.56 27.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.284 -0.885 . . . . 0.0 109.992 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -69.39 -58.75 3.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.248 -0.908 . . . . 0.0 110.094 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -65.62 -28.17 68.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.311 -0.868 . . . . 0.0 110.096 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.479 ' O ' ' HG2' ' A' ' 28' ' ' LYS . 6.9 t-20 -69.07 -40.43 78.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.344 -0.848 . . . . 0.0 109.918 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.57 -46.15 87.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.156 -0.965 . . . . 0.0 110.007 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.1 mt -74.27 -42.69 59.21 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.319 -0.863 . . . . 0.0 109.946 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.467 ' O ' ' HB1' ' A' ' 32' ' ' ALA . 5.7 m -58.95 -39.39 81.53 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.219 -0.926 . . . . 0.0 109.547 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.479 ' HG2' ' O ' ' A' ' 24' ' ' ASN . 2.6 mmmt -60.83 -28.18 68.62 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.196 -0.94 . . . . 0.0 109.443 179.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.12 -35.35 90.69 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 107.677 -2.169 . . . . 0.0 107.677 178.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.508 ' O ' ' HD3' ' A' ' 50' ' ' PRO . 13.6 mt -91.38 21.94 4.21 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.701 -0.882 . . . . 0.0 109.117 178.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.474 ' O ' ' O ' ' A' ' 48' ' ' GLY . 0.7 OUTLIER 67.72 15.43 9.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.426 -0.796 . . . . 0.0 110.95 179.868 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.506 ' HB2' ' CD2' ' A' ' 49' ' ' LEU . . . -83.99 89.44 7.25 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.859 -1.151 . . . . 0.0 109.582 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -48.03 -83.68 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.322 -0.862 . . . . 0.0 111.195 -179.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.473 ' O ' ' HA ' ' A' ' 46' ' ' CYS . 10.0 m -68.97 92.11 0.5 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.296 -0.878 . . . . 0.0 110.5 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.519 ' CA ' ' SG ' ' A' ' 46' ' ' CYS . . . -127.03 97.41 0.48 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.41 ' O ' ' SG ' ' A' ' 44' ' ' CYS . 40.6 p90 -119.73 -169.41 1.76 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.235 -1.156 . . . . 0.0 110.658 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 34.4 t -128.12 127.7 43.5 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.363 -0.836 . . . . 0.0 110.268 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.594 ' CD1' ' HB3' ' A' ' 40' ' ' TRP . 28.0 t-105 -79.77 147.25 31.92 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.994 -1.067 . . . . 0.0 110.054 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -110.91 61.11 0.31 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.594 ' HB3' ' CD1' ' A' ' 38' ' ' TRP . 14.2 t-105 -160.31 -70.38 0.07 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.235 -1.156 . . . . 0.0 110.056 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.577 HG22 ' CD1' ' A' ' 40' ' ' TRP . 7.0 t -171.47 34.99 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.443 -0.786 . . . . 0.0 110.178 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.575 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 12.5 mt -119.69 10.29 11.66 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.261 -0.899 . . . . 0.0 110.358 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.543 ' HA ' ' HB2' ' A' ' 16' ' ' CYS . 50.7 m 54.46 -170.52 0.06 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.236 -0.915 . . . . 0.0 110.317 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.465 ' O ' ' HB3' ' A' ' 5' ' ' TYR . 43.0 t -74.18 155.31 38.5 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.195 -0.941 . . . . 0.0 109.247 179.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.401 ' HB3' ' CZ ' ' A' ' 36' ' ' TYR . 1.0 OUTLIER -137.06 112.56 9.32 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.873 -1.142 . . . . 0.0 111.123 -179.35 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.519 ' SG ' ' CA ' ' A' ' 35' ' ' GLY . 68.1 m -128.8 143.86 51.02 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.296 -0.877 . . . . 0.0 109.837 178.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.462 ' HA ' HD23 ' A' ' 49' ' ' LEU . 1.5 mp0 -126.61 145.68 50.46 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.217 -0.927 . . . . 0.0 110.159 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 31' ' ' LYS . . . 95.56 33.87 6.28 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.522 ' N ' HD21 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -109.14 171.27 4.59 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.275 -1.133 . . . . 0.0 109.741 179.738 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.508 ' HD3' ' O ' ' A' ' 30' ' ' LEU . 42.4 Cg_endo -69.45 158.68 56.47 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.51 1.269 . . . . 0.0 110.774 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -62.0 -15.33 43.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.333 -0.855 . . . . 0.0 109.885 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -96.59 16.14 19.69 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.344 -0.848 . . . . 0.0 109.819 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.509 ' CB ' ' CD1' ' A' ' 49' ' ' LEU . . . -60.46 127.88 33.9 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.386 -0.821 . . . . 0.0 110.528 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.476 ' O ' ' HA ' ' A' ' 6' ' ' PRO . 0.5 OUTLIER -71.32 99.53 1.96 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.284 -0.885 . . . . 0.0 109.887 179.742 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.484 ' C ' ' CD1' ' A' ' 55' ' ' ILE . 2.3 pp -137.4 -160.81 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.181 -0.949 . . . . 0.0 110.463 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.476 ' C ' ' O ' ' A' ' 55' ' ' ILE . 12.8 mttt -29.68 96.8 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 121.382 0.61 . . . . 0.0 111.567 -179.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.437 ' O ' ' CB ' ' A' ' 58' ' ' SER . 0.3 OUTLIER -111.3 0.36 16.67 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.41 -0.806 . . . . 0.0 110.038 179.555 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.437 ' CB ' ' O ' ' A' ' 57' ' ' ARG . 0.4 OUTLIER 66.55 172.9 0.25 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.422 -0.799 . . . . 0.0 110.287 -179.985 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 60' ' ' ARG . . . 86.42 108.75 0.8 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.469 ' O ' ' N ' ' A' ' 62' ' ' ARG . 8.9 mmm-85 -49.36 -179.69 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.283 -1.128 . . . . 0.0 110.302 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 10' ' ' TRP . 16.3 t -43.4 96.51 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.248 -0.908 . . . . 0.0 110.149 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.534 ' CB ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -82.76 46.1 1.05 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.166 -0.959 . . . . 0.0 110.244 179.926 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.196 -0.94 . . . . 0.0 110.12 -179.985 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 1.4 mtpp . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.205 0.526 . . . . 0.0 110.269 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.463 HG21 ' O ' ' A' ' 49' ' ' LEU . 7.1 tt -132.94 161.8 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.324 -0.86 . . . . 0.0 110.264 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.463 ' HA ' ' HA ' ' A' ' 47' ' ' GLN . 4.5 m-20 -128.4 129.53 46.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.341 -0.85 . . . . 0.0 109.66 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -169.06 -170.03 33.16 Favored Glycine 0 N--CA 1.494 2.526 0 C-N-CA 119.372 -1.394 . . . . 0.0 110.259 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.557 ' N ' ' CD1' ' A' ' 5' ' ' TYR . 6.8 m-85 -107.69 102.4 44.74 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.431 -1.041 . . . . 0.0 110.485 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.59 138.17 26.31 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 124.004 1.528 . . . . 0.0 110.425 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.534 HG11 ' CG2' ' A' ' 15' ' ' ILE . 21.4 m -120.47 -168.97 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.239 -0.913 . . . . 0.0 110.449 -179.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.533 ' HB2' ' CB ' ' A' ' 13' ' ' LYS . 8.3 p-10 -66.94 -150.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.352 -0.843 . . . . 0.0 110.283 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.597 ' HB3' ' CD2' ' A' ' 10' ' ' TRP . 0.2 OUTLIER -87.13 -33.93 19.26 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.191 -0.943 . . . . 0.0 110.382 -179.861 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.597 ' CD2' ' HB3' ' A' ' 9' ' ' TYR . 8.7 m-90 -129.23 34.36 4.41 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.001 -1.062 . . . . 0.0 110.367 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.506 ' CA ' ' OD1' ' A' ' 8' ' ' ASP . 62.8 m-80 57.17 16.48 3.01 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.125 -0.984 . . . . 0.0 110.297 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.466 ' HB2' ' HA ' ' A' ' 61' ' ' CYS . 2.0 t -109.9 -44.19 3.86 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.208 -0.933 . . . . 0.0 110.488 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.533 ' CB ' ' HB2' ' A' ' 8' ' ' ASP . 0.0 OUTLIER -69.96 58.32 0.15 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.295 -0.878 . . . . 0.0 110.447 -179.733 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.45 ' HB2' ' O ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER 59.34 122.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.322 -0.861 . . . . 0.0 110.903 179.722 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.58 ' CG2' ' CB ' ' A' ' 43' ' ' SER . 1.3 mp -79.34 -12.81 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-O 121.747 0.784 . . . . 0.0 109.36 179.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.486 ' SG ' ' N ' ' A' ' 44' ' ' CYS . 1.5 t -146.55 158.05 43.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.458 -0.776 . . . . 0.0 109.263 179.35 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.549 ' CE2' ' CD1' ' A' ' 22' ' ' TYR . 0.0 OUTLIER -104.72 165.77 10.84 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.896 -1.128 . . . . 0.0 110.996 -179.511 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -81.17 -32.26 33.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.068 -1.02 . . . . 0.0 110.266 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -96.2 114.21 25.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.301 -0.874 . . . . 0.0 110.356 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -47.17 -27.98 1.65 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.391 -0.818 . . . . 0.0 110.348 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 29.7 tttm -76.19 -33.14 59.3 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.18 -0.95 . . . . 0.0 110.378 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.549 ' CD1' ' CE2' ' A' ' 17' ' ' TRP . 0.3 OUTLIER -55.12 -41.92 72.31 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.191 -0.943 . . . . 0.0 110.11 179.94 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.29 -52.99 7.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.222 -0.924 . . . . 0.0 110.248 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.483 ' HB2' ' O ' ' A' ' 35' ' ' GLY . 28.0 t-20 -48.19 -41.2 26.44 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.243 -0.911 . . . . 0.0 110.44 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -57.2 -52.49 65.12 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.263 -0.898 . . . . 0.0 110.556 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.41 -34.25 70.18 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.152 -0.968 . . . . 0.0 110.428 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.475 ' HB3' ' HB2' ' A' ' 32' ' ' ALA . 9.4 m -62.87 -45.69 91.38 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.084 -1.01 . . . . 0.0 109.788 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.94 -27.72 63.64 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.576 -0.85 . . . . 0.0 109.372 179.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.31 -37.99 93.93 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 108.352 -1.899 . . . . 0.0 108.352 179.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.538 ' O ' ' CB ' ' A' ' 31' ' ' LYS . 16.0 mt -90.6 21.18 4.12 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.54 -0.976 . . . . 0.0 109.342 179.099 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.538 ' CB ' ' O ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER 74.26 12.92 3.98 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.743 -0.598 . . . . 0.0 110.736 179.899 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.527 ' CB ' HD21 ' A' ' 49' ' ' LEU . . . -87.32 85.68 7.19 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.843 -1.16 . . . . 0.0 109.829 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -49.5 -87.57 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.414 -0.804 . . . . 0.0 111.186 -179.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 82.8 p -60.89 96.16 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.303 -0.873 . . . . 0.0 110.73 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.505 ' CA ' ' SG ' ' A' ' 46' ' ' CYS . . . -132.11 123.06 3.5 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.595 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 4.3 p90 -143.98 -174.91 4.4 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.173 -1.193 . . . . 0.0 109.76 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 26.3 t -124.55 138.0 54.36 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.966 -1.084 . . . . 0.0 110.961 -179.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.585 ' CD1' ' HB2' ' A' ' 42' ' ' LEU . 21.2 t-105 -88.25 99.43 12.22 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.171 -0.955 . . . . 0.0 109.653 179.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -69.36 70.3 0.49 Allowed Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.57 ' CD1' HG23 ' A' ' 41' ' ' THR . 7.5 t-105 -160.53 -65.28 0.07 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.317 -1.107 . . . . 0.0 109.648 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.57 HG23 ' CD1' ' A' ' 40' ' ' TRP . 1.7 t 175.34 36.1 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.564 -0.71 . . . . 0.0 109.885 179.357 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.585 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 1.0 OUTLIER -124.52 18.75 8.84 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.291 -0.881 . . . . 0.0 110.573 -179.781 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.58 ' CB ' ' CG2' ' A' ' 15' ' ' ILE . 28.8 t 56.22 -177.54 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.193 -0.942 . . . . 0.0 110.764 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.51 ' O ' ' HA ' ' A' ' 5' ' ' TYR . 15.8 t -70.62 173.21 7.4 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.307 -0.871 . . . . 0.0 109.334 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -154.66 106.27 2.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.945 -1.097 . . . . 0.0 110.528 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.505 ' SG ' ' CA ' ' A' ' 35' ' ' GLY . 75.2 m -127.21 137.8 52.98 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.389 -0.819 . . . . 0.0 109.736 179.442 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.463 ' HA ' ' HA ' ' A' ' 3' ' ' ASP . 16.9 mt-30 -116.66 130.83 56.97 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.152 -0.967 . . . . 0.0 109.966 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.505 ' O ' ' O ' ' A' ' 31' ' ' LYS . . . 117.88 24.38 3.36 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.551 ' CD2' ' N ' ' A' ' 49' ' ' LEU . 0.1 OUTLIER -104.04 173.42 3.4 Favored Pre-proline 0 N--CA 1.498 1.925 0 O-C-N 121.077 -1.249 . . . . 0.0 109.513 179.591 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.515 ' HD2' ' HB2' ' A' ' 49' ' ' LEU . 41.5 Cg_endo -68.87 156.86 64.05 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.443 1.233 . . . . 0.0 110.559 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -59.2 -21.58 59.69 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.259 -0.9 . . . . 0.0 110.222 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -90.48 14.03 14.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.376 -0.827 . . . . 0.0 109.987 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.468 ' O ' HG12 ' A' ' 55' ' ' ILE . . . -57.94 125.51 23.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.291 -0.881 . . . . 0.0 110.153 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.594 ' CB ' ' CZ ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -64.71 140.52 58.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.098 -1.001 . . . . 0.0 109.957 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.484 HG23 ' O ' ' A' ' 5' ' ' TYR . 26.3 mm -141.02 175.33 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.19 -0.943 . . . . 0.0 110.415 -179.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.485 ' HG2' HG11 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -60.82 82.82 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.332 -0.855 . . . . 0.0 110.074 179.486 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.442 ' N ' ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -95.56 20.81 9.06 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.1 -1.0 . . . . 0.0 110.356 -179.964 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.418 ' HB3' ' O ' ' A' ' 57' ' ' ARG . 4.7 t 63.24 -169.13 0.19 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.289 -0.882 . . . . 0.0 110.375 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 60' ' ' ARG . . . 121.03 -5.46 11.21 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.465 ' O ' ' O ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER 41.95 80.91 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.232 -1.158 . . . . 0.0 110.572 179.751 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.466 ' HA ' ' HB2' ' A' ' 12' ' ' CYS . 27.2 m 48.44 100.39 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.347 -0.846 . . . . 0.0 110.619 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.532 ' CB ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -89.75 44.26 1.2 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.241 -0.912 . . . . 0.0 110.095 179.699 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.235 -0.916 . . . . 0.0 110.181 -179.86 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 10.3 ttmt . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.25 0.548 . . . . 0.0 110.221 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.472 ' CG2' ' HG ' ' A' ' 49' ' ' LEU . 18.6 tt -127.58 158.77 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.134 -0.979 . . . . 0.0 110.285 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.465 ' HB2' ' HG3' ' A' ' 47' ' ' GLN . 2.5 p30 -133.37 139.28 46.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.366 -0.834 . . . . 0.0 110.102 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.475 ' C ' ' CD1' ' A' ' 5' ' ' TYR . . . 174.18 -164.53 35.76 Favored Glycine 0 N--CA 1.492 2.373 0 C-N-CA 119.685 -1.245 . . . . 0.0 110.057 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.581 ' N ' ' CD1' ' A' ' 5' ' ' TYR . 1.2 m-85 -112.62 98.58 44.81 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.25 -1.147 . . . . 0.0 110.51 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.501 ' CG ' ' SG ' ' A' ' 27' ' ' CYS . 44.8 Cg_endo -72.94 116.75 4.84 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.928 1.489 . . . . 0.0 110.557 179.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.534 ' CG1' HG22 ' A' ' 15' ' ' ILE . 21.3 m -79.97 -177.22 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.492 -0.755 . . . . 0.0 110.078 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.473 ' O ' ' NE ' ' A' ' 54' ' ' ARG . 77.5 m-20 -61.72 -96.67 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.131 -0.98 . . . . 0.0 110.114 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.476 ' HB3' ' CE3' ' A' ' 10' ' ' TRP . 0.2 OUTLIER -131.94 -59.02 0.95 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.102 -0.999 . . . . 0.0 109.594 179.63 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.501 ' O ' ' HB2' ' A' ' 11' ' ' ASN . 13.8 m-90 -106.99 17.13 23.46 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.468 -0.77 . . . . 0.0 109.46 179.295 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.517 ' N ' ' OD1' ' A' ' 11' ' ' ASN . 1.3 m-20 60.67 11.7 3.26 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.353 -0.842 . . . . 0.0 110.302 -179.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 63.5 m -60.38 -60.25 4.12 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.12 -0.988 . . . . 0.0 110.518 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.44 ' O ' ' CG ' ' A' ' 14' ' ' ARG . 0.8 OUTLIER -63.61 -63.49 1.16 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.365 -0.834 . . . . 0.0 110.325 -179.792 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.44 ' CG ' ' O ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER 173.1 176.78 0.1 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.276 -0.89 . . . . 0.0 110.423 179.977 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.548 ' CG2' ' OG ' ' A' ' 43' ' ' SER . 1.0 OUTLIER -77.68 -15.25 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.297 -0.877 . . . . 0.0 109.452 179.813 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.553 ' HB2' ' N ' ' A' ' 44' ' ' CYS . 10.9 t -141.49 157.99 44.43 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.413 -0.804 . . . . 0.0 109.872 179.068 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.478 ' CE3' ' CG ' ' A' ' 22' ' ' TYR . 22.9 t90 -95.67 -112.58 0.13 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.178 -0.951 . . . . 0.0 110.059 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -157.92 58.64 0.48 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.847 -1.158 . . . . 0.0 110.182 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.442 ' HB2' ' CE3' ' A' ' 17' ' ' TRP . 0.2 OUTLIER -170.91 153.58 3.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.378 -0.826 . . . . 0.0 110.086 179.97 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -84.69 -5.1 59.3 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.177 -0.952 . . . . 0.0 110.5 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -119.2 -30.69 4.89 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.066 -1.021 . . . . 0.0 110.735 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.478 ' CG ' ' CE3' ' A' ' 17' ' ' TRP . 26.3 t80 -54.1 -54.12 43.86 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.089 -1.007 . . . . 0.0 110.178 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.447 ' O ' ' HB2' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -62.04 -20.06 63.55 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.199 -0.938 . . . . 0.0 109.695 179.853 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.517 ' CB ' ' O ' ' A' ' 35' ' ' GLY . 0.2 OUTLIER -84.74 -42.71 14.97 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.266 -0.896 . . . . 0.0 110.457 -179.913 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -59.18 -43.41 92.16 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.028 -1.045 . . . . 0.0 109.759 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.408 ' O ' ' CD1' ' A' ' 30' ' ' LEU . 6.3 mt -71.55 -46.43 59.52 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.272 -0.892 . . . . 0.0 109.898 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.501 ' SG ' ' CG ' ' A' ' 6' ' ' PRO . 1.3 m -59.48 -40.13 85.99 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.301 -0.874 . . . . 0.0 110.017 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.477 ' HD2' ' ND2' ' A' ' 24' ' ' ASN . 0.1 OUTLIER -64.81 -33.31 75.7 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.268 -0.895 . . . . 0.0 109.141 179.389 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -53.43 -34.5 48.94 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 108.356 -1.898 . . . . 0.0 108.356 179.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.652 ' O ' ' CB ' ' A' ' 31' ' ' LYS . 1.8 mp -81.43 -35.51 30.55 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.469 -1.018 . . . . 0.0 109.353 179.149 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.652 ' CB ' ' O ' ' A' ' 30' ' ' LEU . 1.5 ttmm 141.8 -2.66 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.576 0 C-N-CA 123.051 0.54 . . . . 0.0 110.027 179.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.476 ' O ' ' HG3' ' A' ' 28' ' ' LYS . . . -80.7 94.82 6.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.991 -1.068 . . . . 0.0 110.345 -179.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.462 ' HA ' ' CG ' ' A' ' 28' ' ' LYS . 11.5 m-20 -65.11 -46.0 82.85 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.294 -0.878 . . . . 0.0 110.271 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.19 80.39 9.23 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.327 -0.858 . . . . 0.0 110.301 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.517 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -119.06 103.39 0.99 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -126.38 133.15 51.38 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.23 -1.159 . . . . 0.0 110.404 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.0 OUTLIER -84.67 127.48 34.11 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.207 -0.933 . . . . 0.0 110.167 179.875 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.541 ' CD1' HD11 ' A' ' 42' ' ' LEU . 0.3 OUTLIER -79.92 139.81 36.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.254 -0.904 . . . . 0.0 110.258 -179.899 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -90.83 12.16 69.7 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.529 ' CD1' HG23 ' A' ' 41' ' ' THR . 21.4 t-105 -105.03 -70.16 0.79 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.316 -1.108 . . . . 0.0 110.151 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.529 HG23 ' CD1' ' A' ' 40' ' ' TRP . 14.1 t -172.35 32.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.399 -0.813 . . . . 0.0 110.343 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.541 HD11 ' CD1' ' A' ' 38' ' ' TRP . 0.2 OUTLIER -112.16 13.65 20.57 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.201 -0.937 . . . . 0.0 110.236 179.961 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.548 ' OG ' ' CG2' ' A' ' 15' ' ' ILE . 28.0 t 44.12 -166.1 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.281 -0.887 . . . . 0.0 110.916 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.553 ' N ' ' HB2' ' A' ' 16' ' ' CYS . 21.5 t -68.57 113.67 6.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.509 -0.744 . . . . 0.0 109.669 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.424 ' CE2' ' HE1' ' A' ' 5' ' ' TYR . 2.7 t80 -99.62 123.52 43.96 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.176 -0.952 . . . . 0.0 110.145 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.423 ' SG ' ' SG ' ' A' ' 44' ' ' CYS . 59.7 m -134.94 128.13 31.94 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.295 -0.878 . . . . 0.0 110.141 179.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.465 ' HG3' ' HB2' ' A' ' 3' ' ' ASP . 0.5 OUTLIER -117.37 135.64 53.72 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.316 -0.865 . . . . 0.0 109.842 179.843 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 99.63 44.14 2.36 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.572 ' CD2' ' N ' ' A' ' 49' ' ' LEU . 0.1 OUTLIER -115.63 172.25 3.87 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.299 -1.118 . . . . 0.0 109.84 179.64 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.498 ' HD3' ' HB3' ' A' ' 31' ' ' LYS . 46.0 Cg_endo -72.04 157.82 53.63 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.832 1.438 . . . . 0.0 110.599 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -59.38 -19.96 51.1 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.208 -0.932 . . . . 0.0 109.941 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -83.84 6.68 20.58 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.281 -0.887 . . . . 0.0 110.04 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.435 ' HB1' ' O ' ' A' ' 50' ' ' PRO . . . -63.77 106.81 1.06 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.345 -0.847 . . . . 0.0 110.257 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.489 ' O ' ' HA ' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -62.42 156.45 22.61 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.244 -0.91 . . . . 0.0 109.93 179.744 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.469 HG22 ' O ' ' A' ' 5' ' ' TYR . 10.7 mm -142.77 -179.8 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.341 -0.849 . . . . 0.0 110.264 -179.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.493 ' O ' ' CG ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -60.38 84.31 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.436 -0.79 . . . . 0.0 110.124 179.277 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.497 ' NH1' ' HG2' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -106.09 -11.86 15.97 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.246 -0.909 . . . . 0.0 110.264 -179.942 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -146.1 167.04 24.38 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.335 -0.853 . . . . 0.0 110.191 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -148.62 35.64 1.11 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.526 ' O ' ' O ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER -136.98 41.72 2.47 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.111 -1.229 . . . . 0.0 110.383 179.767 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.526 ' O ' ' O ' ' A' ' 60' ' ' ARG . 49.6 t 41.06 106.54 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 121.586 0.708 . . . . 0.0 111.697 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.486 ' CB ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -83.19 40.09 0.69 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.186 -0.946 . . . . 0.0 110.688 179.56 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.658 0 O-C-N 121.086 -1.009 . . . . 0.0 110.296 179.947 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.271 0.558 . . . . 0.0 110.135 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.519 ' CG2' ' HG ' ' A' ' 49' ' ' LEU . 20.6 tt -126.01 160.58 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.295 -0.878 . . . . 0.0 110.181 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -139.75 128.9 23.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.311 -0.868 . . . . 0.0 110.007 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -177.58 -145.36 5.81 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.941 -1.263 . . . . 0.0 109.941 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.625 ' N ' ' CD1' ' A' ' 5' ' ' TYR . 12.8 m-85 -122.5 97.11 45.13 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.274 -1.133 . . . . 0.0 110.099 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.459 ' HA ' ' O ' ' A' ' 54' ' ' ARG . 42.5 Cg_endo -69.91 126.84 13.66 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.003 1.528 . . . . 0.0 110.815 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.534 HG11 ' CG2' ' A' ' 15' ' ' ILE . 15.2 m -85.38 -169.45 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.484 -0.76 . . . . 0.0 110.511 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.479 ' O ' ' NH1' ' A' ' 54' ' ' ARG . 2.6 t70 -63.15 -158.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.367 -0.833 . . . . 0.0 110.296 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.446 ' HB3' ' CE2' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -91.17 -20.3 22.13 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.296 -0.878 . . . . 0.0 110.176 179.972 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.485 ' HB3' ' N ' ' A' ' 62' ' ' ARG . 5.0 m-90 -128.25 18.24 6.5 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.176 -0.953 . . . . 0.0 110.52 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.483 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 8.3 m-20 59.88 12.7 3.19 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.343 -0.848 . . . . 0.0 110.372 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 3.5 t -79.23 -50.22 11.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.118 -0.989 . . . . 0.0 109.634 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.464 ' O ' ' O ' ' A' ' 14' ' ' ARG . 1.2 mptm? -79.97 152.38 29.54 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.464 -0.772 . . . . 0.0 109.611 179.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.464 ' O ' ' O ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -46.11 173.5 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.168 -0.958 . . . . 0.0 110.125 -179.921 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.534 ' CG2' HG11 ' A' ' 7' ' ' VAL . 3.9 mt -71.34 -1.94 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.113 -0.992 . . . . 0.0 109.853 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.56 ' HB2' ' N ' ' A' ' 44' ' ' CYS . 18.9 t -146.6 154.44 41.49 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.384 -0.823 . . . . 0.0 110.006 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.565 ' CZ3' ' CG ' ' A' ' 22' ' ' TYR . 28.3 t90 -118.39 169.54 9.66 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.118 -0.989 . . . . 0.0 109.796 179.438 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.421 ' N ' ' CG ' ' A' ' 17' ' ' TRP . 23.2 t80 -79.48 92.86 5.31 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.216 -0.928 . . . . 0.0 109.564 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.516 ' CB ' ' HB2' ' A' ' 22' ' ' TYR . 4.2 p-10 -174.3 142.47 0.79 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.289 -0.882 . . . . 0.0 110.517 -179.383 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 32.3 p30 -90.69 7.97 36.82 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.237 -0.914 . . . . 0.0 109.871 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.6 mttt -154.64 -28.69 0.11 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.145 -0.972 . . . . 0.0 111.724 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.565 ' CG ' ' CZ3' ' A' ' 17' ' ' TRP . 1.6 t80 -47.85 -21.54 0.43 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.555 -1.341 . . . . 0.0 110.576 -179.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.413 ' O ' ' HB2' ' A' ' 27' ' ' CYS . 0.1 OUTLIER -87.0 -34.9 19.09 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.05 -1.031 . . . . 0.0 110.327 -179.815 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.473 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 12.3 t-20 -72.67 -40.31 66.4 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.07 -1.018 . . . . 0.0 109.697 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -62.75 -33.87 76.05 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.323 -0.86 . . . . 0.0 109.93 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.431 ' HG ' ' N ' ' A' ' 27' ' ' CYS . 0.1 OUTLIER -83.23 -44.22 15.23 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.315 -0.866 . . . . 0.0 109.148 179.55 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.462 ' HB3' ' HB2' ' A' ' 32' ' ' ALA . 1.5 m -58.71 -40.79 84.7 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.536 -0.728 . . . . 0.0 109.562 179.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 24' ' ' ASN . 0.2 OUTLIER -64.34 -33.97 77.07 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.268 -0.895 . . . . 0.0 109.015 179.165 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.07 -37.33 45.5 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 108.589 -1.804 . . . . 0.0 108.589 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.672 ' O ' ' CB ' ' A' ' 31' ' ' LYS . 4.1 mt -79.75 -35.47 38.74 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.454 -1.027 . . . . 0.0 109.472 179.323 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.672 ' CB ' ' O ' ' A' ' 30' ' ' LEU . 21.5 tttt 139.21 2.88 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.575 0 C-N-CA 123.122 0.569 . . . . 0.0 110.131 179.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.497 ' HB3' ' HB3' ' A' ' 49' ' ' LEU . . . -88.25 109.3 19.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.781 -1.199 . . . . 0.0 110.18 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.45 ' HA ' ' HG3' ' A' ' 28' ' ' LYS . 2.6 m-20 -78.62 -44.4 24.05 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.142 -0.974 . . . . 0.0 110.402 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.463 ' O ' ' HA ' ' A' ' 46' ' ' CYS . 2.0 t -82.6 73.72 9.62 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.276 -0.89 . . . . 0.0 110.215 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.486 ' CA ' ' SG ' ' A' ' 46' ' ' CYS . . . -118.32 120.91 4.87 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.531 ' C ' ' CD1' ' A' ' 36' ' ' TYR . 14.0 p90 -143.79 153.89 42.86 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.322 -1.105 . . . . 0.0 109.742 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.0 OUTLIER -107.26 126.6 52.63 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.976 -1.077 . . . . 0.0 110.843 -179.443 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.593 ' CD1' ' HB3' ' A' ' 40' ' ' TRP . 43.7 t-105 -89.1 114.71 25.99 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.461 -0.774 . . . . 0.0 109.816 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.9 73.31 2.45 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 -179.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.593 ' HB3' ' CD1' ' A' ' 38' ' ' TRP . 0.1 OUTLIER -160.59 -73.27 0.07 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.283 -1.127 . . . . 0.0 109.8 179.395 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.504 HG23 ' CD1' ' A' ' 40' ' ' TRP . 15.0 t -169.0 39.29 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.506 -0.746 . . . . 0.0 109.908 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.575 HD11 ' CD1' ' A' ' 38' ' ' TRP . 0.4 OUTLIER -130.21 1.71 4.68 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.253 -0.904 . . . . 0.0 110.344 -179.897 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.471 ' HB3' HG21 ' A' ' 15' ' ' ILE . 48.9 m 56.12 -166.94 0.11 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.148 -0.97 . . . . 0.0 110.365 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.56 ' N ' ' HB2' ' A' ' 16' ' ' CYS . 6.8 t -77.91 151.37 33.81 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.253 -0.904 . . . . 0.0 110.171 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.539 ' CD1' ' CZ ' ' A' ' 5' ' ' TYR . 6.9 t80 -135.16 102.71 5.28 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.271 -0.893 . . . . 0.0 110.484 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.486 ' SG ' ' CA ' ' A' ' 35' ' ' GLY . 76.7 m -118.61 133.96 55.47 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.162 -0.961 . . . . 0.0 109.95 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 16.1 mt-30 -119.86 134.66 55.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.261 -0.899 . . . . 0.0 109.778 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 104.93 38.87 2.43 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.545 ' CD2' ' N ' ' A' ' 49' ' ' LEU . 0.1 OUTLIER -114.61 172.25 3.76 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.385 -1.068 . . . . 0.0 109.739 179.785 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.478 ' HD2' ' HB2' ' A' ' 49' ' ' LEU . 46.0 Cg_endo -71.94 156.31 56.52 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.676 1.356 . . . . 0.0 110.398 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.451 ' O ' ' OD1' ' A' ' 51' ' ' ASP . 21.0 t0 -60.34 -20.07 57.95 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.176 -0.952 . . . . 0.0 110.188 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -79.85 0.7 29.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.309 -0.869 . . . . 0.0 110.102 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.514 ' CB ' HD13 ' A' ' 49' ' ' LEU . . . -62.43 101.12 0.21 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.365 -0.834 . . . . 0.0 110.01 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.487 ' O ' ' CD1' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -55.33 149.85 12.33 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.079 -1.013 . . . . 0.0 110.218 -179.69 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.5 HG21 ' O ' ' A' ' 5' ' ' TYR . 35.5 mm -139.97 169.76 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.309 -0.87 . . . . 0.0 109.939 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.456 ' HD3' ' O ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -42.37 96.21 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.203 -0.936 . . . . 0.0 110.146 179.66 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.485 ' N ' ' O ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -125.51 7.6 7.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.197 -0.939 . . . . 0.0 110.092 179.923 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 58.64 160.39 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.29 -0.881 . . . . 0.0 110.494 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 148.41 -170.29 28.95 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.37 158.69 15.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.2 -1.177 . . . . 0.0 109.997 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 55.9 m -56.73 119.52 6.31 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.226 -0.921 . . . . 0.0 110.13 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.485 ' N ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -83.45 45.35 1.04 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.2 -0.937 . . . . 0.0 110.153 179.834 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.578 0 O-C-N 121.207 -0.933 . . . . 0.0 110.324 -179.758 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 1.5 tttt . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.3 0.571 . . . . 0.0 110.31 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.497 HG22 ' O ' ' A' ' 50' ' ' PRO . 5.9 tt -142.24 160.5 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.137 -0.977 . . . . 0.0 110.136 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.457 ' OD1' ' O ' ' A' ' 3' ' ' ASP . 3.6 p30 -126.9 122.65 35.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.301 -0.875 . . . . 0.0 110.383 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -165.11 -164.77 21.19 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.628 ' CE2' ' CD1' ' A' ' 45' ' ' TYR . 15.8 m-85 -117.31 107.9 44.53 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.227 -1.16 . . . . 0.0 110.487 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.531 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 49.6 Cg_endo -76.82 129.9 11.08 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 124.034 1.544 . . . . 0.0 110.649 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.482 HG12 HG23 ' A' ' 15' ' ' ILE . 32.8 m -105.63 -165.34 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.316 -0.865 . . . . 0.0 109.678 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.496 ' OD1' ' CZ3' ' A' ' 10' ' ' TRP . 5.0 t70 -60.56 -139.27 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.318 -0.864 . . . . 0.0 109.85 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.433 ' C ' ' CG ' ' A' ' 10' ' ' TRP . 3.2 m-85 -110.17 -4.11 15.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.083 -1.01 . . . . 0.0 110.079 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.562 ' CD1' ' O ' ' A' ' 62' ' ' ARG . 1.3 m-90 -143.55 8.58 1.55 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.254 -0.904 . . . . 0.0 110.165 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.533 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 7.5 m-20 66.56 2.29 2.45 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.631 -0.668 . . . . 0.0 110.894 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.429 ' O ' ' C ' ' A' ' 13' ' ' LYS . 0.6 OUTLIER -85.66 -59.09 2.41 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.165 -0.959 . . . . 0.0 110.5 -179.965 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.492 ' CB ' ' OD2' ' A' ' 8' ' ' ASP . 27.8 mmtt -41.99 -70.45 0.11 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.38 -0.825 . . . . 0.0 110.464 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.477 ' HG3' ' O ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -172.55 -178.7 2.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.272 -0.892 . . . . 0.0 110.286 -179.808 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.53 ' CG2' ' OG ' ' A' ' 43' ' ' SER . 0.6 OUTLIER -104.13 -17.85 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.273 -0.892 . . . . 0.0 109.442 179.935 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.555 ' SG ' ' CA ' ' A' ' 44' ' ' CYS . 5.3 t -158.42 174.31 15.31 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.375 -0.828 . . . . 0.0 110.462 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -100.8 -148.85 0.37 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.266 -0.896 . . . . 0.0 110.372 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -120.27 -37.28 3.08 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.152 -0.968 . . . . 0.0 110.331 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -82.3 140.64 33.47 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.351 -0.843 . . . . 0.0 110.402 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -69.24 -5.33 22.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.274 -0.891 . . . . 0.0 110.322 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.2 -31.6 7.84 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.159 -0.963 . . . . 0.0 110.4 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -63.18 -18.59 63.64 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.229 -0.92 . . . . 0.0 110.478 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.453 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 0.1 OUTLIER -90.53 -54.64 3.91 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.067 -1.02 . . . . 0.0 110.283 179.923 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.501 ' CB ' ' O ' ' A' ' 35' ' ' GLY . 52.0 t30 -48.98 -36.67 18.12 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.173 -0.954 . . . . 0.0 110.01 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.406 ' OD1' ' C ' ' A' ' 25' ' ' ASP . 13.1 t0 -57.78 -53.75 54.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.346 -0.846 . . . . 0.0 110.078 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.74 -42.75 85.74 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.201 -0.937 . . . . 0.0 110.263 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.49 ' HB3' ' HB2' ' A' ' 32' ' ' ALA . 1.3 m -58.86 -33.27 70.28 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.156 -0.965 . . . . 0.0 109.54 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.5 tptm -63.37 -30.69 71.78 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.304 -0.873 . . . . 0.0 109.083 179.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.18 -32.58 83.02 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 107.825 -2.11 . . . . 0.0 107.825 178.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.532 ' O ' ' CD ' ' A' ' 50' ' ' PRO . 2.9 mt -90.54 21.56 3.9 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.59 -0.947 . . . . 0.0 109.106 178.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.501 ' HB3' ' O ' ' A' ' 30' ' ' LEU . 13.0 tttm 65.25 20.32 11.88 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.815 -0.553 . . . . 0.0 110.78 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.49 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . . . -91.97 89.9 7.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.028 -1.045 . . . . 0.0 110.039 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -49.79 -79.66 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.371 -0.831 . . . . 0.0 110.667 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 75.2 m -71.04 91.4 0.89 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.215 -0.928 . . . . 0.0 110.438 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.521 ' CA ' ' SG ' ' A' ' 46' ' ' CYS . . . -131.56 123.72 3.81 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.418 ' C ' ' CD1' ' A' ' 36' ' ' TYR . 5.0 p90 -142.81 -175.29 4.44 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.177 -1.19 . . . . 0.0 110.594 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 6.2 t -115.91 136.35 53.12 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.217 -0.927 . . . . 0.0 110.406 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.596 ' CD1' ' HB2' ' A' ' 42' ' ' LEU . 1.9 t-105 -79.92 150.94 30.38 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.146 -0.971 . . . . 0.0 109.674 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -98.1 -13.81 41.37 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 -179.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.601 ' CD1' ' CG2' ' A' ' 41' ' ' THR . 40.8 t-105 -84.06 -73.05 0.44 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.216 -1.167 . . . . 0.0 109.936 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.601 ' CG2' ' CD1' ' A' ' 40' ' ' TRP . 7.5 t -179.66 50.52 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.554 -0.716 . . . . 0.0 109.748 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.596 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 0.5 OUTLIER -120.84 21.32 11.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.315 -0.866 . . . . 0.0 110.638 -179.554 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.53 ' OG ' ' CG2' ' A' ' 15' ' ' ILE . 28.2 t 50.99 -168.57 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.116 -0.99 . . . . 0.0 110.406 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.555 ' CA ' ' SG ' ' A' ' 16' ' ' CYS . 3.0 t -77.25 135.0 38.43 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.201 -0.937 . . . . 0.0 109.67 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.628 ' CD1' ' CE2' ' A' ' 5' ' ' TYR . 8.1 t80 -122.05 109.56 14.71 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.199 -0.938 . . . . 0.0 110.234 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.521 ' SG ' ' CA ' ' A' ' 35' ' ' GLY . 24.2 m -125.52 149.13 48.57 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.471 -0.768 . . . . 0.0 109.732 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.406 ' OE1' ' HB2' ' A' ' 3' ' ' ASP . 24.8 mt-30 -130.03 137.96 50.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.267 -0.895 . . . . 0.0 110.333 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 31' ' ' LYS . . . 112.32 22.84 5.69 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.534 HD13 ' CB ' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -99.85 170.26 6.99 Favored Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.128 -1.219 . . . . 0.0 109.999 179.645 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.532 ' CD ' ' O ' ' A' ' 30' ' ' LEU . 41.5 Cg_endo -67.31 155.06 72.1 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.978 1.515 . . . . 0.0 110.457 -179.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -56.94 -23.06 42.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.324 -0.86 . . . . 0.0 110.162 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -87.56 13.61 9.9 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.276 -0.89 . . . . 0.0 110.237 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.534 ' CB ' HD13 ' A' ' 49' ' ' LEU . . . -62.32 115.41 4.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.282 -0.887 . . . . 0.0 110.074 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.481 ' O ' ' HA ' ' A' ' 6' ' ' PRO . 0.1 OUTLIER -72.29 133.8 45.21 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.228 -0.92 . . . . 0.0 110.551 -179.811 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.531 ' HA ' ' HA ' ' A' ' 6' ' ' PRO . 1.3 pp -142.98 -167.52 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.426 -0.796 . . . . 0.0 110.209 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.453 ' HG3' HD13 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -41.05 91.74 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.342 -0.849 . . . . 0.0 111.007 -179.386 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.566 ' O ' ' C ' ' A' ' 58' ' ' SER . 10.3 mtp85 -120.48 21.81 11.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.199 -0.938 . . . . 0.0 109.323 179.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.566 ' C ' ' O ' ' A' ' 57' ' ' ARG . 0.2 OUTLIER -7.45 122.93 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.255 0 CA-C-O 121.475 0.655 . . . . 0.0 112.432 -179.571 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -142.43 -103.41 0.48 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.457 ' O ' ' O ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER -132.64 48.05 2.45 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.241 -1.153 . . . . 0.0 110.253 179.973 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.457 ' O ' ' O ' ' A' ' 60' ' ' ARG . 0.8 OUTLIER 40.24 91.46 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.505 -0.747 . . . . 0.0 109.933 179.938 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.562 ' O ' ' CD1' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -81.31 47.41 1.03 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.106 -0.997 . . . . 0.0 110.479 -179.666 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.171 -0.955 . . . . 0.0 110.332 -179.935 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 12.4 ptmt . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.255 0.55 . . . . 0.0 110.279 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.478 HG23 HD12 ' A' ' 2' ' ' ILE . 10.3 tt -125.02 163.16 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.326 -0.859 . . . . 0.0 110.159 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.457 ' OD1' ' O ' ' A' ' 2' ' ' ILE . 85.2 m-20 -135.91 136.12 40.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.343 -0.848 . . . . 0.0 109.979 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -178.39 -159.52 23.08 Favored Glycine 0 N--CA 1.492 2.388 0 C-N-CA 119.608 -1.282 . . . . 0.0 109.977 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.638 ' N ' ' CD1' ' A' ' 5' ' ' TYR . 5.4 m-85 -120.14 111.27 35.51 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.41 -1.053 . . . . 0.0 109.774 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 44' ' ' CYS . 45.4 Cg_endo -72.22 144.79 42.44 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.949 1.499 . . . . 0.0 110.877 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.535 ' CG1' HG21 ' A' ' 15' ' ' ILE . 15.7 m -99.71 -168.07 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.324 -0.86 . . . . 0.0 110.392 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -72.87 -128.04 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.4 -0.813 . . . . 0.0 110.105 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -115.55 -33.04 5.36 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.915 -1.115 . . . . 0.0 110.327 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.524 ' O ' ' HB2' ' A' ' 11' ' ' ASN . 4.1 m-90 -112.7 13.38 19.86 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.178 -0.952 . . . . 0.0 110.301 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.524 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 3.0 m-20 62.23 6.61 1.9 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.548 -0.72 . . . . 0.0 110.705 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 16.9 m -76.92 -67.02 0.75 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.062 -1.024 . . . . 0.0 110.358 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.432 ' O ' ' O ' ' A' ' 14' ' ' ARG . 2.9 mptm? -58.63 173.53 0.4 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.497 -0.752 . . . . 0.0 110.506 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.432 ' O ' ' O ' ' A' ' 13' ' ' LYS . 5.0 ttp180 -50.78 -178.54 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.352 -0.842 . . . . 0.0 110.139 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.535 HG21 ' CG1' ' A' ' 7' ' ' VAL . 4.0 mt -95.95 26.04 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.238 -0.914 . . . . 0.0 109.794 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.458 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 8.7 t -151.94 159.41 43.8 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.463 -0.773 . . . . 0.0 110.044 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.599 ' CZ3' ' CD1' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -85.75 -152.68 0.17 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.223 -0.923 . . . . 0.0 110.266 -179.967 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -120.33 44.43 2.45 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.289 -0.882 . . . . 0.0 110.357 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -176.84 158.78 1.67 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.151 -0.968 . . . . 0.0 110.321 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 34.8 t30 -82.9 -7.18 59.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.263 -0.898 . . . . 0.0 110.239 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.6 tptt -110.1 -31.32 7.4 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.256 -0.902 . . . . 0.0 109.971 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -54.64 -31.23 57.09 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.327 -0.858 . . . . 0.0 110.269 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.459 ' O ' ' HB2' ' A' ' 27' ' ' CYS . 0.1 OUTLIER -91.38 -32.77 15.53 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.223 -0.923 . . . . 0.0 110.481 -179.663 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.513 ' CB ' ' O ' ' A' ' 35' ' ' GLY . 25.1 t30 -70.63 -44.32 67.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.106 -0.996 . . . . 0.0 110.133 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -56.27 -45.57 80.07 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.232 -0.918 . . . . 0.0 110.468 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.599 ' CD1' ' CZ3' ' A' ' 17' ' ' TRP . 0.2 OUTLIER -78.1 -40.33 38.65 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.208 -0.932 . . . . 0.0 110.332 -179.9 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.516 ' HB3' ' HB2' ' A' ' 32' ' ' ALA . 1.6 m -57.45 -37.8 73.43 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.146 -0.971 . . . . 0.0 109.522 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.99 -28.12 69.88 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.427 -0.796 . . . . 0.0 109.524 179.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.62 -34.97 90.4 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 107.873 -2.091 . . . . 0.0 107.873 178.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.528 ' O ' ' CB ' ' A' ' 31' ' ' LYS . 1.3 mt -89.16 17.8 5.62 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.707 -0.878 . . . . 0.0 109.325 178.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.528 ' CB ' ' O ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER 72.54 14.79 5.16 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.64 -0.662 . . . . 0.0 111.161 179.688 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.516 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . . . -85.3 81.0 8.96 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.786 -1.196 . . . . 0.0 109.633 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 32' ' ' ALA . 0.1 OUTLIER -39.89 -80.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.373 -0.83 . . . . 0.0 110.842 -179.32 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.472 ' O ' ' HA ' ' A' ' 46' ' ' CYS . 57.9 m -69.85 90.16 0.6 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.33 -0.856 . . . . 0.0 110.514 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.513 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -122.26 89.18 0.42 Allowed Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 29.6 p90 -118.25 153.82 33.28 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.244 -1.151 . . . . 0.0 109.964 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.1 OUTLIER -107.31 134.59 50.16 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.148 -0.97 . . . . 0.0 110.632 -179.567 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.567 ' CD1' ' HB2' ' A' ' 42' ' ' LEU . 14.6 t-105 -83.67 125.57 31.99 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.396 -0.815 . . . . 0.0 109.908 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -89.15 64.25 3.33 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.559 ' CE2' HG23 ' A' ' 41' ' ' THR . 0.1 OUTLIER -155.84 -80.4 0.08 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.299 -1.118 . . . . 0.0 109.648 179.816 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.559 HG23 ' CE2' ' A' ' 40' ' ' TRP . 2.6 t -162.68 33.64 0.1 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.361 -0.837 . . . . 0.0 109.869 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.567 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 0.4 OUTLIER -117.9 4.92 12.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.333 -0.854 . . . . 0.0 110.363 -179.753 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.507 ' CB ' ' HB ' ' A' ' 15' ' ' ILE . 13.0 m 59.96 -170.93 0.13 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.218 -0.927 . . . . 0.0 110.456 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 37' ' ' CYS . 19.3 t -75.57 156.45 34.99 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.297 -0.877 . . . . 0.0 109.977 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -140.82 99.54 3.63 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.016 -1.053 . . . . 0.0 110.917 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.476 ' SG ' ' CA ' ' A' ' 35' ' ' GLY . 65.6 m -120.51 139.77 52.41 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.241 -0.912 . . . . 0.0 109.551 178.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.405 ' HA ' ' OD1' ' A' ' 3' ' ' ASP . 58.8 mt-30 -126.24 138.96 53.67 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.201 -0.937 . . . . 0.0 110.201 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 31' ' ' LYS . . . 103.8 32.61 4.38 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 -179.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.564 ' CD2' ' N ' ' A' ' 49' ' ' LEU . 0.1 OUTLIER -110.2 172.34 3.67 Favored Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 121.276 -1.132 . . . . 0.0 109.506 179.843 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.495 ' HD2' ' HB2' ' A' ' 49' ' ' LEU . 42.5 Cg_endo -67.78 162.17 40.68 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 O-C-N 123.514 1.271 . . . . 0.0 110.7 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -64.58 -19.78 65.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.354 -0.841 . . . . 0.0 110.134 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -92.68 15.57 14.14 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.265 -0.897 . . . . 0.0 109.997 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.513 ' CB ' HD11 ' A' ' 49' ' ' LEU . . . -62.29 141.79 58.08 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.183 -0.948 . . . . 0.0 110.205 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.455 ' O ' HD11 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -66.24 139.7 58.11 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.304 -0.873 . . . . 0.0 109.764 179.722 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.487 ' O ' ' N ' ' A' ' 57' ' ' ARG . 5.3 mm -139.1 -177.76 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.029 -1.045 . . . . 0.0 110.862 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.525 ' HA ' ' CG1' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -59.76 77.78 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.512 -0.742 . . . . 0.0 110.963 -179.528 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.487 ' N ' ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -107.0 17.47 23.02 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.208 -0.932 . . . . 0.0 109.539 179.117 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.438 ' C ' ' O ' ' A' ' 57' ' ' ARG . 0.8 OUTLIER -39.41 136.09 0.98 Allowed 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.25 0.548 . . . . 0.0 110.5 -179.776 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.456 ' O ' ' HD3' ' A' ' 60' ' ' ARG . . . 158.31 -34.45 0.51 Allowed Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.456 ' HD3' ' O ' ' A' ' 59' ' ' GLY . 14.8 mmt85 -114.93 68.92 0.71 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.325 -1.103 . . . . 0.0 110.348 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.423 ' C ' ' O ' ' A' ' 60' ' ' ARG . 0.1 OUTLIER -42.35 100.41 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.32 -0.862 . . . . 0.0 110.098 179.653 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.425 ' CB ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -83.84 45.89 1.12 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.132 -0.98 . . . . 0.0 110.246 -179.969 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.196 -0.94 . . . . 0.0 110.313 -179.931 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.283 0.563 . . . . 0.0 110.156 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.475 HG22 ' O ' ' A' ' 49' ' ' LEU . 4.4 tt -140.21 157.51 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.321 -0.862 . . . . 0.0 110.094 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.574 ' OD1' ' CE1' ' A' ' 45' ' ' TYR . 33.4 t0 -125.42 128.01 47.44 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.632 -0.667 . . . . 0.0 109.863 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -174.68 -160.23 22.36 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.691 ' CE2' ' CD1' ' A' ' 45' ' ' TYR . 3.6 m-85 -126.56 99.64 29.81 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.444 -1.033 . . . . 0.0 110.258 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.522 ' HD2' ' O ' ' A' ' 44' ' ' CYS . 43.4 Cg_endo -69.79 125.61 12.33 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 O-C-N 123.917 1.483 . . . . 0.0 110.659 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.565 ' CG1' ' HA ' ' A' ' 56' ' ' LYS . 17.2 m -79.65 175.49 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.418 -0.801 . . . . 0.0 110.31 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -51.35 167.85 0.08 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.272 -0.892 . . . . 0.0 110.145 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.518 ' HB3' ' CE2' ' A' ' 10' ' ' TRP . 0.3 OUTLIER -66.43 -8.48 26.22 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.244 -0.91 . . . . 0.0 110.287 179.976 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.527 ' CG ' ' HB2' ' A' ' 63' ' ' ALA . 1.7 m-90 -139.59 11.28 2.5 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.28 -0.887 . . . . 0.0 109.993 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.427 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 2.8 m120 55.54 19.06 3.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.205 -0.934 . . . . 0.0 109.572 -179.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 3.5 t -81.78 -38.64 25.29 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.55 -0.719 . . . . 0.0 110.74 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.405 ' O ' ' CB ' ' A' ' 14' ' ' ARG . 2.5 mttp -93.04 53.38 1.97 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.273 -0.892 . . . . 0.0 110.603 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.405 ' CB ' ' O ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER 62.57 -143.85 0.39 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.233 -0.917 . . . . 0.0 110.409 179.694 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.549 ' CD1' ' HB2' ' A' ' 43' ' ' SER . 31.8 pt -109.4 4.06 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.165 -0.959 . . . . 0.0 110.277 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.536 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 0.9 OUTLIER -151.36 -174.23 4.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.18 -0.95 . . . . 0.0 109.708 179.436 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.689 ' CE3' ' CG ' ' A' ' 22' ' ' TYR . 0.0 OUTLIER -118.02 -171.92 2.16 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.121 -0.987 . . . . 0.0 110.156 179.839 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -91.28 -36.59 13.79 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.11 -0.994 . . . . 0.0 110.294 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.466 ' HB2' ' HB2' ' A' ' 22' ' ' TYR . 20.8 m120 -78.87 148.58 32.73 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.326 -0.859 . . . . 0.0 110.302 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -88.66 -16.68 31.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.342 -0.849 . . . . 0.0 110.121 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.28 -14.11 24.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.287 -0.883 . . . . 0.0 110.318 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.689 ' CG ' ' CE3' ' A' ' 17' ' ' TRP . 2.8 t80 -72.62 -40.11 66.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.085 -1.009 . . . . 0.0 109.913 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.46 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 1.3 t -63.3 -34.4 77.6 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.328 -0.857 . . . . 0.0 109.659 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.538 ' CB ' ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -78.0 -51.82 9.76 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.279 -0.888 . . . . 0.0 109.776 179.76 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.476 ' N ' ' CG ' ' A' ' 24' ' ' ASN . 5.7 m-20 -51.54 -49.08 62.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.197 -0.94 . . . . 0.0 110.173 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.7 mt -71.04 -37.59 72.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.242 -0.911 . . . . 0.0 110.282 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.493 ' HB3' ' HB3' ' A' ' 32' ' ' ALA . 1.8 m -62.3 -38.66 90.25 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.159 -0.963 . . . . 0.0 109.616 179.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.515 ' CD ' ' HA ' ' A' ' 33' ' ' ASP . 8.7 mmmt -61.55 -27.07 68.36 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.291 -0.881 . . . . 0.0 109.145 179.277 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.61 -33.46 86.68 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 107.189 -2.364 . . . . 0.0 107.189 178.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.515 ' O ' ' CB ' ' A' ' 31' ' ' LYS . 12.8 mt -90.29 21.65 3.72 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.872 -0.781 . . . . 0.0 108.95 178.485 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.515 ' CB ' ' O ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER 71.81 8.54 6.09 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.452 -0.78 . . . . 0.0 110.81 179.875 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.493 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . . . -87.06 103.76 15.68 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.95 -1.094 . . . . 0.0 109.877 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.515 ' HA ' ' CD ' ' A' ' 28' ' ' LYS . 9.2 m-20 -67.05 -76.49 0.08 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -0.912 . . . . 0.0 110.723 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.473 ' O ' ' HA ' ' A' ' 46' ' ' CYS . 0.5 OUTLIER -66.28 93.68 0.23 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.361 -0.837 . . . . 0.0 110.791 -179.514 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.538 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -133.05 126.2 4.32 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.421 ' C ' ' SG ' ' A' ' 23' ' ' CYS . 40.4 p90 -145.48 151.56 38.38 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.152 -1.204 . . . . 0.0 110.261 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 42.0 t -97.1 133.16 42.12 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.185 -0.947 . . . . 0.0 110.913 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.529 ' CB ' ' HB2' ' A' ' 42' ' ' LEU . 0.7 OUTLIER -97.49 138.62 34.64 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.266 -0.896 . . . . 0.0 109.935 179.535 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -89.06 8.74 79.15 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.533 ' CD1' HG21 ' A' ' 41' ' ' THR . 20.6 t-105 -99.57 -76.46 0.54 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.166 -1.196 . . . . 0.0 110.104 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.533 HG21 ' CD1' ' A' ' 40' ' ' TRP . 11.6 t -169.08 31.63 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.393 -0.817 . . . . 0.0 109.888 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.549 ' O ' ' CD2' ' A' ' 5' ' ' TYR . 10.9 mp -107.0 14.23 26.66 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.442 -0.786 . . . . 0.0 110.215 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.549 ' HB2' ' CD1' ' A' ' 15' ' ' ILE . 8.2 t 47.56 -169.1 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.185 -0.947 . . . . 0.0 110.239 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.522 ' O ' ' HD2' ' A' ' 6' ' ' PRO . 1.8 t -81.41 97.12 7.59 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.691 ' CD1' ' CE2' ' A' ' 5' ' ' TYR . 4.8 t80 -79.81 130.54 35.41 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.12 -0.988 . . . . 0.0 111.251 -178.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 34' ' ' SER . 83.3 m -145.15 145.94 31.58 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.366 -0.834 . . . . 0.0 109.376 179.104 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.47 ' HG2' ' OD1' ' A' ' 3' ' ' ASP . 3.9 mt-30 -127.57 142.23 51.42 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.086 -1.008 . . . . 0.0 110.244 -179.618 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' A' ' 31' ' ' LYS . . . 101.94 31.03 5.54 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 179.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.526 HD22 ' N ' ' A' ' 49' ' ' LEU . 0.1 OUTLIER -108.58 171.75 4.26 Favored Pre-proline 0 N--CA 1.497 1.896 0 O-C-N 121.132 -1.216 . . . . 0.0 109.658 179.456 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.504 ' HD3' ' O ' ' A' ' 30' ' ' LEU . 44.1 Cg_endo -69.41 159.42 53.73 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 123.621 1.327 . . . . 0.0 110.738 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -61.15 -24.04 65.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.32 -0.863 . . . . 0.0 109.822 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -88.05 9.69 21.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.335 -0.853 . . . . 0.0 109.854 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.483 ' O ' HG12 ' A' ' 55' ' ' ILE . . . -59.16 126.09 26.26 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.374 -0.829 . . . . 0.0 110.233 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.546 ' O ' ' CD1' ' A' ' 55' ' ' ILE . 14.1 ttm-85 -53.82 150.08 7.94 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.317 -0.864 . . . . 0.0 110.351 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.546 ' CD1' ' O ' ' A' ' 54' ' ' ARG . 5.8 mm -146.87 175.03 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.443 -0.786 . . . . 0.0 110.013 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.565 ' HA ' ' CG1' ' A' ' 7' ' ' VAL . 0.1 OUTLIER -46.44 94.63 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.35 -0.844 . . . . 0.0 110.211 179.31 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.475 ' N ' ' O ' ' A' ' 55' ' ' ILE . 0.1 OUTLIER -116.29 -13.93 11.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.184 -0.948 . . . . 0.0 110.364 -179.904 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.0 t 49.86 -172.14 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.201 -0.937 . . . . 0.0 110.177 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 133.08 -129.43 5.43 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.33 138.47 53.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.328 -1.101 . . . . 0.0 110.265 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 32.5 t -43.61 113.75 0.55 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.233 -0.917 . . . . 0.0 110.179 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.519 ' CB ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -86.88 35.1 0.68 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.178 -0.951 . . . . 0.0 110.356 -179.961 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.527 ' HB2' ' CG ' ' A' ' 10' ' ' TRP . . . . . . . . 0 N--CA 1.492 1.654 0 O-C-N 121.281 -0.887 . . . . 0.0 110.105 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 2.8 ptmt . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.23 0.538 . . . . 0.0 110.184 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.49 ' CG2' ' HG ' ' A' ' 49' ' ' LEU . 3.3 tt -120.52 163.53 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.269 -0.894 . . . . 0.0 110.313 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.504 ' CB ' ' HG2' ' A' ' 47' ' ' GLN . 35.1 p-10 -125.26 117.19 23.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.589 -0.694 . . . . 0.0 109.675 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -153.37 -165.03 13.1 Favored Glycine 0 N--CA 1.493 2.455 0 C-N-CA 119.529 -1.32 . . . . 0.0 110.285 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.688 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 21.4 m-85 -124.9 97.84 37.66 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.424 -1.045 . . . . 0.0 110.523 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.512 ' HD2' ' O ' ' A' ' 44' ' ' CYS . 44.2 Cg_endo -70.68 130.31 18.01 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.865 1.455 . . . . 0.0 110.691 179.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.46 HG13 ' HA ' ' A' ' 15' ' ' ILE . 15.6 m -80.51 -162.53 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.303 -0.873 . . . . 0.0 110.523 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.424 ' O ' ' NH1' ' A' ' 54' ' ' ARG . 1.0 OUTLIER -74.63 -88.59 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.439 -0.788 . . . . 0.0 110.553 -179.544 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.473 ' O ' ' NH1' ' A' ' 62' ' ' ARG . 0.2 OUTLIER -142.35 -66.79 0.39 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.295 -0.878 . . . . 0.0 110.066 -179.888 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.522 ' O ' ' HB2' ' A' ' 11' ' ' ASN . 4.0 m-90 -90.2 10.38 24.8 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.307 -0.87 . . . . 0.0 109.823 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.522 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 6.2 m-20 65.75 5.44 3.36 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.627 -0.67 . . . . 0.0 110.655 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 2.7 t -73.65 -36.8 65.43 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.047 -1.033 . . . . 0.0 109.617 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.464 ' O ' ' O ' ' A' ' 14' ' ' ARG . 5.8 tttt -86.72 152.3 22.65 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.42 -0.8 . . . . 0.0 109.333 179.092 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.464 ' O ' ' O ' ' A' ' 13' ' ' LYS . 1.1 ptp180 -38.31 160.25 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.419 -0.801 . . . . 0.0 110.983 -179.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.538 ' CD1' ' OG ' ' A' ' 43' ' ' SER . 30.3 pt -70.5 0.71 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.383 -0.823 . . . . 0.0 110.84 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.502 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 1.7 t -141.74 121.86 13.8 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.174 -0.954 . . . . 0.0 109.406 179.192 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.66 ' CD2' ' CD2' ' A' ' 22' ' ' TYR . 1.1 t90 -60.94 -137.28 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.14 -0.975 . . . . 0.0 110.111 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -142.6 30.6 1.51 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.159 -0.963 . . . . 0.0 110.468 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.533 ' HB2' ' CE3' ' A' ' 17' ' ' TRP . 0.1 OUTLIER -143.63 134.47 25.27 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.152 -0.967 . . . . 0.0 110.235 179.759 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -69.17 -6.81 31.11 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.313 -0.867 . . . . 0.0 110.119 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.84 -21.84 12.89 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.32 -0.863 . . . . 0.0 110.224 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.66 ' CD2' ' CD2' ' A' ' 17' ' ' TRP . 8.5 t80 -72.53 -56.74 4.9 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.243 -0.911 . . . . 0.0 109.579 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.479 ' O ' ' HB2' ' A' ' 27' ' ' CYS . 1.6 t -56.3 -30.25 62.27 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.435 -0.791 . . . . 0.0 109.51 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.488 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 10.0 t-20 -81.14 -36.04 30.76 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.134 -0.979 . . . . 0.0 109.99 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -64.06 -48.77 74.95 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.197 -0.939 . . . . 0.0 109.711 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.64 -40.02 73.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.372 -0.83 . . . . 0.0 109.867 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.517 ' HB3' ' HB2' ' A' ' 32' ' ' ALA . 9.7 m -62.74 -41.01 98.99 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.314 -0.867 . . . . 0.0 109.747 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 24' ' ' ASN . 0.0 OUTLIER -63.79 -24.4 67.74 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.204 -0.935 . . . . 0.0 109.347 179.302 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.83 -37.03 91.89 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 107.638 -2.185 . . . . 0.0 107.638 178.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.496 ' O ' ' HB3' ' A' ' 31' ' ' LYS . 1.1 mt -93.67 20.19 7.76 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.815 -0.815 . . . . 0.0 109.245 178.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.496 ' HB3' ' O ' ' A' ' 30' ' ' LEU . 0.1 OUTLIER 69.61 15.78 8.12 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.851 -0.53 . . . . 0.0 111.365 179.557 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.517 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . . . -78.36 86.04 4.45 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.744 -1.222 . . . . 0.0 109.26 179.273 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.416 ' C ' ' O ' ' A' ' 32' ' ' ALA . 2.2 m-20 -39.38 -90.3 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.621 -0.675 . . . . 0.0 111.488 -178.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.493 ' O ' ' HA ' ' A' ' 46' ' ' CYS . 12.5 p -67.01 92.34 0.24 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.31 -0.869 . . . . 0.0 111.109 -178.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.508 ' CA ' ' SG ' ' A' ' 46' ' ' CYS . . . -122.31 108.79 1.32 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 108.91 -1.676 . . . . 0.0 108.91 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.411 ' CD1' ' C ' ' A' ' 36' ' ' TYR . 30.4 p90 -135.8 165.57 25.3 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.178 -1.19 . . . . 0.0 110.651 -179.516 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.511 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.0 OUTLIER -107.59 128.99 55.03 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.317 -0.864 . . . . 0.0 109.94 179.608 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.587 ' CD1' ' HB2' ' A' ' 42' ' ' LEU . 35.5 t-105 -79.6 166.87 21.43 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.091 -1.006 . . . . 0.0 110.005 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -98.25 -27.35 8.77 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 120.003 -1.094 . . . . 0.0 110.369 -179.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.566 ' HB3' ' CD1' ' A' ' 38' ' ' TRP . 48.6 t-105 -79.51 -91.8 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.994 -1.298 . . . . 0.0 110.074 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.487 HG21 ' CD2' ' A' ' 40' ' ' TRP . 41.6 p -150.54 34.9 0.63 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.074 -1.016 . . . . 0.0 110.346 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.587 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 0.2 OUTLIER -89.53 0.29 57.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.303 -0.873 . . . . 0.0 110.074 179.809 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.538 ' OG ' ' CD1' ' A' ' 15' ' ' ILE . 0.9 OUTLIER 60.77 -176.4 0.11 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.227 -0.921 . . . . 0.0 110.201 -179.897 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.512 ' O ' ' HD2' ' A' ' 6' ' ' PRO . 0.9 OUTLIER -80.19 94.48 6.05 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.991 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.688 ' CD1' ' CZ ' ' A' ' 5' ' ' TYR . 9.3 t80 -79.98 138.97 37.18 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.117 -0.989 . . . . 0.0 110.682 -179.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.508 ' SG ' ' CA ' ' A' ' 35' ' ' GLY . 74.2 m -149.3 144.44 26.47 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.343 -0.848 . . . . 0.0 110.228 179.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.504 ' HG2' ' CB ' ' A' ' 3' ' ' ASP . 39.1 mt-30 -126.64 149.39 49.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.387 -0.821 . . . . 0.0 110.069 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.486 ' O ' ' O ' ' A' ' 31' ' ' LYS . . . 99.59 21.73 13.97 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.503 ' HB2' ' HD2' ' A' ' 50' ' ' PRO . 0.1 OUTLIER -101.48 169.29 7.91 Favored Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 121.072 -1.252 . . . . 0.0 109.898 179.626 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.503 ' HD2' ' HB2' ' A' ' 49' ' ' LEU . 44.6 Cg_endo -71.56 159.02 52.4 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 123.717 1.377 . . . . 0.0 110.342 -179.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.442 ' HA ' HD13 ' A' ' 2' ' ' ILE . 18.9 t70 -60.47 -23.66 64.64 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.157 -0.964 . . . . 0.0 109.723 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -92.87 17.24 10.88 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.466 -0.771 . . . . 0.0 109.609 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.516 ' O ' ' CD1' ' A' ' 55' ' ' ILE . . . -47.72 143.67 3.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.372 -0.83 . . . . 0.0 110.104 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.481 ' O ' ' HA ' ' A' ' 6' ' ' PRO . 41.8 ttp85 -85.24 91.7 8.22 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.344 -0.848 . . . . 0.0 110.334 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.546 ' CD1' ' N ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -140.3 166.81 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.324 -0.86 . . . . 0.0 109.965 179.69 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 6.1 mttt 45.25 67.12 0.77 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.135 -0.978 . . . . 0.0 109.759 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.477 ' HG2' ' O ' ' A' ' 55' ' ' ILE . 34.2 mmm-85 -125.44 17.25 8.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.247 -0.908 . . . . 0.0 110.458 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 57' ' ' ARG . 0.7 OUTLIER -42.23 138.99 1.52 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.334 -0.854 . . . . 0.0 109.941 179.884 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -164.25 -128.28 0.94 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.492 ' O ' ' O ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER -117.32 46.67 1.65 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.394 -1.063 . . . . 0.0 110.242 -179.97 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.492 ' O ' ' O ' ' A' ' 60' ' ' ARG . 52.2 m 56.06 121.46 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.476 0.655 . . . . 0.0 110.643 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.475 ' NH1' ' HA ' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -87.66 39.18 0.87 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.024 -1.048 . . . . 0.0 110.235 179.747 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.234 -0.917 . . . . 0.0 110.264 -179.938 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 7.5 mttt . . . . . 0 N--CA 1.494 1.749 0 CA-C-O 121.158 0.504 . . . . 0.0 110.025 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.461 HG23 ' O ' ' A' ' 50' ' ' PRO . 13.5 tt -118.98 161.81 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.143 -0.973 . . . . 0.0 110.337 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -131.34 131.46 43.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.259 -0.901 . . . . 0.0 110.032 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.449 ' O ' ' CD1' ' A' ' 45' ' ' TYR . . . -169.95 -176.17 39.43 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.702 -1.237 . . . . 0.0 110.011 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.681 ' CE1' ' CE1' ' A' ' 45' ' ' TYR . 66.8 m-85 -106.27 100.85 31.62 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.381 -1.07 . . . . 0.0 110.15 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.477 ' O ' ' HB3' ' A' ' 44' ' ' CYS . 43.3 Cg_endo -70.59 140.98 40.76 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.845 1.445 . . . . 0.0 110.478 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.529 ' CG1' HG21 ' A' ' 15' ' ' ILE . 5.1 m -110.12 -170.99 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.194 -0.941 . . . . 0.0 110.168 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -63.99 -145.04 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.24 -0.913 . . . . 0.0 110.686 -179.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -85.97 -47.57 9.49 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.427 -0.796 . . . . 0.0 110.648 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.486 ' HB3' ' CB ' ' A' ' 62' ' ' ARG . 3.3 m-90 -120.36 21.35 11.7 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.098 -1.001 . . . . 0.0 110.546 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.49 ' N ' ' OD1' ' A' ' 11' ' ' ASN . 1.8 m-20 57.7 15.12 2.74 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.118 -0.989 . . . . 0.0 110.154 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.8 t -84.94 -52.8 5.73 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.244 -0.91 . . . . 0.0 110.46 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.426 ' O ' ' CG ' ' A' ' 14' ' ' ARG . 5.6 tptt -61.49 -51.91 66.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.33 -0.856 . . . . 0.0 110.326 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.426 ' CG ' ' O ' ' A' ' 13' ' ' LYS . 0.1 OUTLIER 176.66 -158.71 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.204 -0.935 . . . . 0.0 110.511 -179.963 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.538 ' CD1' ' N ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -119.33 -18.04 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.368 -0.832 . . . . 0.0 109.491 179.558 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.556 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 1.8 t -132.64 111.99 11.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.469 -0.769 . . . . 0.0 110.22 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.466 ' CD2' ' HB3' ' A' ' 22' ' ' TYR . 0.0 OUTLIER -50.27 163.55 0.16 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.24 -0.913 . . . . 0.0 110.157 179.868 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -79.88 -24.75 40.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.305 -0.872 . . . . 0.0 109.983 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -83.88 145.72 28.46 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.272 -0.892 . . . . 0.0 110.047 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 16.0 p30 -80.46 7.6 9.47 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.212 -0.93 . . . . 0.0 110.416 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -131.23 -18.42 2.91 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.137 -0.977 . . . . 0.0 110.954 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.466 ' HB3' ' CD2' ' A' ' 17' ' ' TRP . 0.1 OUTLIER -60.36 -14.07 16.66 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.926 -1.109 . . . . 0.0 110.286 -179.753 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.464 ' O ' ' HB2' ' A' ' 27' ' ' CYS . 0.1 OUTLIER -103.58 -29.85 10.86 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.152 -0.967 . . . . 0.0 110.204 179.926 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.461 ' O ' ' CG ' ' A' ' 28' ' ' LYS . 55.1 t-20 -72.81 -52.58 14.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.192 -0.943 . . . . 0.0 109.582 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -54.75 -42.34 71.51 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.257 -0.902 . . . . 0.0 109.91 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.434 ' CD1' ' C ' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -72.89 -41.64 64.45 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.279 -0.888 . . . . 0.0 109.431 179.749 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.504 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . 1.5 m -60.61 -39.75 89.34 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.4 -0.813 . . . . 0.0 109.638 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.461 ' CG ' ' O ' ' A' ' 24' ' ' ASN . 1.7 mmmp? -61.73 -30.17 70.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.362 -0.837 . . . . 0.0 109.6 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.82 -34.01 80.74 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 108.149 -1.981 . . . . 0.0 108.149 179.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.55 ' O ' ' CB ' ' A' ' 31' ' ' LYS . 62.4 mt -93.06 18.56 9.07 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.605 -0.938 . . . . 0.0 109.785 179.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.55 ' CB ' ' O ' ' A' ' 30' ' ' LEU . 0.1 OUTLIER 76.11 12.76 2.75 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.618 -0.676 . . . . 0.0 111.133 179.717 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.53 ' CB ' HD21 ' A' ' 49' ' ' LEU . . . -88.52 82.1 7.0 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.845 -1.159 . . . . 0.0 109.734 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.406 ' O ' ' HD3' ' A' ' 28' ' ' LYS . 72.1 m-20 -46.25 -74.91 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.576 -0.702 . . . . 0.0 111.151 -179.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.0 t -69.76 90.38 0.59 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.424 -0.798 . . . . 0.0 110.983 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.482 ' CA ' ' SG ' ' A' ' 46' ' ' CYS . . . -122.04 113.89 2.37 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 108.976 -1.65 . . . . 0.0 108.976 179.212 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.567 ' CE1' ' HB3' ' A' ' 45' ' ' TYR . 27.4 p90 -133.28 154.6 50.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.123 -1.222 . . . . 0.0 110.485 -179.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.479 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.5 OUTLIER -107.73 118.08 35.81 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.332 -0.855 . . . . 0.0 110.151 179.775 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.597 ' CD1' ' HB3' ' A' ' 40' ' ' TRP . 25.0 t-105 -85.71 99.37 11.28 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.157 -0.965 . . . . 0.0 110.248 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.71 68.03 1.02 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.597 ' HB3' ' CD1' ' A' ' 38' ' ' TRP . 57.3 t-105 -157.94 -88.61 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.251 -1.147 . . . . 0.0 110.254 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 67.0 p -144.74 23.12 1.59 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.114 -0.991 . . . . 0.0 110.281 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.583 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 0.4 OUTLIER -121.01 11.17 10.94 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.168 -0.958 . . . . 0.0 110.537 -179.82 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.556 ' HA ' ' HB2' ' A' ' 16' ' ' CYS . 25.7 m 46.81 -170.23 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.919 -1.113 . . . . 0.0 109.973 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.494 ' HB2' ' HA ' ' A' ' 16' ' ' CYS . 51.2 t -77.65 151.65 34.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.101 -1.0 . . . . 0.0 109.139 179.224 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.681 ' CE1' ' CE1' ' A' ' 5' ' ' TYR . 6.1 t80 -147.85 123.86 10.72 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.836 -1.165 . . . . 0.0 111.299 -179.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.496 ' HB3' ' HB3' ' A' ' 32' ' ' ALA . 80.0 m -130.63 142.73 50.45 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.444 -0.785 . . . . 0.0 109.453 178.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 13.2 mp0 -116.98 131.17 57.02 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.082 -1.011 . . . . 0.0 110.22 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 31' ' ' LYS . . . 105.35 42.04 1.81 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.602 ' CD2' ' N ' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -103.51 -174.79 0.35 Allowed Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.1 -1.236 . . . . 0.0 109.466 179.744 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.559 ' CD ' ' CB ' ' A' ' 49' ' ' LEU . 49.9 Cg_endo -86.23 160.33 9.88 Favored 'Trans proline' 0 C--N 1.303 -1.842 0 O-C-N 123.938 1.493 . . . . 0.0 109.764 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -59.91 -19.54 52.19 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.051 -1.031 . . . . 0.0 109.756 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -99.54 22.01 11.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.331 -0.856 . . . . 0.0 109.645 179.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.474 ' HB3' ' O ' ' A' ' 50' ' ' PRO . . . -60.1 137.9 58.0 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.374 -0.828 . . . . 0.0 110.244 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.478 ' NH2' ' HB3' ' A' ' 54' ' ' ARG . 12.2 ttp-105 -77.69 129.61 35.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.267 -0.896 . . . . 0.0 110.03 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.53 ' O ' ' N ' ' A' ' 57' ' ' ARG . 12.9 mm -134.5 177.15 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.182 -0.949 . . . . 0.0 109.616 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 2.4 ptmt -67.14 61.77 0.05 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.121 -0.987 . . . . 0.0 109.191 179.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.53 ' N ' ' O ' ' A' ' 55' ' ' ILE . 20.0 ttm-85 -86.86 -25.17 24.63 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.598 -0.689 . . . . 0.0 110.665 -179.205 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.8 m -123.19 162.0 23.4 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.14 -0.975 . . . . 0.0 110.119 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -145.17 13.97 1.88 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.515 ' O ' ' O ' ' A' ' 61' ' ' CYS . 2.4 mpp_? -106.55 41.86 1.37 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.096 -1.238 . . . . 0.0 110.211 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.515 ' O ' ' O ' ' A' ' 60' ' ' ARG . 42.7 t 42.42 104.25 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.501 0.667 . . . . 0.0 111.285 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.486 ' CB ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -81.53 45.39 0.87 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.087 -1.008 . . . . 0.0 110.412 179.588 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.069 -1.019 . . . . 0.0 110.183 179.873 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 4.0 pttp . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.265 0.555 . . . . 0.0 110.248 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.5 ' CG2' ' HG ' ' A' ' 49' ' ' LEU . 15.2 tt -131.68 161.1 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.266 -0.896 . . . . 0.0 110.136 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.409 ' OD1' ' HA ' ' A' ' 47' ' ' GLN . 48.8 m-20 -127.46 147.57 50.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.379 -0.826 . . . . 0.0 110.133 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 164.21 -179.93 38.78 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.668 ' CZ ' ' CD2' ' A' ' 45' ' ' TYR . 23.8 m-85 -98.22 109.82 53.68 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.331 -1.1 . . . . 0.0 110.241 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.495 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 48.8 Cg_endo -74.8 130.53 13.58 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 123.972 1.512 . . . . 0.0 110.576 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.424 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . 16.4 m -119.66 -168.22 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.23 -0.919 . . . . 0.0 109.767 179.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.489 ' HB2' ' HB2' ' A' ' 14' ' ' ARG . 0.7 OUTLIER -66.58 -176.84 0.51 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.332 -0.855 . . . . 0.0 110.139 179.712 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.483 ' HB3' ' CE2' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -79.1 -5.85 55.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.326 -0.859 . . . . 0.0 109.9 179.723 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.483 ' CE2' ' HB3' ' A' ' 9' ' ' TYR . 4.5 m-90 -137.98 3.62 2.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.282 -0.886 . . . . 0.0 110.513 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.478 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 2.2 m-20 59.73 12.21 2.83 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.283 -0.886 . . . . 0.0 110.524 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 4.2 t -77.78 -62.85 1.54 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.097 -1.002 . . . . 0.0 111.186 -178.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.516 ' O ' ' CB ' ' A' ' 14' ' ' ARG . 1.5 tmtt? -136.39 98.98 3.97 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.059 -1.026 . . . . 0.0 111.313 -179.089 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.566 ' O ' ' N ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER 168.04 -88.74 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.361 -0.837 . . . . 0.0 110.222 179.098 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.533 HG21 ' CB ' ' A' ' 43' ' ' SER . 5.0 mt 55.57 -81.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.142 -0.974 . . . . 0.0 110.087 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.566 ' N ' ' O ' ' A' ' 14' ' ' ARG . 37.5 t -122.77 127.91 49.78 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.428 -0.795 . . . . 0.0 109.946 179.238 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.64 ' CZ3' ' CD2' ' A' ' 22' ' ' TYR . 0.1 OUTLIER -69.8 -145.5 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.051 -1.03 . . . . 0.0 109.92 179.609 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -118.02 -9.73 10.5 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.239 -0.913 . . . . 0.0 110.21 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.437 ' CB ' ' HB2' ' A' ' 22' ' ' TYR . 0.7 OUTLIER -117.8 166.65 12.2 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.318 -0.864 . . . . 0.0 110.296 -179.896 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -88.68 -59.47 2.22 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.254 -0.904 . . . . 0.0 110.308 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.28 -26.98 66.9 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.208 -0.932 . . . . 0.0 110.24 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.64 ' CD2' ' CZ3' ' A' ' 17' ' ' TRP . 0.4 OUTLIER -58.86 -53.65 56.01 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.316 -0.865 . . . . 0.0 110.506 -179.818 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -66.77 -27.18 67.38 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.17 -0.956 . . . . 0.0 110.337 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.439 ' OD1' ' O ' ' A' ' 33' ' ' ASP . 25.0 t-20 -66.71 -55.61 14.32 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.276 -0.89 . . . . 0.0 110.272 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -44.09 -49.86 8.7 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.347 -0.846 . . . . 0.0 110.417 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.53 -42.1 95.96 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.201 -0.937 . . . . 0.0 110.154 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.462 ' HB3' ' HB2' ' A' ' 32' ' ' ALA . 0.8 OUTLIER -59.54 -39.87 85.38 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.243 -0.911 . . . . 0.0 109.419 179.474 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.1 mtmt -62.91 -33.9 76.3 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.258 -0.901 . . . . 0.0 109.154 179.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -50.87 -39.42 39.84 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.766 -1.734 . . . . 0.0 108.766 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.655 ' O ' ' CB ' ' A' ' 31' ' ' LYS . 6.9 mt -79.94 -34.07 39.14 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.248 -1.148 . . . . 0.0 109.609 179.415 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.655 ' CB ' ' O ' ' A' ' 30' ' ' LEU . 1.8 tttp 141.14 0.35 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.658 0 C-N-CA 123.015 0.526 . . . . 0.0 110.126 179.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' A' ' 48' ' ' GLY . . . -85.44 117.12 24.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.95 -1.094 . . . . 0.0 110.511 -179.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.439 ' O ' ' OD1' ' A' ' 24' ' ' ASN . 11.3 t0 -83.32 -59.15 2.55 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.272 -0.893 . . . . 0.0 110.309 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.93 88.04 2.9 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.388 -0.82 . . . . 0.0 110.117 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.482 ' CA ' ' SG ' ' A' ' 46' ' ' CYS . . . -124.03 109.68 1.33 Allowed Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.446 ' OH ' ' CD2' ' A' ' 45' ' ' TYR . 47.6 p90 -127.27 147.44 50.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.279 -1.13 . . . . 0.0 109.861 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.1 OUTLIER -91.66 140.64 29.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.284 -0.885 . . . . 0.0 110.815 -179.282 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.583 ' CD1' ' HB3' ' A' ' 40' ' ' TRP . 45.5 t-105 -79.78 104.11 10.14 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.276 -0.89 . . . . 0.0 109.407 179.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -76.4 76.09 1.53 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -179.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.583 ' HB3' ' CD1' ' A' ' 38' ' ' TRP . 5.8 t-105 -160.5 -72.21 0.07 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.41 -1.053 . . . . 0.0 109.583 179.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.471 ' HB ' ' O ' ' A' ' 40' ' ' TRP . 12.7 t -179.11 35.3 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.569 -0.707 . . . . 0.0 109.79 179.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.569 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 1.7 mt -113.12 -84.3 0.59 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.244 -0.91 . . . . 0.0 110.866 -179.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.533 ' CB ' HG21 ' A' ' 15' ' ' ILE . 3.2 t 170.36 175.76 0.06 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.411 -0.806 . . . . 0.0 109.59 -179.394 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.497 ' O ' ' CD2' ' A' ' 5' ' ' TYR . 10.3 t -63.49 159.96 17.43 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.003 -1.06 . . . . 0.0 108.923 179.415 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.668 ' CD2' ' CZ ' ' A' ' 5' ' ' TYR . 1.0 OUTLIER -147.99 116.41 6.59 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.877 -1.14 . . . . 0.0 110.935 -179.755 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.482 ' SG ' ' CA ' ' A' ' 35' ' ' GLY . 71.6 m -128.46 149.38 50.6 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.28 -0.887 . . . . 0.0 109.686 179.238 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.409 ' HA ' ' OD1' ' A' ' 3' ' ' ASP . 0.2 OUTLIER -127.96 104.51 7.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.163 -0.96 . . . . 0.0 110.074 -179.853 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 32' ' ' ALA . . . 131.51 49.86 0.1 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.525 HD13 ' CB ' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -120.37 173.47 3.69 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.351 -1.087 . . . . 0.0 110.106 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.501 ' HD2' ' HB2' ' A' ' 49' ' ' LEU . 43.0 Cg_endo -70.38 157.7 58.4 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.944 1.497 . . . . 0.0 110.362 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -60.39 -18.0 47.62 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.285 -0.884 . . . . 0.0 110.033 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -89.83 9.18 28.45 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.34 -0.85 . . . . 0.0 109.968 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.525 ' CB ' HD13 ' A' ' 49' ' ' LEU . . . -58.42 122.01 12.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.388 -0.82 . . . . 0.0 110.275 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.412 ' O ' HG21 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -78.03 130.88 37.01 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.181 -0.949 . . . . 0.0 110.297 -179.98 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.523 ' O ' ' N ' ' A' ' 57' ' ' ARG . 2.3 pp -145.0 -179.56 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.317 -0.865 . . . . 0.0 110.074 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.423 ' O ' ' HG3' ' A' ' 56' ' ' LYS . 4.1 ptpt -51.35 88.2 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.323 -0.861 . . . . 0.0 110.479 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.523 ' N ' ' O ' ' A' ' 55' ' ' ILE . 0.3 OUTLIER -110.25 -28.85 8.42 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.408 -0.808 . . . . 0.0 109.382 179.526 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -125.48 170.84 11.01 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.67 -0.644 . . . . 0.0 110.222 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -124.71 -3.8 7.61 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.402 ' O ' ' HG3' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -108.14 131.64 54.43 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.272 -1.134 . . . . 0.0 110.041 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 33.5 m -44.31 126.57 5.27 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.196 -0.94 . . . . 0.0 109.813 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.475 ' HB2' ' HA ' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -86.68 50.31 1.98 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.131 -0.98 . . . . 0.0 110.127 179.879 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.187 -0.946 . . . . 0.0 110.246 179.96 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 38.1 pttt . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.298 0.57 . . . . 0.0 110.219 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.532 ' CG2' ' O ' ' A' ' 50' ' ' PRO . 2.8 tt -154.36 166.07 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.261 -0.899 . . . . 0.0 110.056 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.497 ' N ' HG12 ' A' ' 2' ' ' ILE . 2.4 p-10 -147.87 166.04 28.81 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.369 -0.832 . . . . 0.0 109.965 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 157.36 -152.12 23.41 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.474 ' HA ' ' O ' ' A' ' 44' ' ' CYS . 6.9 m-85 -110.58 99.22 40.41 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.276 -1.131 . . . . 0.0 110.393 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.532 ' HA ' ' CG2' ' A' ' 55' ' ' ILE . 46.7 Cg_endo -73.85 126.76 10.94 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 124.066 1.561 . . . . 0.0 110.146 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.423 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . 16.0 m -79.59 -172.29 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.243 -0.911 . . . . 0.0 110.256 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.459 ' O ' ' HB2' ' A' ' 9' ' ' TYR . 6.9 p-10 -77.28 -44.63 29.06 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.155 -0.966 . . . . 0.0 109.87 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.565 ' HB3' ' CE3' ' A' ' 10' ' ' TRP . 1.7 t80 178.98 -66.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.675 -0.641 . . . . 0.0 109.444 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.565 ' CE3' ' HB3' ' A' ' 9' ' ' TYR . 2.6 m-90 -107.27 21.68 17.14 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.35 -0.844 . . . . 0.0 109.37 179.272 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.475 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 2.3 m120 59.11 14.07 3.29 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.46 -0.775 . . . . 0.0 110.307 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.9 m -68.9 -36.26 77.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.259 -0.901 . . . . 0.0 109.969 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.1 44.7 1.01 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.423 -0.798 . . . . 0.0 109.773 179.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 62.32 -179.8 0.13 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.332 -0.855 . . . . 0.0 110.081 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.449 ' HB ' ' HB3' ' A' ' 43' ' ' SER . 3.3 mt -82.11 -6.56 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.211 -0.931 . . . . 0.0 110.548 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.447 ' HB2' ' C ' ' A' ' 43' ' ' SER . 46.3 t -132.12 162.56 30.54 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.286 -0.884 . . . . 0.0 110.37 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.669 ' CE3' ' CG ' ' A' ' 22' ' ' TYR . 0.3 OUTLIER -105.77 -153.66 0.5 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.274 -0.891 . . . . 0.0 109.889 179.605 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -105.48 -20.27 13.53 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.184 -0.948 . . . . 0.0 110.113 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.457 ' HB3' ' HB2' ' A' ' 22' ' ' TYR . 0.3 OUTLIER -100.98 149.7 23.65 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.262 -0.899 . . . . 0.0 110.137 179.963 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -84.32 -25.56 29.16 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.215 -0.928 . . . . 0.0 110.276 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -90.22 -28.61 18.74 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.23 -0.919 . . . . 0.0 110.355 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.669 ' CG ' ' CE3' ' A' ' 17' ' ' TRP . 28.4 t80 -57.54 -46.36 83.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.262 -0.899 . . . . 0.0 110.179 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -64.45 -43.41 94.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.193 -0.942 . . . . 0.0 109.792 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.489 ' O ' ' CG ' ' A' ' 28' ' ' LYS . 50.0 t30 -57.92 -40.9 81.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.222 -0.924 . . . . 0.0 109.675 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.57 -56.82 17.0 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.222 -0.923 . . . . 0.0 110.066 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.72 -36.87 82.19 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.238 -0.914 . . . . 0.0 109.966 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.489 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . 5.2 m -63.02 -43.06 99.77 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.173 -0.955 . . . . 0.0 109.469 179.553 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.489 ' CG ' ' O ' ' A' ' 24' ' ' ASN . 0.3 OUTLIER -58.36 -27.78 64.52 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.294 -0.879 . . . . 0.0 109.257 179.027 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.14 -38.34 94.26 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 107.956 -2.057 . . . . 0.0 107.956 179.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.486 ' O ' ' HB3' ' A' ' 31' ' ' LYS . 5.0 mt -89.78 21.47 3.54 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.65 -0.912 . . . . 0.0 109.14 178.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.488 ' O ' ' O ' ' A' ' 48' ' ' GLY . 0.4 OUTLIER 69.65 15.92 8.06 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.647 -0.658 . . . . 0.0 110.798 179.922 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.518 ' CB ' HD21 ' A' ' 49' ' ' LEU . . . -88.38 73.6 8.76 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.933 -1.105 . . . . 0.0 109.383 179.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.425 ' C ' ' O ' ' A' ' 32' ' ' ALA . 0.1 OUTLIER -39.82 -76.94 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.565 -0.709 . . . . 0.0 110.848 -179.289 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.463 ' O ' ' HA ' ' A' ' 46' ' ' CYS . 1.8 t -65.88 93.65 0.19 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.443 -0.786 . . . . 0.0 110.454 -179.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.522 ' CA ' ' SG ' ' A' ' 46' ' ' CYS . . . -128.52 93.64 0.36 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.523 ' C ' ' CD1' ' A' ' 36' ' ' TYR . 9.4 p90 -113.47 153.35 28.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.294 -1.121 . . . . 0.0 109.859 179.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.1 OUTLIER -108.8 139.99 42.86 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.097 -1.002 . . . . 0.0 110.428 -179.863 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.639 ' CD1' ' CD1' ' A' ' 42' ' ' LEU . 49.1 t-105 -79.54 86.85 5.16 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.292 -0.88 . . . . 0.0 109.848 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -62.38 80.77 0.03 OUTLIER Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -179.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.571 ' HB3' ' CD1' ' A' ' 38' ' ' TRP . 14.0 t-105 -160.53 -73.16 0.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.435 -1.038 . . . . 0.0 109.6 179.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.554 HG22 ' CD1' ' A' ' 40' ' ' TRP . 15.0 t -179.07 40.1 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.634 -0.666 . . . . 0.0 109.588 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.639 ' CD1' ' CD1' ' A' ' 38' ' ' TRP . 0.3 OUTLIER -123.25 -80.65 0.63 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.281 -0.887 . . . . 0.0 110.818 -179.485 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.468 ' CB ' ' O ' ' A' ' 42' ' ' LEU . 1.2 p 170.01 176.09 0.05 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.263 -0.898 . . . . 0.0 109.901 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 5' ' ' TYR . 6.8 t -74.6 166.54 23.39 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.23 -0.919 . . . . 0.0 110.176 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.501 ' CD2' ' OH ' ' A' ' 36' ' ' TYR . 0.8 OUTLIER -148.98 108.47 3.98 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.191 -0.943 . . . . 0.0 110.35 -179.973 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.522 ' SG ' ' CA ' ' A' ' 35' ' ' GLY . 64.9 m -129.23 137.71 51.26 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.375 -0.828 . . . . 0.0 109.729 179.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.467 ' OE1' ' CE1' ' A' ' 45' ' ' TYR . 2.2 mt-30 -124.18 128.4 49.17 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.086 -1.009 . . . . 0.0 110.314 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.488 ' O ' ' O ' ' A' ' 31' ' ' LYS . . . 121.25 28.9 1.56 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.528 HD13 ' CB ' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -106.2 169.5 6.84 Favored Pre-proline 0 N--CA 1.497 1.883 0 O-C-N 121.135 -1.215 . . . . 0.0 109.993 179.6 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.532 ' O ' ' CG2' ' A' ' 2' ' ' ILE . 42.4 Cg_endo -67.23 157.62 60.85 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 O-C-N 123.87 1.458 . . . . 0.0 111.126 -179.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -58.46 -27.86 64.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.488 -0.758 . . . . 0.0 109.883 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.4 ' O ' ' OD1' ' A' ' 52' ' ' ASN . 15.8 t-20 -90.75 20.42 4.74 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.393 -0.817 . . . . 0.0 109.457 179.437 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.528 ' CB ' HD13 ' A' ' 49' ' ' LEU . . . -62.84 110.83 1.89 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.665 -0.647 . . . . 0.0 110.592 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.509 ' NH1' ' O ' ' A' ' 9' ' ' TYR . 1.3 tmm_? -65.02 129.36 39.43 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.324 -0.86 . . . . 0.0 110.307 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.532 ' CG2' ' HA ' ' A' ' 6' ' ' PRO . 2.7 pt -152.55 -163.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.543 -0.723 . . . . 0.0 109.907 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.474 ' O ' ' HG3' ' A' ' 56' ' ' LYS . 2.5 ptmm? -40.72 93.43 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.569 -0.707 . . . . 0.0 110.498 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.526 ' N ' ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -135.17 2.95 3.1 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.294 -0.879 . . . . 0.0 110.113 -179.935 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -153.46 -173.63 4.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.239 -0.913 . . . . 0.0 109.864 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -166.73 23.93 0.13 Allowed Glycine 0 N--CA 1.49 2.272 0 C-N-CA 119.674 -1.25 . . . . 0.0 110.049 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.485 ' O ' ' O ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER -137.16 47.47 2.11 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.959 -1.318 . . . . 0.0 110.411 179.802 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.485 ' O ' ' O ' ' A' ' 60' ' ' ARG . 0.5 OUTLIER 47.36 103.07 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.619 -0.676 . . . . 0.0 110.742 179.885 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.485 ' N ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -79.9 54.68 1.92 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.382 -0.824 . . . . 0.0 110.171 179.811 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.165 -0.959 . . . . 0.0 110.263 -179.962 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 20.2 mttt . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.277 0.561 . . . . 0.0 110.232 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.552 HG22 ' O ' ' A' ' 49' ' ' LEU . 10.8 tt -120.26 165.16 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.33 -0.856 . . . . 0.0 110.051 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -143.34 144.12 31.96 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.277 -0.889 . . . . 0.0 110.136 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 173.51 -151.6 13.81 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.585 ' N ' ' CD1' ' A' ' 5' ' ' TYR . 20.0 m-85 -110.15 98.31 34.53 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.325 -1.103 . . . . 0.0 110.413 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.657 ' HA ' HG22 ' A' ' 55' ' ' ILE . 49.2 Cg_endo -75.77 144.2 27.55 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 124.025 1.54 . . . . 0.0 110.738 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 1.07 ' CG1' HG23 ' A' ' 15' ' ' ILE . 6.3 m -109.14 -171.97 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.199 -0.938 . . . . 0.0 110.015 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -89.2 -88.47 0.16 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.217 -0.927 . . . . 0.0 110.19 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.519 ' HB3' ' CD2' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -141.09 -42.71 0.38 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.143 -0.973 . . . . 0.0 110.239 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.519 ' CD2' ' HB3' ' A' ' 9' ' ' TYR . 6.2 m-90 -116.46 16.57 15.61 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.256 -0.902 . . . . 0.0 110.057 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 88.6 m-20 56.54 17.12 2.85 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.261 -0.9 . . . . 0.0 110.146 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 56.4 m -70.14 -11.01 60.59 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.266 -0.896 . . . . 0.0 110.197 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.462 ' HD2' ' N ' ' A' ' 13' ' ' LYS . 5.5 mptt -108.04 40.01 1.83 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.328 -0.858 . . . . 0.0 110.241 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.497 ' O ' ' HB ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER 46.17 36.22 3.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.173 -0.954 . . . . 0.0 109.997 -179.997 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 1.07 HG23 ' CG1' ' A' ' 7' ' ' VAL . 2.5 mt 62.91 7.65 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.491 -0.755 . . . . 0.0 110.65 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.554 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 32.8 t -148.64 111.96 4.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.054 -1.029 . . . . 0.0 109.696 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.465 ' O ' ' O ' ' A' ' 16' ' ' CYS . 5.2 t90 -43.44 -94.3 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.329 -0.857 . . . . 0.0 110.306 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -160.54 -64.0 0.06 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.771 -1.206 . . . . 0.0 110.366 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.546 ' HB2' ' CG ' ' A' ' 22' ' ' TYR . 0.8 OUTLIER -70.15 171.02 10.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.464 -0.773 . . . . 0.0 110.367 -179.937 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -75.75 -54.69 6.55 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.234 -0.916 . . . . 0.0 109.966 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -71.9 -16.99 62.13 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.363 -0.836 . . . . 0.0 110.061 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.546 ' CG ' ' HB2' ' A' ' 19' ' ' ASN . 1.4 m-30 -57.72 -26.41 61.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.195 -0.941 . . . . 0.0 110.033 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.4 t -98.19 -17.69 18.86 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.252 -0.905 . . . . 0.0 110.243 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 35' ' ' GLY . 66.9 t30 -72.0 -40.28 68.63 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.258 -0.902 . . . . 0.0 110.069 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.13 -47.45 82.68 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.012 -1.055 . . . . 0.0 109.397 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.48 -43.44 85.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.374 -0.829 . . . . 0.0 109.354 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.644 ' HA ' HD12 ' A' ' 30' ' ' LEU . 1.8 m -60.23 -39.59 87.21 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.407 -0.808 . . . . 0.0 109.423 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.454 ' HG3' ' HA ' ' A' ' 33' ' ' ASP . 0.0 OUTLIER -60.05 -30.74 69.4 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.261 -0.899 . . . . 0.0 109.488 179.365 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.05 -31.65 79.47 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 107.798 -2.121 . . . . 0.0 107.798 179.096 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.644 HD12 ' HA ' ' A' ' 27' ' ' CYS . 1.8 mt -91.8 19.0 6.91 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.672 -0.899 . . . . 0.0 109.217 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.533 ' HB3' ' O ' ' A' ' 30' ' ' LEU . 1.5 tptt 72.76 13.38 5.15 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.805 -0.559 . . . . 0.0 111.019 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.622 ' HB2' HD22 ' A' ' 49' ' ' LEU . . . -92.34 73.06 5.3 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.902 -1.124 . . . . 0.0 109.975 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.454 ' HA ' ' HG3' ' A' ' 28' ' ' LYS . 18.9 m-20 -43.96 -62.0 1.27 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.316 -0.865 . . . . 0.0 110.407 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.416 ' HB3' ' NE2' ' A' ' 47' ' ' GLN . 0.3 OUTLIER -74.05 84.18 1.79 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.363 -0.836 . . . . 0.0 110.035 179.989 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.524 ' CA ' ' SG ' ' A' ' 46' ' ' CYS . . . -124.35 116.17 2.72 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.528 ' C ' ' CD1' ' A' ' 36' ' ' TYR . 12.8 p90 -139.04 147.44 42.06 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.316 -1.108 . . . . 0.0 109.85 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.458 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.0 OUTLIER -100.26 139.63 35.65 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.165 -0.959 . . . . 0.0 110.492 -179.619 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.58 ' CD1' ' HB2' ' A' ' 42' ' ' LEU . 26.0 t-105 -79.65 103.71 9.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.235 -0.916 . . . . 0.0 109.626 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -67.12 65.59 0.22 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.847 ' CD1' HG22 ' A' ' 41' ' ' THR . 6.3 t-105 -160.21 -65.77 0.07 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.284 -1.127 . . . . 0.0 109.883 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.847 HG22 ' CD1' ' A' ' 40' ' ' TRP . 3.8 t 177.62 35.83 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.53 -0.731 . . . . 0.0 109.903 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.58 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 9.6 mt -119.15 20.51 12.63 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.089 -1.007 . . . . 0.0 110.458 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.554 ' HA ' ' HB2' ' A' ' 16' ' ' CYS . 3.3 m 55.58 -170.42 0.07 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.153 -0.967 . . . . 0.0 110.179 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.468 ' O ' ' CD2' ' A' ' 5' ' ' TYR . 12.2 t -79.04 163.14 25.4 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.342 -0.849 . . . . 0.0 110.307 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -148.04 100.07 3.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.29 -0.882 . . . . 0.0 109.955 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.593 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . 63.7 m -123.3 148.93 45.45 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.173 -0.954 . . . . 0.0 110.357 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.426 ' N ' ' CD ' ' A' ' 47' ' ' GLN . 0.7 OUTLIER -131.64 140.19 49.3 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.352 -0.843 . . . . 0.0 109.857 179.717 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.479 ' O ' ' O ' ' A' ' 31' ' ' LYS . . . 111.26 20.39 7.09 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.915 HD12 ' CB ' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -99.49 168.31 9.77 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 121.232 -1.158 . . . . 0.0 109.65 179.472 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.508 ' HD3' ' O ' ' A' ' 30' ' ' LEU . 43.3 Cg_endo -70.5 161.2 46.88 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.619 1.326 . . . . 0.0 110.62 -179.381 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -62.05 -16.68 53.68 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.219 -0.926 . . . . 0.0 109.717 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -94.84 15.01 19.62 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.435 -0.791 . . . . 0.0 109.941 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.915 ' CB ' HD12 ' A' ' 49' ' ' LEU . . . -56.01 149.22 15.83 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.283 -0.886 . . . . 0.0 110.304 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.7 mtm105 -92.08 88.64 6.61 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.294 -0.879 . . . . 0.0 110.261 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.898 ' H ' HD13 ' A' ' 55' ' ' ILE . 0.2 OUTLIER -131.81 156.01 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.161 -0.962 . . . . 0.0 110.006 179.671 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 55' ' ' ILE . 8.9 mttt 42.45 56.0 3.91 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.236 -0.915 . . . . 0.0 110.303 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -88.05 -5.98 58.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.265 -0.897 . . . . 0.0 110.363 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.429 ' O ' ' ND2' ' A' ' 11' ' ' ASN . 0.1 OUTLIER 57.05 173.21 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.342 -0.849 . . . . 0.0 110.111 -179.909 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 101.41 132.94 7.92 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.67 173.44 8.1 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.188 -1.183 . . . . 0.0 110.236 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 35.1 t -43.4 104.99 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.364 -0.835 . . . . 0.0 110.169 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.518 ' CB ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -87.02 49.55 1.84 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.213 -0.929 . . . . 0.0 110.179 -179.882 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.432 ' HB2' ' O ' ' A' ' 62' ' ' ARG . . . . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.131 -0.98 . . . . 0.0 110.309 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.247 0.546 . . . . 0.0 110.237 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.489 HG22 ' O ' ' A' ' 49' ' ' LEU . 7.7 tt -119.22 163.95 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.272 -0.893 . . . . 0.0 110.28 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 3' ' ' ASP . 1.9 p30 -141.0 138.45 33.72 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.409 -0.807 . . . . 0.0 110.14 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.495 ' O ' ' HA ' ' A' ' 45' ' ' TYR . . . -177.59 -163.29 29.19 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.49 ' HA ' ' O ' ' A' ' 44' ' ' CYS . 3.0 m-85 -105.86 102.7 40.39 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.301 -1.117 . . . . 0.0 110.262 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.509 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 47.7 Cg_endo -74.3 109.98 3.0 Favored 'Trans proline' 0 C--N 1.301 -1.945 0 O-C-N 123.994 1.523 . . . . 0.0 111.187 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.777 HG12 HG13 ' A' ' 15' ' ' ILE . 14.6 m -91.29 -162.48 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.291 -0.88 . . . . 0.0 109.762 179.072 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.535 ' CB ' ' HB2' ' A' ' 13' ' ' LYS . 11.5 t0 -77.58 -87.97 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.334 -0.854 . . . . 0.0 109.829 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.488 ' O ' ' NH1' ' A' ' 54' ' ' ARG . 1.1 m-85 -141.29 -58.97 0.49 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.328 -0.857 . . . . 0.0 109.745 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.817 ' CD2' ' HB2' ' A' ' 63' ' ' ALA . 4.8 m-90 -106.22 24.42 12.51 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.442 -0.786 . . . . 0.0 109.678 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.484 ' OD1' HG21 ' A' ' 7' ' ' VAL . 58.9 m-80 57.58 15.5 2.85 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.367 -0.833 . . . . 0.0 109.726 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 5.1 t -92.5 -42.11 9.89 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.308 -0.87 . . . . 0.0 110.417 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.535 ' HB2' ' CB ' ' A' ' 8' ' ' ASP . 5.3 mmtp -60.41 -93.18 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.42 -0.8 . . . . 0.0 110.27 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.465 ' HG2' ' O ' ' A' ' 13' ' ' LYS . 2.7 mmp_? -144.68 101.4 3.66 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.175 -0.953 . . . . 0.0 110.511 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.777 HG13 HG12 ' A' ' 7' ' ' VAL . 4.3 tt -44.0 -27.6 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.218 -0.926 . . . . 0.0 109.458 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.623 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 30.9 t -158.91 106.25 1.82 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.597 -0.689 . . . . 0.0 110.415 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.405 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -54.58 -172.57 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.179 -0.951 . . . . 0.0 109.81 179.773 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -114.55 33.59 5.24 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.109 -0.994 . . . . 0.0 110.174 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -131.55 145.55 51.78 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.257 -0.902 . . . . 0.0 109.959 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.426 ' OD1' ' N ' ' A' ' 20' ' ' ASN . 15.5 p-10 -82.06 9.09 9.11 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.243 -0.911 . . . . 0.0 110.352 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.46 -33.77 2.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.238 -0.914 . . . . 0.0 110.313 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -52.72 -35.75 56.36 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.107 -0.996 . . . . 0.0 110.199 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.406 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 0.1 OUTLIER -88.86 -30.57 18.82 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.219 -0.925 . . . . 0.0 110.049 179.846 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -69.93 -52.43 24.61 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.347 -0.846 . . . . 0.0 110.316 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -50.12 -47.9 53.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.212 -0.93 . . . . 0.0 110.308 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.3 -41.24 66.85 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.239 -0.913 . . . . 0.0 110.15 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.456 ' SG ' ' HG3' ' A' ' 6' ' ' PRO . 8.3 m -59.91 -34.33 73.05 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.106 -0.996 . . . . 0.0 109.794 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.55 -31.79 73.06 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.391 -0.818 . . . . 0.0 109.726 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.13 -33.95 86.16 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 107.957 -2.057 . . . . 0.0 107.957 178.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.515 ' O ' ' HD3' ' A' ' 50' ' ' PRO . 1.4 mt -89.54 19.58 4.48 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.61 -0.936 . . . . 0.0 109.426 179.021 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.501 ' HB3' ' O ' ' A' ' 30' ' ' LEU . 0.4 OUTLIER 68.27 18.42 9.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.699 -0.625 . . . . 0.0 111.02 179.749 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.58 ' HB1' ' HB3' ' A' ' 46' ' ' CYS . . . -92.31 74.77 5.31 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.913 -1.117 . . . . 0.0 109.78 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 32' ' ' ALA . 62.9 t0 -39.99 -70.48 0.1 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.415 -0.803 . . . . 0.0 110.677 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.17 86.25 1.06 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.508 -0.745 . . . . 0.0 110.192 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.522 ' CA ' ' SG ' ' A' ' 46' ' ' CYS . . . -121.15 98.73 0.67 Allowed Glycine 0 N--CA 1.488 2.102 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.493 ' OH ' ' CD2' ' A' ' 45' ' ' TYR . 53.1 p90 -126.42 153.64 44.73 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.353 -1.087 . . . . 0.0 109.855 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.524 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.1 OUTLIER -102.2 146.33 28.14 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.139 -0.976 . . . . 0.0 110.367 -179.638 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.634 ' CD1' ' HB2' ' A' ' 42' ' ' LEU . 25.8 t-105 -79.82 148.57 31.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.139 -0.976 . . . . 0.0 109.645 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -106.36 53.19 0.64 Allowed Glycine 0 N--CA 1.491 2.335 0 C-N-CA 119.615 -1.279 . . . . 0.0 110.204 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.563 ' C ' HG23 ' A' ' 41' ' ' THR . 30.9 t-105 -160.54 -83.08 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.255 -1.144 . . . . 0.0 110.021 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.563 HG23 ' C ' ' A' ' 40' ' ' TRP . 72.6 p -155.25 38.54 0.4 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.407 -0.808 . . . . 0.0 110.354 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.634 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 0.4 OUTLIER -119.46 24.03 10.89 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.093 -1.004 . . . . 0.0 110.681 -179.847 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.623 ' HA ' ' HB2' ' A' ' 16' ' ' CYS . 90.5 p 45.52 -174.01 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.3 -0.875 . . . . 0.0 110.363 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.54 ' N ' ' HB2' ' A' ' 16' ' ' CYS . 25.3 t -71.87 171.97 10.75 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.184 -0.948 . . . . 0.0 109.261 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.495 ' HA ' ' O ' ' A' ' 4' ' ' GLY . 1.1 t80 -158.26 100.95 1.71 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.999 -1.063 . . . . 0.0 111.001 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.629 ' O ' HD21 ' A' ' 49' ' ' LEU . 85.9 m -121.05 137.2 54.76 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.353 -0.842 . . . . 0.0 109.533 179.109 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.451 ' OE1' ' N ' ' A' ' 47' ' ' GLN . 9.6 mp0 -121.87 148.11 45.14 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.163 -0.961 . . . . 0.0 110.35 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.5 ' O ' ' O ' ' A' ' 31' ' ' LYS . . . 100.05 27.18 7.94 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 1.103 HD12 ' CB ' ' A' ' 53' ' ' ALA . 0.2 OUTLIER -109.32 170.9 4.9 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.191 -1.182 . . . . 0.0 109.872 179.751 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.516 ' HD2' ' HB2' ' A' ' 49' ' ' LEU . 42.0 Cg_endo -68.43 158.35 58.01 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.689 1.363 . . . . 0.0 110.717 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -60.66 -22.61 64.04 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.332 -0.855 . . . . 0.0 110.173 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -85.38 11.73 9.71 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.243 -0.91 . . . . 0.0 109.94 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 1.103 ' CB ' HD12 ' A' ' 49' ' ' LEU . . . -62.16 135.82 57.67 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.304 -0.872 . . . . 0.0 110.548 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.631 ' O ' HG23 ' A' ' 55' ' ' ILE . 15.7 tpp85 -77.2 131.69 38.37 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.3 -0.875 . . . . 0.0 109.869 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.631 HG23 ' O ' ' A' ' 54' ' ' ARG . 1.3 pp -156.85 -173.24 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.276 -0.89 . . . . 0.0 110.303 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -45.89 93.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.212 -0.93 . . . . 0.0 110.608 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.479 ' N ' ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -112.6 22.39 14.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.333 -0.854 . . . . 0.0 109.856 179.604 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.87 -178.17 0.11 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.354 -0.841 . . . . 0.0 110.373 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.458 ' O ' ' O ' ' A' ' 60' ' ' ARG . . . 92.89 101.1 1.47 Allowed Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.529 ' O ' ' N ' ' A' ' 62' ' ' ARG . 2.8 ptm85 -50.73 -175.8 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.254 -1.145 . . . . 0.0 110.212 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.413 ' C ' ' O ' ' A' ' 60' ' ' ARG . 33.9 t -42.21 93.32 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.379 -0.825 . . . . 0.0 110.389 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.538 ' CB ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -84.07 43.66 0.95 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.339 -0.851 . . . . 0.0 110.481 -179.754 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.817 ' HB2' ' CD2' ' A' ' 10' ' ' TRP . . . . . . . . 0 N--CA 1.492 1.643 0 O-C-N 121.179 -0.95 . . . . 0.0 110.184 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 1' ' ' LYS . . . . . 0.492 ' HG2' ' O ' ' A' ' 1' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.491 0.662 . . . . 0.0 110.34 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.524 ' CG2' ' HG ' ' A' ' 49' ' ' LEU . 8.6 tt -120.44 160.58 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.384 -0.823 . . . . 0.0 110.075 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -142.7 144.28 32.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.328 -0.858 . . . . 0.0 110.096 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 179.83 -149.46 8.61 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.618 ' N ' ' CD1' ' A' ' 5' ' ' TYR . 12.4 m-85 -122.29 110.1 32.75 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.291 -1.123 . . . . 0.0 110.266 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.631 ' HB3' HG22 ' A' ' 55' ' ' ILE . 46.6 Cg_endo -73.95 128.76 12.63 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 124.055 1.555 . . . . 0.0 110.685 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.887 HG12 HG23 ' A' ' 15' ' ' ILE . 14.7 m -83.15 -175.87 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.283 -0.885 . . . . 0.0 110.156 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.439 ' O ' ' NH1' ' A' ' 54' ' ' ARG . 16.2 t70 -64.37 -117.54 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.171 -0.955 . . . . 0.0 109.582 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.601 ' HB3' ' CD2' ' A' ' 10' ' ' TRP . 2.0 t80 -119.62 -50.77 2.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.828 -1.17 . . . . 0.0 109.792 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.601 ' CD2' ' HB3' ' A' ' 9' ' ' TYR . 3.3 m-90 -106.08 21.32 17.53 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.233 -0.917 . . . . 0.0 109.709 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.47 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 42.5 m-20 59.5 12.33 2.71 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.388 -0.82 . . . . 0.0 110.167 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 6.8 m -67.21 -62.85 1.22 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.255 -0.903 . . . . 0.0 109.808 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.1 mmtp -73.58 -178.37 3.07 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.591 -0.693 . . . . 0.0 109.87 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.74 -174.58 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.131 -0.981 . . . . 0.0 110.059 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.887 HG23 HG12 ' A' ' 7' ' ' VAL . 20.2 mt -86.76 23.75 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.129 -0.982 . . . . 0.0 110.205 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.517 ' HB2' ' N ' ' A' ' 44' ' ' CYS . 14.4 t -160.16 165.53 31.45 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.239 -0.913 . . . . 0.0 110.595 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.468 ' N ' ' SG ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -115.8 -157.39 0.64 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.371 -0.831 . . . . 0.0 109.821 179.617 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -119.61 -3.79 10.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.211 -0.931 . . . . 0.0 109.989 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.584 ' HB2' ' CG ' ' A' ' 22' ' ' TYR . 0.7 OUTLIER -100.79 133.31 45.45 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.328 -0.858 . . . . 0.0 110.083 179.87 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -60.32 -45.93 91.68 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.194 -0.941 . . . . 0.0 110.641 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.33 -13.23 59.97 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.163 -0.961 . . . . 0.0 110.37 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.584 ' CG ' ' HB2' ' A' ' 19' ' ' ASN . 1.0 OUTLIER -66.66 -11.5 54.21 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.18 -0.95 . . . . 0.0 110.385 -179.771 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.452 ' O ' ' HB2' ' A' ' 27' ' ' CYS . 0.1 OUTLIER -118.73 -31.72 4.75 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.232 -0.917 . . . . 0.0 110.078 179.857 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.529 ' CA ' ' O ' ' A' ' 35' ' ' GLY . 2.0 t-20 -82.53 -49.17 10.19 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.224 -0.922 . . . . 0.0 109.47 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -54.99 -26.91 40.09 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.028 -1.045 . . . . 0.0 109.065 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.656 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -90.85 -46.87 7.94 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.646 -0.659 . . . . 0.0 109.486 179.628 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.499 ' SG ' ' HG3' ' A' ' 6' ' ' PRO . 7.7 m -60.05 -34.77 73.86 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.394 -0.816 . . . . 0.0 110.149 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.41 ' HG2' ' O ' ' A' ' 24' ' ' ASN . 1.9 mmmt -61.55 -32.75 72.83 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.183 -0.948 . . . . 0.0 109.319 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.82 -30.98 78.77 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 107.24 -2.344 . . . . 0.0 107.24 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.529 ' O ' ' CD ' ' A' ' 50' ' ' PRO . 11.9 mt -89.69 20.35 4.1 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.777 -0.837 . . . . 0.0 109.261 178.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.512 ' HB3' ' HD3' ' A' ' 50' ' ' PRO . 1.0 OUTLIER 66.95 16.5 10.37 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.661 -0.65 . . . . 0.0 110.695 -179.872 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.676 ' HB1' ' HB3' ' A' ' 46' ' ' CYS . . . -90.71 82.76 5.73 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.996 -1.065 . . . . 0.0 110.197 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 32' ' ' ALA . 26.0 t0 -43.25 -71.46 0.08 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.287 -0.883 . . . . 0.0 110.24 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.495 ' O ' ' HA ' ' A' ' 46' ' ' CYS . 0.0 OUTLIER -76.47 86.65 3.2 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.283 -0.886 . . . . 0.0 109.954 179.877 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.529 ' O ' ' CA ' ' A' ' 24' ' ' ASN . . . -125.6 87.69 0.36 Allowed Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.54 ' OH ' ' CZ3' ' A' ' 38' ' ' TRP . 29.4 p90 -130.59 153.91 48.4 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.957 -1.319 . . . . 0.0 109.624 179.143 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.544 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.1 OUTLIER -83.39 155.21 23.61 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.191 -0.943 . . . . 0.0 111.464 -178.686 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.628 ' CD1' HD13 ' A' ' 42' ' ' LEU . 2.5 t-105 -79.45 140.26 37.4 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.3 -21.09 63.18 Favored Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.662 -1.256 . . . . 0.0 110.861 -178.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.95 ' CD1' HG22 ' A' ' 41' ' ' THR . 49.4 t-105 -79.4 -77.19 0.18 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.884 -1.363 . . . . 0.0 109.847 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.95 HG22 ' CD1' ' A' ' 40' ' ' TRP . 13.5 t -178.14 43.92 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.478 -0.764 . . . . 0.0 109.704 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.628 HD13 ' CD1' ' A' ' 38' ' ' TRP . 0.8 OUTLIER -109.47 36.72 2.84 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.222 -0.924 . . . . 0.0 110.578 -179.524 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.487 ' CB ' ' HB ' ' A' ' 15' ' ' ILE . 74.6 m 52.69 -174.32 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.166 -0.958 . . . . 0.0 110.323 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.544 ' HA ' ' HA ' ' A' ' 37' ' ' CYS . 15.9 t -77.97 161.09 27.78 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.218 -0.926 . . . . 0.0 110.081 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -144.1 110.38 5.47 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.088 -1.007 . . . . 0.0 111.215 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.676 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . 60.0 m -130.15 134.65 47.46 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.324 -0.86 . . . . 0.0 109.263 178.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -127.42 143.7 51.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.128 -0.983 . . . . 0.0 110.508 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 31' ' ' LYS . . . 103.81 26.93 6.53 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 1.082 HD12 ' CB ' ' A' ' 53' ' ' ALA . 0.2 OUTLIER -105.62 169.39 7.06 Favored Pre-proline 0 N--CA 1.495 1.813 0 O-C-N 121.267 -1.137 . . . . 0.0 110.052 179.743 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.529 ' CD ' ' O ' ' A' ' 30' ' ' LEU . 48.2 Cg_endo -74.51 161.67 39.5 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.671 1.353 . . . . 0.0 110.397 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -59.99 -20.61 58.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.311 -0.868 . . . . 0.0 109.906 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.405 ' O ' ' CG ' ' A' ' 52' ' ' ASN . 6.1 t-20 -81.73 5.13 19.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.383 -0.823 . . . . 0.0 110.009 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 1.082 ' CB ' HD12 ' A' ' 49' ' ' LEU . . . -53.68 153.32 4.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.236 -0.915 . . . . 0.0 110.2 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.462 ' C ' HG23 ' A' ' 55' ' ' ILE . 35.2 ttp85 -105.05 91.18 3.69 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.228 -0.92 . . . . 0.0 110.312 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.87 ' H ' HD13 ' A' ' 55' ' ' ILE . 0.2 OUTLIER -149.17 157.87 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.259 -0.901 . . . . 0.0 110.149 179.842 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.433 ' C ' ' O ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER 41.63 53.79 3.83 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.417 -0.802 . . . . 0.0 110.283 179.843 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.415 ' CD ' ' HG3' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -97.21 -20.48 17.9 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.33 -0.857 . . . . 0.0 109.899 179.915 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.473 ' OG ' ' N ' ' A' ' 59' ' ' GLY . 0.1 OUTLIER 60.74 -176.68 0.11 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.537 -0.727 . . . . 0.0 110.273 179.844 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.473 ' N ' ' OG ' ' A' ' 58' ' ' SER . . . 110.34 -177.89 19.77 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.9 ptm180 -107.09 -177.16 3.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.153 -1.204 . . . . 0.0 110.245 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -48.71 124.06 7.82 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.201 -0.937 . . . . 0.0 110.105 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.506 ' CB ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -81.64 47.11 1.03 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.264 -0.897 . . . . 0.0 110.463 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.642 0 O-C-N 121.258 -0.901 . . . . 0.0 110.245 179.882 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.262 0.553 . . . . 0.0 110.244 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.838 HG23 ' HG ' ' A' ' 49' ' ' LEU . 17.1 tt -119.97 164.32 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.205 -0.934 . . . . 0.0 110.341 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -143.79 126.39 15.98 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.327 -0.858 . . . . 0.0 109.722 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -168.93 -155.97 10.17 Favored Glycine 0 N--CA 1.492 2.396 0 C-N-CA 119.561 -1.304 . . . . 0.0 110.041 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.573 ' CE1' HD22 ' A' ' 42' ' ' LEU . 77.2 m-85 -111.7 106.83 56.71 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.304 -1.115 . . . . 0.0 110.706 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.52 ' HA ' ' O ' ' A' ' 54' ' ' ARG . 49.8 Cg_endo -78.91 113.37 3.24 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.957 1.504 . . . . 0.0 109.907 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.507 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . 15.5 m -94.04 -169.11 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.012 -1.055 . . . . 0.0 111.05 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.433 ' OD2' ' CB ' ' A' ' 14' ' ' ARG . 9.9 t0 -59.53 -152.23 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.433 -0.792 . . . . 0.0 110.53 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.464 ' HB2' ' CE2' ' A' ' 10' ' ' TRP . 22.0 m-85 -98.84 -11.8 21.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.365 -0.834 . . . . 0.0 110.582 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.534 ' HB3' ' CB ' ' A' ' 62' ' ' ARG . 0.3 OUTLIER -130.22 4.26 4.79 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.03 -1.044 . . . . 0.0 109.74 -179.872 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.509 ' N ' ' OD1' ' A' ' 11' ' ' ASN . 1.6 m120 57.13 16.12 2.8 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.253 -0.905 . . . . 0.0 109.531 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 5.5 t -70.59 -64.04 0.98 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.365 -0.835 . . . . 0.0 110.504 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.495 ' O ' ' CD ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -161.52 82.6 0.61 Allowed 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.259 -0.901 . . . . 0.0 110.502 -179.565 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.437 ' CB ' ' O ' ' A' ' 13' ' ' LYS . 2.0 mtt180 173.06 35.06 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.392 -0.818 . . . . 0.0 109.795 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.946 HD12 ' HB2' ' A' ' 43' ' ' SER . 46.6 pt -54.25 -30.26 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.439 -0.788 . . . . 0.0 110.69 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.542 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 8.5 t -139.36 129.33 24.99 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.137 -0.977 . . . . 0.0 110.589 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.426 ' CE3' ' HB3' ' A' ' 22' ' ' TYR . 0.0 OUTLIER -73.24 170.17 15.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.361 -0.837 . . . . 0.0 110.067 179.785 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -88.23 55.0 3.26 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.318 -0.864 . . . . 0.0 110.075 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.608 ' ND2' ' CE1' ' A' ' 22' ' ' TYR . 2.2 t-20 -165.52 156.28 13.67 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.338 -0.852 . . . . 0.0 110.032 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.422 ' C ' ' OD1' ' A' ' 20' ' ' ASN . 49.7 p30 -87.38 -1.58 58.02 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.226 -0.921 . . . . 0.0 110.266 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.429 ' HA ' ' CB ' ' A' ' 24' ' ' ASN . 0.0 OUTLIER -129.37 -6.02 4.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.19 -0.944 . . . . 0.0 110.586 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.608 ' CE1' ' ND2' ' A' ' 19' ' ' ASN . 3.1 m-30 -59.69 -69.41 0.21 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.1 -1.0 . . . . 0.0 110.247 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.598 ' HA ' HD23 ' A' ' 26' ' ' LEU . 6.0 p -69.37 -6.36 29.39 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.98 -1.075 . . . . 0.0 109.852 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.539 ' CB ' ' O ' ' A' ' 35' ' ' GLY . 64.3 t30 -75.71 -61.06 2.05 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.388 -0.82 . . . . 0.0 109.506 179.083 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -49.25 -48.56 45.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.41 -0.806 . . . . 0.0 109.733 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.598 HD23 ' HA ' ' A' ' 23' ' ' CYS . 0.1 OUTLIER -64.52 -37.35 87.24 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.307 -0.87 . . . . 0.0 109.088 179.423 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.526 ' N ' ' HG ' ' A' ' 26' ' ' LEU . 1.3 m -61.86 -39.26 91.24 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.244 -0.91 . . . . 0.0 109.281 179.23 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.76 -31.49 69.71 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.466 -0.771 . . . . 0.0 109.55 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.64 -36.9 91.28 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 108.304 -1.919 . . . . 0.0 108.304 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.554 ' O ' ' CB ' ' A' ' 31' ' ' LYS . 6.9 mt -87.69 17.58 4.61 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.535 -0.979 . . . . 0.0 109.746 179.188 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.554 ' CB ' ' O ' ' A' ' 30' ' ' LEU . 0.7 OUTLIER 78.83 11.27 1.58 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.711 -0.618 . . . . 0.0 110.79 179.991 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.791 ' CB ' HD22 ' A' ' 49' ' ' LEU . . . -95.04 84.16 4.07 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.959 -1.088 . . . . 0.0 109.812 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -54.09 -73.78 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.279 -0.888 . . . . 0.0 111.143 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.51 ' O ' ' HA ' ' A' ' 46' ' ' CYS . 23.2 t -66.87 92.37 0.23 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.386 -0.821 . . . . 0.0 110.663 -179.41 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.539 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -129.4 88.12 0.31 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.594 ' CZ ' ' HB3' ' A' ' 45' ' ' TYR . 11.1 p90 -99.57 -175.93 3.13 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.165 -1.197 . . . . 0.0 110.422 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.512 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.1 OUTLIER -131.91 131.45 42.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.122 -0.986 . . . . 0.0 110.73 -179.656 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.592 ' CD1' ' HB2' ' A' ' 42' ' ' LEU . 1.9 t-105 -86.87 122.33 30.58 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.299 -0.875 . . . . 0.0 109.839 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.6 -10.14 86.13 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.583 ' HB3' ' CD1' ' A' ' 38' ' ' TRP . 41.1 t-105 -79.77 -92.9 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.207 -1.172 . . . . 0.0 110.095 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.501 ' CG2' ' C ' ' A' ' 40' ' ' TRP . 14.4 p -152.94 54.47 0.77 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.037 -1.039 . . . . 0.0 110.039 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.592 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 6.0 mt -132.3 8.76 4.34 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.203 -0.936 . . . . 0.0 110.813 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.946 ' HB2' HD12 ' A' ' 15' ' ' ILE . 1.4 t 56.77 -174.4 0.07 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.956 -1.09 . . . . 0.0 109.869 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.512 ' HA ' ' HA ' ' A' ' 37' ' ' CYS . 15.3 t -72.26 156.53 39.03 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.106 -0.996 . . . . 0.0 109.186 179.31 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.594 ' HB3' ' CZ ' ' A' ' 36' ' ' TYR . 67.4 t80 -138.04 113.85 9.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.113 -0.992 . . . . 0.0 110.478 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.69 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . 62.5 m -125.28 138.93 54.09 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.207 -0.933 . . . . 0.0 109.735 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.494 ' CG ' ' HB3' ' A' ' 34' ' ' SER . 0.0 OUTLIER -118.16 137.65 52.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.359 -0.838 . . . . 0.0 110.072 -179.949 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 31' ' ' LYS . . . 102.22 32.51 4.91 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.838 ' HG ' HG23 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -101.46 -177.27 0.54 Allowed Pre-proline 0 N--CA 1.496 1.865 0 O-C-N 121.185 -1.185 . . . . 0.0 109.303 179.646 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.537 ' HD2' ' HB2' ' A' ' 49' ' ' LEU . 47.6 Cg_endo -85.12 161.11 11.55 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 O-C-N 123.619 1.326 . . . . 0.0 110.123 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -59.53 -19.95 51.99 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.1 -1.0 . . . . 0.0 109.883 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -96.25 19.54 11.74 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.372 -0.83 . . . . 0.0 109.695 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.575 ' HB2' ' HB2' ' A' ' 49' ' ' LEU . . . -53.79 134.01 42.31 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.346 -0.846 . . . . 0.0 110.562 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.576 ' HB3' ' CZ ' ' A' ' 54' ' ' ARG . 1.3 ttm105 -71.71 87.49 0.96 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.298 -0.876 . . . . 0.0 109.976 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.694 HD12 ' C ' ' A' ' 55' ' ' ILE . 1.9 pp -124.34 -166.41 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.062 -1.024 . . . . 0.0 110.626 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.48 ' O ' ' HG3' ' A' ' 56' ' ' LYS . 0.4 OUTLIER -61.39 70.41 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.486 -0.758 . . . . 0.0 110.837 -179.555 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.531 ' N ' ' O ' ' A' ' 55' ' ' ILE . 9.1 tpp85 -114.79 -16.03 11.81 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.074 -1.016 . . . . 0.0 109.799 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.9 132.02 46.24 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.419 -0.801 . . . . 0.0 109.984 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -107.77 33.42 6.32 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.431 ' HG2' ' O ' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -122.77 107.4 11.86 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.276 -1.132 . . . . 0.0 110.28 179.954 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 2.6 t -50.74 107.52 0.18 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.288 -0.882 . . . . 0.0 109.882 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.534 ' CB ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -87.32 48.61 1.67 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.324 -0.86 . . . . 0.0 110.375 179.973 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.152 -0.967 . . . . 0.0 110.228 -179.99 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 13.3 tttm . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.178 0.513 . . . . 0.0 110.219 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.611 HG22 ' O ' ' A' ' 49' ' ' LEU . 4.5 tt -146.93 159.85 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.334 -0.854 . . . . 0.0 110.1 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.506 ' HB3' ' CG ' ' A' ' 47' ' ' GLN . 65.8 m-20 -131.14 136.2 48.14 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.347 -0.845 . . . . 0.0 109.873 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 178.77 -160.8 26.8 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.606 ' CE2' ' CD1' ' A' ' 45' ' ' TYR . 15.0 m-85 -109.28 109.25 60.46 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.305 -1.115 . . . . 0.0 110.256 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.516 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 49.4 Cg_endo -80.51 108.09 2.09 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.928 1.489 . . . . 0.0 110.9 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.477 HG12 ' HA ' ' A' ' 15' ' ' ILE . 17.0 m -83.49 -170.59 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.228 -0.92 . . . . 0.0 109.83 179.411 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -70.65 -118.23 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.111 -0.993 . . . . 0.0 109.827 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.413 ' HB3' ' CD2' ' A' ' 10' ' ' TRP . 0.2 OUTLIER -115.94 -55.06 2.45 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.816 -1.177 . . . . 0.0 110.073 179.792 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.543 ' HB3' ' CB ' ' A' ' 62' ' ' ARG . 3.0 m-90 -99.6 15.23 27.32 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.24 -0.913 . . . . 0.0 110.121 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.459 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 5.1 m-20 59.4 12.74 2.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.219 -0.925 . . . . 0.0 110.067 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.8 t -90.89 -28.68 17.96 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.277 -0.889 . . . . 0.0 110.43 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.489 ' O ' ' CB ' ' A' ' 14' ' ' ARG . 4.5 mmtp -86.79 41.38 0.95 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.272 -0.892 . . . . 0.0 110.619 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.489 ' CB ' ' O ' ' A' ' 13' ' ' LYS . 0.1 OUTLIER 69.03 141.6 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.159 -0.963 . . . . 0.0 110.536 179.787 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.477 ' HA ' HG12 ' A' ' 7' ' ' VAL . 6.9 pt -74.48 -6.29 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.376 -0.828 . . . . 0.0 110.104 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.599 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 4.4 t -148.25 153.99 39.46 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.267 -0.896 . . . . 0.0 110.257 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.458 ' CE3' ' HB3' ' A' ' 22' ' ' TYR . 0.2 OUTLIER -86.56 -161.99 0.72 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.359 -0.838 . . . . 0.0 110.105 179.886 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.471 ' CD1' ' O ' ' A' ' 18' ' ' TYR . 9.3 t80 -106.61 -25.85 11.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.283 -0.886 . . . . 0.0 110.118 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -93.36 152.7 18.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.329 -0.857 . . . . 0.0 110.165 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 -81.99 -9.02 59.7 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.173 -0.954 . . . . 0.0 110.214 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.424 ' O ' ' N ' ' A' ' 24' ' ' ASN . 13.8 tttp -105.41 -39.59 6.09 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.181 -0.949 . . . . 0.0 110.07 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.458 ' HB3' ' CE3' ' A' ' 17' ' ' TRP . 1.5 m-85 -44.65 -33.63 1.89 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.296 -0.878 . . . . 0.0 110.259 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -78.32 -28.53 47.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.278 -0.889 . . . . 0.0 110.008 -179.993 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.485 ' OD1' ' HD2' ' A' ' 28' ' ' LYS . 0.3 OUTLIER -68.98 -41.31 78.05 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.399 -0.813 . . . . 0.0 109.305 179.465 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.2 -43.04 99.73 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.377 -0.827 . . . . 0.0 110.055 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.742 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -74.56 -42.68 58.37 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.318 -0.864 . . . . 0.0 109.591 179.74 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.51 ' SG ' ' CG ' ' A' ' 6' ' ' PRO . 1.5 m -61.09 -30.78 70.55 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.293 -0.879 . . . . 0.0 109.303 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.561 ' CA ' ' HE3' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -65.43 -27.42 68.51 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.17 -0.956 . . . . 0.0 108.87 178.572 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.94 -34.52 89.13 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 107.197 -2.361 . . . . 0.0 107.197 178.393 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.533 ' O ' ' CD ' ' A' ' 50' ' ' PRO . 53.1 mt -91.01 22.03 3.9 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.763 -0.845 . . . . 0.0 109.16 178.587 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.488 ' O ' ' O ' ' A' ' 48' ' ' GLY . 0.0 OUTLIER 60.48 22.53 12.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.611 -0.681 . . . . 0.0 110.653 179.907 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.617 ' HB1' ' HB3' ' A' ' 46' ' ' CYS . . . -86.15 86.4 7.35 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.984 -1.072 . . . . 0.0 109.995 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.511 ' O ' ' NZ ' ' A' ' 28' ' ' LYS . 6.7 t70 -40.28 -86.62 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.498 -0.751 . . . . 0.0 110.597 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.9 m -69.99 93.65 0.8 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.993 -1.067 . . . . 0.0 110.058 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.544 ' CA ' ' SG ' ' A' ' 46' ' ' CYS . . . -128.72 112.77 1.45 Allowed Glycine 0 N--CA 1.487 2.099 0 C-N-CA 119.638 -1.268 . . . . 0.0 110.018 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -148.21 159.97 43.41 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.273 -1.134 . . . . 0.0 109.985 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.475 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.1 OUTLIER -93.32 146.15 23.93 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.153 -0.967 . . . . 0.0 110.684 -179.599 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.53 ' CD1' ' HB2' ' A' ' 42' ' ' LEU . 8.7 t-105 -79.55 111.06 15.45 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.238 -0.914 . . . . 0.0 109.439 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -66.2 61.25 0.16 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 -179.049 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.64 ' CD1' HG22 ' A' ' 41' ' ' THR . 14.7 t-105 -160.94 -69.67 0.06 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.329 -1.1 . . . . 0.0 109.453 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.64 HG22 ' CD1' ' A' ' 40' ' ' TRP . 11.8 t -179.91 33.42 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.586 -0.696 . . . . 0.0 109.588 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.53 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 0.3 OUTLIER -109.46 30.83 6.26 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.293 -0.88 . . . . 0.0 111.013 -179.433 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.599 ' HA ' ' HB2' ' A' ' 16' ' ' CYS . 6.1 p 48.29 -175.3 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.934 -1.104 . . . . 0.0 110.235 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.491 ' O ' ' HA ' ' A' ' 5' ' ' TYR . 14.7 t -78.55 140.47 38.51 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.259 -0.901 . . . . 0.0 109.366 179.351 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.606 ' CD1' ' CE2' ' A' ' 5' ' ' TYR . 4.7 t80 -128.94 118.77 23.18 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.053 -1.029 . . . . 0.0 110.696 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.617 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . 63.1 m -136.17 152.18 50.53 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.488 -0.758 . . . . 0.0 109.719 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.506 ' CG ' ' HB3' ' A' ' 3' ' ' ASP . 1.6 mt-30 -134.83 147.24 49.88 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.142 -0.973 . . . . 0.0 110.701 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.488 ' O ' ' O ' ' A' ' 31' ' ' LYS . . . 97.98 30.05 7.31 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.982 HD12 ' CB ' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -108.07 170.9 5.04 Favored Pre-proline 0 N--CA 1.498 1.963 0 O-C-N 121.158 -1.201 . . . . 0.0 109.77 179.66 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.533 ' CD ' ' O ' ' A' ' 30' ' ' LEU . 42.7 Cg_endo -68.93 157.85 60.25 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.692 1.364 . . . . 0.0 110.917 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -59.37 -24.02 63.06 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.379 -0.825 . . . . 0.0 110.008 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -86.46 14.18 7.17 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.335 -0.853 . . . . 0.0 109.783 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.982 ' CB ' HD12 ' A' ' 49' ' ' LEU . . . -56.86 113.69 1.77 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.459 -0.776 . . . . 0.0 110.86 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.502 ' O ' ' HA ' ' A' ' 6' ' ' PRO . 6.7 ttm-85 -59.9 116.39 4.08 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.252 -0.905 . . . . 0.0 109.645 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.69 ' O ' HD12 ' A' ' 55' ' ' ILE . 1.8 pp -140.19 178.06 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.074 -1.016 . . . . 0.0 111.004 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 55' ' ' ILE . 0.1 OUTLIER -41.81 93.74 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.529 -0.732 . . . . 0.0 110.736 -179.566 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.506 ' N ' ' O ' ' A' ' 55' ' ' ILE . 11.6 ttp180 -119.73 -18.91 8.2 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.294 -0.879 . . . . 0.0 109.782 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.32 155.9 35.96 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.367 -0.833 . . . . 0.0 110.148 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -118.13 14.71 12.31 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.424 ' O ' ' C ' ' A' ' 61' ' ' CYS . 4.6 mpt_? -99.39 98.95 9.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.431 -1.04 . . . . 0.0 110.205 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.424 ' C ' ' O ' ' A' ' 60' ' ' ARG . 4.5 t -40.05 109.76 0.12 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.507 -0.746 . . . . 0.0 110.096 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.543 ' CB ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -90.52 52.0 2.12 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.279 -0.888 . . . . 0.0 110.329 -179.808 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.437 ' HB2' ' O ' ' A' ' 62' ' ' ARG . . . . . . . . 0 N--CA 1.491 1.604 0 O-C-N 121.22 -0.925 . . . . 0.0 110.219 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 20.7 mttt . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.251 0.548 . . . . 0.0 110.235 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.477 HG12 ' N ' ' A' ' 3' ' ' ASP . 6.9 tt -134.34 165.11 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.414 -0.804 . . . . 0.0 109.943 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.477 ' N ' HG12 ' A' ' 2' ' ' ILE . 1.0 OUTLIER -135.2 128.6 32.29 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.308 -0.87 . . . . 0.0 110.107 179.895 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -167.56 -176.26 38.12 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.794 -1.323 . . . . 0.0 109.794 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.972 ' HB2' HD11 ' A' ' 15' ' ' ILE . 6.1 m-30 -99.07 109.58 54.7 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.296 -1.12 . . . . 0.0 110.407 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.569 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 48.8 Cg_endo -78.89 129.56 9.09 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.934 1.491 . . . . 0.0 110.277 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.589 HG12 ' CB ' ' A' ' 15' ' ' ILE . 30.1 m -93.46 -170.25 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.125 -0.985 . . . . 0.0 110.185 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.514 ' CB ' ' HB2' ' A' ' 13' ' ' LYS . 7.9 t70 -74.68 -89.36 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.319 -0.863 . . . . 0.0 109.792 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.657 ' CZ ' ' CH2' ' A' ' 10' ' ' TRP . 24.5 t80 -138.32 -75.11 0.39 Allowed 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.308 -0.87 . . . . 0.0 109.611 179.439 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.657 ' CH2' ' CZ ' ' A' ' 9' ' ' TYR . 0.0 OUTLIER -89.62 23.02 2.78 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.447 -0.783 . . . . 0.0 109.386 179.322 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 3.7 m120 61.18 24.17 14.3 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.83 -0.543 . . . . 0.0 110.834 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.501 ' HA ' ' HB2' ' A' ' 61' ' ' CYS . 48.3 t -93.25 -37.46 12.05 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.986 -1.071 . . . . 0.0 110.43 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.514 ' HB2' ' CB ' ' A' ' 8' ' ' ASP . 54.4 mmtt -85.08 44.1 1.06 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.282 -0.886 . . . . 0.0 109.894 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' A' ' 13' ' ' LYS . 1.3 tpp180 54.73 165.13 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.307 -0.871 . . . . 0.0 110.152 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.972 HD11 ' HB2' ' A' ' 5' ' ' TYR . 7.7 tt -84.1 1.29 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.326 -0.859 . . . . 0.0 110.423 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.595 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 33.7 t -142.44 127.19 18.12 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.268 -0.895 . . . . 0.0 110.424 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -69.22 -149.49 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.265 -0.897 . . . . 0.0 110.337 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -140.08 40.45 1.95 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.146 -0.971 . . . . 0.0 110.313 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.435 ' HB2' ' HB2' ' A' ' 22' ' ' TYR . 0.6 OUTLIER -149.25 162.72 39.46 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.328 -0.858 . . . . 0.0 109.914 179.758 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 25.1 m-20 -88.7 30.25 0.93 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.13 -0.981 . . . . 0.0 109.915 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -156.09 -39.98 0.08 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.396 -0.815 . . . . 0.0 109.764 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.435 ' HB2' ' HB2' ' A' ' 19' ' ' ASN . 0.1 OUTLIER -45.97 -27.58 0.94 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.243 -0.91 . . . . 0.0 110.008 179.769 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -100.0 -50.97 3.82 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.292 -0.88 . . . . 0.0 110.104 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.508 ' N ' ' OD1' ' A' ' 24' ' ' ASN . 1.4 m-20 -55.42 -60.07 3.93 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.376 -0.828 . . . . 0.0 109.95 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 24' ' ' ASN . 6.8 t0 -42.99 -51.54 5.6 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.223 -0.923 . . . . 0.0 110.378 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.6 mt -65.16 -42.72 93.47 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.201 -0.937 . . . . 0.0 110.46 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.498 ' SG ' ' HG3' ' A' ' 6' ' ' PRO . 2.4 m -61.18 -39.62 90.82 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.388 -0.82 . . . . 0.0 110.478 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.539 ' HD3' ' HA ' ' A' ' 33' ' ' ASP . 0.5 OUTLIER -60.82 -31.87 71.26 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.284 -0.885 . . . . 0.0 109.602 179.954 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.28 -28.27 73.38 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 107.993 -2.043 . . . . 0.0 107.993 179.114 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.54 ' O ' ' CD ' ' A' ' 50' ' ' PRO . 13.5 mt -92.42 19.52 7.11 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.691 -0.888 . . . . 0.0 109.127 178.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.527 ' HB3' ' O ' ' A' ' 30' ' ' LEU . 28.7 tptt 72.93 15.02 4.71 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.694 -0.629 . . . . 0.0 110.939 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.709 ' HB2' HD22 ' A' ' 49' ' ' LEU . . . -99.96 55.87 0.94 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.866 -1.146 . . . . 0.0 109.667 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.539 ' HA ' ' HD3' ' A' ' 28' ' ' LYS . 17.9 p30 -40.29 -30.05 0.09 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.462 -0.773 . . . . 0.0 110.649 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.5 ' N ' ' OD1' ' A' ' 33' ' ' ASP . 70.2 p -91.09 62.77 4.92 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.244 -0.91 . . . . 0.0 110.368 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.484 ' HA2' ' SG ' ' A' ' 46' ' ' CYS . . . -104.64 134.44 12.0 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.539 ' CD1' ' O ' ' A' ' 36' ' ' TYR . 29.3 p90 -160.17 129.74 5.18 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.394 -1.062 . . . . 0.0 109.39 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.524 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.0 OUTLIER -89.74 136.32 33.1 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.162 -0.961 . . . . 0.0 110.994 -179.059 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.576 ' CD1' ' HB2' ' A' ' 42' ' ' LEU . 4.6 t-105 -80.35 111.05 16.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.302 -0.874 . . . . 0.0 109.448 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -61.63 -10.96 26.87 Favored Glycine 0 N--CA 1.49 2.277 0 C-N-CA 120.434 -0.888 . . . . 0.0 110.943 -178.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.86 ' CD1' HG22 ' A' ' 41' ' ' THR . 16.7 t-105 -79.66 -78.43 0.16 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.793 -1.416 . . . . 0.0 110.249 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.86 HG22 ' CD1' ' A' ' 40' ' ' TRP . 5.8 t -173.46 38.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.27 -0.894 . . . . 0.0 109.714 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.576 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 0.3 OUTLIER -110.04 24.66 12.72 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.245 -0.909 . . . . 0.0 110.414 -179.679 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.595 ' HA ' ' HB2' ' A' ' 16' ' ' CYS . 7.7 m 54.53 -176.55 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.049 -1.032 . . . . 0.0 109.827 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.524 ' HA ' ' HA ' ' A' ' 37' ' ' CYS . 7.4 t -76.64 151.82 36.05 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.178 -0.951 . . . . 0.0 109.131 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.532 ' HB3' ' CZ ' ' A' ' 36' ' ' TYR . 0.8 OUTLIER -138.58 104.74 5.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.866 -1.146 . . . . 0.0 111.378 -179.632 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.67 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . 63.8 m -121.02 140.66 51.62 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.397 -0.814 . . . . 0.0 109.393 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.407 ' O ' ' OG ' ' A' ' 34' ' ' SER . 14.6 mt-30 -129.92 149.43 51.66 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.107 -0.996 . . . . 0.0 110.407 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 31' ' ' LYS . . . 97.62 24.84 11.49 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 1.018 HD12 ' CB ' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -103.09 172.1 4.58 Favored Pre-proline 0 N--CA 1.499 2.019 0 O-C-N 121.279 -1.13 . . . . 0.0 109.444 179.438 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.54 ' CD ' ' O ' ' A' ' 30' ' ' LEU . 41.9 Cg_endo -68.57 154.44 71.59 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 O-C-N 123.335 1.176 . . . . 0.0 110.352 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -58.28 -21.98 50.91 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.325 -0.86 . . . . 0.0 110.191 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 16.6 t30 -86.44 11.71 11.88 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.306 -0.871 . . . . 0.0 110.085 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 1.018 ' CB ' HD12 ' A' ' 49' ' ' LEU . . . -52.71 143.89 15.31 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.446 -0.783 . . . . 0.0 110.669 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.499 ' NH1' ' O ' ' A' ' 8' ' ' ASP . 1.2 ttm105 -88.54 116.72 26.98 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.365 -0.834 . . . . 0.0 109.996 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.595 HD12 ' C ' ' A' ' 55' ' ' ILE . 1.3 pp -139.24 -164.74 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.188 -0.945 . . . . 0.0 110.733 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.843 ' HG3' HD12 ' A' ' 15' ' ' ILE . 0.3 OUTLIER -36.24 96.12 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 121.371 0.605 . . . . 0.0 111.107 -179.414 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.456 ' N ' ' O ' ' A' ' 55' ' ' ILE . 8.3 ttm-85 -110.1 -20.02 12.84 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.376 -0.828 . . . . 0.0 109.762 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.8 m -166.32 162.59 17.32 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.412 -0.805 . . . . 0.0 110.056 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -114.61 45.75 1.27 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.459 ' O ' ' HB2' ' A' ' 11' ' ' ASN . 7.7 ptm180 -137.17 172.15 13.42 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.162 -1.199 . . . . 0.0 110.485 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.501 ' HB2' ' HA ' ' A' ' 12' ' ' CYS . 0.5 OUTLIER -116.7 103.26 10.18 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.402 -0.811 . . . . 0.0 109.695 179.993 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.646 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -85.53 28.77 0.73 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.888 -1.132 . . . . 0.0 110.547 179.766 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.124 -0.985 . . . . 0.0 110.283 -179.949 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 9.8 ptpt . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.221 0.534 . . . . 0.0 110.193 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.526 ' CG2' ' HG ' ' A' ' 49' ' ' LEU . 19.3 tt -131.18 160.56 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.322 -0.861 . . . . 0.0 110.056 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 3' ' ' ASP . 5.0 p-10 -134.52 127.5 31.48 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.381 -0.824 . . . . 0.0 109.654 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -177.32 -172.86 42.3 Favored Glycine 0 N--CA 1.49 2.286 0 C-N-CA 119.253 -1.451 . . . . 0.0 110.21 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.603 ' N ' ' CD1' ' A' ' 5' ' ' TYR . 3.2 m-30 -102.36 113.36 65.91 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.438 -1.036 . . . . 0.0 110.088 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.495 ' HG3' ' SG ' ' A' ' 27' ' ' CYS . 46.3 Cg_endo -75.15 142.48 27.47 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.815 1.429 . . . . 0.0 110.452 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.727 HG12 ' HA ' ' A' ' 15' ' ' ILE . 30.0 m -141.08 -170.18 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.35 -0.843 . . . . 0.0 110.149 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.502 ' HB3' ' HB3' ' A' ' 14' ' ' ARG . 21.3 p-10 -69.45 -148.29 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.234 -0.916 . . . . 0.0 109.979 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.582 ' HB3' ' CD2' ' A' ' 10' ' ' TRP . 6.3 t80 -98.82 -14.9 19.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.197 -0.939 . . . . 0.0 110.316 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.582 ' CD2' ' HB3' ' A' ' 9' ' ' TYR . 7.9 m-90 -133.32 24.04 4.12 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.227 -0.921 . . . . 0.0 110.252 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.501 ' O ' HD11 ' A' ' 15' ' ' ILE . 2.4 m-20 59.41 13.78 3.4 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.192 -0.942 . . . . 0.0 110.166 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.49 ' SG ' ' HB2' ' A' ' 10' ' ' TRP . 71.5 m -83.0 -77.17 0.25 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.299 -0.876 . . . . 0.0 110.82 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.439 ' O ' ' HB3' ' A' ' 14' ' ' ARG . 14.6 mttt -95.51 -167.83 1.68 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.368 -0.833 . . . . 0.0 111.076 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.542 ' O ' ' N ' ' A' ' 16' ' ' CYS . 16.8 tpp180 58.57 -106.0 0.28 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.48 -0.763 . . . . 0.0 110.45 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.77 HG23 ' OG ' ' A' ' 43' ' ' SER . 78.0 mt 57.19 -81.7 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.08 -1.012 . . . . 0.0 109.914 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.568 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 40.3 t -137.37 115.21 11.41 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.41 -0.806 . . . . 0.0 110.19 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -66.7 -149.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.214 -0.928 . . . . 0.0 109.939 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.57 59.25 1.55 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.122 -0.986 . . . . 0.0 110.14 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.528 ' CB ' ' HB2' ' A' ' 22' ' ' TYR . 0.2 OUTLIER -159.15 -177.86 6.79 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.276 -0.89 . . . . 0.0 110.091 179.857 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -90.74 -41.03 11.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.281 -0.887 . . . . 0.0 110.854 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.6 mtmp? -110.63 -1.12 16.95 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.132 -0.98 . . . . 0.0 110.811 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.528 ' HB2' ' CB ' ' A' ' 19' ' ' ASN . 1.2 m-85 -56.5 -52.36 65.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.057 -1.027 . . . . 0.0 109.986 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.4 t -78.03 -14.84 59.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.271 -0.893 . . . . 0.0 110.14 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.527 ' O ' ' CG ' ' A' ' 28' ' ' LYS . 33.5 t30 -76.49 -41.45 46.97 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.259 -0.901 . . . . 0.0 110.006 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.1 -40.27 89.07 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.199 -0.938 . . . . 0.0 109.766 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -74.23 -45.06 50.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.325 -0.859 . . . . 0.0 109.954 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.495 ' SG ' ' HG3' ' A' ' 6' ' ' PRO . 1.2 m -60.85 -45.03 96.12 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.339 -0.851 . . . . 0.0 109.615 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.551 ' CD ' ' HA ' ' A' ' 33' ' ' ASP . 2.2 mmmt -59.65 -31.08 69.19 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.334 -0.854 . . . . 0.0 109.323 179.084 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -56.57 -35.58 67.39 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 108.851 -1.699 . . . . 0.0 108.851 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.695 ' O ' ' CB ' ' A' ' 31' ' ' LYS . 10.5 mt -81.65 -28.91 33.38 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.387 -1.067 . . . . 0.0 109.617 179.489 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.695 ' CB ' ' O ' ' A' ' 30' ' ' LEU . 10.0 tttt 131.54 5.82 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.748 0 C-N-CA 123.528 0.731 . . . . 0.0 109.839 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.544 ' HB1' ' HB3' ' A' ' 46' ' ' CYS . . . -82.73 113.1 20.16 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.901 -1.124 . . . . 0.0 110.226 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.551 ' HA ' ' CD ' ' A' ' 28' ' ' LYS . 0.2 OUTLIER -73.66 -62.41 1.5 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.308 -0.87 . . . . 0.0 110.134 179.893 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -80.45 82.84 6.38 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.399 -0.813 . . . . 0.0 109.996 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.531 ' CA ' ' SG ' ' A' ' 46' ' ' CYS . . . -121.06 104.07 0.93 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.53 ' OH ' ' CD2' ' A' ' 45' ' ' TYR . 41.4 p90 -126.35 -177.16 3.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.178 -1.19 . . . . 0.0 109.794 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.522 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.1 OUTLIER -110.72 147.28 34.72 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.087 -1.008 . . . . 0.0 110.277 -179.916 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.592 ' CD1' ' HB2' ' A' ' 42' ' ' LEU . 15.6 t-105 -79.53 166.61 21.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.084 -1.01 . . . . 0.0 109.855 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -125.54 55.67 0.72 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.869 ' CD1' HG22 ' A' ' 41' ' ' THR . 11.6 t-105 -160.33 -69.66 0.07 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.374 -1.074 . . . . 0.0 109.335 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.869 HG22 ' CD1' ' A' ' 40' ' ' TRP . 5.1 t -179.06 32.37 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.67 -0.644 . . . . 0.0 109.883 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.592 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 0.8 OUTLIER -113.58 21.39 15.13 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.102 -0.999 . . . . 0.0 110.908 -179.433 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.77 ' OG ' HG23 ' A' ' 15' ' ' ILE . 8.2 t 57.34 -168.69 0.11 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.13 -0.981 . . . . 0.0 110.784 179.298 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.522 ' HA ' ' HA ' ' A' ' 37' ' ' CYS . 19.4 t -71.91 171.98 10.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.391 -0.818 . . . . 0.0 110.162 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.53 ' CD2' ' OH ' ' A' ' 36' ' ' TYR . 1.1 t80 -151.5 110.21 3.83 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.994 -1.066 . . . . 0.0 110.752 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.583 ' O ' HD21 ' A' ' 49' ' ' LEU . 82.9 m -125.44 137.49 53.99 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.327 -0.858 . . . . 0.0 109.824 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -119.92 131.95 55.37 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.206 -0.934 . . . . 0.0 109.931 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.598 ' N ' HD23 ' A' ' 49' ' ' LEU . . . 107.82 41.22 1.6 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.758 HD12 ' CB ' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -119.6 172.9 3.98 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.362 -1.081 . . . . 0.0 109.83 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.511 ' HD2' ' HB2' ' A' ' 49' ' ' LEU . 42.1 Cg_endo -68.32 155.22 70.05 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 O-C-N 123.677 1.356 . . . . 0.0 110.516 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -61.12 -19.95 62.08 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.359 -0.838 . . . . 0.0 110.459 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -88.62 11.87 16.23 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.208 -0.933 . . . . 0.0 110.095 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.758 ' CB ' HD12 ' A' ' 49' ' ' LEU . . . -65.27 110.38 2.57 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.24 -0.913 . . . . 0.0 110.167 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.551 ' O ' HG23 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -57.71 136.08 56.83 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.234 -0.916 . . . . 0.0 110.282 179.982 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.614 HD12 ' C ' ' A' ' 55' ' ' ILE . 1.4 pp -154.36 -169.94 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.204 -0.935 . . . . 0.0 110.319 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.427 ' O ' ' CG ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -50.07 91.1 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.315 -0.866 . . . . 0.0 110.662 -179.523 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.471 ' N ' ' O ' ' A' ' 55' ' ' ILE . 2.4 ttt85 -119.76 -5.86 10.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.204 -0.935 . . . . 0.0 110.022 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.432 ' HB2' ' CG ' ' A' ' 11' ' ' ASN . 46.3 m -120.67 -178.53 3.74 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.309 -0.87 . . . . 0.0 110.031 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -118.94 -36.86 0.85 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.401 ' O ' ' C ' ' A' ' 61' ' ' CYS . 0.3 OUTLIER -131.74 155.32 47.9 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.19 -1.183 . . . . 0.0 110.393 -179.922 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.401 ' C ' ' O ' ' A' ' 60' ' ' ARG . 43.3 t -43.79 115.4 0.8 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.285 -0.884 . . . . 0.0 110.305 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.521 ' CB ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -90.85 48.26 1.51 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.253 -0.904 . . . . 0.0 110.262 -179.975 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.678 0 O-C-N 121.272 -0.893 . . . . 0.0 110.147 179.991 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' LYS . . . . . 0.497 ' CG ' ' O ' ' A' ' 1' ' ' LYS . 2.2 tttm . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.191 0.52 . . . . 0.0 110.167 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.502 ' CG2' ' HG ' ' A' ' 49' ' ' LEU . 10.1 tt -111.15 157.45 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.239 -0.913 . . . . 0.0 110.497 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.584 ' CB ' ' CG ' ' A' ' 47' ' ' GLN . 7.1 p30 -133.21 117.28 17.24 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.733 -0.604 . . . . 0.0 109.66 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -155.45 -150.61 5.63 Favored Glycine 0 N--CA 1.491 2.353 0 C-N-CA 119.496 -1.335 . . . . 0.0 109.846 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.493 ' HA ' ' O ' ' A' ' 44' ' ' CYS . 14.1 m-85 -122.83 114.33 29.8 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.403 -1.057 . . . . 0.0 110.29 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.494 ' HG3' ' SG ' ' A' ' 27' ' ' CYS . 48.2 Cg_endo -76.04 144.8 27.33 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 124.047 1.551 . . . . 0.0 110.619 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.745 HG12 ' HA ' ' A' ' 15' ' ' ILE . 32.8 m -141.76 -171.47 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.297 -0.877 . . . . 0.0 109.894 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.544 ' N ' ' HB3' ' A' ' 14' ' ' ARG . 3.9 t0 -67.54 -176.0 0.57 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.227 -0.92 . . . . 0.0 110.175 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.494 ' HB3' ' CE2' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -76.55 -11.02 59.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.359 -0.838 . . . . 0.0 109.68 179.739 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.568 ' HB3' ' N ' ' A' ' 62' ' ' ARG . 4.0 m-90 -132.22 8.38 4.34 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.382 -0.824 . . . . 0.0 110.115 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 18.3 m-20 60.09 33.08 21.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.162 -0.961 . . . . 0.0 110.25 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.466 ' O ' ' HD3' ' A' ' 13' ' ' LYS . 5.5 t -98.12 -67.27 0.85 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.237 -0.914 . . . . 0.0 110.683 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.476 ' O ' ' HB2' ' A' ' 14' ' ' ARG . 45.2 mmtt -131.32 86.02 2.32 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.297 -0.877 . . . . 0.0 110.587 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.544 ' HB3' ' N ' ' A' ' 8' ' ' ASP . 1.0 OUTLIER 177.75 -22.88 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.488 -0.758 . . . . 0.0 111.008 179.739 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.745 ' HA ' HG12 ' A' ' 7' ' ' VAL . 6.8 tt -30.33 -45.13 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.749 -0.595 . . . . 0.0 111.203 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.581 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 43.0 t -159.18 154.3 25.21 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.226 -0.921 . . . . 0.0 109.967 179.107 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -114.84 -151.76 0.49 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.21 -0.931 . . . . 0.0 110.629 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -123.91 16.14 9.33 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.334 -0.854 . . . . 0.0 110.51 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.508 ' HB2' ' HB2' ' A' ' 22' ' ' TYR . 36.4 m-20 -119.16 148.02 43.55 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.083 -1.011 . . . . 0.0 110.395 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -88.16 26.45 1.39 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.323 -0.86 . . . . 0.0 110.165 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.4 pttm -150.29 -35.23 0.16 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.292 -0.88 . . . . 0.0 110.457 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.508 ' HB2' ' HB2' ' A' ' 19' ' ' ASN . 0.1 OUTLIER -51.51 -28.82 14.59 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -0.918 . . . . 0.0 110.691 -179.661 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.443 ' O ' ' C ' ' A' ' 24' ' ' ASN . 0.5 OUTLIER -87.18 -59.68 2.19 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.1 -1.0 . . . . 0.0 110.333 -179.905 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 35' ' ' GLY . 0.1 OUTLIER -40.72 -40.41 1.3 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.488 -0.758 . . . . 0.0 110.001 179.879 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.99 -47.69 80.21 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.315 -0.866 . . . . 0.0 110.311 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.8 mt -74.84 -37.92 62.12 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.192 -0.942 . . . . 0.0 110.046 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.494 ' SG ' ' HG3' ' A' ' 6' ' ' PRO . 15.2 m -58.38 -39.68 80.26 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.161 -0.962 . . . . 0.0 109.473 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.87 -29.9 68.62 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.329 -0.857 . . . . 0.0 109.37 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.2 -37.35 92.82 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 108.311 -1.916 . . . . 0.0 108.311 179.037 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.509 ' O ' ' CB ' ' A' ' 31' ' ' LYS . 39.5 mt -89.02 19.39 4.2 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.462 -1.022 . . . . 0.0 109.524 179.053 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.509 ' CB ' ' O ' ' A' ' 30' ' ' LEU . 0.3 OUTLIER 73.18 16.22 4.27 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.657 -0.652 . . . . 0.0 110.809 179.912 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.69 ' HB2' HD22 ' A' ' 49' ' ' LEU . . . -95.65 89.7 5.43 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.957 -1.089 . . . . 0.0 109.797 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -55.31 -75.15 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.22 -0.925 . . . . 0.0 111.018 -179.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.5 ' O ' ' HA ' ' A' ' 46' ' ' CYS . 8.6 t -62.34 95.42 0.07 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.389 -0.82 . . . . 0.0 110.912 -179.283 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.487 ' HA2' ' SG ' ' A' ' 46' ' ' CYS . . . -123.06 110.87 1.6 Allowed Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.585 ' CD1' ' O ' ' A' ' 36' ' ' TYR . 13.1 p90 -138.99 144.25 38.84 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.388 -1.066 . . . . 0.0 109.738 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.512 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.0 OUTLIER -90.97 154.56 19.36 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.038 -1.039 . . . . 0.0 110.832 -179.359 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.452 ' CG ' ' HB2' ' A' ' 42' ' ' LEU . 18.5 t-105 -79.95 -172.03 3.19 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.271 -0.893 . . . . 0.0 109.936 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -119.55 -29.3 1.76 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.911 ' CD1' HG22 ' A' ' 41' ' ' THR . 12.8 t-105 -79.38 -83.1 0.1 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.233 -1.157 . . . . 0.0 109.986 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.911 HG22 ' CD1' ' A' ' 40' ' ' TRP . 5.3 t -166.41 48.42 0.07 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.347 -0.845 . . . . 0.0 109.707 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.452 ' HB2' ' CG ' ' A' ' 38' ' ' TRP . 8.0 mp -106.9 23.49 14.28 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.312 -0.868 . . . . 0.0 110.745 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.581 ' HA ' ' HB2' ' A' ' 16' ' ' CYS . 5.1 m 58.48 -166.93 0.15 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 120.935 -1.103 . . . . 0.0 110.027 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.512 ' HA ' ' HA ' ' A' ' 37' ' ' CYS . 9.3 t -83.68 156.27 22.73 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.34 -0.85 . . . . 0.0 108.88 178.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.458 ' HB3' ' CE1' ' A' ' 36' ' ' TYR . 0.8 OUTLIER -128.72 116.95 20.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.96 -1.088 . . . . 0.0 110.354 -179.629 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.649 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . 74.0 m -137.52 137.45 38.65 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.353 -0.842 . . . . 0.0 109.848 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.584 ' CG ' ' CB ' ' A' ' 3' ' ' ASP . 1.7 mp0 -123.78 154.63 39.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.273 -0.892 . . . . 0.0 110.431 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.489 ' O ' ' O ' ' A' ' 31' ' ' LYS . . . 99.73 15.46 31.55 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 1.044 HD12 ' CB ' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -98.66 170.35 7.09 Favored Pre-proline 0 N--CA 1.497 1.891 0 O-C-N 121.133 -1.216 . . . . 0.0 109.723 179.669 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.552 ' HD2' ' HB2' ' A' ' 49' ' ' LEU . 43.3 Cg_endo -70.61 156.46 61.07 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 123.515 1.271 . . . . 0.0 110.706 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -58.99 -24.85 63.1 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.334 -0.854 . . . . 0.0 110.01 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -85.79 14.18 6.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.373 -0.829 . . . . 0.0 109.806 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 1.044 ' CB ' HD12 ' A' ' 49' ' ' LEU . . . -56.25 152.15 11.46 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.449 -0.782 . . . . 0.0 110.381 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.465 ' O ' ' HA ' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -92.19 110.48 21.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.309 -0.87 . . . . 0.0 109.536 179.476 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.828 HD13 ' N ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -148.65 -164.62 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.256 -0.903 . . . . 0.0 110.647 -179.384 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' A' ' 55' ' ' ILE . 0.1 OUTLIER -40.45 108.63 0.09 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.573 -0.705 . . . . 0.0 110.54 -179.816 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.456 ' HG2' ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -136.43 20.68 3.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.381 -0.824 . . . . 0.0 109.872 179.807 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.451 ' CB ' ' O ' ' A' ' 57' ' ' ARG . 0.5 OUTLIER 66.86 153.49 0.08 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.408 -0.807 . . . . 0.0 110.161 -179.969 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 128.73 101.57 1.03 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.709 -1.357 . . . . 0.0 109.709 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.436 ' O ' ' C ' ' A' ' 61' ' ' CYS . 1.6 mmt180 -70.13 94.85 0.92 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.257 -1.143 . . . . 0.0 109.965 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.436 ' C ' ' O ' ' A' ' 60' ' ' ARG . 41.8 t 42.54 88.95 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 0.0 109.967 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.687 ' O ' ' HB3' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -83.11 26.48 0.62 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.357 -0.84 . . . . 0.0 110.844 -179.905 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.687 ' HB3' ' O ' ' A' ' 62' ' ' ARG . . . . . . . . 0 N--CA 1.492 1.644 0 O-C-N 121.01 -1.056 . . . . 0.0 110.244 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 5.4 mtmm . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.21 0.528 . . . . 0.0 110.152 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.887 HG22 ' O ' ' A' ' 49' ' ' LEU . 6.0 tt -133.09 154.72 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.202 -0.936 . . . . 0.0 110.418 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -124.88 128.6 48.9 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.345 -0.847 . . . . 0.0 109.983 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -168.19 -166.07 26.64 Favored Glycine 0 N--CA 1.491 2.347 0 C-N-CA 119.554 -1.307 . . . . 0.0 110.114 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.592 ' N ' ' CD1' ' A' ' 5' ' ' TYR . 13.7 m-85 -111.05 104.3 56.01 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.318 -1.107 . . . . 0.0 109.656 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.736 ' CA ' HG22 ' A' ' 55' ' ' ILE . 50.1 Cg_endo -76.98 111.44 3.23 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 123.948 1.499 . . . . 0.0 111.281 -179.057 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.602 HG12 ' HB ' ' A' ' 15' ' ' ILE . 15.8 m -83.4 -169.99 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.231 -0.918 . . . . 0.0 109.877 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.57 ' CB ' ' HB2' ' A' ' 13' ' ' LYS . 11.8 p-10 -71.9 -134.77 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.287 -0.883 . . . . 0.0 109.852 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.586 ' HB3' ' CD2' ' A' ' 10' ' ' TRP . 0.2 OUTLIER -92.43 -63.26 1.25 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.035 -1.041 . . . . 0.0 110.397 -179.871 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.586 ' CD2' ' HB3' ' A' ' 9' ' ' TYR . 2.8 m-90 -107.11 26.79 9.71 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.134 -0.979 . . . . 0.0 110.125 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.5 ' HA ' ' OD1' ' A' ' 8' ' ' ASP . 1.3 m-20 67.31 5.83 4.48 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.134 -0.979 . . . . 0.0 109.853 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.454 ' O ' ' C ' ' A' ' 13' ' ' LYS . 89.2 m -83.86 -66.1 0.93 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.277 -0.889 . . . . 0.0 110.733 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.57 ' HB2' ' CB ' ' A' ' 8' ' ' ASP . 6.8 mmmt -37.95 -85.68 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.726 -0.609 . . . . 0.0 110.843 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 4.6 ttm180 -165.33 109.02 0.85 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.002 -1.061 . . . . 0.0 110.673 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.602 ' HB ' HG12 ' A' ' 7' ' ' VAL . 46.3 pt -48.77 -24.24 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.139 -0.975 . . . . 0.0 109.348 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.555 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 34.4 t -150.15 126.39 10.69 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.714 -0.616 . . . . 0.0 109.865 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.652 ' CE3' ' CD2' ' A' ' 22' ' ' TYR . 0.0 OUTLIER -85.36 -162.05 0.67 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.184 -0.948 . . . . 0.0 110.197 -179.901 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -101.72 -54.74 2.67 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.328 -0.857 . . . . 0.0 110.181 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -60.66 113.86 2.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.449 -0.782 . . . . 0.0 110.29 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 29.4 p30 -59.65 -15.22 17.7 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.354 -0.841 . . . . 0.0 110.329 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.416 ' HG3' ' N ' ' A' ' 22' ' ' TYR . 8.2 pttp -92.98 -27.89 16.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.203 -0.936 . . . . 0.0 110.293 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.652 ' CD2' ' CE3' ' A' ' 17' ' ' TRP . 45.3 t80 -60.63 -47.9 84.18 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.245 -0.909 . . . . 0.0 110.046 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -64.6 -40.44 95.53 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.334 -0.854 . . . . 0.0 110.174 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -57.59 -35.44 70.41 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.226 -0.921 . . . . 0.0 110.133 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -58.72 -57.52 12.62 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.241 -0.912 . . . . 0.0 110.015 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.87 -39.01 93.1 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.274 -0.891 . . . . 0.0 110.149 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.489 ' SG ' ' HG3' ' A' ' 6' ' ' PRO . 11.4 m -62.65 -37.19 85.38 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.223 -0.923 . . . . 0.0 109.877 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.88 -29.4 70.58 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.181 -0.949 . . . . 0.0 109.368 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.78 -27.34 69.88 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 107.438 -2.265 . . . . 0.0 107.438 178.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.537 ' O ' ' HD3' ' A' ' 50' ' ' PRO . 9.9 mt -96.3 19.41 11.99 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.879 -0.777 . . . . 0.0 109.051 178.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.508 ' CB ' ' O ' ' A' ' 30' ' ' LEU . 0.7 OUTLIER 71.47 10.92 6.6 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.468 -0.77 . . . . 0.0 110.985 179.684 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.809 ' HB2' HD22 ' A' ' 49' ' ' LEU . . . -85.3 103.46 14.25 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.833 -1.167 . . . . 0.0 109.983 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.441 ' N ' ' OD1' ' A' ' 33' ' ' ASP . 4.4 m-20 -61.25 -80.25 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.407 -0.808 . . . . 0.0 110.885 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.492 ' O ' ' HA ' ' A' ' 46' ' ' CYS . 60.3 p -66.26 94.04 0.24 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.234 -0.916 . . . . 0.0 110.348 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.442 ' HA2' ' SG ' ' A' ' 46' ' ' CYS . . . -116.75 84.5 0.37 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.421 ' C ' ' CD1' ' A' ' 36' ' ' TYR . 31.5 p90 -114.88 151.49 33.87 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.203 -1.175 . . . . 0.0 109.841 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.562 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.1 OUTLIER -95.62 155.3 16.8 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.118 -0.989 . . . . 0.0 110.505 -179.642 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.594 ' CD1' ' HB3' ' A' ' 40' ' ' TRP . 27.6 t-105 -79.52 168.15 19.82 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.188 -0.945 . . . . 0.0 109.613 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -106.66 -26.42 5.87 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.594 ' HB3' ' CD1' ' A' ' 38' ' ' TRP . 53.8 t-105 -79.61 -92.02 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.26 -1.141 . . . . 0.0 109.726 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.585 HG23 ' C ' ' A' ' 40' ' ' TRP . 70.7 p -158.07 46.37 0.35 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.357 -0.84 . . . . 0.0 109.857 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.587 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 1.1 mt -110.92 30.92 6.42 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.14 -0.975 . . . . 0.0 110.686 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.555 ' HA ' ' HB2' ' A' ' 16' ' ' CYS . 3.2 t 54.85 -172.68 0.05 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.201 -0.937 . . . . 0.0 110.386 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.562 ' HA ' ' HA ' ' A' ' 37' ' ' CYS . 17.5 t -78.77 166.63 22.24 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.335 -0.853 . . . . 0.0 109.814 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.573 ' HE2' ' HH ' ' A' ' 5' ' ' TYR . 0.8 OUTLIER -139.82 120.08 13.85 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.243 -0.911 . . . . 0.0 110.488 -179.613 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.676 ' O ' HD21 ' A' ' 49' ' ' LEU . 80.5 m -136.07 135.19 39.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.121 -0.987 . . . . 0.0 109.697 179.199 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -115.53 142.94 46.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.353 -0.842 . . . . 0.0 110.205 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 31' ' ' LYS . . . 99.9 31.91 5.82 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.887 ' O ' HG22 ' A' ' 2' ' ' ILE . 0.1 OUTLIER -103.49 176.3 1.86 Allowed Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.052 -1.263 . . . . 0.0 109.327 179.38 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.787 ' O ' HG21 ' A' ' 2' ' ' ILE . 47.2 Cg_endo -70.56 155.93 62.3 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 123.692 1.364 . . . . 0.0 110.24 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -59.7 -19.03 47.09 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.052 -1.03 . . . . 0.0 109.597 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -102.31 24.71 9.87 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.395 -0.815 . . . . 0.0 109.472 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.672 ' HB2' ' HB2' ' A' ' 49' ' ' LEU . . . -64.22 123.14 18.34 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.355 -0.841 . . . . 0.0 110.509 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.525 ' CZ ' ' O ' ' A' ' 9' ' ' TYR . 0.1 OUTLIER -68.64 112.31 5.32 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.217 -0.927 . . . . 0.0 110.278 179.834 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 1.07 ' O ' HD12 ' A' ' 55' ' ' ILE . 2.5 pp -143.68 128.07 14.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.44 -0.788 . . . . 0.0 110.589 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.504 ' HE3' HG11 ' A' ' 7' ' ' VAL . 0.0 OUTLIER 29.17 52.67 0.08 Allowed 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 121.227 0.537 . . . . 0.0 111.689 179.862 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.436 ' HD3' ' HG2' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -128.62 7.98 5.8 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.231 -0.918 . . . . 0.0 110.196 179.479 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.478 ' HB3' ' HB2' ' A' ' 11' ' ' ASN . 0.4 OUTLIER -92.32 151.92 20.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.32 -0.862 . . . . 0.0 110.114 179.87 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.15 -136.54 1.26 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.44 ' O ' ' O ' ' A' ' 61' ' ' CYS . 25.4 mmt85 -88.16 92.41 9.14 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.172 -1.193 . . . . 0.0 110.271 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 10' ' ' TRP . 0.0 OUTLIER 52.74 101.79 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.241 -0.912 . . . . 0.0 110.137 179.935 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.515 ' CB ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -82.32 46.77 1.07 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.243 -0.911 . . . . 0.0 110.293 -179.875 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.252 -0.905 . . . . 0.0 110.261 179.964 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' LYS . . . . . 0.436 ' O ' ' HG3' ' A' ' 1' ' ' LYS . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.308 0.575 . . . . 0.0 110.163 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.527 ' CG2' ' HG ' ' A' ' 49' ' ' LEU . 15.9 tt -133.62 166.31 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.242 -0.912 . . . . 0.0 109.991 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -142.24 138.11 31.2 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.297 -0.877 . . . . 0.0 110.011 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 176.78 -148.67 9.13 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.549 ' N ' ' CD1' ' A' ' 5' ' ' TYR . 18.2 m-85 -123.61 117.61 27.6 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.285 -1.127 . . . . 0.0 110.321 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.609 ' CA ' HG22 ' A' ' 55' ' ' ILE . 45.5 Cg_endo -74.03 134.18 19.2 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.923 1.486 . . . . 0.0 110.159 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.714 HG12 ' HA ' ' A' ' 15' ' ' ILE . 27.2 m -136.99 -168.79 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.142 -0.974 . . . . 0.0 110.475 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.562 ' CB ' ' HB3' ' A' ' 14' ' ' ARG . 0.7 OUTLIER -80.13 172.28 13.98 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.342 -0.849 . . . . 0.0 110.383 -179.821 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.593 ' HB3' ' CE2' ' A' ' 10' ' ' TRP . 0.4 OUTLIER -62.34 -19.56 63.48 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.306 -0.871 . . . . 0.0 109.817 179.706 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.593 ' CE2' ' HB3' ' A' ' 9' ' ' TYR . 2.9 m-90 -131.23 12.87 5.1 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.333 -0.854 . . . . 0.0 110.15 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.611 ' OD1' HG21 ' A' ' 7' ' ' VAL . 88.6 m-20 56.5 35.44 26.01 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.129 -0.982 . . . . 0.0 109.375 -179.289 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.437 ' SG ' ' HB2' ' A' ' 10' ' ' TRP . 34.8 m -90.74 -53.2 4.51 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.481 -0.762 . . . . 0.0 111.642 -179.086 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.489 ' O ' ' O ' ' A' ' 14' ' ' ARG . 1.2 mppt? -125.21 -56.41 1.54 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.059 -1.026 . . . . 0.0 111.885 -178.518 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.562 ' HB3' ' CB ' ' A' ' 8' ' ' ASP . 14.6 tpp180 -36.76 -96.02 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.371 -0.831 . . . . 0.0 111.064 -178.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.714 ' HA ' HG12 ' A' ' 7' ' ' VAL . 72.0 mt 50.4 -88.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 120.954 -1.092 . . . . 0.0 110.515 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.62 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 1.6 t -135.13 134.4 40.18 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.371 -0.831 . . . . 0.0 109.714 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.425 ' O ' ' SG ' ' A' ' 37' ' ' CYS . 0.0 OUTLIER -88.62 -156.52 0.38 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.165 -0.959 . . . . 0.0 110.631 -179.654 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -107.25 -32.32 7.84 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.224 -0.923 . . . . 0.0 110.161 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -87.45 153.52 21.36 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.289 -0.882 . . . . 0.0 110.136 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -86.24 -17.55 34.45 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.179 -0.951 . . . . 0.0 109.997 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.7 ttpp -96.15 -10.56 27.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.284 -0.885 . . . . 0.0 109.992 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -69.39 -58.75 3.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.248 -0.908 . . . . 0.0 110.094 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -65.62 -28.17 68.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.311 -0.868 . . . . 0.0 110.096 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.496 ' O ' ' HG2' ' A' ' 28' ' ' LYS . 63.6 t30 -69.07 -40.43 78.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.344 -0.848 . . . . 0.0 109.918 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.57 -46.15 87.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.156 -0.965 . . . . 0.0 110.007 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.1 mt -74.27 -42.69 59.21 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.319 -0.863 . . . . 0.0 109.946 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.479 ' SG ' ' HG3' ' A' ' 6' ' ' PRO . 5.7 m -58.95 -39.39 81.53 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.219 -0.926 . . . . 0.0 109.547 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.496 ' HG2' ' O ' ' A' ' 24' ' ' ASN . 2.6 mmmt -60.83 -28.18 68.62 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.196 -0.94 . . . . 0.0 109.443 179.169 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.12 -35.35 90.69 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 107.677 -2.169 . . . . 0.0 107.677 178.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.547 ' O ' ' HD3' ' A' ' 50' ' ' PRO . 13.6 mt -91.38 21.94 4.21 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.701 -0.882 . . . . 0.0 109.117 178.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.474 ' O ' ' O ' ' A' ' 48' ' ' GLY . 0.7 OUTLIER 67.72 15.43 9.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.426 -0.796 . . . . 0.0 110.95 179.868 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.701 ' HB1' ' HB3' ' A' ' 46' ' ' CYS . . . -83.99 89.44 7.25 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.859 -1.151 . . . . 0.0 109.582 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.402 ' HA ' ' HD3' ' A' ' 28' ' ' LYS . 0.2 OUTLIER -48.03 -83.68 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.322 -0.862 . . . . 0.0 111.195 -179.213 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.509 ' O ' ' HA ' ' A' ' 46' ' ' CYS . 10.0 m -68.97 92.11 0.5 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.296 -0.878 . . . . 0.0 110.5 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.519 ' CA ' ' SG ' ' A' ' 46' ' ' CYS . . . -127.03 97.41 0.48 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.41 ' O ' ' SG ' ' A' ' 44' ' ' CYS . 40.6 p90 -119.73 -169.41 1.76 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.235 -1.156 . . . . 0.0 110.658 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 34.4 t -128.12 127.7 43.5 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.363 -0.836 . . . . 0.0 110.268 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.608 ' CD1' ' HB3' ' A' ' 40' ' ' TRP . 28.0 t-105 -79.77 147.25 31.92 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.994 -1.067 . . . . 0.0 110.054 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -110.91 61.11 0.31 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.967 ' CD1' HG22 ' A' ' 41' ' ' THR . 14.2 t-105 -160.31 -70.38 0.07 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.235 -1.156 . . . . 0.0 110.056 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.967 HG22 ' CD1' ' A' ' 40' ' ' TRP . 7.0 t -171.47 34.99 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.443 -0.786 . . . . 0.0 110.178 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.581 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 12.5 mt -119.69 10.29 11.66 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.261 -0.899 . . . . 0.0 110.358 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.62 ' HA ' ' HB2' ' A' ' 16' ' ' CYS . 50.7 m 54.46 -170.52 0.06 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.236 -0.915 . . . . 0.0 110.317 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 15' ' ' ILE . 43.0 t -74.18 155.31 38.5 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.195 -0.941 . . . . 0.0 109.247 179.266 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.41 ' HB3' ' CZ ' ' A' ' 36' ' ' TYR . 1.0 OUTLIER -137.06 112.56 9.32 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.873 -1.142 . . . . 0.0 111.123 -179.35 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.701 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . 68.1 m -128.8 143.86 51.02 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.296 -0.877 . . . . 0.0 109.837 178.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -126.61 145.68 50.46 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.217 -0.927 . . . . 0.0 110.159 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.476 ' N ' HD23 ' A' ' 49' ' ' LEU . . . 95.56 33.87 6.28 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.987 HD12 ' CB ' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -109.14 171.27 4.59 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.275 -1.133 . . . . 0.0 109.741 179.738 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.547 ' HD3' ' O ' ' A' ' 30' ' ' LEU . 42.4 Cg_endo -69.45 158.68 56.47 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.51 1.269 . . . . 0.0 110.774 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -62.0 -15.33 43.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.333 -0.855 . . . . 0.0 109.885 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -96.59 16.14 19.69 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.344 -0.848 . . . . 0.0 109.819 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.987 ' CB ' HD12 ' A' ' 49' ' ' LEU . . . -60.46 127.88 33.9 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.386 -0.821 . . . . 0.0 110.528 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.508 ' O ' ' HA ' ' A' ' 6' ' ' PRO . 0.5 OUTLIER -71.32 99.53 1.96 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.284 -0.885 . . . . 0.0 109.887 179.742 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.721 HD12 ' C ' ' A' ' 55' ' ' ILE . 2.3 pp -137.4 -160.81 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.181 -0.949 . . . . 0.0 110.463 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.476 ' C ' ' O ' ' A' ' 55' ' ' ILE . 12.8 mttt -29.68 96.8 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 121.382 0.61 . . . . 0.0 111.567 -179.312 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.437 ' O ' ' CB ' ' A' ' 58' ' ' SER . 0.3 OUTLIER -111.3 0.36 16.67 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.41 -0.806 . . . . 0.0 110.038 179.555 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.437 ' CB ' ' O ' ' A' ' 57' ' ' ARG . 0.4 OUTLIER 66.55 172.9 0.25 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.422 -0.799 . . . . 0.0 110.287 -179.985 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 60' ' ' ARG . . . 86.42 108.75 0.8 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.469 ' O ' ' N ' ' A' ' 62' ' ' ARG . 8.9 mmm-85 -49.36 -179.69 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.283 -1.128 . . . . 0.0 110.302 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.495 ' HA ' ' O ' ' A' ' 10' ' ' TRP . 16.3 t -43.4 96.51 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.248 -0.908 . . . . 0.0 110.149 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.54 ' CA ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -82.76 46.1 1.05 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.166 -0.959 . . . . 0.0 110.244 179.926 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.196 -0.94 . . . . 0.0 110.12 -179.985 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 1.4 mtpp . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.205 0.526 . . . . 0.0 110.269 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.537 HG22 ' O ' ' A' ' 49' ' ' LEU . 7.1 tt -132.94 161.8 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.324 -0.86 . . . . 0.0 110.264 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.463 ' OD1' ' HB3' ' A' ' 47' ' ' GLN . 4.5 m-20 -128.4 129.53 46.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.341 -0.85 . . . . 0.0 109.66 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -169.06 -170.03 33.16 Favored Glycine 0 N--CA 1.494 2.526 0 C-N-CA 119.372 -1.394 . . . . 0.0 110.259 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.557 ' N ' ' CD1' ' A' ' 5' ' ' TYR . 6.8 m-85 -107.69 102.4 44.74 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.431 -1.041 . . . . 0.0 110.485 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.59 138.17 26.31 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 124.004 1.528 . . . . 0.0 110.425 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 1.074 HG12 HG23 ' A' ' 15' ' ' ILE . 21.4 m -120.47 -168.97 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.239 -0.913 . . . . 0.0 110.449 -179.571 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.557 ' HB2' ' CB ' ' A' ' 13' ' ' LYS . 8.3 p-10 -66.94 -150.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.352 -0.843 . . . . 0.0 110.283 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.617 ' HB3' ' CD2' ' A' ' 10' ' ' TRP . 0.2 OUTLIER -87.13 -33.93 19.26 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.191 -0.943 . . . . 0.0 110.382 -179.861 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.617 ' CD2' ' HB3' ' A' ' 9' ' ' TYR . 8.7 m-90 -129.23 34.36 4.41 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.001 -1.062 . . . . 0.0 110.367 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.506 ' CA ' ' OD1' ' A' ' 8' ' ' ASP . 62.8 m-80 57.17 16.48 3.01 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.125 -0.984 . . . . 0.0 110.297 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.46 ' HB2' ' HA ' ' A' ' 61' ' ' CYS . 2.0 t -109.9 -44.19 3.86 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.208 -0.933 . . . . 0.0 110.488 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.557 ' CB ' ' HB2' ' A' ' 8' ' ' ASP . 0.0 OUTLIER -69.96 58.32 0.15 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.295 -0.878 . . . . 0.0 110.447 -179.733 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.457 ' HB2' ' O ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER 59.34 122.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.322 -0.861 . . . . 0.0 110.903 179.722 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 1.074 HG23 HG12 ' A' ' 7' ' ' VAL . 1.3 mp -79.34 -12.81 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-O 121.747 0.784 . . . . 0.0 109.36 179.331 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.517 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 1.5 t -146.55 158.05 43.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.458 -0.776 . . . . 0.0 109.263 179.35 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.549 ' CE2' ' CD1' ' A' ' 22' ' ' TYR . 0.0 OUTLIER -104.72 165.77 10.84 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.896 -1.128 . . . . 0.0 110.996 -179.511 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -81.17 -32.26 33.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.068 -1.02 . . . . 0.0 110.266 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -96.2 114.21 25.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.301 -0.874 . . . . 0.0 110.356 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -47.17 -27.98 1.65 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.391 -0.818 . . . . 0.0 110.348 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 29.7 tttm -76.19 -33.14 59.3 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.18 -0.95 . . . . 0.0 110.378 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.549 ' CD1' ' CE2' ' A' ' 17' ' ' TRP . 0.3 OUTLIER -55.12 -41.92 72.31 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.191 -0.943 . . . . 0.0 110.11 179.94 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.29 -52.99 7.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.222 -0.924 . . . . 0.0 110.248 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 35' ' ' GLY . 28.0 t-20 -48.19 -41.2 26.44 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.243 -0.911 . . . . 0.0 110.44 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -57.2 -52.49 65.12 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.263 -0.898 . . . . 0.0 110.556 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.468 HD13 ' CZ3' ' A' ' 17' ' ' TRP . 0.2 OUTLIER -71.41 -34.25 70.18 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.152 -0.968 . . . . 0.0 110.428 -179.753 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.446 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 9.4 m -62.87 -45.69 91.38 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.084 -1.01 . . . . 0.0 109.788 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.94 -27.72 63.64 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.576 -0.85 . . . . 0.0 109.372 179.523 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.31 -37.99 93.93 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 108.352 -1.899 . . . . 0.0 108.352 179.214 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.538 ' O ' ' CB ' ' A' ' 31' ' ' LYS . 16.0 mt -90.6 21.18 4.12 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.54 -0.976 . . . . 0.0 109.342 179.099 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.538 ' CB ' ' O ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER 74.26 12.92 3.98 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.743 -0.598 . . . . 0.0 110.736 179.899 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.665 ' CB ' HD22 ' A' ' 49' ' ' LEU . . . -87.32 85.68 7.19 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.843 -1.16 . . . . 0.0 109.829 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -49.5 -87.57 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.414 -0.804 . . . . 0.0 111.186 -179.287 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.421 ' O ' ' HA ' ' A' ' 46' ' ' CYS . 82.8 p -60.89 96.16 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.303 -0.873 . . . . 0.0 110.73 -179.175 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.505 ' CA ' ' SG ' ' A' ' 46' ' ' CYS . . . -132.11 123.06 3.5 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.595 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 4.3 p90 -143.98 -174.91 4.4 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.173 -1.193 . . . . 0.0 109.76 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.512 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 26.3 t -124.55 138.0 54.36 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.966 -1.084 . . . . 0.0 110.961 -179.364 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.602 ' CD1' ' HB2' ' A' ' 42' ' ' LEU . 21.2 t-105 -88.25 99.43 12.22 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.171 -0.955 . . . . 0.0 109.653 179.276 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -69.36 70.3 0.49 Allowed Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.689 ' CD1' HG22 ' A' ' 41' ' ' THR . 7.5 t-105 -160.53 -65.28 0.07 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.317 -1.107 . . . . 0.0 109.648 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.689 HG22 ' CD1' ' A' ' 40' ' ' TRP . 1.7 t 175.34 36.1 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.564 -0.71 . . . . 0.0 109.885 179.357 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.602 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 1.0 OUTLIER -124.52 18.75 8.84 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.291 -0.881 . . . . 0.0 110.573 -179.781 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.58 ' CB ' ' CG2' ' A' ' 15' ' ' ILE . 28.8 t 56.22 -177.54 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.193 -0.942 . . . . 0.0 110.764 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.512 ' HA ' ' HA ' ' A' ' 37' ' ' CYS . 15.8 t -70.62 173.21 7.4 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.307 -0.871 . . . . 0.0 109.334 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -154.66 106.27 2.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.945 -1.097 . . . . 0.0 110.528 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.739 ' O ' HD21 ' A' ' 49' ' ' LEU . 75.2 m -127.21 137.8 52.98 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.389 -0.819 . . . . 0.0 109.736 179.442 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.463 ' HB3' ' OD1' ' A' ' 3' ' ' ASP . 16.9 mt-30 -116.66 130.83 56.97 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.152 -0.967 . . . . 0.0 109.966 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.505 ' O ' ' O ' ' A' ' 31' ' ' LYS . . . 117.88 24.38 3.36 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.944 HD12 ' CB ' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -104.04 173.42 3.4 Favored Pre-proline 0 N--CA 1.498 1.925 0 O-C-N 121.077 -1.249 . . . . 0.0 109.513 179.591 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.528 ' HD2' ' HB2' ' A' ' 49' ' ' LEU . 41.5 Cg_endo -68.87 156.86 64.05 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.443 1.233 . . . . 0.0 110.559 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -59.2 -21.58 59.69 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.259 -0.9 . . . . 0.0 110.222 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -90.48 14.03 14.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.376 -0.827 . . . . 0.0 109.987 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.944 ' CB ' HD12 ' A' ' 49' ' ' LEU . . . -57.94 125.51 23.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.291 -0.881 . . . . 0.0 110.153 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.594 ' CB ' ' CZ ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -64.71 140.52 58.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.098 -1.001 . . . . 0.0 109.957 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.579 HG22 ' N ' ' A' ' 56' ' ' LYS . 26.3 mm -141.02 175.33 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.19 -0.943 . . . . 0.0 110.415 -179.301 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.855 ' HG2' HG11 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -60.82 82.82 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.332 -0.855 . . . . 0.0 110.074 179.486 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.442 ' N ' ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -95.56 20.81 9.06 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.1 -1.0 . . . . 0.0 110.356 -179.964 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.42 ' HB3' ' O ' ' A' ' 57' ' ' ARG . 4.7 t 63.24 -169.13 0.19 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.289 -0.882 . . . . 0.0 110.375 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 60' ' ' ARG . . . 121.03 -5.46 11.21 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.465 ' O ' ' O ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER 41.95 80.91 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.232 -1.158 . . . . 0.0 110.572 179.751 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.465 ' O ' ' O ' ' A' ' 60' ' ' ARG . 27.2 m 48.44 100.39 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.347 -0.846 . . . . 0.0 110.619 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.53 ' CB ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -89.75 44.26 1.2 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.241 -0.912 . . . . 0.0 110.095 179.699 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.235 -0.916 . . . . 0.0 110.181 -179.86 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 10.3 ttmt . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.25 0.548 . . . . 0.0 110.221 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.671 HG22 ' O ' ' A' ' 49' ' ' LEU . 18.6 tt -127.58 158.77 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.134 -0.979 . . . . 0.0 110.285 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.512 ' HB2' ' HG3' ' A' ' 47' ' ' GLN . 2.5 p30 -133.37 139.28 46.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.366 -0.834 . . . . 0.0 110.102 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.475 ' C ' ' CD1' ' A' ' 5' ' ' TYR . . . 174.18 -164.53 35.76 Favored Glycine 0 N--CA 1.492 2.373 0 C-N-CA 119.685 -1.245 . . . . 0.0 110.057 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.581 ' N ' ' CD1' ' A' ' 5' ' ' TYR . 1.2 m-85 -112.62 98.58 44.81 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.25 -1.147 . . . . 0.0 110.51 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.506 ' HD2' ' O ' ' A' ' 44' ' ' CYS . 44.8 Cg_endo -72.94 116.75 4.84 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.928 1.489 . . . . 0.0 110.557 179.526 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 1.035 HG12 HG23 ' A' ' 15' ' ' ILE . 21.3 m -79.97 -177.22 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.492 -0.755 . . . . 0.0 110.078 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.473 ' O ' ' NE ' ' A' ' 54' ' ' ARG . 77.5 m-20 -61.72 -96.67 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.131 -0.98 . . . . 0.0 110.114 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.499 ' HB3' ' CE3' ' A' ' 10' ' ' TRP . 0.2 OUTLIER -131.94 -59.02 0.95 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.102 -0.999 . . . . 0.0 109.594 179.63 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.499 ' CE3' ' HB3' ' A' ' 9' ' ' TYR . 13.8 m-90 -106.99 17.13 23.46 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.468 -0.77 . . . . 0.0 109.46 179.295 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.517 ' N ' ' OD1' ' A' ' 11' ' ' ASN . 1.3 m-20 60.67 11.7 3.26 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.353 -0.842 . . . . 0.0 110.302 -179.607 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 63.5 m -60.38 -60.25 4.12 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.12 -0.988 . . . . 0.0 110.518 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.44 ' O ' ' CG ' ' A' ' 14' ' ' ARG . 0.8 OUTLIER -63.61 -63.49 1.16 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.365 -0.834 . . . . 0.0 110.325 -179.792 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.44 ' CG ' ' O ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER 173.1 176.78 0.1 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.276 -0.89 . . . . 0.0 110.423 179.977 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 1.035 HG23 HG12 ' A' ' 7' ' ' VAL . 1.0 OUTLIER -77.68 -15.25 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.297 -0.877 . . . . 0.0 109.452 179.813 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.608 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 10.9 t -141.49 157.99 44.43 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.413 -0.804 . . . . 0.0 109.872 179.068 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.478 ' CE3' ' CG ' ' A' ' 22' ' ' TYR . 22.9 t90 -95.67 -112.58 0.13 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.178 -0.951 . . . . 0.0 110.059 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -157.92 58.64 0.48 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.847 -1.158 . . . . 0.0 110.182 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.459 ' HB2' ' CE3' ' A' ' 17' ' ' TRP . 0.2 OUTLIER -170.91 153.58 3.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.378 -0.826 . . . . 0.0 110.086 179.97 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -84.69 -5.1 59.3 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.177 -0.952 . . . . 0.0 110.5 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -119.2 -30.69 4.89 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.066 -1.021 . . . . 0.0 110.735 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.478 ' CG ' ' CE3' ' A' ' 17' ' ' TRP . 26.3 t80 -54.1 -54.12 43.86 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.089 -1.007 . . . . 0.0 110.178 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.438 ' O ' ' HB2' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -62.04 -20.06 63.55 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.199 -0.938 . . . . 0.0 109.695 179.853 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.517 ' CB ' ' O ' ' A' ' 35' ' ' GLY . 9.5 t-20 -84.74 -42.71 14.97 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.266 -0.896 . . . . 0.0 110.457 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -59.18 -43.41 92.16 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.028 -1.045 . . . . 0.0 109.759 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.703 ' O ' HD12 ' A' ' 30' ' ' LEU . 6.3 mt -71.55 -46.43 59.52 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.272 -0.892 . . . . 0.0 109.898 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.501 ' SG ' ' CG ' ' A' ' 6' ' ' PRO . 1.3 m -59.48 -40.13 85.99 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.301 -0.874 . . . . 0.0 110.017 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' A' ' 32' ' ' ALA . 0.1 OUTLIER -64.81 -33.31 75.7 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.268 -0.895 . . . . 0.0 109.141 179.389 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -53.43 -34.5 48.94 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 108.356 -1.898 . . . . 0.0 108.356 179.237 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.703 HD12 ' O ' ' A' ' 26' ' ' LEU . 1.8 mp -81.43 -35.51 30.55 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.469 -1.018 . . . . 0.0 109.353 179.149 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.652 ' CB ' ' O ' ' A' ' 30' ' ' LEU . 1.5 ttmm 141.8 -2.66 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.576 0 C-N-CA 123.051 0.54 . . . . 0.0 110.027 179.303 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.574 ' HB1' ' HB3' ' A' ' 46' ' ' CYS . . . -80.7 94.82 6.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.991 -1.068 . . . . 0.0 110.345 -179.487 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.484 ' HA ' ' CG ' ' A' ' 28' ' ' LYS . 11.5 m-20 -65.11 -46.0 82.85 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.294 -0.878 . . . . 0.0 110.271 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.426 ' O ' ' HA ' ' A' ' 46' ' ' CYS . 0.2 OUTLIER -85.19 80.39 9.23 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.327 -0.858 . . . . 0.0 110.301 -179.865 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.517 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -119.06 103.39 0.99 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -126.38 133.15 51.38 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.23 -1.159 . . . . 0.0 110.404 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.0 OUTLIER -84.67 127.48 34.11 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.207 -0.933 . . . . 0.0 110.167 179.875 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.535 ' CB ' ' HB2' ' A' ' 42' ' ' LEU . 0.3 OUTLIER -79.92 139.81 36.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.254 -0.904 . . . . 0.0 110.258 -179.899 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -90.83 12.16 69.7 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.883 ' CD1' HG22 ' A' ' 41' ' ' THR . 21.4 t-105 -105.03 -70.16 0.79 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.316 -1.108 . . . . 0.0 110.151 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.883 HG22 ' CD1' ' A' ' 40' ' ' TRP . 14.1 t -172.35 32.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.399 -0.813 . . . . 0.0 110.343 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.535 ' HB2' ' CB ' ' A' ' 38' ' ' TRP . 0.2 OUTLIER -112.16 13.65 20.57 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.201 -0.937 . . . . 0.0 110.236 179.961 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.654 ' OG ' HG22 ' A' ' 15' ' ' ILE . 28.0 t 44.12 -166.1 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.281 -0.887 . . . . 0.0 110.916 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.557 ' N ' ' HB2' ' A' ' 16' ' ' CYS . 21.5 t -68.57 113.67 6.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.509 -0.744 . . . . 0.0 109.669 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.425 ' CE2' ' HE1' ' A' ' 5' ' ' TYR . 2.7 t80 -99.62 123.52 43.96 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.176 -0.952 . . . . 0.0 110.145 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.644 ' O ' HD21 ' A' ' 49' ' ' LEU . 59.7 m -134.94 128.13 31.94 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.295 -0.878 . . . . 0.0 110.141 179.712 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.512 ' HG3' ' HB2' ' A' ' 3' ' ' ASP . 0.5 OUTLIER -117.37 135.64 53.72 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.316 -0.865 . . . . 0.0 109.842 179.843 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.55 ' N ' HD23 ' A' ' 49' ' ' LEU . . . 99.63 44.14 2.36 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.804 HD12 ' CB ' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -115.63 172.25 3.87 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.299 -1.118 . . . . 0.0 109.84 179.64 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.533 ' HD3' ' HB3' ' A' ' 31' ' ' LYS . 46.0 Cg_endo -72.04 157.82 53.63 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.832 1.438 . . . . 0.0 110.599 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -59.38 -19.96 51.1 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.208 -0.932 . . . . 0.0 109.941 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -83.84 6.68 20.58 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.281 -0.887 . . . . 0.0 110.04 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.804 ' CB ' HD12 ' A' ' 49' ' ' LEU . . . -63.77 106.81 1.06 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.345 -0.847 . . . . 0.0 110.257 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.738 ' O ' HD13 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -62.42 156.45 22.61 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.244 -0.91 . . . . 0.0 109.93 179.744 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.738 HD13 ' O ' ' A' ' 54' ' ' ARG . 10.7 mm -142.77 -179.8 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.341 -0.849 . . . . 0.0 110.264 -179.638 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.643 ' H ' HG22 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -60.38 84.31 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.436 -0.79 . . . . 0.0 110.124 179.277 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.504 ' NH1' ' HG2' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -106.09 -11.86 15.97 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.246 -0.909 . . . . 0.0 110.264 -179.942 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -146.1 167.04 24.38 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.335 -0.853 . . . . 0.0 110.191 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -148.62 35.64 1.11 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.526 ' O ' ' O ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER -136.98 41.72 2.47 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.111 -1.229 . . . . 0.0 110.383 179.767 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.526 ' O ' ' O ' ' A' ' 60' ' ' ARG . 49.6 t 41.06 106.54 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 121.586 0.708 . . . . 0.0 111.697 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.479 ' CB ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -83.19 40.09 0.69 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.186 -0.946 . . . . 0.0 110.688 179.56 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.658 0 O-C-N 121.086 -1.009 . . . . 0.0 110.296 179.947 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.271 0.558 . . . . 0.0 110.135 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.559 HG23 ' HG ' ' A' ' 49' ' ' LEU . 20.6 tt -126.01 160.58 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.295 -0.878 . . . . 0.0 110.181 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -139.75 128.9 23.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.311 -0.868 . . . . 0.0 110.007 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -177.58 -145.36 5.81 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.941 -1.263 . . . . 0.0 109.941 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.625 ' N ' ' CD1' ' A' ' 5' ' ' TYR . 12.8 m-85 -122.5 97.11 45.13 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.274 -1.133 . . . . 0.0 110.099 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.454 ' HA ' ' O ' ' A' ' 54' ' ' ARG . 42.5 Cg_endo -69.91 126.84 13.66 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.003 1.528 . . . . 0.0 110.815 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.633 HG12 ' CG1' ' A' ' 15' ' ' ILE . 15.2 m -85.38 -169.45 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.484 -0.76 . . . . 0.0 110.511 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.479 ' O ' ' NH1' ' A' ' 54' ' ' ARG . 2.6 t70 -63.15 -158.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.367 -0.833 . . . . 0.0 110.296 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.465 ' HB3' ' CE2' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -91.17 -20.3 22.13 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.296 -0.878 . . . . 0.0 110.176 179.972 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.501 ' HB3' ' N ' ' A' ' 62' ' ' ARG . 5.0 m-90 -128.25 18.24 6.5 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.176 -0.953 . . . . 0.0 110.52 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.469 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 8.3 m-20 59.88 12.7 3.19 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.343 -0.848 . . . . 0.0 110.372 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 3.5 t -79.23 -50.22 11.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.118 -0.989 . . . . 0.0 109.634 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.464 ' O ' ' O ' ' A' ' 14' ' ' ARG . 1.2 mptm? -79.97 152.38 29.54 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.464 -0.772 . . . . 0.0 109.611 179.357 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.464 ' O ' ' O ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -46.11 173.5 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.168 -0.958 . . . . 0.0 110.125 -179.921 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.633 ' CG1' HG12 ' A' ' 7' ' ' VAL . 3.9 mt -71.34 -1.94 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.113 -0.992 . . . . 0.0 109.853 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.568 ' HB2' ' N ' ' A' ' 44' ' ' CYS . 18.9 t -146.6 154.44 41.49 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.384 -0.823 . . . . 0.0 110.006 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.565 ' CZ3' ' CG ' ' A' ' 22' ' ' TYR . 28.3 t90 -118.39 169.54 9.66 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.118 -0.989 . . . . 0.0 109.796 179.438 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.421 ' N ' ' CG ' ' A' ' 17' ' ' TRP . 23.2 t80 -79.48 92.86 5.31 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.216 -0.928 . . . . 0.0 109.564 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.54 ' HB2' ' HB2' ' A' ' 22' ' ' TYR . 4.2 p-10 -174.3 142.47 0.79 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.289 -0.882 . . . . 0.0 110.517 -179.383 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 32.3 p30 -90.69 7.97 36.82 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.237 -0.914 . . . . 0.0 109.871 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.6 mttt -154.64 -28.69 0.11 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.145 -0.972 . . . . 0.0 111.724 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.565 ' CG ' ' CZ3' ' A' ' 17' ' ' TRP . 1.6 t80 -47.85 -21.54 0.43 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.555 -1.341 . . . . 0.0 110.576 -179.355 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -87.0 -34.9 19.09 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.05 -1.031 . . . . 0.0 110.327 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.475 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 12.3 t-20 -72.67 -40.31 66.4 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.07 -1.018 . . . . 0.0 109.697 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -62.75 -33.87 76.05 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.323 -0.86 . . . . 0.0 109.93 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.601 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -83.23 -44.22 15.23 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.315 -0.866 . . . . 0.0 109.148 179.55 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.435 ' N ' ' HG ' ' A' ' 26' ' ' LEU . 1.5 m -58.71 -40.79 84.7 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.536 -0.728 . . . . 0.0 109.562 179.691 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 24' ' ' ASN . 0.2 OUTLIER -64.34 -33.97 77.07 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.268 -0.895 . . . . 0.0 109.015 179.165 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.07 -37.33 45.5 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 108.589 -1.804 . . . . 0.0 108.589 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.672 ' O ' ' CB ' ' A' ' 31' ' ' LYS . 4.1 mt -79.75 -35.47 38.74 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.454 -1.027 . . . . 0.0 109.472 179.323 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.672 ' CB ' ' O ' ' A' ' 30' ' ' LEU . 21.5 tttt 139.21 2.88 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.575 0 C-N-CA 123.122 0.569 . . . . 0.0 110.131 179.284 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.543 ' HB2' HD22 ' A' ' 49' ' ' LEU . . . -88.25 109.3 19.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.781 -1.199 . . . . 0.0 110.18 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.447 ' HA ' ' HG3' ' A' ' 28' ' ' LYS . 2.6 m-20 -78.62 -44.4 24.05 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.142 -0.974 . . . . 0.0 110.402 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.494 ' O ' ' HA ' ' A' ' 46' ' ' CYS . 2.0 t -82.6 73.72 9.62 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.276 -0.89 . . . . 0.0 110.215 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.486 ' CA ' ' SG ' ' A' ' 46' ' ' CYS . . . -118.32 120.91 4.87 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.531 ' C ' ' CD1' ' A' ' 36' ' ' TYR . 14.0 p90 -143.79 153.89 42.86 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.322 -1.105 . . . . 0.0 109.742 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.503 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.0 OUTLIER -107.26 126.6 52.63 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.976 -1.077 . . . . 0.0 110.843 -179.443 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.609 ' CD1' ' HB3' ' A' ' 40' ' ' TRP . 43.7 t-105 -89.1 114.71 25.99 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.461 -0.774 . . . . 0.0 109.816 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.9 73.31 2.45 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 -179.232 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.688 ' CD1' HG22 ' A' ' 41' ' ' THR . 0.1 OUTLIER -160.59 -73.27 0.07 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.283 -1.127 . . . . 0.0 109.8 179.395 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.688 HG22 ' CD1' ' A' ' 40' ' ' TRP . 15.0 t -169.0 39.29 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.506 -0.746 . . . . 0.0 109.908 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.569 HD13 ' CD1' ' A' ' 38' ' ' TRP . 0.4 OUTLIER -130.21 1.71 4.68 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.253 -0.904 . . . . 0.0 110.344 -179.897 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.538 ' HA ' ' HB2' ' A' ' 16' ' ' CYS . 48.9 m 56.12 -166.94 0.11 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.148 -0.97 . . . . 0.0 110.365 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.568 ' N ' ' HB2' ' A' ' 16' ' ' CYS . 6.8 t -77.91 151.37 33.81 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.253 -0.904 . . . . 0.0 110.171 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.539 ' CD1' ' CZ ' ' A' ' 5' ' ' TYR . 6.9 t80 -135.16 102.71 5.28 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.271 -0.893 . . . . 0.0 110.484 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.637 ' O ' HD21 ' A' ' 49' ' ' LEU . 76.7 m -118.61 133.96 55.47 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.162 -0.961 . . . . 0.0 109.95 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 16.1 mt-30 -119.86 134.66 55.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.261 -0.899 . . . . 0.0 109.778 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.516 ' N ' HD23 ' A' ' 49' ' ' LEU . . . 104.93 38.87 2.43 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.771 HD12 ' CB ' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -114.61 172.25 3.76 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.385 -1.068 . . . . 0.0 109.739 179.785 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.492 ' HD2' ' HB2' ' A' ' 49' ' ' LEU . 46.0 Cg_endo -71.94 156.31 56.52 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.676 1.356 . . . . 0.0 110.398 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.451 ' O ' ' OD1' ' A' ' 51' ' ' ASP . 21.0 t0 -60.34 -20.07 57.95 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.176 -0.952 . . . . 0.0 110.188 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -79.85 0.7 29.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.309 -0.869 . . . . 0.0 110.102 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.771 ' CB ' HD12 ' A' ' 49' ' ' LEU . . . -62.43 101.12 0.21 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.365 -0.834 . . . . 0.0 110.01 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.871 ' O ' HD13 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -55.33 149.85 12.33 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.079 -1.013 . . . . 0.0 110.218 -179.69 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.871 HD13 ' O ' ' A' ' 54' ' ' ARG . 35.5 mm -139.97 169.76 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.309 -0.87 . . . . 0.0 109.939 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.694 ' HG3' HG22 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -42.37 96.21 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.203 -0.936 . . . . 0.0 110.146 179.66 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.485 ' N ' ' O ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -125.51 7.6 7.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.197 -0.939 . . . . 0.0 110.092 179.923 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 58.64 160.39 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.29 -0.881 . . . . 0.0 110.494 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 148.41 -170.29 28.95 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.37 158.69 15.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.2 -1.177 . . . . 0.0 109.997 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 55.9 m -56.73 119.52 6.31 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.226 -0.921 . . . . 0.0 110.13 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.501 ' N ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -83.45 45.35 1.04 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.2 -0.937 . . . . 0.0 110.153 179.834 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.578 0 O-C-N 121.207 -0.933 . . . . 0.0 110.324 -179.758 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 1.5 tttt . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.3 0.571 . . . . 0.0 110.31 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.781 HG22 ' O ' ' A' ' 49' ' ' LEU . 5.9 tt -142.24 160.5 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.137 -0.977 . . . . 0.0 110.136 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.457 ' OD1' ' O ' ' A' ' 3' ' ' ASP . 3.6 p30 -126.9 122.65 35.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.301 -0.875 . . . . 0.0 110.383 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -165.11 -164.77 21.19 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.786 ' CE2' HD22 ' A' ' 42' ' ' LEU . 15.8 m-85 -117.31 107.9 44.53 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.227 -1.16 . . . . 0.0 110.487 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.629 ' N ' HG22 ' A' ' 55' ' ' ILE . 49.6 Cg_endo -76.82 129.9 11.08 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 124.034 1.544 . . . . 0.0 110.649 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.729 HG12 HG23 ' A' ' 15' ' ' ILE . 32.8 m -105.63 -165.34 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.316 -0.865 . . . . 0.0 109.678 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.496 ' OD1' ' CZ3' ' A' ' 10' ' ' TRP . 5.0 t70 -60.56 -139.27 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.318 -0.864 . . . . 0.0 109.85 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.433 ' C ' ' CG ' ' A' ' 10' ' ' TRP . 3.2 m-85 -110.17 -4.11 15.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.083 -1.01 . . . . 0.0 110.079 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.642 ' CG ' ' HB2' ' A' ' 63' ' ' ALA . 1.3 m-90 -143.55 8.58 1.55 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.254 -0.904 . . . . 0.0 110.165 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.517 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 7.5 m-20 66.56 2.29 2.45 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.631 -0.668 . . . . 0.0 110.894 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.429 ' O ' ' C ' ' A' ' 13' ' ' LYS . 0.6 OUTLIER -85.66 -59.09 2.41 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.165 -0.959 . . . . 0.0 110.5 -179.965 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.492 ' CB ' ' OD2' ' A' ' 8' ' ' ASP . 27.8 mmtt -41.99 -70.45 0.11 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.38 -0.825 . . . . 0.0 110.464 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.486 ' HG3' ' O ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -172.55 -178.7 2.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.272 -0.892 . . . . 0.0 110.286 -179.808 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.841 HG22 ' OG ' ' A' ' 43' ' ' SER . 0.6 OUTLIER -104.13 -17.85 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.273 -0.892 . . . . 0.0 109.442 179.935 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.628 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 5.3 t -158.42 174.31 15.31 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.375 -0.828 . . . . 0.0 110.462 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -100.8 -148.85 0.37 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.266 -0.896 . . . . 0.0 110.372 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -120.27 -37.28 3.08 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.152 -0.968 . . . . 0.0 110.331 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -82.3 140.64 33.47 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.351 -0.843 . . . . 0.0 110.402 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -69.24 -5.33 22.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.274 -0.891 . . . . 0.0 110.322 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.2 -31.6 7.84 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.159 -0.963 . . . . 0.0 110.4 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -63.18 -18.59 63.64 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.229 -0.92 . . . . 0.0 110.478 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.453 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 0.1 OUTLIER -90.53 -54.64 3.91 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.067 -1.02 . . . . 0.0 110.283 179.923 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.501 ' CB ' ' O ' ' A' ' 35' ' ' GLY . 52.0 t30 -48.98 -36.67 18.12 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.173 -0.954 . . . . 0.0 110.01 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.406 ' OD1' ' C ' ' A' ' 25' ' ' ASP . 13.1 t0 -57.78 -53.75 54.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.346 -0.846 . . . . 0.0 110.078 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.74 -42.75 85.74 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.201 -0.937 . . . . 0.0 110.263 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.477 ' HA ' HD12 ' A' ' 30' ' ' LEU . 1.3 m -58.86 -33.27 70.28 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.156 -0.965 . . . . 0.0 109.54 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.5 tptm -63.37 -30.69 71.78 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.304 -0.873 . . . . 0.0 109.083 179.158 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.18 -32.58 83.02 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 107.825 -2.11 . . . . 0.0 107.825 178.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.532 ' O ' ' CD ' ' A' ' 50' ' ' PRO . 2.9 mt -90.54 21.56 3.9 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.59 -0.947 . . . . 0.0 109.106 178.841 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.517 ' HB3' ' O ' ' A' ' 30' ' ' LEU . 13.0 tttm 65.25 20.32 11.88 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.815 -0.553 . . . . 0.0 110.78 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.842 ' HB2' HD22 ' A' ' 49' ' ' LEU . . . -91.97 89.9 7.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.028 -1.045 . . . . 0.0 110.039 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -49.79 -79.66 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.371 -0.831 . . . . 0.0 110.667 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.419 ' O ' ' HA ' ' A' ' 46' ' ' CYS . 75.2 m -71.04 91.4 0.89 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.215 -0.928 . . . . 0.0 110.438 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.521 ' CA ' ' SG ' ' A' ' 46' ' ' CYS . . . -131.56 123.72 3.81 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.418 ' C ' ' CD1' ' A' ' 36' ' ' TYR . 5.0 p90 -142.81 -175.29 4.44 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.177 -1.19 . . . . 0.0 110.594 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 6.2 t -115.91 136.35 53.12 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.217 -0.927 . . . . 0.0 110.406 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.617 ' CD1' ' HB2' ' A' ' 42' ' ' LEU . 1.9 t-105 -79.92 150.94 30.38 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.146 -0.971 . . . . 0.0 109.674 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -98.1 -13.81 41.37 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 -179.444 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 1.059 ' CD1' HG22 ' A' ' 41' ' ' THR . 40.8 t-105 -84.06 -73.05 0.44 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.216 -1.167 . . . . 0.0 109.936 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' THR . . . . . 1.059 HG22 ' CD1' ' A' ' 40' ' ' TRP . 7.5 t -179.66 50.52 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.554 -0.716 . . . . 0.0 109.748 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.786 HD22 ' CE2' ' A' ' 5' ' ' TYR . 0.5 OUTLIER -120.84 21.32 11.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.315 -0.866 . . . . 0.0 110.638 -179.554 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.841 ' OG ' HG22 ' A' ' 15' ' ' ILE . 28.2 t 50.99 -168.57 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.116 -0.99 . . . . 0.0 110.406 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.555 ' CA ' ' SG ' ' A' ' 16' ' ' CYS . 3.0 t -77.25 135.0 38.43 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.201 -0.937 . . . . 0.0 109.67 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.628 ' CD1' ' CE2' ' A' ' 5' ' ' TYR . 8.1 t80 -122.05 109.56 14.71 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.199 -0.938 . . . . 0.0 110.234 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.627 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . 24.2 m -125.52 149.13 48.57 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.471 -0.768 . . . . 0.0 109.732 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.429 ' OE1' ' HB2' ' A' ' 3' ' ' ASP . 24.8 mt-30 -130.03 137.96 50.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.267 -0.895 . . . . 0.0 110.333 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 31' ' ' LYS . . . 112.32 22.84 5.69 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.92 HD12 ' CB ' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -99.85 170.26 6.99 Favored Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.128 -1.219 . . . . 0.0 109.999 179.645 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.532 ' CD ' ' O ' ' A' ' 30' ' ' LEU . 41.5 Cg_endo -67.31 155.06 72.1 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.978 1.515 . . . . 0.0 110.457 -179.394 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -56.94 -23.06 42.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.324 -0.86 . . . . 0.0 110.162 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -87.56 13.61 9.9 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.276 -0.89 . . . . 0.0 110.237 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.92 ' CB ' HD12 ' A' ' 49' ' ' LEU . . . -62.32 115.41 4.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.282 -0.887 . . . . 0.0 110.074 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.464 ' O ' ' HA ' ' A' ' 6' ' ' PRO . 0.1 OUTLIER -72.29 133.8 45.21 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.228 -0.92 . . . . 0.0 110.551 -179.811 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.76 HG22 ' C ' ' A' ' 5' ' ' TYR . 1.3 pp -142.98 -167.52 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.426 -0.796 . . . . 0.0 110.209 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.431 ' HG3' HD13 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -41.05 91.74 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.342 -0.849 . . . . 0.0 111.007 -179.386 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.566 ' O ' ' C ' ' A' ' 58' ' ' SER . 10.3 mtp85 -120.48 21.81 11.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.199 -0.938 . . . . 0.0 109.323 179.208 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.566 ' C ' ' O ' ' A' ' 57' ' ' ARG . 0.2 OUTLIER -7.45 122.93 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.255 0 CA-C-O 121.475 0.655 . . . . 0.0 112.432 -179.571 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -142.43 -103.41 0.48 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.457 ' O ' ' O ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER -132.64 48.05 2.45 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.241 -1.153 . . . . 0.0 110.253 179.973 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.457 ' O ' ' O ' ' A' ' 60' ' ' ARG . 0.8 OUTLIER 40.24 91.46 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.505 -0.747 . . . . 0.0 109.933 179.938 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.562 ' O ' ' CD1' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -81.31 47.41 1.03 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.106 -0.997 . . . . 0.0 110.479 -179.666 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.642 ' HB2' ' CG ' ' A' ' 10' ' ' TRP . . . . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.171 -0.955 . . . . 0.0 110.332 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 12.4 ptmt . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.255 0.55 . . . . 0.0 110.279 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.457 ' O ' ' OD1' ' A' ' 3' ' ' ASP . 10.3 tt -125.02 163.16 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.326 -0.859 . . . . 0.0 110.159 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.457 ' OD1' ' O ' ' A' ' 2' ' ' ILE . 85.2 m-20 -135.91 136.12 40.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.343 -0.848 . . . . 0.0 109.979 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -178.39 -159.52 23.08 Favored Glycine 0 N--CA 1.492 2.388 0 C-N-CA 119.608 -1.282 . . . . 0.0 109.977 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.638 ' N ' ' CD1' ' A' ' 5' ' ' TYR . 5.4 m-85 -120.14 111.27 35.51 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.41 -1.053 . . . . 0.0 109.774 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.438 ' HD2' ' HB3' ' A' ' 44' ' ' CYS . 45.4 Cg_endo -72.22 144.79 42.44 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.949 1.499 . . . . 0.0 110.877 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.9 HG12 HG23 ' A' ' 15' ' ' ILE . 15.7 m -99.71 -168.07 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.324 -0.86 . . . . 0.0 110.392 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -72.87 -128.04 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.4 -0.813 . . . . 0.0 110.105 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -115.55 -33.04 5.36 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.915 -1.115 . . . . 0.0 110.327 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.528 ' O ' ' HB2' ' A' ' 11' ' ' ASN . 4.1 m-90 -112.7 13.38 19.86 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.178 -0.952 . . . . 0.0 110.301 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.528 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.0 OUTLIER 62.23 6.61 1.9 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.548 -0.72 . . . . 0.0 110.705 -179.722 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 16.9 m -76.92 -67.02 0.75 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.062 -1.024 . . . . 0.0 110.358 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.432 ' O ' ' O ' ' A' ' 14' ' ' ARG . 2.9 mptm? -58.63 173.53 0.4 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.497 -0.752 . . . . 0.0 110.506 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.432 ' O ' ' O ' ' A' ' 13' ' ' LYS . 5.0 ttp180 -50.78 -178.54 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.352 -0.842 . . . . 0.0 110.139 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.9 HG23 HG12 ' A' ' 7' ' ' VAL . 4.0 mt -95.95 26.04 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.238 -0.914 . . . . 0.0 109.794 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.551 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 8.7 t -151.94 159.41 43.8 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.463 -0.773 . . . . 0.0 110.044 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.96 ' CZ3' HD13 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -85.75 -152.68 0.17 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.223 -0.923 . . . . 0.0 110.266 -179.967 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -120.33 44.43 2.45 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.289 -0.882 . . . . 0.0 110.357 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -176.84 158.78 1.67 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.151 -0.968 . . . . 0.0 110.321 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 34.8 t30 -82.9 -7.18 59.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.263 -0.898 . . . . 0.0 110.239 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.6 tptt -110.1 -31.32 7.4 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.256 -0.902 . . . . 0.0 109.971 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -54.64 -31.23 57.09 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.327 -0.858 . . . . 0.0 110.269 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 27' ' ' CYS . 0.1 OUTLIER -91.38 -32.77 15.53 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.223 -0.923 . . . . 0.0 110.481 -179.663 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.513 ' CB ' ' O ' ' A' ' 35' ' ' GLY . 25.1 t30 -70.63 -44.32 67.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.106 -0.996 . . . . 0.0 110.133 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -56.27 -45.57 80.07 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.232 -0.918 . . . . 0.0 110.468 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.96 HD13 ' CZ3' ' A' ' 17' ' ' TRP . 0.2 OUTLIER -78.1 -40.33 38.65 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.208 -0.932 . . . . 0.0 110.332 -179.9 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 23' ' ' CYS . 1.6 m -57.45 -37.8 73.43 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.146 -0.971 . . . . 0.0 109.522 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.99 -28.12 69.88 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.427 -0.796 . . . . 0.0 109.524 179.6 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.62 -34.97 90.4 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 107.873 -2.091 . . . . 0.0 107.873 178.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.532 ' O ' ' HD3' ' A' ' 50' ' ' PRO . 1.3 mt -89.16 17.8 5.62 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.707 -0.878 . . . . 0.0 109.325 178.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.528 ' CB ' ' O ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER 72.54 14.79 5.16 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.64 -0.662 . . . . 0.0 111.161 179.688 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.687 ' HB1' ' HB3' ' A' ' 46' ' ' CYS . . . -85.3 81.0 8.96 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.786 -1.196 . . . . 0.0 109.633 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 32' ' ' ALA . 0.1 OUTLIER -39.89 -80.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.373 -0.83 . . . . 0.0 110.842 -179.32 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.497 ' O ' ' HA ' ' A' ' 46' ' ' CYS . 57.9 m -69.85 90.16 0.6 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.33 -0.856 . . . . 0.0 110.514 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.513 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -122.26 89.18 0.42 Allowed Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 29.6 p90 -118.25 153.82 33.28 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.244 -1.151 . . . . 0.0 109.964 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.507 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.1 OUTLIER -107.31 134.59 50.16 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.148 -0.97 . . . . 0.0 110.632 -179.567 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.575 ' CD1' ' HB2' ' A' ' 42' ' ' LEU . 14.6 t-105 -83.67 125.57 31.99 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.396 -0.815 . . . . 0.0 109.908 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -89.15 64.25 3.33 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.568 ' HB3' ' CD1' ' A' ' 38' ' ' TRP . 0.1 OUTLIER -155.84 -80.4 0.08 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.299 -1.118 . . . . 0.0 109.648 179.816 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.615 HG23 ' O ' ' A' ' 41' ' ' THR . 2.6 t -162.68 33.64 0.1 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.361 -0.837 . . . . 0.0 109.869 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.575 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 0.4 OUTLIER -117.9 4.92 12.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.333 -0.854 . . . . 0.0 110.363 -179.753 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.551 ' HA ' ' HB2' ' A' ' 16' ' ' CYS . 13.0 m 59.96 -170.93 0.13 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.218 -0.927 . . . . 0.0 110.456 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.507 ' HA ' ' HA ' ' A' ' 37' ' ' CYS . 19.3 t -75.57 156.45 34.99 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.297 -0.877 . . . . 0.0 109.977 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -140.82 99.54 3.63 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.016 -1.053 . . . . 0.0 110.917 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.687 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . 65.6 m -120.51 139.77 52.41 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.241 -0.912 . . . . 0.0 109.551 178.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.44 ' HA ' ' OD1' ' A' ' 3' ' ' ASP . 58.8 mt-30 -126.24 138.96 53.67 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.201 -0.937 . . . . 0.0 110.201 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.55 ' N ' HD23 ' A' ' 49' ' ' LEU . . . 103.8 32.61 4.38 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 -179.658 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.961 HD12 ' CB ' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -110.2 172.34 3.67 Favored Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 121.276 -1.132 . . . . 0.0 109.506 179.843 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.532 ' HD3' ' O ' ' A' ' 30' ' ' LEU . 42.5 Cg_endo -67.78 162.17 40.68 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 O-C-N 123.514 1.271 . . . . 0.0 110.7 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -64.58 -19.78 65.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.354 -0.841 . . . . 0.0 110.134 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -92.68 15.57 14.14 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.265 -0.897 . . . . 0.0 109.997 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.961 ' CB ' HD12 ' A' ' 49' ' ' LEU . . . -62.29 141.79 58.08 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.183 -0.948 . . . . 0.0 110.205 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.774 ' O ' HD13 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -66.24 139.7 58.11 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.304 -0.873 . . . . 0.0 109.764 179.722 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.774 HD13 ' O ' ' A' ' 54' ' ' ARG . 5.3 mm -139.1 -177.76 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.029 -1.045 . . . . 0.0 110.862 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.672 ' H ' HG22 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -59.76 77.78 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.512 -0.742 . . . . 0.0 110.963 -179.528 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.487 ' N ' ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -107.0 17.47 23.02 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.208 -0.932 . . . . 0.0 109.539 179.117 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.438 ' C ' ' O ' ' A' ' 57' ' ' ARG . 0.8 OUTLIER -39.41 136.09 0.98 Allowed 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.25 0.548 . . . . 0.0 110.5 -179.776 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.472 ' O ' ' HD3' ' A' ' 60' ' ' ARG . . . 158.31 -34.45 0.51 Allowed Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.472 ' HD3' ' O ' ' A' ' 59' ' ' GLY . 14.8 mmt85 -114.93 68.92 0.71 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.325 -1.103 . . . . 0.0 110.348 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.423 ' C ' ' O ' ' A' ' 60' ' ' ARG . 0.1 OUTLIER -42.35 100.41 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.32 -0.862 . . . . 0.0 110.098 179.653 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.426 ' C ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -83.84 45.89 1.12 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.132 -0.98 . . . . 0.0 110.246 -179.969 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.196 -0.94 . . . . 0.0 110.313 -179.931 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.283 0.563 . . . . 0.0 110.156 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.564 HG22 ' O ' ' A' ' 49' ' ' LEU . 4.4 tt -140.21 157.51 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.321 -0.862 . . . . 0.0 110.094 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.574 ' OD1' ' CE1' ' A' ' 45' ' ' TYR . 33.4 t0 -125.42 128.01 47.44 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.632 -0.667 . . . . 0.0 109.863 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -174.68 -160.23 22.36 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.691 ' CE2' ' CD1' ' A' ' 45' ' ' TYR . 3.6 m-85 -126.56 99.64 29.81 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.444 -1.033 . . . . 0.0 110.258 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.535 ' HD2' ' O ' ' A' ' 44' ' ' CYS . 43.4 Cg_endo -69.79 125.61 12.33 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 O-C-N 123.917 1.483 . . . . 0.0 110.659 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.572 ' CG1' ' HA ' ' A' ' 56' ' ' LYS . 17.2 m -79.65 175.49 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.418 -0.801 . . . . 0.0 110.31 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -51.35 167.85 0.08 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.272 -0.892 . . . . 0.0 110.145 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.541 ' HB3' ' CE2' ' A' ' 10' ' ' TRP . 0.3 OUTLIER -66.43 -8.48 26.22 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.244 -0.91 . . . . 0.0 110.287 179.976 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.541 ' CE2' ' HB3' ' A' ' 9' ' ' TYR . 1.7 m-90 -139.59 11.28 2.5 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.28 -0.887 . . . . 0.0 109.993 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.417 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 2.8 m120 55.54 19.06 3.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.205 -0.934 . . . . 0.0 109.572 -179.665 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 3.5 t -81.78 -38.64 25.29 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.55 -0.719 . . . . 0.0 110.74 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.405 ' O ' ' CB ' ' A' ' 14' ' ' ARG . 2.5 mttp -93.04 53.38 1.97 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.273 -0.892 . . . . 0.0 110.603 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.405 ' CB ' ' O ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER 62.57 -143.85 0.39 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.233 -0.917 . . . . 0.0 110.409 179.694 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.834 HD12 ' HB2' ' A' ' 43' ' ' SER . 31.8 pt -109.4 4.06 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.165 -0.959 . . . . 0.0 110.277 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.601 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 0.9 OUTLIER -151.36 -174.23 4.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.18 -0.95 . . . . 0.0 109.708 179.436 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.689 ' CE3' ' CG ' ' A' ' 22' ' ' TYR . 0.0 OUTLIER -118.02 -171.92 2.16 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.121 -0.987 . . . . 0.0 110.156 179.839 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -91.28 -36.59 13.79 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.11 -0.994 . . . . 0.0 110.294 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.545 HD21 ' HZ3' ' A' ' 17' ' ' TRP . 72.4 m-20 -78.87 148.58 32.73 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.326 -0.859 . . . . 0.0 110.302 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -88.66 -16.68 31.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.342 -0.849 . . . . 0.0 110.121 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.28 -14.11 24.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.287 -0.883 . . . . 0.0 110.318 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.689 ' CG ' ' CE3' ' A' ' 17' ' ' TRP . 2.8 t80 -72.62 -40.11 66.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.085 -1.009 . . . . 0.0 109.913 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.46 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 1.3 t -63.3 -34.4 77.6 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.328 -0.857 . . . . 0.0 109.659 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.538 ' CB ' ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -78.0 -51.82 9.76 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.279 -0.888 . . . . 0.0 109.776 179.76 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.476 ' N ' ' CG ' ' A' ' 24' ' ' ASN . 5.7 m-20 -51.54 -49.08 62.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.197 -0.94 . . . . 0.0 110.173 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.7 mt -71.04 -37.59 72.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.242 -0.911 . . . . 0.0 110.282 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 23' ' ' CYS . 1.8 m -62.3 -38.66 90.25 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.159 -0.963 . . . . 0.0 109.616 179.659 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.556 ' CD ' ' HA ' ' A' ' 33' ' ' ASP . 8.7 mmmt -61.55 -27.07 68.36 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.291 -0.881 . . . . 0.0 109.145 179.277 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.61 -33.46 86.68 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 107.189 -2.364 . . . . 0.0 107.189 178.51 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.549 ' O ' ' HD3' ' A' ' 50' ' ' PRO . 12.8 mt -90.29 21.65 3.72 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.872 -0.781 . . . . 0.0 108.95 178.485 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.515 ' CB ' ' O ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER 71.81 8.54 6.09 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.452 -0.78 . . . . 0.0 110.81 179.875 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.618 ' HB2' HD22 ' A' ' 49' ' ' LEU . . . -87.06 103.76 15.68 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.95 -1.094 . . . . 0.0 109.877 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.556 ' HA ' ' CD ' ' A' ' 28' ' ' LYS . 9.2 m-20 -67.05 -76.49 0.08 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -0.912 . . . . 0.0 110.723 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.508 ' O ' ' HA ' ' A' ' 46' ' ' CYS . 0.5 OUTLIER -66.28 93.68 0.23 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.361 -0.837 . . . . 0.0 110.791 -179.514 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.538 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -133.05 126.2 4.32 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.421 ' C ' ' SG ' ' A' ' 23' ' ' CYS . 40.4 p90 -145.48 151.56 38.38 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.152 -1.204 . . . . 0.0 110.261 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 42.0 t -97.1 133.16 42.12 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.185 -0.947 . . . . 0.0 110.913 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.61 ' CD1' HD22 ' A' ' 42' ' ' LEU . 0.7 OUTLIER -97.49 138.62 34.64 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.266 -0.896 . . . . 0.0 109.935 179.535 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -89.06 8.74 79.15 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.829 ' CD1' HG22 ' A' ' 41' ' ' THR . 20.6 t-105 -99.57 -76.46 0.54 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.166 -1.196 . . . . 0.0 110.104 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.829 HG22 ' CD1' ' A' ' 40' ' ' TRP . 11.6 t -169.08 31.63 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.393 -0.817 . . . . 0.0 109.888 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.61 HD22 ' CD1' ' A' ' 38' ' ' TRP . 10.9 mp -107.0 14.23 26.66 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.442 -0.786 . . . . 0.0 110.215 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.834 ' HB2' HD12 ' A' ' 15' ' ' ILE . 8.2 t 47.56 -169.1 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.185 -0.947 . . . . 0.0 110.239 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.535 ' O ' ' HD2' ' A' ' 6' ' ' PRO . 1.8 t -81.41 97.12 7.59 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.691 ' CD1' ' CE2' ' A' ' 5' ' ' TYR . 4.8 t80 -79.81 130.54 35.41 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.12 -0.988 . . . . 0.0 111.251 -178.481 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.574 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . 83.3 m -145.15 145.94 31.58 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.366 -0.834 . . . . 0.0 109.376 179.104 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.469 ' HG2' ' OD1' ' A' ' 3' ' ' ASP . 3.9 mt-30 -127.57 142.23 51.42 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.086 -1.008 . . . . 0.0 110.244 -179.618 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' A' ' 31' ' ' LYS . . . 101.94 31.03 5.54 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 179.493 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.851 HD12 ' CB ' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -108.58 171.75 4.26 Favored Pre-proline 0 N--CA 1.497 1.896 0 O-C-N 121.132 -1.216 . . . . 0.0 109.658 179.456 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.549 ' HD3' ' O ' ' A' ' 30' ' ' LEU . 44.1 Cg_endo -69.41 159.42 53.73 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 123.621 1.327 . . . . 0.0 110.738 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -61.15 -24.04 65.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.32 -0.863 . . . . 0.0 109.822 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -88.05 9.69 21.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.335 -0.853 . . . . 0.0 109.854 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.851 ' CB ' HD12 ' A' ' 49' ' ' LEU . . . -59.16 126.09 26.26 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.374 -0.829 . . . . 0.0 110.233 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.924 ' O ' HD13 ' A' ' 55' ' ' ILE . 14.1 ttm-85 -53.82 150.08 7.94 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.317 -0.864 . . . . 0.0 110.351 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.924 HD13 ' O ' ' A' ' 54' ' ' ARG . 5.8 mm -146.87 175.03 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.443 -0.786 . . . . 0.0 110.013 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.572 ' HA ' ' CG1' ' A' ' 7' ' ' VAL . 0.1 OUTLIER -46.44 94.63 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.35 -0.844 . . . . 0.0 110.211 179.31 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.475 ' N ' ' O ' ' A' ' 55' ' ' ILE . 0.1 OUTLIER -116.29 -13.93 11.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.184 -0.948 . . . . 0.0 110.364 -179.904 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.0 t 49.86 -172.14 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.201 -0.937 . . . . 0.0 110.177 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 133.08 -129.43 5.43 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.33 138.47 53.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.328 -1.101 . . . . 0.0 110.265 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 32.5 t -43.61 113.75 0.55 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.233 -0.917 . . . . 0.0 110.179 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.514 ' CB ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -86.88 35.1 0.68 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.178 -0.951 . . . . 0.0 110.356 -179.961 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.654 0 O-C-N 121.281 -0.887 . . . . 0.0 110.105 179.978 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 2.8 ptmt . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.23 0.538 . . . . 0.0 110.184 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.502 HG22 ' HG ' ' A' ' 49' ' ' LEU . 3.3 tt -120.52 163.53 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.269 -0.894 . . . . 0.0 110.313 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.509 ' CB ' ' HG2' ' A' ' 47' ' ' GLN . 35.1 p-10 -125.26 117.19 23.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.589 -0.694 . . . . 0.0 109.675 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -153.37 -165.03 13.1 Favored Glycine 0 N--CA 1.493 2.455 0 C-N-CA 119.529 -1.32 . . . . 0.0 110.285 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.688 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 21.4 m-85 -124.9 97.84 37.66 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.424 -1.045 . . . . 0.0 110.523 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.894 ' CA ' HG22 ' A' ' 55' ' ' ILE . 44.2 Cg_endo -70.68 130.31 18.01 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.865 1.455 . . . . 0.0 110.691 179.449 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.589 HG12 HG22 ' A' ' 15' ' ' ILE . 15.6 m -80.51 -162.53 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.303 -0.873 . . . . 0.0 110.523 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.424 ' O ' ' NH1' ' A' ' 54' ' ' ARG . 1.0 OUTLIER -74.63 -88.59 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.439 -0.788 . . . . 0.0 110.553 -179.544 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.473 ' O ' ' NH1' ' A' ' 62' ' ' ARG . 0.2 OUTLIER -142.35 -66.79 0.39 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.295 -0.878 . . . . 0.0 110.066 -179.888 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.5 ' O ' ' HB2' ' A' ' 11' ' ' ASN . 4.0 m-90 -90.2 10.38 24.8 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.307 -0.87 . . . . 0.0 109.823 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.5 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 6.2 m-20 65.75 5.44 3.36 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.627 -0.67 . . . . 0.0 110.655 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 2.7 t -73.65 -36.8 65.43 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.047 -1.033 . . . . 0.0 109.617 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.464 ' O ' ' O ' ' A' ' 14' ' ' ARG . 5.8 tttt -86.72 152.3 22.65 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.42 -0.8 . . . . 0.0 109.333 179.092 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.464 ' O ' ' O ' ' A' ' 13' ' ' LYS . 1.1 ptp180 -38.31 160.25 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.419 -0.801 . . . . 0.0 110.983 -179.421 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.598 HD12 ' CB ' ' A' ' 43' ' ' SER . 30.3 pt -70.5 0.71 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.383 -0.823 . . . . 0.0 110.84 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.596 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 1.7 t -141.74 121.86 13.8 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.174 -0.954 . . . . 0.0 109.406 179.192 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.66 ' CD2' ' CD2' ' A' ' 22' ' ' TYR . 1.1 t90 -60.94 -137.28 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.14 -0.975 . . . . 0.0 110.111 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -142.6 30.6 1.51 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.159 -0.963 . . . . 0.0 110.468 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.555 ' HB2' ' CE3' ' A' ' 17' ' ' TRP . 0.7 OUTLIER -143.63 134.47 25.27 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.152 -0.967 . . . . 0.0 110.235 179.759 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -69.17 -6.81 31.11 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.313 -0.867 . . . . 0.0 110.119 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.84 -21.84 12.89 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.32 -0.863 . . . . 0.0 110.224 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.66 ' CD2' ' CD2' ' A' ' 17' ' ' TRP . 8.5 t80 -72.53 -56.74 4.9 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.243 -0.911 . . . . 0.0 109.579 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.475 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 1.6 t -56.3 -30.25 62.27 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.435 -0.791 . . . . 0.0 109.51 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.488 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 10.0 t-20 -81.14 -36.04 30.76 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.134 -0.979 . . . . 0.0 109.99 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -64.06 -48.77 74.95 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.197 -0.939 . . . . 0.0 109.711 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.64 -40.02 73.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.372 -0.83 . . . . 0.0 109.867 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.475 ' SG ' ' O ' ' A' ' 23' ' ' CYS . 9.7 m -62.74 -41.01 98.99 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.314 -0.867 . . . . 0.0 109.747 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 24' ' ' ASN . 0.0 OUTLIER -63.79 -24.4 67.74 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.204 -0.935 . . . . 0.0 109.347 179.302 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.83 -37.03 91.89 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 107.638 -2.185 . . . . 0.0 107.638 178.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.509 ' O ' ' HB3' ' A' ' 31' ' ' LYS . 1.1 mt -93.67 20.19 7.76 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.815 -0.815 . . . . 0.0 109.245 178.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.509 ' HB3' ' O ' ' A' ' 30' ' ' LEU . 0.1 OUTLIER 69.61 15.78 8.12 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.851 -0.53 . . . . 0.0 111.365 179.557 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.667 ' HB1' ' HB3' ' A' ' 46' ' ' CYS . . . -78.36 86.04 4.45 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.744 -1.222 . . . . 0.0 109.26 179.273 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.416 ' C ' ' O ' ' A' ' 32' ' ' ALA . 2.2 m-20 -39.38 -90.3 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.621 -0.675 . . . . 0.0 111.488 -178.777 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.53 ' O ' ' HA ' ' A' ' 46' ' ' CYS . 12.5 p -67.01 92.34 0.24 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.31 -0.869 . . . . 0.0 111.109 -178.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.508 ' CA ' ' SG ' ' A' ' 46' ' ' CYS . . . -122.31 108.79 1.32 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 108.91 -1.676 . . . . 0.0 108.91 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.411 ' CD1' ' C ' ' A' ' 36' ' ' TYR . 30.4 p90 -135.8 165.57 25.3 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.178 -1.19 . . . . 0.0 110.651 -179.516 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.495 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.0 OUTLIER -107.59 128.99 55.03 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.317 -0.864 . . . . 0.0 109.94 179.608 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.601 ' CD1' ' HB2' ' A' ' 42' ' ' LEU . 35.5 t-105 -79.6 166.87 21.43 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.091 -1.006 . . . . 0.0 110.005 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -98.25 -27.35 8.77 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 120.003 -1.094 . . . . 0.0 110.369 -179.147 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.577 ' HB3' ' CD1' ' A' ' 38' ' ' TRP . 48.6 t-105 -79.51 -91.8 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.994 -1.298 . . . . 0.0 110.074 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.527 HG23 ' C ' ' A' ' 40' ' ' TRP . 41.6 p -150.54 34.9 0.63 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.074 -1.016 . . . . 0.0 110.346 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.601 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 0.2 OUTLIER -89.53 0.29 57.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.303 -0.873 . . . . 0.0 110.074 179.809 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.598 ' CB ' HD12 ' A' ' 15' ' ' ILE . 0.9 OUTLIER 60.77 -176.4 0.11 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.227 -0.921 . . . . 0.0 110.201 -179.897 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.517 ' O ' ' HD2' ' A' ' 6' ' ' PRO . 0.9 OUTLIER -80.19 94.48 6.05 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.991 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.688 ' CD1' ' CZ ' ' A' ' 5' ' ' TYR . 9.3 t80 -79.98 138.97 37.18 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.117 -0.989 . . . . 0.0 110.682 -179.009 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.667 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . 74.2 m -149.3 144.44 26.47 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.343 -0.848 . . . . 0.0 110.228 179.561 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.509 ' HG2' ' CB ' ' A' ' 3' ' ' ASP . 39.1 mt-30 -126.64 149.39 49.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.387 -0.821 . . . . 0.0 110.069 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.486 ' O ' ' O ' ' A' ' 31' ' ' LYS . . . 99.59 21.73 13.97 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.844 HD12 ' CB ' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -101.48 169.29 7.91 Favored Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 121.072 -1.252 . . . . 0.0 109.898 179.626 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.519 ' HD2' ' HB2' ' A' ' 49' ' ' LEU . 44.6 Cg_endo -71.56 159.02 52.4 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 123.717 1.377 . . . . 0.0 110.342 -179.547 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.464 ' HA ' HD12 ' A' ' 2' ' ' ILE . 18.9 t70 -60.47 -23.66 64.64 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.157 -0.964 . . . . 0.0 109.723 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -92.87 17.24 10.88 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.466 -0.771 . . . . 0.0 109.609 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.844 ' CB ' HD12 ' A' ' 49' ' ' LEU . . . -47.72 143.67 3.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.372 -0.83 . . . . 0.0 110.104 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.48 ' O ' ' HA ' ' A' ' 6' ' ' PRO . 41.8 ttp85 -85.24 91.7 8.22 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.344 -0.848 . . . . 0.0 110.334 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.894 HG22 ' CA ' ' A' ' 6' ' ' PRO . 0.2 OUTLIER -140.3 166.81 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.324 -0.86 . . . . 0.0 109.965 179.69 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 6.1 mttt 45.25 67.12 0.77 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.135 -0.978 . . . . 0.0 109.759 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.494 ' HG2' ' O ' ' A' ' 55' ' ' ILE . 34.2 mmm-85 -125.44 17.25 8.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.247 -0.908 . . . . 0.0 110.458 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 57' ' ' ARG . 0.7 OUTLIER -42.23 138.99 1.52 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.334 -0.854 . . . . 0.0 109.941 179.884 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -164.25 -128.28 0.94 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.492 ' O ' ' O ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER -117.32 46.67 1.65 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.394 -1.063 . . . . 0.0 110.242 -179.97 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.492 ' O ' ' O ' ' A' ' 60' ' ' ARG . 52.2 m 56.06 121.46 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.476 0.655 . . . . 0.0 110.643 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.497 ' NH1' ' HA ' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -87.66 39.18 0.87 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.024 -1.048 . . . . 0.0 110.235 179.747 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.234 -0.917 . . . . 0.0 110.264 -179.938 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 7.5 mttt . . . . . 0 N--CA 1.494 1.749 0 CA-C-O 121.158 0.504 . . . . 0.0 110.025 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.72 HG22 ' O ' ' A' ' 49' ' ' LEU . 13.5 tt -118.98 161.81 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.143 -0.973 . . . . 0.0 110.337 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -131.34 131.46 43.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.259 -0.901 . . . . 0.0 110.032 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.449 ' O ' ' CD1' ' A' ' 45' ' ' TYR . . . -169.95 -176.17 39.43 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.702 -1.237 . . . . 0.0 110.011 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.681 ' CE1' ' CE1' ' A' ' 45' ' ' TYR . 66.8 m-85 -106.27 100.85 31.62 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.381 -1.07 . . . . 0.0 110.15 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.49 ' O ' ' HB3' ' A' ' 44' ' ' CYS . 43.3 Cg_endo -70.59 140.98 40.76 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.845 1.445 . . . . 0.0 110.478 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.915 ' CG1' HG22 ' A' ' 15' ' ' ILE . 5.1 m -110.12 -170.99 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.194 -0.941 . . . . 0.0 110.168 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -63.99 -145.04 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.24 -0.913 . . . . 0.0 110.686 -179.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -85.97 -47.57 9.49 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.427 -0.796 . . . . 0.0 110.648 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.476 ' HB3' ' CB ' ' A' ' 62' ' ' ARG . 3.3 m-90 -120.36 21.35 11.7 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.098 -1.001 . . . . 0.0 110.546 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.49 ' N ' ' OD1' ' A' ' 11' ' ' ASN . 1.8 m-20 57.7 15.12 2.74 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.118 -0.989 . . . . 0.0 110.154 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.8 t -84.94 -52.8 5.73 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.244 -0.91 . . . . 0.0 110.46 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.426 ' O ' ' CG ' ' A' ' 14' ' ' ARG . 5.6 tptt -61.49 -51.91 66.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.33 -0.856 . . . . 0.0 110.326 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.426 ' CG ' ' O ' ' A' ' 13' ' ' LYS . 0.1 OUTLIER 176.66 -158.71 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.204 -0.935 . . . . 0.0 110.511 -179.963 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.915 HG22 ' CG1' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -119.33 -18.04 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.368 -0.832 . . . . 0.0 109.491 179.558 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.623 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 1.8 t -132.64 111.99 11.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.469 -0.769 . . . . 0.0 110.22 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.464 ' CD2' ' HB3' ' A' ' 22' ' ' TYR . 0.0 OUTLIER -50.27 163.55 0.16 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.24 -0.913 . . . . 0.0 110.157 179.868 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -79.88 -24.75 40.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.305 -0.872 . . . . 0.0 109.983 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -83.88 145.72 28.46 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.272 -0.892 . . . . 0.0 110.047 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 16.0 p30 -80.46 7.6 9.47 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.212 -0.93 . . . . 0.0 110.416 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -131.23 -18.42 2.91 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.137 -0.977 . . . . 0.0 110.954 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.464 ' HB3' ' CD2' ' A' ' 17' ' ' TRP . 0.1 OUTLIER -60.36 -14.07 16.66 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.926 -1.109 . . . . 0.0 110.286 -179.753 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.449 ' O ' ' HB2' ' A' ' 27' ' ' CYS . 0.1 OUTLIER -103.58 -29.85 10.86 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.152 -0.967 . . . . 0.0 110.204 179.926 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.469 ' O ' ' HG2' ' A' ' 28' ' ' LYS . 55.1 t-20 -72.81 -52.58 14.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.192 -0.943 . . . . 0.0 109.582 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -54.75 -42.34 71.51 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.257 -0.902 . . . . 0.0 109.91 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.692 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -72.89 -41.64 64.45 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.279 -0.888 . . . . 0.0 109.431 179.749 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.478 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 1.5 m -60.61 -39.75 89.34 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.4 -0.813 . . . . 0.0 109.638 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.469 ' HG2' ' O ' ' A' ' 24' ' ' ASN . 1.7 mmmp? -61.73 -30.17 70.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.362 -0.837 . . . . 0.0 109.6 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.82 -34.01 80.74 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 108.149 -1.981 . . . . 0.0 108.149 179.223 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.55 ' O ' ' CB ' ' A' ' 31' ' ' LYS . 62.4 mt -93.06 18.56 9.07 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.605 -0.938 . . . . 0.0 109.785 179.395 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.55 ' CB ' ' O ' ' A' ' 30' ' ' LEU . 0.1 OUTLIER 76.11 12.76 2.75 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.618 -0.676 . . . . 0.0 111.133 179.717 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.815 ' HB2' HD22 ' A' ' 49' ' ' LEU . . . -88.52 82.1 7.0 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.845 -1.159 . . . . 0.0 109.734 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.417 ' O ' ' HD3' ' A' ' 28' ' ' LYS . 72.1 m-20 -46.25 -74.91 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.576 -0.702 . . . . 0.0 111.151 -179.357 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.409 ' O ' ' HA ' ' A' ' 46' ' ' CYS . 11.0 t -69.76 90.38 0.59 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.424 -0.798 . . . . 0.0 110.983 -179.16 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.486 ' HA2' ' SG ' ' A' ' 46' ' ' CYS . . . -122.04 113.89 2.37 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 108.976 -1.65 . . . . 0.0 108.976 179.212 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.572 ' CE1' ' HB3' ' A' ' 45' ' ' TYR . 27.4 p90 -133.28 154.6 50.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.123 -1.222 . . . . 0.0 110.485 -179.534 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.487 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.5 OUTLIER -107.73 118.08 35.81 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.332 -0.855 . . . . 0.0 110.151 179.775 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.616 ' CD1' ' HB3' ' A' ' 40' ' ' TRP . 25.0 t-105 -85.71 99.37 11.28 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.157 -0.965 . . . . 0.0 110.248 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.71 68.03 1.02 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.616 ' HB3' ' CD1' ' A' ' 38' ' ' TRP . 57.3 t-105 -157.94 -88.61 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.251 -1.147 . . . . 0.0 110.254 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 67.0 p -144.74 23.12 1.59 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.114 -0.991 . . . . 0.0 110.281 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.591 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 0.4 OUTLIER -121.01 11.17 10.94 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.168 -0.958 . . . . 0.0 110.537 -179.82 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.623 ' HA ' ' HB2' ' A' ' 16' ' ' CYS . 25.7 m 46.81 -170.23 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.919 -1.113 . . . . 0.0 109.973 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.49 ' HB3' ' O ' ' A' ' 6' ' ' PRO . 51.2 t -77.65 151.65 34.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.101 -1.0 . . . . 0.0 109.139 179.224 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.681 ' CE1' ' CE1' ' A' ' 5' ' ' TYR . 6.1 t80 -147.85 123.86 10.72 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.836 -1.165 . . . . 0.0 111.299 -179.413 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.637 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . 80.0 m -130.63 142.73 50.45 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.444 -0.785 . . . . 0.0 109.453 178.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 13.2 mp0 -116.98 131.17 57.02 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.082 -1.011 . . . . 0.0 110.22 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.598 ' C ' HD23 ' A' ' 49' ' ' LEU . . . 105.35 42.04 1.81 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.815 HD22 ' HB2' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -103.51 -174.79 0.35 Allowed Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.1 -1.236 . . . . 0.0 109.466 179.744 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.692 ' HD2' ' HB2' ' A' ' 53' ' ' ALA . 49.9 Cg_endo -86.23 160.33 9.88 Favored 'Trans proline' 0 C--N 1.303 -1.842 0 O-C-N 123.938 1.493 . . . . 0.0 109.764 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -59.91 -19.54 52.19 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.051 -1.031 . . . . 0.0 109.756 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -99.54 22.01 11.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.331 -0.856 . . . . 0.0 109.645 179.373 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.692 ' HB2' ' HD2' ' A' ' 50' ' ' PRO . . . -60.1 137.9 58.0 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.374 -0.828 . . . . 0.0 110.244 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.671 ' O ' HD13 ' A' ' 55' ' ' ILE . 12.2 ttp-105 -77.69 129.61 35.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.267 -0.896 . . . . 0.0 110.03 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.671 HD13 ' O ' ' A' ' 54' ' ' ARG . 12.9 mm -134.5 177.15 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.182 -0.949 . . . . 0.0 109.616 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.496 ' H ' HG22 ' A' ' 55' ' ' ILE . 2.4 ptmt -67.14 61.77 0.05 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.121 -0.987 . . . . 0.0 109.191 179.446 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.53 ' N ' ' O ' ' A' ' 55' ' ' ILE . 20.0 ttm-85 -86.86 -25.17 24.63 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.598 -0.689 . . . . 0.0 110.665 -179.205 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.8 m -123.19 162.0 23.4 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.14 -0.975 . . . . 0.0 110.119 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -145.17 13.97 1.88 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.515 ' O ' ' O ' ' A' ' 61' ' ' CYS . 2.4 mpp_? -106.55 41.86 1.37 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.096 -1.238 . . . . 0.0 110.211 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.515 ' O ' ' O ' ' A' ' 60' ' ' ARG . 42.7 t 42.42 104.25 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.501 0.667 . . . . 0.0 111.285 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.476 ' CB ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -81.53 45.39 0.87 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.087 -1.008 . . . . 0.0 110.412 179.588 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.069 -1.019 . . . . 0.0 110.183 179.873 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 4.0 pttp . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.265 0.555 . . . . 0.0 110.248 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.503 ' CG2' ' HG ' ' A' ' 49' ' ' LEU . 15.2 tt -131.68 161.1 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.266 -0.896 . . . . 0.0 110.136 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.443 ' OD1' ' HA ' ' A' ' 47' ' ' GLN . 48.8 m-20 -127.46 147.57 50.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.379 -0.826 . . . . 0.0 110.133 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 164.21 -179.93 38.78 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.668 ' CZ ' ' CD2' ' A' ' 45' ' ' TYR . 23.8 m-85 -98.22 109.82 53.68 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.331 -1.1 . . . . 0.0 110.241 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.521 ' CA ' HG22 ' A' ' 55' ' ' ILE . 48.8 Cg_endo -74.8 130.53 13.58 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 123.972 1.512 . . . . 0.0 110.576 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.593 HG12 ' HA ' ' A' ' 15' ' ' ILE . 16.4 m -119.66 -168.22 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.23 -0.919 . . . . 0.0 109.767 179.617 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.512 ' HB2' ' HB2' ' A' ' 14' ' ' ARG . 0.7 OUTLIER -66.58 -176.84 0.51 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.332 -0.855 . . . . 0.0 110.139 179.712 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.506 ' HB3' ' CE2' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -79.1 -5.85 55.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.326 -0.859 . . . . 0.0 109.9 179.723 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.528 ' HA ' ' HB2' ' A' ' 62' ' ' ARG . 4.5 m-90 -137.98 3.62 2.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.282 -0.886 . . . . 0.0 110.513 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.47 ' N ' ' OD1' ' A' ' 11' ' ' ASN . 2.2 m-20 59.73 12.21 2.83 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.283 -0.886 . . . . 0.0 110.524 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 4.2 t -77.78 -62.85 1.54 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.097 -1.002 . . . . 0.0 111.186 -178.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.516 ' O ' ' CB ' ' A' ' 14' ' ' ARG . 1.5 tmtt? -136.39 98.98 3.97 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.059 -1.026 . . . . 0.0 111.313 -179.089 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.566 ' O ' ' N ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER 168.04 -88.74 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.361 -0.837 . . . . 0.0 110.222 179.098 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.657 HG23 ' CB ' ' A' ' 43' ' ' SER . 5.0 mt 55.57 -81.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.142 -0.974 . . . . 0.0 110.087 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.629 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 37.5 t -122.77 127.91 49.78 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.428 -0.795 . . . . 0.0 109.946 179.238 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.64 ' CZ3' ' CD2' ' A' ' 22' ' ' TYR . 0.1 OUTLIER -69.8 -145.5 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.051 -1.03 . . . . 0.0 109.92 179.609 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -118.02 -9.73 10.5 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.239 -0.913 . . . . 0.0 110.21 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.443 ' CB ' ' HB2' ' A' ' 22' ' ' TYR . 2.1 m-20 -117.8 166.65 12.2 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.318 -0.864 . . . . 0.0 110.296 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -88.68 -59.47 2.22 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.254 -0.904 . . . . 0.0 110.308 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.28 -26.98 66.9 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.208 -0.932 . . . . 0.0 110.24 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.64 ' CD2' ' CZ3' ' A' ' 17' ' ' TRP . 0.4 OUTLIER -58.86 -53.65 56.01 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.316 -0.865 . . . . 0.0 110.506 -179.818 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -66.77 -27.18 67.38 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.17 -0.956 . . . . 0.0 110.337 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.439 ' OD1' ' O ' ' A' ' 33' ' ' ASP . 25.0 t-20 -66.71 -55.61 14.32 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.276 -0.89 . . . . 0.0 110.272 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -44.09 -49.86 8.7 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.347 -0.846 . . . . 0.0 110.417 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.53 -42.1 95.96 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.201 -0.937 . . . . 0.0 110.154 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.411 ' SG ' ' HG3' ' A' ' 6' ' ' PRO . 0.8 OUTLIER -59.54 -39.87 85.38 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.243 -0.911 . . . . 0.0 109.419 179.474 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.1 mtmt -62.91 -33.9 76.3 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.258 -0.901 . . . . 0.0 109.154 179.107 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -50.87 -39.42 39.84 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.766 -1.734 . . . . 0.0 108.766 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.655 ' O ' ' CB ' ' A' ' 31' ' ' LYS . 6.9 mt -79.94 -34.07 39.14 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.248 -1.148 . . . . 0.0 109.609 179.415 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.655 ' CB ' ' O ' ' A' ' 30' ' ' LEU . 1.8 tttp 141.14 0.35 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.658 0 C-N-CA 123.015 0.526 . . . . 0.0 110.126 179.403 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.498 ' HB1' ' HB3' ' A' ' 46' ' ' CYS . . . -85.44 117.12 24.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.95 -1.094 . . . . 0.0 110.511 -179.328 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.439 ' O ' ' OD1' ' A' ' 24' ' ' ASN . 11.3 t0 -83.32 -59.15 2.55 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.272 -0.893 . . . . 0.0 110.309 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.93 88.04 2.9 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.388 -0.82 . . . . 0.0 110.117 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.482 ' CA ' ' SG ' ' A' ' 46' ' ' CYS . . . -124.03 109.68 1.33 Allowed Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -127.27 147.44 50.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.279 -1.13 . . . . 0.0 109.861 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.1 OUTLIER -91.66 140.64 29.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.284 -0.885 . . . . 0.0 110.815 -179.282 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.602 ' CD1' ' HB3' ' A' ' 40' ' ' TRP . 45.5 t-105 -79.78 104.11 10.14 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.276 -0.89 . . . . 0.0 109.407 179.217 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -76.4 76.09 1.53 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -179.184 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.811 ' CD1' HG22 ' A' ' 41' ' ' THR . 5.8 t-105 -160.5 -72.21 0.07 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.41 -1.053 . . . . 0.0 109.583 179.342 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.811 HG22 ' CD1' ' A' ' 40' ' ' TRP . 12.7 t -179.11 35.3 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.569 -0.707 . . . . 0.0 109.79 179.754 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.578 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 1.7 mt -113.12 -84.3 0.59 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.244 -0.91 . . . . 0.0 110.866 -179.549 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.657 ' CB ' HG23 ' A' ' 15' ' ' ILE . 3.2 t 170.36 175.76 0.06 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.411 -0.806 . . . . 0.0 109.59 -179.394 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.497 ' O ' ' CD2' ' A' ' 5' ' ' TYR . 10.3 t -63.49 159.96 17.43 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.003 -1.06 . . . . 0.0 108.923 179.415 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.668 ' CD2' ' CZ ' ' A' ' 5' ' ' TYR . 1.0 OUTLIER -147.99 116.41 6.59 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.877 -1.14 . . . . 0.0 110.935 -179.755 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.498 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . 71.6 m -128.46 149.38 50.6 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.28 -0.887 . . . . 0.0 109.686 179.238 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.443 ' HA ' ' OD1' ' A' ' 3' ' ' ASP . 8.4 mp0 -127.96 104.51 7.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.163 -0.96 . . . . 0.0 110.074 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.51 ' C ' HD23 ' A' ' 49' ' ' LEU . . . 131.51 49.86 0.1 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.869 HD12 ' CB ' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -120.37 173.47 3.69 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.351 -1.087 . . . . 0.0 110.106 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.515 ' HD2' ' HB2' ' A' ' 49' ' ' LEU . 43.0 Cg_endo -70.38 157.7 58.4 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.944 1.497 . . . . 0.0 110.362 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -60.39 -18.0 47.62 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.285 -0.884 . . . . 0.0 110.033 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -89.83 9.18 28.45 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.34 -0.85 . . . . 0.0 109.968 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.869 ' CB ' HD12 ' A' ' 49' ' ' LEU . . . -58.42 122.01 12.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.388 -0.82 . . . . 0.0 110.275 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.03 130.88 37.01 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.181 -0.949 . . . . 0.0 110.297 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.709 HD12 ' C ' ' A' ' 55' ' ' ILE . 2.3 pp -145.0 -179.56 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.317 -0.865 . . . . 0.0 110.074 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.403 ' O ' ' HG3' ' A' ' 56' ' ' LYS . 4.1 ptpt -51.35 88.2 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.323 -0.861 . . . . 0.0 110.479 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.523 ' N ' ' O ' ' A' ' 55' ' ' ILE . 0.3 OUTLIER -110.25 -28.85 8.42 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.408 -0.808 . . . . 0.0 109.382 179.526 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -125.48 170.84 11.01 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.67 -0.644 . . . . 0.0 110.222 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -124.71 -3.8 7.61 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.14 131.64 54.43 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.272 -1.134 . . . . 0.0 110.041 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 33.5 m -44.31 126.57 5.27 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.196 -0.94 . . . . 0.0 109.813 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.528 ' HB2' ' HA ' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -86.68 50.31 1.98 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.131 -0.98 . . . . 0.0 110.127 179.879 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.187 -0.946 . . . . 0.0 110.246 179.96 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 38.1 pttt . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.298 0.57 . . . . 0.0 110.219 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.721 HG22 ' O ' ' A' ' 49' ' ' LEU . 2.8 tt -154.36 166.07 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.261 -0.899 . . . . 0.0 110.056 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.508 ' N ' HG12 ' A' ' 2' ' ' ILE . 2.4 p-10 -147.87 166.04 28.81 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.369 -0.832 . . . . 0.0 109.965 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 157.36 -152.12 23.41 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.456 ' HA ' ' O ' ' A' ' 44' ' ' CYS . 6.9 m-85 -110.58 99.22 40.41 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.276 -1.131 . . . . 0.0 110.393 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.818 ' HA ' HG22 ' A' ' 55' ' ' ILE . 46.7 Cg_endo -73.85 126.76 10.94 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 124.066 1.561 . . . . 0.0 110.146 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.707 HG12 HG23 ' A' ' 15' ' ' ILE . 16.0 m -79.59 -172.29 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.243 -0.911 . . . . 0.0 110.256 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.451 ' O ' ' HB2' ' A' ' 9' ' ' TYR . 6.9 p-10 -77.28 -44.63 29.06 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.155 -0.966 . . . . 0.0 109.87 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.581 ' HB3' ' CE3' ' A' ' 10' ' ' TRP . 1.7 t80 178.98 -66.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.675 -0.641 . . . . 0.0 109.444 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.581 ' CE3' ' HB3' ' A' ' 9' ' ' TYR . 2.6 m-90 -107.27 21.68 17.14 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.35 -0.844 . . . . 0.0 109.37 179.272 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 2.3 m120 59.11 14.07 3.29 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.46 -0.775 . . . . 0.0 110.307 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.9 m -68.9 -36.26 77.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.259 -0.901 . . . . 0.0 109.969 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.1 44.7 1.01 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.423 -0.798 . . . . 0.0 109.773 179.642 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 62.32 -179.8 0.13 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.332 -0.855 . . . . 0.0 110.081 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.707 HG23 HG12 ' A' ' 7' ' ' VAL . 3.3 mt -82.11 -6.56 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.211 -0.931 . . . . 0.0 110.548 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.525 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 46.3 t -132.12 162.56 30.54 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.286 -0.884 . . . . 0.0 110.37 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.669 ' CE3' ' CG ' ' A' ' 22' ' ' TYR . 0.3 OUTLIER -105.77 -153.66 0.5 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.274 -0.891 . . . . 0.0 109.889 179.605 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -105.48 -20.27 13.53 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.184 -0.948 . . . . 0.0 110.113 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.503 ' HB3' ' HB2' ' A' ' 22' ' ' TYR . 0.3 OUTLIER -100.98 149.7 23.65 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.262 -0.899 . . . . 0.0 110.137 179.963 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -84.32 -25.56 29.16 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.215 -0.928 . . . . 0.0 110.276 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -90.22 -28.61 18.74 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.23 -0.919 . . . . 0.0 110.355 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.669 ' CG ' ' CE3' ' A' ' 17' ' ' TRP . 28.4 t80 -57.54 -46.36 83.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.262 -0.899 . . . . 0.0 110.179 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -64.45 -43.41 94.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.193 -0.942 . . . . 0.0 109.792 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.507 ' O ' ' HG2' ' A' ' 28' ' ' LYS . 50.0 t30 -57.92 -40.9 81.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.222 -0.924 . . . . 0.0 109.675 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.57 -56.82 17.0 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.222 -0.923 . . . . 0.0 110.066 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.72 -36.87 82.19 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.238 -0.914 . . . . 0.0 109.966 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.48 ' SG ' ' HG3' ' A' ' 6' ' ' PRO . 5.2 m -63.02 -43.06 99.77 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.173 -0.955 . . . . 0.0 109.469 179.553 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.507 ' HG2' ' O ' ' A' ' 24' ' ' ASN . 0.3 OUTLIER -58.36 -27.78 64.52 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.294 -0.879 . . . . 0.0 109.257 179.027 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.14 -38.34 94.26 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 107.956 -2.057 . . . . 0.0 107.956 179.104 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.529 ' O ' ' HD3' ' A' ' 50' ' ' PRO . 5.0 mt -89.78 21.47 3.54 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.65 -0.912 . . . . 0.0 109.14 178.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.504 ' HB3' ' O ' ' A' ' 30' ' ' LEU . 0.4 OUTLIER 69.65 15.92 8.06 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.647 -0.658 . . . . 0.0 110.798 179.922 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.623 ' HB1' ' HB3' ' A' ' 46' ' ' CYS . . . -88.38 73.6 8.76 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.933 -1.105 . . . . 0.0 109.383 179.544 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.425 ' C ' ' O ' ' A' ' 32' ' ' ALA . 0.1 OUTLIER -39.82 -76.94 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.565 -0.709 . . . . 0.0 110.848 -179.289 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.495 ' O ' ' HA ' ' A' ' 46' ' ' CYS . 1.8 t -65.88 93.65 0.19 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.443 -0.786 . . . . 0.0 110.454 -179.629 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.522 ' CA ' ' SG ' ' A' ' 46' ' ' CYS . . . -128.52 93.64 0.36 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.523 ' C ' ' CD1' ' A' ' 36' ' ' TYR . 9.4 p90 -113.47 153.35 28.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.294 -1.121 . . . . 0.0 109.859 179.645 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.511 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.1 OUTLIER -108.8 139.99 42.86 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.097 -1.002 . . . . 0.0 110.428 -179.863 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.639 ' CD1' ' CD1' ' A' ' 42' ' ' LEU . 49.1 t-105 -79.54 86.85 5.16 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.292 -0.88 . . . . 0.0 109.848 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -62.38 80.77 0.03 OUTLIER Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -179.449 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.825 ' CD1' HG22 ' A' ' 41' ' ' THR . 14.0 t-105 -160.53 -73.16 0.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.435 -1.038 . . . . 0.0 109.6 179.668 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.825 HG22 ' CD1' ' A' ' 40' ' ' TRP . 15.0 t -179.07 40.1 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.634 -0.666 . . . . 0.0 109.588 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.639 ' CD1' ' CD1' ' A' ' 38' ' ' TRP . 0.3 OUTLIER -123.25 -80.65 0.63 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.281 -0.887 . . . . 0.0 110.818 -179.485 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.525 ' HA ' ' HB2' ' A' ' 16' ' ' CYS . 1.2 p 170.01 176.09 0.05 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.263 -0.898 . . . . 0.0 109.901 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.511 ' HA ' ' HA ' ' A' ' 37' ' ' CYS . 6.8 t -74.6 166.54 23.39 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.23 -0.919 . . . . 0.0 110.176 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.467 ' CE1' ' OE1' ' A' ' 47' ' ' GLN . 0.8 OUTLIER -148.98 108.47 3.98 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.191 -0.943 . . . . 0.0 110.35 -179.973 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.623 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . 64.9 m -129.23 137.71 51.26 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.375 -0.828 . . . . 0.0 109.729 179.424 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.467 ' OE1' ' CE1' ' A' ' 45' ' ' TYR . 2.2 mt-30 -124.18 128.4 49.17 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.086 -1.009 . . . . 0.0 110.314 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.488 ' O ' ' O ' ' A' ' 31' ' ' LYS . . . 121.25 28.9 1.56 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.892 HD12 ' CB ' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -106.2 169.5 6.84 Favored Pre-proline 0 N--CA 1.497 1.883 0 O-C-N 121.135 -1.215 . . . . 0.0 109.993 179.6 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.671 ' O ' HG21 ' A' ' 2' ' ' ILE . 42.4 Cg_endo -67.23 157.62 60.85 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 O-C-N 123.87 1.458 . . . . 0.0 111.126 -179.491 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -58.46 -27.86 64.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.488 -0.758 . . . . 0.0 109.883 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.55 ' ND2' ' O ' ' A' ' 52' ' ' ASN . 0.5 OUTLIER -90.75 20.42 4.74 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.393 -0.817 . . . . 0.0 109.457 179.437 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.892 ' CB ' HD12 ' A' ' 49' ' ' LEU . . . -62.84 110.83 1.89 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.665 -0.647 . . . . 0.0 110.592 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.509 ' NH1' ' O ' ' A' ' 9' ' ' TYR . 1.3 tmm_? -65.02 129.36 39.43 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.324 -0.86 . . . . 0.0 110.307 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.818 HG22 ' HA ' ' A' ' 6' ' ' PRO . 2.7 pt -152.55 -163.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.543 -0.723 . . . . 0.0 109.907 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.488 ' O ' ' HG3' ' A' ' 56' ' ' LYS . 2.5 ptmm? -40.72 93.43 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.569 -0.707 . . . . 0.0 110.498 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.526 ' N ' ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -135.17 2.95 3.1 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.294 -0.879 . . . . 0.0 110.113 -179.935 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -153.46 -173.63 4.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.239 -0.913 . . . . 0.0 109.864 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -166.73 23.93 0.13 Allowed Glycine 0 N--CA 1.49 2.272 0 C-N-CA 119.674 -1.25 . . . . 0.0 110.049 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.485 ' O ' ' O ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER -137.16 47.47 2.11 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.959 -1.318 . . . . 0.0 110.411 179.802 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.485 ' O ' ' O ' ' A' ' 60' ' ' ARG . 0.5 OUTLIER 47.36 103.07 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.619 -0.676 . . . . 0.0 110.742 179.885 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.501 ' N ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -79.9 54.68 1.92 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.382 -0.824 . . . . 0.0 110.171 179.811 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.165 -0.959 . . . . 0.0 110.263 -179.962 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 20.2 mttt . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.277 0.561 . . . . 0.0 110.232 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.552 HG22 ' O ' ' A' ' 49' ' ' LEU . 10.8 tt -120.26 165.16 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.33 -0.856 . . . . 0.0 110.051 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -143.34 144.12 31.96 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.277 -0.889 . . . . 0.0 110.136 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 173.51 -151.6 13.81 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.585 ' N ' ' CD1' ' A' ' 5' ' ' TYR . 20.0 m-85 -110.15 98.31 34.53 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.325 -1.103 . . . . 0.0 110.413 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.657 ' HA ' HG22 ' A' ' 55' ' ' ILE . 49.2 Cg_endo -75.77 144.2 27.55 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 124.025 1.54 . . . . 0.0 110.738 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 1.07 ' CG1' HG23 ' A' ' 15' ' ' ILE . 6.3 m -109.14 -171.97 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.199 -0.938 . . . . 0.0 110.015 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -89.2 -88.47 0.16 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.217 -0.927 . . . . 0.0 110.19 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.519 ' HB3' ' CD2' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -141.09 -42.71 0.38 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.143 -0.973 . . . . 0.0 110.239 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.519 ' CD2' ' HB3' ' A' ' 9' ' ' TYR . 6.2 m-90 -116.46 16.57 15.61 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.256 -0.902 . . . . 0.0 110.057 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 88.6 m-20 56.54 17.12 2.85 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.261 -0.9 . . . . 0.0 110.146 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 56.4 m -70.14 -11.01 60.59 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.266 -0.896 . . . . 0.0 110.197 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.462 ' HD2' ' N ' ' A' ' 13' ' ' LYS . 5.5 mptt -108.04 40.01 1.83 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.328 -0.858 . . . . 0.0 110.241 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.497 ' O ' ' HB ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER 46.17 36.22 3.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.173 -0.954 . . . . 0.0 109.997 -179.997 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 1.07 HG23 ' CG1' ' A' ' 7' ' ' VAL . 2.5 mt 62.91 7.65 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.491 -0.755 . . . . 0.0 110.65 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.554 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 32.8 t -148.64 111.96 4.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.054 -1.029 . . . . 0.0 109.696 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.465 ' O ' ' O ' ' A' ' 16' ' ' CYS . 5.2 t90 -43.44 -94.3 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.329 -0.857 . . . . 0.0 110.306 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -160.54 -64.0 0.06 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.771 -1.206 . . . . 0.0 110.366 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.546 ' HB2' ' CG ' ' A' ' 22' ' ' TYR . 0.8 OUTLIER -70.15 171.02 10.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.464 -0.773 . . . . 0.0 110.367 -179.937 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -75.75 -54.69 6.55 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.234 -0.916 . . . . 0.0 109.966 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -71.9 -16.99 62.13 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.363 -0.836 . . . . 0.0 110.061 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.546 ' CG ' ' HB2' ' A' ' 19' ' ' ASN . 1.4 m-30 -57.72 -26.41 61.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.195 -0.941 . . . . 0.0 110.033 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.4 t -98.19 -17.69 18.86 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.252 -0.905 . . . . 0.0 110.243 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 35' ' ' GLY . 66.9 t30 -72.0 -40.28 68.63 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.258 -0.902 . . . . 0.0 110.069 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.13 -47.45 82.68 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.012 -1.055 . . . . 0.0 109.397 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.48 -43.44 85.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.374 -0.829 . . . . 0.0 109.354 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.644 ' HA ' HD12 ' A' ' 30' ' ' LEU . 1.8 m -60.23 -39.59 87.21 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.407 -0.808 . . . . 0.0 109.423 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.454 ' HG3' ' HA ' ' A' ' 33' ' ' ASP . 0.0 OUTLIER -60.05 -30.74 69.4 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.261 -0.899 . . . . 0.0 109.488 179.365 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.05 -31.65 79.47 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 107.798 -2.121 . . . . 0.0 107.798 179.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.644 HD12 ' HA ' ' A' ' 27' ' ' CYS . 1.8 mt -91.8 19.0 6.91 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.672 -0.899 . . . . 0.0 109.217 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.533 ' HB3' ' O ' ' A' ' 30' ' ' LEU . 1.5 tptt 72.76 13.38 5.15 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.805 -0.559 . . . . 0.0 111.019 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.622 ' HB2' HD22 ' A' ' 49' ' ' LEU . . . -92.34 73.06 5.3 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.902 -1.124 . . . . 0.0 109.975 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.454 ' HA ' ' HG3' ' A' ' 28' ' ' LYS . 18.9 m-20 -43.96 -62.0 1.27 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.316 -0.865 . . . . 0.0 110.407 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.416 ' HB3' ' NE2' ' A' ' 47' ' ' GLN . 0.3 OUTLIER -74.05 84.18 1.79 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.363 -0.836 . . . . 0.0 110.035 179.989 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.524 ' CA ' ' SG ' ' A' ' 46' ' ' CYS . . . -124.35 116.17 2.72 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.528 ' C ' ' CD1' ' A' ' 36' ' ' TYR . 12.8 p90 -139.04 147.44 42.06 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.316 -1.108 . . . . 0.0 109.85 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.458 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.0 OUTLIER -100.26 139.63 35.65 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.165 -0.959 . . . . 0.0 110.492 -179.619 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.58 ' CD1' ' HB2' ' A' ' 42' ' ' LEU . 26.0 t-105 -79.65 103.71 9.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.235 -0.916 . . . . 0.0 109.626 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -67.12 65.59 0.22 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.847 ' CD1' HG22 ' A' ' 41' ' ' THR . 6.3 t-105 -160.21 -65.77 0.07 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.284 -1.127 . . . . 0.0 109.883 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.847 HG22 ' CD1' ' A' ' 40' ' ' TRP . 3.8 t 177.62 35.83 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.53 -0.731 . . . . 0.0 109.903 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.58 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 9.6 mt -119.15 20.51 12.63 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.089 -1.007 . . . . 0.0 110.458 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.554 ' HA ' ' HB2' ' A' ' 16' ' ' CYS . 3.3 m 55.58 -170.42 0.07 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.153 -0.967 . . . . 0.0 110.179 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.468 ' O ' ' CD2' ' A' ' 5' ' ' TYR . 12.2 t -79.04 163.14 25.4 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.342 -0.849 . . . . 0.0 110.307 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -148.04 100.07 3.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.29 -0.882 . . . . 0.0 109.955 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.593 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . 63.7 m -123.3 148.93 45.45 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.173 -0.954 . . . . 0.0 110.357 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.426 ' N ' ' CD ' ' A' ' 47' ' ' GLN . 0.7 OUTLIER -131.64 140.19 49.3 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.352 -0.843 . . . . 0.0 109.857 179.717 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.479 ' O ' ' O ' ' A' ' 31' ' ' LYS . . . 111.26 20.39 7.09 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.915 HD12 ' CB ' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -99.49 168.31 9.77 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 121.232 -1.158 . . . . 0.0 109.65 179.472 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.508 ' HD3' ' O ' ' A' ' 30' ' ' LEU . 43.3 Cg_endo -70.5 161.2 46.88 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.619 1.326 . . . . 0.0 110.62 -179.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -62.05 -16.68 53.68 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.219 -0.926 . . . . 0.0 109.717 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -94.84 15.01 19.62 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.435 -0.791 . . . . 0.0 109.941 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.915 ' CB ' HD12 ' A' ' 49' ' ' LEU . . . -56.01 149.22 15.83 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.283 -0.886 . . . . 0.0 110.304 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.7 mtm105 -92.08 88.64 6.61 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.294 -0.879 . . . . 0.0 110.261 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.898 ' H ' HD13 ' A' ' 55' ' ' ILE . 0.2 OUTLIER -131.81 156.01 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.161 -0.962 . . . . 0.0 110.006 179.671 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 55' ' ' ILE . 8.9 mttt 42.45 56.0 3.91 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.236 -0.915 . . . . 0.0 110.303 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -88.05 -5.98 58.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.265 -0.897 . . . . 0.0 110.363 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.429 ' O ' ' ND2' ' A' ' 11' ' ' ASN . 0.1 OUTLIER 57.05 173.21 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.342 -0.849 . . . . 0.0 110.111 -179.909 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 101.41 132.94 7.92 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.67 173.44 8.1 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.188 -1.183 . . . . 0.0 110.236 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 35.1 t -43.4 104.99 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.364 -0.835 . . . . 0.0 110.169 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.518 ' CB ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -87.02 49.55 1.84 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.213 -0.929 . . . . 0.0 110.179 -179.882 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.432 ' HB2' ' O ' ' A' ' 62' ' ' ARG . . . . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.131 -0.98 . . . . 0.0 110.309 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.247 0.546 . . . . 0.0 110.237 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.489 HG22 ' O ' ' A' ' 49' ' ' LEU . 7.7 tt -119.22 163.95 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.272 -0.893 . . . . 0.0 110.28 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 3' ' ' ASP . 1.9 p30 -141.0 138.45 33.72 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.409 -0.807 . . . . 0.0 110.14 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.495 ' O ' ' HA ' ' A' ' 45' ' ' TYR . . . -177.59 -163.29 29.19 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.49 ' HA ' ' O ' ' A' ' 44' ' ' CYS . 3.0 m-85 -105.86 102.7 40.39 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.301 -1.117 . . . . 0.0 110.262 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.509 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 47.7 Cg_endo -74.3 109.98 3.0 Favored 'Trans proline' 0 C--N 1.301 -1.945 0 O-C-N 123.994 1.523 . . . . 0.0 111.187 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.777 HG12 HG13 ' A' ' 15' ' ' ILE . 14.6 m -91.29 -162.48 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.291 -0.88 . . . . 0.0 109.762 179.072 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.535 ' CB ' ' HB2' ' A' ' 13' ' ' LYS . 11.5 t0 -77.58 -87.97 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.334 -0.854 . . . . 0.0 109.829 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.488 ' O ' ' NH1' ' A' ' 54' ' ' ARG . 1.1 m-85 -141.29 -58.97 0.49 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.328 -0.857 . . . . 0.0 109.745 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.817 ' CD2' ' HB2' ' A' ' 63' ' ' ALA . 4.8 m-90 -106.22 24.42 12.51 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.442 -0.786 . . . . 0.0 109.678 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.484 ' OD1' HG21 ' A' ' 7' ' ' VAL . 58.9 m-80 57.58 15.5 2.85 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.367 -0.833 . . . . 0.0 109.726 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 5.1 t -92.5 -42.11 9.89 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.308 -0.87 . . . . 0.0 110.417 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.535 ' HB2' ' CB ' ' A' ' 8' ' ' ASP . 5.3 mmtp -60.41 -93.18 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.42 -0.8 . . . . 0.0 110.27 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.465 ' HG2' ' O ' ' A' ' 13' ' ' LYS . 2.7 mmp_? -144.68 101.4 3.66 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.175 -0.953 . . . . 0.0 110.511 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.777 HG13 HG12 ' A' ' 7' ' ' VAL . 4.3 tt -44.0 -27.6 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.218 -0.926 . . . . 0.0 109.458 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.623 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 30.9 t -158.91 106.25 1.82 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.597 -0.689 . . . . 0.0 110.415 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.405 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -54.58 -172.57 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.179 -0.951 . . . . 0.0 109.81 179.773 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -114.55 33.59 5.24 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.109 -0.994 . . . . 0.0 110.174 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -131.55 145.55 51.78 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.257 -0.902 . . . . 0.0 109.959 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.426 ' OD1' ' N ' ' A' ' 20' ' ' ASN . 15.5 p-10 -82.06 9.09 9.11 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.243 -0.911 . . . . 0.0 110.352 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.46 -33.77 2.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.238 -0.914 . . . . 0.0 110.313 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -52.72 -35.75 56.36 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.107 -0.996 . . . . 0.0 110.199 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.406 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 0.1 OUTLIER -88.86 -30.57 18.82 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.219 -0.925 . . . . 0.0 110.049 179.846 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -69.93 -52.43 24.61 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.347 -0.846 . . . . 0.0 110.316 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -50.12 -47.9 53.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.212 -0.93 . . . . 0.0 110.308 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.3 -41.24 66.85 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.239 -0.913 . . . . 0.0 110.15 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.456 ' SG ' ' HG3' ' A' ' 6' ' ' PRO . 8.3 m -59.91 -34.33 73.05 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.106 -0.996 . . . . 0.0 109.794 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.55 -31.79 73.06 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.391 -0.818 . . . . 0.0 109.726 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.13 -33.95 86.16 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 107.957 -2.057 . . . . 0.0 107.957 178.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.515 ' O ' ' HD3' ' A' ' 50' ' ' PRO . 1.4 mt -89.54 19.58 4.48 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.61 -0.936 . . . . 0.0 109.426 179.021 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.501 ' HB3' ' O ' ' A' ' 30' ' ' LEU . 0.4 OUTLIER 68.27 18.42 9.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.699 -0.625 . . . . 0.0 111.02 179.749 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.58 ' HB1' ' HB3' ' A' ' 46' ' ' CYS . . . -92.31 74.77 5.31 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.913 -1.117 . . . . 0.0 109.78 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 32' ' ' ALA . 62.9 t0 -39.99 -70.48 0.1 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.415 -0.803 . . . . 0.0 110.677 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.17 86.25 1.06 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.508 -0.745 . . . . 0.0 110.192 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.522 ' CA ' ' SG ' ' A' ' 46' ' ' CYS . . . -121.15 98.73 0.67 Allowed Glycine 0 N--CA 1.488 2.102 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.493 ' OH ' ' CD2' ' A' ' 45' ' ' TYR . 53.1 p90 -126.42 153.64 44.73 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.353 -1.087 . . . . 0.0 109.855 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.524 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.1 OUTLIER -102.2 146.33 28.14 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.139 -0.976 . . . . 0.0 110.367 -179.638 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.634 ' CD1' ' HB2' ' A' ' 42' ' ' LEU . 25.8 t-105 -79.82 148.57 31.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.139 -0.976 . . . . 0.0 109.645 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -106.36 53.19 0.64 Allowed Glycine 0 N--CA 1.491 2.335 0 C-N-CA 119.615 -1.279 . . . . 0.0 110.204 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.563 ' C ' HG23 ' A' ' 41' ' ' THR . 30.9 t-105 -160.54 -83.08 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.255 -1.144 . . . . 0.0 110.021 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.563 HG23 ' C ' ' A' ' 40' ' ' TRP . 72.6 p -155.25 38.54 0.4 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.407 -0.808 . . . . 0.0 110.354 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.634 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 0.4 OUTLIER -119.46 24.03 10.89 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.093 -1.004 . . . . 0.0 110.681 -179.847 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.623 ' HA ' ' HB2' ' A' ' 16' ' ' CYS . 90.5 p 45.52 -174.01 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.3 -0.875 . . . . 0.0 110.363 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.54 ' N ' ' HB2' ' A' ' 16' ' ' CYS . 25.3 t -71.87 171.97 10.75 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.184 -0.948 . . . . 0.0 109.261 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.495 ' HA ' ' O ' ' A' ' 4' ' ' GLY . 1.1 t80 -158.26 100.95 1.71 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.999 -1.063 . . . . 0.0 111.001 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.629 ' O ' HD21 ' A' ' 49' ' ' LEU . 85.9 m -121.05 137.2 54.76 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.353 -0.842 . . . . 0.0 109.533 179.109 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.451 ' OE1' ' N ' ' A' ' 47' ' ' GLN . 9.6 mp0 -121.87 148.11 45.14 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.163 -0.961 . . . . 0.0 110.35 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.5 ' O ' ' O ' ' A' ' 31' ' ' LYS . . . 100.05 27.18 7.94 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 1.103 HD12 ' CB ' ' A' ' 53' ' ' ALA . 0.2 OUTLIER -109.32 170.9 4.9 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.191 -1.182 . . . . 0.0 109.872 179.751 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.516 ' HD2' ' HB2' ' A' ' 49' ' ' LEU . 42.0 Cg_endo -68.43 158.35 58.01 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.689 1.363 . . . . 0.0 110.717 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -60.66 -22.61 64.04 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.332 -0.855 . . . . 0.0 110.173 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -85.38 11.73 9.71 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.243 -0.91 . . . . 0.0 109.94 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 1.103 ' CB ' HD12 ' A' ' 49' ' ' LEU . . . -62.16 135.82 57.67 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.304 -0.872 . . . . 0.0 110.548 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.631 ' O ' HG23 ' A' ' 55' ' ' ILE . 15.7 tpp85 -77.2 131.69 38.37 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.3 -0.875 . . . . 0.0 109.869 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.631 HG23 ' O ' ' A' ' 54' ' ' ARG . 1.3 pp -156.85 -173.24 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.276 -0.89 . . . . 0.0 110.303 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -45.89 93.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.212 -0.93 . . . . 0.0 110.608 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.479 ' N ' ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -112.6 22.39 14.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.333 -0.854 . . . . 0.0 109.856 179.604 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.87 -178.17 0.11 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.354 -0.841 . . . . 0.0 110.373 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.458 ' O ' ' O ' ' A' ' 60' ' ' ARG . . . 92.89 101.1 1.47 Allowed Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.529 ' O ' ' N ' ' A' ' 62' ' ' ARG . 2.8 ptm85 -50.73 -175.8 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.254 -1.145 . . . . 0.0 110.212 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.413 ' C ' ' O ' ' A' ' 60' ' ' ARG . 33.9 t -42.21 93.32 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.379 -0.825 . . . . 0.0 110.389 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.538 ' CB ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -84.07 43.66 0.95 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.339 -0.851 . . . . 0.0 110.481 -179.754 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.817 ' HB2' ' CD2' ' A' ' 10' ' ' TRP . . . . . . . . 0 N--CA 1.492 1.643 0 O-C-N 121.179 -0.95 . . . . 0.0 110.184 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.492 ' HG2' ' O ' ' A' ' 1' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.491 0.662 . . . . 0.0 110.34 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.524 ' CG2' ' HG ' ' A' ' 49' ' ' LEU . 8.6 tt -120.44 160.58 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.384 -0.823 . . . . 0.0 110.075 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -142.7 144.28 32.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.328 -0.858 . . . . 0.0 110.096 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 179.83 -149.46 8.61 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.618 ' N ' ' CD1' ' A' ' 5' ' ' TYR . 12.4 m-85 -122.29 110.1 32.75 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.291 -1.123 . . . . 0.0 110.266 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.631 ' HB3' HG22 ' A' ' 55' ' ' ILE . 46.6 Cg_endo -73.95 128.76 12.63 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 124.055 1.555 . . . . 0.0 110.685 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.887 HG12 HG23 ' A' ' 15' ' ' ILE . 14.7 m -83.15 -175.87 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.283 -0.885 . . . . 0.0 110.156 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.439 ' O ' ' NH1' ' A' ' 54' ' ' ARG . 16.2 t70 -64.37 -117.54 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.171 -0.955 . . . . 0.0 109.582 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.601 ' HB3' ' CD2' ' A' ' 10' ' ' TRP . 2.0 t80 -119.62 -50.77 2.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.828 -1.17 . . . . 0.0 109.792 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.601 ' CD2' ' HB3' ' A' ' 9' ' ' TYR . 3.3 m-90 -106.08 21.32 17.53 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.233 -0.917 . . . . 0.0 109.709 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.47 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 42.5 m-20 59.5 12.33 2.71 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.388 -0.82 . . . . 0.0 110.167 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 6.8 m -67.21 -62.85 1.22 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.255 -0.903 . . . . 0.0 109.808 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.1 mmtp -73.58 -178.37 3.07 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.591 -0.693 . . . . 0.0 109.87 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.74 -174.58 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.131 -0.981 . . . . 0.0 110.059 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.887 HG23 HG12 ' A' ' 7' ' ' VAL . 20.2 mt -86.76 23.75 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.129 -0.982 . . . . 0.0 110.205 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.517 ' HB2' ' N ' ' A' ' 44' ' ' CYS . 14.4 t -160.16 165.53 31.45 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.239 -0.913 . . . . 0.0 110.595 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.468 ' N ' ' SG ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -115.8 -157.39 0.64 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.371 -0.831 . . . . 0.0 109.821 179.617 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -119.61 -3.79 10.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.211 -0.931 . . . . 0.0 109.989 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.584 ' HB2' ' CG ' ' A' ' 22' ' ' TYR . 0.7 OUTLIER -100.79 133.31 45.45 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.328 -0.858 . . . . 0.0 110.083 179.87 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -60.32 -45.93 91.68 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.194 -0.941 . . . . 0.0 110.641 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.33 -13.23 59.97 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.163 -0.961 . . . . 0.0 110.37 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.584 ' CG ' ' HB2' ' A' ' 19' ' ' ASN . 1.0 OUTLIER -66.66 -11.5 54.21 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.18 -0.95 . . . . 0.0 110.385 -179.771 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.452 ' O ' ' HB2' ' A' ' 27' ' ' CYS . 0.1 OUTLIER -118.73 -31.72 4.75 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.232 -0.917 . . . . 0.0 110.078 179.857 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.529 ' CA ' ' O ' ' A' ' 35' ' ' GLY . 2.0 t-20 -82.53 -49.17 10.19 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.224 -0.922 . . . . 0.0 109.47 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -54.99 -26.91 40.09 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.028 -1.045 . . . . 0.0 109.065 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.656 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -90.85 -46.87 7.94 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.646 -0.659 . . . . 0.0 109.486 179.628 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.499 ' SG ' ' HG3' ' A' ' 6' ' ' PRO . 7.7 m -60.05 -34.77 73.86 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.394 -0.816 . . . . 0.0 110.149 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.41 ' HG2' ' O ' ' A' ' 24' ' ' ASN . 1.9 mmmt -61.55 -32.75 72.83 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.183 -0.948 . . . . 0.0 109.319 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.82 -30.98 78.77 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 107.24 -2.344 . . . . 0.0 107.24 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.529 ' O ' ' CD ' ' A' ' 50' ' ' PRO . 11.9 mt -89.69 20.35 4.1 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.777 -0.837 . . . . 0.0 109.261 178.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.512 ' HB3' ' HD3' ' A' ' 50' ' ' PRO . 1.0 OUTLIER 66.95 16.5 10.37 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.661 -0.65 . . . . 0.0 110.695 -179.872 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.676 ' HB1' ' HB3' ' A' ' 46' ' ' CYS . . . -90.71 82.76 5.73 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.996 -1.065 . . . . 0.0 110.197 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 32' ' ' ALA . 26.0 t0 -43.25 -71.46 0.08 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.287 -0.883 . . . . 0.0 110.24 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.495 ' O ' ' HA ' ' A' ' 46' ' ' CYS . 0.0 OUTLIER -76.47 86.65 3.2 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.283 -0.886 . . . . 0.0 109.954 179.877 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.529 ' O ' ' CA ' ' A' ' 24' ' ' ASN . . . -125.6 87.69 0.36 Allowed Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.54 ' OH ' ' CZ3' ' A' ' 38' ' ' TRP . 29.4 p90 -130.59 153.91 48.4 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.957 -1.319 . . . . 0.0 109.624 179.143 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.544 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.1 OUTLIER -83.39 155.21 23.61 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.191 -0.943 . . . . 0.0 111.464 -178.686 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.628 ' CD1' HD13 ' A' ' 42' ' ' LEU . 2.5 t-105 -79.45 140.26 37.4 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.3 -21.09 63.18 Favored Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.662 -1.256 . . . . 0.0 110.861 -178.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.95 ' CD1' HG22 ' A' ' 41' ' ' THR . 49.4 t-105 -79.4 -77.19 0.18 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.884 -1.363 . . . . 0.0 109.847 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.95 HG22 ' CD1' ' A' ' 40' ' ' TRP . 13.5 t -178.14 43.92 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.478 -0.764 . . . . 0.0 109.704 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.628 HD13 ' CD1' ' A' ' 38' ' ' TRP . 0.8 OUTLIER -109.47 36.72 2.84 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.222 -0.924 . . . . 0.0 110.578 -179.524 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.487 ' CB ' ' HB ' ' A' ' 15' ' ' ILE . 74.6 m 52.69 -174.32 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.166 -0.958 . . . . 0.0 110.323 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.544 ' HA ' ' HA ' ' A' ' 37' ' ' CYS . 15.9 t -77.97 161.09 27.78 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.218 -0.926 . . . . 0.0 110.081 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -144.1 110.38 5.47 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.088 -1.007 . . . . 0.0 111.215 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.676 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . 60.0 m -130.15 134.65 47.46 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.324 -0.86 . . . . 0.0 109.263 178.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -127.42 143.7 51.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.128 -0.983 . . . . 0.0 110.508 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 31' ' ' LYS . . . 103.81 26.93 6.53 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 1.082 HD12 ' CB ' ' A' ' 53' ' ' ALA . 0.2 OUTLIER -105.62 169.39 7.06 Favored Pre-proline 0 N--CA 1.495 1.813 0 O-C-N 121.267 -1.137 . . . . 0.0 110.052 179.743 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.529 ' CD ' ' O ' ' A' ' 30' ' ' LEU . 48.2 Cg_endo -74.51 161.67 39.5 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.671 1.353 . . . . 0.0 110.397 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -59.99 -20.61 58.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.311 -0.868 . . . . 0.0 109.906 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.405 ' O ' ' CG ' ' A' ' 52' ' ' ASN . 6.1 t-20 -81.73 5.13 19.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.383 -0.823 . . . . 0.0 110.009 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 1.082 ' CB ' HD12 ' A' ' 49' ' ' LEU . . . -53.68 153.32 4.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.236 -0.915 . . . . 0.0 110.2 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.462 ' C ' HG23 ' A' ' 55' ' ' ILE . 35.2 ttp85 -105.05 91.18 3.69 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.228 -0.92 . . . . 0.0 110.312 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.87 ' H ' HD13 ' A' ' 55' ' ' ILE . 0.2 OUTLIER -149.17 157.87 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.259 -0.901 . . . . 0.0 110.149 179.842 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.433 ' C ' ' O ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER 41.63 53.79 3.83 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.417 -0.802 . . . . 0.0 110.283 179.843 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.415 ' CD ' ' HG3' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -97.21 -20.48 17.9 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.33 -0.857 . . . . 0.0 109.899 179.915 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.473 ' OG ' ' N ' ' A' ' 59' ' ' GLY . 0.1 OUTLIER 60.74 -176.68 0.11 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.537 -0.727 . . . . 0.0 110.273 179.844 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.473 ' N ' ' OG ' ' A' ' 58' ' ' SER . . . 110.34 -177.89 19.77 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.9 ptm180 -107.09 -177.16 3.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.153 -1.204 . . . . 0.0 110.245 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -48.71 124.06 7.82 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.201 -0.937 . . . . 0.0 110.105 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.506 ' CB ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -81.64 47.11 1.03 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.264 -0.897 . . . . 0.0 110.463 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.642 0 O-C-N 121.258 -0.901 . . . . 0.0 110.245 179.882 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.262 0.553 . . . . 0.0 110.244 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.838 HG23 ' HG ' ' A' ' 49' ' ' LEU . 17.1 tt -119.97 164.32 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.205 -0.934 . . . . 0.0 110.341 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -143.79 126.39 15.98 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.327 -0.858 . . . . 0.0 109.722 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -168.93 -155.97 10.17 Favored Glycine 0 N--CA 1.492 2.396 0 C-N-CA 119.561 -1.304 . . . . 0.0 110.041 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.573 ' CE1' HD22 ' A' ' 42' ' ' LEU . 77.2 m-85 -111.7 106.83 56.71 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.304 -1.115 . . . . 0.0 110.706 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.52 ' HA ' ' O ' ' A' ' 54' ' ' ARG . 49.8 Cg_endo -78.91 113.37 3.24 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.957 1.504 . . . . 0.0 109.907 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.507 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . 15.5 m -94.04 -169.11 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.012 -1.055 . . . . 0.0 111.05 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.433 ' OD2' ' CB ' ' A' ' 14' ' ' ARG . 9.9 t0 -59.53 -152.23 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.433 -0.792 . . . . 0.0 110.53 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.464 ' HB2' ' CE2' ' A' ' 10' ' ' TRP . 22.0 m-85 -98.84 -11.8 21.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.365 -0.834 . . . . 0.0 110.582 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.534 ' HB3' ' CB ' ' A' ' 62' ' ' ARG . 0.3 OUTLIER -130.22 4.26 4.79 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.03 -1.044 . . . . 0.0 109.74 -179.872 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.509 ' N ' ' OD1' ' A' ' 11' ' ' ASN . 1.6 m120 57.13 16.12 2.8 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.253 -0.905 . . . . 0.0 109.531 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 5.5 t -70.59 -64.04 0.98 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.365 -0.835 . . . . 0.0 110.504 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.495 ' O ' ' CD ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -161.52 82.6 0.61 Allowed 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.259 -0.901 . . . . 0.0 110.502 -179.565 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.437 ' CB ' ' O ' ' A' ' 13' ' ' LYS . 2.0 mtt180 173.06 35.06 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.392 -0.818 . . . . 0.0 109.795 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.946 HD12 ' HB2' ' A' ' 43' ' ' SER . 46.6 pt -54.25 -30.26 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.439 -0.788 . . . . 0.0 110.69 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.542 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 8.5 t -139.36 129.33 24.99 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.137 -0.977 . . . . 0.0 110.589 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.426 ' CE3' ' HB3' ' A' ' 22' ' ' TYR . 0.0 OUTLIER -73.24 170.17 15.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.361 -0.837 . . . . 0.0 110.067 179.785 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -88.23 55.0 3.26 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.318 -0.864 . . . . 0.0 110.075 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.608 ' ND2' ' CE1' ' A' ' 22' ' ' TYR . 2.2 t-20 -165.52 156.28 13.67 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.338 -0.852 . . . . 0.0 110.032 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.422 ' C ' ' OD1' ' A' ' 20' ' ' ASN . 49.7 p30 -87.38 -1.58 58.02 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.226 -0.921 . . . . 0.0 110.266 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.429 ' HA ' ' CB ' ' A' ' 24' ' ' ASN . 0.0 OUTLIER -129.37 -6.02 4.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.19 -0.944 . . . . 0.0 110.586 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.608 ' CE1' ' ND2' ' A' ' 19' ' ' ASN . 3.1 m-30 -59.69 -69.41 0.21 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.1 -1.0 . . . . 0.0 110.247 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.598 ' HA ' HD23 ' A' ' 26' ' ' LEU . 6.0 p -69.37 -6.36 29.39 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.98 -1.075 . . . . 0.0 109.852 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.539 ' CB ' ' O ' ' A' ' 35' ' ' GLY . 64.3 t30 -75.71 -61.06 2.05 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.388 -0.82 . . . . 0.0 109.506 179.083 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -49.25 -48.56 45.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.41 -0.806 . . . . 0.0 109.733 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.598 HD23 ' HA ' ' A' ' 23' ' ' CYS . 0.1 OUTLIER -64.52 -37.35 87.24 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.307 -0.87 . . . . 0.0 109.088 179.423 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.526 ' N ' ' HG ' ' A' ' 26' ' ' LEU . 1.3 m -61.86 -39.26 91.24 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.244 -0.91 . . . . 0.0 109.281 179.23 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.76 -31.49 69.71 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.466 -0.771 . . . . 0.0 109.55 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.64 -36.9 91.28 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 108.304 -1.919 . . . . 0.0 108.304 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.554 ' O ' ' CB ' ' A' ' 31' ' ' LYS . 6.9 mt -87.69 17.58 4.61 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.535 -0.979 . . . . 0.0 109.746 179.188 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.554 ' CB ' ' O ' ' A' ' 30' ' ' LEU . 0.7 OUTLIER 78.83 11.27 1.58 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.711 -0.618 . . . . 0.0 110.79 179.991 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.791 ' CB ' HD22 ' A' ' 49' ' ' LEU . . . -95.04 84.16 4.07 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.959 -1.088 . . . . 0.0 109.812 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -54.09 -73.78 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.279 -0.888 . . . . 0.0 111.143 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.51 ' O ' ' HA ' ' A' ' 46' ' ' CYS . 23.2 t -66.87 92.37 0.23 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.386 -0.821 . . . . 0.0 110.663 -179.41 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.539 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -129.4 88.12 0.31 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.594 ' CZ ' ' HB3' ' A' ' 45' ' ' TYR . 11.1 p90 -99.57 -175.93 3.13 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.165 -1.197 . . . . 0.0 110.422 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.512 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.1 OUTLIER -131.91 131.45 42.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.122 -0.986 . . . . 0.0 110.73 -179.656 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.592 ' CD1' ' HB2' ' A' ' 42' ' ' LEU . 1.9 t-105 -86.87 122.33 30.58 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.299 -0.875 . . . . 0.0 109.839 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.6 -10.14 86.13 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.583 ' HB3' ' CD1' ' A' ' 38' ' ' TRP . 41.1 t-105 -79.77 -92.9 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.207 -1.172 . . . . 0.0 110.095 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.501 ' CG2' ' C ' ' A' ' 40' ' ' TRP . 14.4 p -152.94 54.47 0.77 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.037 -1.039 . . . . 0.0 110.039 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.592 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 6.0 mt -132.3 8.76 4.34 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.203 -0.936 . . . . 0.0 110.813 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.946 ' HB2' HD12 ' A' ' 15' ' ' ILE . 1.4 t 56.77 -174.4 0.07 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.956 -1.09 . . . . 0.0 109.869 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.512 ' HA ' ' HA ' ' A' ' 37' ' ' CYS . 15.3 t -72.26 156.53 39.03 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.106 -0.996 . . . . 0.0 109.186 179.31 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.594 ' HB3' ' CZ ' ' A' ' 36' ' ' TYR . 67.4 t80 -138.04 113.85 9.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.113 -0.992 . . . . 0.0 110.478 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.69 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . 62.5 m -125.28 138.93 54.09 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.207 -0.933 . . . . 0.0 109.735 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.494 ' CG ' ' HB3' ' A' ' 34' ' ' SER . 0.0 OUTLIER -118.16 137.65 52.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.359 -0.838 . . . . 0.0 110.072 -179.949 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 31' ' ' LYS . . . 102.22 32.51 4.91 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.838 ' HG ' HG23 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -101.46 -177.27 0.54 Allowed Pre-proline 0 N--CA 1.496 1.865 0 O-C-N 121.185 -1.185 . . . . 0.0 109.303 179.646 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.537 ' HD2' ' HB2' ' A' ' 49' ' ' LEU . 47.6 Cg_endo -85.12 161.11 11.55 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 O-C-N 123.619 1.326 . . . . 0.0 110.123 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -59.53 -19.95 51.99 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.1 -1.0 . . . . 0.0 109.883 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -96.25 19.54 11.74 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.372 -0.83 . . . . 0.0 109.695 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.575 ' HB2' ' HB2' ' A' ' 49' ' ' LEU . . . -53.79 134.01 42.31 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.346 -0.846 . . . . 0.0 110.562 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.576 ' HB3' ' CZ ' ' A' ' 54' ' ' ARG . 1.3 ttm105 -71.71 87.49 0.96 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.298 -0.876 . . . . 0.0 109.976 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.694 HD12 ' C ' ' A' ' 55' ' ' ILE . 1.9 pp -124.34 -166.41 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.062 -1.024 . . . . 0.0 110.626 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.48 ' O ' ' HG3' ' A' ' 56' ' ' LYS . 0.4 OUTLIER -61.39 70.41 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.486 -0.758 . . . . 0.0 110.837 -179.555 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.531 ' N ' ' O ' ' A' ' 55' ' ' ILE . 9.1 tpp85 -114.79 -16.03 11.81 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.074 -1.016 . . . . 0.0 109.799 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.9 132.02 46.24 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.419 -0.801 . . . . 0.0 109.984 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -107.77 33.42 6.32 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.431 ' HG2' ' O ' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -122.77 107.4 11.86 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.276 -1.132 . . . . 0.0 110.28 179.954 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 2.6 t -50.74 107.52 0.18 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.288 -0.882 . . . . 0.0 109.882 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.534 ' CB ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -87.32 48.61 1.67 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.324 -0.86 . . . . 0.0 110.375 179.973 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.152 -0.967 . . . . 0.0 110.228 -179.99 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 13.3 tttm . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.178 0.513 . . . . 0.0 110.219 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.611 HG22 ' O ' ' A' ' 49' ' ' LEU . 4.5 tt -146.93 159.85 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.334 -0.854 . . . . 0.0 110.1 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.506 ' HB3' ' CG ' ' A' ' 47' ' ' GLN . 65.8 m-20 -131.14 136.2 48.14 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.347 -0.845 . . . . 0.0 109.873 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 178.77 -160.8 26.8 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.606 ' CE2' ' CD1' ' A' ' 45' ' ' TYR . 15.0 m-85 -109.28 109.25 60.46 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.305 -1.115 . . . . 0.0 110.256 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.516 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 49.4 Cg_endo -80.51 108.09 2.09 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.928 1.489 . . . . 0.0 110.9 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.477 HG12 ' HA ' ' A' ' 15' ' ' ILE . 17.0 m -83.49 -170.59 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.228 -0.92 . . . . 0.0 109.83 179.411 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -70.65 -118.23 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.111 -0.993 . . . . 0.0 109.827 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.413 ' HB3' ' CD2' ' A' ' 10' ' ' TRP . 0.2 OUTLIER -115.94 -55.06 2.45 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.816 -1.177 . . . . 0.0 110.073 179.792 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.543 ' HB3' ' CB ' ' A' ' 62' ' ' ARG . 3.0 m-90 -99.6 15.23 27.32 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.24 -0.913 . . . . 0.0 110.121 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.459 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 5.1 m-20 59.4 12.74 2.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.219 -0.925 . . . . 0.0 110.067 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.8 t -90.89 -28.68 17.96 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.277 -0.889 . . . . 0.0 110.43 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.489 ' O ' ' CB ' ' A' ' 14' ' ' ARG . 4.5 mmtp -86.79 41.38 0.95 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.272 -0.892 . . . . 0.0 110.619 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.489 ' CB ' ' O ' ' A' ' 13' ' ' LYS . 0.1 OUTLIER 69.03 141.6 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.159 -0.963 . . . . 0.0 110.536 179.787 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.477 ' HA ' HG12 ' A' ' 7' ' ' VAL . 6.9 pt -74.48 -6.29 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.376 -0.828 . . . . 0.0 110.104 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.599 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 4.4 t -148.25 153.99 39.46 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.267 -0.896 . . . . 0.0 110.257 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.458 ' CE3' ' HB3' ' A' ' 22' ' ' TYR . 0.2 OUTLIER -86.56 -161.99 0.72 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.359 -0.838 . . . . 0.0 110.105 179.886 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.471 ' CD1' ' O ' ' A' ' 18' ' ' TYR . 9.3 t80 -106.61 -25.85 11.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.283 -0.886 . . . . 0.0 110.118 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -93.36 152.7 18.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.329 -0.857 . . . . 0.0 110.165 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 -81.99 -9.02 59.7 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.173 -0.954 . . . . 0.0 110.214 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.424 ' O ' ' N ' ' A' ' 24' ' ' ASN . 13.8 tttp -105.41 -39.59 6.09 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.181 -0.949 . . . . 0.0 110.07 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.458 ' HB3' ' CE3' ' A' ' 17' ' ' TRP . 1.5 m-85 -44.65 -33.63 1.89 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.296 -0.878 . . . . 0.0 110.259 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -78.32 -28.53 47.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.278 -0.889 . . . . 0.0 110.008 -179.993 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.485 ' OD1' ' HD2' ' A' ' 28' ' ' LYS . 0.3 OUTLIER -68.98 -41.31 78.05 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.399 -0.813 . . . . 0.0 109.305 179.465 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.2 -43.04 99.73 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.377 -0.827 . . . . 0.0 110.055 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.742 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -74.56 -42.68 58.37 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.318 -0.864 . . . . 0.0 109.591 179.74 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.51 ' SG ' ' CG ' ' A' ' 6' ' ' PRO . 1.5 m -61.09 -30.78 70.55 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.293 -0.879 . . . . 0.0 109.303 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.561 ' CA ' ' HE3' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -65.43 -27.42 68.51 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.17 -0.956 . . . . 0.0 108.87 178.572 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.94 -34.52 89.13 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 107.197 -2.361 . . . . 0.0 107.197 178.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.533 ' O ' ' CD ' ' A' ' 50' ' ' PRO . 53.1 mt -91.01 22.03 3.9 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.763 -0.845 . . . . 0.0 109.16 178.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.488 ' O ' ' O ' ' A' ' 48' ' ' GLY . 0.0 OUTLIER 60.48 22.53 12.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.611 -0.681 . . . . 0.0 110.653 179.907 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.617 ' HB1' ' HB3' ' A' ' 46' ' ' CYS . . . -86.15 86.4 7.35 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.984 -1.072 . . . . 0.0 109.995 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.511 ' O ' ' NZ ' ' A' ' 28' ' ' LYS . 6.7 t70 -40.28 -86.62 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.498 -0.751 . . . . 0.0 110.597 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.9 m -69.99 93.65 0.8 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.993 -1.067 . . . . 0.0 110.058 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.544 ' CA ' ' SG ' ' A' ' 46' ' ' CYS . . . -128.72 112.77 1.45 Allowed Glycine 0 N--CA 1.487 2.099 0 C-N-CA 119.638 -1.268 . . . . 0.0 110.018 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -148.21 159.97 43.41 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.273 -1.134 . . . . 0.0 109.985 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.475 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.1 OUTLIER -93.32 146.15 23.93 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.153 -0.967 . . . . 0.0 110.684 -179.599 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.53 ' CD1' ' HB2' ' A' ' 42' ' ' LEU . 8.7 t-105 -79.55 111.06 15.45 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.238 -0.914 . . . . 0.0 109.439 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -66.2 61.25 0.16 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 -179.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.64 ' CD1' HG22 ' A' ' 41' ' ' THR . 14.7 t-105 -160.94 -69.67 0.06 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.329 -1.1 . . . . 0.0 109.453 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.64 HG22 ' CD1' ' A' ' 40' ' ' TRP . 11.8 t -179.91 33.42 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.586 -0.696 . . . . 0.0 109.588 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.53 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 0.3 OUTLIER -109.46 30.83 6.26 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.293 -0.88 . . . . 0.0 111.013 -179.433 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.599 ' HA ' ' HB2' ' A' ' 16' ' ' CYS . 6.1 p 48.29 -175.3 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.934 -1.104 . . . . 0.0 110.235 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.491 ' O ' ' HA ' ' A' ' 5' ' ' TYR . 14.7 t -78.55 140.47 38.51 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.259 -0.901 . . . . 0.0 109.366 179.351 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.606 ' CD1' ' CE2' ' A' ' 5' ' ' TYR . 4.7 t80 -128.94 118.77 23.18 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.053 -1.029 . . . . 0.0 110.696 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.617 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . 63.1 m -136.17 152.18 50.53 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.488 -0.758 . . . . 0.0 109.719 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.506 ' CG ' ' HB3' ' A' ' 3' ' ' ASP . 1.6 mt-30 -134.83 147.24 49.88 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.142 -0.973 . . . . 0.0 110.701 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.488 ' O ' ' O ' ' A' ' 31' ' ' LYS . . . 97.98 30.05 7.31 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.982 HD12 ' CB ' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -108.07 170.9 5.04 Favored Pre-proline 0 N--CA 1.498 1.963 0 O-C-N 121.158 -1.201 . . . . 0.0 109.77 179.66 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.533 ' CD ' ' O ' ' A' ' 30' ' ' LEU . 42.7 Cg_endo -68.93 157.85 60.25 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.692 1.364 . . . . 0.0 110.917 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -59.37 -24.02 63.06 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.379 -0.825 . . . . 0.0 110.008 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -86.46 14.18 7.17 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.335 -0.853 . . . . 0.0 109.783 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.982 ' CB ' HD12 ' A' ' 49' ' ' LEU . . . -56.86 113.69 1.77 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.459 -0.776 . . . . 0.0 110.86 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.502 ' O ' ' HA ' ' A' ' 6' ' ' PRO . 6.7 ttm-85 -59.9 116.39 4.08 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.252 -0.905 . . . . 0.0 109.645 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.69 ' O ' HD12 ' A' ' 55' ' ' ILE . 1.8 pp -140.19 178.06 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.074 -1.016 . . . . 0.0 111.004 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 55' ' ' ILE . 0.1 OUTLIER -41.81 93.74 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.529 -0.732 . . . . 0.0 110.736 -179.566 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.506 ' N ' ' O ' ' A' ' 55' ' ' ILE . 11.6 ttp180 -119.73 -18.91 8.2 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.294 -0.879 . . . . 0.0 109.782 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.32 155.9 35.96 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.367 -0.833 . . . . 0.0 110.148 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -118.13 14.71 12.31 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.424 ' O ' ' C ' ' A' ' 61' ' ' CYS . 4.6 mpt_? -99.39 98.95 9.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.431 -1.04 . . . . 0.0 110.205 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.424 ' C ' ' O ' ' A' ' 60' ' ' ARG . 4.5 t -40.05 109.76 0.12 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.507 -0.746 . . . . 0.0 110.096 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.543 ' CB ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -90.52 52.0 2.12 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.279 -0.888 . . . . 0.0 110.329 -179.808 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.437 ' HB2' ' O ' ' A' ' 62' ' ' ARG . . . . . . . . 0 N--CA 1.491 1.604 0 O-C-N 121.22 -0.925 . . . . 0.0 110.219 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 20.7 mttt . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.251 0.548 . . . . 0.0 110.235 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.477 HG12 ' N ' ' A' ' 3' ' ' ASP . 6.9 tt -134.34 165.11 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.414 -0.804 . . . . 0.0 109.943 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.477 ' N ' HG12 ' A' ' 2' ' ' ILE . 1.0 OUTLIER -135.2 128.6 32.29 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.308 -0.87 . . . . 0.0 110.107 179.895 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -167.56 -176.26 38.12 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.794 -1.323 . . . . 0.0 109.794 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.972 ' HB2' HD11 ' A' ' 15' ' ' ILE . 6.1 m-30 -99.07 109.58 54.7 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.296 -1.12 . . . . 0.0 110.407 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.569 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 48.8 Cg_endo -78.89 129.56 9.09 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.934 1.491 . . . . 0.0 110.277 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.589 HG12 ' CB ' ' A' ' 15' ' ' ILE . 30.1 m -93.46 -170.25 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.125 -0.985 . . . . 0.0 110.185 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.514 ' CB ' ' HB2' ' A' ' 13' ' ' LYS . 7.9 t70 -74.68 -89.36 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.319 -0.863 . . . . 0.0 109.792 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.657 ' CZ ' ' CH2' ' A' ' 10' ' ' TRP . 24.5 t80 -138.32 -75.11 0.39 Allowed 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.308 -0.87 . . . . 0.0 109.611 179.439 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.657 ' CH2' ' CZ ' ' A' ' 9' ' ' TYR . 0.0 OUTLIER -89.62 23.02 2.78 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.447 -0.783 . . . . 0.0 109.386 179.322 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 3.7 m120 61.18 24.17 14.3 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.83 -0.543 . . . . 0.0 110.834 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.501 ' HA ' ' HB2' ' A' ' 61' ' ' CYS . 48.3 t -93.25 -37.46 12.05 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.986 -1.071 . . . . 0.0 110.43 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.514 ' HB2' ' CB ' ' A' ' 8' ' ' ASP . 54.4 mmtt -85.08 44.1 1.06 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.282 -0.886 . . . . 0.0 109.894 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' A' ' 13' ' ' LYS . 1.3 tpp180 54.73 165.13 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.307 -0.871 . . . . 0.0 110.152 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.972 HD11 ' HB2' ' A' ' 5' ' ' TYR . 7.7 tt -84.1 1.29 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.326 -0.859 . . . . 0.0 110.423 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.595 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 33.7 t -142.44 127.19 18.12 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.268 -0.895 . . . . 0.0 110.424 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -69.22 -149.49 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.265 -0.897 . . . . 0.0 110.337 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -140.08 40.45 1.95 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.146 -0.971 . . . . 0.0 110.313 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.435 ' HB2' ' HB2' ' A' ' 22' ' ' TYR . 0.6 OUTLIER -149.25 162.72 39.46 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.328 -0.858 . . . . 0.0 109.914 179.758 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 25.1 m-20 -88.7 30.25 0.93 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.13 -0.981 . . . . 0.0 109.915 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -156.09 -39.98 0.08 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.396 -0.815 . . . . 0.0 109.764 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.435 ' HB2' ' HB2' ' A' ' 19' ' ' ASN . 0.1 OUTLIER -45.97 -27.58 0.94 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.243 -0.91 . . . . 0.0 110.008 179.769 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -100.0 -50.97 3.82 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.292 -0.88 . . . . 0.0 110.104 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.508 ' N ' ' OD1' ' A' ' 24' ' ' ASN . 1.4 m-20 -55.42 -60.07 3.93 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.376 -0.828 . . . . 0.0 109.95 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 24' ' ' ASN . 6.8 t0 -42.99 -51.54 5.6 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.223 -0.923 . . . . 0.0 110.378 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.6 mt -65.16 -42.72 93.47 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.201 -0.937 . . . . 0.0 110.46 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.498 ' SG ' ' HG3' ' A' ' 6' ' ' PRO . 2.4 m -61.18 -39.62 90.82 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.388 -0.82 . . . . 0.0 110.478 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.539 ' HD3' ' HA ' ' A' ' 33' ' ' ASP . 0.5 OUTLIER -60.82 -31.87 71.26 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.284 -0.885 . . . . 0.0 109.602 179.954 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.28 -28.27 73.38 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 107.993 -2.043 . . . . 0.0 107.993 179.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.54 ' O ' ' CD ' ' A' ' 50' ' ' PRO . 13.5 mt -92.42 19.52 7.11 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.691 -0.888 . . . . 0.0 109.127 178.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.527 ' HB3' ' O ' ' A' ' 30' ' ' LEU . 28.7 tptt 72.93 15.02 4.71 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.694 -0.629 . . . . 0.0 110.939 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.709 ' HB2' HD22 ' A' ' 49' ' ' LEU . . . -99.96 55.87 0.94 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.866 -1.146 . . . . 0.0 109.667 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.539 ' HA ' ' HD3' ' A' ' 28' ' ' LYS . 17.9 p30 -40.29 -30.05 0.09 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.462 -0.773 . . . . 0.0 110.649 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.5 ' N ' ' OD1' ' A' ' 33' ' ' ASP . 70.2 p -91.09 62.77 4.92 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.244 -0.91 . . . . 0.0 110.368 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.484 ' HA2' ' SG ' ' A' ' 46' ' ' CYS . . . -104.64 134.44 12.0 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.539 ' CD1' ' O ' ' A' ' 36' ' ' TYR . 29.3 p90 -160.17 129.74 5.18 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.394 -1.062 . . . . 0.0 109.39 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.524 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.0 OUTLIER -89.74 136.32 33.1 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.162 -0.961 . . . . 0.0 110.994 -179.059 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.576 ' CD1' ' HB2' ' A' ' 42' ' ' LEU . 4.6 t-105 -80.35 111.05 16.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.302 -0.874 . . . . 0.0 109.448 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -61.63 -10.96 26.87 Favored Glycine 0 N--CA 1.49 2.277 0 C-N-CA 120.434 -0.888 . . . . 0.0 110.943 -178.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.86 ' CD1' HG22 ' A' ' 41' ' ' THR . 16.7 t-105 -79.66 -78.43 0.16 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.793 -1.416 . . . . 0.0 110.249 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.86 HG22 ' CD1' ' A' ' 40' ' ' TRP . 5.8 t -173.46 38.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.27 -0.894 . . . . 0.0 109.714 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.576 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 0.3 OUTLIER -110.04 24.66 12.72 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.245 -0.909 . . . . 0.0 110.414 -179.679 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.595 ' HA ' ' HB2' ' A' ' 16' ' ' CYS . 7.7 m 54.53 -176.55 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.049 -1.032 . . . . 0.0 109.827 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.524 ' HA ' ' HA ' ' A' ' 37' ' ' CYS . 7.4 t -76.64 151.82 36.05 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.178 -0.951 . . . . 0.0 109.131 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.532 ' HB3' ' CZ ' ' A' ' 36' ' ' TYR . 0.8 OUTLIER -138.58 104.74 5.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.866 -1.146 . . . . 0.0 111.378 -179.632 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.67 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . 63.8 m -121.02 140.66 51.62 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.397 -0.814 . . . . 0.0 109.393 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.407 ' O ' ' OG ' ' A' ' 34' ' ' SER . 14.6 mt-30 -129.92 149.43 51.66 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.107 -0.996 . . . . 0.0 110.407 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 31' ' ' LYS . . . 97.62 24.84 11.49 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 1.018 HD12 ' CB ' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -103.09 172.1 4.58 Favored Pre-proline 0 N--CA 1.499 2.019 0 O-C-N 121.279 -1.13 . . . . 0.0 109.444 179.438 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.54 ' CD ' ' O ' ' A' ' 30' ' ' LEU . 41.9 Cg_endo -68.57 154.44 71.59 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 O-C-N 123.335 1.176 . . . . 0.0 110.352 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -58.28 -21.98 50.91 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.325 -0.86 . . . . 0.0 110.191 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 16.6 t30 -86.44 11.71 11.88 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.306 -0.871 . . . . 0.0 110.085 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 1.018 ' CB ' HD12 ' A' ' 49' ' ' LEU . . . -52.71 143.89 15.31 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.446 -0.783 . . . . 0.0 110.669 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.499 ' NH1' ' O ' ' A' ' 8' ' ' ASP . 1.2 ttm105 -88.54 116.72 26.98 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.365 -0.834 . . . . 0.0 109.996 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.595 HD12 ' C ' ' A' ' 55' ' ' ILE . 1.3 pp -139.24 -164.74 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.188 -0.945 . . . . 0.0 110.733 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.843 ' HG3' HD12 ' A' ' 15' ' ' ILE . 0.3 OUTLIER -36.24 96.12 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 121.371 0.605 . . . . 0.0 111.107 -179.414 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.456 ' N ' ' O ' ' A' ' 55' ' ' ILE . 8.3 ttm-85 -110.1 -20.02 12.84 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.376 -0.828 . . . . 0.0 109.762 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.8 m -166.32 162.59 17.32 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.412 -0.805 . . . . 0.0 110.056 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -114.61 45.75 1.27 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.459 ' O ' ' HB2' ' A' ' 11' ' ' ASN . 7.7 ptm180 -137.17 172.15 13.42 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.162 -1.199 . . . . 0.0 110.485 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.501 ' HB2' ' HA ' ' A' ' 12' ' ' CYS . 0.5 OUTLIER -116.7 103.26 10.18 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.402 -0.811 . . . . 0.0 109.695 179.993 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.646 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -85.53 28.77 0.73 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.888 -1.132 . . . . 0.0 110.547 179.766 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.124 -0.985 . . . . 0.0 110.283 -179.949 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 9.8 ptpt . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.221 0.534 . . . . 0.0 110.193 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.526 ' CG2' ' HG ' ' A' ' 49' ' ' LEU . 19.3 tt -131.18 160.56 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.322 -0.861 . . . . 0.0 110.056 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 3' ' ' ASP . 5.0 p-10 -134.52 127.5 31.48 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.381 -0.824 . . . . 0.0 109.654 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -177.32 -172.86 42.3 Favored Glycine 0 N--CA 1.49 2.286 0 C-N-CA 119.253 -1.451 . . . . 0.0 110.21 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.603 ' N ' ' CD1' ' A' ' 5' ' ' TYR . 3.2 m-30 -102.36 113.36 65.91 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.438 -1.036 . . . . 0.0 110.088 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.495 ' HG3' ' SG ' ' A' ' 27' ' ' CYS . 46.3 Cg_endo -75.15 142.48 27.47 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.815 1.429 . . . . 0.0 110.452 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.727 HG12 ' HA ' ' A' ' 15' ' ' ILE . 30.0 m -141.08 -170.18 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.35 -0.843 . . . . 0.0 110.149 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.502 ' HB3' ' HB3' ' A' ' 14' ' ' ARG . 21.3 p-10 -69.45 -148.29 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.234 -0.916 . . . . 0.0 109.979 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.582 ' HB3' ' CD2' ' A' ' 10' ' ' TRP . 6.3 t80 -98.82 -14.9 19.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.197 -0.939 . . . . 0.0 110.316 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.582 ' CD2' ' HB3' ' A' ' 9' ' ' TYR . 7.9 m-90 -133.32 24.04 4.12 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.227 -0.921 . . . . 0.0 110.252 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.501 ' O ' HD11 ' A' ' 15' ' ' ILE . 2.4 m-20 59.41 13.78 3.4 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.192 -0.942 . . . . 0.0 110.166 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.49 ' SG ' ' HB2' ' A' ' 10' ' ' TRP . 71.5 m -83.0 -77.17 0.25 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.299 -0.876 . . . . 0.0 110.82 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.439 ' O ' ' HB3' ' A' ' 14' ' ' ARG . 14.6 mttt -95.51 -167.83 1.68 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.368 -0.833 . . . . 0.0 111.076 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.542 ' O ' ' N ' ' A' ' 16' ' ' CYS . 16.8 tpp180 58.57 -106.0 0.28 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.48 -0.763 . . . . 0.0 110.45 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.77 HG23 ' OG ' ' A' ' 43' ' ' SER . 78.0 mt 57.19 -81.7 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.08 -1.012 . . . . 0.0 109.914 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.568 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 40.3 t -137.37 115.21 11.41 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.41 -0.806 . . . . 0.0 110.19 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -66.7 -149.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.214 -0.928 . . . . 0.0 109.939 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.57 59.25 1.55 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.122 -0.986 . . . . 0.0 110.14 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.528 ' CB ' ' HB2' ' A' ' 22' ' ' TYR . 0.2 OUTLIER -159.15 -177.86 6.79 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.276 -0.89 . . . . 0.0 110.091 179.857 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -90.74 -41.03 11.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.281 -0.887 . . . . 0.0 110.854 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.6 mtmp? -110.63 -1.12 16.95 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.132 -0.98 . . . . 0.0 110.811 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.528 ' HB2' ' CB ' ' A' ' 19' ' ' ASN . 1.2 m-85 -56.5 -52.36 65.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.057 -1.027 . . . . 0.0 109.986 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.4 t -78.03 -14.84 59.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.271 -0.893 . . . . 0.0 110.14 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.527 ' O ' ' CG ' ' A' ' 28' ' ' LYS . 33.5 t30 -76.49 -41.45 46.97 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.259 -0.901 . . . . 0.0 110.006 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.1 -40.27 89.07 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.199 -0.938 . . . . 0.0 109.766 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -74.23 -45.06 50.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.325 -0.859 . . . . 0.0 109.954 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.495 ' SG ' ' HG3' ' A' ' 6' ' ' PRO . 1.2 m -60.85 -45.03 96.12 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.339 -0.851 . . . . 0.0 109.615 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.551 ' CD ' ' HA ' ' A' ' 33' ' ' ASP . 2.2 mmmt -59.65 -31.08 69.19 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.334 -0.854 . . . . 0.0 109.323 179.084 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -56.57 -35.58 67.39 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 108.851 -1.699 . . . . 0.0 108.851 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.695 ' O ' ' CB ' ' A' ' 31' ' ' LYS . 10.5 mt -81.65 -28.91 33.38 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.387 -1.067 . . . . 0.0 109.617 179.489 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.695 ' CB ' ' O ' ' A' ' 30' ' ' LEU . 10.0 tttt 131.54 5.82 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.748 0 C-N-CA 123.528 0.731 . . . . 0.0 109.839 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.544 ' HB1' ' HB3' ' A' ' 46' ' ' CYS . . . -82.73 113.1 20.16 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.901 -1.124 . . . . 0.0 110.226 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.551 ' HA ' ' CD ' ' A' ' 28' ' ' LYS . 0.2 OUTLIER -73.66 -62.41 1.5 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.308 -0.87 . . . . 0.0 110.134 179.893 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -80.45 82.84 6.38 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.399 -0.813 . . . . 0.0 109.996 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.531 ' CA ' ' SG ' ' A' ' 46' ' ' CYS . . . -121.06 104.07 0.93 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.53 ' OH ' ' CD2' ' A' ' 45' ' ' TYR . 41.4 p90 -126.35 -177.16 3.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.178 -1.19 . . . . 0.0 109.794 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.522 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.1 OUTLIER -110.72 147.28 34.72 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.087 -1.008 . . . . 0.0 110.277 -179.916 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.592 ' CD1' ' HB2' ' A' ' 42' ' ' LEU . 15.6 t-105 -79.53 166.61 21.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.084 -1.01 . . . . 0.0 109.855 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -125.54 55.67 0.72 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.869 ' CD1' HG22 ' A' ' 41' ' ' THR . 11.6 t-105 -160.33 -69.66 0.07 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.374 -1.074 . . . . 0.0 109.335 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.869 HG22 ' CD1' ' A' ' 40' ' ' TRP . 5.1 t -179.06 32.37 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.67 -0.644 . . . . 0.0 109.883 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.592 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 0.8 OUTLIER -113.58 21.39 15.13 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.102 -0.999 . . . . 0.0 110.908 -179.433 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.77 ' OG ' HG23 ' A' ' 15' ' ' ILE . 8.2 t 57.34 -168.69 0.11 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.13 -0.981 . . . . 0.0 110.784 179.298 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.522 ' HA ' ' HA ' ' A' ' 37' ' ' CYS . 19.4 t -71.91 171.98 10.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.391 -0.818 . . . . 0.0 110.162 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.53 ' CD2' ' OH ' ' A' ' 36' ' ' TYR . 1.1 t80 -151.5 110.21 3.83 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.994 -1.066 . . . . 0.0 110.752 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.583 ' O ' HD21 ' A' ' 49' ' ' LEU . 82.9 m -125.44 137.49 53.99 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.327 -0.858 . . . . 0.0 109.824 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -119.92 131.95 55.37 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.206 -0.934 . . . . 0.0 109.931 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.598 ' N ' HD23 ' A' ' 49' ' ' LEU . . . 107.82 41.22 1.6 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.758 HD12 ' CB ' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -119.6 172.9 3.98 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.362 -1.081 . . . . 0.0 109.83 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.511 ' HD2' ' HB2' ' A' ' 49' ' ' LEU . 42.1 Cg_endo -68.32 155.22 70.05 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 O-C-N 123.677 1.356 . . . . 0.0 110.516 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -61.12 -19.95 62.08 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.359 -0.838 . . . . 0.0 110.459 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -88.62 11.87 16.23 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.208 -0.933 . . . . 0.0 110.095 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.758 ' CB ' HD12 ' A' ' 49' ' ' LEU . . . -65.27 110.38 2.57 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.24 -0.913 . . . . 0.0 110.167 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.551 ' O ' HG23 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -57.71 136.08 56.83 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.234 -0.916 . . . . 0.0 110.282 179.982 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.614 HD12 ' C ' ' A' ' 55' ' ' ILE . 1.4 pp -154.36 -169.94 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.204 -0.935 . . . . 0.0 110.319 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.427 ' O ' ' CG ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -50.07 91.1 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.315 -0.866 . . . . 0.0 110.662 -179.523 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.471 ' N ' ' O ' ' A' ' 55' ' ' ILE . 2.4 ttt85 -119.76 -5.86 10.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.204 -0.935 . . . . 0.0 110.022 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.432 ' HB2' ' CG ' ' A' ' 11' ' ' ASN . 46.3 m -120.67 -178.53 3.74 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.309 -0.87 . . . . 0.0 110.031 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -118.94 -36.86 0.85 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.401 ' O ' ' C ' ' A' ' 61' ' ' CYS . 0.3 OUTLIER -131.74 155.32 47.9 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.19 -1.183 . . . . 0.0 110.393 -179.922 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.401 ' C ' ' O ' ' A' ' 60' ' ' ARG . 43.3 t -43.79 115.4 0.8 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.285 -0.884 . . . . 0.0 110.305 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.521 ' CB ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -90.85 48.26 1.51 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.253 -0.904 . . . . 0.0 110.262 -179.975 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.678 0 O-C-N 121.272 -0.893 . . . . 0.0 110.147 179.991 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.497 ' CG ' ' O ' ' A' ' 1' ' ' LYS . 2.2 tttm . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.191 0.52 . . . . 0.0 110.167 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.502 ' CG2' ' HG ' ' A' ' 49' ' ' LEU . 10.1 tt -111.15 157.45 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.239 -0.913 . . . . 0.0 110.497 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.584 ' CB ' ' CG ' ' A' ' 47' ' ' GLN . 7.1 p30 -133.21 117.28 17.24 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.733 -0.604 . . . . 0.0 109.66 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -155.45 -150.61 5.63 Favored Glycine 0 N--CA 1.491 2.353 0 C-N-CA 119.496 -1.335 . . . . 0.0 109.846 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.493 ' HA ' ' O ' ' A' ' 44' ' ' CYS . 14.1 m-85 -122.83 114.33 29.8 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.403 -1.057 . . . . 0.0 110.29 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.494 ' HG3' ' SG ' ' A' ' 27' ' ' CYS . 48.2 Cg_endo -76.04 144.8 27.33 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 124.047 1.551 . . . . 0.0 110.619 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.745 HG12 ' HA ' ' A' ' 15' ' ' ILE . 32.8 m -141.76 -171.47 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.297 -0.877 . . . . 0.0 109.894 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.544 ' N ' ' HB3' ' A' ' 14' ' ' ARG . 3.9 t0 -67.54 -176.0 0.57 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.227 -0.92 . . . . 0.0 110.175 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.494 ' HB3' ' CE2' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -76.55 -11.02 59.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.359 -0.838 . . . . 0.0 109.68 179.739 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.568 ' HB3' ' N ' ' A' ' 62' ' ' ARG . 4.0 m-90 -132.22 8.38 4.34 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.382 -0.824 . . . . 0.0 110.115 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 18.3 m-20 60.09 33.08 21.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.162 -0.961 . . . . 0.0 110.25 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.466 ' O ' ' HD3' ' A' ' 13' ' ' LYS . 5.5 t -98.12 -67.27 0.85 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.237 -0.914 . . . . 0.0 110.683 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.476 ' O ' ' HB2' ' A' ' 14' ' ' ARG . 45.2 mmtt -131.32 86.02 2.32 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.297 -0.877 . . . . 0.0 110.587 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.544 ' HB3' ' N ' ' A' ' 8' ' ' ASP . 1.0 OUTLIER 177.75 -22.88 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.488 -0.758 . . . . 0.0 111.008 179.739 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.745 ' HA ' HG12 ' A' ' 7' ' ' VAL . 6.8 tt -30.33 -45.13 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.749 -0.595 . . . . 0.0 111.203 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.581 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 43.0 t -159.18 154.3 25.21 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.226 -0.921 . . . . 0.0 109.967 179.107 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -114.84 -151.76 0.49 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.21 -0.931 . . . . 0.0 110.629 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -123.91 16.14 9.33 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.334 -0.854 . . . . 0.0 110.51 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.508 ' HB2' ' HB2' ' A' ' 22' ' ' TYR . 36.4 m-20 -119.16 148.02 43.55 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.083 -1.011 . . . . 0.0 110.395 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -88.16 26.45 1.39 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.323 -0.86 . . . . 0.0 110.165 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.4 pttm -150.29 -35.23 0.16 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.292 -0.88 . . . . 0.0 110.457 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.508 ' HB2' ' HB2' ' A' ' 19' ' ' ASN . 0.1 OUTLIER -51.51 -28.82 14.59 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -0.918 . . . . 0.0 110.691 -179.661 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.443 ' O ' ' C ' ' A' ' 24' ' ' ASN . 0.5 OUTLIER -87.18 -59.68 2.19 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.1 -1.0 . . . . 0.0 110.333 -179.905 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 35' ' ' GLY . 0.1 OUTLIER -40.72 -40.41 1.3 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.488 -0.758 . . . . 0.0 110.001 179.879 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.99 -47.69 80.21 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.315 -0.866 . . . . 0.0 110.311 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.8 mt -74.84 -37.92 62.12 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.192 -0.942 . . . . 0.0 110.046 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.494 ' SG ' ' HG3' ' A' ' 6' ' ' PRO . 15.2 m -58.38 -39.68 80.26 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.161 -0.962 . . . . 0.0 109.473 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.87 -29.9 68.62 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.329 -0.857 . . . . 0.0 109.37 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.2 -37.35 92.82 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 108.311 -1.916 . . . . 0.0 108.311 179.037 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.509 ' O ' ' CB ' ' A' ' 31' ' ' LYS . 39.5 mt -89.02 19.39 4.2 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.462 -1.022 . . . . 0.0 109.524 179.053 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.509 ' CB ' ' O ' ' A' ' 30' ' ' LEU . 0.3 OUTLIER 73.18 16.22 4.27 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.657 -0.652 . . . . 0.0 110.809 179.912 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.69 ' HB2' HD22 ' A' ' 49' ' ' LEU . . . -95.65 89.7 5.43 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.957 -1.089 . . . . 0.0 109.797 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -55.31 -75.15 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.22 -0.925 . . . . 0.0 111.018 -179.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.5 ' O ' ' HA ' ' A' ' 46' ' ' CYS . 8.6 t -62.34 95.42 0.07 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.389 -0.82 . . . . 0.0 110.912 -179.283 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.487 ' HA2' ' SG ' ' A' ' 46' ' ' CYS . . . -123.06 110.87 1.6 Allowed Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.585 ' CD1' ' O ' ' A' ' 36' ' ' TYR . 13.1 p90 -138.99 144.25 38.84 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.388 -1.066 . . . . 0.0 109.738 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.512 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.0 OUTLIER -90.97 154.56 19.36 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.038 -1.039 . . . . 0.0 110.832 -179.359 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.452 ' CG ' ' HB2' ' A' ' 42' ' ' LEU . 18.5 t-105 -79.95 -172.03 3.19 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.271 -0.893 . . . . 0.0 109.936 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -119.55 -29.3 1.76 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.911 ' CD1' HG22 ' A' ' 41' ' ' THR . 12.8 t-105 -79.38 -83.1 0.1 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.233 -1.157 . . . . 0.0 109.986 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.911 HG22 ' CD1' ' A' ' 40' ' ' TRP . 5.3 t -166.41 48.42 0.07 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.347 -0.845 . . . . 0.0 109.707 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.452 ' HB2' ' CG ' ' A' ' 38' ' ' TRP . 8.0 mp -106.9 23.49 14.28 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.312 -0.868 . . . . 0.0 110.745 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.581 ' HA ' ' HB2' ' A' ' 16' ' ' CYS . 5.1 m 58.48 -166.93 0.15 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 120.935 -1.103 . . . . 0.0 110.027 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.512 ' HA ' ' HA ' ' A' ' 37' ' ' CYS . 9.3 t -83.68 156.27 22.73 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.34 -0.85 . . . . 0.0 108.88 178.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.458 ' HB3' ' CE1' ' A' ' 36' ' ' TYR . 0.8 OUTLIER -128.72 116.95 20.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.96 -1.088 . . . . 0.0 110.354 -179.629 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.649 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . 74.0 m -137.52 137.45 38.65 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.353 -0.842 . . . . 0.0 109.848 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.584 ' CG ' ' CB ' ' A' ' 3' ' ' ASP . 1.7 mp0 -123.78 154.63 39.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.273 -0.892 . . . . 0.0 110.431 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.489 ' O ' ' O ' ' A' ' 31' ' ' LYS . . . 99.73 15.46 31.55 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 1.044 HD12 ' CB ' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -98.66 170.35 7.09 Favored Pre-proline 0 N--CA 1.497 1.891 0 O-C-N 121.133 -1.216 . . . . 0.0 109.723 179.669 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.552 ' HD2' ' HB2' ' A' ' 49' ' ' LEU . 43.3 Cg_endo -70.61 156.46 61.07 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 123.515 1.271 . . . . 0.0 110.706 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -58.99 -24.85 63.1 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.334 -0.854 . . . . 0.0 110.01 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -85.79 14.18 6.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.373 -0.829 . . . . 0.0 109.806 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 1.044 ' CB ' HD12 ' A' ' 49' ' ' LEU . . . -56.25 152.15 11.46 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.449 -0.782 . . . . 0.0 110.381 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.465 ' O ' ' HA ' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -92.19 110.48 21.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.309 -0.87 . . . . 0.0 109.536 179.476 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.828 HD13 ' N ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -148.65 -164.62 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.256 -0.903 . . . . 0.0 110.647 -179.384 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' A' ' 55' ' ' ILE . 0.1 OUTLIER -40.45 108.63 0.09 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.573 -0.705 . . . . 0.0 110.54 -179.816 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.456 ' HG2' ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -136.43 20.68 3.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.381 -0.824 . . . . 0.0 109.872 179.807 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.451 ' CB ' ' O ' ' A' ' 57' ' ' ARG . 0.5 OUTLIER 66.86 153.49 0.08 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.408 -0.807 . . . . 0.0 110.161 -179.969 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 128.73 101.57 1.03 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.709 -1.357 . . . . 0.0 109.709 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.436 ' O ' ' C ' ' A' ' 61' ' ' CYS . 1.6 mmt180 -70.13 94.85 0.92 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.257 -1.143 . . . . 0.0 109.965 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.436 ' C ' ' O ' ' A' ' 60' ' ' ARG . 41.8 t 42.54 88.95 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 0.0 109.967 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.687 ' O ' ' HB3' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -83.11 26.48 0.62 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.357 -0.84 . . . . 0.0 110.844 -179.905 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.687 ' HB3' ' O ' ' A' ' 62' ' ' ARG . . . . . . . . 0 N--CA 1.492 1.644 0 O-C-N 121.01 -1.056 . . . . 0.0 110.244 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 5.4 mtmm . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.21 0.528 . . . . 0.0 110.152 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.887 HG22 ' O ' ' A' ' 49' ' ' LEU . 6.0 tt -133.09 154.72 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.202 -0.936 . . . . 0.0 110.418 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -124.88 128.6 48.9 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.345 -0.847 . . . . 0.0 109.983 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -168.19 -166.07 26.64 Favored Glycine 0 N--CA 1.491 2.347 0 C-N-CA 119.554 -1.307 . . . . 0.0 110.114 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.592 ' N ' ' CD1' ' A' ' 5' ' ' TYR . 13.7 m-85 -111.05 104.3 56.01 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.318 -1.107 . . . . 0.0 109.656 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.736 ' CA ' HG22 ' A' ' 55' ' ' ILE . 50.1 Cg_endo -76.98 111.44 3.23 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 123.948 1.499 . . . . 0.0 111.281 -179.057 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.602 HG12 ' HB ' ' A' ' 15' ' ' ILE . 15.8 m -83.4 -169.99 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.231 -0.918 . . . . 0.0 109.877 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.57 ' CB ' ' HB2' ' A' ' 13' ' ' LYS . 11.8 p-10 -71.9 -134.77 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.287 -0.883 . . . . 0.0 109.852 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.586 ' HB3' ' CD2' ' A' ' 10' ' ' TRP . 0.2 OUTLIER -92.43 -63.26 1.25 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.035 -1.041 . . . . 0.0 110.397 -179.871 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.586 ' CD2' ' HB3' ' A' ' 9' ' ' TYR . 2.8 m-90 -107.11 26.79 9.71 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.134 -0.979 . . . . 0.0 110.125 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.5 ' HA ' ' OD1' ' A' ' 8' ' ' ASP . 1.3 m-20 67.31 5.83 4.48 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.134 -0.979 . . . . 0.0 109.853 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.454 ' O ' ' C ' ' A' ' 13' ' ' LYS . 89.2 m -83.86 -66.1 0.93 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.277 -0.889 . . . . 0.0 110.733 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.57 ' HB2' ' CB ' ' A' ' 8' ' ' ASP . 6.8 mmmt -37.95 -85.68 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.726 -0.609 . . . . 0.0 110.843 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 4.6 ttm180 -165.33 109.02 0.85 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.002 -1.061 . . . . 0.0 110.673 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.602 ' HB ' HG12 ' A' ' 7' ' ' VAL . 46.3 pt -48.77 -24.24 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.139 -0.975 . . . . 0.0 109.348 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.555 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 34.4 t -150.15 126.39 10.69 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.714 -0.616 . . . . 0.0 109.865 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.652 ' CE3' ' CD2' ' A' ' 22' ' ' TYR . 0.0 OUTLIER -85.36 -162.05 0.67 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.184 -0.948 . . . . 0.0 110.197 -179.901 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -101.72 -54.74 2.67 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.328 -0.857 . . . . 0.0 110.181 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -60.66 113.86 2.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.449 -0.782 . . . . 0.0 110.29 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 29.4 p30 -59.65 -15.22 17.7 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.354 -0.841 . . . . 0.0 110.329 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.416 ' HG3' ' N ' ' A' ' 22' ' ' TYR . 8.2 pttp -92.98 -27.89 16.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.203 -0.936 . . . . 0.0 110.293 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.652 ' CD2' ' CE3' ' A' ' 17' ' ' TRP . 45.3 t80 -60.63 -47.9 84.18 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.245 -0.909 . . . . 0.0 110.046 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -64.6 -40.44 95.53 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.334 -0.854 . . . . 0.0 110.174 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -57.59 -35.44 70.41 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.226 -0.921 . . . . 0.0 110.133 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -58.72 -57.52 12.62 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.241 -0.912 . . . . 0.0 110.015 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.87 -39.01 93.1 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.274 -0.891 . . . . 0.0 110.149 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.489 ' SG ' ' HG3' ' A' ' 6' ' ' PRO . 11.4 m -62.65 -37.19 85.38 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.223 -0.923 . . . . 0.0 109.877 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.88 -29.4 70.58 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.181 -0.949 . . . . 0.0 109.368 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.78 -27.34 69.88 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 107.438 -2.265 . . . . 0.0 107.438 178.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.537 ' O ' ' HD3' ' A' ' 50' ' ' PRO . 9.9 mt -96.3 19.41 11.99 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.879 -0.777 . . . . 0.0 109.051 178.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.508 ' CB ' ' O ' ' A' ' 30' ' ' LEU . 0.7 OUTLIER 71.47 10.92 6.6 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.468 -0.77 . . . . 0.0 110.985 179.684 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.809 ' HB2' HD22 ' A' ' 49' ' ' LEU . . . -85.3 103.46 14.25 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.833 -1.167 . . . . 0.0 109.983 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.441 ' N ' ' OD1' ' A' ' 33' ' ' ASP . 4.4 m-20 -61.25 -80.25 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.407 -0.808 . . . . 0.0 110.885 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.492 ' O ' ' HA ' ' A' ' 46' ' ' CYS . 60.3 p -66.26 94.04 0.24 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.234 -0.916 . . . . 0.0 110.348 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.442 ' HA2' ' SG ' ' A' ' 46' ' ' CYS . . . -116.75 84.5 0.37 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.421 ' C ' ' CD1' ' A' ' 36' ' ' TYR . 31.5 p90 -114.88 151.49 33.87 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.203 -1.175 . . . . 0.0 109.841 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.562 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.1 OUTLIER -95.62 155.3 16.8 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.118 -0.989 . . . . 0.0 110.505 -179.642 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.594 ' CD1' ' HB3' ' A' ' 40' ' ' TRP . 27.6 t-105 -79.52 168.15 19.82 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.188 -0.945 . . . . 0.0 109.613 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -106.66 -26.42 5.87 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.594 ' HB3' ' CD1' ' A' ' 38' ' ' TRP . 53.8 t-105 -79.61 -92.02 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.26 -1.141 . . . . 0.0 109.726 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.585 HG23 ' C ' ' A' ' 40' ' ' TRP . 70.7 p -158.07 46.37 0.35 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.357 -0.84 . . . . 0.0 109.857 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.587 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 1.1 mt -110.92 30.92 6.42 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.14 -0.975 . . . . 0.0 110.686 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.555 ' HA ' ' HB2' ' A' ' 16' ' ' CYS . 3.2 t 54.85 -172.68 0.05 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.201 -0.937 . . . . 0.0 110.386 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.562 ' HA ' ' HA ' ' A' ' 37' ' ' CYS . 17.5 t -78.77 166.63 22.24 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.335 -0.853 . . . . 0.0 109.814 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.573 ' HE2' ' HH ' ' A' ' 5' ' ' TYR . 0.8 OUTLIER -139.82 120.08 13.85 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.243 -0.911 . . . . 0.0 110.488 -179.613 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.676 ' O ' HD21 ' A' ' 49' ' ' LEU . 80.5 m -136.07 135.19 39.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.121 -0.987 . . . . 0.0 109.697 179.199 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -115.53 142.94 46.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.353 -0.842 . . . . 0.0 110.205 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 31' ' ' LYS . . . 99.9 31.91 5.82 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.887 ' O ' HG22 ' A' ' 2' ' ' ILE . 0.1 OUTLIER -103.49 176.3 1.86 Allowed Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.052 -1.263 . . . . 0.0 109.327 179.38 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.787 ' O ' HG21 ' A' ' 2' ' ' ILE . 47.2 Cg_endo -70.56 155.93 62.3 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 123.692 1.364 . . . . 0.0 110.24 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -59.7 -19.03 47.09 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.052 -1.03 . . . . 0.0 109.597 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -102.31 24.71 9.87 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.395 -0.815 . . . . 0.0 109.472 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.672 ' HB2' ' HB2' ' A' ' 49' ' ' LEU . . . -64.22 123.14 18.34 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.355 -0.841 . . . . 0.0 110.509 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.525 ' CZ ' ' O ' ' A' ' 9' ' ' TYR . 0.1 OUTLIER -68.64 112.31 5.32 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.217 -0.927 . . . . 0.0 110.278 179.834 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 1.07 ' O ' HD12 ' A' ' 55' ' ' ILE . 2.5 pp -143.68 128.07 14.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.44 -0.788 . . . . 0.0 110.589 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.504 ' HE3' HG11 ' A' ' 7' ' ' VAL . 0.0 OUTLIER 29.17 52.67 0.08 Allowed 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 121.227 0.537 . . . . 0.0 111.689 179.862 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.436 ' HD3' ' HG2' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -128.62 7.98 5.8 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.231 -0.918 . . . . 0.0 110.196 179.479 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.478 ' HB3' ' HB2' ' A' ' 11' ' ' ASN . 0.4 OUTLIER -92.32 151.92 20.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.32 -0.862 . . . . 0.0 110.114 179.87 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.15 -136.54 1.26 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.44 ' O ' ' O ' ' A' ' 61' ' ' CYS . 25.4 mmt85 -88.16 92.41 9.14 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.172 -1.193 . . . . 0.0 110.271 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 10' ' ' TRP . 0.0 OUTLIER 52.74 101.79 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.241 -0.912 . . . . 0.0 110.137 179.935 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.515 ' CB ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -82.32 46.77 1.07 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.243 -0.911 . . . . 0.0 110.293 -179.875 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.252 -0.905 . . . . 0.0 110.261 179.964 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.436 ' O ' ' HG3' ' A' ' 1' ' ' LYS . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.308 0.575 . . . . 0.0 110.163 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.527 ' CG2' ' HG ' ' A' ' 49' ' ' LEU . 15.9 tt -133.62 166.31 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.242 -0.912 . . . . 0.0 109.991 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -142.24 138.11 31.2 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.297 -0.877 . . . . 0.0 110.011 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 176.78 -148.67 9.13 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.549 ' N ' ' CD1' ' A' ' 5' ' ' TYR . 18.2 m-85 -123.61 117.61 27.6 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.285 -1.127 . . . . 0.0 110.321 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.609 ' CA ' HG22 ' A' ' 55' ' ' ILE . 45.5 Cg_endo -74.03 134.18 19.2 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.923 1.486 . . . . 0.0 110.159 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.714 HG12 ' HA ' ' A' ' 15' ' ' ILE . 27.2 m -136.99 -168.79 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.142 -0.974 . . . . 0.0 110.475 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.562 ' CB ' ' HB3' ' A' ' 14' ' ' ARG . 0.7 OUTLIER -80.13 172.28 13.98 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.342 -0.849 . . . . 0.0 110.383 -179.821 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.593 ' HB3' ' CE2' ' A' ' 10' ' ' TRP . 0.4 OUTLIER -62.34 -19.56 63.48 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.306 -0.871 . . . . 0.0 109.817 179.706 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.593 ' CE2' ' HB3' ' A' ' 9' ' ' TYR . 2.9 m-90 -131.23 12.87 5.1 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.333 -0.854 . . . . 0.0 110.15 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.611 ' OD1' HG21 ' A' ' 7' ' ' VAL . 88.6 m-20 56.5 35.44 26.01 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.129 -0.982 . . . . 0.0 109.375 -179.289 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.437 ' SG ' ' HB2' ' A' ' 10' ' ' TRP . 34.8 m -90.74 -53.2 4.51 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.481 -0.762 . . . . 0.0 111.642 -179.086 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.489 ' O ' ' O ' ' A' ' 14' ' ' ARG . 1.2 mppt? -125.21 -56.41 1.54 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.059 -1.026 . . . . 0.0 111.885 -178.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.562 ' HB3' ' CB ' ' A' ' 8' ' ' ASP . 14.6 tpp180 -36.76 -96.02 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.371 -0.831 . . . . 0.0 111.064 -178.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.714 ' HA ' HG12 ' A' ' 7' ' ' VAL . 72.0 mt 50.4 -88.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 120.954 -1.092 . . . . 0.0 110.515 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.62 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 1.6 t -135.13 134.4 40.18 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.371 -0.831 . . . . 0.0 109.714 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.425 ' O ' ' SG ' ' A' ' 37' ' ' CYS . 0.0 OUTLIER -88.62 -156.52 0.38 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.165 -0.959 . . . . 0.0 110.631 -179.654 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -107.25 -32.32 7.84 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.224 -0.923 . . . . 0.0 110.161 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -87.45 153.52 21.36 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.289 -0.882 . . . . 0.0 110.136 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -86.24 -17.55 34.45 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.179 -0.951 . . . . 0.0 109.997 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.7 ttpp -96.15 -10.56 27.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.284 -0.885 . . . . 0.0 109.992 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -69.39 -58.75 3.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.248 -0.908 . . . . 0.0 110.094 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -65.62 -28.17 68.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.311 -0.868 . . . . 0.0 110.096 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.496 ' O ' ' HG2' ' A' ' 28' ' ' LYS . 63.6 t30 -69.07 -40.43 78.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.344 -0.848 . . . . 0.0 109.918 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.57 -46.15 87.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.156 -0.965 . . . . 0.0 110.007 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.1 mt -74.27 -42.69 59.21 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.319 -0.863 . . . . 0.0 109.946 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.479 ' SG ' ' HG3' ' A' ' 6' ' ' PRO . 5.7 m -58.95 -39.39 81.53 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.219 -0.926 . . . . 0.0 109.547 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.496 ' HG2' ' O ' ' A' ' 24' ' ' ASN . 2.6 mmmt -60.83 -28.18 68.62 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.196 -0.94 . . . . 0.0 109.443 179.169 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.12 -35.35 90.69 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 107.677 -2.169 . . . . 0.0 107.677 178.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.547 ' O ' ' HD3' ' A' ' 50' ' ' PRO . 13.6 mt -91.38 21.94 4.21 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.701 -0.882 . . . . 0.0 109.117 178.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.474 ' O ' ' O ' ' A' ' 48' ' ' GLY . 0.7 OUTLIER 67.72 15.43 9.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.426 -0.796 . . . . 0.0 110.95 179.868 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.701 ' HB1' ' HB3' ' A' ' 46' ' ' CYS . . . -83.99 89.44 7.25 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.859 -1.151 . . . . 0.0 109.582 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.402 ' HA ' ' HD3' ' A' ' 28' ' ' LYS . 0.2 OUTLIER -48.03 -83.68 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.322 -0.862 . . . . 0.0 111.195 -179.213 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.509 ' O ' ' HA ' ' A' ' 46' ' ' CYS . 10.0 m -68.97 92.11 0.5 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.296 -0.878 . . . . 0.0 110.5 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.519 ' CA ' ' SG ' ' A' ' 46' ' ' CYS . . . -127.03 97.41 0.48 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.41 ' O ' ' SG ' ' A' ' 44' ' ' CYS . 40.6 p90 -119.73 -169.41 1.76 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.235 -1.156 . . . . 0.0 110.658 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 34.4 t -128.12 127.7 43.5 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.363 -0.836 . . . . 0.0 110.268 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.608 ' CD1' ' HB3' ' A' ' 40' ' ' TRP . 28.0 t-105 -79.77 147.25 31.92 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.994 -1.067 . . . . 0.0 110.054 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -110.91 61.11 0.31 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.967 ' CD1' HG22 ' A' ' 41' ' ' THR . 14.2 t-105 -160.31 -70.38 0.07 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.235 -1.156 . . . . 0.0 110.056 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.967 HG22 ' CD1' ' A' ' 40' ' ' TRP . 7.0 t -171.47 34.99 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.443 -0.786 . . . . 0.0 110.178 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.581 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 12.5 mt -119.69 10.29 11.66 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.261 -0.899 . . . . 0.0 110.358 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.62 ' HA ' ' HB2' ' A' ' 16' ' ' CYS . 50.7 m 54.46 -170.52 0.06 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.236 -0.915 . . . . 0.0 110.317 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 15' ' ' ILE . 43.0 t -74.18 155.31 38.5 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.195 -0.941 . . . . 0.0 109.247 179.266 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.41 ' HB3' ' CZ ' ' A' ' 36' ' ' TYR . 1.0 OUTLIER -137.06 112.56 9.32 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.873 -1.142 . . . . 0.0 111.123 -179.35 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.701 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . 68.1 m -128.8 143.86 51.02 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.296 -0.877 . . . . 0.0 109.837 178.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -126.61 145.68 50.46 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.217 -0.927 . . . . 0.0 110.159 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.476 ' N ' HD23 ' A' ' 49' ' ' LEU . . . 95.56 33.87 6.28 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.987 HD12 ' CB ' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -109.14 171.27 4.59 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.275 -1.133 . . . . 0.0 109.741 179.738 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.547 ' HD3' ' O ' ' A' ' 30' ' ' LEU . 42.4 Cg_endo -69.45 158.68 56.47 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.51 1.269 . . . . 0.0 110.774 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -62.0 -15.33 43.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.333 -0.855 . . . . 0.0 109.885 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -96.59 16.14 19.69 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.344 -0.848 . . . . 0.0 109.819 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.987 ' CB ' HD12 ' A' ' 49' ' ' LEU . . . -60.46 127.88 33.9 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.386 -0.821 . . . . 0.0 110.528 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.508 ' O ' ' HA ' ' A' ' 6' ' ' PRO . 0.5 OUTLIER -71.32 99.53 1.96 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.284 -0.885 . . . . 0.0 109.887 179.742 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.721 HD12 ' C ' ' A' ' 55' ' ' ILE . 2.3 pp -137.4 -160.81 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.181 -0.949 . . . . 0.0 110.463 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.476 ' C ' ' O ' ' A' ' 55' ' ' ILE . 12.8 mttt -29.68 96.8 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 121.382 0.61 . . . . 0.0 111.567 -179.312 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.437 ' O ' ' CB ' ' A' ' 58' ' ' SER . 0.3 OUTLIER -111.3 0.36 16.67 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.41 -0.806 . . . . 0.0 110.038 179.555 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.437 ' CB ' ' O ' ' A' ' 57' ' ' ARG . 0.4 OUTLIER 66.55 172.9 0.25 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.422 -0.799 . . . . 0.0 110.287 -179.985 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 60' ' ' ARG . . . 86.42 108.75 0.8 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.469 ' O ' ' N ' ' A' ' 62' ' ' ARG . 8.9 mmm-85 -49.36 -179.69 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.283 -1.128 . . . . 0.0 110.302 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.495 ' HA ' ' O ' ' A' ' 10' ' ' TRP . 16.3 t -43.4 96.51 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.248 -0.908 . . . . 0.0 110.149 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.54 ' CA ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -82.76 46.1 1.05 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.166 -0.959 . . . . 0.0 110.244 179.926 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.196 -0.94 . . . . 0.0 110.12 -179.985 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 1.4 mtpp . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.205 0.526 . . . . 0.0 110.269 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.537 HG22 ' O ' ' A' ' 49' ' ' LEU . 7.1 tt -132.94 161.8 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.324 -0.86 . . . . 0.0 110.264 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.463 ' OD1' ' HB3' ' A' ' 47' ' ' GLN . 4.5 m-20 -128.4 129.53 46.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.341 -0.85 . . . . 0.0 109.66 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -169.06 -170.03 33.16 Favored Glycine 0 N--CA 1.494 2.526 0 C-N-CA 119.372 -1.394 . . . . 0.0 110.259 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.557 ' N ' ' CD1' ' A' ' 5' ' ' TYR . 6.8 m-85 -107.69 102.4 44.74 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.431 -1.041 . . . . 0.0 110.485 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.59 138.17 26.31 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 124.004 1.528 . . . . 0.0 110.425 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 1.074 HG12 HG23 ' A' ' 15' ' ' ILE . 21.4 m -120.47 -168.97 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.239 -0.913 . . . . 0.0 110.449 -179.571 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.557 ' HB2' ' CB ' ' A' ' 13' ' ' LYS . 8.3 p-10 -66.94 -150.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.352 -0.843 . . . . 0.0 110.283 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.617 ' HB3' ' CD2' ' A' ' 10' ' ' TRP . 0.2 OUTLIER -87.13 -33.93 19.26 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.191 -0.943 . . . . 0.0 110.382 -179.861 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.617 ' CD2' ' HB3' ' A' ' 9' ' ' TYR . 8.7 m-90 -129.23 34.36 4.41 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.001 -1.062 . . . . 0.0 110.367 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.506 ' CA ' ' OD1' ' A' ' 8' ' ' ASP . 62.8 m-80 57.17 16.48 3.01 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.125 -0.984 . . . . 0.0 110.297 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.46 ' HB2' ' HA ' ' A' ' 61' ' ' CYS . 2.0 t -109.9 -44.19 3.86 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.208 -0.933 . . . . 0.0 110.488 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.557 ' CB ' ' HB2' ' A' ' 8' ' ' ASP . 0.0 OUTLIER -69.96 58.32 0.15 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.295 -0.878 . . . . 0.0 110.447 -179.733 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.457 ' HB2' ' O ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER 59.34 122.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.322 -0.861 . . . . 0.0 110.903 179.722 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 1.074 HG23 HG12 ' A' ' 7' ' ' VAL . 1.3 mp -79.34 -12.81 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-O 121.747 0.784 . . . . 0.0 109.36 179.331 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.517 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 1.5 t -146.55 158.05 43.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.458 -0.776 . . . . 0.0 109.263 179.35 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.549 ' CE2' ' CD1' ' A' ' 22' ' ' TYR . 0.0 OUTLIER -104.72 165.77 10.84 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.896 -1.128 . . . . 0.0 110.996 -179.511 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -81.17 -32.26 33.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.068 -1.02 . . . . 0.0 110.266 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -96.2 114.21 25.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.301 -0.874 . . . . 0.0 110.356 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -47.17 -27.98 1.65 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.391 -0.818 . . . . 0.0 110.348 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 29.7 tttm -76.19 -33.14 59.3 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.18 -0.95 . . . . 0.0 110.378 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.549 ' CD1' ' CE2' ' A' ' 17' ' ' TRP . 0.3 OUTLIER -55.12 -41.92 72.31 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.191 -0.943 . . . . 0.0 110.11 179.94 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.29 -52.99 7.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.222 -0.924 . . . . 0.0 110.248 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 35' ' ' GLY . 28.0 t-20 -48.19 -41.2 26.44 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.243 -0.911 . . . . 0.0 110.44 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -57.2 -52.49 65.12 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.263 -0.898 . . . . 0.0 110.556 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.468 HD13 ' CZ3' ' A' ' 17' ' ' TRP . 0.2 OUTLIER -71.41 -34.25 70.18 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.152 -0.968 . . . . 0.0 110.428 -179.753 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.446 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 9.4 m -62.87 -45.69 91.38 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.084 -1.01 . . . . 0.0 109.788 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.94 -27.72 63.64 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.576 -0.85 . . . . 0.0 109.372 179.523 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.31 -37.99 93.93 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 108.352 -1.899 . . . . 0.0 108.352 179.214 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.538 ' O ' ' CB ' ' A' ' 31' ' ' LYS . 16.0 mt -90.6 21.18 4.12 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.54 -0.976 . . . . 0.0 109.342 179.099 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.538 ' CB ' ' O ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER 74.26 12.92 3.98 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.743 -0.598 . . . . 0.0 110.736 179.899 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.665 ' CB ' HD22 ' A' ' 49' ' ' LEU . . . -87.32 85.68 7.19 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.843 -1.16 . . . . 0.0 109.829 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -49.5 -87.57 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.414 -0.804 . . . . 0.0 111.186 -179.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.421 ' O ' ' HA ' ' A' ' 46' ' ' CYS . 82.8 p -60.89 96.16 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.303 -0.873 . . . . 0.0 110.73 -179.175 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.505 ' CA ' ' SG ' ' A' ' 46' ' ' CYS . . . -132.11 123.06 3.5 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.595 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 4.3 p90 -143.98 -174.91 4.4 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.173 -1.193 . . . . 0.0 109.76 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.512 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 26.3 t -124.55 138.0 54.36 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.966 -1.084 . . . . 0.0 110.961 -179.364 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.602 ' CD1' ' HB2' ' A' ' 42' ' ' LEU . 21.2 t-105 -88.25 99.43 12.22 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.171 -0.955 . . . . 0.0 109.653 179.276 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -69.36 70.3 0.49 Allowed Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.689 ' CD1' HG22 ' A' ' 41' ' ' THR . 7.5 t-105 -160.53 -65.28 0.07 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.317 -1.107 . . . . 0.0 109.648 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.689 HG22 ' CD1' ' A' ' 40' ' ' TRP . 1.7 t 175.34 36.1 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.564 -0.71 . . . . 0.0 109.885 179.357 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.602 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 1.0 OUTLIER -124.52 18.75 8.84 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.291 -0.881 . . . . 0.0 110.573 -179.781 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.58 ' CB ' ' CG2' ' A' ' 15' ' ' ILE . 28.8 t 56.22 -177.54 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.193 -0.942 . . . . 0.0 110.764 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.512 ' HA ' ' HA ' ' A' ' 37' ' ' CYS . 15.8 t -70.62 173.21 7.4 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.307 -0.871 . . . . 0.0 109.334 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -154.66 106.27 2.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.945 -1.097 . . . . 0.0 110.528 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.739 ' O ' HD21 ' A' ' 49' ' ' LEU . 75.2 m -127.21 137.8 52.98 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.389 -0.819 . . . . 0.0 109.736 179.442 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.463 ' HB3' ' OD1' ' A' ' 3' ' ' ASP . 16.9 mt-30 -116.66 130.83 56.97 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.152 -0.967 . . . . 0.0 109.966 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.505 ' O ' ' O ' ' A' ' 31' ' ' LYS . . . 117.88 24.38 3.36 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.944 HD12 ' CB ' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -104.04 173.42 3.4 Favored Pre-proline 0 N--CA 1.498 1.925 0 O-C-N 121.077 -1.249 . . . . 0.0 109.513 179.591 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.528 ' HD2' ' HB2' ' A' ' 49' ' ' LEU . 41.5 Cg_endo -68.87 156.86 64.05 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.443 1.233 . . . . 0.0 110.559 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -59.2 -21.58 59.69 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.259 -0.9 . . . . 0.0 110.222 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -90.48 14.03 14.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.376 -0.827 . . . . 0.0 109.987 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.944 ' CB ' HD12 ' A' ' 49' ' ' LEU . . . -57.94 125.51 23.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.291 -0.881 . . . . 0.0 110.153 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.594 ' CB ' ' CZ ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -64.71 140.52 58.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.098 -1.001 . . . . 0.0 109.957 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.579 HG22 ' N ' ' A' ' 56' ' ' LYS . 26.3 mm -141.02 175.33 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.19 -0.943 . . . . 0.0 110.415 -179.301 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.855 ' HG2' HG11 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -60.82 82.82 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.332 -0.855 . . . . 0.0 110.074 179.486 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.442 ' N ' ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -95.56 20.81 9.06 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.1 -1.0 . . . . 0.0 110.356 -179.964 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.42 ' HB3' ' O ' ' A' ' 57' ' ' ARG . 4.7 t 63.24 -169.13 0.19 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.289 -0.882 . . . . 0.0 110.375 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 60' ' ' ARG . . . 121.03 -5.46 11.21 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.465 ' O ' ' O ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER 41.95 80.91 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.232 -1.158 . . . . 0.0 110.572 179.751 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.465 ' O ' ' O ' ' A' ' 60' ' ' ARG . 27.2 m 48.44 100.39 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.347 -0.846 . . . . 0.0 110.619 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.53 ' CB ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -89.75 44.26 1.2 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.241 -0.912 . . . . 0.0 110.095 179.699 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.235 -0.916 . . . . 0.0 110.181 -179.86 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 10.3 ttmt . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.25 0.548 . . . . 0.0 110.221 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.671 HG22 ' O ' ' A' ' 49' ' ' LEU . 18.6 tt -127.58 158.77 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.134 -0.979 . . . . 0.0 110.285 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.512 ' HB2' ' HG3' ' A' ' 47' ' ' GLN . 2.5 p30 -133.37 139.28 46.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.366 -0.834 . . . . 0.0 110.102 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.475 ' C ' ' CD1' ' A' ' 5' ' ' TYR . . . 174.18 -164.53 35.76 Favored Glycine 0 N--CA 1.492 2.373 0 C-N-CA 119.685 -1.245 . . . . 0.0 110.057 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.581 ' N ' ' CD1' ' A' ' 5' ' ' TYR . 1.2 m-85 -112.62 98.58 44.81 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.25 -1.147 . . . . 0.0 110.51 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.506 ' HD2' ' O ' ' A' ' 44' ' ' CYS . 44.8 Cg_endo -72.94 116.75 4.84 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.928 1.489 . . . . 0.0 110.557 179.526 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 1.035 HG12 HG23 ' A' ' 15' ' ' ILE . 21.3 m -79.97 -177.22 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.492 -0.755 . . . . 0.0 110.078 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.473 ' O ' ' NE ' ' A' ' 54' ' ' ARG . 77.5 m-20 -61.72 -96.67 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.131 -0.98 . . . . 0.0 110.114 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.499 ' HB3' ' CE3' ' A' ' 10' ' ' TRP . 0.2 OUTLIER -131.94 -59.02 0.95 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.102 -0.999 . . . . 0.0 109.594 179.63 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.499 ' CE3' ' HB3' ' A' ' 9' ' ' TYR . 13.8 m-90 -106.99 17.13 23.46 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.468 -0.77 . . . . 0.0 109.46 179.295 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.517 ' N ' ' OD1' ' A' ' 11' ' ' ASN . 1.3 m-20 60.67 11.7 3.26 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.353 -0.842 . . . . 0.0 110.302 -179.607 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 63.5 m -60.38 -60.25 4.12 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.12 -0.988 . . . . 0.0 110.518 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.44 ' O ' ' CG ' ' A' ' 14' ' ' ARG . 0.8 OUTLIER -63.61 -63.49 1.16 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.365 -0.834 . . . . 0.0 110.325 -179.792 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.44 ' CG ' ' O ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER 173.1 176.78 0.1 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.276 -0.89 . . . . 0.0 110.423 179.977 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 1.035 HG23 HG12 ' A' ' 7' ' ' VAL . 1.0 OUTLIER -77.68 -15.25 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.297 -0.877 . . . . 0.0 109.452 179.813 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.608 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 10.9 t -141.49 157.99 44.43 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.413 -0.804 . . . . 0.0 109.872 179.068 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.478 ' CE3' ' CG ' ' A' ' 22' ' ' TYR . 22.9 t90 -95.67 -112.58 0.13 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.178 -0.951 . . . . 0.0 110.059 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -157.92 58.64 0.48 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.847 -1.158 . . . . 0.0 110.182 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.459 ' HB2' ' CE3' ' A' ' 17' ' ' TRP . 0.2 OUTLIER -170.91 153.58 3.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.378 -0.826 . . . . 0.0 110.086 179.97 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -84.69 -5.1 59.3 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.177 -0.952 . . . . 0.0 110.5 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -119.2 -30.69 4.89 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.066 -1.021 . . . . 0.0 110.735 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.478 ' CG ' ' CE3' ' A' ' 17' ' ' TRP . 26.3 t80 -54.1 -54.12 43.86 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.089 -1.007 . . . . 0.0 110.178 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.438 ' O ' ' HB2' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -62.04 -20.06 63.55 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.199 -0.938 . . . . 0.0 109.695 179.853 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.517 ' CB ' ' O ' ' A' ' 35' ' ' GLY . 9.5 t-20 -84.74 -42.71 14.97 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.266 -0.896 . . . . 0.0 110.457 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -59.18 -43.41 92.16 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.028 -1.045 . . . . 0.0 109.759 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.703 ' O ' HD12 ' A' ' 30' ' ' LEU . 6.3 mt -71.55 -46.43 59.52 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.272 -0.892 . . . . 0.0 109.898 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.501 ' SG ' ' CG ' ' A' ' 6' ' ' PRO . 1.3 m -59.48 -40.13 85.99 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.301 -0.874 . . . . 0.0 110.017 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' A' ' 32' ' ' ALA . 0.1 OUTLIER -64.81 -33.31 75.7 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.268 -0.895 . . . . 0.0 109.141 179.389 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -53.43 -34.5 48.94 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 108.356 -1.898 . . . . 0.0 108.356 179.237 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.703 HD12 ' O ' ' A' ' 26' ' ' LEU . 1.8 mp -81.43 -35.51 30.55 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.469 -1.018 . . . . 0.0 109.353 179.149 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.652 ' CB ' ' O ' ' A' ' 30' ' ' LEU . 1.5 ttmm 141.8 -2.66 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.576 0 C-N-CA 123.051 0.54 . . . . 0.0 110.027 179.303 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.574 ' HB1' ' HB3' ' A' ' 46' ' ' CYS . . . -80.7 94.82 6.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.991 -1.068 . . . . 0.0 110.345 -179.487 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.484 ' HA ' ' CG ' ' A' ' 28' ' ' LYS . 11.5 m-20 -65.11 -46.0 82.85 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.294 -0.878 . . . . 0.0 110.271 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.426 ' O ' ' HA ' ' A' ' 46' ' ' CYS . 0.2 OUTLIER -85.19 80.39 9.23 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.327 -0.858 . . . . 0.0 110.301 -179.865 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.517 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -119.06 103.39 0.99 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -126.38 133.15 51.38 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.23 -1.159 . . . . 0.0 110.404 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.0 OUTLIER -84.67 127.48 34.11 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.207 -0.933 . . . . 0.0 110.167 179.875 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.535 ' CB ' ' HB2' ' A' ' 42' ' ' LEU . 0.3 OUTLIER -79.92 139.81 36.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.254 -0.904 . . . . 0.0 110.258 -179.899 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -90.83 12.16 69.7 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.883 ' CD1' HG22 ' A' ' 41' ' ' THR . 21.4 t-105 -105.03 -70.16 0.79 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.316 -1.108 . . . . 0.0 110.151 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.883 HG22 ' CD1' ' A' ' 40' ' ' TRP . 14.1 t -172.35 32.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.399 -0.813 . . . . 0.0 110.343 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.535 ' HB2' ' CB ' ' A' ' 38' ' ' TRP . 0.2 OUTLIER -112.16 13.65 20.57 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.201 -0.937 . . . . 0.0 110.236 179.961 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.654 ' OG ' HG22 ' A' ' 15' ' ' ILE . 28.0 t 44.12 -166.1 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.281 -0.887 . . . . 0.0 110.916 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.557 ' N ' ' HB2' ' A' ' 16' ' ' CYS . 21.5 t -68.57 113.67 6.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.509 -0.744 . . . . 0.0 109.669 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.425 ' CE2' ' HE1' ' A' ' 5' ' ' TYR . 2.7 t80 -99.62 123.52 43.96 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.176 -0.952 . . . . 0.0 110.145 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.644 ' O ' HD21 ' A' ' 49' ' ' LEU . 59.7 m -134.94 128.13 31.94 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.295 -0.878 . . . . 0.0 110.141 179.712 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.512 ' HG3' ' HB2' ' A' ' 3' ' ' ASP . 0.5 OUTLIER -117.37 135.64 53.72 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.316 -0.865 . . . . 0.0 109.842 179.843 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.55 ' N ' HD23 ' A' ' 49' ' ' LEU . . . 99.63 44.14 2.36 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.804 HD12 ' CB ' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -115.63 172.25 3.87 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.299 -1.118 . . . . 0.0 109.84 179.64 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.533 ' HD3' ' HB3' ' A' ' 31' ' ' LYS . 46.0 Cg_endo -72.04 157.82 53.63 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.832 1.438 . . . . 0.0 110.599 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -59.38 -19.96 51.1 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.208 -0.932 . . . . 0.0 109.941 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -83.84 6.68 20.58 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.281 -0.887 . . . . 0.0 110.04 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.804 ' CB ' HD12 ' A' ' 49' ' ' LEU . . . -63.77 106.81 1.06 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.345 -0.847 . . . . 0.0 110.257 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.738 ' O ' HD13 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -62.42 156.45 22.61 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.244 -0.91 . . . . 0.0 109.93 179.744 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.738 HD13 ' O ' ' A' ' 54' ' ' ARG . 10.7 mm -142.77 -179.8 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.341 -0.849 . . . . 0.0 110.264 -179.638 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.643 ' H ' HG22 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -60.38 84.31 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.436 -0.79 . . . . 0.0 110.124 179.277 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.504 ' NH1' ' HG2' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -106.09 -11.86 15.97 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.246 -0.909 . . . . 0.0 110.264 -179.942 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -146.1 167.04 24.38 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.335 -0.853 . . . . 0.0 110.191 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -148.62 35.64 1.11 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.526 ' O ' ' O ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER -136.98 41.72 2.47 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.111 -1.229 . . . . 0.0 110.383 179.767 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.526 ' O ' ' O ' ' A' ' 60' ' ' ARG . 49.6 t 41.06 106.54 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 121.586 0.708 . . . . 0.0 111.697 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.479 ' CB ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -83.19 40.09 0.69 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.186 -0.946 . . . . 0.0 110.688 179.56 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.658 0 O-C-N 121.086 -1.009 . . . . 0.0 110.296 179.947 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.271 0.558 . . . . 0.0 110.135 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.559 HG23 ' HG ' ' A' ' 49' ' ' LEU . 20.6 tt -126.01 160.58 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.295 -0.878 . . . . 0.0 110.181 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -139.75 128.9 23.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.311 -0.868 . . . . 0.0 110.007 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -177.58 -145.36 5.81 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.941 -1.263 . . . . 0.0 109.941 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.625 ' N ' ' CD1' ' A' ' 5' ' ' TYR . 12.8 m-85 -122.5 97.11 45.13 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.274 -1.133 . . . . 0.0 110.099 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.454 ' HA ' ' O ' ' A' ' 54' ' ' ARG . 42.5 Cg_endo -69.91 126.84 13.66 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.003 1.528 . . . . 0.0 110.815 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.633 HG12 ' CG1' ' A' ' 15' ' ' ILE . 15.2 m -85.38 -169.45 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.484 -0.76 . . . . 0.0 110.511 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.479 ' O ' ' NH1' ' A' ' 54' ' ' ARG . 2.6 t70 -63.15 -158.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.367 -0.833 . . . . 0.0 110.296 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.465 ' HB3' ' CE2' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -91.17 -20.3 22.13 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.296 -0.878 . . . . 0.0 110.176 179.972 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.501 ' HB3' ' N ' ' A' ' 62' ' ' ARG . 5.0 m-90 -128.25 18.24 6.5 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.176 -0.953 . . . . 0.0 110.52 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.469 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 8.3 m-20 59.88 12.7 3.19 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.343 -0.848 . . . . 0.0 110.372 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 3.5 t -79.23 -50.22 11.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.118 -0.989 . . . . 0.0 109.634 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.464 ' O ' ' O ' ' A' ' 14' ' ' ARG . 1.2 mptm? -79.97 152.38 29.54 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.464 -0.772 . . . . 0.0 109.611 179.357 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.464 ' O ' ' O ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -46.11 173.5 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.168 -0.958 . . . . 0.0 110.125 -179.921 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.633 ' CG1' HG12 ' A' ' 7' ' ' VAL . 3.9 mt -71.34 -1.94 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.113 -0.992 . . . . 0.0 109.853 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.568 ' HB2' ' N ' ' A' ' 44' ' ' CYS . 18.9 t -146.6 154.44 41.49 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.384 -0.823 . . . . 0.0 110.006 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.565 ' CZ3' ' CG ' ' A' ' 22' ' ' TYR . 28.3 t90 -118.39 169.54 9.66 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.118 -0.989 . . . . 0.0 109.796 179.438 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.421 ' N ' ' CG ' ' A' ' 17' ' ' TRP . 23.2 t80 -79.48 92.86 5.31 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.216 -0.928 . . . . 0.0 109.564 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.54 ' HB2' ' HB2' ' A' ' 22' ' ' TYR . 4.2 p-10 -174.3 142.47 0.79 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.289 -0.882 . . . . 0.0 110.517 -179.383 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 32.3 p30 -90.69 7.97 36.82 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.237 -0.914 . . . . 0.0 109.871 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.6 mttt -154.64 -28.69 0.11 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.145 -0.972 . . . . 0.0 111.724 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.565 ' CG ' ' CZ3' ' A' ' 17' ' ' TRP . 1.6 t80 -47.85 -21.54 0.43 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.555 -1.341 . . . . 0.0 110.576 -179.355 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -87.0 -34.9 19.09 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.05 -1.031 . . . . 0.0 110.327 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.475 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 12.3 t-20 -72.67 -40.31 66.4 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.07 -1.018 . . . . 0.0 109.697 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -62.75 -33.87 76.05 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.323 -0.86 . . . . 0.0 109.93 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.601 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -83.23 -44.22 15.23 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.315 -0.866 . . . . 0.0 109.148 179.55 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.435 ' N ' ' HG ' ' A' ' 26' ' ' LEU . 1.5 m -58.71 -40.79 84.7 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.536 -0.728 . . . . 0.0 109.562 179.691 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 24' ' ' ASN . 0.2 OUTLIER -64.34 -33.97 77.07 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.268 -0.895 . . . . 0.0 109.015 179.165 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.07 -37.33 45.5 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 108.589 -1.804 . . . . 0.0 108.589 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.672 ' O ' ' CB ' ' A' ' 31' ' ' LYS . 4.1 mt -79.75 -35.47 38.74 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.454 -1.027 . . . . 0.0 109.472 179.323 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.672 ' CB ' ' O ' ' A' ' 30' ' ' LEU . 21.5 tttt 139.21 2.88 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.575 0 C-N-CA 123.122 0.569 . . . . 0.0 110.131 179.284 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.543 ' HB2' HD22 ' A' ' 49' ' ' LEU . . . -88.25 109.3 19.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.781 -1.199 . . . . 0.0 110.18 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.447 ' HA ' ' HG3' ' A' ' 28' ' ' LYS . 2.6 m-20 -78.62 -44.4 24.05 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.142 -0.974 . . . . 0.0 110.402 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.494 ' O ' ' HA ' ' A' ' 46' ' ' CYS . 2.0 t -82.6 73.72 9.62 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.276 -0.89 . . . . 0.0 110.215 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.486 ' CA ' ' SG ' ' A' ' 46' ' ' CYS . . . -118.32 120.91 4.87 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.531 ' C ' ' CD1' ' A' ' 36' ' ' TYR . 14.0 p90 -143.79 153.89 42.86 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.322 -1.105 . . . . 0.0 109.742 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.503 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.0 OUTLIER -107.26 126.6 52.63 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.976 -1.077 . . . . 0.0 110.843 -179.443 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.609 ' CD1' ' HB3' ' A' ' 40' ' ' TRP . 43.7 t-105 -89.1 114.71 25.99 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.461 -0.774 . . . . 0.0 109.816 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.9 73.31 2.45 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 -179.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.688 ' CD1' HG22 ' A' ' 41' ' ' THR . 0.1 OUTLIER -160.59 -73.27 0.07 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.283 -1.127 . . . . 0.0 109.8 179.395 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.688 HG22 ' CD1' ' A' ' 40' ' ' TRP . 15.0 t -169.0 39.29 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.506 -0.746 . . . . 0.0 109.908 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.569 HD13 ' CD1' ' A' ' 38' ' ' TRP . 0.4 OUTLIER -130.21 1.71 4.68 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.253 -0.904 . . . . 0.0 110.344 -179.897 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.538 ' HA ' ' HB2' ' A' ' 16' ' ' CYS . 48.9 m 56.12 -166.94 0.11 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.148 -0.97 . . . . 0.0 110.365 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.568 ' N ' ' HB2' ' A' ' 16' ' ' CYS . 6.8 t -77.91 151.37 33.81 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.253 -0.904 . . . . 0.0 110.171 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.539 ' CD1' ' CZ ' ' A' ' 5' ' ' TYR . 6.9 t80 -135.16 102.71 5.28 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.271 -0.893 . . . . 0.0 110.484 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.637 ' O ' HD21 ' A' ' 49' ' ' LEU . 76.7 m -118.61 133.96 55.47 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.162 -0.961 . . . . 0.0 109.95 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 16.1 mt-30 -119.86 134.66 55.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.261 -0.899 . . . . 0.0 109.778 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.516 ' N ' HD23 ' A' ' 49' ' ' LEU . . . 104.93 38.87 2.43 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.771 HD12 ' CB ' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -114.61 172.25 3.76 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.385 -1.068 . . . . 0.0 109.739 179.785 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.492 ' HD2' ' HB2' ' A' ' 49' ' ' LEU . 46.0 Cg_endo -71.94 156.31 56.52 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.676 1.356 . . . . 0.0 110.398 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.451 ' O ' ' OD1' ' A' ' 51' ' ' ASP . 21.0 t0 -60.34 -20.07 57.95 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.176 -0.952 . . . . 0.0 110.188 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -79.85 0.7 29.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.309 -0.869 . . . . 0.0 110.102 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.771 ' CB ' HD12 ' A' ' 49' ' ' LEU . . . -62.43 101.12 0.21 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.365 -0.834 . . . . 0.0 110.01 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.871 ' O ' HD13 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -55.33 149.85 12.33 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.079 -1.013 . . . . 0.0 110.218 -179.69 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.871 HD13 ' O ' ' A' ' 54' ' ' ARG . 35.5 mm -139.97 169.76 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.309 -0.87 . . . . 0.0 109.939 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.694 ' HG3' HG22 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -42.37 96.21 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.203 -0.936 . . . . 0.0 110.146 179.66 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.485 ' N ' ' O ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -125.51 7.6 7.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.197 -0.939 . . . . 0.0 110.092 179.923 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 58.64 160.39 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.29 -0.881 . . . . 0.0 110.494 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 148.41 -170.29 28.95 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.37 158.69 15.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.2 -1.177 . . . . 0.0 109.997 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 55.9 m -56.73 119.52 6.31 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.226 -0.921 . . . . 0.0 110.13 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.501 ' N ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -83.45 45.35 1.04 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.2 -0.937 . . . . 0.0 110.153 179.834 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.578 0 O-C-N 121.207 -0.933 . . . . 0.0 110.324 -179.758 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 1.5 tttt . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.3 0.571 . . . . 0.0 110.31 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.781 HG22 ' O ' ' A' ' 49' ' ' LEU . 5.9 tt -142.24 160.5 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.137 -0.977 . . . . 0.0 110.136 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.457 ' OD1' ' O ' ' A' ' 3' ' ' ASP . 3.6 p30 -126.9 122.65 35.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.301 -0.875 . . . . 0.0 110.383 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -165.11 -164.77 21.19 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.786 ' CE2' HD22 ' A' ' 42' ' ' LEU . 15.8 m-85 -117.31 107.9 44.53 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.227 -1.16 . . . . 0.0 110.487 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.629 ' N ' HG22 ' A' ' 55' ' ' ILE . 49.6 Cg_endo -76.82 129.9 11.08 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 124.034 1.544 . . . . 0.0 110.649 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.729 HG12 HG23 ' A' ' 15' ' ' ILE . 32.8 m -105.63 -165.34 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.316 -0.865 . . . . 0.0 109.678 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.496 ' OD1' ' CZ3' ' A' ' 10' ' ' TRP . 5.0 t70 -60.56 -139.27 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.318 -0.864 . . . . 0.0 109.85 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.433 ' C ' ' CG ' ' A' ' 10' ' ' TRP . 3.2 m-85 -110.17 -4.11 15.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.083 -1.01 . . . . 0.0 110.079 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.642 ' CG ' ' HB2' ' A' ' 63' ' ' ALA . 1.3 m-90 -143.55 8.58 1.55 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.254 -0.904 . . . . 0.0 110.165 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.517 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 7.5 m-20 66.56 2.29 2.45 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.631 -0.668 . . . . 0.0 110.894 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.429 ' O ' ' C ' ' A' ' 13' ' ' LYS . 0.6 OUTLIER -85.66 -59.09 2.41 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.165 -0.959 . . . . 0.0 110.5 -179.965 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.492 ' CB ' ' OD2' ' A' ' 8' ' ' ASP . 27.8 mmtt -41.99 -70.45 0.11 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.38 -0.825 . . . . 0.0 110.464 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.486 ' HG3' ' O ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -172.55 -178.7 2.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.272 -0.892 . . . . 0.0 110.286 -179.808 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.841 HG22 ' OG ' ' A' ' 43' ' ' SER . 0.6 OUTLIER -104.13 -17.85 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.273 -0.892 . . . . 0.0 109.442 179.935 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.628 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 5.3 t -158.42 174.31 15.31 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.375 -0.828 . . . . 0.0 110.462 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -100.8 -148.85 0.37 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.266 -0.896 . . . . 0.0 110.372 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -120.27 -37.28 3.08 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.152 -0.968 . . . . 0.0 110.331 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -82.3 140.64 33.47 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.351 -0.843 . . . . 0.0 110.402 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -69.24 -5.33 22.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.274 -0.891 . . . . 0.0 110.322 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.2 -31.6 7.84 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.159 -0.963 . . . . 0.0 110.4 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -63.18 -18.59 63.64 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.229 -0.92 . . . . 0.0 110.478 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.453 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 0.1 OUTLIER -90.53 -54.64 3.91 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.067 -1.02 . . . . 0.0 110.283 179.923 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.501 ' CB ' ' O ' ' A' ' 35' ' ' GLY . 52.0 t30 -48.98 -36.67 18.12 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.173 -0.954 . . . . 0.0 110.01 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.406 ' OD1' ' C ' ' A' ' 25' ' ' ASP . 13.1 t0 -57.78 -53.75 54.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.346 -0.846 . . . . 0.0 110.078 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.74 -42.75 85.74 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.201 -0.937 . . . . 0.0 110.263 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.477 ' HA ' HD12 ' A' ' 30' ' ' LEU . 1.3 m -58.86 -33.27 70.28 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.156 -0.965 . . . . 0.0 109.54 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.5 tptm -63.37 -30.69 71.78 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.304 -0.873 . . . . 0.0 109.083 179.158 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.18 -32.58 83.02 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 107.825 -2.11 . . . . 0.0 107.825 178.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.532 ' O ' ' CD ' ' A' ' 50' ' ' PRO . 2.9 mt -90.54 21.56 3.9 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.59 -0.947 . . . . 0.0 109.106 178.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.517 ' HB3' ' O ' ' A' ' 30' ' ' LEU . 13.0 tttm 65.25 20.32 11.88 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.815 -0.553 . . . . 0.0 110.78 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.842 ' HB2' HD22 ' A' ' 49' ' ' LEU . . . -91.97 89.9 7.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.028 -1.045 . . . . 0.0 110.039 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -49.79 -79.66 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.371 -0.831 . . . . 0.0 110.667 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.419 ' O ' ' HA ' ' A' ' 46' ' ' CYS . 75.2 m -71.04 91.4 0.89 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.215 -0.928 . . . . 0.0 110.438 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.521 ' CA ' ' SG ' ' A' ' 46' ' ' CYS . . . -131.56 123.72 3.81 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.418 ' C ' ' CD1' ' A' ' 36' ' ' TYR . 5.0 p90 -142.81 -175.29 4.44 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.177 -1.19 . . . . 0.0 110.594 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 6.2 t -115.91 136.35 53.12 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.217 -0.927 . . . . 0.0 110.406 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.617 ' CD1' ' HB2' ' A' ' 42' ' ' LEU . 1.9 t-105 -79.92 150.94 30.38 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.146 -0.971 . . . . 0.0 109.674 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -98.1 -13.81 41.37 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 -179.444 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 1.059 ' CD1' HG22 ' A' ' 41' ' ' THR . 40.8 t-105 -84.06 -73.05 0.44 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.216 -1.167 . . . . 0.0 109.936 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' THR . . . . . 1.059 HG22 ' CD1' ' A' ' 40' ' ' TRP . 7.5 t -179.66 50.52 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.554 -0.716 . . . . 0.0 109.748 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.786 HD22 ' CE2' ' A' ' 5' ' ' TYR . 0.5 OUTLIER -120.84 21.32 11.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.315 -0.866 . . . . 0.0 110.638 -179.554 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.841 ' OG ' HG22 ' A' ' 15' ' ' ILE . 28.2 t 50.99 -168.57 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.116 -0.99 . . . . 0.0 110.406 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.555 ' CA ' ' SG ' ' A' ' 16' ' ' CYS . 3.0 t -77.25 135.0 38.43 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.201 -0.937 . . . . 0.0 109.67 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.628 ' CD1' ' CE2' ' A' ' 5' ' ' TYR . 8.1 t80 -122.05 109.56 14.71 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.199 -0.938 . . . . 0.0 110.234 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.627 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . 24.2 m -125.52 149.13 48.57 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.471 -0.768 . . . . 0.0 109.732 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.429 ' OE1' ' HB2' ' A' ' 3' ' ' ASP . 24.8 mt-30 -130.03 137.96 50.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.267 -0.895 . . . . 0.0 110.333 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 31' ' ' LYS . . . 112.32 22.84 5.69 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.92 HD12 ' CB ' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -99.85 170.26 6.99 Favored Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.128 -1.219 . . . . 0.0 109.999 179.645 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.532 ' CD ' ' O ' ' A' ' 30' ' ' LEU . 41.5 Cg_endo -67.31 155.06 72.1 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.978 1.515 . . . . 0.0 110.457 -179.394 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -56.94 -23.06 42.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.324 -0.86 . . . . 0.0 110.162 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -87.56 13.61 9.9 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.276 -0.89 . . . . 0.0 110.237 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.92 ' CB ' HD12 ' A' ' 49' ' ' LEU . . . -62.32 115.41 4.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.282 -0.887 . . . . 0.0 110.074 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.464 ' O ' ' HA ' ' A' ' 6' ' ' PRO . 0.1 OUTLIER -72.29 133.8 45.21 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.228 -0.92 . . . . 0.0 110.551 -179.811 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.76 HG22 ' C ' ' A' ' 5' ' ' TYR . 1.3 pp -142.98 -167.52 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.426 -0.796 . . . . 0.0 110.209 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.431 ' HG3' HD13 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -41.05 91.74 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.342 -0.849 . . . . 0.0 111.007 -179.386 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.566 ' O ' ' C ' ' A' ' 58' ' ' SER . 10.3 mtp85 -120.48 21.81 11.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.199 -0.938 . . . . 0.0 109.323 179.208 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.566 ' C ' ' O ' ' A' ' 57' ' ' ARG . 0.2 OUTLIER -7.45 122.93 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.255 0 CA-C-O 121.475 0.655 . . . . 0.0 112.432 -179.571 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -142.43 -103.41 0.48 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.457 ' O ' ' O ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER -132.64 48.05 2.45 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.241 -1.153 . . . . 0.0 110.253 179.973 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.457 ' O ' ' O ' ' A' ' 60' ' ' ARG . 0.8 OUTLIER 40.24 91.46 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.505 -0.747 . . . . 0.0 109.933 179.938 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.562 ' O ' ' CD1' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -81.31 47.41 1.03 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.106 -0.997 . . . . 0.0 110.479 -179.666 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.642 ' HB2' ' CG ' ' A' ' 10' ' ' TRP . . . . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.171 -0.955 . . . . 0.0 110.332 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 12.4 ptmt . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.255 0.55 . . . . 0.0 110.279 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.457 ' O ' ' OD1' ' A' ' 3' ' ' ASP . 10.3 tt -125.02 163.16 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.326 -0.859 . . . . 0.0 110.159 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.457 ' OD1' ' O ' ' A' ' 2' ' ' ILE . 85.2 m-20 -135.91 136.12 40.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.343 -0.848 . . . . 0.0 109.979 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -178.39 -159.52 23.08 Favored Glycine 0 N--CA 1.492 2.388 0 C-N-CA 119.608 -1.282 . . . . 0.0 109.977 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.638 ' N ' ' CD1' ' A' ' 5' ' ' TYR . 5.4 m-85 -120.14 111.27 35.51 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.41 -1.053 . . . . 0.0 109.774 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.438 ' HD2' ' HB3' ' A' ' 44' ' ' CYS . 45.4 Cg_endo -72.22 144.79 42.44 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.949 1.499 . . . . 0.0 110.877 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.9 HG12 HG23 ' A' ' 15' ' ' ILE . 15.7 m -99.71 -168.07 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.324 -0.86 . . . . 0.0 110.392 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -72.87 -128.04 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.4 -0.813 . . . . 0.0 110.105 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -115.55 -33.04 5.36 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.915 -1.115 . . . . 0.0 110.327 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.528 ' O ' ' HB2' ' A' ' 11' ' ' ASN . 4.1 m-90 -112.7 13.38 19.86 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.178 -0.952 . . . . 0.0 110.301 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.528 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.0 OUTLIER 62.23 6.61 1.9 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.548 -0.72 . . . . 0.0 110.705 -179.722 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 16.9 m -76.92 -67.02 0.75 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.062 -1.024 . . . . 0.0 110.358 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.432 ' O ' ' O ' ' A' ' 14' ' ' ARG . 2.9 mptm? -58.63 173.53 0.4 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.497 -0.752 . . . . 0.0 110.506 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.432 ' O ' ' O ' ' A' ' 13' ' ' LYS . 5.0 ttp180 -50.78 -178.54 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.352 -0.842 . . . . 0.0 110.139 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.9 HG23 HG12 ' A' ' 7' ' ' VAL . 4.0 mt -95.95 26.04 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.238 -0.914 . . . . 0.0 109.794 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.551 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 8.7 t -151.94 159.41 43.8 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.463 -0.773 . . . . 0.0 110.044 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.96 ' CZ3' HD13 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -85.75 -152.68 0.17 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.223 -0.923 . . . . 0.0 110.266 -179.967 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -120.33 44.43 2.45 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.289 -0.882 . . . . 0.0 110.357 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -176.84 158.78 1.67 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.151 -0.968 . . . . 0.0 110.321 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 34.8 t30 -82.9 -7.18 59.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.263 -0.898 . . . . 0.0 110.239 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.6 tptt -110.1 -31.32 7.4 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.256 -0.902 . . . . 0.0 109.971 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -54.64 -31.23 57.09 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.327 -0.858 . . . . 0.0 110.269 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 27' ' ' CYS . 0.1 OUTLIER -91.38 -32.77 15.53 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.223 -0.923 . . . . 0.0 110.481 -179.663 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.513 ' CB ' ' O ' ' A' ' 35' ' ' GLY . 25.1 t30 -70.63 -44.32 67.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.106 -0.996 . . . . 0.0 110.133 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -56.27 -45.57 80.07 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.232 -0.918 . . . . 0.0 110.468 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.96 HD13 ' CZ3' ' A' ' 17' ' ' TRP . 0.2 OUTLIER -78.1 -40.33 38.65 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.208 -0.932 . . . . 0.0 110.332 -179.9 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 23' ' ' CYS . 1.6 m -57.45 -37.8 73.43 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.146 -0.971 . . . . 0.0 109.522 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.99 -28.12 69.88 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.427 -0.796 . . . . 0.0 109.524 179.6 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.62 -34.97 90.4 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 107.873 -2.091 . . . . 0.0 107.873 178.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.532 ' O ' ' HD3' ' A' ' 50' ' ' PRO . 1.3 mt -89.16 17.8 5.62 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.707 -0.878 . . . . 0.0 109.325 178.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.528 ' CB ' ' O ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER 72.54 14.79 5.16 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.64 -0.662 . . . . 0.0 111.161 179.688 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.687 ' HB1' ' HB3' ' A' ' 46' ' ' CYS . . . -85.3 81.0 8.96 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.786 -1.196 . . . . 0.0 109.633 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 32' ' ' ALA . 0.1 OUTLIER -39.89 -80.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.373 -0.83 . . . . 0.0 110.842 -179.32 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.497 ' O ' ' HA ' ' A' ' 46' ' ' CYS . 57.9 m -69.85 90.16 0.6 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.33 -0.856 . . . . 0.0 110.514 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.513 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -122.26 89.18 0.42 Allowed Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 29.6 p90 -118.25 153.82 33.28 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.244 -1.151 . . . . 0.0 109.964 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.507 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.1 OUTLIER -107.31 134.59 50.16 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.148 -0.97 . . . . 0.0 110.632 -179.567 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.575 ' CD1' ' HB2' ' A' ' 42' ' ' LEU . 14.6 t-105 -83.67 125.57 31.99 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.396 -0.815 . . . . 0.0 109.908 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -89.15 64.25 3.33 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.568 ' HB3' ' CD1' ' A' ' 38' ' ' TRP . 0.1 OUTLIER -155.84 -80.4 0.08 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.299 -1.118 . . . . 0.0 109.648 179.816 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.615 HG23 ' O ' ' A' ' 41' ' ' THR . 2.6 t -162.68 33.64 0.1 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.361 -0.837 . . . . 0.0 109.869 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.575 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 0.4 OUTLIER -117.9 4.92 12.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.333 -0.854 . . . . 0.0 110.363 -179.753 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.551 ' HA ' ' HB2' ' A' ' 16' ' ' CYS . 13.0 m 59.96 -170.93 0.13 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.218 -0.927 . . . . 0.0 110.456 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.507 ' HA ' ' HA ' ' A' ' 37' ' ' CYS . 19.3 t -75.57 156.45 34.99 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.297 -0.877 . . . . 0.0 109.977 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -140.82 99.54 3.63 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.016 -1.053 . . . . 0.0 110.917 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.687 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . 65.6 m -120.51 139.77 52.41 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.241 -0.912 . . . . 0.0 109.551 178.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.44 ' HA ' ' OD1' ' A' ' 3' ' ' ASP . 58.8 mt-30 -126.24 138.96 53.67 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.201 -0.937 . . . . 0.0 110.201 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.55 ' N ' HD23 ' A' ' 49' ' ' LEU . . . 103.8 32.61 4.38 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 -179.658 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.961 HD12 ' CB ' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -110.2 172.34 3.67 Favored Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 121.276 -1.132 . . . . 0.0 109.506 179.843 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.532 ' HD3' ' O ' ' A' ' 30' ' ' LEU . 42.5 Cg_endo -67.78 162.17 40.68 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 O-C-N 123.514 1.271 . . . . 0.0 110.7 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -64.58 -19.78 65.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.354 -0.841 . . . . 0.0 110.134 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -92.68 15.57 14.14 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.265 -0.897 . . . . 0.0 109.997 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.961 ' CB ' HD12 ' A' ' 49' ' ' LEU . . . -62.29 141.79 58.08 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.183 -0.948 . . . . 0.0 110.205 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.774 ' O ' HD13 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -66.24 139.7 58.11 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.304 -0.873 . . . . 0.0 109.764 179.722 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.774 HD13 ' O ' ' A' ' 54' ' ' ARG . 5.3 mm -139.1 -177.76 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.029 -1.045 . . . . 0.0 110.862 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.672 ' H ' HG22 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -59.76 77.78 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.512 -0.742 . . . . 0.0 110.963 -179.528 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.487 ' N ' ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -107.0 17.47 23.02 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.208 -0.932 . . . . 0.0 109.539 179.117 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.438 ' C ' ' O ' ' A' ' 57' ' ' ARG . 0.8 OUTLIER -39.41 136.09 0.98 Allowed 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.25 0.548 . . . . 0.0 110.5 -179.776 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.472 ' O ' ' HD3' ' A' ' 60' ' ' ARG . . . 158.31 -34.45 0.51 Allowed Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.472 ' HD3' ' O ' ' A' ' 59' ' ' GLY . 14.8 mmt85 -114.93 68.92 0.71 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.325 -1.103 . . . . 0.0 110.348 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.423 ' C ' ' O ' ' A' ' 60' ' ' ARG . 0.1 OUTLIER -42.35 100.41 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.32 -0.862 . . . . 0.0 110.098 179.653 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.426 ' C ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -83.84 45.89 1.12 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.132 -0.98 . . . . 0.0 110.246 -179.969 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.196 -0.94 . . . . 0.0 110.313 -179.931 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.283 0.563 . . . . 0.0 110.156 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.564 HG22 ' O ' ' A' ' 49' ' ' LEU . 4.4 tt -140.21 157.51 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.321 -0.862 . . . . 0.0 110.094 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.574 ' OD1' ' CE1' ' A' ' 45' ' ' TYR . 33.4 t0 -125.42 128.01 47.44 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.632 -0.667 . . . . 0.0 109.863 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -174.68 -160.23 22.36 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.691 ' CE2' ' CD1' ' A' ' 45' ' ' TYR . 3.6 m-85 -126.56 99.64 29.81 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.444 -1.033 . . . . 0.0 110.258 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.535 ' HD2' ' O ' ' A' ' 44' ' ' CYS . 43.4 Cg_endo -69.79 125.61 12.33 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 O-C-N 123.917 1.483 . . . . 0.0 110.659 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.572 ' CG1' ' HA ' ' A' ' 56' ' ' LYS . 17.2 m -79.65 175.49 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.418 -0.801 . . . . 0.0 110.31 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -51.35 167.85 0.08 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.272 -0.892 . . . . 0.0 110.145 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.541 ' HB3' ' CE2' ' A' ' 10' ' ' TRP . 0.3 OUTLIER -66.43 -8.48 26.22 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.244 -0.91 . . . . 0.0 110.287 179.976 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.541 ' CE2' ' HB3' ' A' ' 9' ' ' TYR . 1.7 m-90 -139.59 11.28 2.5 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.28 -0.887 . . . . 0.0 109.993 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.417 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 2.8 m120 55.54 19.06 3.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.205 -0.934 . . . . 0.0 109.572 -179.665 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 3.5 t -81.78 -38.64 25.29 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.55 -0.719 . . . . 0.0 110.74 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.405 ' O ' ' CB ' ' A' ' 14' ' ' ARG . 2.5 mttp -93.04 53.38 1.97 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.273 -0.892 . . . . 0.0 110.603 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.405 ' CB ' ' O ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER 62.57 -143.85 0.39 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.233 -0.917 . . . . 0.0 110.409 179.694 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.834 HD12 ' HB2' ' A' ' 43' ' ' SER . 31.8 pt -109.4 4.06 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.165 -0.959 . . . . 0.0 110.277 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.601 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 0.9 OUTLIER -151.36 -174.23 4.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.18 -0.95 . . . . 0.0 109.708 179.436 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.689 ' CE3' ' CG ' ' A' ' 22' ' ' TYR . 0.0 OUTLIER -118.02 -171.92 2.16 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.121 -0.987 . . . . 0.0 110.156 179.839 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -91.28 -36.59 13.79 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.11 -0.994 . . . . 0.0 110.294 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.545 HD21 ' HZ3' ' A' ' 17' ' ' TRP . 72.4 m-20 -78.87 148.58 32.73 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.326 -0.859 . . . . 0.0 110.302 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -88.66 -16.68 31.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.342 -0.849 . . . . 0.0 110.121 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.28 -14.11 24.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.287 -0.883 . . . . 0.0 110.318 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.689 ' CG ' ' CE3' ' A' ' 17' ' ' TRP . 2.8 t80 -72.62 -40.11 66.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.085 -1.009 . . . . 0.0 109.913 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.46 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 1.3 t -63.3 -34.4 77.6 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.328 -0.857 . . . . 0.0 109.659 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.538 ' CB ' ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -78.0 -51.82 9.76 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.279 -0.888 . . . . 0.0 109.776 179.76 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.476 ' N ' ' CG ' ' A' ' 24' ' ' ASN . 5.7 m-20 -51.54 -49.08 62.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.197 -0.94 . . . . 0.0 110.173 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.7 mt -71.04 -37.59 72.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.242 -0.911 . . . . 0.0 110.282 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 23' ' ' CYS . 1.8 m -62.3 -38.66 90.25 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.159 -0.963 . . . . 0.0 109.616 179.659 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.556 ' CD ' ' HA ' ' A' ' 33' ' ' ASP . 8.7 mmmt -61.55 -27.07 68.36 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.291 -0.881 . . . . 0.0 109.145 179.277 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.61 -33.46 86.68 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 107.189 -2.364 . . . . 0.0 107.189 178.51 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.549 ' O ' ' HD3' ' A' ' 50' ' ' PRO . 12.8 mt -90.29 21.65 3.72 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.872 -0.781 . . . . 0.0 108.95 178.485 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.515 ' CB ' ' O ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER 71.81 8.54 6.09 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.452 -0.78 . . . . 0.0 110.81 179.875 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.618 ' HB2' HD22 ' A' ' 49' ' ' LEU . . . -87.06 103.76 15.68 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.95 -1.094 . . . . 0.0 109.877 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.556 ' HA ' ' CD ' ' A' ' 28' ' ' LYS . 9.2 m-20 -67.05 -76.49 0.08 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -0.912 . . . . 0.0 110.723 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.508 ' O ' ' HA ' ' A' ' 46' ' ' CYS . 0.5 OUTLIER -66.28 93.68 0.23 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.361 -0.837 . . . . 0.0 110.791 -179.514 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.538 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -133.05 126.2 4.32 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.421 ' C ' ' SG ' ' A' ' 23' ' ' CYS . 40.4 p90 -145.48 151.56 38.38 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.152 -1.204 . . . . 0.0 110.261 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 42.0 t -97.1 133.16 42.12 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.185 -0.947 . . . . 0.0 110.913 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.61 ' CD1' HD22 ' A' ' 42' ' ' LEU . 0.7 OUTLIER -97.49 138.62 34.64 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.266 -0.896 . . . . 0.0 109.935 179.535 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -89.06 8.74 79.15 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.829 ' CD1' HG22 ' A' ' 41' ' ' THR . 20.6 t-105 -99.57 -76.46 0.54 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.166 -1.196 . . . . 0.0 110.104 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.829 HG22 ' CD1' ' A' ' 40' ' ' TRP . 11.6 t -169.08 31.63 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.393 -0.817 . . . . 0.0 109.888 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.61 HD22 ' CD1' ' A' ' 38' ' ' TRP . 10.9 mp -107.0 14.23 26.66 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.442 -0.786 . . . . 0.0 110.215 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.834 ' HB2' HD12 ' A' ' 15' ' ' ILE . 8.2 t 47.56 -169.1 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.185 -0.947 . . . . 0.0 110.239 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.535 ' O ' ' HD2' ' A' ' 6' ' ' PRO . 1.8 t -81.41 97.12 7.59 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.691 ' CD1' ' CE2' ' A' ' 5' ' ' TYR . 4.8 t80 -79.81 130.54 35.41 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.12 -0.988 . . . . 0.0 111.251 -178.481 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.574 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . 83.3 m -145.15 145.94 31.58 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.366 -0.834 . . . . 0.0 109.376 179.104 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.469 ' HG2' ' OD1' ' A' ' 3' ' ' ASP . 3.9 mt-30 -127.57 142.23 51.42 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.086 -1.008 . . . . 0.0 110.244 -179.618 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' A' ' 31' ' ' LYS . . . 101.94 31.03 5.54 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 179.493 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.851 HD12 ' CB ' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -108.58 171.75 4.26 Favored Pre-proline 0 N--CA 1.497 1.896 0 O-C-N 121.132 -1.216 . . . . 0.0 109.658 179.456 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.549 ' HD3' ' O ' ' A' ' 30' ' ' LEU . 44.1 Cg_endo -69.41 159.42 53.73 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 123.621 1.327 . . . . 0.0 110.738 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -61.15 -24.04 65.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.32 -0.863 . . . . 0.0 109.822 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -88.05 9.69 21.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.335 -0.853 . . . . 0.0 109.854 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.851 ' CB ' HD12 ' A' ' 49' ' ' LEU . . . -59.16 126.09 26.26 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.374 -0.829 . . . . 0.0 110.233 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.924 ' O ' HD13 ' A' ' 55' ' ' ILE . 14.1 ttm-85 -53.82 150.08 7.94 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.317 -0.864 . . . . 0.0 110.351 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.924 HD13 ' O ' ' A' ' 54' ' ' ARG . 5.8 mm -146.87 175.03 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.443 -0.786 . . . . 0.0 110.013 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.572 ' HA ' ' CG1' ' A' ' 7' ' ' VAL . 0.1 OUTLIER -46.44 94.63 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.35 -0.844 . . . . 0.0 110.211 179.31 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.475 ' N ' ' O ' ' A' ' 55' ' ' ILE . 0.1 OUTLIER -116.29 -13.93 11.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.184 -0.948 . . . . 0.0 110.364 -179.904 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.0 t 49.86 -172.14 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.201 -0.937 . . . . 0.0 110.177 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 133.08 -129.43 5.43 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.33 138.47 53.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.328 -1.101 . . . . 0.0 110.265 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 32.5 t -43.61 113.75 0.55 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.233 -0.917 . . . . 0.0 110.179 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.514 ' CB ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -86.88 35.1 0.68 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.178 -0.951 . . . . 0.0 110.356 -179.961 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.654 0 O-C-N 121.281 -0.887 . . . . 0.0 110.105 179.978 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 2.8 ptmt . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.23 0.538 . . . . 0.0 110.184 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.502 HG22 ' HG ' ' A' ' 49' ' ' LEU . 3.3 tt -120.52 163.53 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.269 -0.894 . . . . 0.0 110.313 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.509 ' CB ' ' HG2' ' A' ' 47' ' ' GLN . 35.1 p-10 -125.26 117.19 23.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.589 -0.694 . . . . 0.0 109.675 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -153.37 -165.03 13.1 Favored Glycine 0 N--CA 1.493 2.455 0 C-N-CA 119.529 -1.32 . . . . 0.0 110.285 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.688 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 21.4 m-85 -124.9 97.84 37.66 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.424 -1.045 . . . . 0.0 110.523 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.894 ' CA ' HG22 ' A' ' 55' ' ' ILE . 44.2 Cg_endo -70.68 130.31 18.01 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.865 1.455 . . . . 0.0 110.691 179.449 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.589 HG12 HG22 ' A' ' 15' ' ' ILE . 15.6 m -80.51 -162.53 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.303 -0.873 . . . . 0.0 110.523 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.424 ' O ' ' NH1' ' A' ' 54' ' ' ARG . 1.0 OUTLIER -74.63 -88.59 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.439 -0.788 . . . . 0.0 110.553 -179.544 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.473 ' O ' ' NH1' ' A' ' 62' ' ' ARG . 0.2 OUTLIER -142.35 -66.79 0.39 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.295 -0.878 . . . . 0.0 110.066 -179.888 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.5 ' O ' ' HB2' ' A' ' 11' ' ' ASN . 4.0 m-90 -90.2 10.38 24.8 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.307 -0.87 . . . . 0.0 109.823 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.5 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 6.2 m-20 65.75 5.44 3.36 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.627 -0.67 . . . . 0.0 110.655 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 2.7 t -73.65 -36.8 65.43 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.047 -1.033 . . . . 0.0 109.617 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.464 ' O ' ' O ' ' A' ' 14' ' ' ARG . 5.8 tttt -86.72 152.3 22.65 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.42 -0.8 . . . . 0.0 109.333 179.092 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.464 ' O ' ' O ' ' A' ' 13' ' ' LYS . 1.1 ptp180 -38.31 160.25 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.419 -0.801 . . . . 0.0 110.983 -179.421 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.598 HD12 ' CB ' ' A' ' 43' ' ' SER . 30.3 pt -70.5 0.71 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.383 -0.823 . . . . 0.0 110.84 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.596 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 1.7 t -141.74 121.86 13.8 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.174 -0.954 . . . . 0.0 109.406 179.192 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.66 ' CD2' ' CD2' ' A' ' 22' ' ' TYR . 1.1 t90 -60.94 -137.28 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.14 -0.975 . . . . 0.0 110.111 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -142.6 30.6 1.51 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.159 -0.963 . . . . 0.0 110.468 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.555 ' HB2' ' CE3' ' A' ' 17' ' ' TRP . 0.7 OUTLIER -143.63 134.47 25.27 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.152 -0.967 . . . . 0.0 110.235 179.759 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -69.17 -6.81 31.11 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.313 -0.867 . . . . 0.0 110.119 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.84 -21.84 12.89 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.32 -0.863 . . . . 0.0 110.224 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.66 ' CD2' ' CD2' ' A' ' 17' ' ' TRP . 8.5 t80 -72.53 -56.74 4.9 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.243 -0.911 . . . . 0.0 109.579 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.475 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 1.6 t -56.3 -30.25 62.27 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.435 -0.791 . . . . 0.0 109.51 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.488 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 10.0 t-20 -81.14 -36.04 30.76 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.134 -0.979 . . . . 0.0 109.99 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -64.06 -48.77 74.95 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.197 -0.939 . . . . 0.0 109.711 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.64 -40.02 73.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.372 -0.83 . . . . 0.0 109.867 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.475 ' SG ' ' O ' ' A' ' 23' ' ' CYS . 9.7 m -62.74 -41.01 98.99 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.314 -0.867 . . . . 0.0 109.747 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 24' ' ' ASN . 0.0 OUTLIER -63.79 -24.4 67.74 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.204 -0.935 . . . . 0.0 109.347 179.302 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.83 -37.03 91.89 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 107.638 -2.185 . . . . 0.0 107.638 178.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.509 ' O ' ' HB3' ' A' ' 31' ' ' LYS . 1.1 mt -93.67 20.19 7.76 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.815 -0.815 . . . . 0.0 109.245 178.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.509 ' HB3' ' O ' ' A' ' 30' ' ' LEU . 0.1 OUTLIER 69.61 15.78 8.12 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.851 -0.53 . . . . 0.0 111.365 179.557 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.667 ' HB1' ' HB3' ' A' ' 46' ' ' CYS . . . -78.36 86.04 4.45 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.744 -1.222 . . . . 0.0 109.26 179.273 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.416 ' C ' ' O ' ' A' ' 32' ' ' ALA . 2.2 m-20 -39.38 -90.3 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.621 -0.675 . . . . 0.0 111.488 -178.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.53 ' O ' ' HA ' ' A' ' 46' ' ' CYS . 12.5 p -67.01 92.34 0.24 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.31 -0.869 . . . . 0.0 111.109 -178.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.508 ' CA ' ' SG ' ' A' ' 46' ' ' CYS . . . -122.31 108.79 1.32 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 108.91 -1.676 . . . . 0.0 108.91 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.411 ' CD1' ' C ' ' A' ' 36' ' ' TYR . 30.4 p90 -135.8 165.57 25.3 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.178 -1.19 . . . . 0.0 110.651 -179.516 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.495 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.0 OUTLIER -107.59 128.99 55.03 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.317 -0.864 . . . . 0.0 109.94 179.608 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.601 ' CD1' ' HB2' ' A' ' 42' ' ' LEU . 35.5 t-105 -79.6 166.87 21.43 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.091 -1.006 . . . . 0.0 110.005 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -98.25 -27.35 8.77 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 120.003 -1.094 . . . . 0.0 110.369 -179.147 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.577 ' HB3' ' CD1' ' A' ' 38' ' ' TRP . 48.6 t-105 -79.51 -91.8 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.994 -1.298 . . . . 0.0 110.074 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.527 HG23 ' C ' ' A' ' 40' ' ' TRP . 41.6 p -150.54 34.9 0.63 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.074 -1.016 . . . . 0.0 110.346 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.601 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 0.2 OUTLIER -89.53 0.29 57.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.303 -0.873 . . . . 0.0 110.074 179.809 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.598 ' CB ' HD12 ' A' ' 15' ' ' ILE . 0.9 OUTLIER 60.77 -176.4 0.11 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.227 -0.921 . . . . 0.0 110.201 -179.897 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.517 ' O ' ' HD2' ' A' ' 6' ' ' PRO . 0.9 OUTLIER -80.19 94.48 6.05 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.991 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.688 ' CD1' ' CZ ' ' A' ' 5' ' ' TYR . 9.3 t80 -79.98 138.97 37.18 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.117 -0.989 . . . . 0.0 110.682 -179.009 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.667 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . 74.2 m -149.3 144.44 26.47 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.343 -0.848 . . . . 0.0 110.228 179.561 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.509 ' HG2' ' CB ' ' A' ' 3' ' ' ASP . 39.1 mt-30 -126.64 149.39 49.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.387 -0.821 . . . . 0.0 110.069 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.486 ' O ' ' O ' ' A' ' 31' ' ' LYS . . . 99.59 21.73 13.97 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.844 HD12 ' CB ' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -101.48 169.29 7.91 Favored Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 121.072 -1.252 . . . . 0.0 109.898 179.626 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.519 ' HD2' ' HB2' ' A' ' 49' ' ' LEU . 44.6 Cg_endo -71.56 159.02 52.4 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 123.717 1.377 . . . . 0.0 110.342 -179.547 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.464 ' HA ' HD12 ' A' ' 2' ' ' ILE . 18.9 t70 -60.47 -23.66 64.64 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.157 -0.964 . . . . 0.0 109.723 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -92.87 17.24 10.88 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.466 -0.771 . . . . 0.0 109.609 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.844 ' CB ' HD12 ' A' ' 49' ' ' LEU . . . -47.72 143.67 3.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.372 -0.83 . . . . 0.0 110.104 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.48 ' O ' ' HA ' ' A' ' 6' ' ' PRO . 41.8 ttp85 -85.24 91.7 8.22 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.344 -0.848 . . . . 0.0 110.334 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.894 HG22 ' CA ' ' A' ' 6' ' ' PRO . 0.2 OUTLIER -140.3 166.81 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.324 -0.86 . . . . 0.0 109.965 179.69 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 6.1 mttt 45.25 67.12 0.77 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.135 -0.978 . . . . 0.0 109.759 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.494 ' HG2' ' O ' ' A' ' 55' ' ' ILE . 34.2 mmm-85 -125.44 17.25 8.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.247 -0.908 . . . . 0.0 110.458 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 57' ' ' ARG . 0.7 OUTLIER -42.23 138.99 1.52 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.334 -0.854 . . . . 0.0 109.941 179.884 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -164.25 -128.28 0.94 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.492 ' O ' ' O ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER -117.32 46.67 1.65 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.394 -1.063 . . . . 0.0 110.242 -179.97 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.492 ' O ' ' O ' ' A' ' 60' ' ' ARG . 52.2 m 56.06 121.46 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.476 0.655 . . . . 0.0 110.643 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.497 ' NH1' ' HA ' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -87.66 39.18 0.87 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.024 -1.048 . . . . 0.0 110.235 179.747 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.234 -0.917 . . . . 0.0 110.264 -179.938 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 7.5 mttt . . . . . 0 N--CA 1.494 1.749 0 CA-C-O 121.158 0.504 . . . . 0.0 110.025 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.72 HG22 ' O ' ' A' ' 49' ' ' LEU . 13.5 tt -118.98 161.81 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.143 -0.973 . . . . 0.0 110.337 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -131.34 131.46 43.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.259 -0.901 . . . . 0.0 110.032 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.449 ' O ' ' CD1' ' A' ' 45' ' ' TYR . . . -169.95 -176.17 39.43 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.702 -1.237 . . . . 0.0 110.011 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.681 ' CE1' ' CE1' ' A' ' 45' ' ' TYR . 66.8 m-85 -106.27 100.85 31.62 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.381 -1.07 . . . . 0.0 110.15 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.49 ' O ' ' HB3' ' A' ' 44' ' ' CYS . 43.3 Cg_endo -70.59 140.98 40.76 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.845 1.445 . . . . 0.0 110.478 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.915 ' CG1' HG22 ' A' ' 15' ' ' ILE . 5.1 m -110.12 -170.99 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.194 -0.941 . . . . 0.0 110.168 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -63.99 -145.04 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.24 -0.913 . . . . 0.0 110.686 -179.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -85.97 -47.57 9.49 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.427 -0.796 . . . . 0.0 110.648 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.476 ' HB3' ' CB ' ' A' ' 62' ' ' ARG . 3.3 m-90 -120.36 21.35 11.7 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.098 -1.001 . . . . 0.0 110.546 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.49 ' N ' ' OD1' ' A' ' 11' ' ' ASN . 1.8 m-20 57.7 15.12 2.74 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.118 -0.989 . . . . 0.0 110.154 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.8 t -84.94 -52.8 5.73 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.244 -0.91 . . . . 0.0 110.46 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.426 ' O ' ' CG ' ' A' ' 14' ' ' ARG . 5.6 tptt -61.49 -51.91 66.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.33 -0.856 . . . . 0.0 110.326 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.426 ' CG ' ' O ' ' A' ' 13' ' ' LYS . 0.1 OUTLIER 176.66 -158.71 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.204 -0.935 . . . . 0.0 110.511 -179.963 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.915 HG22 ' CG1' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -119.33 -18.04 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.368 -0.832 . . . . 0.0 109.491 179.558 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.623 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 1.8 t -132.64 111.99 11.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.469 -0.769 . . . . 0.0 110.22 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.464 ' CD2' ' HB3' ' A' ' 22' ' ' TYR . 0.0 OUTLIER -50.27 163.55 0.16 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.24 -0.913 . . . . 0.0 110.157 179.868 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -79.88 -24.75 40.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.305 -0.872 . . . . 0.0 109.983 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -83.88 145.72 28.46 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.272 -0.892 . . . . 0.0 110.047 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 16.0 p30 -80.46 7.6 9.47 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.212 -0.93 . . . . 0.0 110.416 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -131.23 -18.42 2.91 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.137 -0.977 . . . . 0.0 110.954 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.464 ' HB3' ' CD2' ' A' ' 17' ' ' TRP . 0.1 OUTLIER -60.36 -14.07 16.66 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.926 -1.109 . . . . 0.0 110.286 -179.753 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.449 ' O ' ' HB2' ' A' ' 27' ' ' CYS . 0.1 OUTLIER -103.58 -29.85 10.86 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.152 -0.967 . . . . 0.0 110.204 179.926 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.469 ' O ' ' HG2' ' A' ' 28' ' ' LYS . 55.1 t-20 -72.81 -52.58 14.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.192 -0.943 . . . . 0.0 109.582 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -54.75 -42.34 71.51 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.257 -0.902 . . . . 0.0 109.91 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.692 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -72.89 -41.64 64.45 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.279 -0.888 . . . . 0.0 109.431 179.749 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.478 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 1.5 m -60.61 -39.75 89.34 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.4 -0.813 . . . . 0.0 109.638 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.469 ' HG2' ' O ' ' A' ' 24' ' ' ASN . 1.7 mmmp? -61.73 -30.17 70.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.362 -0.837 . . . . 0.0 109.6 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.82 -34.01 80.74 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 108.149 -1.981 . . . . 0.0 108.149 179.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.55 ' O ' ' CB ' ' A' ' 31' ' ' LYS . 62.4 mt -93.06 18.56 9.07 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.605 -0.938 . . . . 0.0 109.785 179.395 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.55 ' CB ' ' O ' ' A' ' 30' ' ' LEU . 0.1 OUTLIER 76.11 12.76 2.75 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.618 -0.676 . . . . 0.0 111.133 179.717 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.815 ' HB2' HD22 ' A' ' 49' ' ' LEU . . . -88.52 82.1 7.0 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.845 -1.159 . . . . 0.0 109.734 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.417 ' O ' ' HD3' ' A' ' 28' ' ' LYS . 72.1 m-20 -46.25 -74.91 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.576 -0.702 . . . . 0.0 111.151 -179.357 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.409 ' O ' ' HA ' ' A' ' 46' ' ' CYS . 11.0 t -69.76 90.38 0.59 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.424 -0.798 . . . . 0.0 110.983 -179.16 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.486 ' HA2' ' SG ' ' A' ' 46' ' ' CYS . . . -122.04 113.89 2.37 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 108.976 -1.65 . . . . 0.0 108.976 179.212 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.572 ' CE1' ' HB3' ' A' ' 45' ' ' TYR . 27.4 p90 -133.28 154.6 50.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.123 -1.222 . . . . 0.0 110.485 -179.534 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.487 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.5 OUTLIER -107.73 118.08 35.81 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.332 -0.855 . . . . 0.0 110.151 179.775 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.616 ' CD1' ' HB3' ' A' ' 40' ' ' TRP . 25.0 t-105 -85.71 99.37 11.28 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.157 -0.965 . . . . 0.0 110.248 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.71 68.03 1.02 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.616 ' HB3' ' CD1' ' A' ' 38' ' ' TRP . 57.3 t-105 -157.94 -88.61 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.251 -1.147 . . . . 0.0 110.254 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 67.0 p -144.74 23.12 1.59 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.114 -0.991 . . . . 0.0 110.281 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.591 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 0.4 OUTLIER -121.01 11.17 10.94 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.168 -0.958 . . . . 0.0 110.537 -179.82 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.623 ' HA ' ' HB2' ' A' ' 16' ' ' CYS . 25.7 m 46.81 -170.23 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.919 -1.113 . . . . 0.0 109.973 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.49 ' HB3' ' O ' ' A' ' 6' ' ' PRO . 51.2 t -77.65 151.65 34.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.101 -1.0 . . . . 0.0 109.139 179.224 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.681 ' CE1' ' CE1' ' A' ' 5' ' ' TYR . 6.1 t80 -147.85 123.86 10.72 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.836 -1.165 . . . . 0.0 111.299 -179.413 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.637 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . 80.0 m -130.63 142.73 50.45 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.444 -0.785 . . . . 0.0 109.453 178.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 13.2 mp0 -116.98 131.17 57.02 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.082 -1.011 . . . . 0.0 110.22 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.598 ' C ' HD23 ' A' ' 49' ' ' LEU . . . 105.35 42.04 1.81 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.815 HD22 ' HB2' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -103.51 -174.79 0.35 Allowed Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.1 -1.236 . . . . 0.0 109.466 179.744 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.692 ' HD2' ' HB2' ' A' ' 53' ' ' ALA . 49.9 Cg_endo -86.23 160.33 9.88 Favored 'Trans proline' 0 C--N 1.303 -1.842 0 O-C-N 123.938 1.493 . . . . 0.0 109.764 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -59.91 -19.54 52.19 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.051 -1.031 . . . . 0.0 109.756 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -99.54 22.01 11.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.331 -0.856 . . . . 0.0 109.645 179.373 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.692 ' HB2' ' HD2' ' A' ' 50' ' ' PRO . . . -60.1 137.9 58.0 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.374 -0.828 . . . . 0.0 110.244 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.671 ' O ' HD13 ' A' ' 55' ' ' ILE . 12.2 ttp-105 -77.69 129.61 35.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.267 -0.896 . . . . 0.0 110.03 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.671 HD13 ' O ' ' A' ' 54' ' ' ARG . 12.9 mm -134.5 177.15 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.182 -0.949 . . . . 0.0 109.616 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.496 ' H ' HG22 ' A' ' 55' ' ' ILE . 2.4 ptmt -67.14 61.77 0.05 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.121 -0.987 . . . . 0.0 109.191 179.446 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.53 ' N ' ' O ' ' A' ' 55' ' ' ILE . 20.0 ttm-85 -86.86 -25.17 24.63 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.598 -0.689 . . . . 0.0 110.665 -179.205 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.8 m -123.19 162.0 23.4 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.14 -0.975 . . . . 0.0 110.119 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -145.17 13.97 1.88 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.515 ' O ' ' O ' ' A' ' 61' ' ' CYS . 2.4 mpp_? -106.55 41.86 1.37 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.096 -1.238 . . . . 0.0 110.211 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.515 ' O ' ' O ' ' A' ' 60' ' ' ARG . 42.7 t 42.42 104.25 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.501 0.667 . . . . 0.0 111.285 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.476 ' CB ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -81.53 45.39 0.87 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.087 -1.008 . . . . 0.0 110.412 179.588 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.069 -1.019 . . . . 0.0 110.183 179.873 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 4.0 pttp . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.265 0.555 . . . . 0.0 110.248 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.503 ' CG2' ' HG ' ' A' ' 49' ' ' LEU . 15.2 tt -131.68 161.1 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.266 -0.896 . . . . 0.0 110.136 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.443 ' OD1' ' HA ' ' A' ' 47' ' ' GLN . 48.8 m-20 -127.46 147.57 50.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.379 -0.826 . . . . 0.0 110.133 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 164.21 -179.93 38.78 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.668 ' CZ ' ' CD2' ' A' ' 45' ' ' TYR . 23.8 m-85 -98.22 109.82 53.68 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.331 -1.1 . . . . 0.0 110.241 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.521 ' CA ' HG22 ' A' ' 55' ' ' ILE . 48.8 Cg_endo -74.8 130.53 13.58 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 123.972 1.512 . . . . 0.0 110.576 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.593 HG12 ' HA ' ' A' ' 15' ' ' ILE . 16.4 m -119.66 -168.22 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.23 -0.919 . . . . 0.0 109.767 179.617 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.512 ' HB2' ' HB2' ' A' ' 14' ' ' ARG . 0.7 OUTLIER -66.58 -176.84 0.51 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.332 -0.855 . . . . 0.0 110.139 179.712 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.506 ' HB3' ' CE2' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -79.1 -5.85 55.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.326 -0.859 . . . . 0.0 109.9 179.723 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.528 ' HA ' ' HB2' ' A' ' 62' ' ' ARG . 4.5 m-90 -137.98 3.62 2.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.282 -0.886 . . . . 0.0 110.513 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.47 ' N ' ' OD1' ' A' ' 11' ' ' ASN . 2.2 m-20 59.73 12.21 2.83 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.283 -0.886 . . . . 0.0 110.524 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 4.2 t -77.78 -62.85 1.54 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.097 -1.002 . . . . 0.0 111.186 -178.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.516 ' O ' ' CB ' ' A' ' 14' ' ' ARG . 1.5 tmtt? -136.39 98.98 3.97 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.059 -1.026 . . . . 0.0 111.313 -179.089 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.566 ' O ' ' N ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER 168.04 -88.74 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.361 -0.837 . . . . 0.0 110.222 179.098 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.657 HG23 ' CB ' ' A' ' 43' ' ' SER . 5.0 mt 55.57 -81.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.142 -0.974 . . . . 0.0 110.087 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.629 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 37.5 t -122.77 127.91 49.78 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.428 -0.795 . . . . 0.0 109.946 179.238 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.64 ' CZ3' ' CD2' ' A' ' 22' ' ' TYR . 0.1 OUTLIER -69.8 -145.5 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.051 -1.03 . . . . 0.0 109.92 179.609 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -118.02 -9.73 10.5 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.239 -0.913 . . . . 0.0 110.21 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.443 ' CB ' ' HB2' ' A' ' 22' ' ' TYR . 2.1 m-20 -117.8 166.65 12.2 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.318 -0.864 . . . . 0.0 110.296 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -88.68 -59.47 2.22 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.254 -0.904 . . . . 0.0 110.308 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.28 -26.98 66.9 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.208 -0.932 . . . . 0.0 110.24 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.64 ' CD2' ' CZ3' ' A' ' 17' ' ' TRP . 0.4 OUTLIER -58.86 -53.65 56.01 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.316 -0.865 . . . . 0.0 110.506 -179.818 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -66.77 -27.18 67.38 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.17 -0.956 . . . . 0.0 110.337 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.439 ' OD1' ' O ' ' A' ' 33' ' ' ASP . 25.0 t-20 -66.71 -55.61 14.32 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.276 -0.89 . . . . 0.0 110.272 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -44.09 -49.86 8.7 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.347 -0.846 . . . . 0.0 110.417 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.53 -42.1 95.96 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.201 -0.937 . . . . 0.0 110.154 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.411 ' SG ' ' HG3' ' A' ' 6' ' ' PRO . 0.8 OUTLIER -59.54 -39.87 85.38 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.243 -0.911 . . . . 0.0 109.419 179.474 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.1 mtmt -62.91 -33.9 76.3 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.258 -0.901 . . . . 0.0 109.154 179.107 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -50.87 -39.42 39.84 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.766 -1.734 . . . . 0.0 108.766 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.655 ' O ' ' CB ' ' A' ' 31' ' ' LYS . 6.9 mt -79.94 -34.07 39.14 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.248 -1.148 . . . . 0.0 109.609 179.415 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.655 ' CB ' ' O ' ' A' ' 30' ' ' LEU . 1.8 tttp 141.14 0.35 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.658 0 C-N-CA 123.015 0.526 . . . . 0.0 110.126 179.403 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.498 ' HB1' ' HB3' ' A' ' 46' ' ' CYS . . . -85.44 117.12 24.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.95 -1.094 . . . . 0.0 110.511 -179.328 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.439 ' O ' ' OD1' ' A' ' 24' ' ' ASN . 11.3 t0 -83.32 -59.15 2.55 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.272 -0.893 . . . . 0.0 110.309 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.93 88.04 2.9 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.388 -0.82 . . . . 0.0 110.117 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.482 ' CA ' ' SG ' ' A' ' 46' ' ' CYS . . . -124.03 109.68 1.33 Allowed Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -127.27 147.44 50.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.279 -1.13 . . . . 0.0 109.861 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.1 OUTLIER -91.66 140.64 29.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.284 -0.885 . . . . 0.0 110.815 -179.282 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.602 ' CD1' ' HB3' ' A' ' 40' ' ' TRP . 45.5 t-105 -79.78 104.11 10.14 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.276 -0.89 . . . . 0.0 109.407 179.217 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -76.4 76.09 1.53 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -179.184 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.811 ' CD1' HG22 ' A' ' 41' ' ' THR . 5.8 t-105 -160.5 -72.21 0.07 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.41 -1.053 . . . . 0.0 109.583 179.342 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.811 HG22 ' CD1' ' A' ' 40' ' ' TRP . 12.7 t -179.11 35.3 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.569 -0.707 . . . . 0.0 109.79 179.754 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.578 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 1.7 mt -113.12 -84.3 0.59 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.244 -0.91 . . . . 0.0 110.866 -179.549 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.657 ' CB ' HG23 ' A' ' 15' ' ' ILE . 3.2 t 170.36 175.76 0.06 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.411 -0.806 . . . . 0.0 109.59 -179.394 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.497 ' O ' ' CD2' ' A' ' 5' ' ' TYR . 10.3 t -63.49 159.96 17.43 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.003 -1.06 . . . . 0.0 108.923 179.415 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.668 ' CD2' ' CZ ' ' A' ' 5' ' ' TYR . 1.0 OUTLIER -147.99 116.41 6.59 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.877 -1.14 . . . . 0.0 110.935 -179.755 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.498 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . 71.6 m -128.46 149.38 50.6 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.28 -0.887 . . . . 0.0 109.686 179.238 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.443 ' HA ' ' OD1' ' A' ' 3' ' ' ASP . 8.4 mp0 -127.96 104.51 7.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.163 -0.96 . . . . 0.0 110.074 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.51 ' C ' HD23 ' A' ' 49' ' ' LEU . . . 131.51 49.86 0.1 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.869 HD12 ' CB ' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -120.37 173.47 3.69 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.351 -1.087 . . . . 0.0 110.106 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.515 ' HD2' ' HB2' ' A' ' 49' ' ' LEU . 43.0 Cg_endo -70.38 157.7 58.4 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.944 1.497 . . . . 0.0 110.362 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -60.39 -18.0 47.62 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.285 -0.884 . . . . 0.0 110.033 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -89.83 9.18 28.45 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.34 -0.85 . . . . 0.0 109.968 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.869 ' CB ' HD12 ' A' ' 49' ' ' LEU . . . -58.42 122.01 12.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.388 -0.82 . . . . 0.0 110.275 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.03 130.88 37.01 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.181 -0.949 . . . . 0.0 110.297 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.709 HD12 ' C ' ' A' ' 55' ' ' ILE . 2.3 pp -145.0 -179.56 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.317 -0.865 . . . . 0.0 110.074 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.403 ' O ' ' HG3' ' A' ' 56' ' ' LYS . 4.1 ptpt -51.35 88.2 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.323 -0.861 . . . . 0.0 110.479 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.523 ' N ' ' O ' ' A' ' 55' ' ' ILE . 0.3 OUTLIER -110.25 -28.85 8.42 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.408 -0.808 . . . . 0.0 109.382 179.526 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -125.48 170.84 11.01 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.67 -0.644 . . . . 0.0 110.222 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -124.71 -3.8 7.61 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.14 131.64 54.43 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.272 -1.134 . . . . 0.0 110.041 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 33.5 m -44.31 126.57 5.27 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.196 -0.94 . . . . 0.0 109.813 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.528 ' HB2' ' HA ' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -86.68 50.31 1.98 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.131 -0.98 . . . . 0.0 110.127 179.879 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.187 -0.946 . . . . 0.0 110.246 179.96 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 38.1 pttt . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.298 0.57 . . . . 0.0 110.219 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.721 HG22 ' O ' ' A' ' 49' ' ' LEU . 2.8 tt -154.36 166.07 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.261 -0.899 . . . . 0.0 110.056 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.508 ' N ' HG12 ' A' ' 2' ' ' ILE . 2.4 p-10 -147.87 166.04 28.81 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.369 -0.832 . . . . 0.0 109.965 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 157.36 -152.12 23.41 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.456 ' HA ' ' O ' ' A' ' 44' ' ' CYS . 6.9 m-85 -110.58 99.22 40.41 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.276 -1.131 . . . . 0.0 110.393 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.818 ' HA ' HG22 ' A' ' 55' ' ' ILE . 46.7 Cg_endo -73.85 126.76 10.94 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 124.066 1.561 . . . . 0.0 110.146 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.707 HG12 HG23 ' A' ' 15' ' ' ILE . 16.0 m -79.59 -172.29 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.243 -0.911 . . . . 0.0 110.256 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.451 ' O ' ' HB2' ' A' ' 9' ' ' TYR . 6.9 p-10 -77.28 -44.63 29.06 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.155 -0.966 . . . . 0.0 109.87 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.581 ' HB3' ' CE3' ' A' ' 10' ' ' TRP . 1.7 t80 178.98 -66.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.675 -0.641 . . . . 0.0 109.444 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.581 ' CE3' ' HB3' ' A' ' 9' ' ' TYR . 2.6 m-90 -107.27 21.68 17.14 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.35 -0.844 . . . . 0.0 109.37 179.272 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 2.3 m120 59.11 14.07 3.29 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.46 -0.775 . . . . 0.0 110.307 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.9 m -68.9 -36.26 77.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.259 -0.901 . . . . 0.0 109.969 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.1 44.7 1.01 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.423 -0.798 . . . . 0.0 109.773 179.642 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 62.32 -179.8 0.13 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.332 -0.855 . . . . 0.0 110.081 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.707 HG23 HG12 ' A' ' 7' ' ' VAL . 3.3 mt -82.11 -6.56 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.211 -0.931 . . . . 0.0 110.548 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.525 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 46.3 t -132.12 162.56 30.54 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.286 -0.884 . . . . 0.0 110.37 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.669 ' CE3' ' CG ' ' A' ' 22' ' ' TYR . 0.3 OUTLIER -105.77 -153.66 0.5 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.274 -0.891 . . . . 0.0 109.889 179.605 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -105.48 -20.27 13.53 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.184 -0.948 . . . . 0.0 110.113 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.503 ' HB3' ' HB2' ' A' ' 22' ' ' TYR . 0.3 OUTLIER -100.98 149.7 23.65 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.262 -0.899 . . . . 0.0 110.137 179.963 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -84.32 -25.56 29.16 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.215 -0.928 . . . . 0.0 110.276 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -90.22 -28.61 18.74 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.23 -0.919 . . . . 0.0 110.355 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.669 ' CG ' ' CE3' ' A' ' 17' ' ' TRP . 28.4 t80 -57.54 -46.36 83.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.262 -0.899 . . . . 0.0 110.179 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -64.45 -43.41 94.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.193 -0.942 . . . . 0.0 109.792 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.507 ' O ' ' HG2' ' A' ' 28' ' ' LYS . 50.0 t30 -57.92 -40.9 81.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.222 -0.924 . . . . 0.0 109.675 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.57 -56.82 17.0 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.222 -0.923 . . . . 0.0 110.066 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.72 -36.87 82.19 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.238 -0.914 . . . . 0.0 109.966 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.48 ' SG ' ' HG3' ' A' ' 6' ' ' PRO . 5.2 m -63.02 -43.06 99.77 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.173 -0.955 . . . . 0.0 109.469 179.553 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.507 ' HG2' ' O ' ' A' ' 24' ' ' ASN . 0.3 OUTLIER -58.36 -27.78 64.52 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.294 -0.879 . . . . 0.0 109.257 179.027 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.14 -38.34 94.26 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 107.956 -2.057 . . . . 0.0 107.956 179.104 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.529 ' O ' ' HD3' ' A' ' 50' ' ' PRO . 5.0 mt -89.78 21.47 3.54 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.65 -0.912 . . . . 0.0 109.14 178.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.504 ' HB3' ' O ' ' A' ' 30' ' ' LEU . 0.4 OUTLIER 69.65 15.92 8.06 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.647 -0.658 . . . . 0.0 110.798 179.922 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.623 ' HB1' ' HB3' ' A' ' 46' ' ' CYS . . . -88.38 73.6 8.76 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.933 -1.105 . . . . 0.0 109.383 179.544 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.425 ' C ' ' O ' ' A' ' 32' ' ' ALA . 0.1 OUTLIER -39.82 -76.94 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.565 -0.709 . . . . 0.0 110.848 -179.289 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.495 ' O ' ' HA ' ' A' ' 46' ' ' CYS . 1.8 t -65.88 93.65 0.19 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.443 -0.786 . . . . 0.0 110.454 -179.629 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.522 ' CA ' ' SG ' ' A' ' 46' ' ' CYS . . . -128.52 93.64 0.36 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.523 ' C ' ' CD1' ' A' ' 36' ' ' TYR . 9.4 p90 -113.47 153.35 28.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.294 -1.121 . . . . 0.0 109.859 179.645 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.511 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.1 OUTLIER -108.8 139.99 42.86 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.097 -1.002 . . . . 0.0 110.428 -179.863 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.639 ' CD1' ' CD1' ' A' ' 42' ' ' LEU . 49.1 t-105 -79.54 86.85 5.16 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.292 -0.88 . . . . 0.0 109.848 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -62.38 80.77 0.03 OUTLIER Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -179.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.825 ' CD1' HG22 ' A' ' 41' ' ' THR . 14.0 t-105 -160.53 -73.16 0.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.435 -1.038 . . . . 0.0 109.6 179.668 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.825 HG22 ' CD1' ' A' ' 40' ' ' TRP . 15.0 t -179.07 40.1 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.634 -0.666 . . . . 0.0 109.588 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.639 ' CD1' ' CD1' ' A' ' 38' ' ' TRP . 0.3 OUTLIER -123.25 -80.65 0.63 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.281 -0.887 . . . . 0.0 110.818 -179.485 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.525 ' HA ' ' HB2' ' A' ' 16' ' ' CYS . 1.2 p 170.01 176.09 0.05 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.263 -0.898 . . . . 0.0 109.901 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.511 ' HA ' ' HA ' ' A' ' 37' ' ' CYS . 6.8 t -74.6 166.54 23.39 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.23 -0.919 . . . . 0.0 110.176 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.467 ' CE1' ' OE1' ' A' ' 47' ' ' GLN . 0.8 OUTLIER -148.98 108.47 3.98 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.191 -0.943 . . . . 0.0 110.35 -179.973 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.623 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . 64.9 m -129.23 137.71 51.26 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.375 -0.828 . . . . 0.0 109.729 179.424 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.467 ' OE1' ' CE1' ' A' ' 45' ' ' TYR . 2.2 mt-30 -124.18 128.4 49.17 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.086 -1.009 . . . . 0.0 110.314 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.488 ' O ' ' O ' ' A' ' 31' ' ' LYS . . . 121.25 28.9 1.56 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.892 HD12 ' CB ' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -106.2 169.5 6.84 Favored Pre-proline 0 N--CA 1.497 1.883 0 O-C-N 121.135 -1.215 . . . . 0.0 109.993 179.6 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.671 ' O ' HG21 ' A' ' 2' ' ' ILE . 42.4 Cg_endo -67.23 157.62 60.85 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 O-C-N 123.87 1.458 . . . . 0.0 111.126 -179.491 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -58.46 -27.86 64.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.488 -0.758 . . . . 0.0 109.883 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.55 ' ND2' ' O ' ' A' ' 52' ' ' ASN . 0.5 OUTLIER -90.75 20.42 4.74 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.393 -0.817 . . . . 0.0 109.457 179.437 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.892 ' CB ' HD12 ' A' ' 49' ' ' LEU . . . -62.84 110.83 1.89 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.665 -0.647 . . . . 0.0 110.592 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.509 ' NH1' ' O ' ' A' ' 9' ' ' TYR . 1.3 tmm_? -65.02 129.36 39.43 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.324 -0.86 . . . . 0.0 110.307 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.818 HG22 ' HA ' ' A' ' 6' ' ' PRO . 2.7 pt -152.55 -163.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.543 -0.723 . . . . 0.0 109.907 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.488 ' O ' ' HG3' ' A' ' 56' ' ' LYS . 2.5 ptmm? -40.72 93.43 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.569 -0.707 . . . . 0.0 110.498 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.526 ' N ' ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -135.17 2.95 3.1 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.294 -0.879 . . . . 0.0 110.113 -179.935 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -153.46 -173.63 4.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.239 -0.913 . . . . 0.0 109.864 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -166.73 23.93 0.13 Allowed Glycine 0 N--CA 1.49 2.272 0 C-N-CA 119.674 -1.25 . . . . 0.0 110.049 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.485 ' O ' ' O ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER -137.16 47.47 2.11 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.959 -1.318 . . . . 0.0 110.411 179.802 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.485 ' O ' ' O ' ' A' ' 60' ' ' ARG . 0.5 OUTLIER 47.36 103.07 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.619 -0.676 . . . . 0.0 110.742 179.885 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.501 ' N ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -79.9 54.68 1.92 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.382 -0.824 . . . . 0.0 110.171 179.811 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.165 -0.959 . . . . 0.0 110.263 -179.962 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 20.2 mttt . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.277 0.561 . . . . 0.0 110.232 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.552 HG22 ' O ' ' A' ' 49' ' ' LEU . 10.8 tt -120.26 165.16 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.33 -0.856 . . . . 0.0 110.051 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -143.34 144.12 31.96 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.277 -0.889 . . . . 0.0 110.136 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 173.51 -151.6 13.81 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.585 ' CD1' ' N ' ' A' ' 5' ' ' TYR . 20.0 m-85 -110.15 98.31 34.53 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.325 -1.103 . . . . 0.0 110.413 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.657 ' HA ' HG22 ' A' ' 55' ' ' ILE . 49.2 Cg_endo -75.77 144.2 27.55 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 124.025 1.54 . . . . 0.0 110.738 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 1.07 ' CG1' HG23 ' A' ' 15' ' ' ILE . 6.3 m -109.14 -171.97 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.199 -0.938 . . . . 0.0 110.015 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -89.2 -88.47 0.16 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.217 -0.927 . . . . 0.0 110.19 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.519 ' HB3' ' CD2' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -141.09 -42.71 0.38 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.143 -0.973 . . . . 0.0 110.239 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.519 ' CD2' ' HB3' ' A' ' 9' ' ' TYR . 6.2 m-90 -116.46 16.57 15.61 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.256 -0.902 . . . . 0.0 110.057 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 88.6 m-20 56.54 17.12 2.85 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.261 -0.9 . . . . 0.0 110.146 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 56.4 m -70.14 -11.01 60.59 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.266 -0.896 . . . . 0.0 110.197 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.462 ' HD2' ' N ' ' A' ' 13' ' ' LYS . 5.5 mptt -108.04 40.01 1.83 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.328 -0.858 . . . . 0.0 110.241 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.497 ' O ' ' HB ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER 46.17 36.22 3.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.173 -0.954 . . . . 0.0 109.997 -179.997 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 1.07 HG23 ' CG1' ' A' ' 7' ' ' VAL . 2.5 mt 62.91 7.65 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.491 -0.755 . . . . 0.0 110.65 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.554 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 32.8 t -148.64 111.96 4.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.054 -1.029 . . . . 0.0 109.696 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.465 ' O ' ' O ' ' A' ' 16' ' ' CYS . 5.2 t90 -43.44 -94.3 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.329 -0.857 . . . . 0.0 110.306 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -160.54 -64.0 0.06 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.771 -1.206 . . . . 0.0 110.366 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.546 ' HB2' ' CG ' ' A' ' 22' ' ' TYR . 0.8 OUTLIER -70.15 171.02 10.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.464 -0.773 . . . . 0.0 110.367 -179.937 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -75.75 -54.69 6.55 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.234 -0.916 . . . . 0.0 109.966 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -71.9 -16.99 62.13 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.363 -0.836 . . . . 0.0 110.061 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.546 ' CG ' ' HB2' ' A' ' 19' ' ' ASN . 1.4 m-30 -57.72 -26.41 61.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.195 -0.941 . . . . 0.0 110.033 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.4 t -98.19 -17.69 18.86 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.252 -0.905 . . . . 0.0 110.243 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 35' ' ' GLY . 66.9 t30 -72.0 -40.28 68.63 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.258 -0.902 . . . . 0.0 110.069 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.13 -47.45 82.68 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.012 -1.055 . . . . 0.0 109.397 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.48 -43.44 85.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.374 -0.829 . . . . 0.0 109.354 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.644 ' HA ' HD12 ' A' ' 30' ' ' LEU . 1.8 m -60.23 -39.59 87.21 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.407 -0.808 . . . . 0.0 109.423 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.454 ' HG3' ' HA ' ' A' ' 33' ' ' ASP . 0.0 OUTLIER -60.05 -30.74 69.4 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.261 -0.899 . . . . 0.0 109.488 179.365 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.05 -31.65 79.47 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 107.798 -2.121 . . . . 0.0 107.798 179.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.644 HD12 ' HA ' ' A' ' 27' ' ' CYS . 1.8 mt -91.8 19.0 6.91 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.672 -0.899 . . . . 0.0 109.217 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.533 ' HB3' ' O ' ' A' ' 30' ' ' LEU . 1.5 tptt 72.76 13.38 5.15 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.805 -0.559 . . . . 0.0 111.019 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.622 ' HB2' HD22 ' A' ' 49' ' ' LEU . . . -92.34 73.06 5.3 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.902 -1.124 . . . . 0.0 109.975 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.454 ' HA ' ' HG3' ' A' ' 28' ' ' LYS . 18.9 m-20 -43.96 -62.0 1.27 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.316 -0.865 . . . . 0.0 110.407 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.416 ' HB3' ' NE2' ' A' ' 47' ' ' GLN . 0.3 OUTLIER -74.05 84.18 1.79 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.363 -0.836 . . . . 0.0 110.035 179.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.524 ' CA ' ' SG ' ' A' ' 46' ' ' CYS . . . -124.35 116.17 2.72 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.528 ' CD1' ' C ' ' A' ' 36' ' ' TYR . 12.8 p90 -139.04 147.44 42.06 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.316 -1.108 . . . . 0.0 109.85 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.458 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.0 OUTLIER -100.26 139.63 35.65 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.165 -0.959 . . . . 0.0 110.492 -179.619 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.58 ' CD1' ' HB2' ' A' ' 42' ' ' LEU . 26.0 t-105 -79.65 103.71 9.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.235 -0.916 . . . . 0.0 109.626 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -67.12 65.59 0.22 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.847 ' CD1' HG22 ' A' ' 41' ' ' THR . 6.3 t-105 -160.21 -65.77 0.07 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.284 -1.127 . . . . 0.0 109.883 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.847 HG22 ' CD1' ' A' ' 40' ' ' TRP . 3.8 t 177.62 35.83 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.53 -0.731 . . . . 0.0 109.903 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.58 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 9.6 mt -119.15 20.51 12.63 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.089 -1.007 . . . . 0.0 110.458 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.554 ' HA ' ' HB2' ' A' ' 16' ' ' CYS . 3.3 m 55.58 -170.42 0.07 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.153 -0.967 . . . . 0.0 110.179 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.468 ' O ' ' CD2' ' A' ' 5' ' ' TYR . 12.2 t -79.04 163.14 25.4 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.342 -0.849 . . . . 0.0 110.307 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -148.04 100.07 3.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.29 -0.882 . . . . 0.0 109.955 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.593 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . 63.7 m -123.3 148.93 45.45 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.173 -0.954 . . . . 0.0 110.357 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.426 ' N ' ' CD ' ' A' ' 47' ' ' GLN . 0.7 OUTLIER -131.64 140.19 49.3 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.352 -0.843 . . . . 0.0 109.857 179.717 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.479 ' O ' ' O ' ' A' ' 31' ' ' LYS . . . 111.26 20.39 7.09 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.915 HD12 ' CB ' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -99.49 168.31 9.77 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 121.232 -1.158 . . . . 0.0 109.65 179.472 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.508 ' HD3' ' O ' ' A' ' 30' ' ' LEU . 43.3 Cg_endo -70.5 161.2 46.88 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.619 1.326 . . . . 0.0 110.62 -179.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -62.05 -16.68 53.68 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.219 -0.926 . . . . 0.0 109.717 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -94.84 15.01 19.62 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.435 -0.791 . . . . 0.0 109.941 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.915 ' CB ' HD12 ' A' ' 49' ' ' LEU . . . -56.01 149.22 15.83 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.283 -0.886 . . . . 0.0 110.304 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.7 mtm105 -92.08 88.64 6.61 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.294 -0.879 . . . . 0.0 110.261 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.898 HD13 ' H ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -131.81 156.01 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.161 -0.962 . . . . 0.0 110.006 179.671 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 55' ' ' ILE . 8.9 mttt 42.45 56.0 3.91 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.236 -0.915 . . . . 0.0 110.303 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -88.05 -5.98 58.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.265 -0.897 . . . . 0.0 110.363 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.429 ' O ' ' ND2' ' A' ' 11' ' ' ASN . 0.1 OUTLIER 57.05 173.21 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.342 -0.849 . . . . 0.0 110.111 -179.909 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 101.41 132.94 7.92 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.67 173.44 8.1 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.188 -1.183 . . . . 0.0 110.236 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 35.1 t -43.4 104.99 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.364 -0.835 . . . . 0.0 110.169 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.518 ' CB ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -87.02 49.55 1.84 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.213 -0.929 . . . . 0.0 110.179 -179.882 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.432 ' HB2' ' O ' ' A' ' 62' ' ' ARG . . . . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.131 -0.98 . . . . 0.0 110.309 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.247 0.546 . . . . 0.0 110.237 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.489 HG22 ' O ' ' A' ' 49' ' ' LEU . 7.7 tt -119.22 163.95 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.272 -0.893 . . . . 0.0 110.28 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 3' ' ' ASP . 1.9 p30 -141.0 138.45 33.72 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.409 -0.807 . . . . 0.0 110.14 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.495 ' O ' ' HA ' ' A' ' 45' ' ' TYR . . . -177.59 -163.29 29.19 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.49 ' HA ' ' O ' ' A' ' 44' ' ' CYS . 3.0 m-85 -105.86 102.7 40.39 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.301 -1.117 . . . . 0.0 110.262 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.509 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 47.7 Cg_endo -74.3 109.98 3.0 Favored 'Trans proline' 0 C--N 1.301 -1.945 0 O-C-N 123.994 1.523 . . . . 0.0 111.187 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.777 HG12 HG13 ' A' ' 15' ' ' ILE . 14.6 m -91.29 -162.48 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.291 -0.88 . . . . 0.0 109.762 179.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.535 ' CB ' ' HB2' ' A' ' 13' ' ' LYS . 11.5 t0 -77.58 -87.97 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.334 -0.854 . . . . 0.0 109.829 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.488 ' O ' ' NH1' ' A' ' 54' ' ' ARG . 1.1 m-85 -141.29 -58.97 0.49 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.328 -0.857 . . . . 0.0 109.745 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.817 ' CD2' ' HB2' ' A' ' 63' ' ' ALA . 4.8 m-90 -106.22 24.42 12.51 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.442 -0.786 . . . . 0.0 109.678 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.484 ' OD1' HG21 ' A' ' 7' ' ' VAL . 58.9 m-80 57.58 15.5 2.85 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.367 -0.833 . . . . 0.0 109.726 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 5.1 t -92.5 -42.11 9.89 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.308 -0.87 . . . . 0.0 110.417 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.535 ' HB2' ' CB ' ' A' ' 8' ' ' ASP . 5.3 mmtp -60.41 -93.18 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.42 -0.8 . . . . 0.0 110.27 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.465 ' HG2' ' O ' ' A' ' 13' ' ' LYS . 2.7 mmp_? -144.68 101.4 3.66 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.175 -0.953 . . . . 0.0 110.511 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.777 HG13 HG12 ' A' ' 7' ' ' VAL . 4.3 tt -44.0 -27.6 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.218 -0.926 . . . . 0.0 109.458 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.623 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 30.9 t -158.91 106.25 1.82 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.597 -0.689 . . . . 0.0 110.415 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.405 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -54.58 -172.57 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.179 -0.951 . . . . 0.0 109.81 179.773 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -114.55 33.59 5.24 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.109 -0.994 . . . . 0.0 110.174 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -131.55 145.55 51.78 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.257 -0.902 . . . . 0.0 109.959 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.426 ' OD1' ' N ' ' A' ' 20' ' ' ASN . 15.5 p-10 -82.06 9.09 9.11 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.243 -0.911 . . . . 0.0 110.352 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.46 -33.77 2.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.238 -0.914 . . . . 0.0 110.313 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -52.72 -35.75 56.36 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.107 -0.996 . . . . 0.0 110.199 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.406 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 0.1 OUTLIER -88.86 -30.57 18.82 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.219 -0.925 . . . . 0.0 110.049 179.846 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -69.93 -52.43 24.61 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.347 -0.846 . . . . 0.0 110.316 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -50.12 -47.9 53.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.212 -0.93 . . . . 0.0 110.308 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.3 -41.24 66.85 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.239 -0.913 . . . . 0.0 110.15 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.456 ' SG ' ' HG3' ' A' ' 6' ' ' PRO . 8.3 m -59.91 -34.33 73.05 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.106 -0.996 . . . . 0.0 109.794 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.55 -31.79 73.06 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.391 -0.818 . . . . 0.0 109.726 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.13 -33.95 86.16 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 107.957 -2.057 . . . . 0.0 107.957 178.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.515 ' O ' ' HD3' ' A' ' 50' ' ' PRO . 1.4 mt -89.54 19.58 4.48 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.61 -0.936 . . . . 0.0 109.426 179.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.501 ' HB3' ' O ' ' A' ' 30' ' ' LEU . 0.4 OUTLIER 68.27 18.42 9.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.699 -0.625 . . . . 0.0 111.02 179.749 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.58 ' HB1' ' HB3' ' A' ' 46' ' ' CYS . . . -92.31 74.77 5.31 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.913 -1.117 . . . . 0.0 109.78 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 32' ' ' ALA . 62.9 t0 -39.99 -70.48 0.1 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.415 -0.803 . . . . 0.0 110.677 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.17 86.25 1.06 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.508 -0.745 . . . . 0.0 110.192 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.522 ' CA ' ' SG ' ' A' ' 46' ' ' CYS . . . -121.15 98.73 0.67 Allowed Glycine 0 N--CA 1.488 2.102 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.493 ' OH ' ' CD2' ' A' ' 45' ' ' TYR . 53.1 p90 -126.42 153.64 44.73 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.353 -1.087 . . . . 0.0 109.855 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.524 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.1 OUTLIER -102.2 146.33 28.14 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.139 -0.976 . . . . 0.0 110.367 -179.638 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.634 ' CD1' ' HB2' ' A' ' 42' ' ' LEU . 25.8 t-105 -79.82 148.57 31.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.139 -0.976 . . . . 0.0 109.645 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -106.36 53.19 0.64 Allowed Glycine 0 N--CA 1.491 2.335 0 C-N-CA 119.615 -1.279 . . . . 0.0 110.204 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.563 ' C ' HG23 ' A' ' 41' ' ' THR . 30.9 t-105 -160.54 -83.08 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.255 -1.144 . . . . 0.0 110.021 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.563 HG23 ' C ' ' A' ' 40' ' ' TRP . 72.6 p -155.25 38.54 0.4 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.407 -0.808 . . . . 0.0 110.354 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.634 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 0.4 OUTLIER -119.46 24.03 10.89 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.093 -1.004 . . . . 0.0 110.681 -179.847 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.623 ' HA ' ' HB2' ' A' ' 16' ' ' CYS . 90.5 p 45.52 -174.01 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.3 -0.875 . . . . 0.0 110.363 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.54 ' N ' ' HB2' ' A' ' 16' ' ' CYS . 25.3 t -71.87 171.97 10.75 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.184 -0.948 . . . . 0.0 109.261 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.495 ' HA ' ' O ' ' A' ' 4' ' ' GLY . 1.1 t80 -158.26 100.95 1.71 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.999 -1.063 . . . . 0.0 111.001 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.629 ' O ' HD21 ' A' ' 49' ' ' LEU . 85.9 m -121.05 137.2 54.76 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.353 -0.842 . . . . 0.0 109.533 179.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.451 ' N ' ' OE1' ' A' ' 47' ' ' GLN . 9.6 mp0 -121.87 148.11 45.14 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.163 -0.961 . . . . 0.0 110.35 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.5 ' O ' ' O ' ' A' ' 31' ' ' LYS . . . 100.05 27.18 7.94 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 1.103 HD12 ' CB ' ' A' ' 53' ' ' ALA . 0.2 OUTLIER -109.32 170.9 4.9 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.191 -1.182 . . . . 0.0 109.872 179.751 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.516 ' HD2' ' HB2' ' A' ' 49' ' ' LEU . 42.0 Cg_endo -68.43 158.35 58.01 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.689 1.363 . . . . 0.0 110.717 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -60.66 -22.61 64.04 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.332 -0.855 . . . . 0.0 110.173 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -85.38 11.73 9.71 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.243 -0.91 . . . . 0.0 109.94 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 1.103 ' CB ' HD12 ' A' ' 49' ' ' LEU . . . -62.16 135.82 57.67 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.304 -0.872 . . . . 0.0 110.548 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.631 ' O ' HG23 ' A' ' 55' ' ' ILE . 15.7 tpp85 -77.2 131.69 38.37 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.3 -0.875 . . . . 0.0 109.869 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.631 HG23 ' O ' ' A' ' 54' ' ' ARG . 1.3 pp -156.85 -173.24 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.276 -0.89 . . . . 0.0 110.303 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -45.89 93.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.212 -0.93 . . . . 0.0 110.608 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.479 ' N ' ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -112.6 22.39 14.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.333 -0.854 . . . . 0.0 109.856 179.604 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.87 -178.17 0.11 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.354 -0.841 . . . . 0.0 110.373 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.458 ' O ' ' O ' ' A' ' 60' ' ' ARG . . . 92.89 101.1 1.47 Allowed Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.529 ' O ' ' N ' ' A' ' 62' ' ' ARG . 2.8 ptm85 -50.73 -175.8 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.254 -1.145 . . . . 0.0 110.212 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.413 ' C ' ' O ' ' A' ' 60' ' ' ARG . 33.9 t -42.21 93.32 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.379 -0.825 . . . . 0.0 110.389 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.538 ' CB ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -84.07 43.66 0.95 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.339 -0.851 . . . . 0.0 110.481 -179.754 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.817 ' HB2' ' CD2' ' A' ' 10' ' ' TRP . . . . . . . . 0 N--CA 1.492 1.643 0 O-C-N 121.179 -0.95 . . . . 0.0 110.184 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . 0.492 ' O ' ' HG2' ' A' ' 1' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.491 0.662 . . . . 0.0 110.34 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.524 ' CG2' ' HG ' ' A' ' 49' ' ' LEU . 8.6 tt -120.44 160.58 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.384 -0.823 . . . . 0.0 110.075 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -142.7 144.28 32.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.328 -0.858 . . . . 0.0 110.096 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 179.83 -149.46 8.61 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.618 ' CD1' ' N ' ' A' ' 5' ' ' TYR . 12.4 m-85 -122.29 110.1 32.75 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.291 -1.123 . . . . 0.0 110.266 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.631 ' HB3' HG22 ' A' ' 55' ' ' ILE . 46.6 Cg_endo -73.95 128.76 12.63 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 124.055 1.555 . . . . 0.0 110.685 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.887 HG12 HG23 ' A' ' 15' ' ' ILE . 14.7 m -83.15 -175.87 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.283 -0.885 . . . . 0.0 110.156 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.439 ' O ' ' NH1' ' A' ' 54' ' ' ARG . 16.2 t70 -64.37 -117.54 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.171 -0.955 . . . . 0.0 109.582 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.601 ' HB3' ' CD2' ' A' ' 10' ' ' TRP . 2.0 t80 -119.62 -50.77 2.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.828 -1.17 . . . . 0.0 109.792 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.601 ' CD2' ' HB3' ' A' ' 9' ' ' TYR . 3.3 m-90 -106.08 21.32 17.53 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.233 -0.917 . . . . 0.0 109.709 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.47 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 42.5 m-20 59.5 12.33 2.71 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.388 -0.82 . . . . 0.0 110.167 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 6.8 m -67.21 -62.85 1.22 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.255 -0.903 . . . . 0.0 109.808 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.1 mmtp -73.58 -178.37 3.07 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.591 -0.693 . . . . 0.0 109.87 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.74 -174.58 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.131 -0.981 . . . . 0.0 110.059 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.887 HG23 HG12 ' A' ' 7' ' ' VAL . 20.2 mt -86.76 23.75 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.129 -0.982 . . . . 0.0 110.205 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.517 ' HB2' ' N ' ' A' ' 44' ' ' CYS . 14.4 t -160.16 165.53 31.45 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.239 -0.913 . . . . 0.0 110.595 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.468 ' N ' ' SG ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -115.8 -157.39 0.64 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.371 -0.831 . . . . 0.0 109.821 179.617 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -119.61 -3.79 10.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.211 -0.931 . . . . 0.0 109.989 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.584 ' HB2' ' CG ' ' A' ' 22' ' ' TYR . 0.7 OUTLIER -100.79 133.31 45.45 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.328 -0.858 . . . . 0.0 110.083 179.87 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -60.32 -45.93 91.68 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.194 -0.941 . . . . 0.0 110.641 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.33 -13.23 59.97 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.163 -0.961 . . . . 0.0 110.37 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.584 ' CG ' ' HB2' ' A' ' 19' ' ' ASN . 1.0 OUTLIER -66.66 -11.5 54.21 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.18 -0.95 . . . . 0.0 110.385 -179.771 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.452 ' O ' ' HB2' ' A' ' 27' ' ' CYS . 0.1 OUTLIER -118.73 -31.72 4.75 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.232 -0.917 . . . . 0.0 110.078 179.857 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.529 ' CA ' ' O ' ' A' ' 35' ' ' GLY . 2.0 t-20 -82.53 -49.17 10.19 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.224 -0.922 . . . . 0.0 109.47 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -54.99 -26.91 40.09 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.028 -1.045 . . . . 0.0 109.065 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.656 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -90.85 -46.87 7.94 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.646 -0.659 . . . . 0.0 109.486 179.628 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.499 ' SG ' ' HG3' ' A' ' 6' ' ' PRO . 7.7 m -60.05 -34.77 73.86 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.394 -0.816 . . . . 0.0 110.149 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.41 ' HG2' ' O ' ' A' ' 24' ' ' ASN . 1.9 mmmt -61.55 -32.75 72.83 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.183 -0.948 . . . . 0.0 109.319 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.82 -30.98 78.77 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 107.24 -2.344 . . . . 0.0 107.24 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.529 ' O ' ' CD ' ' A' ' 50' ' ' PRO . 11.9 mt -89.69 20.35 4.1 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.777 -0.837 . . . . 0.0 109.261 178.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.512 ' HB3' ' HD3' ' A' ' 50' ' ' PRO . 1.0 OUTLIER 66.95 16.5 10.37 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.661 -0.65 . . . . 0.0 110.695 -179.872 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.676 ' HB1' ' HB3' ' A' ' 46' ' ' CYS . . . -90.71 82.76 5.73 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.996 -1.065 . . . . 0.0 110.197 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 32' ' ' ALA . 26.0 t0 -43.25 -71.46 0.08 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.287 -0.883 . . . . 0.0 110.24 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.495 ' O ' ' HA ' ' A' ' 46' ' ' CYS . 0.0 OUTLIER -76.47 86.65 3.2 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.283 -0.886 . . . . 0.0 109.954 179.877 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.529 ' O ' ' CA ' ' A' ' 24' ' ' ASN . . . -125.6 87.69 0.36 Allowed Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.54 ' OH ' ' CZ3' ' A' ' 38' ' ' TRP . 29.4 p90 -130.59 153.91 48.4 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.957 -1.319 . . . . 0.0 109.624 179.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.544 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.1 OUTLIER -83.39 155.21 23.61 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.191 -0.943 . . . . 0.0 111.464 -178.686 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.628 ' CD1' HD13 ' A' ' 42' ' ' LEU . 2.5 t-105 -79.45 140.26 37.4 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.3 -21.09 63.18 Favored Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.662 -1.256 . . . . 0.0 110.861 -178.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.95 ' CD1' HG22 ' A' ' 41' ' ' THR . 49.4 t-105 -79.4 -77.19 0.18 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.884 -1.363 . . . . 0.0 109.847 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.95 HG22 ' CD1' ' A' ' 40' ' ' TRP . 13.5 t -178.14 43.92 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.478 -0.764 . . . . 0.0 109.704 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.628 HD13 ' CD1' ' A' ' 38' ' ' TRP . 0.8 OUTLIER -109.47 36.72 2.84 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.222 -0.924 . . . . 0.0 110.578 -179.524 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.487 ' CB ' ' HB ' ' A' ' 15' ' ' ILE . 74.6 m 52.69 -174.32 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.166 -0.958 . . . . 0.0 110.323 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.544 ' HA ' ' HA ' ' A' ' 37' ' ' CYS . 15.9 t -77.97 161.09 27.78 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.218 -0.926 . . . . 0.0 110.081 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -144.1 110.38 5.47 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.088 -1.007 . . . . 0.0 111.215 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.676 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . 60.0 m -130.15 134.65 47.46 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.324 -0.86 . . . . 0.0 109.263 178.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -127.42 143.7 51.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.128 -0.983 . . . . 0.0 110.508 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 31' ' ' LYS . . . 103.81 26.93 6.53 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 1.082 HD12 ' CB ' ' A' ' 53' ' ' ALA . 0.2 OUTLIER -105.62 169.39 7.06 Favored Pre-proline 0 N--CA 1.495 1.813 0 O-C-N 121.267 -1.137 . . . . 0.0 110.052 179.743 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.529 ' CD ' ' O ' ' A' ' 30' ' ' LEU . 48.2 Cg_endo -74.51 161.67 39.5 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.671 1.353 . . . . 0.0 110.397 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -59.99 -20.61 58.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.311 -0.868 . . . . 0.0 109.906 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.405 ' O ' ' CG ' ' A' ' 52' ' ' ASN . 6.1 t-20 -81.73 5.13 19.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.383 -0.823 . . . . 0.0 110.009 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 1.082 ' CB ' HD12 ' A' ' 49' ' ' LEU . . . -53.68 153.32 4.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.236 -0.915 . . . . 0.0 110.2 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.462 ' C ' HG23 ' A' ' 55' ' ' ILE . 35.2 ttp85 -105.05 91.18 3.69 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.228 -0.92 . . . . 0.0 110.312 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.87 HD13 ' H ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -149.17 157.87 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.259 -0.901 . . . . 0.0 110.149 179.842 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.433 ' C ' ' O ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER 41.63 53.79 3.83 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.417 -0.802 . . . . 0.0 110.283 179.843 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.415 ' CD ' ' HG3' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -97.21 -20.48 17.9 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.33 -0.857 . . . . 0.0 109.899 179.915 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.473 ' OG ' ' N ' ' A' ' 59' ' ' GLY . 0.1 OUTLIER 60.74 -176.68 0.11 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.537 -0.727 . . . . 0.0 110.273 179.844 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.473 ' N ' ' OG ' ' A' ' 58' ' ' SER . . . 110.34 -177.89 19.77 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.9 ptm180 -107.09 -177.16 3.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.153 -1.204 . . . . 0.0 110.245 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -48.71 124.06 7.82 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.201 -0.937 . . . . 0.0 110.105 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.506 ' CB ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -81.64 47.11 1.03 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.264 -0.897 . . . . 0.0 110.463 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.642 0 O-C-N 121.258 -0.901 . . . . 0.0 110.245 179.882 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.262 0.553 . . . . 0.0 110.244 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.838 HG23 ' HG ' ' A' ' 49' ' ' LEU . 17.1 tt -119.97 164.32 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.205 -0.934 . . . . 0.0 110.341 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -143.79 126.39 15.98 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.327 -0.858 . . . . 0.0 109.722 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -168.93 -155.97 10.17 Favored Glycine 0 N--CA 1.492 2.396 0 C-N-CA 119.561 -1.304 . . . . 0.0 110.041 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.573 ' CE1' HD22 ' A' ' 42' ' ' LEU . 77.2 m-85 -111.7 106.83 56.71 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.304 -1.115 . . . . 0.0 110.706 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.52 ' HA ' ' O ' ' A' ' 54' ' ' ARG . 49.8 Cg_endo -78.91 113.37 3.24 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.957 1.504 . . . . 0.0 109.907 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.507 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . 15.5 m -94.04 -169.11 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.012 -1.055 . . . . 0.0 111.05 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.433 ' OD2' ' CB ' ' A' ' 14' ' ' ARG . 9.9 t0 -59.53 -152.23 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.433 -0.792 . . . . 0.0 110.53 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.464 ' HB2' ' CE2' ' A' ' 10' ' ' TRP . 22.0 m-85 -98.84 -11.8 21.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.365 -0.834 . . . . 0.0 110.582 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.534 ' HB3' ' CB ' ' A' ' 62' ' ' ARG . 0.3 OUTLIER -130.22 4.26 4.79 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.03 -1.044 . . . . 0.0 109.74 -179.872 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.509 ' N ' ' OD1' ' A' ' 11' ' ' ASN . 1.6 m120 57.13 16.12 2.8 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.253 -0.905 . . . . 0.0 109.531 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 5.5 t -70.59 -64.04 0.98 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.365 -0.835 . . . . 0.0 110.504 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.495 ' CD ' ' O ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -161.52 82.6 0.61 Allowed 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.259 -0.901 . . . . 0.0 110.502 -179.565 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.437 ' CB ' ' O ' ' A' ' 13' ' ' LYS . 2.0 mtt180 173.06 35.06 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.392 -0.818 . . . . 0.0 109.795 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.946 HD12 ' HB2' ' A' ' 43' ' ' SER . 46.6 pt -54.25 -30.26 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.439 -0.788 . . . . 0.0 110.69 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.542 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 8.5 t -139.36 129.33 24.99 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.137 -0.977 . . . . 0.0 110.589 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.426 ' CE3' ' HB3' ' A' ' 22' ' ' TYR . 0.0 OUTLIER -73.24 170.17 15.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.361 -0.837 . . . . 0.0 110.067 179.785 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -88.23 55.0 3.26 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.318 -0.864 . . . . 0.0 110.075 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.608 ' ND2' ' CE1' ' A' ' 22' ' ' TYR . 2.2 t-20 -165.52 156.28 13.67 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.338 -0.852 . . . . 0.0 110.032 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.422 ' C ' ' OD1' ' A' ' 20' ' ' ASN . 49.7 p30 -87.38 -1.58 58.02 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.226 -0.921 . . . . 0.0 110.266 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.429 ' HA ' ' CB ' ' A' ' 24' ' ' ASN . 0.0 OUTLIER -129.37 -6.02 4.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.19 -0.944 . . . . 0.0 110.586 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.608 ' CE1' ' ND2' ' A' ' 19' ' ' ASN . 3.1 m-30 -59.69 -69.41 0.21 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.1 -1.0 . . . . 0.0 110.247 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.598 ' HA ' HD23 ' A' ' 26' ' ' LEU . 6.0 p -69.37 -6.36 29.39 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.98 -1.075 . . . . 0.0 109.852 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.539 ' CB ' ' O ' ' A' ' 35' ' ' GLY . 64.3 t30 -75.71 -61.06 2.05 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.388 -0.82 . . . . 0.0 109.506 179.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -49.25 -48.56 45.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.41 -0.806 . . . . 0.0 109.733 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.598 HD23 ' HA ' ' A' ' 23' ' ' CYS . 0.1 OUTLIER -64.52 -37.35 87.24 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.307 -0.87 . . . . 0.0 109.088 179.423 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.526 ' N ' ' HG ' ' A' ' 26' ' ' LEU . 1.3 m -61.86 -39.26 91.24 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.244 -0.91 . . . . 0.0 109.281 179.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.76 -31.49 69.71 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.466 -0.771 . . . . 0.0 109.55 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.64 -36.9 91.28 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 108.304 -1.919 . . . . 0.0 108.304 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.554 ' O ' ' CB ' ' A' ' 31' ' ' LYS . 6.9 mt -87.69 17.58 4.61 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.535 -0.979 . . . . 0.0 109.746 179.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.554 ' CB ' ' O ' ' A' ' 30' ' ' LEU . 0.7 OUTLIER 78.83 11.27 1.58 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.711 -0.618 . . . . 0.0 110.79 179.991 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.791 ' CB ' HD22 ' A' ' 49' ' ' LEU . . . -95.04 84.16 4.07 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.959 -1.088 . . . . 0.0 109.812 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -54.09 -73.78 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.279 -0.888 . . . . 0.0 111.143 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.51 ' O ' ' HA ' ' A' ' 46' ' ' CYS . 23.2 t -66.87 92.37 0.23 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.386 -0.821 . . . . 0.0 110.663 -179.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.539 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -129.4 88.12 0.31 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.594 ' CZ ' ' HB3' ' A' ' 45' ' ' TYR . 11.1 p90 -99.57 -175.93 3.13 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.165 -1.197 . . . . 0.0 110.422 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.512 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.1 OUTLIER -131.91 131.45 42.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.122 -0.986 . . . . 0.0 110.73 -179.656 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.592 ' CD1' ' HB2' ' A' ' 42' ' ' LEU . 1.9 t-105 -86.87 122.33 30.58 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.299 -0.875 . . . . 0.0 109.839 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.6 -10.14 86.13 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.583 ' HB3' ' CD1' ' A' ' 38' ' ' TRP . 41.1 t-105 -79.77 -92.9 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.207 -1.172 . . . . 0.0 110.095 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.501 ' CG2' ' C ' ' A' ' 40' ' ' TRP . 14.4 p -152.94 54.47 0.77 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.037 -1.039 . . . . 0.0 110.039 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.592 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 6.0 mt -132.3 8.76 4.34 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.203 -0.936 . . . . 0.0 110.813 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.946 ' HB2' HD12 ' A' ' 15' ' ' ILE . 1.4 t 56.77 -174.4 0.07 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.956 -1.09 . . . . 0.0 109.869 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.512 ' HA ' ' HA ' ' A' ' 37' ' ' CYS . 15.3 t -72.26 156.53 39.03 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.106 -0.996 . . . . 0.0 109.186 179.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.594 ' HB3' ' CZ ' ' A' ' 36' ' ' TYR . 67.4 t80 -138.04 113.85 9.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.113 -0.992 . . . . 0.0 110.478 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.69 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . 62.5 m -125.28 138.93 54.09 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.207 -0.933 . . . . 0.0 109.735 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.494 ' CG ' ' HB3' ' A' ' 34' ' ' SER . 0.0 OUTLIER -118.16 137.65 52.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.359 -0.838 . . . . 0.0 110.072 -179.949 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 31' ' ' LYS . . . 102.22 32.51 4.91 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.838 ' HG ' HG23 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -101.46 -177.27 0.54 Allowed Pre-proline 0 N--CA 1.496 1.865 0 O-C-N 121.185 -1.185 . . . . 0.0 109.303 179.646 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.537 ' HD2' ' HB2' ' A' ' 49' ' ' LEU . 47.6 Cg_endo -85.12 161.11 11.55 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 O-C-N 123.619 1.326 . . . . 0.0 110.123 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -59.53 -19.95 51.99 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.1 -1.0 . . . . 0.0 109.883 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -96.25 19.54 11.74 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.372 -0.83 . . . . 0.0 109.695 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.575 ' HB2' ' HB2' ' A' ' 49' ' ' LEU . . . -53.79 134.01 42.31 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.346 -0.846 . . . . 0.0 110.562 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.576 ' CZ ' ' HB3' ' A' ' 54' ' ' ARG . 1.3 ttm105 -71.71 87.49 0.96 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.298 -0.876 . . . . 0.0 109.976 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.694 HD12 ' C ' ' A' ' 55' ' ' ILE . 1.9 pp -124.34 -166.41 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.062 -1.024 . . . . 0.0 110.626 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.48 ' O ' ' HG3' ' A' ' 56' ' ' LYS . 0.4 OUTLIER -61.39 70.41 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.486 -0.758 . . . . 0.0 110.837 -179.555 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.531 ' N ' ' O ' ' A' ' 55' ' ' ILE . 9.1 tpp85 -114.79 -16.03 11.81 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.074 -1.016 . . . . 0.0 109.799 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.9 132.02 46.24 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.419 -0.801 . . . . 0.0 109.984 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -107.77 33.42 6.32 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.431 ' O ' ' HG2' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -122.77 107.4 11.86 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.276 -1.132 . . . . 0.0 110.28 179.954 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 2.6 t -50.74 107.52 0.18 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.288 -0.882 . . . . 0.0 109.882 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.534 ' CB ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -87.32 48.61 1.67 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.324 -0.86 . . . . 0.0 110.375 179.973 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.152 -0.967 . . . . 0.0 110.228 -179.99 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 13.3 tttm . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.178 0.513 . . . . 0.0 110.219 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.611 HG22 ' O ' ' A' ' 49' ' ' LEU . 4.5 tt -146.93 159.85 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.334 -0.854 . . . . 0.0 110.1 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.506 ' HB3' ' CG ' ' A' ' 47' ' ' GLN . 65.8 m-20 -131.14 136.2 48.14 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.347 -0.845 . . . . 0.0 109.873 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 178.77 -160.8 26.8 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.606 ' CE2' ' CD1' ' A' ' 45' ' ' TYR . 15.0 m-85 -109.28 109.25 60.46 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.305 -1.115 . . . . 0.0 110.256 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.516 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 49.4 Cg_endo -80.51 108.09 2.09 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.928 1.489 . . . . 0.0 110.9 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.477 HG12 ' HA ' ' A' ' 15' ' ' ILE . 17.0 m -83.49 -170.59 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.228 -0.92 . . . . 0.0 109.83 179.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -70.65 -118.23 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.111 -0.993 . . . . 0.0 109.827 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.413 ' HB3' ' CD2' ' A' ' 10' ' ' TRP . 0.2 OUTLIER -115.94 -55.06 2.45 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.816 -1.177 . . . . 0.0 110.073 179.792 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.543 ' HB3' ' CB ' ' A' ' 62' ' ' ARG . 3.0 m-90 -99.6 15.23 27.32 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.24 -0.913 . . . . 0.0 110.121 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.459 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 5.1 m-20 59.4 12.74 2.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.219 -0.925 . . . . 0.0 110.067 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.8 t -90.89 -28.68 17.96 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.277 -0.889 . . . . 0.0 110.43 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.489 ' O ' ' CB ' ' A' ' 14' ' ' ARG . 4.5 mmtp -86.79 41.38 0.95 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.272 -0.892 . . . . 0.0 110.619 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.489 ' CB ' ' O ' ' A' ' 13' ' ' LYS . 0.1 OUTLIER 69.03 141.6 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.159 -0.963 . . . . 0.0 110.536 179.787 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.477 ' HA ' HG12 ' A' ' 7' ' ' VAL . 6.9 pt -74.48 -6.29 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.376 -0.828 . . . . 0.0 110.104 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.599 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 4.4 t -148.25 153.99 39.46 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.267 -0.896 . . . . 0.0 110.257 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.458 ' CE3' ' HB3' ' A' ' 22' ' ' TYR . 0.2 OUTLIER -86.56 -161.99 0.72 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.359 -0.838 . . . . 0.0 110.105 179.886 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.471 ' CD1' ' O ' ' A' ' 18' ' ' TYR . 9.3 t80 -106.61 -25.85 11.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.283 -0.886 . . . . 0.0 110.118 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -93.36 152.7 18.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.329 -0.857 . . . . 0.0 110.165 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 -81.99 -9.02 59.7 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.173 -0.954 . . . . 0.0 110.214 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.424 ' O ' ' N ' ' A' ' 24' ' ' ASN . 13.8 tttp -105.41 -39.59 6.09 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.181 -0.949 . . . . 0.0 110.07 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.458 ' HB3' ' CE3' ' A' ' 17' ' ' TRP . 1.5 m-85 -44.65 -33.63 1.89 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.296 -0.878 . . . . 0.0 110.259 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -78.32 -28.53 47.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.278 -0.889 . . . . 0.0 110.008 -179.993 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.485 ' OD1' ' HD2' ' A' ' 28' ' ' LYS . 0.3 OUTLIER -68.98 -41.31 78.05 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.399 -0.813 . . . . 0.0 109.305 179.465 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.2 -43.04 99.73 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.377 -0.827 . . . . 0.0 110.055 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.742 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -74.56 -42.68 58.37 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.318 -0.864 . . . . 0.0 109.591 179.74 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.51 ' SG ' ' CG ' ' A' ' 6' ' ' PRO . 1.5 m -61.09 -30.78 70.55 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.293 -0.879 . . . . 0.0 109.303 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.561 ' HE3' ' CA ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -65.43 -27.42 68.51 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.17 -0.956 . . . . 0.0 108.87 178.572 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.94 -34.52 89.13 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 107.197 -2.361 . . . . 0.0 107.197 178.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.533 ' O ' ' CD ' ' A' ' 50' ' ' PRO . 53.1 mt -91.01 22.03 3.9 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.763 -0.845 . . . . 0.0 109.16 178.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.488 ' O ' ' O ' ' A' ' 48' ' ' GLY . 0.0 OUTLIER 60.48 22.53 12.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.611 -0.681 . . . . 0.0 110.653 179.907 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.617 ' HB1' ' HB3' ' A' ' 46' ' ' CYS . . . -86.15 86.4 7.35 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.984 -1.072 . . . . 0.0 109.995 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.511 ' O ' ' NZ ' ' A' ' 28' ' ' LYS . 6.7 t70 -40.28 -86.62 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.498 -0.751 . . . . 0.0 110.597 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.9 m -69.99 93.65 0.8 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.993 -1.067 . . . . 0.0 110.058 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.544 ' CA ' ' SG ' ' A' ' 46' ' ' CYS . . . -128.72 112.77 1.45 Allowed Glycine 0 N--CA 1.487 2.099 0 C-N-CA 119.638 -1.268 . . . . 0.0 110.018 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -148.21 159.97 43.41 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.273 -1.134 . . . . 0.0 109.985 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.475 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.1 OUTLIER -93.32 146.15 23.93 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.153 -0.967 . . . . 0.0 110.684 -179.599 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.53 ' CD1' ' HB2' ' A' ' 42' ' ' LEU . 8.7 t-105 -79.55 111.06 15.45 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.238 -0.914 . . . . 0.0 109.439 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -66.2 61.25 0.16 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 -179.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.64 ' CD1' HG22 ' A' ' 41' ' ' THR . 14.7 t-105 -160.94 -69.67 0.06 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.329 -1.1 . . . . 0.0 109.453 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.64 HG22 ' CD1' ' A' ' 40' ' ' TRP . 11.8 t -179.91 33.42 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.586 -0.696 . . . . 0.0 109.588 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.53 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 0.3 OUTLIER -109.46 30.83 6.26 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.293 -0.88 . . . . 0.0 111.013 -179.433 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.599 ' HA ' ' HB2' ' A' ' 16' ' ' CYS . 6.1 p 48.29 -175.3 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.934 -1.104 . . . . 0.0 110.235 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.491 ' O ' ' HA ' ' A' ' 5' ' ' TYR . 14.7 t -78.55 140.47 38.51 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.259 -0.901 . . . . 0.0 109.366 179.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.606 ' CD1' ' CE2' ' A' ' 5' ' ' TYR . 4.7 t80 -128.94 118.77 23.18 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.053 -1.029 . . . . 0.0 110.696 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.617 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . 63.1 m -136.17 152.18 50.53 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.488 -0.758 . . . . 0.0 109.719 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.506 ' CG ' ' HB3' ' A' ' 3' ' ' ASP . 1.6 mt-30 -134.83 147.24 49.88 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.142 -0.973 . . . . 0.0 110.701 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.488 ' O ' ' O ' ' A' ' 31' ' ' LYS . . . 97.98 30.05 7.31 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.982 HD12 ' CB ' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -108.07 170.9 5.04 Favored Pre-proline 0 N--CA 1.498 1.963 0 O-C-N 121.158 -1.201 . . . . 0.0 109.77 179.66 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.533 ' CD ' ' O ' ' A' ' 30' ' ' LEU . 42.7 Cg_endo -68.93 157.85 60.25 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.692 1.364 . . . . 0.0 110.917 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -59.37 -24.02 63.06 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.379 -0.825 . . . . 0.0 110.008 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -86.46 14.18 7.17 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.335 -0.853 . . . . 0.0 109.783 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.982 ' CB ' HD12 ' A' ' 49' ' ' LEU . . . -56.86 113.69 1.77 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.459 -0.776 . . . . 0.0 110.86 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.502 ' O ' ' HA ' ' A' ' 6' ' ' PRO . 6.7 ttm-85 -59.9 116.39 4.08 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.252 -0.905 . . . . 0.0 109.645 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.69 ' O ' HD12 ' A' ' 55' ' ' ILE . 1.8 pp -140.19 178.06 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.074 -1.016 . . . . 0.0 111.004 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 55' ' ' ILE . 0.1 OUTLIER -41.81 93.74 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.529 -0.732 . . . . 0.0 110.736 -179.566 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.506 ' N ' ' O ' ' A' ' 55' ' ' ILE . 11.6 ttp180 -119.73 -18.91 8.2 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.294 -0.879 . . . . 0.0 109.782 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.32 155.9 35.96 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.367 -0.833 . . . . 0.0 110.148 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -118.13 14.71 12.31 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.424 ' O ' ' C ' ' A' ' 61' ' ' CYS . 4.6 mpt_? -99.39 98.95 9.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.431 -1.04 . . . . 0.0 110.205 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.424 ' C ' ' O ' ' A' ' 60' ' ' ARG . 4.5 t -40.05 109.76 0.12 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.507 -0.746 . . . . 0.0 110.096 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.543 ' CB ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -90.52 52.0 2.12 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.279 -0.888 . . . . 0.0 110.329 -179.808 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.437 ' HB2' ' O ' ' A' ' 62' ' ' ARG . . . . . . . . 0 N--CA 1.491 1.604 0 O-C-N 121.22 -0.925 . . . . 0.0 110.219 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 20.7 mttt . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.251 0.548 . . . . 0.0 110.235 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.477 HG12 ' N ' ' A' ' 3' ' ' ASP . 6.9 tt -134.34 165.11 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.414 -0.804 . . . . 0.0 109.943 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.477 ' N ' HG12 ' A' ' 2' ' ' ILE . 1.0 OUTLIER -135.2 128.6 32.29 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.308 -0.87 . . . . 0.0 110.107 179.895 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -167.56 -176.26 38.12 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.794 -1.323 . . . . 0.0 109.794 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.972 ' HB2' HD11 ' A' ' 15' ' ' ILE . 6.1 m-30 -99.07 109.58 54.7 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.296 -1.12 . . . . 0.0 110.407 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.569 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 48.8 Cg_endo -78.89 129.56 9.09 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.934 1.491 . . . . 0.0 110.277 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.589 HG12 ' CB ' ' A' ' 15' ' ' ILE . 30.1 m -93.46 -170.25 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.125 -0.985 . . . . 0.0 110.185 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.514 ' CB ' ' HB2' ' A' ' 13' ' ' LYS . 7.9 t70 -74.68 -89.36 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.319 -0.863 . . . . 0.0 109.792 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.657 ' CZ ' ' CH2' ' A' ' 10' ' ' TRP . 24.5 t80 -138.32 -75.11 0.39 Allowed 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.308 -0.87 . . . . 0.0 109.611 179.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.657 ' CH2' ' CZ ' ' A' ' 9' ' ' TYR . 0.0 OUTLIER -89.62 23.02 2.78 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.447 -0.783 . . . . 0.0 109.386 179.322 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 3.7 m120 61.18 24.17 14.3 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.83 -0.543 . . . . 0.0 110.834 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.501 ' HA ' ' HB2' ' A' ' 61' ' ' CYS . 48.3 t -93.25 -37.46 12.05 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.986 -1.071 . . . . 0.0 110.43 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.514 ' HB2' ' CB ' ' A' ' 8' ' ' ASP . 54.4 mmtt -85.08 44.1 1.06 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.282 -0.886 . . . . 0.0 109.894 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' A' ' 13' ' ' LYS . 1.3 tpp180 54.73 165.13 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.307 -0.871 . . . . 0.0 110.152 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.972 HD11 ' HB2' ' A' ' 5' ' ' TYR . 7.7 tt -84.1 1.29 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.326 -0.859 . . . . 0.0 110.423 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.595 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 33.7 t -142.44 127.19 18.12 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.268 -0.895 . . . . 0.0 110.424 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -69.22 -149.49 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.265 -0.897 . . . . 0.0 110.337 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -140.08 40.45 1.95 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.146 -0.971 . . . . 0.0 110.313 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.435 ' HB2' ' HB2' ' A' ' 22' ' ' TYR . 0.6 OUTLIER -149.25 162.72 39.46 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.328 -0.858 . . . . 0.0 109.914 179.758 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 25.1 m-20 -88.7 30.25 0.93 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.13 -0.981 . . . . 0.0 109.915 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -156.09 -39.98 0.08 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.396 -0.815 . . . . 0.0 109.764 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.435 ' HB2' ' HB2' ' A' ' 19' ' ' ASN . 0.1 OUTLIER -45.97 -27.58 0.94 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.243 -0.91 . . . . 0.0 110.008 179.769 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -100.0 -50.97 3.82 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.292 -0.88 . . . . 0.0 110.104 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.508 ' N ' ' OD1' ' A' ' 24' ' ' ASN . 1.4 m-20 -55.42 -60.07 3.93 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.376 -0.828 . . . . 0.0 109.95 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 24' ' ' ASN . 6.8 t0 -42.99 -51.54 5.6 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.223 -0.923 . . . . 0.0 110.378 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.6 mt -65.16 -42.72 93.47 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.201 -0.937 . . . . 0.0 110.46 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.498 ' SG ' ' HG3' ' A' ' 6' ' ' PRO . 2.4 m -61.18 -39.62 90.82 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.388 -0.82 . . . . 0.0 110.478 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.539 ' HD3' ' HA ' ' A' ' 33' ' ' ASP . 0.5 OUTLIER -60.82 -31.87 71.26 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.284 -0.885 . . . . 0.0 109.602 179.954 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.28 -28.27 73.38 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 107.993 -2.043 . . . . 0.0 107.993 179.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.54 ' O ' ' CD ' ' A' ' 50' ' ' PRO . 13.5 mt -92.42 19.52 7.11 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.691 -0.888 . . . . 0.0 109.127 178.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.527 ' HB3' ' O ' ' A' ' 30' ' ' LEU . 28.7 tptt 72.93 15.02 4.71 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.694 -0.629 . . . . 0.0 110.939 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.709 ' HB2' HD22 ' A' ' 49' ' ' LEU . . . -99.96 55.87 0.94 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.866 -1.146 . . . . 0.0 109.667 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.539 ' HA ' ' HD3' ' A' ' 28' ' ' LYS . 17.9 p30 -40.29 -30.05 0.09 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.462 -0.773 . . . . 0.0 110.649 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.5 ' N ' ' OD1' ' A' ' 33' ' ' ASP . 70.2 p -91.09 62.77 4.92 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.244 -0.91 . . . . 0.0 110.368 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.484 ' HA2' ' SG ' ' A' ' 46' ' ' CYS . . . -104.64 134.44 12.0 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.539 ' CD1' ' O ' ' A' ' 36' ' ' TYR . 29.3 p90 -160.17 129.74 5.18 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.394 -1.062 . . . . 0.0 109.39 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.524 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.0 OUTLIER -89.74 136.32 33.1 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.162 -0.961 . . . . 0.0 110.994 -179.059 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.576 ' CD1' ' HB2' ' A' ' 42' ' ' LEU . 4.6 t-105 -80.35 111.05 16.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.302 -0.874 . . . . 0.0 109.448 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -61.63 -10.96 26.87 Favored Glycine 0 N--CA 1.49 2.277 0 C-N-CA 120.434 -0.888 . . . . 0.0 110.943 -178.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.86 ' CD1' HG22 ' A' ' 41' ' ' THR . 16.7 t-105 -79.66 -78.43 0.16 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.793 -1.416 . . . . 0.0 110.249 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.86 HG22 ' CD1' ' A' ' 40' ' ' TRP . 5.8 t -173.46 38.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.27 -0.894 . . . . 0.0 109.714 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.576 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 0.3 OUTLIER -110.04 24.66 12.72 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.245 -0.909 . . . . 0.0 110.414 -179.679 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.595 ' HA ' ' HB2' ' A' ' 16' ' ' CYS . 7.7 m 54.53 -176.55 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.049 -1.032 . . . . 0.0 109.827 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.524 ' HA ' ' HA ' ' A' ' 37' ' ' CYS . 7.4 t -76.64 151.82 36.05 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.178 -0.951 . . . . 0.0 109.131 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.532 ' HB3' ' CZ ' ' A' ' 36' ' ' TYR . 0.8 OUTLIER -138.58 104.74 5.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.866 -1.146 . . . . 0.0 111.378 -179.632 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.67 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . 63.8 m -121.02 140.66 51.62 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.397 -0.814 . . . . 0.0 109.393 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.407 ' O ' ' OG ' ' A' ' 34' ' ' SER . 14.6 mt-30 -129.92 149.43 51.66 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.107 -0.996 . . . . 0.0 110.407 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 31' ' ' LYS . . . 97.62 24.84 11.49 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 1.018 HD12 ' CB ' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -103.09 172.1 4.58 Favored Pre-proline 0 N--CA 1.499 2.019 0 O-C-N 121.279 -1.13 . . . . 0.0 109.444 179.438 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.54 ' CD ' ' O ' ' A' ' 30' ' ' LEU . 41.9 Cg_endo -68.57 154.44 71.59 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 O-C-N 123.335 1.176 . . . . 0.0 110.352 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -58.28 -21.98 50.91 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.325 -0.86 . . . . 0.0 110.191 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 16.6 t30 -86.44 11.71 11.88 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.306 -0.871 . . . . 0.0 110.085 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 1.018 ' CB ' HD12 ' A' ' 49' ' ' LEU . . . -52.71 143.89 15.31 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.446 -0.783 . . . . 0.0 110.669 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.499 ' NH1' ' O ' ' A' ' 8' ' ' ASP . 1.2 ttm105 -88.54 116.72 26.98 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.365 -0.834 . . . . 0.0 109.996 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.595 HD12 ' C ' ' A' ' 55' ' ' ILE . 1.3 pp -139.24 -164.74 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.188 -0.945 . . . . 0.0 110.733 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.843 ' HG3' HD12 ' A' ' 15' ' ' ILE . 0.3 OUTLIER -36.24 96.12 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 121.371 0.605 . . . . 0.0 111.107 -179.414 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.456 ' N ' ' O ' ' A' ' 55' ' ' ILE . 8.3 ttm-85 -110.1 -20.02 12.84 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.376 -0.828 . . . . 0.0 109.762 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.8 m -166.32 162.59 17.32 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.412 -0.805 . . . . 0.0 110.056 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -114.61 45.75 1.27 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.459 ' O ' ' HB2' ' A' ' 11' ' ' ASN . 7.7 ptm180 -137.17 172.15 13.42 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.162 -1.199 . . . . 0.0 110.485 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.501 ' HB2' ' HA ' ' A' ' 12' ' ' CYS . 0.5 OUTLIER -116.7 103.26 10.18 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.402 -0.811 . . . . 0.0 109.695 179.993 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.646 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -85.53 28.77 0.73 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.888 -1.132 . . . . 0.0 110.547 179.766 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.124 -0.985 . . . . 0.0 110.283 -179.949 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 9.8 ptpt . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.221 0.534 . . . . 0.0 110.193 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.526 ' CG2' ' HG ' ' A' ' 49' ' ' LEU . 19.3 tt -131.18 160.56 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.322 -0.861 . . . . 0.0 110.056 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 3' ' ' ASP . 5.0 p-10 -134.52 127.5 31.48 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.381 -0.824 . . . . 0.0 109.654 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -177.32 -172.86 42.3 Favored Glycine 0 N--CA 1.49 2.286 0 C-N-CA 119.253 -1.451 . . . . 0.0 110.21 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.603 ' CD1' ' N ' ' A' ' 5' ' ' TYR . 3.2 m-30 -102.36 113.36 65.91 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.438 -1.036 . . . . 0.0 110.088 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.495 ' HG3' ' SG ' ' A' ' 27' ' ' CYS . 46.3 Cg_endo -75.15 142.48 27.47 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.815 1.429 . . . . 0.0 110.452 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.727 HG12 ' HA ' ' A' ' 15' ' ' ILE . 30.0 m -141.08 -170.18 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.35 -0.843 . . . . 0.0 110.149 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.502 ' HB3' ' HB3' ' A' ' 14' ' ' ARG . 21.3 p-10 -69.45 -148.29 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.234 -0.916 . . . . 0.0 109.979 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.582 ' HB3' ' CD2' ' A' ' 10' ' ' TRP . 6.3 t80 -98.82 -14.9 19.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.197 -0.939 . . . . 0.0 110.316 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.582 ' CD2' ' HB3' ' A' ' 9' ' ' TYR . 7.9 m-90 -133.32 24.04 4.12 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.227 -0.921 . . . . 0.0 110.252 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.501 ' O ' HD11 ' A' ' 15' ' ' ILE . 2.4 m-20 59.41 13.78 3.4 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.192 -0.942 . . . . 0.0 110.166 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.49 ' SG ' ' HB2' ' A' ' 10' ' ' TRP . 71.5 m -83.0 -77.17 0.25 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.299 -0.876 . . . . 0.0 110.82 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.439 ' O ' ' HB3' ' A' ' 14' ' ' ARG . 14.6 mttt -95.51 -167.83 1.68 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.368 -0.833 . . . . 0.0 111.076 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.542 ' O ' ' N ' ' A' ' 16' ' ' CYS . 16.8 tpp180 58.57 -106.0 0.28 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.48 -0.763 . . . . 0.0 110.45 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.77 HG23 ' OG ' ' A' ' 43' ' ' SER . 78.0 mt 57.19 -81.7 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.08 -1.012 . . . . 0.0 109.914 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.568 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 40.3 t -137.37 115.21 11.41 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.41 -0.806 . . . . 0.0 110.19 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -66.7 -149.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.214 -0.928 . . . . 0.0 109.939 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.57 59.25 1.55 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.122 -0.986 . . . . 0.0 110.14 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.528 ' CB ' ' HB2' ' A' ' 22' ' ' TYR . 1.1 m-80 -159.15 -177.86 6.79 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.276 -0.89 . . . . 0.0 110.091 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -90.74 -41.03 11.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.281 -0.887 . . . . 0.0 110.854 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.6 mtmp? -110.63 -1.12 16.95 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.132 -0.98 . . . . 0.0 110.811 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.528 ' HB2' ' CB ' ' A' ' 19' ' ' ASN . 1.2 m-85 -56.5 -52.36 65.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.057 -1.027 . . . . 0.0 109.986 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.4 t -78.03 -14.84 59.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.271 -0.893 . . . . 0.0 110.14 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.527 ' O ' ' CG ' ' A' ' 28' ' ' LYS . 9.6 t-20 -76.49 -41.45 46.97 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.259 -0.901 . . . . 0.0 110.006 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.1 -40.27 89.07 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.199 -0.938 . . . . 0.0 109.766 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -74.23 -45.06 50.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.325 -0.859 . . . . 0.0 109.954 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.495 ' SG ' ' HG3' ' A' ' 6' ' ' PRO . 1.2 m -60.85 -45.03 96.12 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.339 -0.851 . . . . 0.0 109.615 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.551 ' CD ' ' HA ' ' A' ' 33' ' ' ASP . 2.2 mmmt -59.65 -31.08 69.19 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.334 -0.854 . . . . 0.0 109.323 179.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -56.57 -35.58 67.39 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 108.851 -1.699 . . . . 0.0 108.851 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.695 ' O ' ' CB ' ' A' ' 31' ' ' LYS . 10.5 mt -81.65 -28.91 33.38 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.387 -1.067 . . . . 0.0 109.617 179.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.695 ' CB ' ' O ' ' A' ' 30' ' ' LEU . 10.0 tttt 131.54 5.82 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.748 0 C-N-CA 123.528 0.731 . . . . 0.0 109.839 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.544 ' HB1' ' HB3' ' A' ' 46' ' ' CYS . . . -82.73 113.1 20.16 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.901 -1.124 . . . . 0.0 110.226 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.551 ' HA ' ' CD ' ' A' ' 28' ' ' LYS . 0.2 OUTLIER -73.66 -62.41 1.5 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.308 -0.87 . . . . 0.0 110.134 179.893 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -80.45 82.84 6.38 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.399 -0.813 . . . . 0.0 109.996 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.531 ' CA ' ' SG ' ' A' ' 46' ' ' CYS . . . -121.06 104.07 0.93 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.53 ' OH ' ' CD2' ' A' ' 45' ' ' TYR . 41.4 p90 -126.35 -177.16 3.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.178 -1.19 . . . . 0.0 109.794 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.522 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.1 OUTLIER -110.72 147.28 34.72 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.087 -1.008 . . . . 0.0 110.277 -179.916 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.592 ' CD1' ' HB2' ' A' ' 42' ' ' LEU . 15.6 t-105 -79.53 166.61 21.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.084 -1.01 . . . . 0.0 109.855 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -125.54 55.67 0.72 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.869 ' CD1' HG22 ' A' ' 41' ' ' THR . 11.6 t-105 -160.33 -69.66 0.07 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.374 -1.074 . . . . 0.0 109.335 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.869 HG22 ' CD1' ' A' ' 40' ' ' TRP . 5.1 t -179.06 32.37 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.67 -0.644 . . . . 0.0 109.883 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.592 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 0.8 OUTLIER -113.58 21.39 15.13 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.102 -0.999 . . . . 0.0 110.908 -179.433 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.77 ' OG ' HG23 ' A' ' 15' ' ' ILE . 8.2 t 57.34 -168.69 0.11 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.13 -0.981 . . . . 0.0 110.784 179.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.522 ' HA ' ' HA ' ' A' ' 37' ' ' CYS . 19.4 t -71.91 171.98 10.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.391 -0.818 . . . . 0.0 110.162 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.53 ' CD2' ' OH ' ' A' ' 36' ' ' TYR . 1.1 t80 -151.5 110.21 3.83 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.994 -1.066 . . . . 0.0 110.752 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.583 ' O ' HD21 ' A' ' 49' ' ' LEU . 82.9 m -125.44 137.49 53.99 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.327 -0.858 . . . . 0.0 109.824 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -119.92 131.95 55.37 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.206 -0.934 . . . . 0.0 109.931 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.598 ' N ' HD23 ' A' ' 49' ' ' LEU . . . 107.82 41.22 1.6 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.758 HD12 ' CB ' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -119.6 172.9 3.98 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.362 -1.081 . . . . 0.0 109.83 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.511 ' HD2' ' HB2' ' A' ' 49' ' ' LEU . 42.1 Cg_endo -68.32 155.22 70.05 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 O-C-N 123.677 1.356 . . . . 0.0 110.516 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -61.12 -19.95 62.08 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.359 -0.838 . . . . 0.0 110.459 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -88.62 11.87 16.23 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.208 -0.933 . . . . 0.0 110.095 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.758 ' CB ' HD12 ' A' ' 49' ' ' LEU . . . -65.27 110.38 2.57 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.24 -0.913 . . . . 0.0 110.167 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.551 ' O ' HG23 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -57.71 136.08 56.83 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.234 -0.916 . . . . 0.0 110.282 179.982 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.614 HD12 ' C ' ' A' ' 55' ' ' ILE . 1.4 pp -154.36 -169.94 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.204 -0.935 . . . . 0.0 110.319 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.427 ' CG ' ' O ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -50.07 91.1 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.315 -0.866 . . . . 0.0 110.662 -179.523 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.471 ' N ' ' O ' ' A' ' 55' ' ' ILE . 2.4 ttt85 -119.76 -5.86 10.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.204 -0.935 . . . . 0.0 110.022 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.432 ' HB2' ' CG ' ' A' ' 11' ' ' ASN . 46.3 m -120.67 -178.53 3.74 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.309 -0.87 . . . . 0.0 110.031 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -118.94 -36.86 0.85 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.401 ' O ' ' C ' ' A' ' 61' ' ' CYS . 0.3 OUTLIER -131.74 155.32 47.9 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.19 -1.183 . . . . 0.0 110.393 -179.922 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.401 ' C ' ' O ' ' A' ' 60' ' ' ARG . 43.3 t -43.79 115.4 0.8 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.285 -0.884 . . . . 0.0 110.305 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.521 ' CB ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -90.85 48.26 1.51 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.253 -0.904 . . . . 0.0 110.262 -179.975 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.678 0 O-C-N 121.272 -0.893 . . . . 0.0 110.147 179.991 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . 0.497 ' CG ' ' O ' ' A' ' 1' ' ' LYS . 2.2 tttm . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.191 0.52 . . . . 0.0 110.167 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.502 ' CG2' ' HG ' ' A' ' 49' ' ' LEU . 10.1 tt -111.15 157.45 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.239 -0.913 . . . . 0.0 110.497 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.584 ' CB ' ' CG ' ' A' ' 47' ' ' GLN . 7.1 p30 -133.21 117.28 17.24 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.733 -0.604 . . . . 0.0 109.66 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -155.45 -150.61 5.63 Favored Glycine 0 N--CA 1.491 2.353 0 C-N-CA 119.496 -1.335 . . . . 0.0 109.846 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.493 ' HA ' ' O ' ' A' ' 44' ' ' CYS . 14.1 m-85 -122.83 114.33 29.8 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.403 -1.057 . . . . 0.0 110.29 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.494 ' HG3' ' SG ' ' A' ' 27' ' ' CYS . 48.2 Cg_endo -76.04 144.8 27.33 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 124.047 1.551 . . . . 0.0 110.619 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.745 HG12 ' HA ' ' A' ' 15' ' ' ILE . 32.8 m -141.76 -171.47 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.297 -0.877 . . . . 0.0 109.894 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.544 ' N ' ' HB3' ' A' ' 14' ' ' ARG . 3.9 t0 -67.54 -176.0 0.57 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.227 -0.92 . . . . 0.0 110.175 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.494 ' HB3' ' CE2' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -76.55 -11.02 59.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.359 -0.838 . . . . 0.0 109.68 179.739 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.568 ' HB3' ' N ' ' A' ' 62' ' ' ARG . 4.0 m-90 -132.22 8.38 4.34 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.382 -0.824 . . . . 0.0 110.115 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 18.3 m-20 60.09 33.08 21.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.162 -0.961 . . . . 0.0 110.25 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.466 ' O ' ' HD3' ' A' ' 13' ' ' LYS . 5.5 t -98.12 -67.27 0.85 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.237 -0.914 . . . . 0.0 110.683 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.476 ' O ' ' HB2' ' A' ' 14' ' ' ARG . 45.2 mmtt -131.32 86.02 2.32 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.297 -0.877 . . . . 0.0 110.587 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.544 ' HB3' ' N ' ' A' ' 8' ' ' ASP . 1.0 OUTLIER 177.75 -22.88 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.488 -0.758 . . . . 0.0 111.008 179.739 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.745 ' HA ' HG12 ' A' ' 7' ' ' VAL . 6.8 tt -30.33 -45.13 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.749 -0.595 . . . . 0.0 111.203 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.581 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 43.0 t -159.18 154.3 25.21 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.226 -0.921 . . . . 0.0 109.967 179.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -114.84 -151.76 0.49 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.21 -0.931 . . . . 0.0 110.629 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -123.91 16.14 9.33 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.334 -0.854 . . . . 0.0 110.51 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.508 ' HB2' ' HB2' ' A' ' 22' ' ' TYR . 36.4 m-20 -119.16 148.02 43.55 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.083 -1.011 . . . . 0.0 110.395 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.417 ' ND2' ' H ' ' A' ' 20' ' ' ASN . 8.3 p30 -88.16 26.45 1.39 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.323 -0.86 . . . . 0.0 110.165 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.4 pttm -150.29 -35.23 0.16 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.292 -0.88 . . . . 0.0 110.457 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.508 ' HB2' ' HB2' ' A' ' 19' ' ' ASN . 0.1 OUTLIER -51.51 -28.82 14.59 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -0.918 . . . . 0.0 110.691 -179.661 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.443 ' O ' ' C ' ' A' ' 24' ' ' ASN . 0.5 OUTLIER -87.18 -59.68 2.19 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.1 -1.0 . . . . 0.0 110.333 -179.905 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 35' ' ' GLY . 0.1 OUTLIER -40.72 -40.41 1.3 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.488 -0.758 . . . . 0.0 110.001 179.879 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.99 -47.69 80.21 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.315 -0.866 . . . . 0.0 110.311 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.8 mt -74.84 -37.92 62.12 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.192 -0.942 . . . . 0.0 110.046 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.494 ' SG ' ' HG3' ' A' ' 6' ' ' PRO . 15.2 m -58.38 -39.68 80.26 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.161 -0.962 . . . . 0.0 109.473 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.87 -29.9 68.62 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.329 -0.857 . . . . 0.0 109.37 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.2 -37.35 92.82 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 108.311 -1.916 . . . . 0.0 108.311 179.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.509 ' O ' ' CB ' ' A' ' 31' ' ' LYS . 39.5 mt -89.02 19.39 4.2 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.462 -1.022 . . . . 0.0 109.524 179.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.509 ' CB ' ' O ' ' A' ' 30' ' ' LEU . 0.3 OUTLIER 73.18 16.22 4.27 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.657 -0.652 . . . . 0.0 110.809 179.912 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.69 ' HB2' HD22 ' A' ' 49' ' ' LEU . . . -95.65 89.7 5.43 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.957 -1.089 . . . . 0.0 109.797 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -55.31 -75.15 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.22 -0.925 . . . . 0.0 111.018 -179.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.5 ' O ' ' HA ' ' A' ' 46' ' ' CYS . 8.6 t -62.34 95.42 0.07 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.389 -0.82 . . . . 0.0 110.912 -179.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.487 ' HA2' ' SG ' ' A' ' 46' ' ' CYS . . . -123.06 110.87 1.6 Allowed Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.585 ' CD1' ' O ' ' A' ' 36' ' ' TYR . 13.1 p90 -138.99 144.25 38.84 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.388 -1.066 . . . . 0.0 109.738 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.512 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.0 OUTLIER -90.97 154.56 19.36 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.038 -1.039 . . . . 0.0 110.832 -179.359 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.452 ' CG ' ' HB2' ' A' ' 42' ' ' LEU . 18.5 t-105 -79.95 -172.03 3.19 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.271 -0.893 . . . . 0.0 109.936 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -119.55 -29.3 1.76 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.911 ' CD1' HG22 ' A' ' 41' ' ' THR . 12.8 t-105 -79.38 -83.1 0.1 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.233 -1.157 . . . . 0.0 109.986 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.911 HG22 ' CD1' ' A' ' 40' ' ' TRP . 5.3 t -166.41 48.42 0.07 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.347 -0.845 . . . . 0.0 109.707 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.452 ' HB2' ' CG ' ' A' ' 38' ' ' TRP . 8.0 mp -106.9 23.49 14.28 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.312 -0.868 . . . . 0.0 110.745 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.581 ' HA ' ' HB2' ' A' ' 16' ' ' CYS . 5.1 m 58.48 -166.93 0.15 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 120.935 -1.103 . . . . 0.0 110.027 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.512 ' HA ' ' HA ' ' A' ' 37' ' ' CYS . 9.3 t -83.68 156.27 22.73 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.34 -0.85 . . . . 0.0 108.88 178.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.458 ' HB3' ' CE1' ' A' ' 36' ' ' TYR . 0.8 OUTLIER -128.72 116.95 20.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.96 -1.088 . . . . 0.0 110.354 -179.629 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.649 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . 74.0 m -137.52 137.45 38.65 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.353 -0.842 . . . . 0.0 109.848 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.584 ' CG ' ' CB ' ' A' ' 3' ' ' ASP . 1.7 mp0 -123.78 154.63 39.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.273 -0.892 . . . . 0.0 110.431 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.489 ' O ' ' O ' ' A' ' 31' ' ' LYS . . . 99.73 15.46 31.55 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 1.044 HD12 ' CB ' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -98.66 170.35 7.09 Favored Pre-proline 0 N--CA 1.497 1.891 0 O-C-N 121.133 -1.216 . . . . 0.0 109.723 179.669 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.552 ' HD2' ' HB2' ' A' ' 49' ' ' LEU . 43.3 Cg_endo -70.61 156.46 61.07 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 123.515 1.271 . . . . 0.0 110.706 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -58.99 -24.85 63.1 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.334 -0.854 . . . . 0.0 110.01 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -85.79 14.18 6.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.373 -0.829 . . . . 0.0 109.806 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 1.044 ' CB ' HD12 ' A' ' 49' ' ' LEU . . . -56.25 152.15 11.46 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.449 -0.782 . . . . 0.0 110.381 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.465 ' O ' ' HA ' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -92.19 110.48 21.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.309 -0.87 . . . . 0.0 109.536 179.476 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.828 ' N ' HD13 ' A' ' 55' ' ' ILE . 0.2 OUTLIER -148.65 -164.62 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.256 -0.903 . . . . 0.0 110.647 -179.384 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' A' ' 55' ' ' ILE . 0.1 OUTLIER -40.45 108.63 0.09 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.573 -0.705 . . . . 0.0 110.54 -179.816 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.456 ' CG ' ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -136.43 20.68 3.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.381 -0.824 . . . . 0.0 109.872 179.807 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.451 ' CB ' ' O ' ' A' ' 57' ' ' ARG . 0.5 OUTLIER 66.86 153.49 0.08 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.408 -0.807 . . . . 0.0 110.161 -179.969 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 128.73 101.57 1.03 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.709 -1.357 . . . . 0.0 109.709 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.436 ' O ' ' C ' ' A' ' 61' ' ' CYS . 1.6 mmt180 -70.13 94.85 0.92 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.257 -1.143 . . . . 0.0 109.965 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.436 ' C ' ' O ' ' A' ' 60' ' ' ARG . 41.8 t 42.54 88.95 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 0.0 109.967 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.687 ' O ' ' HB3' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -83.11 26.48 0.62 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.357 -0.84 . . . . 0.0 110.844 -179.905 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.687 ' HB3' ' O ' ' A' ' 62' ' ' ARG . . . . . . . . 0 N--CA 1.492 1.644 0 O-C-N 121.01 -1.056 . . . . 0.0 110.244 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 5.4 mtmm . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.21 0.528 . . . . 0.0 110.152 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.887 HG22 ' O ' ' A' ' 49' ' ' LEU . 6.0 tt -133.09 154.72 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.202 -0.936 . . . . 0.0 110.418 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -124.88 128.6 48.9 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.345 -0.847 . . . . 0.0 109.983 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -168.19 -166.07 26.64 Favored Glycine 0 N--CA 1.491 2.347 0 C-N-CA 119.554 -1.307 . . . . 0.0 110.114 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.592 ' CD1' ' N ' ' A' ' 5' ' ' TYR . 13.7 m-85 -111.05 104.3 56.01 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.318 -1.107 . . . . 0.0 109.656 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.736 ' CA ' HG22 ' A' ' 55' ' ' ILE . 50.1 Cg_endo -76.98 111.44 3.23 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 123.948 1.499 . . . . 0.0 111.281 -179.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.602 HG12 ' HB ' ' A' ' 15' ' ' ILE . 15.8 m -83.4 -169.99 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.231 -0.918 . . . . 0.0 109.877 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.57 ' CB ' ' HB2' ' A' ' 13' ' ' LYS . 11.8 p-10 -71.9 -134.77 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.287 -0.883 . . . . 0.0 109.852 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.586 ' HB3' ' CD2' ' A' ' 10' ' ' TRP . 0.2 OUTLIER -92.43 -63.26 1.25 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.035 -1.041 . . . . 0.0 110.397 -179.871 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.586 ' CD2' ' HB3' ' A' ' 9' ' ' TYR . 2.8 m-90 -107.11 26.79 9.71 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.134 -0.979 . . . . 0.0 110.125 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.5 ' HA ' ' OD1' ' A' ' 8' ' ' ASP . 1.3 m-20 67.31 5.83 4.48 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.134 -0.979 . . . . 0.0 109.853 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.454 ' O ' ' C ' ' A' ' 13' ' ' LYS . 89.2 m -83.86 -66.1 0.93 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.277 -0.889 . . . . 0.0 110.733 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.57 ' HB2' ' CB ' ' A' ' 8' ' ' ASP . 6.8 mmmt -37.95 -85.68 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.726 -0.609 . . . . 0.0 110.843 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 4.6 ttm180 -165.33 109.02 0.85 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.002 -1.061 . . . . 0.0 110.673 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.602 ' HB ' HG12 ' A' ' 7' ' ' VAL . 46.3 pt -48.77 -24.24 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.139 -0.975 . . . . 0.0 109.348 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.555 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 34.4 t -150.15 126.39 10.69 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.714 -0.616 . . . . 0.0 109.865 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.652 ' CE3' ' CD2' ' A' ' 22' ' ' TYR . 0.0 OUTLIER -85.36 -162.05 0.67 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.184 -0.948 . . . . 0.0 110.197 -179.901 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -101.72 -54.74 2.67 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.328 -0.857 . . . . 0.0 110.181 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -60.66 113.86 2.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.449 -0.782 . . . . 0.0 110.29 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 29.4 p30 -59.65 -15.22 17.7 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.354 -0.841 . . . . 0.0 110.329 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.416 ' HG3' ' N ' ' A' ' 22' ' ' TYR . 8.2 pttp -92.98 -27.89 16.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.203 -0.936 . . . . 0.0 110.293 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.652 ' CD2' ' CE3' ' A' ' 17' ' ' TRP . 45.3 t80 -60.63 -47.9 84.18 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.245 -0.909 . . . . 0.0 110.046 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -64.6 -40.44 95.53 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.334 -0.854 . . . . 0.0 110.174 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -57.59 -35.44 70.41 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.226 -0.921 . . . . 0.0 110.133 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -58.72 -57.52 12.62 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.241 -0.912 . . . . 0.0 110.015 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.87 -39.01 93.1 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.274 -0.891 . . . . 0.0 110.149 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.489 ' SG ' ' HG3' ' A' ' 6' ' ' PRO . 11.4 m -62.65 -37.19 85.38 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.223 -0.923 . . . . 0.0 109.877 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.88 -29.4 70.58 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.181 -0.949 . . . . 0.0 109.368 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.78 -27.34 69.88 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 107.438 -2.265 . . . . 0.0 107.438 178.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.537 ' O ' ' HD3' ' A' ' 50' ' ' PRO . 9.9 mt -96.3 19.41 11.99 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.879 -0.777 . . . . 0.0 109.051 178.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.508 ' CB ' ' O ' ' A' ' 30' ' ' LEU . 0.7 OUTLIER 71.47 10.92 6.6 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.468 -0.77 . . . . 0.0 110.985 179.684 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.809 ' HB2' HD22 ' A' ' 49' ' ' LEU . . . -85.3 103.46 14.25 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.833 -1.167 . . . . 0.0 109.983 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.441 ' N ' ' OD1' ' A' ' 33' ' ' ASP . 4.4 m-20 -61.25 -80.25 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.407 -0.808 . . . . 0.0 110.885 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.492 ' O ' ' HA ' ' A' ' 46' ' ' CYS . 60.3 p -66.26 94.04 0.24 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.234 -0.916 . . . . 0.0 110.348 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.442 ' HA2' ' SG ' ' A' ' 46' ' ' CYS . . . -116.75 84.5 0.37 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.421 ' CD1' ' C ' ' A' ' 36' ' ' TYR . 31.5 p90 -114.88 151.49 33.87 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.203 -1.175 . . . . 0.0 109.841 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.562 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.1 OUTLIER -95.62 155.3 16.8 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.118 -0.989 . . . . 0.0 110.505 -179.642 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.594 ' CD1' ' HB3' ' A' ' 40' ' ' TRP . 27.6 t-105 -79.52 168.15 19.82 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.188 -0.945 . . . . 0.0 109.613 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -106.66 -26.42 5.87 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.594 ' HB3' ' CD1' ' A' ' 38' ' ' TRP . 53.8 t-105 -79.61 -92.02 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.26 -1.141 . . . . 0.0 109.726 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.585 HG23 ' C ' ' A' ' 40' ' ' TRP . 70.7 p -158.07 46.37 0.35 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.357 -0.84 . . . . 0.0 109.857 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.587 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 1.1 mt -110.92 30.92 6.42 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.14 -0.975 . . . . 0.0 110.686 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.555 ' HA ' ' HB2' ' A' ' 16' ' ' CYS . 3.2 t 54.85 -172.68 0.05 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.201 -0.937 . . . . 0.0 110.386 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.562 ' HA ' ' HA ' ' A' ' 37' ' ' CYS . 17.5 t -78.77 166.63 22.24 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.335 -0.853 . . . . 0.0 109.814 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.573 ' HE2' ' HH ' ' A' ' 5' ' ' TYR . 0.8 OUTLIER -139.82 120.08 13.85 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.243 -0.911 . . . . 0.0 110.488 -179.613 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.676 ' O ' HD21 ' A' ' 49' ' ' LEU . 80.5 m -136.07 135.19 39.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.121 -0.987 . . . . 0.0 109.697 179.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -115.53 142.94 46.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.353 -0.842 . . . . 0.0 110.205 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 31' ' ' LYS . . . 99.9 31.91 5.82 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.887 ' O ' HG22 ' A' ' 2' ' ' ILE . 0.1 OUTLIER -103.49 176.3 1.86 Allowed Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.052 -1.263 . . . . 0.0 109.327 179.38 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.787 ' O ' HG21 ' A' ' 2' ' ' ILE . 47.2 Cg_endo -70.56 155.93 62.3 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 123.692 1.364 . . . . 0.0 110.24 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -59.7 -19.03 47.09 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.052 -1.03 . . . . 0.0 109.597 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -102.31 24.71 9.87 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.395 -0.815 . . . . 0.0 109.472 179.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.672 ' HB2' ' HB2' ' A' ' 49' ' ' LEU . . . -64.22 123.14 18.34 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.355 -0.841 . . . . 0.0 110.509 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.525 ' CZ ' ' O ' ' A' ' 9' ' ' TYR . 0.1 OUTLIER -68.64 112.31 5.32 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.217 -0.927 . . . . 0.0 110.278 179.834 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 1.07 ' O ' HD12 ' A' ' 55' ' ' ILE . 2.5 pp -143.68 128.07 14.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.44 -0.788 . . . . 0.0 110.589 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.504 ' HE3' HG11 ' A' ' 7' ' ' VAL . 0.0 OUTLIER 29.17 52.67 0.08 Allowed 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 121.227 0.537 . . . . 0.0 111.689 179.862 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.436 ' HD3' ' HG2' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -128.62 7.98 5.8 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.231 -0.918 . . . . 0.0 110.196 179.479 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.478 ' HB3' ' HB2' ' A' ' 11' ' ' ASN . 0.4 OUTLIER -92.32 151.92 20.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.32 -0.862 . . . . 0.0 110.114 179.87 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.15 -136.54 1.26 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.44 ' O ' ' O ' ' A' ' 61' ' ' CYS . 25.4 mmt85 -88.16 92.41 9.14 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.172 -1.193 . . . . 0.0 110.271 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 10' ' ' TRP . 0.0 OUTLIER 52.74 101.79 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.241 -0.912 . . . . 0.0 110.137 179.935 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.515 ' CB ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -82.32 46.77 1.07 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.243 -0.911 . . . . 0.0 110.293 -179.875 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.252 -0.905 . . . . 0.0 110.261 179.964 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . 0.436 ' O ' ' HG3' ' A' ' 1' ' ' LYS . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.308 0.575 . . . . 0.0 110.163 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.527 ' CG2' ' HG ' ' A' ' 49' ' ' LEU . 15.9 tt -133.62 166.31 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.242 -0.912 . . . . 0.0 109.991 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -142.24 138.11 31.2 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.297 -0.877 . . . . 0.0 110.011 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 176.78 -148.67 9.13 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.549 ' CD1' ' N ' ' A' ' 5' ' ' TYR . 18.2 m-85 -123.61 117.61 27.6 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.285 -1.127 . . . . 0.0 110.321 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.609 ' CA ' HG22 ' A' ' 55' ' ' ILE . 45.5 Cg_endo -74.03 134.18 19.2 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.923 1.486 . . . . 0.0 110.159 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.714 HG12 ' HA ' ' A' ' 15' ' ' ILE . 27.2 m -136.99 -168.79 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.142 -0.974 . . . . 0.0 110.475 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.562 ' CB ' ' HB3' ' A' ' 14' ' ' ARG . 0.7 OUTLIER -80.13 172.28 13.98 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.342 -0.849 . . . . 0.0 110.383 -179.821 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.593 ' HB3' ' CE2' ' A' ' 10' ' ' TRP . 0.4 OUTLIER -62.34 -19.56 63.48 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.306 -0.871 . . . . 0.0 109.817 179.706 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.593 ' CE2' ' HB3' ' A' ' 9' ' ' TYR . 2.9 m-90 -131.23 12.87 5.1 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.333 -0.854 . . . . 0.0 110.15 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.611 ' OD1' HG21 ' A' ' 7' ' ' VAL . 88.6 m-20 56.5 35.44 26.01 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.129 -0.982 . . . . 0.0 109.375 -179.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.437 ' SG ' ' HB2' ' A' ' 10' ' ' TRP . 34.8 m -90.74 -53.2 4.51 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.481 -0.762 . . . . 0.0 111.642 -179.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.489 ' O ' ' O ' ' A' ' 14' ' ' ARG . 1.2 mppt? -125.21 -56.41 1.54 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.059 -1.026 . . . . 0.0 111.885 -178.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.562 ' HB3' ' CB ' ' A' ' 8' ' ' ASP . 14.6 tpp180 -36.76 -96.02 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.371 -0.831 . . . . 0.0 111.064 -178.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.714 ' HA ' HG12 ' A' ' 7' ' ' VAL . 72.0 mt 50.4 -88.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 120.954 -1.092 . . . . 0.0 110.515 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.62 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 1.6 t -135.13 134.4 40.18 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.371 -0.831 . . . . 0.0 109.714 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.425 ' O ' ' SG ' ' A' ' 37' ' ' CYS . 0.0 OUTLIER -88.62 -156.52 0.38 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.165 -0.959 . . . . 0.0 110.631 -179.654 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -107.25 -32.32 7.84 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.224 -0.923 . . . . 0.0 110.161 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -87.45 153.52 21.36 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.289 -0.882 . . . . 0.0 110.136 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -86.24 -17.55 34.45 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.179 -0.951 . . . . 0.0 109.997 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.7 ttpp -96.15 -10.56 27.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.284 -0.885 . . . . 0.0 109.992 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -69.39 -58.75 3.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.248 -0.908 . . . . 0.0 110.094 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -65.62 -28.17 68.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.311 -0.868 . . . . 0.0 110.096 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.496 ' O ' ' HG2' ' A' ' 28' ' ' LYS . 6.9 t-20 -69.07 -40.43 78.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.344 -0.848 . . . . 0.0 109.918 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.57 -46.15 87.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.156 -0.965 . . . . 0.0 110.007 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.1 mt -74.27 -42.69 59.21 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.319 -0.863 . . . . 0.0 109.946 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.479 ' SG ' ' HG3' ' A' ' 6' ' ' PRO . 5.7 m -58.95 -39.39 81.53 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.219 -0.926 . . . . 0.0 109.547 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.496 ' HG2' ' O ' ' A' ' 24' ' ' ASN . 2.6 mmmt -60.83 -28.18 68.62 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.196 -0.94 . . . . 0.0 109.443 179.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.12 -35.35 90.69 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 107.677 -2.169 . . . . 0.0 107.677 178.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.547 ' O ' ' HD3' ' A' ' 50' ' ' PRO . 13.6 mt -91.38 21.94 4.21 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.701 -0.882 . . . . 0.0 109.117 178.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.474 ' O ' ' O ' ' A' ' 48' ' ' GLY . 0.7 OUTLIER 67.72 15.43 9.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.426 -0.796 . . . . 0.0 110.95 179.868 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.701 ' HB1' ' HB3' ' A' ' 46' ' ' CYS . . . -83.99 89.44 7.25 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.859 -1.151 . . . . 0.0 109.582 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.402 ' HA ' ' HD3' ' A' ' 28' ' ' LYS . 0.2 OUTLIER -48.03 -83.68 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.322 -0.862 . . . . 0.0 111.195 -179.213 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.509 ' O ' ' HA ' ' A' ' 46' ' ' CYS . 10.0 m -68.97 92.11 0.5 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.296 -0.878 . . . . 0.0 110.5 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.519 ' CA ' ' SG ' ' A' ' 46' ' ' CYS . . . -127.03 97.41 0.48 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.41 ' CZ ' ' HB3' ' A' ' 45' ' ' TYR . 40.6 p90 -119.73 -169.41 1.76 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.235 -1.156 . . . . 0.0 110.658 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 34.4 t -128.12 127.7 43.5 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.363 -0.836 . . . . 0.0 110.268 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.608 ' CD1' ' HB3' ' A' ' 40' ' ' TRP . 28.0 t-105 -79.77 147.25 31.92 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.994 -1.067 . . . . 0.0 110.054 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -110.91 61.11 0.31 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.967 ' CD1' HG22 ' A' ' 41' ' ' THR . 14.2 t-105 -160.31 -70.38 0.07 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.235 -1.156 . . . . 0.0 110.056 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.967 HG22 ' CD1' ' A' ' 40' ' ' TRP . 7.0 t -171.47 34.99 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.443 -0.786 . . . . 0.0 110.178 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.581 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 12.5 mt -119.69 10.29 11.66 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.261 -0.899 . . . . 0.0 110.358 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.62 ' HA ' ' HB2' ' A' ' 16' ' ' CYS . 50.7 m 54.46 -170.52 0.06 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.236 -0.915 . . . . 0.0 110.317 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 15' ' ' ILE . 43.0 t -74.18 155.31 38.5 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.195 -0.941 . . . . 0.0 109.247 179.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.41 ' HB3' ' CZ ' ' A' ' 36' ' ' TYR . 1.0 OUTLIER -137.06 112.56 9.32 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.873 -1.142 . . . . 0.0 111.123 -179.35 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.701 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . 68.1 m -128.8 143.86 51.02 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.296 -0.877 . . . . 0.0 109.837 178.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -126.61 145.68 50.46 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.217 -0.927 . . . . 0.0 110.159 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.476 ' N ' HD23 ' A' ' 49' ' ' LEU . . . 95.56 33.87 6.28 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.987 HD12 ' CB ' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -109.14 171.27 4.59 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.275 -1.133 . . . . 0.0 109.741 179.738 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.547 ' HD3' ' O ' ' A' ' 30' ' ' LEU . 42.4 Cg_endo -69.45 158.68 56.47 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.51 1.269 . . . . 0.0 110.774 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -62.0 -15.33 43.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.333 -0.855 . . . . 0.0 109.885 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -96.59 16.14 19.69 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.344 -0.848 . . . . 0.0 109.819 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.987 ' CB ' HD12 ' A' ' 49' ' ' LEU . . . -60.46 127.88 33.9 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.386 -0.821 . . . . 0.0 110.528 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.508 ' O ' ' HA ' ' A' ' 6' ' ' PRO . 0.5 OUTLIER -71.32 99.53 1.96 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.284 -0.885 . . . . 0.0 109.887 179.742 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.721 HD12 ' C ' ' A' ' 55' ' ' ILE . 2.3 pp -137.4 -160.81 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.181 -0.949 . . . . 0.0 110.463 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.476 ' C ' ' O ' ' A' ' 55' ' ' ILE . 12.8 mttt -29.68 96.8 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 121.382 0.61 . . . . 0.0 111.567 -179.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.437 ' O ' ' CB ' ' A' ' 58' ' ' SER . 0.3 OUTLIER -111.3 0.36 16.67 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.41 -0.806 . . . . 0.0 110.038 179.555 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.437 ' CB ' ' O ' ' A' ' 57' ' ' ARG . 0.4 OUTLIER 66.55 172.9 0.25 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.422 -0.799 . . . . 0.0 110.287 -179.985 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 60' ' ' ARG . . . 86.42 108.75 0.8 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.469 ' O ' ' N ' ' A' ' 62' ' ' ARG . 8.9 mmm-85 -49.36 -179.69 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.283 -1.128 . . . . 0.0 110.302 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.495 ' HA ' ' O ' ' A' ' 10' ' ' TRP . 16.3 t -43.4 96.51 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.248 -0.908 . . . . 0.0 110.149 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.54 ' CA ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -82.76 46.1 1.05 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.166 -0.959 . . . . 0.0 110.244 179.926 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.196 -0.94 . . . . 0.0 110.12 -179.985 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 1.4 mtpp . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.205 0.526 . . . . 0.0 110.269 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.537 HG22 ' O ' ' A' ' 49' ' ' LEU . 7.1 tt -132.94 161.8 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.324 -0.86 . . . . 0.0 110.264 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.463 ' OD1' ' HB3' ' A' ' 47' ' ' GLN . 4.5 m-20 -128.4 129.53 46.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.341 -0.85 . . . . 0.0 109.66 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -169.06 -170.03 33.16 Favored Glycine 0 N--CA 1.494 2.526 0 C-N-CA 119.372 -1.394 . . . . 0.0 110.259 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.557 ' CD1' ' N ' ' A' ' 5' ' ' TYR . 6.8 m-85 -107.69 102.4 44.74 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.431 -1.041 . . . . 0.0 110.485 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.59 138.17 26.31 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 124.004 1.528 . . . . 0.0 110.425 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 1.074 HG12 HG23 ' A' ' 15' ' ' ILE . 21.4 m -120.47 -168.97 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.239 -0.913 . . . . 0.0 110.449 -179.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.557 ' HB2' ' CB ' ' A' ' 13' ' ' LYS . 8.3 p-10 -66.94 -150.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.352 -0.843 . . . . 0.0 110.283 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.617 ' HB3' ' CD2' ' A' ' 10' ' ' TRP . 0.2 OUTLIER -87.13 -33.93 19.26 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.191 -0.943 . . . . 0.0 110.382 -179.861 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.617 ' CD2' ' HB3' ' A' ' 9' ' ' TYR . 8.7 m-90 -129.23 34.36 4.41 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.001 -1.062 . . . . 0.0 110.367 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.506 ' CA ' ' OD1' ' A' ' 8' ' ' ASP . 62.8 m-80 57.17 16.48 3.01 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.125 -0.984 . . . . 0.0 110.297 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.46 ' HB2' ' HA ' ' A' ' 61' ' ' CYS . 2.0 t -109.9 -44.19 3.86 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.208 -0.933 . . . . 0.0 110.488 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.557 ' CB ' ' HB2' ' A' ' 8' ' ' ASP . 0.0 OUTLIER -69.96 58.32 0.15 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.295 -0.878 . . . . 0.0 110.447 -179.733 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.457 ' HB2' ' O ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER 59.34 122.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.322 -0.861 . . . . 0.0 110.903 179.722 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 1.074 HG23 HG12 ' A' ' 7' ' ' VAL . 1.3 mp -79.34 -12.81 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-O 121.747 0.784 . . . . 0.0 109.36 179.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.517 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 1.5 t -146.55 158.05 43.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.458 -0.776 . . . . 0.0 109.263 179.35 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.549 ' CE2' ' CD1' ' A' ' 22' ' ' TYR . 0.0 OUTLIER -104.72 165.77 10.84 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.896 -1.128 . . . . 0.0 110.996 -179.511 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -81.17 -32.26 33.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.068 -1.02 . . . . 0.0 110.266 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -96.2 114.21 25.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.301 -0.874 . . . . 0.0 110.356 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -47.17 -27.98 1.65 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.391 -0.818 . . . . 0.0 110.348 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 29.7 tttm -76.19 -33.14 59.3 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.18 -0.95 . . . . 0.0 110.378 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.549 ' CD1' ' CE2' ' A' ' 17' ' ' TRP . 0.3 OUTLIER -55.12 -41.92 72.31 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.191 -0.943 . . . . 0.0 110.11 179.94 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.29 -52.99 7.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.222 -0.924 . . . . 0.0 110.248 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 35' ' ' GLY . 28.0 t-20 -48.19 -41.2 26.44 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.243 -0.911 . . . . 0.0 110.44 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -57.2 -52.49 65.12 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.263 -0.898 . . . . 0.0 110.556 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.468 HD13 ' CZ3' ' A' ' 17' ' ' TRP . 0.2 OUTLIER -71.41 -34.25 70.18 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.152 -0.968 . . . . 0.0 110.428 -179.753 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.446 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 9.4 m -62.87 -45.69 91.38 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.084 -1.01 . . . . 0.0 109.788 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.94 -27.72 63.64 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.576 -0.85 . . . . 0.0 109.372 179.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.31 -37.99 93.93 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 108.352 -1.899 . . . . 0.0 108.352 179.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.538 ' O ' ' CB ' ' A' ' 31' ' ' LYS . 16.0 mt -90.6 21.18 4.12 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.54 -0.976 . . . . 0.0 109.342 179.099 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.538 ' CB ' ' O ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER 74.26 12.92 3.98 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.743 -0.598 . . . . 0.0 110.736 179.899 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.665 ' CB ' HD22 ' A' ' 49' ' ' LEU . . . -87.32 85.68 7.19 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.843 -1.16 . . . . 0.0 109.829 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -49.5 -87.57 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.414 -0.804 . . . . 0.0 111.186 -179.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.421 ' O ' ' HA ' ' A' ' 46' ' ' CYS . 82.8 p -60.89 96.16 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.303 -0.873 . . . . 0.0 110.73 -179.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.505 ' CA ' ' SG ' ' A' ' 46' ' ' CYS . . . -132.11 123.06 3.5 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.595 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 4.3 p90 -143.98 -174.91 4.4 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.173 -1.193 . . . . 0.0 109.76 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.512 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 26.3 t -124.55 138.0 54.36 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.966 -1.084 . . . . 0.0 110.961 -179.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.602 ' CD1' ' HB2' ' A' ' 42' ' ' LEU . 21.2 t-105 -88.25 99.43 12.22 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.171 -0.955 . . . . 0.0 109.653 179.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -69.36 70.3 0.49 Allowed Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.689 ' CD1' HG22 ' A' ' 41' ' ' THR . 7.5 t-105 -160.53 -65.28 0.07 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.317 -1.107 . . . . 0.0 109.648 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.689 HG22 ' CD1' ' A' ' 40' ' ' TRP . 1.7 t 175.34 36.1 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.564 -0.71 . . . . 0.0 109.885 179.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.602 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 1.0 OUTLIER -124.52 18.75 8.84 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.291 -0.881 . . . . 0.0 110.573 -179.781 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.58 ' CB ' ' CG2' ' A' ' 15' ' ' ILE . 28.8 t 56.22 -177.54 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.193 -0.942 . . . . 0.0 110.764 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.512 ' HA ' ' HA ' ' A' ' 37' ' ' CYS . 15.8 t -70.62 173.21 7.4 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.307 -0.871 . . . . 0.0 109.334 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -154.66 106.27 2.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.945 -1.097 . . . . 0.0 110.528 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.739 ' O ' HD21 ' A' ' 49' ' ' LEU . 75.2 m -127.21 137.8 52.98 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.389 -0.819 . . . . 0.0 109.736 179.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.463 ' HB3' ' OD1' ' A' ' 3' ' ' ASP . 16.9 mt-30 -116.66 130.83 56.97 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.152 -0.967 . . . . 0.0 109.966 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.505 ' O ' ' O ' ' A' ' 31' ' ' LYS . . . 117.88 24.38 3.36 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.944 HD12 ' CB ' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -104.04 173.42 3.4 Favored Pre-proline 0 N--CA 1.498 1.925 0 O-C-N 121.077 -1.249 . . . . 0.0 109.513 179.591 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.528 ' HD2' ' HB2' ' A' ' 49' ' ' LEU . 41.5 Cg_endo -68.87 156.86 64.05 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.443 1.233 . . . . 0.0 110.559 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -59.2 -21.58 59.69 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.259 -0.9 . . . . 0.0 110.222 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -90.48 14.03 14.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.376 -0.827 . . . . 0.0 109.987 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.944 ' CB ' HD12 ' A' ' 49' ' ' LEU . . . -57.94 125.51 23.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.291 -0.881 . . . . 0.0 110.153 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.594 ' CB ' ' CZ ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -64.71 140.52 58.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.098 -1.001 . . . . 0.0 109.957 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.579 HG22 ' N ' ' A' ' 56' ' ' LYS . 26.3 mm -141.02 175.33 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.19 -0.943 . . . . 0.0 110.415 -179.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.855 ' HG2' HG11 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -60.82 82.82 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.332 -0.855 . . . . 0.0 110.074 179.486 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.442 ' N ' ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -95.56 20.81 9.06 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.1 -1.0 . . . . 0.0 110.356 -179.964 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.42 ' HB3' ' O ' ' A' ' 57' ' ' ARG . 4.7 t 63.24 -169.13 0.19 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.289 -0.882 . . . . 0.0 110.375 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 60' ' ' ARG . . . 121.03 -5.46 11.21 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.465 ' O ' ' O ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER 41.95 80.91 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.232 -1.158 . . . . 0.0 110.572 179.751 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.465 ' O ' ' O ' ' A' ' 60' ' ' ARG . 27.2 m 48.44 100.39 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.347 -0.846 . . . . 0.0 110.619 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.53 ' CB ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -89.75 44.26 1.2 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.241 -0.912 . . . . 0.0 110.095 179.699 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.235 -0.916 . . . . 0.0 110.181 -179.86 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 10.3 ttmt . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.25 0.548 . . . . 0.0 110.221 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.671 HG22 ' O ' ' A' ' 49' ' ' LEU . 18.6 tt -127.58 158.77 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.134 -0.979 . . . . 0.0 110.285 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.512 ' HB2' ' HG3' ' A' ' 47' ' ' GLN . 2.5 p30 -133.37 139.28 46.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.366 -0.834 . . . . 0.0 110.102 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.475 ' C ' ' CD1' ' A' ' 5' ' ' TYR . . . 174.18 -164.53 35.76 Favored Glycine 0 N--CA 1.492 2.373 0 C-N-CA 119.685 -1.245 . . . . 0.0 110.057 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.581 ' CD1' ' N ' ' A' ' 5' ' ' TYR . 1.2 m-85 -112.62 98.58 44.81 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.25 -1.147 . . . . 0.0 110.51 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.506 ' HD2' ' O ' ' A' ' 44' ' ' CYS . 44.8 Cg_endo -72.94 116.75 4.84 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.928 1.489 . . . . 0.0 110.557 179.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 1.035 HG12 HG23 ' A' ' 15' ' ' ILE . 21.3 m -79.97 -177.22 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.492 -0.755 . . . . 0.0 110.078 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.473 ' O ' ' NE ' ' A' ' 54' ' ' ARG . 77.5 m-20 -61.72 -96.67 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.131 -0.98 . . . . 0.0 110.114 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.499 ' HB3' ' CE3' ' A' ' 10' ' ' TRP . 0.2 OUTLIER -131.94 -59.02 0.95 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.102 -0.999 . . . . 0.0 109.594 179.63 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.499 ' CE3' ' HB3' ' A' ' 9' ' ' TYR . 13.8 m-90 -106.99 17.13 23.46 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.468 -0.77 . . . . 0.0 109.46 179.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.517 ' N ' ' OD1' ' A' ' 11' ' ' ASN . 1.3 m-20 60.67 11.7 3.26 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.353 -0.842 . . . . 0.0 110.302 -179.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 63.5 m -60.38 -60.25 4.12 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.12 -0.988 . . . . 0.0 110.518 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.44 ' O ' ' CG ' ' A' ' 14' ' ' ARG . 0.8 OUTLIER -63.61 -63.49 1.16 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.365 -0.834 . . . . 0.0 110.325 -179.792 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.44 ' CG ' ' O ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER 173.1 176.78 0.1 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.276 -0.89 . . . . 0.0 110.423 179.977 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 1.035 HG23 HG12 ' A' ' 7' ' ' VAL . 1.0 OUTLIER -77.68 -15.25 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.297 -0.877 . . . . 0.0 109.452 179.813 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.608 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 10.9 t -141.49 157.99 44.43 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.413 -0.804 . . . . 0.0 109.872 179.068 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.478 ' CE3' ' CG ' ' A' ' 22' ' ' TYR . 22.9 t90 -95.67 -112.58 0.13 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.178 -0.951 . . . . 0.0 110.059 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -157.92 58.64 0.48 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.847 -1.158 . . . . 0.0 110.182 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.459 ' HB2' ' CE3' ' A' ' 17' ' ' TRP . 0.2 OUTLIER -170.91 153.58 3.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.378 -0.826 . . . . 0.0 110.086 179.97 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -84.69 -5.1 59.3 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.177 -0.952 . . . . 0.0 110.5 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -119.2 -30.69 4.89 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.066 -1.021 . . . . 0.0 110.735 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.478 ' CG ' ' CE3' ' A' ' 17' ' ' TRP . 26.3 t80 -54.1 -54.12 43.86 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.089 -1.007 . . . . 0.0 110.178 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.438 ' O ' ' HB2' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -62.04 -20.06 63.55 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.199 -0.938 . . . . 0.0 109.695 179.853 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.517 ' CB ' ' O ' ' A' ' 35' ' ' GLY . 0.2 OUTLIER -84.74 -42.71 14.97 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.266 -0.896 . . . . 0.0 110.457 -179.913 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -59.18 -43.41 92.16 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.028 -1.045 . . . . 0.0 109.759 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.703 ' O ' HD12 ' A' ' 30' ' ' LEU . 6.3 mt -71.55 -46.43 59.52 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.272 -0.892 . . . . 0.0 109.898 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.501 ' SG ' ' CG ' ' A' ' 6' ' ' PRO . 1.3 m -59.48 -40.13 85.99 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.301 -0.874 . . . . 0.0 110.017 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' A' ' 32' ' ' ALA . 0.1 OUTLIER -64.81 -33.31 75.7 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.268 -0.895 . . . . 0.0 109.141 179.389 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -53.43 -34.5 48.94 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 108.356 -1.898 . . . . 0.0 108.356 179.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.703 HD12 ' O ' ' A' ' 26' ' ' LEU . 1.8 mp -81.43 -35.51 30.55 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.469 -1.018 . . . . 0.0 109.353 179.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.652 ' CB ' ' O ' ' A' ' 30' ' ' LEU . 1.5 ttmm 141.8 -2.66 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.576 0 C-N-CA 123.051 0.54 . . . . 0.0 110.027 179.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.574 ' HB1' ' HB3' ' A' ' 46' ' ' CYS . . . -80.7 94.82 6.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.991 -1.068 . . . . 0.0 110.345 -179.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.484 ' HA ' ' CG ' ' A' ' 28' ' ' LYS . 11.5 m-20 -65.11 -46.0 82.85 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.294 -0.878 . . . . 0.0 110.271 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.426 ' O ' ' HA ' ' A' ' 46' ' ' CYS . 0.2 OUTLIER -85.19 80.39 9.23 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.327 -0.858 . . . . 0.0 110.301 -179.865 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.517 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -119.06 103.39 0.99 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -126.38 133.15 51.38 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.23 -1.159 . . . . 0.0 110.404 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.0 OUTLIER -84.67 127.48 34.11 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.207 -0.933 . . . . 0.0 110.167 179.875 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.535 ' CB ' ' HB2' ' A' ' 42' ' ' LEU . 0.3 OUTLIER -79.92 139.81 36.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.254 -0.904 . . . . 0.0 110.258 -179.899 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -90.83 12.16 69.7 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.883 ' CD1' HG22 ' A' ' 41' ' ' THR . 21.4 t-105 -105.03 -70.16 0.79 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.316 -1.108 . . . . 0.0 110.151 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.883 HG22 ' CD1' ' A' ' 40' ' ' TRP . 14.1 t -172.35 32.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.399 -0.813 . . . . 0.0 110.343 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.535 ' HB2' ' CB ' ' A' ' 38' ' ' TRP . 0.2 OUTLIER -112.16 13.65 20.57 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.201 -0.937 . . . . 0.0 110.236 179.961 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.654 ' OG ' HG22 ' A' ' 15' ' ' ILE . 28.0 t 44.12 -166.1 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.281 -0.887 . . . . 0.0 110.916 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.557 ' N ' ' HB2' ' A' ' 16' ' ' CYS . 21.5 t -68.57 113.67 6.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.509 -0.744 . . . . 0.0 109.669 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.425 ' CE2' ' HE1' ' A' ' 5' ' ' TYR . 2.7 t80 -99.62 123.52 43.96 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.176 -0.952 . . . . 0.0 110.145 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.644 ' O ' HD21 ' A' ' 49' ' ' LEU . 59.7 m -134.94 128.13 31.94 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.295 -0.878 . . . . 0.0 110.141 179.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.512 ' HG3' ' HB2' ' A' ' 3' ' ' ASP . 0.5 OUTLIER -117.37 135.64 53.72 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.316 -0.865 . . . . 0.0 109.842 179.843 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.55 ' N ' HD23 ' A' ' 49' ' ' LEU . . . 99.63 44.14 2.36 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.804 HD12 ' CB ' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -115.63 172.25 3.87 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.299 -1.118 . . . . 0.0 109.84 179.64 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.533 ' HD3' ' HB3' ' A' ' 31' ' ' LYS . 46.0 Cg_endo -72.04 157.82 53.63 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.832 1.438 . . . . 0.0 110.599 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -59.38 -19.96 51.1 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.208 -0.932 . . . . 0.0 109.941 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -83.84 6.68 20.58 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.281 -0.887 . . . . 0.0 110.04 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.804 ' CB ' HD12 ' A' ' 49' ' ' LEU . . . -63.77 106.81 1.06 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.345 -0.847 . . . . 0.0 110.257 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.738 ' O ' HD13 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -62.42 156.45 22.61 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.244 -0.91 . . . . 0.0 109.93 179.744 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.738 HD13 ' O ' ' A' ' 54' ' ' ARG . 10.7 mm -142.77 -179.8 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.341 -0.849 . . . . 0.0 110.264 -179.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.643 ' H ' HG22 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -60.38 84.31 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.436 -0.79 . . . . 0.0 110.124 179.277 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.504 ' HG2' ' NH1' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -106.09 -11.86 15.97 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.246 -0.909 . . . . 0.0 110.264 -179.942 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -146.1 167.04 24.38 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.335 -0.853 . . . . 0.0 110.191 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -148.62 35.64 1.11 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.526 ' O ' ' O ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER -136.98 41.72 2.47 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.111 -1.229 . . . . 0.0 110.383 179.767 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.526 ' O ' ' O ' ' A' ' 60' ' ' ARG . 49.6 t 41.06 106.54 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 121.586 0.708 . . . . 0.0 111.697 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.479 ' CB ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -83.19 40.09 0.69 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.186 -0.946 . . . . 0.0 110.688 179.56 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.658 0 O-C-N 121.086 -1.009 . . . . 0.0 110.296 179.947 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.271 0.558 . . . . 0.0 110.135 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.559 HG23 ' HG ' ' A' ' 49' ' ' LEU . 20.6 tt -126.01 160.58 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.295 -0.878 . . . . 0.0 110.181 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -139.75 128.9 23.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.311 -0.868 . . . . 0.0 110.007 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -177.58 -145.36 5.81 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.941 -1.263 . . . . 0.0 109.941 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.625 ' CD1' ' N ' ' A' ' 5' ' ' TYR . 12.8 m-85 -122.5 97.11 45.13 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.274 -1.133 . . . . 0.0 110.099 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.454 ' HA ' ' O ' ' A' ' 54' ' ' ARG . 42.5 Cg_endo -69.91 126.84 13.66 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.003 1.528 . . . . 0.0 110.815 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.633 HG12 ' CG1' ' A' ' 15' ' ' ILE . 15.2 m -85.38 -169.45 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.484 -0.76 . . . . 0.0 110.511 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.479 ' O ' ' NH1' ' A' ' 54' ' ' ARG . 2.6 t70 -63.15 -158.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.367 -0.833 . . . . 0.0 110.296 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.465 ' HB3' ' CE2' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -91.17 -20.3 22.13 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.296 -0.878 . . . . 0.0 110.176 179.972 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.501 ' HB3' ' N ' ' A' ' 62' ' ' ARG . 5.0 m-90 -128.25 18.24 6.5 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.176 -0.953 . . . . 0.0 110.52 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.469 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 8.3 m-20 59.88 12.7 3.19 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.343 -0.848 . . . . 0.0 110.372 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 3.5 t -79.23 -50.22 11.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.118 -0.989 . . . . 0.0 109.634 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.464 ' O ' ' O ' ' A' ' 14' ' ' ARG . 1.2 mptm? -79.97 152.38 29.54 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.464 -0.772 . . . . 0.0 109.611 179.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.464 ' O ' ' O ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -46.11 173.5 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.168 -0.958 . . . . 0.0 110.125 -179.921 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.633 ' CG1' HG12 ' A' ' 7' ' ' VAL . 3.9 mt -71.34 -1.94 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.113 -0.992 . . . . 0.0 109.853 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.568 ' HB2' ' N ' ' A' ' 44' ' ' CYS . 18.9 t -146.6 154.44 41.49 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.384 -0.823 . . . . 0.0 110.006 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.565 ' CZ3' ' CG ' ' A' ' 22' ' ' TYR . 28.3 t90 -118.39 169.54 9.66 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.118 -0.989 . . . . 0.0 109.796 179.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.421 ' N ' ' CG ' ' A' ' 17' ' ' TRP . 23.2 t80 -79.48 92.86 5.31 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.216 -0.928 . . . . 0.0 109.564 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.54 ' HB2' ' HB2' ' A' ' 22' ' ' TYR . 4.2 p-10 -174.3 142.47 0.79 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.289 -0.882 . . . . 0.0 110.517 -179.383 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 32.3 p30 -90.69 7.97 36.82 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.237 -0.914 . . . . 0.0 109.871 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.6 mttt -154.64 -28.69 0.11 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.145 -0.972 . . . . 0.0 111.724 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.565 ' CG ' ' CZ3' ' A' ' 17' ' ' TRP . 1.6 t80 -47.85 -21.54 0.43 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.555 -1.341 . . . . 0.0 110.576 -179.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -87.0 -34.9 19.09 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.05 -1.031 . . . . 0.0 110.327 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.475 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 12.3 t-20 -72.67 -40.31 66.4 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.07 -1.018 . . . . 0.0 109.697 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -62.75 -33.87 76.05 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.323 -0.86 . . . . 0.0 109.93 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.601 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -83.23 -44.22 15.23 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.315 -0.866 . . . . 0.0 109.148 179.55 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.435 ' N ' ' HG ' ' A' ' 26' ' ' LEU . 1.5 m -58.71 -40.79 84.7 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.536 -0.728 . . . . 0.0 109.562 179.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 24' ' ' ASN . 0.2 OUTLIER -64.34 -33.97 77.07 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.268 -0.895 . . . . 0.0 109.015 179.165 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.07 -37.33 45.5 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 108.589 -1.804 . . . . 0.0 108.589 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.672 ' O ' ' CB ' ' A' ' 31' ' ' LYS . 4.1 mt -79.75 -35.47 38.74 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.454 -1.027 . . . . 0.0 109.472 179.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.672 ' CB ' ' O ' ' A' ' 30' ' ' LEU . 21.5 tttt 139.21 2.88 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.575 0 C-N-CA 123.122 0.569 . . . . 0.0 110.131 179.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.543 ' HB2' HD22 ' A' ' 49' ' ' LEU . . . -88.25 109.3 19.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.781 -1.199 . . . . 0.0 110.18 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.447 ' HA ' ' HG3' ' A' ' 28' ' ' LYS . 2.6 m-20 -78.62 -44.4 24.05 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.142 -0.974 . . . . 0.0 110.402 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.494 ' O ' ' HA ' ' A' ' 46' ' ' CYS . 2.0 t -82.6 73.72 9.62 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.276 -0.89 . . . . 0.0 110.215 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.486 ' CA ' ' SG ' ' A' ' 46' ' ' CYS . . . -118.32 120.91 4.87 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.531 ' CD1' ' C ' ' A' ' 36' ' ' TYR . 14.0 p90 -143.79 153.89 42.86 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.322 -1.105 . . . . 0.0 109.742 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.503 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.0 OUTLIER -107.26 126.6 52.63 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.976 -1.077 . . . . 0.0 110.843 -179.443 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.609 ' CD1' ' HB3' ' A' ' 40' ' ' TRP . 43.7 t-105 -89.1 114.71 25.99 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.461 -0.774 . . . . 0.0 109.816 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.9 73.31 2.45 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 -179.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.688 ' CD1' HG22 ' A' ' 41' ' ' THR . 0.1 OUTLIER -160.59 -73.27 0.07 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.283 -1.127 . . . . 0.0 109.8 179.395 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.688 HG22 ' CD1' ' A' ' 40' ' ' TRP . 15.0 t -169.0 39.29 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.506 -0.746 . . . . 0.0 109.908 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.569 HD13 ' CD1' ' A' ' 38' ' ' TRP . 0.4 OUTLIER -130.21 1.71 4.68 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.253 -0.904 . . . . 0.0 110.344 -179.897 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.538 ' HA ' ' HB2' ' A' ' 16' ' ' CYS . 48.9 m 56.12 -166.94 0.11 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.148 -0.97 . . . . 0.0 110.365 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.568 ' N ' ' HB2' ' A' ' 16' ' ' CYS . 6.8 t -77.91 151.37 33.81 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.253 -0.904 . . . . 0.0 110.171 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.539 ' CD1' ' CZ ' ' A' ' 5' ' ' TYR . 6.9 t80 -135.16 102.71 5.28 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.271 -0.893 . . . . 0.0 110.484 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.637 ' O ' HD21 ' A' ' 49' ' ' LEU . 76.7 m -118.61 133.96 55.47 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.162 -0.961 . . . . 0.0 109.95 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 16.1 mt-30 -119.86 134.66 55.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.261 -0.899 . . . . 0.0 109.778 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.516 ' N ' HD23 ' A' ' 49' ' ' LEU . . . 104.93 38.87 2.43 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.771 HD12 ' CB ' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -114.61 172.25 3.76 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.385 -1.068 . . . . 0.0 109.739 179.785 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.492 ' HD2' ' HB2' ' A' ' 49' ' ' LEU . 46.0 Cg_endo -71.94 156.31 56.52 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.676 1.356 . . . . 0.0 110.398 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.451 ' OD1' ' O ' ' A' ' 51' ' ' ASP . 21.0 t0 -60.34 -20.07 57.95 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.176 -0.952 . . . . 0.0 110.188 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -79.85 0.7 29.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.309 -0.869 . . . . 0.0 110.102 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.771 ' CB ' HD12 ' A' ' 49' ' ' LEU . . . -62.43 101.12 0.21 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.365 -0.834 . . . . 0.0 110.01 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.871 ' O ' HD13 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -55.33 149.85 12.33 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.079 -1.013 . . . . 0.0 110.218 -179.69 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.871 HD13 ' O ' ' A' ' 54' ' ' ARG . 35.5 mm -139.97 169.76 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.309 -0.87 . . . . 0.0 109.939 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.694 ' HG3' HG22 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -42.37 96.21 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.203 -0.936 . . . . 0.0 110.146 179.66 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.485 ' N ' ' O ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -125.51 7.6 7.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.197 -0.939 . . . . 0.0 110.092 179.923 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 58.64 160.39 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.29 -0.881 . . . . 0.0 110.494 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 148.41 -170.29 28.95 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.37 158.69 15.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.2 -1.177 . . . . 0.0 109.997 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 55.9 m -56.73 119.52 6.31 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.226 -0.921 . . . . 0.0 110.13 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.501 ' N ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -83.45 45.35 1.04 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.2 -0.937 . . . . 0.0 110.153 179.834 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.578 0 O-C-N 121.207 -0.933 . . . . 0.0 110.324 -179.758 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 1.5 tttt . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.3 0.571 . . . . 0.0 110.31 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.781 HG22 ' O ' ' A' ' 49' ' ' LEU . 5.9 tt -142.24 160.5 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.137 -0.977 . . . . 0.0 110.136 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.457 ' OD1' ' O ' ' A' ' 3' ' ' ASP . 3.6 p30 -126.9 122.65 35.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.301 -0.875 . . . . 0.0 110.383 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -165.11 -164.77 21.19 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.786 ' CE2' HD22 ' A' ' 42' ' ' LEU . 15.8 m-85 -117.31 107.9 44.53 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.227 -1.16 . . . . 0.0 110.487 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.629 ' N ' HG22 ' A' ' 55' ' ' ILE . 49.6 Cg_endo -76.82 129.9 11.08 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 124.034 1.544 . . . . 0.0 110.649 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.729 HG12 HG23 ' A' ' 15' ' ' ILE . 32.8 m -105.63 -165.34 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.316 -0.865 . . . . 0.0 109.678 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.496 ' OD1' ' CZ3' ' A' ' 10' ' ' TRP . 5.0 t70 -60.56 -139.27 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.318 -0.864 . . . . 0.0 109.85 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.433 ' C ' ' CG ' ' A' ' 10' ' ' TRP . 3.2 m-85 -110.17 -4.11 15.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.083 -1.01 . . . . 0.0 110.079 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.642 ' CG ' ' HB2' ' A' ' 63' ' ' ALA . 1.3 m-90 -143.55 8.58 1.55 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.254 -0.904 . . . . 0.0 110.165 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.517 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 7.5 m-20 66.56 2.29 2.45 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.631 -0.668 . . . . 0.0 110.894 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.429 ' O ' ' C ' ' A' ' 13' ' ' LYS . 0.6 OUTLIER -85.66 -59.09 2.41 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.165 -0.959 . . . . 0.0 110.5 -179.965 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.492 ' CB ' ' OD2' ' A' ' 8' ' ' ASP . 27.8 mmtt -41.99 -70.45 0.11 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.38 -0.825 . . . . 0.0 110.464 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.486 ' HG3' ' O ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -172.55 -178.7 2.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.272 -0.892 . . . . 0.0 110.286 -179.808 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.841 HG22 ' OG ' ' A' ' 43' ' ' SER . 0.6 OUTLIER -104.13 -17.85 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.273 -0.892 . . . . 0.0 109.442 179.935 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.628 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 5.3 t -158.42 174.31 15.31 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.375 -0.828 . . . . 0.0 110.462 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -100.8 -148.85 0.37 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.266 -0.896 . . . . 0.0 110.372 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -120.27 -37.28 3.08 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.152 -0.968 . . . . 0.0 110.331 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -82.3 140.64 33.47 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.351 -0.843 . . . . 0.0 110.402 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -69.24 -5.33 22.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.274 -0.891 . . . . 0.0 110.322 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.2 -31.6 7.84 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.159 -0.963 . . . . 0.0 110.4 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -63.18 -18.59 63.64 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.229 -0.92 . . . . 0.0 110.478 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.453 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 0.1 OUTLIER -90.53 -54.64 3.91 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.067 -1.02 . . . . 0.0 110.283 179.923 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.501 ' CB ' ' O ' ' A' ' 35' ' ' GLY . 52.0 t30 -48.98 -36.67 18.12 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.173 -0.954 . . . . 0.0 110.01 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.406 ' OD1' ' C ' ' A' ' 25' ' ' ASP . 13.1 t0 -57.78 -53.75 54.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.346 -0.846 . . . . 0.0 110.078 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.74 -42.75 85.74 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.201 -0.937 . . . . 0.0 110.263 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.477 ' HA ' HD12 ' A' ' 30' ' ' LEU . 1.3 m -58.86 -33.27 70.28 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.156 -0.965 . . . . 0.0 109.54 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.5 tptm -63.37 -30.69 71.78 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.304 -0.873 . . . . 0.0 109.083 179.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.18 -32.58 83.02 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 107.825 -2.11 . . . . 0.0 107.825 178.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.532 ' O ' ' CD ' ' A' ' 50' ' ' PRO . 2.9 mt -90.54 21.56 3.9 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.59 -0.947 . . . . 0.0 109.106 178.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.517 ' HB3' ' O ' ' A' ' 30' ' ' LEU . 13.0 tttm 65.25 20.32 11.88 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.815 -0.553 . . . . 0.0 110.78 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.842 ' HB2' HD22 ' A' ' 49' ' ' LEU . . . -91.97 89.9 7.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.028 -1.045 . . . . 0.0 110.039 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -49.79 -79.66 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.371 -0.831 . . . . 0.0 110.667 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.419 ' O ' ' HA ' ' A' ' 46' ' ' CYS . 75.2 m -71.04 91.4 0.89 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.215 -0.928 . . . . 0.0 110.438 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.521 ' CA ' ' SG ' ' A' ' 46' ' ' CYS . . . -131.56 123.72 3.81 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.418 ' CD1' ' C ' ' A' ' 36' ' ' TYR . 5.0 p90 -142.81 -175.29 4.44 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.177 -1.19 . . . . 0.0 110.594 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 6.2 t -115.91 136.35 53.12 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.217 -0.927 . . . . 0.0 110.406 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.617 ' CD1' ' HB2' ' A' ' 42' ' ' LEU . 1.9 t-105 -79.92 150.94 30.38 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.146 -0.971 . . . . 0.0 109.674 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -98.1 -13.81 41.37 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 -179.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 1.059 ' CD1' HG22 ' A' ' 41' ' ' THR . 40.8 t-105 -84.06 -73.05 0.44 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.216 -1.167 . . . . 0.0 109.936 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 1.059 HG22 ' CD1' ' A' ' 40' ' ' TRP . 7.5 t -179.66 50.52 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.554 -0.716 . . . . 0.0 109.748 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.786 HD22 ' CE2' ' A' ' 5' ' ' TYR . 0.5 OUTLIER -120.84 21.32 11.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.315 -0.866 . . . . 0.0 110.638 -179.554 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.841 ' OG ' HG22 ' A' ' 15' ' ' ILE . 28.2 t 50.99 -168.57 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.116 -0.99 . . . . 0.0 110.406 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.555 ' CA ' ' SG ' ' A' ' 16' ' ' CYS . 3.0 t -77.25 135.0 38.43 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.201 -0.937 . . . . 0.0 109.67 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.628 ' CD1' ' CE2' ' A' ' 5' ' ' TYR . 8.1 t80 -122.05 109.56 14.71 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.199 -0.938 . . . . 0.0 110.234 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.627 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . 24.2 m -125.52 149.13 48.57 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.471 -0.768 . . . . 0.0 109.732 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.429 ' OE1' ' HB2' ' A' ' 3' ' ' ASP . 24.8 mt-30 -130.03 137.96 50.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.267 -0.895 . . . . 0.0 110.333 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 31' ' ' LYS . . . 112.32 22.84 5.69 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.92 HD12 ' CB ' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -99.85 170.26 6.99 Favored Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.128 -1.219 . . . . 0.0 109.999 179.645 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.532 ' CD ' ' O ' ' A' ' 30' ' ' LEU . 41.5 Cg_endo -67.31 155.06 72.1 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.978 1.515 . . . . 0.0 110.457 -179.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -56.94 -23.06 42.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.324 -0.86 . . . . 0.0 110.162 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -87.56 13.61 9.9 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.276 -0.89 . . . . 0.0 110.237 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.92 ' CB ' HD12 ' A' ' 49' ' ' LEU . . . -62.32 115.41 4.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.282 -0.887 . . . . 0.0 110.074 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.464 ' O ' ' HA ' ' A' ' 6' ' ' PRO . 0.1 OUTLIER -72.29 133.8 45.21 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.228 -0.92 . . . . 0.0 110.551 -179.811 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.76 HG22 ' C ' ' A' ' 5' ' ' TYR . 1.3 pp -142.98 -167.52 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.426 -0.796 . . . . 0.0 110.209 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.431 ' HG3' HD13 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -41.05 91.74 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.342 -0.849 . . . . 0.0 111.007 -179.386 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.566 ' O ' ' C ' ' A' ' 58' ' ' SER . 10.3 mtp85 -120.48 21.81 11.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.199 -0.938 . . . . 0.0 109.323 179.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.566 ' C ' ' O ' ' A' ' 57' ' ' ARG . 0.2 OUTLIER -7.45 122.93 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.255 0 CA-C-O 121.475 0.655 . . . . 0.0 112.432 -179.571 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -142.43 -103.41 0.48 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.457 ' O ' ' O ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER -132.64 48.05 2.45 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.241 -1.153 . . . . 0.0 110.253 179.973 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.457 ' O ' ' O ' ' A' ' 60' ' ' ARG . 0.8 OUTLIER 40.24 91.46 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.505 -0.747 . . . . 0.0 109.933 179.938 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.562 ' O ' ' CD1' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -81.31 47.41 1.03 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.106 -0.997 . . . . 0.0 110.479 -179.666 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.642 ' HB2' ' CG ' ' A' ' 10' ' ' TRP . . . . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.171 -0.955 . . . . 0.0 110.332 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 12.4 ptmt . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.255 0.55 . . . . 0.0 110.279 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.457 ' O ' ' OD1' ' A' ' 3' ' ' ASP . 10.3 tt -125.02 163.16 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.326 -0.859 . . . . 0.0 110.159 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.457 ' OD1' ' O ' ' A' ' 2' ' ' ILE . 85.2 m-20 -135.91 136.12 40.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.343 -0.848 . . . . 0.0 109.979 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -178.39 -159.52 23.08 Favored Glycine 0 N--CA 1.492 2.388 0 C-N-CA 119.608 -1.282 . . . . 0.0 109.977 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.638 ' CD1' ' N ' ' A' ' 5' ' ' TYR . 5.4 m-85 -120.14 111.27 35.51 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.41 -1.053 . . . . 0.0 109.774 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.438 ' HD2' ' HB3' ' A' ' 44' ' ' CYS . 45.4 Cg_endo -72.22 144.79 42.44 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.949 1.499 . . . . 0.0 110.877 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.9 HG12 HG23 ' A' ' 15' ' ' ILE . 15.7 m -99.71 -168.07 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.324 -0.86 . . . . 0.0 110.392 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -72.87 -128.04 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.4 -0.813 . . . . 0.0 110.105 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -115.55 -33.04 5.36 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.915 -1.115 . . . . 0.0 110.327 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.528 ' O ' ' HB2' ' A' ' 11' ' ' ASN . 4.1 m-90 -112.7 13.38 19.86 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.178 -0.952 . . . . 0.0 110.301 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.528 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 3.0 m-20 62.23 6.61 1.9 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.548 -0.72 . . . . 0.0 110.705 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 16.9 m -76.92 -67.02 0.75 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.062 -1.024 . . . . 0.0 110.358 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.432 ' O ' ' O ' ' A' ' 14' ' ' ARG . 2.9 mptm? -58.63 173.53 0.4 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.497 -0.752 . . . . 0.0 110.506 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.432 ' O ' ' O ' ' A' ' 13' ' ' LYS . 5.0 ttp180 -50.78 -178.54 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.352 -0.842 . . . . 0.0 110.139 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.9 HG23 HG12 ' A' ' 7' ' ' VAL . 4.0 mt -95.95 26.04 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.238 -0.914 . . . . 0.0 109.794 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.551 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 8.7 t -151.94 159.41 43.8 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.463 -0.773 . . . . 0.0 110.044 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.96 ' CZ3' HD13 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -85.75 -152.68 0.17 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.223 -0.923 . . . . 0.0 110.266 -179.967 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -120.33 44.43 2.45 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.289 -0.882 . . . . 0.0 110.357 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -176.84 158.78 1.67 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.151 -0.968 . . . . 0.0 110.321 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 34.8 t30 -82.9 -7.18 59.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.263 -0.898 . . . . 0.0 110.239 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.6 tptt -110.1 -31.32 7.4 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.256 -0.902 . . . . 0.0 109.971 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -54.64 -31.23 57.09 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.327 -0.858 . . . . 0.0 110.269 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 27' ' ' CYS . 0.1 OUTLIER -91.38 -32.77 15.53 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.223 -0.923 . . . . 0.0 110.481 -179.663 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.513 ' CB ' ' O ' ' A' ' 35' ' ' GLY . 25.1 t30 -70.63 -44.32 67.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.106 -0.996 . . . . 0.0 110.133 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -56.27 -45.57 80.07 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.232 -0.918 . . . . 0.0 110.468 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.96 HD13 ' CZ3' ' A' ' 17' ' ' TRP . 0.2 OUTLIER -78.1 -40.33 38.65 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.208 -0.932 . . . . 0.0 110.332 -179.9 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 23' ' ' CYS . 1.6 m -57.45 -37.8 73.43 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.146 -0.971 . . . . 0.0 109.522 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.99 -28.12 69.88 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.427 -0.796 . . . . 0.0 109.524 179.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.62 -34.97 90.4 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 107.873 -2.091 . . . . 0.0 107.873 178.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.532 ' O ' ' HD3' ' A' ' 50' ' ' PRO . 1.3 mt -89.16 17.8 5.62 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.707 -0.878 . . . . 0.0 109.325 178.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.528 ' CB ' ' O ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER 72.54 14.79 5.16 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.64 -0.662 . . . . 0.0 111.161 179.688 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.687 ' HB1' ' HB3' ' A' ' 46' ' ' CYS . . . -85.3 81.0 8.96 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.786 -1.196 . . . . 0.0 109.633 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 32' ' ' ALA . 0.1 OUTLIER -39.89 -80.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.373 -0.83 . . . . 0.0 110.842 -179.32 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.497 ' O ' ' HA ' ' A' ' 46' ' ' CYS . 57.9 m -69.85 90.16 0.6 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.33 -0.856 . . . . 0.0 110.514 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.513 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -122.26 89.18 0.42 Allowed Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 29.6 p90 -118.25 153.82 33.28 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.244 -1.151 . . . . 0.0 109.964 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.507 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.1 OUTLIER -107.31 134.59 50.16 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.148 -0.97 . . . . 0.0 110.632 -179.567 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.575 ' CD1' ' HB2' ' A' ' 42' ' ' LEU . 14.6 t-105 -83.67 125.57 31.99 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.396 -0.815 . . . . 0.0 109.908 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -89.15 64.25 3.33 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.568 ' HB3' ' CD1' ' A' ' 38' ' ' TRP . 0.1 OUTLIER -155.84 -80.4 0.08 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.299 -1.118 . . . . 0.0 109.648 179.816 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.615 HG23 ' O ' ' A' ' 41' ' ' THR . 2.6 t -162.68 33.64 0.1 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.361 -0.837 . . . . 0.0 109.869 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.575 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 0.4 OUTLIER -117.9 4.92 12.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.333 -0.854 . . . . 0.0 110.363 -179.753 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.551 ' HA ' ' HB2' ' A' ' 16' ' ' CYS . 13.0 m 59.96 -170.93 0.13 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.218 -0.927 . . . . 0.0 110.456 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.507 ' HA ' ' HA ' ' A' ' 37' ' ' CYS . 19.3 t -75.57 156.45 34.99 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.297 -0.877 . . . . 0.0 109.977 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -140.82 99.54 3.63 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.016 -1.053 . . . . 0.0 110.917 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.687 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . 65.6 m -120.51 139.77 52.41 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.241 -0.912 . . . . 0.0 109.551 178.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.44 ' HA ' ' OD1' ' A' ' 3' ' ' ASP . 58.8 mt-30 -126.24 138.96 53.67 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.201 -0.937 . . . . 0.0 110.201 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.55 ' N ' HD23 ' A' ' 49' ' ' LEU . . . 103.8 32.61 4.38 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 -179.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.961 HD12 ' CB ' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -110.2 172.34 3.67 Favored Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 121.276 -1.132 . . . . 0.0 109.506 179.843 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.532 ' HD3' ' O ' ' A' ' 30' ' ' LEU . 42.5 Cg_endo -67.78 162.17 40.68 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 O-C-N 123.514 1.271 . . . . 0.0 110.7 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -64.58 -19.78 65.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.354 -0.841 . . . . 0.0 110.134 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -92.68 15.57 14.14 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.265 -0.897 . . . . 0.0 109.997 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.961 ' CB ' HD12 ' A' ' 49' ' ' LEU . . . -62.29 141.79 58.08 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.183 -0.948 . . . . 0.0 110.205 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.774 ' O ' HD13 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -66.24 139.7 58.11 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.304 -0.873 . . . . 0.0 109.764 179.722 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.774 HD13 ' O ' ' A' ' 54' ' ' ARG . 5.3 mm -139.1 -177.76 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.029 -1.045 . . . . 0.0 110.862 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.672 ' H ' HG22 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -59.76 77.78 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.512 -0.742 . . . . 0.0 110.963 -179.528 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.487 ' N ' ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -107.0 17.47 23.02 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.208 -0.932 . . . . 0.0 109.539 179.117 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.438 ' C ' ' O ' ' A' ' 57' ' ' ARG . 0.8 OUTLIER -39.41 136.09 0.98 Allowed 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.25 0.548 . . . . 0.0 110.5 -179.776 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.472 ' O ' ' HD3' ' A' ' 60' ' ' ARG . . . 158.31 -34.45 0.51 Allowed Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.472 ' HD3' ' O ' ' A' ' 59' ' ' GLY . 14.8 mmt85 -114.93 68.92 0.71 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.325 -1.103 . . . . 0.0 110.348 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.423 ' C ' ' O ' ' A' ' 60' ' ' ARG . 0.1 OUTLIER -42.35 100.41 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.32 -0.862 . . . . 0.0 110.098 179.653 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.426 ' C ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -83.84 45.89 1.12 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.132 -0.98 . . . . 0.0 110.246 -179.969 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.196 -0.94 . . . . 0.0 110.313 -179.931 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.283 0.563 . . . . 0.0 110.156 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.564 HG22 ' O ' ' A' ' 49' ' ' LEU . 4.4 tt -140.21 157.51 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.321 -0.862 . . . . 0.0 110.094 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.574 ' OD1' ' CE1' ' A' ' 45' ' ' TYR . 33.4 t0 -125.42 128.01 47.44 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.632 -0.667 . . . . 0.0 109.863 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -174.68 -160.23 22.36 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.691 ' CE2' ' CD1' ' A' ' 45' ' ' TYR . 3.6 m-85 -126.56 99.64 29.81 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.444 -1.033 . . . . 0.0 110.258 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.535 ' HD2' ' O ' ' A' ' 44' ' ' CYS . 43.4 Cg_endo -69.79 125.61 12.33 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 O-C-N 123.917 1.483 . . . . 0.0 110.659 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.572 ' CG1' ' HA ' ' A' ' 56' ' ' LYS . 17.2 m -79.65 175.49 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.418 -0.801 . . . . 0.0 110.31 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -51.35 167.85 0.08 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.272 -0.892 . . . . 0.0 110.145 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.541 ' HB3' ' CE2' ' A' ' 10' ' ' TRP . 0.3 OUTLIER -66.43 -8.48 26.22 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.244 -0.91 . . . . 0.0 110.287 179.976 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.541 ' CE2' ' HB3' ' A' ' 9' ' ' TYR . 1.7 m-90 -139.59 11.28 2.5 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.28 -0.887 . . . . 0.0 109.993 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.417 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 2.8 m120 55.54 19.06 3.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.205 -0.934 . . . . 0.0 109.572 -179.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 3.5 t -81.78 -38.64 25.29 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.55 -0.719 . . . . 0.0 110.74 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.405 ' O ' ' CB ' ' A' ' 14' ' ' ARG . 2.5 mttp -93.04 53.38 1.97 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.273 -0.892 . . . . 0.0 110.603 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.405 ' CB ' ' O ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER 62.57 -143.85 0.39 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.233 -0.917 . . . . 0.0 110.409 179.694 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.834 HD12 ' HB2' ' A' ' 43' ' ' SER . 31.8 pt -109.4 4.06 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.165 -0.959 . . . . 0.0 110.277 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.601 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 0.9 OUTLIER -151.36 -174.23 4.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.18 -0.95 . . . . 0.0 109.708 179.436 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.689 ' CE3' ' CG ' ' A' ' 22' ' ' TYR . 0.0 OUTLIER -118.02 -171.92 2.16 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.121 -0.987 . . . . 0.0 110.156 179.839 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -91.28 -36.59 13.79 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.11 -0.994 . . . . 0.0 110.294 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.519 ' HB2' ' HB2' ' A' ' 22' ' ' TYR . 20.8 m120 -78.87 148.58 32.73 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.326 -0.859 . . . . 0.0 110.302 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -88.66 -16.68 31.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.342 -0.849 . . . . 0.0 110.121 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.28 -14.11 24.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.287 -0.883 . . . . 0.0 110.318 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.689 ' CG ' ' CE3' ' A' ' 17' ' ' TRP . 2.8 t80 -72.62 -40.11 66.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.085 -1.009 . . . . 0.0 109.913 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.46 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 1.3 t -63.3 -34.4 77.6 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.328 -0.857 . . . . 0.0 109.659 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.538 ' CB ' ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -78.0 -51.82 9.76 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.279 -0.888 . . . . 0.0 109.776 179.76 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.476 ' N ' ' CG ' ' A' ' 24' ' ' ASN . 5.7 m-20 -51.54 -49.08 62.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.197 -0.94 . . . . 0.0 110.173 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.7 mt -71.04 -37.59 72.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.242 -0.911 . . . . 0.0 110.282 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 23' ' ' CYS . 1.8 m -62.3 -38.66 90.25 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.159 -0.963 . . . . 0.0 109.616 179.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.556 ' CD ' ' HA ' ' A' ' 33' ' ' ASP . 8.7 mmmt -61.55 -27.07 68.36 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.291 -0.881 . . . . 0.0 109.145 179.277 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.61 -33.46 86.68 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 107.189 -2.364 . . . . 0.0 107.189 178.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.549 ' O ' ' HD3' ' A' ' 50' ' ' PRO . 12.8 mt -90.29 21.65 3.72 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.872 -0.781 . . . . 0.0 108.95 178.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.515 ' CB ' ' O ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER 71.81 8.54 6.09 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.452 -0.78 . . . . 0.0 110.81 179.875 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.618 ' HB2' HD22 ' A' ' 49' ' ' LEU . . . -87.06 103.76 15.68 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.95 -1.094 . . . . 0.0 109.877 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.556 ' HA ' ' CD ' ' A' ' 28' ' ' LYS . 9.2 m-20 -67.05 -76.49 0.08 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -0.912 . . . . 0.0 110.723 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.508 ' O ' ' HA ' ' A' ' 46' ' ' CYS . 0.5 OUTLIER -66.28 93.68 0.23 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.361 -0.837 . . . . 0.0 110.791 -179.514 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.538 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -133.05 126.2 4.32 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.421 ' C ' ' SG ' ' A' ' 23' ' ' CYS . 40.4 p90 -145.48 151.56 38.38 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.152 -1.204 . . . . 0.0 110.261 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 42.0 t -97.1 133.16 42.12 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.185 -0.947 . . . . 0.0 110.913 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.61 ' CD1' HD22 ' A' ' 42' ' ' LEU . 0.7 OUTLIER -97.49 138.62 34.64 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.266 -0.896 . . . . 0.0 109.935 179.535 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -89.06 8.74 79.15 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.829 ' CD1' HG22 ' A' ' 41' ' ' THR . 20.6 t-105 -99.57 -76.46 0.54 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.166 -1.196 . . . . 0.0 110.104 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.829 HG22 ' CD1' ' A' ' 40' ' ' TRP . 11.6 t -169.08 31.63 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.393 -0.817 . . . . 0.0 109.888 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.61 HD22 ' CD1' ' A' ' 38' ' ' TRP . 10.9 mp -107.0 14.23 26.66 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.442 -0.786 . . . . 0.0 110.215 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.834 ' HB2' HD12 ' A' ' 15' ' ' ILE . 8.2 t 47.56 -169.1 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.185 -0.947 . . . . 0.0 110.239 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.535 ' O ' ' HD2' ' A' ' 6' ' ' PRO . 1.8 t -81.41 97.12 7.59 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.691 ' CD1' ' CE2' ' A' ' 5' ' ' TYR . 4.8 t80 -79.81 130.54 35.41 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.12 -0.988 . . . . 0.0 111.251 -178.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.574 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . 83.3 m -145.15 145.94 31.58 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.366 -0.834 . . . . 0.0 109.376 179.104 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.469 ' HG2' ' OD1' ' A' ' 3' ' ' ASP . 3.9 mt-30 -127.57 142.23 51.42 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.086 -1.008 . . . . 0.0 110.244 -179.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' A' ' 31' ' ' LYS . . . 101.94 31.03 5.54 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 179.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.851 HD12 ' CB ' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -108.58 171.75 4.26 Favored Pre-proline 0 N--CA 1.497 1.896 0 O-C-N 121.132 -1.216 . . . . 0.0 109.658 179.456 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.549 ' HD3' ' O ' ' A' ' 30' ' ' LEU . 44.1 Cg_endo -69.41 159.42 53.73 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 123.621 1.327 . . . . 0.0 110.738 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -61.15 -24.04 65.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.32 -0.863 . . . . 0.0 109.822 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -88.05 9.69 21.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.335 -0.853 . . . . 0.0 109.854 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.851 ' CB ' HD12 ' A' ' 49' ' ' LEU . . . -59.16 126.09 26.26 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.374 -0.829 . . . . 0.0 110.233 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.924 ' O ' HD13 ' A' ' 55' ' ' ILE . 14.1 ttm-85 -53.82 150.08 7.94 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.317 -0.864 . . . . 0.0 110.351 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.924 HD13 ' O ' ' A' ' 54' ' ' ARG . 5.8 mm -146.87 175.03 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.443 -0.786 . . . . 0.0 110.013 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.572 ' HA ' ' CG1' ' A' ' 7' ' ' VAL . 0.1 OUTLIER -46.44 94.63 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.35 -0.844 . . . . 0.0 110.211 179.31 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.475 ' N ' ' O ' ' A' ' 55' ' ' ILE . 0.1 OUTLIER -116.29 -13.93 11.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.184 -0.948 . . . . 0.0 110.364 -179.904 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.0 t 49.86 -172.14 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.201 -0.937 . . . . 0.0 110.177 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 133.08 -129.43 5.43 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.33 138.47 53.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.328 -1.101 . . . . 0.0 110.265 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 32.5 t -43.61 113.75 0.55 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.233 -0.917 . . . . 0.0 110.179 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.514 ' CA ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -86.88 35.1 0.68 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.178 -0.951 . . . . 0.0 110.356 -179.961 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.654 0 O-C-N 121.281 -0.887 . . . . 0.0 110.105 179.978 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 2.8 ptmt . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.23 0.538 . . . . 0.0 110.184 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.502 HG22 ' HG ' ' A' ' 49' ' ' LEU . 3.3 tt -120.52 163.53 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.269 -0.894 . . . . 0.0 110.313 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.509 ' CB ' ' HG2' ' A' ' 47' ' ' GLN . 35.1 p-10 -125.26 117.19 23.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.589 -0.694 . . . . 0.0 109.675 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -153.37 -165.03 13.1 Favored Glycine 0 N--CA 1.493 2.455 0 C-N-CA 119.529 -1.32 . . . . 0.0 110.285 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.688 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 21.4 m-85 -124.9 97.84 37.66 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.424 -1.045 . . . . 0.0 110.523 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.894 ' CA ' HG22 ' A' ' 55' ' ' ILE . 44.2 Cg_endo -70.68 130.31 18.01 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.865 1.455 . . . . 0.0 110.691 179.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.589 HG12 HG22 ' A' ' 15' ' ' ILE . 15.6 m -80.51 -162.53 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.303 -0.873 . . . . 0.0 110.523 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.424 ' O ' ' NH1' ' A' ' 54' ' ' ARG . 1.0 OUTLIER -74.63 -88.59 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.439 -0.788 . . . . 0.0 110.553 -179.544 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.473 ' O ' ' NH1' ' A' ' 62' ' ' ARG . 0.2 OUTLIER -142.35 -66.79 0.39 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.295 -0.878 . . . . 0.0 110.066 -179.888 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.5 ' O ' ' HB2' ' A' ' 11' ' ' ASN . 4.0 m-90 -90.2 10.38 24.8 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.307 -0.87 . . . . 0.0 109.823 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.5 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 6.2 m-20 65.75 5.44 3.36 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.627 -0.67 . . . . 0.0 110.655 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 2.7 t -73.65 -36.8 65.43 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.047 -1.033 . . . . 0.0 109.617 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.464 ' O ' ' O ' ' A' ' 14' ' ' ARG . 5.8 tttt -86.72 152.3 22.65 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.42 -0.8 . . . . 0.0 109.333 179.092 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.464 ' O ' ' O ' ' A' ' 13' ' ' LYS . 1.1 ptp180 -38.31 160.25 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.419 -0.801 . . . . 0.0 110.983 -179.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.598 HD12 ' CB ' ' A' ' 43' ' ' SER . 30.3 pt -70.5 0.71 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.383 -0.823 . . . . 0.0 110.84 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.596 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 1.7 t -141.74 121.86 13.8 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.174 -0.954 . . . . 0.0 109.406 179.192 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.66 ' CD2' ' CD2' ' A' ' 22' ' ' TYR . 1.1 t90 -60.94 -137.28 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.14 -0.975 . . . . 0.0 110.111 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -142.6 30.6 1.51 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.159 -0.963 . . . . 0.0 110.468 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.555 ' HB2' ' CE3' ' A' ' 17' ' ' TRP . 0.1 OUTLIER -143.63 134.47 25.27 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.152 -0.967 . . . . 0.0 110.235 179.759 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -69.17 -6.81 31.11 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.313 -0.867 . . . . 0.0 110.119 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.84 -21.84 12.89 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.32 -0.863 . . . . 0.0 110.224 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.66 ' CD2' ' CD2' ' A' ' 17' ' ' TRP . 8.5 t80 -72.53 -56.74 4.9 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.243 -0.911 . . . . 0.0 109.579 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.475 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 1.6 t -56.3 -30.25 62.27 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.435 -0.791 . . . . 0.0 109.51 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.488 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 10.0 t-20 -81.14 -36.04 30.76 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.134 -0.979 . . . . 0.0 109.99 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -64.06 -48.77 74.95 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.197 -0.939 . . . . 0.0 109.711 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.64 -40.02 73.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.372 -0.83 . . . . 0.0 109.867 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.475 ' SG ' ' O ' ' A' ' 23' ' ' CYS . 9.7 m -62.74 -41.01 98.99 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.314 -0.867 . . . . 0.0 109.747 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 24' ' ' ASN . 0.0 OUTLIER -63.79 -24.4 67.74 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.204 -0.935 . . . . 0.0 109.347 179.302 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.83 -37.03 91.89 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 107.638 -2.185 . . . . 0.0 107.638 178.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.509 ' O ' ' HB3' ' A' ' 31' ' ' LYS . 1.1 mt -93.67 20.19 7.76 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.815 -0.815 . . . . 0.0 109.245 178.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.509 ' HB3' ' O ' ' A' ' 30' ' ' LEU . 0.1 OUTLIER 69.61 15.78 8.12 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.851 -0.53 . . . . 0.0 111.365 179.557 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.667 ' HB1' ' HB3' ' A' ' 46' ' ' CYS . . . -78.36 86.04 4.45 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.744 -1.222 . . . . 0.0 109.26 179.273 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.416 ' C ' ' O ' ' A' ' 32' ' ' ALA . 2.2 m-20 -39.38 -90.3 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.621 -0.675 . . . . 0.0 111.488 -178.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.53 ' O ' ' HA ' ' A' ' 46' ' ' CYS . 12.5 p -67.01 92.34 0.24 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.31 -0.869 . . . . 0.0 111.109 -178.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.508 ' CA ' ' SG ' ' A' ' 46' ' ' CYS . . . -122.31 108.79 1.32 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 108.91 -1.676 . . . . 0.0 108.91 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.411 ' CD1' ' C ' ' A' ' 36' ' ' TYR . 30.4 p90 -135.8 165.57 25.3 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.178 -1.19 . . . . 0.0 110.651 -179.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.495 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.0 OUTLIER -107.59 128.99 55.03 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.317 -0.864 . . . . 0.0 109.94 179.608 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.601 ' CD1' ' HB2' ' A' ' 42' ' ' LEU . 35.5 t-105 -79.6 166.87 21.43 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.091 -1.006 . . . . 0.0 110.005 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -98.25 -27.35 8.77 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 120.003 -1.094 . . . . 0.0 110.369 -179.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.577 ' HB3' ' CD1' ' A' ' 38' ' ' TRP . 48.6 t-105 -79.51 -91.8 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.994 -1.298 . . . . 0.0 110.074 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.527 HG23 ' C ' ' A' ' 40' ' ' TRP . 41.6 p -150.54 34.9 0.63 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.074 -1.016 . . . . 0.0 110.346 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.601 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 0.2 OUTLIER -89.53 0.29 57.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.303 -0.873 . . . . 0.0 110.074 179.809 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.598 ' CB ' HD12 ' A' ' 15' ' ' ILE . 0.9 OUTLIER 60.77 -176.4 0.11 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.227 -0.921 . . . . 0.0 110.201 -179.897 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.517 ' O ' ' HD2' ' A' ' 6' ' ' PRO . 0.9 OUTLIER -80.19 94.48 6.05 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.991 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.688 ' CD1' ' CZ ' ' A' ' 5' ' ' TYR . 9.3 t80 -79.98 138.97 37.18 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.117 -0.989 . . . . 0.0 110.682 -179.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.667 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . 74.2 m -149.3 144.44 26.47 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.343 -0.848 . . . . 0.0 110.228 179.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.509 ' HG2' ' CB ' ' A' ' 3' ' ' ASP . 39.1 mt-30 -126.64 149.39 49.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.387 -0.821 . . . . 0.0 110.069 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.486 ' O ' ' O ' ' A' ' 31' ' ' LYS . . . 99.59 21.73 13.97 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.844 HD12 ' CB ' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -101.48 169.29 7.91 Favored Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 121.072 -1.252 . . . . 0.0 109.898 179.626 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.519 ' HD2' ' HB2' ' A' ' 49' ' ' LEU . 44.6 Cg_endo -71.56 159.02 52.4 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 123.717 1.377 . . . . 0.0 110.342 -179.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.464 ' HA ' HD12 ' A' ' 2' ' ' ILE . 18.9 t70 -60.47 -23.66 64.64 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.157 -0.964 . . . . 0.0 109.723 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -92.87 17.24 10.88 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.466 -0.771 . . . . 0.0 109.609 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.844 ' CB ' HD12 ' A' ' 49' ' ' LEU . . . -47.72 143.67 3.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.372 -0.83 . . . . 0.0 110.104 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.48 ' O ' ' HA ' ' A' ' 6' ' ' PRO . 41.8 ttp85 -85.24 91.7 8.22 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.344 -0.848 . . . . 0.0 110.334 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.894 HG22 ' CA ' ' A' ' 6' ' ' PRO . 0.2 OUTLIER -140.3 166.81 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.324 -0.86 . . . . 0.0 109.965 179.69 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 6.1 mttt 45.25 67.12 0.77 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.135 -0.978 . . . . 0.0 109.759 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.494 ' HG2' ' O ' ' A' ' 55' ' ' ILE . 34.2 mmm-85 -125.44 17.25 8.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.247 -0.908 . . . . 0.0 110.458 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 57' ' ' ARG . 0.7 OUTLIER -42.23 138.99 1.52 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.334 -0.854 . . . . 0.0 109.941 179.884 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -164.25 -128.28 0.94 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.492 ' O ' ' O ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER -117.32 46.67 1.65 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.394 -1.063 . . . . 0.0 110.242 -179.97 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.492 ' O ' ' O ' ' A' ' 60' ' ' ARG . 52.2 m 56.06 121.46 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.476 0.655 . . . . 0.0 110.643 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.497 ' NH1' ' HA ' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -87.66 39.18 0.87 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.024 -1.048 . . . . 0.0 110.235 179.747 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.234 -0.917 . . . . 0.0 110.264 -179.938 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 7.5 mttt . . . . . 0 N--CA 1.494 1.749 0 CA-C-O 121.158 0.504 . . . . 0.0 110.025 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.72 HG22 ' O ' ' A' ' 49' ' ' LEU . 13.5 tt -118.98 161.81 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.143 -0.973 . . . . 0.0 110.337 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -131.34 131.46 43.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.259 -0.901 . . . . 0.0 110.032 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.449 ' O ' ' CD1' ' A' ' 45' ' ' TYR . . . -169.95 -176.17 39.43 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.702 -1.237 . . . . 0.0 110.011 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.681 ' CE1' ' CE1' ' A' ' 45' ' ' TYR . 66.8 m-85 -106.27 100.85 31.62 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.381 -1.07 . . . . 0.0 110.15 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.49 ' O ' ' HB3' ' A' ' 44' ' ' CYS . 43.3 Cg_endo -70.59 140.98 40.76 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.845 1.445 . . . . 0.0 110.478 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.915 ' CG1' HG22 ' A' ' 15' ' ' ILE . 5.1 m -110.12 -170.99 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.194 -0.941 . . . . 0.0 110.168 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -63.99 -145.04 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.24 -0.913 . . . . 0.0 110.686 -179.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -85.97 -47.57 9.49 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.427 -0.796 . . . . 0.0 110.648 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.476 ' HB3' ' CB ' ' A' ' 62' ' ' ARG . 3.3 m-90 -120.36 21.35 11.7 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.098 -1.001 . . . . 0.0 110.546 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.49 ' N ' ' OD1' ' A' ' 11' ' ' ASN . 1.8 m-20 57.7 15.12 2.74 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.118 -0.989 . . . . 0.0 110.154 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.8 t -84.94 -52.8 5.73 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.244 -0.91 . . . . 0.0 110.46 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.426 ' O ' ' CG ' ' A' ' 14' ' ' ARG . 5.6 tptt -61.49 -51.91 66.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.33 -0.856 . . . . 0.0 110.326 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.426 ' CG ' ' O ' ' A' ' 13' ' ' LYS . 0.1 OUTLIER 176.66 -158.71 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.204 -0.935 . . . . 0.0 110.511 -179.963 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.915 HG22 ' CG1' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -119.33 -18.04 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.368 -0.832 . . . . 0.0 109.491 179.558 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.623 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 1.8 t -132.64 111.99 11.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.469 -0.769 . . . . 0.0 110.22 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.464 ' CD2' ' HB3' ' A' ' 22' ' ' TYR . 0.0 OUTLIER -50.27 163.55 0.16 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.24 -0.913 . . . . 0.0 110.157 179.868 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -79.88 -24.75 40.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.305 -0.872 . . . . 0.0 109.983 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -83.88 145.72 28.46 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.272 -0.892 . . . . 0.0 110.047 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 16.0 p30 -80.46 7.6 9.47 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.212 -0.93 . . . . 0.0 110.416 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -131.23 -18.42 2.91 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.137 -0.977 . . . . 0.0 110.954 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.464 ' HB3' ' CD2' ' A' ' 17' ' ' TRP . 0.1 OUTLIER -60.36 -14.07 16.66 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.926 -1.109 . . . . 0.0 110.286 -179.753 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.449 ' O ' ' HB2' ' A' ' 27' ' ' CYS . 0.1 OUTLIER -103.58 -29.85 10.86 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.152 -0.967 . . . . 0.0 110.204 179.926 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.469 ' O ' ' HG2' ' A' ' 28' ' ' LYS . 55.1 t-20 -72.81 -52.58 14.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.192 -0.943 . . . . 0.0 109.582 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -54.75 -42.34 71.51 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.257 -0.902 . . . . 0.0 109.91 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.692 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -72.89 -41.64 64.45 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.279 -0.888 . . . . 0.0 109.431 179.749 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.478 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 1.5 m -60.61 -39.75 89.34 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.4 -0.813 . . . . 0.0 109.638 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.469 ' HG2' ' O ' ' A' ' 24' ' ' ASN . 1.7 mmmp? -61.73 -30.17 70.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.362 -0.837 . . . . 0.0 109.6 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.82 -34.01 80.74 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 108.149 -1.981 . . . . 0.0 108.149 179.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.55 ' O ' ' CB ' ' A' ' 31' ' ' LYS . 62.4 mt -93.06 18.56 9.07 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.605 -0.938 . . . . 0.0 109.785 179.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.55 ' CB ' ' O ' ' A' ' 30' ' ' LEU . 0.1 OUTLIER 76.11 12.76 2.75 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.618 -0.676 . . . . 0.0 111.133 179.717 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.815 ' HB2' HD22 ' A' ' 49' ' ' LEU . . . -88.52 82.1 7.0 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.845 -1.159 . . . . 0.0 109.734 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.417 ' O ' ' HD3' ' A' ' 28' ' ' LYS . 72.1 m-20 -46.25 -74.91 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.576 -0.702 . . . . 0.0 111.151 -179.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.409 ' O ' ' HA ' ' A' ' 46' ' ' CYS . 11.0 t -69.76 90.38 0.59 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.424 -0.798 . . . . 0.0 110.983 -179.16 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.486 ' HA2' ' SG ' ' A' ' 46' ' ' CYS . . . -122.04 113.89 2.37 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 108.976 -1.65 . . . . 0.0 108.976 179.212 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.572 ' CE1' ' HB3' ' A' ' 45' ' ' TYR . 27.4 p90 -133.28 154.6 50.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.123 -1.222 . . . . 0.0 110.485 -179.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.487 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.5 OUTLIER -107.73 118.08 35.81 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.332 -0.855 . . . . 0.0 110.151 179.775 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.616 ' CD1' ' HB3' ' A' ' 40' ' ' TRP . 25.0 t-105 -85.71 99.37 11.28 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.157 -0.965 . . . . 0.0 110.248 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.71 68.03 1.02 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.616 ' HB3' ' CD1' ' A' ' 38' ' ' TRP . 57.3 t-105 -157.94 -88.61 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.251 -1.147 . . . . 0.0 110.254 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 67.0 p -144.74 23.12 1.59 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.114 -0.991 . . . . 0.0 110.281 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.591 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 0.4 OUTLIER -121.01 11.17 10.94 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.168 -0.958 . . . . 0.0 110.537 -179.82 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.623 ' HA ' ' HB2' ' A' ' 16' ' ' CYS . 25.7 m 46.81 -170.23 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.919 -1.113 . . . . 0.0 109.973 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.49 ' HB3' ' O ' ' A' ' 6' ' ' PRO . 51.2 t -77.65 151.65 34.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.101 -1.0 . . . . 0.0 109.139 179.224 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.681 ' CE1' ' CE1' ' A' ' 5' ' ' TYR . 6.1 t80 -147.85 123.86 10.72 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.836 -1.165 . . . . 0.0 111.299 -179.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.637 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . 80.0 m -130.63 142.73 50.45 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.444 -0.785 . . . . 0.0 109.453 178.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 13.2 mp0 -116.98 131.17 57.02 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.082 -1.011 . . . . 0.0 110.22 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.598 ' C ' HD23 ' A' ' 49' ' ' LEU . . . 105.35 42.04 1.81 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.815 HD22 ' HB2' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -103.51 -174.79 0.35 Allowed Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.1 -1.236 . . . . 0.0 109.466 179.744 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.692 ' HD2' ' HB2' ' A' ' 53' ' ' ALA . 49.9 Cg_endo -86.23 160.33 9.88 Favored 'Trans proline' 0 C--N 1.303 -1.842 0 O-C-N 123.938 1.493 . . . . 0.0 109.764 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -59.91 -19.54 52.19 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.051 -1.031 . . . . 0.0 109.756 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -99.54 22.01 11.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.331 -0.856 . . . . 0.0 109.645 179.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.692 ' HB2' ' HD2' ' A' ' 50' ' ' PRO . . . -60.1 137.9 58.0 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.374 -0.828 . . . . 0.0 110.244 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.671 ' O ' HD13 ' A' ' 55' ' ' ILE . 12.2 ttp-105 -77.69 129.61 35.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.267 -0.896 . . . . 0.0 110.03 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.671 HD13 ' O ' ' A' ' 54' ' ' ARG . 12.9 mm -134.5 177.15 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.182 -0.949 . . . . 0.0 109.616 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.496 ' H ' HG22 ' A' ' 55' ' ' ILE . 2.4 ptmt -67.14 61.77 0.05 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.121 -0.987 . . . . 0.0 109.191 179.446 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.53 ' N ' ' O ' ' A' ' 55' ' ' ILE . 20.0 ttm-85 -86.86 -25.17 24.63 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.598 -0.689 . . . . 0.0 110.665 -179.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.8 m -123.19 162.0 23.4 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.14 -0.975 . . . . 0.0 110.119 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -145.17 13.97 1.88 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.515 ' O ' ' O ' ' A' ' 61' ' ' CYS . 2.4 mpp_? -106.55 41.86 1.37 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.096 -1.238 . . . . 0.0 110.211 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.515 ' O ' ' O ' ' A' ' 60' ' ' ARG . 42.7 t 42.42 104.25 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.501 0.667 . . . . 0.0 111.285 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.476 ' CB ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -81.53 45.39 0.87 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.087 -1.008 . . . . 0.0 110.412 179.588 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.069 -1.019 . . . . 0.0 110.183 179.873 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 4.0 pttp . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.265 0.555 . . . . 0.0 110.248 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.503 ' CG2' ' HG ' ' A' ' 49' ' ' LEU . 15.2 tt -131.68 161.1 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.266 -0.896 . . . . 0.0 110.136 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.443 ' OD1' ' HA ' ' A' ' 47' ' ' GLN . 48.8 m-20 -127.46 147.57 50.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.379 -0.826 . . . . 0.0 110.133 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 164.21 -179.93 38.78 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.668 ' CZ ' ' CD2' ' A' ' 45' ' ' TYR . 23.8 m-85 -98.22 109.82 53.68 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.331 -1.1 . . . . 0.0 110.241 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.521 ' CA ' HG22 ' A' ' 55' ' ' ILE . 48.8 Cg_endo -74.8 130.53 13.58 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 123.972 1.512 . . . . 0.0 110.576 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.593 HG12 ' HA ' ' A' ' 15' ' ' ILE . 16.4 m -119.66 -168.22 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.23 -0.919 . . . . 0.0 109.767 179.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.512 ' HB2' ' HB2' ' A' ' 14' ' ' ARG . 0.7 OUTLIER -66.58 -176.84 0.51 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.332 -0.855 . . . . 0.0 110.139 179.712 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.506 ' HB3' ' CE2' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -79.1 -5.85 55.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.326 -0.859 . . . . 0.0 109.9 179.723 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.528 ' HA ' ' HB2' ' A' ' 62' ' ' ARG . 4.5 m-90 -137.98 3.62 2.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.282 -0.886 . . . . 0.0 110.513 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.47 ' N ' ' OD1' ' A' ' 11' ' ' ASN . 2.2 m-20 59.73 12.21 2.83 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.283 -0.886 . . . . 0.0 110.524 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 4.2 t -77.78 -62.85 1.54 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.097 -1.002 . . . . 0.0 111.186 -178.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.516 ' O ' ' CB ' ' A' ' 14' ' ' ARG . 1.5 tmtt? -136.39 98.98 3.97 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.059 -1.026 . . . . 0.0 111.313 -179.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.566 ' O ' ' N ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER 168.04 -88.74 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.361 -0.837 . . . . 0.0 110.222 179.098 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.657 HG23 ' CB ' ' A' ' 43' ' ' SER . 5.0 mt 55.57 -81.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.142 -0.974 . . . . 0.0 110.087 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.629 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 37.5 t -122.77 127.91 49.78 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.428 -0.795 . . . . 0.0 109.946 179.238 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.64 ' CZ3' ' CD2' ' A' ' 22' ' ' TYR . 0.1 OUTLIER -69.8 -145.5 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.051 -1.03 . . . . 0.0 109.92 179.609 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -118.02 -9.73 10.5 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.239 -0.913 . . . . 0.0 110.21 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.443 ' CB ' ' HB2' ' A' ' 22' ' ' TYR . 0.7 OUTLIER -117.8 166.65 12.2 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.318 -0.864 . . . . 0.0 110.296 -179.896 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -88.68 -59.47 2.22 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.254 -0.904 . . . . 0.0 110.308 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.28 -26.98 66.9 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.208 -0.932 . . . . 0.0 110.24 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.64 ' CD2' ' CZ3' ' A' ' 17' ' ' TRP . 0.4 OUTLIER -58.86 -53.65 56.01 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.316 -0.865 . . . . 0.0 110.506 -179.818 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -66.77 -27.18 67.38 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.17 -0.956 . . . . 0.0 110.337 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.439 ' OD1' ' O ' ' A' ' 33' ' ' ASP . 25.0 t-20 -66.71 -55.61 14.32 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.276 -0.89 . . . . 0.0 110.272 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -44.09 -49.86 8.7 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.347 -0.846 . . . . 0.0 110.417 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.53 -42.1 95.96 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.201 -0.937 . . . . 0.0 110.154 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.411 ' SG ' ' HG3' ' A' ' 6' ' ' PRO . 0.8 OUTLIER -59.54 -39.87 85.38 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.243 -0.911 . . . . 0.0 109.419 179.474 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.1 mtmt -62.91 -33.9 76.3 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.258 -0.901 . . . . 0.0 109.154 179.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -50.87 -39.42 39.84 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.766 -1.734 . . . . 0.0 108.766 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.655 ' O ' ' CB ' ' A' ' 31' ' ' LYS . 6.9 mt -79.94 -34.07 39.14 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.248 -1.148 . . . . 0.0 109.609 179.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.655 ' CB ' ' O ' ' A' ' 30' ' ' LEU . 1.8 tttp 141.14 0.35 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.658 0 C-N-CA 123.015 0.526 . . . . 0.0 110.126 179.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.498 ' HB1' ' HB3' ' A' ' 46' ' ' CYS . . . -85.44 117.12 24.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.95 -1.094 . . . . 0.0 110.511 -179.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.439 ' O ' ' OD1' ' A' ' 24' ' ' ASN . 11.3 t0 -83.32 -59.15 2.55 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.272 -0.893 . . . . 0.0 110.309 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.93 88.04 2.9 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.388 -0.82 . . . . 0.0 110.117 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.482 ' CA ' ' SG ' ' A' ' 46' ' ' CYS . . . -124.03 109.68 1.33 Allowed Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -127.27 147.44 50.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.279 -1.13 . . . . 0.0 109.861 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.1 OUTLIER -91.66 140.64 29.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.284 -0.885 . . . . 0.0 110.815 -179.282 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.602 ' CD1' ' HB3' ' A' ' 40' ' ' TRP . 45.5 t-105 -79.78 104.11 10.14 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.276 -0.89 . . . . 0.0 109.407 179.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -76.4 76.09 1.53 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -179.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.811 ' CD1' HG22 ' A' ' 41' ' ' THR . 5.8 t-105 -160.5 -72.21 0.07 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.41 -1.053 . . . . 0.0 109.583 179.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.811 HG22 ' CD1' ' A' ' 40' ' ' TRP . 12.7 t -179.11 35.3 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.569 -0.707 . . . . 0.0 109.79 179.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.578 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 1.7 mt -113.12 -84.3 0.59 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.244 -0.91 . . . . 0.0 110.866 -179.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.657 ' CB ' HG23 ' A' ' 15' ' ' ILE . 3.2 t 170.36 175.76 0.06 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.411 -0.806 . . . . 0.0 109.59 -179.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.497 ' O ' ' CD2' ' A' ' 5' ' ' TYR . 10.3 t -63.49 159.96 17.43 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.003 -1.06 . . . . 0.0 108.923 179.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.668 ' CD2' ' CZ ' ' A' ' 5' ' ' TYR . 1.0 OUTLIER -147.99 116.41 6.59 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.877 -1.14 . . . . 0.0 110.935 -179.755 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.498 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . 71.6 m -128.46 149.38 50.6 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.28 -0.887 . . . . 0.0 109.686 179.238 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.443 ' HA ' ' OD1' ' A' ' 3' ' ' ASP . 0.2 OUTLIER -127.96 104.51 7.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.163 -0.96 . . . . 0.0 110.074 -179.853 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.51 ' C ' HD23 ' A' ' 49' ' ' LEU . . . 131.51 49.86 0.1 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.869 HD12 ' CB ' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -120.37 173.47 3.69 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.351 -1.087 . . . . 0.0 110.106 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.515 ' HD2' ' HB2' ' A' ' 49' ' ' LEU . 43.0 Cg_endo -70.38 157.7 58.4 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.944 1.497 . . . . 0.0 110.362 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -60.39 -18.0 47.62 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.285 -0.884 . . . . 0.0 110.033 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -89.83 9.18 28.45 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.34 -0.85 . . . . 0.0 109.968 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.869 ' CB ' HD12 ' A' ' 49' ' ' LEU . . . -58.42 122.01 12.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.388 -0.82 . . . . 0.0 110.275 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.03 130.88 37.01 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.181 -0.949 . . . . 0.0 110.297 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.709 HD12 ' C ' ' A' ' 55' ' ' ILE . 2.3 pp -145.0 -179.56 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.317 -0.865 . . . . 0.0 110.074 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.403 ' O ' ' HG3' ' A' ' 56' ' ' LYS . 4.1 ptpt -51.35 88.2 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.323 -0.861 . . . . 0.0 110.479 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.523 ' N ' ' O ' ' A' ' 55' ' ' ILE . 0.3 OUTLIER -110.25 -28.85 8.42 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.408 -0.808 . . . . 0.0 109.382 179.526 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -125.48 170.84 11.01 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.67 -0.644 . . . . 0.0 110.222 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -124.71 -3.8 7.61 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.14 131.64 54.43 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.272 -1.134 . . . . 0.0 110.041 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 33.5 m -44.31 126.57 5.27 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.196 -0.94 . . . . 0.0 109.813 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.528 ' HB2' ' HA ' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -86.68 50.31 1.98 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.131 -0.98 . . . . 0.0 110.127 179.879 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.187 -0.946 . . . . 0.0 110.246 179.96 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 38.1 pttt . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.298 0.57 . . . . 0.0 110.219 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.721 HG22 ' O ' ' A' ' 49' ' ' LEU . 2.8 tt -154.36 166.07 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.261 -0.899 . . . . 0.0 110.056 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.508 ' N ' HG12 ' A' ' 2' ' ' ILE . 2.4 p-10 -147.87 166.04 28.81 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.369 -0.832 . . . . 0.0 109.965 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 157.36 -152.12 23.41 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.456 ' HA ' ' O ' ' A' ' 44' ' ' CYS . 6.9 m-85 -110.58 99.22 40.41 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.276 -1.131 . . . . 0.0 110.393 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.818 ' HA ' HG22 ' A' ' 55' ' ' ILE . 46.7 Cg_endo -73.85 126.76 10.94 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 124.066 1.561 . . . . 0.0 110.146 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.707 HG12 HG23 ' A' ' 15' ' ' ILE . 16.0 m -79.59 -172.29 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.243 -0.911 . . . . 0.0 110.256 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.451 ' O ' ' HB2' ' A' ' 9' ' ' TYR . 6.9 p-10 -77.28 -44.63 29.06 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.155 -0.966 . . . . 0.0 109.87 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.581 ' HB3' ' CE3' ' A' ' 10' ' ' TRP . 1.7 t80 178.98 -66.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.675 -0.641 . . . . 0.0 109.444 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.581 ' CE3' ' HB3' ' A' ' 9' ' ' TYR . 2.6 m-90 -107.27 21.68 17.14 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.35 -0.844 . . . . 0.0 109.37 179.272 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 2.3 m120 59.11 14.07 3.29 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.46 -0.775 . . . . 0.0 110.307 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.9 m -68.9 -36.26 77.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.259 -0.901 . . . . 0.0 109.969 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.1 44.7 1.01 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.423 -0.798 . . . . 0.0 109.773 179.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 62.32 -179.8 0.13 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.332 -0.855 . . . . 0.0 110.081 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.707 HG23 HG12 ' A' ' 7' ' ' VAL . 3.3 mt -82.11 -6.56 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.211 -0.931 . . . . 0.0 110.548 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.525 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 46.3 t -132.12 162.56 30.54 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.286 -0.884 . . . . 0.0 110.37 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.669 ' CE3' ' CG ' ' A' ' 22' ' ' TYR . 0.3 OUTLIER -105.77 -153.66 0.5 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.274 -0.891 . . . . 0.0 109.889 179.605 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -105.48 -20.27 13.53 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.184 -0.948 . . . . 0.0 110.113 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.503 ' HB3' ' HB2' ' A' ' 22' ' ' TYR . 0.3 OUTLIER -100.98 149.7 23.65 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.262 -0.899 . . . . 0.0 110.137 179.963 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -84.32 -25.56 29.16 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.215 -0.928 . . . . 0.0 110.276 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -90.22 -28.61 18.74 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.23 -0.919 . . . . 0.0 110.355 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.669 ' CG ' ' CE3' ' A' ' 17' ' ' TRP . 28.4 t80 -57.54 -46.36 83.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.262 -0.899 . . . . 0.0 110.179 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -64.45 -43.41 94.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.193 -0.942 . . . . 0.0 109.792 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.507 ' O ' ' HG2' ' A' ' 28' ' ' LYS . 50.0 t30 -57.92 -40.9 81.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.222 -0.924 . . . . 0.0 109.675 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.57 -56.82 17.0 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.222 -0.923 . . . . 0.0 110.066 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.72 -36.87 82.19 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.238 -0.914 . . . . 0.0 109.966 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.48 ' SG ' ' HG3' ' A' ' 6' ' ' PRO . 5.2 m -63.02 -43.06 99.77 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.173 -0.955 . . . . 0.0 109.469 179.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.507 ' HG2' ' O ' ' A' ' 24' ' ' ASN . 0.3 OUTLIER -58.36 -27.78 64.52 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.294 -0.879 . . . . 0.0 109.257 179.027 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.14 -38.34 94.26 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 107.956 -2.057 . . . . 0.0 107.956 179.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.529 ' O ' ' HD3' ' A' ' 50' ' ' PRO . 5.0 mt -89.78 21.47 3.54 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.65 -0.912 . . . . 0.0 109.14 178.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.504 ' HB3' ' O ' ' A' ' 30' ' ' LEU . 0.4 OUTLIER 69.65 15.92 8.06 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.647 -0.658 . . . . 0.0 110.798 179.922 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.623 ' HB1' ' HB3' ' A' ' 46' ' ' CYS . . . -88.38 73.6 8.76 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.933 -1.105 . . . . 0.0 109.383 179.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.425 ' C ' ' O ' ' A' ' 32' ' ' ALA . 0.1 OUTLIER -39.82 -76.94 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.565 -0.709 . . . . 0.0 110.848 -179.289 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.495 ' O ' ' HA ' ' A' ' 46' ' ' CYS . 1.8 t -65.88 93.65 0.19 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.443 -0.786 . . . . 0.0 110.454 -179.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.522 ' CA ' ' SG ' ' A' ' 46' ' ' CYS . . . -128.52 93.64 0.36 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.523 ' CD1' ' C ' ' A' ' 36' ' ' TYR . 9.4 p90 -113.47 153.35 28.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.294 -1.121 . . . . 0.0 109.859 179.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.511 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.1 OUTLIER -108.8 139.99 42.86 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.097 -1.002 . . . . 0.0 110.428 -179.863 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.639 ' CD1' ' CD1' ' A' ' 42' ' ' LEU . 49.1 t-105 -79.54 86.85 5.16 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.292 -0.88 . . . . 0.0 109.848 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -62.38 80.77 0.03 OUTLIER Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -179.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.825 ' CD1' HG22 ' A' ' 41' ' ' THR . 14.0 t-105 -160.53 -73.16 0.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.435 -1.038 . . . . 0.0 109.6 179.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.825 HG22 ' CD1' ' A' ' 40' ' ' TRP . 15.0 t -179.07 40.1 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.634 -0.666 . . . . 0.0 109.588 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.639 ' CD1' ' CD1' ' A' ' 38' ' ' TRP . 0.3 OUTLIER -123.25 -80.65 0.63 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.281 -0.887 . . . . 0.0 110.818 -179.485 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.525 ' HA ' ' HB2' ' A' ' 16' ' ' CYS . 1.2 p 170.01 176.09 0.05 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.263 -0.898 . . . . 0.0 109.901 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.511 ' HA ' ' HA ' ' A' ' 37' ' ' CYS . 6.8 t -74.6 166.54 23.39 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.23 -0.919 . . . . 0.0 110.176 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.467 ' CE1' ' OE1' ' A' ' 47' ' ' GLN . 0.8 OUTLIER -148.98 108.47 3.98 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.191 -0.943 . . . . 0.0 110.35 -179.973 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.623 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . 64.9 m -129.23 137.71 51.26 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.375 -0.828 . . . . 0.0 109.729 179.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.467 ' OE1' ' CE1' ' A' ' 45' ' ' TYR . 2.2 mt-30 -124.18 128.4 49.17 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.086 -1.009 . . . . 0.0 110.314 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.488 ' O ' ' O ' ' A' ' 31' ' ' LYS . . . 121.25 28.9 1.56 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.892 HD12 ' CB ' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -106.2 169.5 6.84 Favored Pre-proline 0 N--CA 1.497 1.883 0 O-C-N 121.135 -1.215 . . . . 0.0 109.993 179.6 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.671 ' O ' HG21 ' A' ' 2' ' ' ILE . 42.4 Cg_endo -67.23 157.62 60.85 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 O-C-N 123.87 1.458 . . . . 0.0 111.126 -179.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -58.46 -27.86 64.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.488 -0.758 . . . . 0.0 109.883 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.4 ' O ' ' OD1' ' A' ' 52' ' ' ASN . 15.8 t-20 -90.75 20.42 4.74 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.393 -0.817 . . . . 0.0 109.457 179.437 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.892 ' CB ' HD12 ' A' ' 49' ' ' LEU . . . -62.84 110.83 1.89 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.665 -0.647 . . . . 0.0 110.592 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.509 ' NH1' ' O ' ' A' ' 9' ' ' TYR . 1.3 tmm_? -65.02 129.36 39.43 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.324 -0.86 . . . . 0.0 110.307 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.818 HG22 ' HA ' ' A' ' 6' ' ' PRO . 2.7 pt -152.55 -163.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.543 -0.723 . . . . 0.0 109.907 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.488 ' O ' ' HG3' ' A' ' 56' ' ' LYS . 2.5 ptmm? -40.72 93.43 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.569 -0.707 . . . . 0.0 110.498 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.526 ' N ' ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -135.17 2.95 3.1 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.294 -0.879 . . . . 0.0 110.113 -179.935 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -153.46 -173.63 4.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.239 -0.913 . . . . 0.0 109.864 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -166.73 23.93 0.13 Allowed Glycine 0 N--CA 1.49 2.272 0 C-N-CA 119.674 -1.25 . . . . 0.0 110.049 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.485 ' O ' ' O ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER -137.16 47.47 2.11 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.959 -1.318 . . . . 0.0 110.411 179.802 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.485 ' O ' ' O ' ' A' ' 60' ' ' ARG . 0.5 OUTLIER 47.36 103.07 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.619 -0.676 . . . . 0.0 110.742 179.885 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.501 ' N ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -79.9 54.68 1.92 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.382 -0.824 . . . . 0.0 110.171 179.811 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.165 -0.959 . . . . 0.0 110.263 -179.962 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 20.2 mttt . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.277 0.561 . . . . 0.0 110.232 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.552 HG22 ' O ' ' A' ' 49' ' ' LEU . 10.8 tt -120.26 165.16 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.33 -0.856 . . . . 0.0 110.051 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -143.34 144.12 31.96 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.277 -0.889 . . . . 0.0 110.136 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 173.51 -151.6 13.81 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.585 ' CD1' ' N ' ' A' ' 5' ' ' TYR . 20.0 m-85 -110.15 98.31 34.53 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.325 -1.103 . . . . 0.0 110.413 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.657 ' HA ' HG22 ' A' ' 55' ' ' ILE . 49.2 Cg_endo -75.77 144.2 27.55 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 124.025 1.54 . . . . 0.0 110.738 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 1.07 ' CG1' HG23 ' A' ' 15' ' ' ILE . 6.3 m -109.14 -171.97 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.199 -0.938 . . . . 0.0 110.015 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -89.2 -88.47 0.16 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.217 -0.927 . . . . 0.0 110.19 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.519 ' HB3' ' CD2' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -141.09 -42.71 0.38 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.143 -0.973 . . . . 0.0 110.239 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.519 ' CD2' ' HB3' ' A' ' 9' ' ' TYR . 6.2 m-90 -116.46 16.57 15.61 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.256 -0.902 . . . . 0.0 110.057 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 88.6 m-20 56.54 17.12 2.85 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.261 -0.9 . . . . 0.0 110.146 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 56.4 m -70.14 -11.01 60.59 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.266 -0.896 . . . . 0.0 110.197 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.462 ' HD2' ' N ' ' A' ' 13' ' ' LYS . 5.5 mptt -108.04 40.01 1.83 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.328 -0.858 . . . . 0.0 110.241 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.497 ' O ' ' HB ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER 46.17 36.22 3.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.173 -0.954 . . . . 0.0 109.997 -179.997 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 1.07 HG23 ' CG1' ' A' ' 7' ' ' VAL . 2.5 mt 62.91 7.65 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.491 -0.755 . . . . 0.0 110.65 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.554 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 32.8 t -148.64 111.96 4.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.054 -1.029 . . . . 0.0 109.696 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.465 ' O ' ' O ' ' A' ' 16' ' ' CYS . 5.2 t90 -43.44 -94.3 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.329 -0.857 . . . . 0.0 110.306 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -160.54 -64.0 0.06 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.771 -1.206 . . . . 0.0 110.366 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.546 ' HB2' ' CG ' ' A' ' 22' ' ' TYR . 0.8 OUTLIER -70.15 171.02 10.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.464 -0.773 . . . . 0.0 110.367 -179.937 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -75.75 -54.69 6.55 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.234 -0.916 . . . . 0.0 109.966 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -71.9 -16.99 62.13 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.363 -0.836 . . . . 0.0 110.061 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.546 ' CG ' ' HB2' ' A' ' 19' ' ' ASN . 1.4 m-30 -57.72 -26.41 61.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.195 -0.941 . . . . 0.0 110.033 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.4 t -98.19 -17.69 18.86 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.252 -0.905 . . . . 0.0 110.243 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 35' ' ' GLY . 66.9 t30 -72.0 -40.28 68.63 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.258 -0.902 . . . . 0.0 110.069 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.13 -47.45 82.68 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.012 -1.055 . . . . 0.0 109.397 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.48 -43.44 85.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.374 -0.829 . . . . 0.0 109.354 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.644 ' HA ' HD12 ' A' ' 30' ' ' LEU . 1.8 m -60.23 -39.59 87.21 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.407 -0.808 . . . . 0.0 109.423 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.454 ' HG3' ' HA ' ' A' ' 33' ' ' ASP . 0.0 OUTLIER -60.05 -30.74 69.4 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.261 -0.899 . . . . 0.0 109.488 179.365 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.05 -31.65 79.47 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 107.798 -2.121 . . . . 0.0 107.798 179.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.644 HD12 ' HA ' ' A' ' 27' ' ' CYS . 1.8 mt -91.8 19.0 6.91 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.672 -0.899 . . . . 0.0 109.217 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.533 ' HB3' ' O ' ' A' ' 30' ' ' LEU . 1.5 tptt 72.76 13.38 5.15 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.805 -0.559 . . . . 0.0 111.019 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.622 ' HB2' HD22 ' A' ' 49' ' ' LEU . . . -92.34 73.06 5.3 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.902 -1.124 . . . . 0.0 109.975 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.454 ' HA ' ' HG3' ' A' ' 28' ' ' LYS . 18.9 m-20 -43.96 -62.0 1.27 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.316 -0.865 . . . . 0.0 110.407 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.416 ' HB3' ' NE2' ' A' ' 47' ' ' GLN . 0.3 OUTLIER -74.05 84.18 1.79 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.363 -0.836 . . . . 0.0 110.035 179.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.524 ' CA ' ' SG ' ' A' ' 46' ' ' CYS . . . -124.35 116.17 2.72 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.528 ' CD1' ' C ' ' A' ' 36' ' ' TYR . 12.8 p90 -139.04 147.44 42.06 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.316 -1.108 . . . . 0.0 109.85 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.458 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.0 OUTLIER -100.26 139.63 35.65 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.165 -0.959 . . . . 0.0 110.492 -179.619 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.58 ' CD1' ' HB2' ' A' ' 42' ' ' LEU . 26.0 t-105 -79.65 103.71 9.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.235 -0.916 . . . . 0.0 109.626 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -67.12 65.59 0.22 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.847 ' CD1' HG22 ' A' ' 41' ' ' THR . 6.3 t-105 -160.21 -65.77 0.07 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.284 -1.127 . . . . 0.0 109.883 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.847 HG22 ' CD1' ' A' ' 40' ' ' TRP . 3.8 t 177.62 35.83 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.53 -0.731 . . . . 0.0 109.903 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.58 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 9.6 mt -119.15 20.51 12.63 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.089 -1.007 . . . . 0.0 110.458 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.554 ' HA ' ' HB2' ' A' ' 16' ' ' CYS . 3.3 m 55.58 -170.42 0.07 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.153 -0.967 . . . . 0.0 110.179 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.468 ' O ' ' CD2' ' A' ' 5' ' ' TYR . 12.2 t -79.04 163.14 25.4 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.342 -0.849 . . . . 0.0 110.307 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -148.04 100.07 3.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.29 -0.882 . . . . 0.0 109.955 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.593 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . 63.7 m -123.3 148.93 45.45 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.173 -0.954 . . . . 0.0 110.357 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.426 ' N ' ' CD ' ' A' ' 47' ' ' GLN . 0.7 OUTLIER -131.64 140.19 49.3 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.352 -0.843 . . . . 0.0 109.857 179.717 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.479 ' O ' ' O ' ' A' ' 31' ' ' LYS . . . 111.26 20.39 7.09 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.915 HD12 ' CB ' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -99.49 168.31 9.77 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 121.232 -1.158 . . . . 0.0 109.65 179.472 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.508 ' HD3' ' O ' ' A' ' 30' ' ' LEU . 43.3 Cg_endo -70.5 161.2 46.88 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.619 1.326 . . . . 0.0 110.62 -179.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -62.05 -16.68 53.68 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.219 -0.926 . . . . 0.0 109.717 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -94.84 15.01 19.62 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.435 -0.791 . . . . 0.0 109.941 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.915 ' CB ' HD12 ' A' ' 49' ' ' LEU . . . -56.01 149.22 15.83 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.283 -0.886 . . . . 0.0 110.304 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.7 mtm105 -92.08 88.64 6.61 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.294 -0.879 . . . . 0.0 110.261 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.898 HD13 ' H ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -131.81 156.01 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.161 -0.962 . . . . 0.0 110.006 179.671 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 55' ' ' ILE . 8.9 mttt 42.45 56.0 3.91 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.236 -0.915 . . . . 0.0 110.303 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -88.05 -5.98 58.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.265 -0.897 . . . . 0.0 110.363 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.429 ' O ' ' ND2' ' A' ' 11' ' ' ASN . 0.1 OUTLIER 57.05 173.21 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.342 -0.849 . . . . 0.0 110.111 -179.909 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 101.41 132.94 7.92 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.67 173.44 8.1 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.188 -1.183 . . . . 0.0 110.236 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 35.1 t -43.4 104.99 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.364 -0.835 . . . . 0.0 110.169 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.518 ' CB ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -87.02 49.55 1.84 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.213 -0.929 . . . . 0.0 110.179 -179.882 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.432 ' HB2' ' O ' ' A' ' 62' ' ' ARG . . . . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.131 -0.98 . . . . 0.0 110.309 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.247 0.546 . . . . 0.0 110.237 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.489 HG22 ' O ' ' A' ' 49' ' ' LEU . 7.7 tt -119.22 163.95 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.272 -0.893 . . . . 0.0 110.28 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 3' ' ' ASP . 1.9 p30 -141.0 138.45 33.72 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.409 -0.807 . . . . 0.0 110.14 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.495 ' O ' ' HA ' ' A' ' 45' ' ' TYR . . . -177.59 -163.29 29.19 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.49 ' HA ' ' O ' ' A' ' 44' ' ' CYS . 3.0 m-85 -105.86 102.7 40.39 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.301 -1.117 . . . . 0.0 110.262 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.509 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 47.7 Cg_endo -74.3 109.98 3.0 Favored 'Trans proline' 0 C--N 1.301 -1.945 0 O-C-N 123.994 1.523 . . . . 0.0 111.187 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.777 HG12 HG13 ' A' ' 15' ' ' ILE . 14.6 m -91.29 -162.48 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.291 -0.88 . . . . 0.0 109.762 179.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.535 ' CB ' ' HB2' ' A' ' 13' ' ' LYS . 11.5 t0 -77.58 -87.97 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.334 -0.854 . . . . 0.0 109.829 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.488 ' O ' ' NH1' ' A' ' 54' ' ' ARG . 1.1 m-85 -141.29 -58.97 0.49 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.328 -0.857 . . . . 0.0 109.745 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.817 ' CD2' ' HB2' ' A' ' 63' ' ' ALA . 4.8 m-90 -106.22 24.42 12.51 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.442 -0.786 . . . . 0.0 109.678 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.484 ' OD1' HG21 ' A' ' 7' ' ' VAL . 58.9 m-80 57.58 15.5 2.85 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.367 -0.833 . . . . 0.0 109.726 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 5.1 t -92.5 -42.11 9.89 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.308 -0.87 . . . . 0.0 110.417 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.535 ' HB2' ' CB ' ' A' ' 8' ' ' ASP . 5.3 mmtp -60.41 -93.18 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.42 -0.8 . . . . 0.0 110.27 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.465 ' HG2' ' O ' ' A' ' 13' ' ' LYS . 2.7 mmp_? -144.68 101.4 3.66 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.175 -0.953 . . . . 0.0 110.511 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.777 HG13 HG12 ' A' ' 7' ' ' VAL . 4.3 tt -44.0 -27.6 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.218 -0.926 . . . . 0.0 109.458 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.623 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 30.9 t -158.91 106.25 1.82 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.597 -0.689 . . . . 0.0 110.415 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.405 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -54.58 -172.57 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.179 -0.951 . . . . 0.0 109.81 179.773 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -114.55 33.59 5.24 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.109 -0.994 . . . . 0.0 110.174 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -131.55 145.55 51.78 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.257 -0.902 . . . . 0.0 109.959 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.426 ' OD1' ' N ' ' A' ' 20' ' ' ASN . 15.5 p-10 -82.06 9.09 9.11 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.243 -0.911 . . . . 0.0 110.352 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.46 -33.77 2.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.238 -0.914 . . . . 0.0 110.313 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -52.72 -35.75 56.36 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.107 -0.996 . . . . 0.0 110.199 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.406 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 0.1 OUTLIER -88.86 -30.57 18.82 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.219 -0.925 . . . . 0.0 110.049 179.846 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -69.93 -52.43 24.61 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.347 -0.846 . . . . 0.0 110.316 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -50.12 -47.9 53.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.212 -0.93 . . . . 0.0 110.308 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.3 -41.24 66.85 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.239 -0.913 . . . . 0.0 110.15 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.456 ' SG ' ' HG3' ' A' ' 6' ' ' PRO . 8.3 m -59.91 -34.33 73.05 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.106 -0.996 . . . . 0.0 109.794 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.55 -31.79 73.06 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.391 -0.818 . . . . 0.0 109.726 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.13 -33.95 86.16 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 107.957 -2.057 . . . . 0.0 107.957 178.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.515 ' O ' ' HD3' ' A' ' 50' ' ' PRO . 1.4 mt -89.54 19.58 4.48 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.61 -0.936 . . . . 0.0 109.426 179.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.501 ' HB3' ' O ' ' A' ' 30' ' ' LEU . 0.4 OUTLIER 68.27 18.42 9.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.699 -0.625 . . . . 0.0 111.02 179.749 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.58 ' HB1' ' HB3' ' A' ' 46' ' ' CYS . . . -92.31 74.77 5.31 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.913 -1.117 . . . . 0.0 109.78 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 32' ' ' ALA . 62.9 t0 -39.99 -70.48 0.1 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.415 -0.803 . . . . 0.0 110.677 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.17 86.25 1.06 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.508 -0.745 . . . . 0.0 110.192 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.522 ' CA ' ' SG ' ' A' ' 46' ' ' CYS . . . -121.15 98.73 0.67 Allowed Glycine 0 N--CA 1.488 2.102 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.493 ' OH ' ' CD2' ' A' ' 45' ' ' TYR . 53.1 p90 -126.42 153.64 44.73 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.353 -1.087 . . . . 0.0 109.855 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.524 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.1 OUTLIER -102.2 146.33 28.14 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.139 -0.976 . . . . 0.0 110.367 -179.638 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.634 ' CD1' ' HB2' ' A' ' 42' ' ' LEU . 25.8 t-105 -79.82 148.57 31.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.139 -0.976 . . . . 0.0 109.645 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -106.36 53.19 0.64 Allowed Glycine 0 N--CA 1.491 2.335 0 C-N-CA 119.615 -1.279 . . . . 0.0 110.204 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.563 ' C ' HG23 ' A' ' 41' ' ' THR . 30.9 t-105 -160.54 -83.08 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.255 -1.144 . . . . 0.0 110.021 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.563 HG23 ' C ' ' A' ' 40' ' ' TRP . 72.6 p -155.25 38.54 0.4 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.407 -0.808 . . . . 0.0 110.354 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.634 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 0.4 OUTLIER -119.46 24.03 10.89 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.093 -1.004 . . . . 0.0 110.681 -179.847 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.623 ' HA ' ' HB2' ' A' ' 16' ' ' CYS . 90.5 p 45.52 -174.01 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.3 -0.875 . . . . 0.0 110.363 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.54 ' N ' ' HB2' ' A' ' 16' ' ' CYS . 25.3 t -71.87 171.97 10.75 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.184 -0.948 . . . . 0.0 109.261 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.495 ' HA ' ' O ' ' A' ' 4' ' ' GLY . 1.1 t80 -158.26 100.95 1.71 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.999 -1.063 . . . . 0.0 111.001 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.629 ' O ' HD21 ' A' ' 49' ' ' LEU . 85.9 m -121.05 137.2 54.76 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.353 -0.842 . . . . 0.0 109.533 179.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.451 ' N ' ' OE1' ' A' ' 47' ' ' GLN . 9.6 mp0 -121.87 148.11 45.14 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.163 -0.961 . . . . 0.0 110.35 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.5 ' O ' ' O ' ' A' ' 31' ' ' LYS . . . 100.05 27.18 7.94 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 1.103 HD12 ' CB ' ' A' ' 53' ' ' ALA . 0.2 OUTLIER -109.32 170.9 4.9 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.191 -1.182 . . . . 0.0 109.872 179.751 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.516 ' HD2' ' HB2' ' A' ' 49' ' ' LEU . 42.0 Cg_endo -68.43 158.35 58.01 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.689 1.363 . . . . 0.0 110.717 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -60.66 -22.61 64.04 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.332 -0.855 . . . . 0.0 110.173 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -85.38 11.73 9.71 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.243 -0.91 . . . . 0.0 109.94 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 1.103 ' CB ' HD12 ' A' ' 49' ' ' LEU . . . -62.16 135.82 57.67 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.304 -0.872 . . . . 0.0 110.548 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.631 ' O ' HG23 ' A' ' 55' ' ' ILE . 15.7 tpp85 -77.2 131.69 38.37 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.3 -0.875 . . . . 0.0 109.869 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.631 HG23 ' O ' ' A' ' 54' ' ' ARG . 1.3 pp -156.85 -173.24 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.276 -0.89 . . . . 0.0 110.303 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -45.89 93.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.212 -0.93 . . . . 0.0 110.608 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.479 ' N ' ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -112.6 22.39 14.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.333 -0.854 . . . . 0.0 109.856 179.604 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.87 -178.17 0.11 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.354 -0.841 . . . . 0.0 110.373 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.458 ' O ' ' O ' ' A' ' 60' ' ' ARG . . . 92.89 101.1 1.47 Allowed Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.529 ' O ' ' N ' ' A' ' 62' ' ' ARG . 2.8 ptm85 -50.73 -175.8 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.254 -1.145 . . . . 0.0 110.212 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.413 ' C ' ' O ' ' A' ' 60' ' ' ARG . 33.9 t -42.21 93.32 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.379 -0.825 . . . . 0.0 110.389 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.538 ' CB ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -84.07 43.66 0.95 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.339 -0.851 . . . . 0.0 110.481 -179.754 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.817 ' HB2' ' CD2' ' A' ' 10' ' ' TRP . . . . . . . . 0 N--CA 1.492 1.643 0 O-C-N 121.179 -0.95 . . . . 0.0 110.184 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.492 ' O ' ' HG2' ' A' ' 1' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.491 0.662 . . . . 0.0 110.34 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.524 ' CG2' ' HG ' ' A' ' 49' ' ' LEU . 8.6 tt -120.44 160.58 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.384 -0.823 . . . . 0.0 110.075 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -142.7 144.28 32.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.328 -0.858 . . . . 0.0 110.096 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 179.83 -149.46 8.61 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.618 ' CD1' ' N ' ' A' ' 5' ' ' TYR . 12.4 m-85 -122.29 110.1 32.75 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.291 -1.123 . . . . 0.0 110.266 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.631 ' HB3' HG22 ' A' ' 55' ' ' ILE . 46.6 Cg_endo -73.95 128.76 12.63 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 124.055 1.555 . . . . 0.0 110.685 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.887 HG12 HG23 ' A' ' 15' ' ' ILE . 14.7 m -83.15 -175.87 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.283 -0.885 . . . . 0.0 110.156 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.439 ' O ' ' NH1' ' A' ' 54' ' ' ARG . 16.2 t70 -64.37 -117.54 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.171 -0.955 . . . . 0.0 109.582 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.601 ' HB3' ' CD2' ' A' ' 10' ' ' TRP . 2.0 t80 -119.62 -50.77 2.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.828 -1.17 . . . . 0.0 109.792 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.601 ' CD2' ' HB3' ' A' ' 9' ' ' TYR . 3.3 m-90 -106.08 21.32 17.53 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.233 -0.917 . . . . 0.0 109.709 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.47 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 42.5 m-20 59.5 12.33 2.71 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.388 -0.82 . . . . 0.0 110.167 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 6.8 m -67.21 -62.85 1.22 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.255 -0.903 . . . . 0.0 109.808 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.1 mmtp -73.58 -178.37 3.07 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.591 -0.693 . . . . 0.0 109.87 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.74 -174.58 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.131 -0.981 . . . . 0.0 110.059 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.887 HG23 HG12 ' A' ' 7' ' ' VAL . 20.2 mt -86.76 23.75 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.129 -0.982 . . . . 0.0 110.205 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.517 ' HB2' ' N ' ' A' ' 44' ' ' CYS . 14.4 t -160.16 165.53 31.45 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.239 -0.913 . . . . 0.0 110.595 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.468 ' N ' ' SG ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -115.8 -157.39 0.64 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.371 -0.831 . . . . 0.0 109.821 179.617 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -119.61 -3.79 10.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.211 -0.931 . . . . 0.0 109.989 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.584 ' HB2' ' CG ' ' A' ' 22' ' ' TYR . 0.7 OUTLIER -100.79 133.31 45.45 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.328 -0.858 . . . . 0.0 110.083 179.87 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -60.32 -45.93 91.68 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.194 -0.941 . . . . 0.0 110.641 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.33 -13.23 59.97 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.163 -0.961 . . . . 0.0 110.37 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.584 ' CG ' ' HB2' ' A' ' 19' ' ' ASN . 1.0 OUTLIER -66.66 -11.5 54.21 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.18 -0.95 . . . . 0.0 110.385 -179.771 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.452 ' O ' ' HB2' ' A' ' 27' ' ' CYS . 0.1 OUTLIER -118.73 -31.72 4.75 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.232 -0.917 . . . . 0.0 110.078 179.857 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.529 ' CA ' ' O ' ' A' ' 35' ' ' GLY . 2.0 t-20 -82.53 -49.17 10.19 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.224 -0.922 . . . . 0.0 109.47 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -54.99 -26.91 40.09 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.028 -1.045 . . . . 0.0 109.065 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.656 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -90.85 -46.87 7.94 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.646 -0.659 . . . . 0.0 109.486 179.628 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.499 ' SG ' ' HG3' ' A' ' 6' ' ' PRO . 7.7 m -60.05 -34.77 73.86 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.394 -0.816 . . . . 0.0 110.149 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.41 ' HG2' ' O ' ' A' ' 24' ' ' ASN . 1.9 mmmt -61.55 -32.75 72.83 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.183 -0.948 . . . . 0.0 109.319 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.82 -30.98 78.77 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 107.24 -2.344 . . . . 0.0 107.24 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.529 ' O ' ' CD ' ' A' ' 50' ' ' PRO . 11.9 mt -89.69 20.35 4.1 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.777 -0.837 . . . . 0.0 109.261 178.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.512 ' HB3' ' HD3' ' A' ' 50' ' ' PRO . 1.0 OUTLIER 66.95 16.5 10.37 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.661 -0.65 . . . . 0.0 110.695 -179.872 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.676 ' HB1' ' HB3' ' A' ' 46' ' ' CYS . . . -90.71 82.76 5.73 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.996 -1.065 . . . . 0.0 110.197 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 32' ' ' ALA . 26.0 t0 -43.25 -71.46 0.08 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.287 -0.883 . . . . 0.0 110.24 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.495 ' O ' ' HA ' ' A' ' 46' ' ' CYS . 0.0 OUTLIER -76.47 86.65 3.2 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.283 -0.886 . . . . 0.0 109.954 179.877 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.529 ' O ' ' CA ' ' A' ' 24' ' ' ASN . . . -125.6 87.69 0.36 Allowed Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.54 ' OH ' ' CZ3' ' A' ' 38' ' ' TRP . 29.4 p90 -130.59 153.91 48.4 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.957 -1.319 . . . . 0.0 109.624 179.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.544 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.1 OUTLIER -83.39 155.21 23.61 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.191 -0.943 . . . . 0.0 111.464 -178.686 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.628 ' CD1' HD13 ' A' ' 42' ' ' LEU . 2.5 t-105 -79.45 140.26 37.4 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.3 -21.09 63.18 Favored Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.662 -1.256 . . . . 0.0 110.861 -178.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.95 ' CD1' HG22 ' A' ' 41' ' ' THR . 49.4 t-105 -79.4 -77.19 0.18 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.884 -1.363 . . . . 0.0 109.847 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.95 HG22 ' CD1' ' A' ' 40' ' ' TRP . 13.5 t -178.14 43.92 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.478 -0.764 . . . . 0.0 109.704 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.628 HD13 ' CD1' ' A' ' 38' ' ' TRP . 0.8 OUTLIER -109.47 36.72 2.84 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.222 -0.924 . . . . 0.0 110.578 -179.524 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.487 ' CB ' ' HB ' ' A' ' 15' ' ' ILE . 74.6 m 52.69 -174.32 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.166 -0.958 . . . . 0.0 110.323 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.544 ' HA ' ' HA ' ' A' ' 37' ' ' CYS . 15.9 t -77.97 161.09 27.78 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.218 -0.926 . . . . 0.0 110.081 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -144.1 110.38 5.47 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.088 -1.007 . . . . 0.0 111.215 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.676 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . 60.0 m -130.15 134.65 47.46 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.324 -0.86 . . . . 0.0 109.263 178.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -127.42 143.7 51.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.128 -0.983 . . . . 0.0 110.508 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 31' ' ' LYS . . . 103.81 26.93 6.53 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 1.082 HD12 ' CB ' ' A' ' 53' ' ' ALA . 0.2 OUTLIER -105.62 169.39 7.06 Favored Pre-proline 0 N--CA 1.495 1.813 0 O-C-N 121.267 -1.137 . . . . 0.0 110.052 179.743 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.529 ' CD ' ' O ' ' A' ' 30' ' ' LEU . 48.2 Cg_endo -74.51 161.67 39.5 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.671 1.353 . . . . 0.0 110.397 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -59.99 -20.61 58.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.311 -0.868 . . . . 0.0 109.906 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.405 ' O ' ' CG ' ' A' ' 52' ' ' ASN . 6.1 t-20 -81.73 5.13 19.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.383 -0.823 . . . . 0.0 110.009 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 1.082 ' CB ' HD12 ' A' ' 49' ' ' LEU . . . -53.68 153.32 4.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.236 -0.915 . . . . 0.0 110.2 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.462 ' C ' HG23 ' A' ' 55' ' ' ILE . 35.2 ttp85 -105.05 91.18 3.69 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.228 -0.92 . . . . 0.0 110.312 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.87 HD13 ' H ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -149.17 157.87 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.259 -0.901 . . . . 0.0 110.149 179.842 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.433 ' C ' ' O ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER 41.63 53.79 3.83 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.417 -0.802 . . . . 0.0 110.283 179.843 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.415 ' CD ' ' HG3' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -97.21 -20.48 17.9 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.33 -0.857 . . . . 0.0 109.899 179.915 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.473 ' OG ' ' N ' ' A' ' 59' ' ' GLY . 0.1 OUTLIER 60.74 -176.68 0.11 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.537 -0.727 . . . . 0.0 110.273 179.844 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.473 ' N ' ' OG ' ' A' ' 58' ' ' SER . . . 110.34 -177.89 19.77 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.9 ptm180 -107.09 -177.16 3.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.153 -1.204 . . . . 0.0 110.245 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -48.71 124.06 7.82 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.201 -0.937 . . . . 0.0 110.105 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.506 ' CB ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -81.64 47.11 1.03 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.264 -0.897 . . . . 0.0 110.463 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.642 0 O-C-N 121.258 -0.901 . . . . 0.0 110.245 179.882 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.262 0.553 . . . . 0.0 110.244 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.838 HG23 ' HG ' ' A' ' 49' ' ' LEU . 17.1 tt -119.97 164.32 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.205 -0.934 . . . . 0.0 110.341 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -143.79 126.39 15.98 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.327 -0.858 . . . . 0.0 109.722 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -168.93 -155.97 10.17 Favored Glycine 0 N--CA 1.492 2.396 0 C-N-CA 119.561 -1.304 . . . . 0.0 110.041 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.573 ' CE1' HD22 ' A' ' 42' ' ' LEU . 77.2 m-85 -111.7 106.83 56.71 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.304 -1.115 . . . . 0.0 110.706 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.52 ' HA ' ' O ' ' A' ' 54' ' ' ARG . 49.8 Cg_endo -78.91 113.37 3.24 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.957 1.504 . . . . 0.0 109.907 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.507 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . 15.5 m -94.04 -169.11 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.012 -1.055 . . . . 0.0 111.05 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.433 ' OD2' ' CB ' ' A' ' 14' ' ' ARG . 9.9 t0 -59.53 -152.23 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.433 -0.792 . . . . 0.0 110.53 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.464 ' HB2' ' CE2' ' A' ' 10' ' ' TRP . 22.0 m-85 -98.84 -11.8 21.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.365 -0.834 . . . . 0.0 110.582 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.534 ' HB3' ' CB ' ' A' ' 62' ' ' ARG . 0.3 OUTLIER -130.22 4.26 4.79 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.03 -1.044 . . . . 0.0 109.74 -179.872 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.509 ' N ' ' OD1' ' A' ' 11' ' ' ASN . 1.6 m120 57.13 16.12 2.8 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.253 -0.905 . . . . 0.0 109.531 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 5.5 t -70.59 -64.04 0.98 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.365 -0.835 . . . . 0.0 110.504 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.495 ' CD ' ' O ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -161.52 82.6 0.61 Allowed 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.259 -0.901 . . . . 0.0 110.502 -179.565 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.437 ' CB ' ' O ' ' A' ' 13' ' ' LYS . 2.0 mtt180 173.06 35.06 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.392 -0.818 . . . . 0.0 109.795 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.946 HD12 ' HB2' ' A' ' 43' ' ' SER . 46.6 pt -54.25 -30.26 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.439 -0.788 . . . . 0.0 110.69 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.542 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 8.5 t -139.36 129.33 24.99 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.137 -0.977 . . . . 0.0 110.589 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.426 ' CE3' ' HB3' ' A' ' 22' ' ' TYR . 0.0 OUTLIER -73.24 170.17 15.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.361 -0.837 . . . . 0.0 110.067 179.785 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -88.23 55.0 3.26 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.318 -0.864 . . . . 0.0 110.075 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.608 ' ND2' ' CE1' ' A' ' 22' ' ' TYR . 2.2 t-20 -165.52 156.28 13.67 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.338 -0.852 . . . . 0.0 110.032 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.422 ' C ' ' OD1' ' A' ' 20' ' ' ASN . 49.7 p30 -87.38 -1.58 58.02 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.226 -0.921 . . . . 0.0 110.266 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.429 ' HA ' ' CB ' ' A' ' 24' ' ' ASN . 0.0 OUTLIER -129.37 -6.02 4.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.19 -0.944 . . . . 0.0 110.586 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.608 ' CE1' ' ND2' ' A' ' 19' ' ' ASN . 3.1 m-30 -59.69 -69.41 0.21 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.1 -1.0 . . . . 0.0 110.247 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.598 ' HA ' HD23 ' A' ' 26' ' ' LEU . 6.0 p -69.37 -6.36 29.39 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.98 -1.075 . . . . 0.0 109.852 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.539 ' CB ' ' O ' ' A' ' 35' ' ' GLY . 64.3 t30 -75.71 -61.06 2.05 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.388 -0.82 . . . . 0.0 109.506 179.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -49.25 -48.56 45.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.41 -0.806 . . . . 0.0 109.733 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.598 HD23 ' HA ' ' A' ' 23' ' ' CYS . 0.1 OUTLIER -64.52 -37.35 87.24 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.307 -0.87 . . . . 0.0 109.088 179.423 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.526 ' N ' ' HG ' ' A' ' 26' ' ' LEU . 1.3 m -61.86 -39.26 91.24 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.244 -0.91 . . . . 0.0 109.281 179.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.76 -31.49 69.71 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.466 -0.771 . . . . 0.0 109.55 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.64 -36.9 91.28 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 108.304 -1.919 . . . . 0.0 108.304 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.554 ' O ' ' CB ' ' A' ' 31' ' ' LYS . 6.9 mt -87.69 17.58 4.61 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.535 -0.979 . . . . 0.0 109.746 179.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.554 ' CB ' ' O ' ' A' ' 30' ' ' LEU . 0.7 OUTLIER 78.83 11.27 1.58 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.711 -0.618 . . . . 0.0 110.79 179.991 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.791 ' CB ' HD22 ' A' ' 49' ' ' LEU . . . -95.04 84.16 4.07 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.959 -1.088 . . . . 0.0 109.812 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -54.09 -73.78 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.279 -0.888 . . . . 0.0 111.143 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.51 ' O ' ' HA ' ' A' ' 46' ' ' CYS . 23.2 t -66.87 92.37 0.23 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.386 -0.821 . . . . 0.0 110.663 -179.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.539 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -129.4 88.12 0.31 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.594 ' CZ ' ' HB3' ' A' ' 45' ' ' TYR . 11.1 p90 -99.57 -175.93 3.13 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.165 -1.197 . . . . 0.0 110.422 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.512 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.1 OUTLIER -131.91 131.45 42.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.122 -0.986 . . . . 0.0 110.73 -179.656 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.592 ' CD1' ' HB2' ' A' ' 42' ' ' LEU . 1.9 t-105 -86.87 122.33 30.58 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.299 -0.875 . . . . 0.0 109.839 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.6 -10.14 86.13 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.583 ' HB3' ' CD1' ' A' ' 38' ' ' TRP . 41.1 t-105 -79.77 -92.9 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.207 -1.172 . . . . 0.0 110.095 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.501 ' CG2' ' C ' ' A' ' 40' ' ' TRP . 14.4 p -152.94 54.47 0.77 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.037 -1.039 . . . . 0.0 110.039 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.592 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 6.0 mt -132.3 8.76 4.34 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.203 -0.936 . . . . 0.0 110.813 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.946 ' HB2' HD12 ' A' ' 15' ' ' ILE . 1.4 t 56.77 -174.4 0.07 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.956 -1.09 . . . . 0.0 109.869 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.512 ' HA ' ' HA ' ' A' ' 37' ' ' CYS . 15.3 t -72.26 156.53 39.03 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.106 -0.996 . . . . 0.0 109.186 179.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.594 ' HB3' ' CZ ' ' A' ' 36' ' ' TYR . 67.4 t80 -138.04 113.85 9.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.113 -0.992 . . . . 0.0 110.478 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.69 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . 62.5 m -125.28 138.93 54.09 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.207 -0.933 . . . . 0.0 109.735 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.494 ' CG ' ' HB3' ' A' ' 34' ' ' SER . 0.0 OUTLIER -118.16 137.65 52.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.359 -0.838 . . . . 0.0 110.072 -179.949 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 31' ' ' LYS . . . 102.22 32.51 4.91 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.838 ' HG ' HG23 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -101.46 -177.27 0.54 Allowed Pre-proline 0 N--CA 1.496 1.865 0 O-C-N 121.185 -1.185 . . . . 0.0 109.303 179.646 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.537 ' HD2' ' HB2' ' A' ' 49' ' ' LEU . 47.6 Cg_endo -85.12 161.11 11.55 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 O-C-N 123.619 1.326 . . . . 0.0 110.123 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -59.53 -19.95 51.99 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.1 -1.0 . . . . 0.0 109.883 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -96.25 19.54 11.74 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.372 -0.83 . . . . 0.0 109.695 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.575 ' HB2' ' HB2' ' A' ' 49' ' ' LEU . . . -53.79 134.01 42.31 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.346 -0.846 . . . . 0.0 110.562 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.576 ' CZ ' ' HB3' ' A' ' 54' ' ' ARG . 1.3 ttm105 -71.71 87.49 0.96 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.298 -0.876 . . . . 0.0 109.976 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.694 HD12 ' C ' ' A' ' 55' ' ' ILE . 1.9 pp -124.34 -166.41 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.062 -1.024 . . . . 0.0 110.626 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.48 ' O ' ' HG3' ' A' ' 56' ' ' LYS . 0.4 OUTLIER -61.39 70.41 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.486 -0.758 . . . . 0.0 110.837 -179.555 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.531 ' N ' ' O ' ' A' ' 55' ' ' ILE . 9.1 tpp85 -114.79 -16.03 11.81 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.074 -1.016 . . . . 0.0 109.799 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.9 132.02 46.24 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.419 -0.801 . . . . 0.0 109.984 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -107.77 33.42 6.32 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.431 ' O ' ' HG2' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -122.77 107.4 11.86 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.276 -1.132 . . . . 0.0 110.28 179.954 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 2.6 t -50.74 107.52 0.18 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.288 -0.882 . . . . 0.0 109.882 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.534 ' CB ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -87.32 48.61 1.67 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.324 -0.86 . . . . 0.0 110.375 179.973 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.152 -0.967 . . . . 0.0 110.228 -179.99 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 13.3 tttm . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.178 0.513 . . . . 0.0 110.219 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.611 HG22 ' O ' ' A' ' 49' ' ' LEU . 4.5 tt -146.93 159.85 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.334 -0.854 . . . . 0.0 110.1 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.506 ' HB3' ' CG ' ' A' ' 47' ' ' GLN . 65.8 m-20 -131.14 136.2 48.14 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.347 -0.845 . . . . 0.0 109.873 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 178.77 -160.8 26.8 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.606 ' CE2' ' CD1' ' A' ' 45' ' ' TYR . 15.0 m-85 -109.28 109.25 60.46 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.305 -1.115 . . . . 0.0 110.256 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.516 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 49.4 Cg_endo -80.51 108.09 2.09 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.928 1.489 . . . . 0.0 110.9 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.477 HG12 ' HA ' ' A' ' 15' ' ' ILE . 17.0 m -83.49 -170.59 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.228 -0.92 . . . . 0.0 109.83 179.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -70.65 -118.23 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.111 -0.993 . . . . 0.0 109.827 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.413 ' HB3' ' CD2' ' A' ' 10' ' ' TRP . 0.2 OUTLIER -115.94 -55.06 2.45 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.816 -1.177 . . . . 0.0 110.073 179.792 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.543 ' HB3' ' CB ' ' A' ' 62' ' ' ARG . 3.0 m-90 -99.6 15.23 27.32 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.24 -0.913 . . . . 0.0 110.121 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.459 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 5.1 m-20 59.4 12.74 2.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.219 -0.925 . . . . 0.0 110.067 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.8 t -90.89 -28.68 17.96 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.277 -0.889 . . . . 0.0 110.43 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.489 ' O ' ' CB ' ' A' ' 14' ' ' ARG . 4.5 mmtp -86.79 41.38 0.95 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.272 -0.892 . . . . 0.0 110.619 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.489 ' CB ' ' O ' ' A' ' 13' ' ' LYS . 0.1 OUTLIER 69.03 141.6 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.159 -0.963 . . . . 0.0 110.536 179.787 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.477 ' HA ' HG12 ' A' ' 7' ' ' VAL . 6.9 pt -74.48 -6.29 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.376 -0.828 . . . . 0.0 110.104 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.599 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 4.4 t -148.25 153.99 39.46 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.267 -0.896 . . . . 0.0 110.257 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.458 ' CE3' ' HB3' ' A' ' 22' ' ' TYR . 0.2 OUTLIER -86.56 -161.99 0.72 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.359 -0.838 . . . . 0.0 110.105 179.886 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.471 ' CD1' ' O ' ' A' ' 18' ' ' TYR . 9.3 t80 -106.61 -25.85 11.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.283 -0.886 . . . . 0.0 110.118 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -93.36 152.7 18.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.329 -0.857 . . . . 0.0 110.165 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 -81.99 -9.02 59.7 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.173 -0.954 . . . . 0.0 110.214 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.424 ' O ' ' N ' ' A' ' 24' ' ' ASN . 13.8 tttp -105.41 -39.59 6.09 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.181 -0.949 . . . . 0.0 110.07 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.458 ' HB3' ' CE3' ' A' ' 17' ' ' TRP . 1.5 m-85 -44.65 -33.63 1.89 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.296 -0.878 . . . . 0.0 110.259 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -78.32 -28.53 47.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.278 -0.889 . . . . 0.0 110.008 -179.993 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.485 ' OD1' ' HD2' ' A' ' 28' ' ' LYS . 0.3 OUTLIER -68.98 -41.31 78.05 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.399 -0.813 . . . . 0.0 109.305 179.465 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.2 -43.04 99.73 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.377 -0.827 . . . . 0.0 110.055 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.742 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -74.56 -42.68 58.37 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.318 -0.864 . . . . 0.0 109.591 179.74 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.51 ' SG ' ' CG ' ' A' ' 6' ' ' PRO . 1.5 m -61.09 -30.78 70.55 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.293 -0.879 . . . . 0.0 109.303 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.561 ' HE3' ' CA ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -65.43 -27.42 68.51 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.17 -0.956 . . . . 0.0 108.87 178.572 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.94 -34.52 89.13 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 107.197 -2.361 . . . . 0.0 107.197 178.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.533 ' O ' ' CD ' ' A' ' 50' ' ' PRO . 53.1 mt -91.01 22.03 3.9 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.763 -0.845 . . . . 0.0 109.16 178.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.488 ' O ' ' O ' ' A' ' 48' ' ' GLY . 0.0 OUTLIER 60.48 22.53 12.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.611 -0.681 . . . . 0.0 110.653 179.907 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.617 ' HB1' ' HB3' ' A' ' 46' ' ' CYS . . . -86.15 86.4 7.35 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.984 -1.072 . . . . 0.0 109.995 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.511 ' O ' ' NZ ' ' A' ' 28' ' ' LYS . 6.7 t70 -40.28 -86.62 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.498 -0.751 . . . . 0.0 110.597 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.9 m -69.99 93.65 0.8 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.993 -1.067 . . . . 0.0 110.058 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.544 ' CA ' ' SG ' ' A' ' 46' ' ' CYS . . . -128.72 112.77 1.45 Allowed Glycine 0 N--CA 1.487 2.099 0 C-N-CA 119.638 -1.268 . . . . 0.0 110.018 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -148.21 159.97 43.41 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.273 -1.134 . . . . 0.0 109.985 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.475 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.1 OUTLIER -93.32 146.15 23.93 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.153 -0.967 . . . . 0.0 110.684 -179.599 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.53 ' CD1' ' HB2' ' A' ' 42' ' ' LEU . 8.7 t-105 -79.55 111.06 15.45 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.238 -0.914 . . . . 0.0 109.439 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -66.2 61.25 0.16 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 -179.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.64 ' CD1' HG22 ' A' ' 41' ' ' THR . 14.7 t-105 -160.94 -69.67 0.06 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.329 -1.1 . . . . 0.0 109.453 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.64 HG22 ' CD1' ' A' ' 40' ' ' TRP . 11.8 t -179.91 33.42 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.586 -0.696 . . . . 0.0 109.588 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.53 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 0.3 OUTLIER -109.46 30.83 6.26 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.293 -0.88 . . . . 0.0 111.013 -179.433 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.599 ' HA ' ' HB2' ' A' ' 16' ' ' CYS . 6.1 p 48.29 -175.3 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.934 -1.104 . . . . 0.0 110.235 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.491 ' O ' ' HA ' ' A' ' 5' ' ' TYR . 14.7 t -78.55 140.47 38.51 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.259 -0.901 . . . . 0.0 109.366 179.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.606 ' CD1' ' CE2' ' A' ' 5' ' ' TYR . 4.7 t80 -128.94 118.77 23.18 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.053 -1.029 . . . . 0.0 110.696 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.617 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . 63.1 m -136.17 152.18 50.53 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.488 -0.758 . . . . 0.0 109.719 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.506 ' CG ' ' HB3' ' A' ' 3' ' ' ASP . 1.6 mt-30 -134.83 147.24 49.88 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.142 -0.973 . . . . 0.0 110.701 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.488 ' O ' ' O ' ' A' ' 31' ' ' LYS . . . 97.98 30.05 7.31 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.982 HD12 ' CB ' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -108.07 170.9 5.04 Favored Pre-proline 0 N--CA 1.498 1.963 0 O-C-N 121.158 -1.201 . . . . 0.0 109.77 179.66 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.533 ' CD ' ' O ' ' A' ' 30' ' ' LEU . 42.7 Cg_endo -68.93 157.85 60.25 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.692 1.364 . . . . 0.0 110.917 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -59.37 -24.02 63.06 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.379 -0.825 . . . . 0.0 110.008 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -86.46 14.18 7.17 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.335 -0.853 . . . . 0.0 109.783 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.982 ' CB ' HD12 ' A' ' 49' ' ' LEU . . . -56.86 113.69 1.77 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.459 -0.776 . . . . 0.0 110.86 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.502 ' O ' ' HA ' ' A' ' 6' ' ' PRO . 6.7 ttm-85 -59.9 116.39 4.08 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.252 -0.905 . . . . 0.0 109.645 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.69 ' O ' HD12 ' A' ' 55' ' ' ILE . 1.8 pp -140.19 178.06 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.074 -1.016 . . . . 0.0 111.004 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 55' ' ' ILE . 0.1 OUTLIER -41.81 93.74 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.529 -0.732 . . . . 0.0 110.736 -179.566 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.506 ' N ' ' O ' ' A' ' 55' ' ' ILE . 11.6 ttp180 -119.73 -18.91 8.2 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.294 -0.879 . . . . 0.0 109.782 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.32 155.9 35.96 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.367 -0.833 . . . . 0.0 110.148 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -118.13 14.71 12.31 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.424 ' O ' ' C ' ' A' ' 61' ' ' CYS . 4.6 mpt_? -99.39 98.95 9.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.431 -1.04 . . . . 0.0 110.205 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.424 ' C ' ' O ' ' A' ' 60' ' ' ARG . 4.5 t -40.05 109.76 0.12 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.507 -0.746 . . . . 0.0 110.096 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.543 ' CB ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -90.52 52.0 2.12 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.279 -0.888 . . . . 0.0 110.329 -179.808 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.437 ' HB2' ' O ' ' A' ' 62' ' ' ARG . . . . . . . . 0 N--CA 1.491 1.604 0 O-C-N 121.22 -0.925 . . . . 0.0 110.219 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 20.7 mttt . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.251 0.548 . . . . 0.0 110.235 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.477 HG12 ' N ' ' A' ' 3' ' ' ASP . 6.9 tt -134.34 165.11 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.414 -0.804 . . . . 0.0 109.943 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.477 ' N ' HG12 ' A' ' 2' ' ' ILE . 1.0 OUTLIER -135.2 128.6 32.29 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.308 -0.87 . . . . 0.0 110.107 179.895 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -167.56 -176.26 38.12 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.794 -1.323 . . . . 0.0 109.794 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.972 ' HB2' HD11 ' A' ' 15' ' ' ILE . 6.1 m-30 -99.07 109.58 54.7 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.296 -1.12 . . . . 0.0 110.407 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.569 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 48.8 Cg_endo -78.89 129.56 9.09 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.934 1.491 . . . . 0.0 110.277 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.589 HG12 ' CB ' ' A' ' 15' ' ' ILE . 30.1 m -93.46 -170.25 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.125 -0.985 . . . . 0.0 110.185 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.514 ' CB ' ' HB2' ' A' ' 13' ' ' LYS . 7.9 t70 -74.68 -89.36 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.319 -0.863 . . . . 0.0 109.792 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.657 ' CZ ' ' CH2' ' A' ' 10' ' ' TRP . 24.5 t80 -138.32 -75.11 0.39 Allowed 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.308 -0.87 . . . . 0.0 109.611 179.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.657 ' CH2' ' CZ ' ' A' ' 9' ' ' TYR . 0.0 OUTLIER -89.62 23.02 2.78 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.447 -0.783 . . . . 0.0 109.386 179.322 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 3.7 m120 61.18 24.17 14.3 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.83 -0.543 . . . . 0.0 110.834 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.501 ' HA ' ' HB2' ' A' ' 61' ' ' CYS . 48.3 t -93.25 -37.46 12.05 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.986 -1.071 . . . . 0.0 110.43 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.514 ' HB2' ' CB ' ' A' ' 8' ' ' ASP . 54.4 mmtt -85.08 44.1 1.06 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.282 -0.886 . . . . 0.0 109.894 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' A' ' 13' ' ' LYS . 1.3 tpp180 54.73 165.13 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.307 -0.871 . . . . 0.0 110.152 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.972 HD11 ' HB2' ' A' ' 5' ' ' TYR . 7.7 tt -84.1 1.29 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.326 -0.859 . . . . 0.0 110.423 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.595 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 33.7 t -142.44 127.19 18.12 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.268 -0.895 . . . . 0.0 110.424 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -69.22 -149.49 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.265 -0.897 . . . . 0.0 110.337 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -140.08 40.45 1.95 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.146 -0.971 . . . . 0.0 110.313 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.435 ' HB2' ' HB2' ' A' ' 22' ' ' TYR . 0.6 OUTLIER -149.25 162.72 39.46 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.328 -0.858 . . . . 0.0 109.914 179.758 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 25.1 m-20 -88.7 30.25 0.93 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.13 -0.981 . . . . 0.0 109.915 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -156.09 -39.98 0.08 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.396 -0.815 . . . . 0.0 109.764 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.435 ' HB2' ' HB2' ' A' ' 19' ' ' ASN . 0.1 OUTLIER -45.97 -27.58 0.94 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.243 -0.91 . . . . 0.0 110.008 179.769 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -100.0 -50.97 3.82 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.292 -0.88 . . . . 0.0 110.104 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.508 ' N ' ' OD1' ' A' ' 24' ' ' ASN . 1.4 m-20 -55.42 -60.07 3.93 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.376 -0.828 . . . . 0.0 109.95 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 24' ' ' ASN . 6.8 t0 -42.99 -51.54 5.6 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.223 -0.923 . . . . 0.0 110.378 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.6 mt -65.16 -42.72 93.47 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.201 -0.937 . . . . 0.0 110.46 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.498 ' SG ' ' HG3' ' A' ' 6' ' ' PRO . 2.4 m -61.18 -39.62 90.82 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.388 -0.82 . . . . 0.0 110.478 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.539 ' HD3' ' HA ' ' A' ' 33' ' ' ASP . 0.5 OUTLIER -60.82 -31.87 71.26 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.284 -0.885 . . . . 0.0 109.602 179.954 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.28 -28.27 73.38 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 107.993 -2.043 . . . . 0.0 107.993 179.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.54 ' O ' ' CD ' ' A' ' 50' ' ' PRO . 13.5 mt -92.42 19.52 7.11 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.691 -0.888 . . . . 0.0 109.127 178.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.527 ' HB3' ' O ' ' A' ' 30' ' ' LEU . 28.7 tptt 72.93 15.02 4.71 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.694 -0.629 . . . . 0.0 110.939 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.709 ' HB2' HD22 ' A' ' 49' ' ' LEU . . . -99.96 55.87 0.94 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.866 -1.146 . . . . 0.0 109.667 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.539 ' HA ' ' HD3' ' A' ' 28' ' ' LYS . 17.9 p30 -40.29 -30.05 0.09 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.462 -0.773 . . . . 0.0 110.649 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.5 ' N ' ' OD1' ' A' ' 33' ' ' ASP . 70.2 p -91.09 62.77 4.92 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.244 -0.91 . . . . 0.0 110.368 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.484 ' HA2' ' SG ' ' A' ' 46' ' ' CYS . . . -104.64 134.44 12.0 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.539 ' CD1' ' O ' ' A' ' 36' ' ' TYR . 29.3 p90 -160.17 129.74 5.18 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.394 -1.062 . . . . 0.0 109.39 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.524 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.0 OUTLIER -89.74 136.32 33.1 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.162 -0.961 . . . . 0.0 110.994 -179.059 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.576 ' CD1' ' HB2' ' A' ' 42' ' ' LEU . 4.6 t-105 -80.35 111.05 16.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.302 -0.874 . . . . 0.0 109.448 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -61.63 -10.96 26.87 Favored Glycine 0 N--CA 1.49 2.277 0 C-N-CA 120.434 -0.888 . . . . 0.0 110.943 -178.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.86 ' CD1' HG22 ' A' ' 41' ' ' THR . 16.7 t-105 -79.66 -78.43 0.16 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.793 -1.416 . . . . 0.0 110.249 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.86 HG22 ' CD1' ' A' ' 40' ' ' TRP . 5.8 t -173.46 38.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.27 -0.894 . . . . 0.0 109.714 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.576 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 0.3 OUTLIER -110.04 24.66 12.72 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.245 -0.909 . . . . 0.0 110.414 -179.679 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.595 ' HA ' ' HB2' ' A' ' 16' ' ' CYS . 7.7 m 54.53 -176.55 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.049 -1.032 . . . . 0.0 109.827 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.524 ' HA ' ' HA ' ' A' ' 37' ' ' CYS . 7.4 t -76.64 151.82 36.05 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.178 -0.951 . . . . 0.0 109.131 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.532 ' HB3' ' CZ ' ' A' ' 36' ' ' TYR . 0.8 OUTLIER -138.58 104.74 5.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.866 -1.146 . . . . 0.0 111.378 -179.632 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.67 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . 63.8 m -121.02 140.66 51.62 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.397 -0.814 . . . . 0.0 109.393 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.407 ' O ' ' OG ' ' A' ' 34' ' ' SER . 14.6 mt-30 -129.92 149.43 51.66 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.107 -0.996 . . . . 0.0 110.407 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 31' ' ' LYS . . . 97.62 24.84 11.49 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 1.018 HD12 ' CB ' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -103.09 172.1 4.58 Favored Pre-proline 0 N--CA 1.499 2.019 0 O-C-N 121.279 -1.13 . . . . 0.0 109.444 179.438 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.54 ' CD ' ' O ' ' A' ' 30' ' ' LEU . 41.9 Cg_endo -68.57 154.44 71.59 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 O-C-N 123.335 1.176 . . . . 0.0 110.352 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -58.28 -21.98 50.91 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.325 -0.86 . . . . 0.0 110.191 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 16.6 t30 -86.44 11.71 11.88 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.306 -0.871 . . . . 0.0 110.085 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 1.018 ' CB ' HD12 ' A' ' 49' ' ' LEU . . . -52.71 143.89 15.31 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.446 -0.783 . . . . 0.0 110.669 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.499 ' NH1' ' O ' ' A' ' 8' ' ' ASP . 1.2 ttm105 -88.54 116.72 26.98 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.365 -0.834 . . . . 0.0 109.996 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.595 HD12 ' C ' ' A' ' 55' ' ' ILE . 1.3 pp -139.24 -164.74 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.188 -0.945 . . . . 0.0 110.733 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.843 ' HG3' HD12 ' A' ' 15' ' ' ILE . 0.3 OUTLIER -36.24 96.12 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 121.371 0.605 . . . . 0.0 111.107 -179.414 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.456 ' N ' ' O ' ' A' ' 55' ' ' ILE . 8.3 ttm-85 -110.1 -20.02 12.84 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.376 -0.828 . . . . 0.0 109.762 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.8 m -166.32 162.59 17.32 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.412 -0.805 . . . . 0.0 110.056 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -114.61 45.75 1.27 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.459 ' O ' ' HB2' ' A' ' 11' ' ' ASN . 7.7 ptm180 -137.17 172.15 13.42 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.162 -1.199 . . . . 0.0 110.485 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.501 ' HB2' ' HA ' ' A' ' 12' ' ' CYS . 0.5 OUTLIER -116.7 103.26 10.18 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.402 -0.811 . . . . 0.0 109.695 179.993 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.646 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -85.53 28.77 0.73 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.888 -1.132 . . . . 0.0 110.547 179.766 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.124 -0.985 . . . . 0.0 110.283 -179.949 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 9.8 ptpt . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.221 0.534 . . . . 0.0 110.193 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.526 ' CG2' ' HG ' ' A' ' 49' ' ' LEU . 19.3 tt -131.18 160.56 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.322 -0.861 . . . . 0.0 110.056 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 3' ' ' ASP . 5.0 p-10 -134.52 127.5 31.48 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.381 -0.824 . . . . 0.0 109.654 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -177.32 -172.86 42.3 Favored Glycine 0 N--CA 1.49 2.286 0 C-N-CA 119.253 -1.451 . . . . 0.0 110.21 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.603 ' CD1' ' N ' ' A' ' 5' ' ' TYR . 3.2 m-30 -102.36 113.36 65.91 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.438 -1.036 . . . . 0.0 110.088 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.495 ' HG3' ' SG ' ' A' ' 27' ' ' CYS . 46.3 Cg_endo -75.15 142.48 27.47 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.815 1.429 . . . . 0.0 110.452 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.727 HG12 ' HA ' ' A' ' 15' ' ' ILE . 30.0 m -141.08 -170.18 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.35 -0.843 . . . . 0.0 110.149 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.502 ' HB3' ' HB3' ' A' ' 14' ' ' ARG . 21.3 p-10 -69.45 -148.29 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.234 -0.916 . . . . 0.0 109.979 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.582 ' HB3' ' CD2' ' A' ' 10' ' ' TRP . 6.3 t80 -98.82 -14.9 19.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.197 -0.939 . . . . 0.0 110.316 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.582 ' CD2' ' HB3' ' A' ' 9' ' ' TYR . 7.9 m-90 -133.32 24.04 4.12 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.227 -0.921 . . . . 0.0 110.252 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.501 ' O ' HD11 ' A' ' 15' ' ' ILE . 2.4 m-20 59.41 13.78 3.4 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.192 -0.942 . . . . 0.0 110.166 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.49 ' SG ' ' HB2' ' A' ' 10' ' ' TRP . 71.5 m -83.0 -77.17 0.25 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.299 -0.876 . . . . 0.0 110.82 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.439 ' O ' ' HB3' ' A' ' 14' ' ' ARG . 14.6 mttt -95.51 -167.83 1.68 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.368 -0.833 . . . . 0.0 111.076 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.542 ' O ' ' N ' ' A' ' 16' ' ' CYS . 16.8 tpp180 58.57 -106.0 0.28 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.48 -0.763 . . . . 0.0 110.45 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.77 HG23 ' OG ' ' A' ' 43' ' ' SER . 78.0 mt 57.19 -81.7 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.08 -1.012 . . . . 0.0 109.914 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.568 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 40.3 t -137.37 115.21 11.41 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.41 -0.806 . . . . 0.0 110.19 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -66.7 -149.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.214 -0.928 . . . . 0.0 109.939 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.57 59.25 1.55 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.122 -0.986 . . . . 0.0 110.14 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.528 ' CB ' ' HB2' ' A' ' 22' ' ' TYR . 1.1 m-80 -159.15 -177.86 6.79 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.276 -0.89 . . . . 0.0 110.091 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -90.74 -41.03 11.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.281 -0.887 . . . . 0.0 110.854 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.6 mtmp? -110.63 -1.12 16.95 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.132 -0.98 . . . . 0.0 110.811 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.528 ' HB2' ' CB ' ' A' ' 19' ' ' ASN . 1.2 m-85 -56.5 -52.36 65.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.057 -1.027 . . . . 0.0 109.986 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.4 t -78.03 -14.84 59.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.271 -0.893 . . . . 0.0 110.14 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.527 ' O ' ' CG ' ' A' ' 28' ' ' LYS . 9.6 t-20 -76.49 -41.45 46.97 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.259 -0.901 . . . . 0.0 110.006 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.1 -40.27 89.07 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.199 -0.938 . . . . 0.0 109.766 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -74.23 -45.06 50.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.325 -0.859 . . . . 0.0 109.954 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.495 ' SG ' ' HG3' ' A' ' 6' ' ' PRO . 1.2 m -60.85 -45.03 96.12 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.339 -0.851 . . . . 0.0 109.615 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.551 ' CD ' ' HA ' ' A' ' 33' ' ' ASP . 2.2 mmmt -59.65 -31.08 69.19 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.334 -0.854 . . . . 0.0 109.323 179.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -56.57 -35.58 67.39 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 108.851 -1.699 . . . . 0.0 108.851 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.695 ' O ' ' CB ' ' A' ' 31' ' ' LYS . 10.5 mt -81.65 -28.91 33.38 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.387 -1.067 . . . . 0.0 109.617 179.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.695 ' CB ' ' O ' ' A' ' 30' ' ' LEU . 10.0 tttt 131.54 5.82 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.748 0 C-N-CA 123.528 0.731 . . . . 0.0 109.839 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.544 ' HB1' ' HB3' ' A' ' 46' ' ' CYS . . . -82.73 113.1 20.16 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.901 -1.124 . . . . 0.0 110.226 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.551 ' HA ' ' CD ' ' A' ' 28' ' ' LYS . 0.2 OUTLIER -73.66 -62.41 1.5 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.308 -0.87 . . . . 0.0 110.134 179.893 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -80.45 82.84 6.38 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.399 -0.813 . . . . 0.0 109.996 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.531 ' CA ' ' SG ' ' A' ' 46' ' ' CYS . . . -121.06 104.07 0.93 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.53 ' OH ' ' CD2' ' A' ' 45' ' ' TYR . 41.4 p90 -126.35 -177.16 3.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.178 -1.19 . . . . 0.0 109.794 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.522 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.1 OUTLIER -110.72 147.28 34.72 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.087 -1.008 . . . . 0.0 110.277 -179.916 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.592 ' CD1' ' HB2' ' A' ' 42' ' ' LEU . 15.6 t-105 -79.53 166.61 21.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.084 -1.01 . . . . 0.0 109.855 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -125.54 55.67 0.72 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.869 ' CD1' HG22 ' A' ' 41' ' ' THR . 11.6 t-105 -160.33 -69.66 0.07 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.374 -1.074 . . . . 0.0 109.335 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.869 HG22 ' CD1' ' A' ' 40' ' ' TRP . 5.1 t -179.06 32.37 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.67 -0.644 . . . . 0.0 109.883 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.592 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 0.8 OUTLIER -113.58 21.39 15.13 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.102 -0.999 . . . . 0.0 110.908 -179.433 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.77 ' OG ' HG23 ' A' ' 15' ' ' ILE . 8.2 t 57.34 -168.69 0.11 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.13 -0.981 . . . . 0.0 110.784 179.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.522 ' HA ' ' HA ' ' A' ' 37' ' ' CYS . 19.4 t -71.91 171.98 10.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.391 -0.818 . . . . 0.0 110.162 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.53 ' CD2' ' OH ' ' A' ' 36' ' ' TYR . 1.1 t80 -151.5 110.21 3.83 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.994 -1.066 . . . . 0.0 110.752 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.583 ' O ' HD21 ' A' ' 49' ' ' LEU . 82.9 m -125.44 137.49 53.99 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.327 -0.858 . . . . 0.0 109.824 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -119.92 131.95 55.37 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.206 -0.934 . . . . 0.0 109.931 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.598 ' N ' HD23 ' A' ' 49' ' ' LEU . . . 107.82 41.22 1.6 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.758 HD12 ' CB ' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -119.6 172.9 3.98 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.362 -1.081 . . . . 0.0 109.83 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.511 ' HD2' ' HB2' ' A' ' 49' ' ' LEU . 42.1 Cg_endo -68.32 155.22 70.05 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 O-C-N 123.677 1.356 . . . . 0.0 110.516 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -61.12 -19.95 62.08 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.359 -0.838 . . . . 0.0 110.459 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -88.62 11.87 16.23 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.208 -0.933 . . . . 0.0 110.095 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.758 ' CB ' HD12 ' A' ' 49' ' ' LEU . . . -65.27 110.38 2.57 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.24 -0.913 . . . . 0.0 110.167 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.551 ' O ' HG23 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -57.71 136.08 56.83 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.234 -0.916 . . . . 0.0 110.282 179.982 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.614 HD12 ' C ' ' A' ' 55' ' ' ILE . 1.4 pp -154.36 -169.94 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.204 -0.935 . . . . 0.0 110.319 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.427 ' CG ' ' O ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -50.07 91.1 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.315 -0.866 . . . . 0.0 110.662 -179.523 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.471 ' N ' ' O ' ' A' ' 55' ' ' ILE . 2.4 ttt85 -119.76 -5.86 10.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.204 -0.935 . . . . 0.0 110.022 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.432 ' HB2' ' CG ' ' A' ' 11' ' ' ASN . 46.3 m -120.67 -178.53 3.74 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.309 -0.87 . . . . 0.0 110.031 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -118.94 -36.86 0.85 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.401 ' O ' ' C ' ' A' ' 61' ' ' CYS . 0.3 OUTLIER -131.74 155.32 47.9 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.19 -1.183 . . . . 0.0 110.393 -179.922 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.401 ' C ' ' O ' ' A' ' 60' ' ' ARG . 43.3 t -43.79 115.4 0.8 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.285 -0.884 . . . . 0.0 110.305 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.521 ' CB ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -90.85 48.26 1.51 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.253 -0.904 . . . . 0.0 110.262 -179.975 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.678 0 O-C-N 121.272 -0.893 . . . . 0.0 110.147 179.991 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.497 ' CG ' ' O ' ' A' ' 1' ' ' LYS . 2.2 tttm . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.191 0.52 . . . . 0.0 110.167 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.502 ' CG2' ' HG ' ' A' ' 49' ' ' LEU . 10.1 tt -111.15 157.45 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.239 -0.913 . . . . 0.0 110.497 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.584 ' CB ' ' CG ' ' A' ' 47' ' ' GLN . 7.1 p30 -133.21 117.28 17.24 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.733 -0.604 . . . . 0.0 109.66 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -155.45 -150.61 5.63 Favored Glycine 0 N--CA 1.491 2.353 0 C-N-CA 119.496 -1.335 . . . . 0.0 109.846 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.493 ' HA ' ' O ' ' A' ' 44' ' ' CYS . 14.1 m-85 -122.83 114.33 29.8 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.403 -1.057 . . . . 0.0 110.29 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.494 ' HG3' ' SG ' ' A' ' 27' ' ' CYS . 48.2 Cg_endo -76.04 144.8 27.33 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 124.047 1.551 . . . . 0.0 110.619 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.745 HG12 ' HA ' ' A' ' 15' ' ' ILE . 32.8 m -141.76 -171.47 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.297 -0.877 . . . . 0.0 109.894 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.544 ' N ' ' HB3' ' A' ' 14' ' ' ARG . 3.9 t0 -67.54 -176.0 0.57 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.227 -0.92 . . . . 0.0 110.175 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.494 ' HB3' ' CE2' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -76.55 -11.02 59.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.359 -0.838 . . . . 0.0 109.68 179.739 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.568 ' HB3' ' N ' ' A' ' 62' ' ' ARG . 4.0 m-90 -132.22 8.38 4.34 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.382 -0.824 . . . . 0.0 110.115 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 18.3 m-20 60.09 33.08 21.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.162 -0.961 . . . . 0.0 110.25 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.466 ' O ' ' HD3' ' A' ' 13' ' ' LYS . 5.5 t -98.12 -67.27 0.85 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.237 -0.914 . . . . 0.0 110.683 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.476 ' O ' ' HB2' ' A' ' 14' ' ' ARG . 45.2 mmtt -131.32 86.02 2.32 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.297 -0.877 . . . . 0.0 110.587 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.544 ' HB3' ' N ' ' A' ' 8' ' ' ASP . 1.0 OUTLIER 177.75 -22.88 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.488 -0.758 . . . . 0.0 111.008 179.739 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.745 ' HA ' HG12 ' A' ' 7' ' ' VAL . 6.8 tt -30.33 -45.13 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.749 -0.595 . . . . 0.0 111.203 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.581 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 43.0 t -159.18 154.3 25.21 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.226 -0.921 . . . . 0.0 109.967 179.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -114.84 -151.76 0.49 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.21 -0.931 . . . . 0.0 110.629 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -123.91 16.14 9.33 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.334 -0.854 . . . . 0.0 110.51 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.508 ' HB2' ' HB2' ' A' ' 22' ' ' TYR . 36.4 m-20 -119.16 148.02 43.55 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.083 -1.011 . . . . 0.0 110.395 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.417 ' ND2' ' H ' ' A' ' 20' ' ' ASN . 8.3 p30 -88.16 26.45 1.39 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.323 -0.86 . . . . 0.0 110.165 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.4 pttm -150.29 -35.23 0.16 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.292 -0.88 . . . . 0.0 110.457 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.508 ' HB2' ' HB2' ' A' ' 19' ' ' ASN . 0.1 OUTLIER -51.51 -28.82 14.59 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -0.918 . . . . 0.0 110.691 -179.661 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.443 ' O ' ' C ' ' A' ' 24' ' ' ASN . 0.5 OUTLIER -87.18 -59.68 2.19 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.1 -1.0 . . . . 0.0 110.333 -179.905 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 35' ' ' GLY . 0.1 OUTLIER -40.72 -40.41 1.3 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.488 -0.758 . . . . 0.0 110.001 179.879 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.99 -47.69 80.21 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.315 -0.866 . . . . 0.0 110.311 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.8 mt -74.84 -37.92 62.12 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.192 -0.942 . . . . 0.0 110.046 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.494 ' SG ' ' HG3' ' A' ' 6' ' ' PRO . 15.2 m -58.38 -39.68 80.26 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.161 -0.962 . . . . 0.0 109.473 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.87 -29.9 68.62 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.329 -0.857 . . . . 0.0 109.37 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.2 -37.35 92.82 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 108.311 -1.916 . . . . 0.0 108.311 179.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.509 ' O ' ' CB ' ' A' ' 31' ' ' LYS . 39.5 mt -89.02 19.39 4.2 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.462 -1.022 . . . . 0.0 109.524 179.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.509 ' CB ' ' O ' ' A' ' 30' ' ' LEU . 0.3 OUTLIER 73.18 16.22 4.27 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.657 -0.652 . . . . 0.0 110.809 179.912 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.69 ' HB2' HD22 ' A' ' 49' ' ' LEU . . . -95.65 89.7 5.43 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.957 -1.089 . . . . 0.0 109.797 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -55.31 -75.15 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.22 -0.925 . . . . 0.0 111.018 -179.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.5 ' O ' ' HA ' ' A' ' 46' ' ' CYS . 8.6 t -62.34 95.42 0.07 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.389 -0.82 . . . . 0.0 110.912 -179.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.487 ' HA2' ' SG ' ' A' ' 46' ' ' CYS . . . -123.06 110.87 1.6 Allowed Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.585 ' CD1' ' O ' ' A' ' 36' ' ' TYR . 13.1 p90 -138.99 144.25 38.84 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.388 -1.066 . . . . 0.0 109.738 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.512 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.0 OUTLIER -90.97 154.56 19.36 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.038 -1.039 . . . . 0.0 110.832 -179.359 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.452 ' CG ' ' HB2' ' A' ' 42' ' ' LEU . 18.5 t-105 -79.95 -172.03 3.19 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.271 -0.893 . . . . 0.0 109.936 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -119.55 -29.3 1.76 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.911 ' CD1' HG22 ' A' ' 41' ' ' THR . 12.8 t-105 -79.38 -83.1 0.1 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.233 -1.157 . . . . 0.0 109.986 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.911 HG22 ' CD1' ' A' ' 40' ' ' TRP . 5.3 t -166.41 48.42 0.07 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.347 -0.845 . . . . 0.0 109.707 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.452 ' HB2' ' CG ' ' A' ' 38' ' ' TRP . 8.0 mp -106.9 23.49 14.28 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.312 -0.868 . . . . 0.0 110.745 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.581 ' HA ' ' HB2' ' A' ' 16' ' ' CYS . 5.1 m 58.48 -166.93 0.15 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 120.935 -1.103 . . . . 0.0 110.027 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.512 ' HA ' ' HA ' ' A' ' 37' ' ' CYS . 9.3 t -83.68 156.27 22.73 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.34 -0.85 . . . . 0.0 108.88 178.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.458 ' HB3' ' CE1' ' A' ' 36' ' ' TYR . 0.8 OUTLIER -128.72 116.95 20.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.96 -1.088 . . . . 0.0 110.354 -179.629 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.649 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . 74.0 m -137.52 137.45 38.65 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.353 -0.842 . . . . 0.0 109.848 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.584 ' CG ' ' CB ' ' A' ' 3' ' ' ASP . 1.7 mp0 -123.78 154.63 39.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.273 -0.892 . . . . 0.0 110.431 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.489 ' O ' ' O ' ' A' ' 31' ' ' LYS . . . 99.73 15.46 31.55 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 1.044 HD12 ' CB ' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -98.66 170.35 7.09 Favored Pre-proline 0 N--CA 1.497 1.891 0 O-C-N 121.133 -1.216 . . . . 0.0 109.723 179.669 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.552 ' HD2' ' HB2' ' A' ' 49' ' ' LEU . 43.3 Cg_endo -70.61 156.46 61.07 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 123.515 1.271 . . . . 0.0 110.706 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -58.99 -24.85 63.1 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.334 -0.854 . . . . 0.0 110.01 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -85.79 14.18 6.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.373 -0.829 . . . . 0.0 109.806 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 1.044 ' CB ' HD12 ' A' ' 49' ' ' LEU . . . -56.25 152.15 11.46 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.449 -0.782 . . . . 0.0 110.381 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.465 ' O ' ' HA ' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -92.19 110.48 21.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.309 -0.87 . . . . 0.0 109.536 179.476 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.828 ' N ' HD13 ' A' ' 55' ' ' ILE . 0.2 OUTLIER -148.65 -164.62 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.256 -0.903 . . . . 0.0 110.647 -179.384 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' A' ' 55' ' ' ILE . 0.1 OUTLIER -40.45 108.63 0.09 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.573 -0.705 . . . . 0.0 110.54 -179.816 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.456 ' CG ' ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -136.43 20.68 3.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.381 -0.824 . . . . 0.0 109.872 179.807 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.451 ' CB ' ' O ' ' A' ' 57' ' ' ARG . 0.5 OUTLIER 66.86 153.49 0.08 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.408 -0.807 . . . . 0.0 110.161 -179.969 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 128.73 101.57 1.03 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.709 -1.357 . . . . 0.0 109.709 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.436 ' O ' ' C ' ' A' ' 61' ' ' CYS . 1.6 mmt180 -70.13 94.85 0.92 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.257 -1.143 . . . . 0.0 109.965 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.436 ' C ' ' O ' ' A' ' 60' ' ' ARG . 41.8 t 42.54 88.95 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 0.0 109.967 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.687 ' O ' ' HB3' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -83.11 26.48 0.62 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.357 -0.84 . . . . 0.0 110.844 -179.905 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.687 ' HB3' ' O ' ' A' ' 62' ' ' ARG . . . . . . . . 0 N--CA 1.492 1.644 0 O-C-N 121.01 -1.056 . . . . 0.0 110.244 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 5.4 mtmm . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.21 0.528 . . . . 0.0 110.152 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.887 HG22 ' O ' ' A' ' 49' ' ' LEU . 6.0 tt -133.09 154.72 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.202 -0.936 . . . . 0.0 110.418 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -124.88 128.6 48.9 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.345 -0.847 . . . . 0.0 109.983 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -168.19 -166.07 26.64 Favored Glycine 0 N--CA 1.491 2.347 0 C-N-CA 119.554 -1.307 . . . . 0.0 110.114 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.592 ' CD1' ' N ' ' A' ' 5' ' ' TYR . 13.7 m-85 -111.05 104.3 56.01 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.318 -1.107 . . . . 0.0 109.656 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.736 ' CA ' HG22 ' A' ' 55' ' ' ILE . 50.1 Cg_endo -76.98 111.44 3.23 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 123.948 1.499 . . . . 0.0 111.281 -179.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.602 HG12 ' HB ' ' A' ' 15' ' ' ILE . 15.8 m -83.4 -169.99 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.231 -0.918 . . . . 0.0 109.877 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.57 ' CB ' ' HB2' ' A' ' 13' ' ' LYS . 11.8 p-10 -71.9 -134.77 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.287 -0.883 . . . . 0.0 109.852 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.586 ' HB3' ' CD2' ' A' ' 10' ' ' TRP . 0.2 OUTLIER -92.43 -63.26 1.25 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.035 -1.041 . . . . 0.0 110.397 -179.871 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.586 ' CD2' ' HB3' ' A' ' 9' ' ' TYR . 2.8 m-90 -107.11 26.79 9.71 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.134 -0.979 . . . . 0.0 110.125 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.5 ' HA ' ' OD1' ' A' ' 8' ' ' ASP . 1.3 m-20 67.31 5.83 4.48 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.134 -0.979 . . . . 0.0 109.853 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.454 ' O ' ' C ' ' A' ' 13' ' ' LYS . 89.2 m -83.86 -66.1 0.93 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.277 -0.889 . . . . 0.0 110.733 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.57 ' HB2' ' CB ' ' A' ' 8' ' ' ASP . 6.8 mmmt -37.95 -85.68 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.726 -0.609 . . . . 0.0 110.843 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 4.6 ttm180 -165.33 109.02 0.85 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.002 -1.061 . . . . 0.0 110.673 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.602 ' HB ' HG12 ' A' ' 7' ' ' VAL . 46.3 pt -48.77 -24.24 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.139 -0.975 . . . . 0.0 109.348 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.555 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 34.4 t -150.15 126.39 10.69 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.714 -0.616 . . . . 0.0 109.865 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.652 ' CE3' ' CD2' ' A' ' 22' ' ' TYR . 0.0 OUTLIER -85.36 -162.05 0.67 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.184 -0.948 . . . . 0.0 110.197 -179.901 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -101.72 -54.74 2.67 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.328 -0.857 . . . . 0.0 110.181 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -60.66 113.86 2.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.449 -0.782 . . . . 0.0 110.29 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 29.4 p30 -59.65 -15.22 17.7 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.354 -0.841 . . . . 0.0 110.329 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.416 ' HG3' ' N ' ' A' ' 22' ' ' TYR . 8.2 pttp -92.98 -27.89 16.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.203 -0.936 . . . . 0.0 110.293 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.652 ' CD2' ' CE3' ' A' ' 17' ' ' TRP . 45.3 t80 -60.63 -47.9 84.18 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.245 -0.909 . . . . 0.0 110.046 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -64.6 -40.44 95.53 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.334 -0.854 . . . . 0.0 110.174 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -57.59 -35.44 70.41 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.226 -0.921 . . . . 0.0 110.133 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -58.72 -57.52 12.62 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.241 -0.912 . . . . 0.0 110.015 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.87 -39.01 93.1 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.274 -0.891 . . . . 0.0 110.149 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.489 ' SG ' ' HG3' ' A' ' 6' ' ' PRO . 11.4 m -62.65 -37.19 85.38 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.223 -0.923 . . . . 0.0 109.877 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.88 -29.4 70.58 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.181 -0.949 . . . . 0.0 109.368 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.78 -27.34 69.88 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 107.438 -2.265 . . . . 0.0 107.438 178.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.537 ' O ' ' HD3' ' A' ' 50' ' ' PRO . 9.9 mt -96.3 19.41 11.99 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.879 -0.777 . . . . 0.0 109.051 178.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.508 ' CB ' ' O ' ' A' ' 30' ' ' LEU . 0.7 OUTLIER 71.47 10.92 6.6 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.468 -0.77 . . . . 0.0 110.985 179.684 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.809 ' HB2' HD22 ' A' ' 49' ' ' LEU . . . -85.3 103.46 14.25 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.833 -1.167 . . . . 0.0 109.983 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.441 ' N ' ' OD1' ' A' ' 33' ' ' ASP . 4.4 m-20 -61.25 -80.25 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.407 -0.808 . . . . 0.0 110.885 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.492 ' O ' ' HA ' ' A' ' 46' ' ' CYS . 60.3 p -66.26 94.04 0.24 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.234 -0.916 . . . . 0.0 110.348 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.442 ' HA2' ' SG ' ' A' ' 46' ' ' CYS . . . -116.75 84.5 0.37 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.421 ' CD1' ' C ' ' A' ' 36' ' ' TYR . 31.5 p90 -114.88 151.49 33.87 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.203 -1.175 . . . . 0.0 109.841 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.562 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.1 OUTLIER -95.62 155.3 16.8 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.118 -0.989 . . . . 0.0 110.505 -179.642 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.594 ' CD1' ' HB3' ' A' ' 40' ' ' TRP . 27.6 t-105 -79.52 168.15 19.82 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.188 -0.945 . . . . 0.0 109.613 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -106.66 -26.42 5.87 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.594 ' HB3' ' CD1' ' A' ' 38' ' ' TRP . 53.8 t-105 -79.61 -92.02 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.26 -1.141 . . . . 0.0 109.726 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.585 HG23 ' C ' ' A' ' 40' ' ' TRP . 70.7 p -158.07 46.37 0.35 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.357 -0.84 . . . . 0.0 109.857 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.587 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 1.1 mt -110.92 30.92 6.42 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.14 -0.975 . . . . 0.0 110.686 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.555 ' HA ' ' HB2' ' A' ' 16' ' ' CYS . 3.2 t 54.85 -172.68 0.05 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.201 -0.937 . . . . 0.0 110.386 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.562 ' HA ' ' HA ' ' A' ' 37' ' ' CYS . 17.5 t -78.77 166.63 22.24 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.335 -0.853 . . . . 0.0 109.814 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.573 ' HE2' ' HH ' ' A' ' 5' ' ' TYR . 0.8 OUTLIER -139.82 120.08 13.85 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.243 -0.911 . . . . 0.0 110.488 -179.613 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.676 ' O ' HD21 ' A' ' 49' ' ' LEU . 80.5 m -136.07 135.19 39.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.121 -0.987 . . . . 0.0 109.697 179.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -115.53 142.94 46.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.353 -0.842 . . . . 0.0 110.205 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 31' ' ' LYS . . . 99.9 31.91 5.82 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.887 ' O ' HG22 ' A' ' 2' ' ' ILE . 0.1 OUTLIER -103.49 176.3 1.86 Allowed Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.052 -1.263 . . . . 0.0 109.327 179.38 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.787 ' O ' HG21 ' A' ' 2' ' ' ILE . 47.2 Cg_endo -70.56 155.93 62.3 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 123.692 1.364 . . . . 0.0 110.24 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -59.7 -19.03 47.09 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.052 -1.03 . . . . 0.0 109.597 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -102.31 24.71 9.87 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.395 -0.815 . . . . 0.0 109.472 179.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.672 ' HB2' ' HB2' ' A' ' 49' ' ' LEU . . . -64.22 123.14 18.34 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.355 -0.841 . . . . 0.0 110.509 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.525 ' CZ ' ' O ' ' A' ' 9' ' ' TYR . 0.1 OUTLIER -68.64 112.31 5.32 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.217 -0.927 . . . . 0.0 110.278 179.834 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 1.07 ' O ' HD12 ' A' ' 55' ' ' ILE . 2.5 pp -143.68 128.07 14.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.44 -0.788 . . . . 0.0 110.589 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.504 ' HE3' HG11 ' A' ' 7' ' ' VAL . 0.0 OUTLIER 29.17 52.67 0.08 Allowed 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 121.227 0.537 . . . . 0.0 111.689 179.862 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.436 ' HD3' ' HG2' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -128.62 7.98 5.8 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.231 -0.918 . . . . 0.0 110.196 179.479 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.478 ' HB3' ' HB2' ' A' ' 11' ' ' ASN . 0.4 OUTLIER -92.32 151.92 20.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.32 -0.862 . . . . 0.0 110.114 179.87 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.15 -136.54 1.26 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.44 ' O ' ' O ' ' A' ' 61' ' ' CYS . 25.4 mmt85 -88.16 92.41 9.14 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.172 -1.193 . . . . 0.0 110.271 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 10' ' ' TRP . 0.0 OUTLIER 52.74 101.79 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.241 -0.912 . . . . 0.0 110.137 179.935 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.515 ' CB ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -82.32 46.77 1.07 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.243 -0.911 . . . . 0.0 110.293 -179.875 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.252 -0.905 . . . . 0.0 110.261 179.964 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.436 ' O ' ' HG3' ' A' ' 1' ' ' LYS . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.308 0.575 . . . . 0.0 110.163 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.527 ' CG2' ' HG ' ' A' ' 49' ' ' LEU . 15.9 tt -133.62 166.31 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.242 -0.912 . . . . 0.0 109.991 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -142.24 138.11 31.2 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.297 -0.877 . . . . 0.0 110.011 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 176.78 -148.67 9.13 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.549 ' CD1' ' N ' ' A' ' 5' ' ' TYR . 18.2 m-85 -123.61 117.61 27.6 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.285 -1.127 . . . . 0.0 110.321 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.609 ' CA ' HG22 ' A' ' 55' ' ' ILE . 45.5 Cg_endo -74.03 134.18 19.2 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.923 1.486 . . . . 0.0 110.159 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.714 HG12 ' HA ' ' A' ' 15' ' ' ILE . 27.2 m -136.99 -168.79 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.142 -0.974 . . . . 0.0 110.475 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.562 ' CB ' ' HB3' ' A' ' 14' ' ' ARG . 0.7 OUTLIER -80.13 172.28 13.98 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.342 -0.849 . . . . 0.0 110.383 -179.821 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.593 ' HB3' ' CE2' ' A' ' 10' ' ' TRP . 0.4 OUTLIER -62.34 -19.56 63.48 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.306 -0.871 . . . . 0.0 109.817 179.706 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.593 ' CE2' ' HB3' ' A' ' 9' ' ' TYR . 2.9 m-90 -131.23 12.87 5.1 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.333 -0.854 . . . . 0.0 110.15 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.611 ' OD1' HG21 ' A' ' 7' ' ' VAL . 88.6 m-20 56.5 35.44 26.01 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.129 -0.982 . . . . 0.0 109.375 -179.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.437 ' SG ' ' HB2' ' A' ' 10' ' ' TRP . 34.8 m -90.74 -53.2 4.51 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.481 -0.762 . . . . 0.0 111.642 -179.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.489 ' O ' ' O ' ' A' ' 14' ' ' ARG . 1.2 mppt? -125.21 -56.41 1.54 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.059 -1.026 . . . . 0.0 111.885 -178.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.562 ' HB3' ' CB ' ' A' ' 8' ' ' ASP . 14.6 tpp180 -36.76 -96.02 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.371 -0.831 . . . . 0.0 111.064 -178.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.714 ' HA ' HG12 ' A' ' 7' ' ' VAL . 72.0 mt 50.4 -88.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 120.954 -1.092 . . . . 0.0 110.515 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.62 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 1.6 t -135.13 134.4 40.18 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.371 -0.831 . . . . 0.0 109.714 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.425 ' O ' ' SG ' ' A' ' 37' ' ' CYS . 0.0 OUTLIER -88.62 -156.52 0.38 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.165 -0.959 . . . . 0.0 110.631 -179.654 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -107.25 -32.32 7.84 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.224 -0.923 . . . . 0.0 110.161 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -87.45 153.52 21.36 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.289 -0.882 . . . . 0.0 110.136 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -86.24 -17.55 34.45 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.179 -0.951 . . . . 0.0 109.997 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.7 ttpp -96.15 -10.56 27.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.284 -0.885 . . . . 0.0 109.992 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -69.39 -58.75 3.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.248 -0.908 . . . . 0.0 110.094 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -65.62 -28.17 68.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.311 -0.868 . . . . 0.0 110.096 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.496 ' O ' ' HG2' ' A' ' 28' ' ' LYS . 6.9 t-20 -69.07 -40.43 78.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.344 -0.848 . . . . 0.0 109.918 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.57 -46.15 87.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.156 -0.965 . . . . 0.0 110.007 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.1 mt -74.27 -42.69 59.21 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.319 -0.863 . . . . 0.0 109.946 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.479 ' SG ' ' HG3' ' A' ' 6' ' ' PRO . 5.7 m -58.95 -39.39 81.53 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.219 -0.926 . . . . 0.0 109.547 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.496 ' HG2' ' O ' ' A' ' 24' ' ' ASN . 2.6 mmmt -60.83 -28.18 68.62 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.196 -0.94 . . . . 0.0 109.443 179.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.12 -35.35 90.69 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 107.677 -2.169 . . . . 0.0 107.677 178.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.547 ' O ' ' HD3' ' A' ' 50' ' ' PRO . 13.6 mt -91.38 21.94 4.21 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.701 -0.882 . . . . 0.0 109.117 178.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.474 ' O ' ' O ' ' A' ' 48' ' ' GLY . 0.7 OUTLIER 67.72 15.43 9.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.426 -0.796 . . . . 0.0 110.95 179.868 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.701 ' HB1' ' HB3' ' A' ' 46' ' ' CYS . . . -83.99 89.44 7.25 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.859 -1.151 . . . . 0.0 109.582 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.402 ' HA ' ' HD3' ' A' ' 28' ' ' LYS . 0.2 OUTLIER -48.03 -83.68 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.322 -0.862 . . . . 0.0 111.195 -179.213 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.509 ' O ' ' HA ' ' A' ' 46' ' ' CYS . 10.0 m -68.97 92.11 0.5 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.296 -0.878 . . . . 0.0 110.5 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.519 ' CA ' ' SG ' ' A' ' 46' ' ' CYS . . . -127.03 97.41 0.48 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.41 ' CZ ' ' HB3' ' A' ' 45' ' ' TYR . 40.6 p90 -119.73 -169.41 1.76 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.235 -1.156 . . . . 0.0 110.658 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 34.4 t -128.12 127.7 43.5 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.363 -0.836 . . . . 0.0 110.268 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.608 ' CD1' ' HB3' ' A' ' 40' ' ' TRP . 28.0 t-105 -79.77 147.25 31.92 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.994 -1.067 . . . . 0.0 110.054 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -110.91 61.11 0.31 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.967 ' CD1' HG22 ' A' ' 41' ' ' THR . 14.2 t-105 -160.31 -70.38 0.07 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.235 -1.156 . . . . 0.0 110.056 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.967 HG22 ' CD1' ' A' ' 40' ' ' TRP . 7.0 t -171.47 34.99 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.443 -0.786 . . . . 0.0 110.178 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.581 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 12.5 mt -119.69 10.29 11.66 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.261 -0.899 . . . . 0.0 110.358 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.62 ' HA ' ' HB2' ' A' ' 16' ' ' CYS . 50.7 m 54.46 -170.52 0.06 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.236 -0.915 . . . . 0.0 110.317 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 15' ' ' ILE . 43.0 t -74.18 155.31 38.5 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.195 -0.941 . . . . 0.0 109.247 179.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.41 ' HB3' ' CZ ' ' A' ' 36' ' ' TYR . 1.0 OUTLIER -137.06 112.56 9.32 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.873 -1.142 . . . . 0.0 111.123 -179.35 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.701 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . 68.1 m -128.8 143.86 51.02 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.296 -0.877 . . . . 0.0 109.837 178.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -126.61 145.68 50.46 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.217 -0.927 . . . . 0.0 110.159 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.476 ' N ' HD23 ' A' ' 49' ' ' LEU . . . 95.56 33.87 6.28 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.987 HD12 ' CB ' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -109.14 171.27 4.59 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.275 -1.133 . . . . 0.0 109.741 179.738 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.547 ' HD3' ' O ' ' A' ' 30' ' ' LEU . 42.4 Cg_endo -69.45 158.68 56.47 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.51 1.269 . . . . 0.0 110.774 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -62.0 -15.33 43.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.333 -0.855 . . . . 0.0 109.885 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -96.59 16.14 19.69 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.344 -0.848 . . . . 0.0 109.819 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.987 ' CB ' HD12 ' A' ' 49' ' ' LEU . . . -60.46 127.88 33.9 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.386 -0.821 . . . . 0.0 110.528 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.508 ' O ' ' HA ' ' A' ' 6' ' ' PRO . 0.5 OUTLIER -71.32 99.53 1.96 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.284 -0.885 . . . . 0.0 109.887 179.742 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.721 HD12 ' C ' ' A' ' 55' ' ' ILE . 2.3 pp -137.4 -160.81 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.181 -0.949 . . . . 0.0 110.463 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.476 ' C ' ' O ' ' A' ' 55' ' ' ILE . 12.8 mttt -29.68 96.8 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 121.382 0.61 . . . . 0.0 111.567 -179.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.437 ' O ' ' CB ' ' A' ' 58' ' ' SER . 0.3 OUTLIER -111.3 0.36 16.67 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.41 -0.806 . . . . 0.0 110.038 179.555 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.437 ' CB ' ' O ' ' A' ' 57' ' ' ARG . 0.4 OUTLIER 66.55 172.9 0.25 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.422 -0.799 . . . . 0.0 110.287 -179.985 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 60' ' ' ARG . . . 86.42 108.75 0.8 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.469 ' O ' ' N ' ' A' ' 62' ' ' ARG . 8.9 mmm-85 -49.36 -179.69 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.283 -1.128 . . . . 0.0 110.302 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.495 ' HA ' ' O ' ' A' ' 10' ' ' TRP . 16.3 t -43.4 96.51 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.248 -0.908 . . . . 0.0 110.149 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.54 ' CA ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -82.76 46.1 1.05 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.166 -0.959 . . . . 0.0 110.244 179.926 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.196 -0.94 . . . . 0.0 110.12 -179.985 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 1.4 mtpp . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.205 0.526 . . . . 0.0 110.269 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.537 HG22 ' O ' ' A' ' 49' ' ' LEU . 7.1 tt -132.94 161.8 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.324 -0.86 . . . . 0.0 110.264 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.463 ' OD1' ' HB3' ' A' ' 47' ' ' GLN . 4.5 m-20 -128.4 129.53 46.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.341 -0.85 . . . . 0.0 109.66 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -169.06 -170.03 33.16 Favored Glycine 0 N--CA 1.494 2.526 0 C-N-CA 119.372 -1.394 . . . . 0.0 110.259 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.557 ' CD1' ' N ' ' A' ' 5' ' ' TYR . 6.8 m-85 -107.69 102.4 44.74 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.431 -1.041 . . . . 0.0 110.485 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.59 138.17 26.31 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 124.004 1.528 . . . . 0.0 110.425 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 1.074 HG12 HG23 ' A' ' 15' ' ' ILE . 21.4 m -120.47 -168.97 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.239 -0.913 . . . . 0.0 110.449 -179.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.557 ' HB2' ' CB ' ' A' ' 13' ' ' LYS . 8.3 p-10 -66.94 -150.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.352 -0.843 . . . . 0.0 110.283 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.617 ' HB3' ' CD2' ' A' ' 10' ' ' TRP . 0.2 OUTLIER -87.13 -33.93 19.26 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.191 -0.943 . . . . 0.0 110.382 -179.861 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.617 ' CD2' ' HB3' ' A' ' 9' ' ' TYR . 8.7 m-90 -129.23 34.36 4.41 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.001 -1.062 . . . . 0.0 110.367 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.506 ' CA ' ' OD1' ' A' ' 8' ' ' ASP . 62.8 m-80 57.17 16.48 3.01 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.125 -0.984 . . . . 0.0 110.297 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.46 ' HB2' ' HA ' ' A' ' 61' ' ' CYS . 2.0 t -109.9 -44.19 3.86 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.208 -0.933 . . . . 0.0 110.488 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.557 ' CB ' ' HB2' ' A' ' 8' ' ' ASP . 0.0 OUTLIER -69.96 58.32 0.15 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.295 -0.878 . . . . 0.0 110.447 -179.733 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.457 ' HB2' ' O ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER 59.34 122.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.322 -0.861 . . . . 0.0 110.903 179.722 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 1.074 HG23 HG12 ' A' ' 7' ' ' VAL . 1.3 mp -79.34 -12.81 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-O 121.747 0.784 . . . . 0.0 109.36 179.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.517 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 1.5 t -146.55 158.05 43.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.458 -0.776 . . . . 0.0 109.263 179.35 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.549 ' CE2' ' CD1' ' A' ' 22' ' ' TYR . 0.0 OUTLIER -104.72 165.77 10.84 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.896 -1.128 . . . . 0.0 110.996 -179.511 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -81.17 -32.26 33.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.068 -1.02 . . . . 0.0 110.266 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -96.2 114.21 25.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.301 -0.874 . . . . 0.0 110.356 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -47.17 -27.98 1.65 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.391 -0.818 . . . . 0.0 110.348 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 29.7 tttm -76.19 -33.14 59.3 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.18 -0.95 . . . . 0.0 110.378 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.549 ' CD1' ' CE2' ' A' ' 17' ' ' TRP . 0.3 OUTLIER -55.12 -41.92 72.31 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.191 -0.943 . . . . 0.0 110.11 179.94 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.29 -52.99 7.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.222 -0.924 . . . . 0.0 110.248 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 35' ' ' GLY . 28.0 t-20 -48.19 -41.2 26.44 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.243 -0.911 . . . . 0.0 110.44 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -57.2 -52.49 65.12 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.263 -0.898 . . . . 0.0 110.556 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.468 HD13 ' CZ3' ' A' ' 17' ' ' TRP . 0.2 OUTLIER -71.41 -34.25 70.18 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.152 -0.968 . . . . 0.0 110.428 -179.753 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.446 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 9.4 m -62.87 -45.69 91.38 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.084 -1.01 . . . . 0.0 109.788 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.94 -27.72 63.64 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.576 -0.85 . . . . 0.0 109.372 179.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.31 -37.99 93.93 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 108.352 -1.899 . . . . 0.0 108.352 179.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.538 ' O ' ' CB ' ' A' ' 31' ' ' LYS . 16.0 mt -90.6 21.18 4.12 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.54 -0.976 . . . . 0.0 109.342 179.099 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.538 ' CB ' ' O ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER 74.26 12.92 3.98 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.743 -0.598 . . . . 0.0 110.736 179.899 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.665 ' CB ' HD22 ' A' ' 49' ' ' LEU . . . -87.32 85.68 7.19 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.843 -1.16 . . . . 0.0 109.829 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -49.5 -87.57 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.414 -0.804 . . . . 0.0 111.186 -179.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.421 ' O ' ' HA ' ' A' ' 46' ' ' CYS . 82.8 p -60.89 96.16 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.303 -0.873 . . . . 0.0 110.73 -179.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.505 ' CA ' ' SG ' ' A' ' 46' ' ' CYS . . . -132.11 123.06 3.5 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.595 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 4.3 p90 -143.98 -174.91 4.4 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.173 -1.193 . . . . 0.0 109.76 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.512 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 26.3 t -124.55 138.0 54.36 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.966 -1.084 . . . . 0.0 110.961 -179.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.602 ' CD1' ' HB2' ' A' ' 42' ' ' LEU . 21.2 t-105 -88.25 99.43 12.22 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.171 -0.955 . . . . 0.0 109.653 179.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -69.36 70.3 0.49 Allowed Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.689 ' CD1' HG22 ' A' ' 41' ' ' THR . 7.5 t-105 -160.53 -65.28 0.07 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.317 -1.107 . . . . 0.0 109.648 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.689 HG22 ' CD1' ' A' ' 40' ' ' TRP . 1.7 t 175.34 36.1 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.564 -0.71 . . . . 0.0 109.885 179.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.602 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 1.0 OUTLIER -124.52 18.75 8.84 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.291 -0.881 . . . . 0.0 110.573 -179.781 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.58 ' CB ' ' CG2' ' A' ' 15' ' ' ILE . 28.8 t 56.22 -177.54 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.193 -0.942 . . . . 0.0 110.764 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.512 ' HA ' ' HA ' ' A' ' 37' ' ' CYS . 15.8 t -70.62 173.21 7.4 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.307 -0.871 . . . . 0.0 109.334 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -154.66 106.27 2.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.945 -1.097 . . . . 0.0 110.528 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.739 ' O ' HD21 ' A' ' 49' ' ' LEU . 75.2 m -127.21 137.8 52.98 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.389 -0.819 . . . . 0.0 109.736 179.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.463 ' HB3' ' OD1' ' A' ' 3' ' ' ASP . 16.9 mt-30 -116.66 130.83 56.97 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.152 -0.967 . . . . 0.0 109.966 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.505 ' O ' ' O ' ' A' ' 31' ' ' LYS . . . 117.88 24.38 3.36 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.944 HD12 ' CB ' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -104.04 173.42 3.4 Favored Pre-proline 0 N--CA 1.498 1.925 0 O-C-N 121.077 -1.249 . . . . 0.0 109.513 179.591 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.528 ' HD2' ' HB2' ' A' ' 49' ' ' LEU . 41.5 Cg_endo -68.87 156.86 64.05 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.443 1.233 . . . . 0.0 110.559 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -59.2 -21.58 59.69 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.259 -0.9 . . . . 0.0 110.222 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -90.48 14.03 14.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.376 -0.827 . . . . 0.0 109.987 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.944 ' CB ' HD12 ' A' ' 49' ' ' LEU . . . -57.94 125.51 23.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.291 -0.881 . . . . 0.0 110.153 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.594 ' CB ' ' CZ ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -64.71 140.52 58.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.098 -1.001 . . . . 0.0 109.957 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.579 HG22 ' N ' ' A' ' 56' ' ' LYS . 26.3 mm -141.02 175.33 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.19 -0.943 . . . . 0.0 110.415 -179.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.855 ' HG2' HG11 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -60.82 82.82 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.332 -0.855 . . . . 0.0 110.074 179.486 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.442 ' N ' ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -95.56 20.81 9.06 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.1 -1.0 . . . . 0.0 110.356 -179.964 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.42 ' HB3' ' O ' ' A' ' 57' ' ' ARG . 4.7 t 63.24 -169.13 0.19 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.289 -0.882 . . . . 0.0 110.375 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 60' ' ' ARG . . . 121.03 -5.46 11.21 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.465 ' O ' ' O ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER 41.95 80.91 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.232 -1.158 . . . . 0.0 110.572 179.751 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.465 ' O ' ' O ' ' A' ' 60' ' ' ARG . 27.2 m 48.44 100.39 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.347 -0.846 . . . . 0.0 110.619 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.53 ' CB ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -89.75 44.26 1.2 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.241 -0.912 . . . . 0.0 110.095 179.699 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.235 -0.916 . . . . 0.0 110.181 -179.86 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 10.3 ttmt . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.25 0.548 . . . . 0.0 110.221 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.671 HG22 ' O ' ' A' ' 49' ' ' LEU . 18.6 tt -127.58 158.77 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.134 -0.979 . . . . 0.0 110.285 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.512 ' HB2' ' HG3' ' A' ' 47' ' ' GLN . 2.5 p30 -133.37 139.28 46.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.366 -0.834 . . . . 0.0 110.102 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.475 ' C ' ' CD1' ' A' ' 5' ' ' TYR . . . 174.18 -164.53 35.76 Favored Glycine 0 N--CA 1.492 2.373 0 C-N-CA 119.685 -1.245 . . . . 0.0 110.057 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.581 ' CD1' ' N ' ' A' ' 5' ' ' TYR . 1.2 m-85 -112.62 98.58 44.81 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.25 -1.147 . . . . 0.0 110.51 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.506 ' HD2' ' O ' ' A' ' 44' ' ' CYS . 44.8 Cg_endo -72.94 116.75 4.84 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.928 1.489 . . . . 0.0 110.557 179.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 1.035 HG12 HG23 ' A' ' 15' ' ' ILE . 21.3 m -79.97 -177.22 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.492 -0.755 . . . . 0.0 110.078 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.473 ' O ' ' NE ' ' A' ' 54' ' ' ARG . 77.5 m-20 -61.72 -96.67 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.131 -0.98 . . . . 0.0 110.114 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.499 ' HB3' ' CE3' ' A' ' 10' ' ' TRP . 0.2 OUTLIER -131.94 -59.02 0.95 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.102 -0.999 . . . . 0.0 109.594 179.63 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.499 ' CE3' ' HB3' ' A' ' 9' ' ' TYR . 13.8 m-90 -106.99 17.13 23.46 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.468 -0.77 . . . . 0.0 109.46 179.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.517 ' N ' ' OD1' ' A' ' 11' ' ' ASN . 1.3 m-20 60.67 11.7 3.26 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.353 -0.842 . . . . 0.0 110.302 -179.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 63.5 m -60.38 -60.25 4.12 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.12 -0.988 . . . . 0.0 110.518 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.44 ' O ' ' CG ' ' A' ' 14' ' ' ARG . 0.8 OUTLIER -63.61 -63.49 1.16 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.365 -0.834 . . . . 0.0 110.325 -179.792 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.44 ' CG ' ' O ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER 173.1 176.78 0.1 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.276 -0.89 . . . . 0.0 110.423 179.977 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 1.035 HG23 HG12 ' A' ' 7' ' ' VAL . 1.0 OUTLIER -77.68 -15.25 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.297 -0.877 . . . . 0.0 109.452 179.813 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.608 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 10.9 t -141.49 157.99 44.43 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.413 -0.804 . . . . 0.0 109.872 179.068 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.478 ' CE3' ' CG ' ' A' ' 22' ' ' TYR . 22.9 t90 -95.67 -112.58 0.13 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.178 -0.951 . . . . 0.0 110.059 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -157.92 58.64 0.48 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.847 -1.158 . . . . 0.0 110.182 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.459 ' HB2' ' CE3' ' A' ' 17' ' ' TRP . 0.2 OUTLIER -170.91 153.58 3.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.378 -0.826 . . . . 0.0 110.086 179.97 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -84.69 -5.1 59.3 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.177 -0.952 . . . . 0.0 110.5 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -119.2 -30.69 4.89 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.066 -1.021 . . . . 0.0 110.735 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.478 ' CG ' ' CE3' ' A' ' 17' ' ' TRP . 26.3 t80 -54.1 -54.12 43.86 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.089 -1.007 . . . . 0.0 110.178 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.438 ' O ' ' HB2' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -62.04 -20.06 63.55 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.199 -0.938 . . . . 0.0 109.695 179.853 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.517 ' CB ' ' O ' ' A' ' 35' ' ' GLY . 0.2 OUTLIER -84.74 -42.71 14.97 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.266 -0.896 . . . . 0.0 110.457 -179.913 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -59.18 -43.41 92.16 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.028 -1.045 . . . . 0.0 109.759 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.703 ' O ' HD12 ' A' ' 30' ' ' LEU . 6.3 mt -71.55 -46.43 59.52 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.272 -0.892 . . . . 0.0 109.898 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.501 ' SG ' ' CG ' ' A' ' 6' ' ' PRO . 1.3 m -59.48 -40.13 85.99 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.301 -0.874 . . . . 0.0 110.017 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' A' ' 32' ' ' ALA . 0.1 OUTLIER -64.81 -33.31 75.7 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.268 -0.895 . . . . 0.0 109.141 179.389 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -53.43 -34.5 48.94 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 108.356 -1.898 . . . . 0.0 108.356 179.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.703 HD12 ' O ' ' A' ' 26' ' ' LEU . 1.8 mp -81.43 -35.51 30.55 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.469 -1.018 . . . . 0.0 109.353 179.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.652 ' CB ' ' O ' ' A' ' 30' ' ' LEU . 1.5 ttmm 141.8 -2.66 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.576 0 C-N-CA 123.051 0.54 . . . . 0.0 110.027 179.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.574 ' HB1' ' HB3' ' A' ' 46' ' ' CYS . . . -80.7 94.82 6.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.991 -1.068 . . . . 0.0 110.345 -179.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.484 ' HA ' ' CG ' ' A' ' 28' ' ' LYS . 11.5 m-20 -65.11 -46.0 82.85 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.294 -0.878 . . . . 0.0 110.271 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.426 ' O ' ' HA ' ' A' ' 46' ' ' CYS . 0.2 OUTLIER -85.19 80.39 9.23 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.327 -0.858 . . . . 0.0 110.301 -179.865 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.517 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -119.06 103.39 0.99 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -126.38 133.15 51.38 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.23 -1.159 . . . . 0.0 110.404 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.0 OUTLIER -84.67 127.48 34.11 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.207 -0.933 . . . . 0.0 110.167 179.875 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.535 ' CB ' ' HB2' ' A' ' 42' ' ' LEU . 0.3 OUTLIER -79.92 139.81 36.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.254 -0.904 . . . . 0.0 110.258 -179.899 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -90.83 12.16 69.7 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.883 ' CD1' HG22 ' A' ' 41' ' ' THR . 21.4 t-105 -105.03 -70.16 0.79 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.316 -1.108 . . . . 0.0 110.151 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.883 HG22 ' CD1' ' A' ' 40' ' ' TRP . 14.1 t -172.35 32.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.399 -0.813 . . . . 0.0 110.343 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.535 ' HB2' ' CB ' ' A' ' 38' ' ' TRP . 0.2 OUTLIER -112.16 13.65 20.57 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.201 -0.937 . . . . 0.0 110.236 179.961 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.654 ' OG ' HG22 ' A' ' 15' ' ' ILE . 28.0 t 44.12 -166.1 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.281 -0.887 . . . . 0.0 110.916 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.557 ' N ' ' HB2' ' A' ' 16' ' ' CYS . 21.5 t -68.57 113.67 6.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.509 -0.744 . . . . 0.0 109.669 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.425 ' CE2' ' HE1' ' A' ' 5' ' ' TYR . 2.7 t80 -99.62 123.52 43.96 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.176 -0.952 . . . . 0.0 110.145 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.644 ' O ' HD21 ' A' ' 49' ' ' LEU . 59.7 m -134.94 128.13 31.94 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.295 -0.878 . . . . 0.0 110.141 179.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.512 ' HG3' ' HB2' ' A' ' 3' ' ' ASP . 0.5 OUTLIER -117.37 135.64 53.72 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.316 -0.865 . . . . 0.0 109.842 179.843 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.55 ' N ' HD23 ' A' ' 49' ' ' LEU . . . 99.63 44.14 2.36 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.804 HD12 ' CB ' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -115.63 172.25 3.87 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.299 -1.118 . . . . 0.0 109.84 179.64 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.533 ' HD3' ' HB3' ' A' ' 31' ' ' LYS . 46.0 Cg_endo -72.04 157.82 53.63 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.832 1.438 . . . . 0.0 110.599 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -59.38 -19.96 51.1 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.208 -0.932 . . . . 0.0 109.941 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -83.84 6.68 20.58 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.281 -0.887 . . . . 0.0 110.04 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.804 ' CB ' HD12 ' A' ' 49' ' ' LEU . . . -63.77 106.81 1.06 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.345 -0.847 . . . . 0.0 110.257 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.738 ' O ' HD13 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -62.42 156.45 22.61 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.244 -0.91 . . . . 0.0 109.93 179.744 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.738 HD13 ' O ' ' A' ' 54' ' ' ARG . 10.7 mm -142.77 -179.8 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.341 -0.849 . . . . 0.0 110.264 -179.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.643 ' H ' HG22 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -60.38 84.31 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.436 -0.79 . . . . 0.0 110.124 179.277 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.504 ' HG2' ' NH1' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -106.09 -11.86 15.97 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.246 -0.909 . . . . 0.0 110.264 -179.942 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -146.1 167.04 24.38 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.335 -0.853 . . . . 0.0 110.191 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -148.62 35.64 1.11 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.526 ' O ' ' O ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER -136.98 41.72 2.47 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.111 -1.229 . . . . 0.0 110.383 179.767 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.526 ' O ' ' O ' ' A' ' 60' ' ' ARG . 49.6 t 41.06 106.54 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 121.586 0.708 . . . . 0.0 111.697 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.479 ' CB ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -83.19 40.09 0.69 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.186 -0.946 . . . . 0.0 110.688 179.56 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.658 0 O-C-N 121.086 -1.009 . . . . 0.0 110.296 179.947 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.271 0.558 . . . . 0.0 110.135 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.559 HG23 ' HG ' ' A' ' 49' ' ' LEU . 20.6 tt -126.01 160.58 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.295 -0.878 . . . . 0.0 110.181 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -139.75 128.9 23.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.311 -0.868 . . . . 0.0 110.007 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -177.58 -145.36 5.81 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.941 -1.263 . . . . 0.0 109.941 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.625 ' CD1' ' N ' ' A' ' 5' ' ' TYR . 12.8 m-85 -122.5 97.11 45.13 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.274 -1.133 . . . . 0.0 110.099 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.454 ' HA ' ' O ' ' A' ' 54' ' ' ARG . 42.5 Cg_endo -69.91 126.84 13.66 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.003 1.528 . . . . 0.0 110.815 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.633 HG12 ' CG1' ' A' ' 15' ' ' ILE . 15.2 m -85.38 -169.45 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.484 -0.76 . . . . 0.0 110.511 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.479 ' O ' ' NH1' ' A' ' 54' ' ' ARG . 2.6 t70 -63.15 -158.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.367 -0.833 . . . . 0.0 110.296 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.465 ' HB3' ' CE2' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -91.17 -20.3 22.13 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.296 -0.878 . . . . 0.0 110.176 179.972 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.501 ' HB3' ' N ' ' A' ' 62' ' ' ARG . 5.0 m-90 -128.25 18.24 6.5 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.176 -0.953 . . . . 0.0 110.52 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.469 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 8.3 m-20 59.88 12.7 3.19 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.343 -0.848 . . . . 0.0 110.372 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 3.5 t -79.23 -50.22 11.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.118 -0.989 . . . . 0.0 109.634 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.464 ' O ' ' O ' ' A' ' 14' ' ' ARG . 1.2 mptm? -79.97 152.38 29.54 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.464 -0.772 . . . . 0.0 109.611 179.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.464 ' O ' ' O ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -46.11 173.5 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.168 -0.958 . . . . 0.0 110.125 -179.921 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.633 ' CG1' HG12 ' A' ' 7' ' ' VAL . 3.9 mt -71.34 -1.94 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.113 -0.992 . . . . 0.0 109.853 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.568 ' HB2' ' N ' ' A' ' 44' ' ' CYS . 18.9 t -146.6 154.44 41.49 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.384 -0.823 . . . . 0.0 110.006 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.565 ' CZ3' ' CG ' ' A' ' 22' ' ' TYR . 28.3 t90 -118.39 169.54 9.66 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.118 -0.989 . . . . 0.0 109.796 179.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.421 ' N ' ' CG ' ' A' ' 17' ' ' TRP . 23.2 t80 -79.48 92.86 5.31 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.216 -0.928 . . . . 0.0 109.564 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.54 ' HB2' ' HB2' ' A' ' 22' ' ' TYR . 4.2 p-10 -174.3 142.47 0.79 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.289 -0.882 . . . . 0.0 110.517 -179.383 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 32.3 p30 -90.69 7.97 36.82 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.237 -0.914 . . . . 0.0 109.871 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.6 mttt -154.64 -28.69 0.11 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.145 -0.972 . . . . 0.0 111.724 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.565 ' CG ' ' CZ3' ' A' ' 17' ' ' TRP . 1.6 t80 -47.85 -21.54 0.43 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.555 -1.341 . . . . 0.0 110.576 -179.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -87.0 -34.9 19.09 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.05 -1.031 . . . . 0.0 110.327 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.475 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 12.3 t-20 -72.67 -40.31 66.4 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.07 -1.018 . . . . 0.0 109.697 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -62.75 -33.87 76.05 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.323 -0.86 . . . . 0.0 109.93 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.601 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -83.23 -44.22 15.23 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.315 -0.866 . . . . 0.0 109.148 179.55 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.435 ' N ' ' HG ' ' A' ' 26' ' ' LEU . 1.5 m -58.71 -40.79 84.7 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.536 -0.728 . . . . 0.0 109.562 179.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 24' ' ' ASN . 0.2 OUTLIER -64.34 -33.97 77.07 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.268 -0.895 . . . . 0.0 109.015 179.165 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.07 -37.33 45.5 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 108.589 -1.804 . . . . 0.0 108.589 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.672 ' O ' ' CB ' ' A' ' 31' ' ' LYS . 4.1 mt -79.75 -35.47 38.74 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.454 -1.027 . . . . 0.0 109.472 179.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.672 ' CB ' ' O ' ' A' ' 30' ' ' LEU . 21.5 tttt 139.21 2.88 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.575 0 C-N-CA 123.122 0.569 . . . . 0.0 110.131 179.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.543 ' HB2' HD22 ' A' ' 49' ' ' LEU . . . -88.25 109.3 19.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.781 -1.199 . . . . 0.0 110.18 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.447 ' HA ' ' HG3' ' A' ' 28' ' ' LYS . 2.6 m-20 -78.62 -44.4 24.05 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.142 -0.974 . . . . 0.0 110.402 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.494 ' O ' ' HA ' ' A' ' 46' ' ' CYS . 2.0 t -82.6 73.72 9.62 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.276 -0.89 . . . . 0.0 110.215 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.486 ' CA ' ' SG ' ' A' ' 46' ' ' CYS . . . -118.32 120.91 4.87 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.531 ' CD1' ' C ' ' A' ' 36' ' ' TYR . 14.0 p90 -143.79 153.89 42.86 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.322 -1.105 . . . . 0.0 109.742 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.503 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.0 OUTLIER -107.26 126.6 52.63 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.976 -1.077 . . . . 0.0 110.843 -179.443 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.609 ' CD1' ' HB3' ' A' ' 40' ' ' TRP . 43.7 t-105 -89.1 114.71 25.99 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.461 -0.774 . . . . 0.0 109.816 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.9 73.31 2.45 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 -179.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.688 ' CD1' HG22 ' A' ' 41' ' ' THR . 0.1 OUTLIER -160.59 -73.27 0.07 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.283 -1.127 . . . . 0.0 109.8 179.395 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.688 HG22 ' CD1' ' A' ' 40' ' ' TRP . 15.0 t -169.0 39.29 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.506 -0.746 . . . . 0.0 109.908 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.569 HD13 ' CD1' ' A' ' 38' ' ' TRP . 0.4 OUTLIER -130.21 1.71 4.68 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.253 -0.904 . . . . 0.0 110.344 -179.897 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.538 ' HA ' ' HB2' ' A' ' 16' ' ' CYS . 48.9 m 56.12 -166.94 0.11 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.148 -0.97 . . . . 0.0 110.365 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.568 ' N ' ' HB2' ' A' ' 16' ' ' CYS . 6.8 t -77.91 151.37 33.81 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.253 -0.904 . . . . 0.0 110.171 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.539 ' CD1' ' CZ ' ' A' ' 5' ' ' TYR . 6.9 t80 -135.16 102.71 5.28 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.271 -0.893 . . . . 0.0 110.484 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.637 ' O ' HD21 ' A' ' 49' ' ' LEU . 76.7 m -118.61 133.96 55.47 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.162 -0.961 . . . . 0.0 109.95 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 16.1 mt-30 -119.86 134.66 55.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.261 -0.899 . . . . 0.0 109.778 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.516 ' N ' HD23 ' A' ' 49' ' ' LEU . . . 104.93 38.87 2.43 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.771 HD12 ' CB ' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -114.61 172.25 3.76 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.385 -1.068 . . . . 0.0 109.739 179.785 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.492 ' HD2' ' HB2' ' A' ' 49' ' ' LEU . 46.0 Cg_endo -71.94 156.31 56.52 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.676 1.356 . . . . 0.0 110.398 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.451 ' OD1' ' O ' ' A' ' 51' ' ' ASP . 21.0 t0 -60.34 -20.07 57.95 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.176 -0.952 . . . . 0.0 110.188 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -79.85 0.7 29.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.309 -0.869 . . . . 0.0 110.102 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.771 ' CB ' HD12 ' A' ' 49' ' ' LEU . . . -62.43 101.12 0.21 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.365 -0.834 . . . . 0.0 110.01 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.871 ' O ' HD13 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -55.33 149.85 12.33 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.079 -1.013 . . . . 0.0 110.218 -179.69 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.871 HD13 ' O ' ' A' ' 54' ' ' ARG . 35.5 mm -139.97 169.76 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.309 -0.87 . . . . 0.0 109.939 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.694 ' HG3' HG22 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -42.37 96.21 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.203 -0.936 . . . . 0.0 110.146 179.66 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.485 ' N ' ' O ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -125.51 7.6 7.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.197 -0.939 . . . . 0.0 110.092 179.923 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 58.64 160.39 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.29 -0.881 . . . . 0.0 110.494 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 148.41 -170.29 28.95 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.37 158.69 15.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.2 -1.177 . . . . 0.0 109.997 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 55.9 m -56.73 119.52 6.31 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.226 -0.921 . . . . 0.0 110.13 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.501 ' N ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -83.45 45.35 1.04 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.2 -0.937 . . . . 0.0 110.153 179.834 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.578 0 O-C-N 121.207 -0.933 . . . . 0.0 110.324 -179.758 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 1.5 tttt . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.3 0.571 . . . . 0.0 110.31 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.781 HG22 ' O ' ' A' ' 49' ' ' LEU . 5.9 tt -142.24 160.5 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.137 -0.977 . . . . 0.0 110.136 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.457 ' OD1' ' O ' ' A' ' 3' ' ' ASP . 3.6 p30 -126.9 122.65 35.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.301 -0.875 . . . . 0.0 110.383 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -165.11 -164.77 21.19 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.786 ' CE2' HD22 ' A' ' 42' ' ' LEU . 15.8 m-85 -117.31 107.9 44.53 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.227 -1.16 . . . . 0.0 110.487 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.629 ' N ' HG22 ' A' ' 55' ' ' ILE . 49.6 Cg_endo -76.82 129.9 11.08 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 124.034 1.544 . . . . 0.0 110.649 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.729 HG12 HG23 ' A' ' 15' ' ' ILE . 32.8 m -105.63 -165.34 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.316 -0.865 . . . . 0.0 109.678 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.496 ' OD1' ' CZ3' ' A' ' 10' ' ' TRP . 5.0 t70 -60.56 -139.27 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.318 -0.864 . . . . 0.0 109.85 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.433 ' C ' ' CG ' ' A' ' 10' ' ' TRP . 3.2 m-85 -110.17 -4.11 15.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.083 -1.01 . . . . 0.0 110.079 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.642 ' CG ' ' HB2' ' A' ' 63' ' ' ALA . 1.3 m-90 -143.55 8.58 1.55 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.254 -0.904 . . . . 0.0 110.165 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.517 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 7.5 m-20 66.56 2.29 2.45 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.631 -0.668 . . . . 0.0 110.894 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.429 ' O ' ' C ' ' A' ' 13' ' ' LYS . 0.6 OUTLIER -85.66 -59.09 2.41 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.165 -0.959 . . . . 0.0 110.5 -179.965 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.492 ' CB ' ' OD2' ' A' ' 8' ' ' ASP . 27.8 mmtt -41.99 -70.45 0.11 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.38 -0.825 . . . . 0.0 110.464 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.486 ' HG3' ' O ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -172.55 -178.7 2.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.272 -0.892 . . . . 0.0 110.286 -179.808 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.841 HG22 ' OG ' ' A' ' 43' ' ' SER . 0.6 OUTLIER -104.13 -17.85 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.273 -0.892 . . . . 0.0 109.442 179.935 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.628 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 5.3 t -158.42 174.31 15.31 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.375 -0.828 . . . . 0.0 110.462 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -100.8 -148.85 0.37 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.266 -0.896 . . . . 0.0 110.372 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -120.27 -37.28 3.08 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.152 -0.968 . . . . 0.0 110.331 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -82.3 140.64 33.47 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.351 -0.843 . . . . 0.0 110.402 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -69.24 -5.33 22.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.274 -0.891 . . . . 0.0 110.322 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.2 -31.6 7.84 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.159 -0.963 . . . . 0.0 110.4 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -63.18 -18.59 63.64 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.229 -0.92 . . . . 0.0 110.478 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.453 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 0.1 OUTLIER -90.53 -54.64 3.91 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.067 -1.02 . . . . 0.0 110.283 179.923 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.501 ' CB ' ' O ' ' A' ' 35' ' ' GLY . 52.0 t30 -48.98 -36.67 18.12 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.173 -0.954 . . . . 0.0 110.01 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.406 ' OD1' ' C ' ' A' ' 25' ' ' ASP . 13.1 t0 -57.78 -53.75 54.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.346 -0.846 . . . . 0.0 110.078 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.74 -42.75 85.74 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.201 -0.937 . . . . 0.0 110.263 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.477 ' HA ' HD12 ' A' ' 30' ' ' LEU . 1.3 m -58.86 -33.27 70.28 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.156 -0.965 . . . . 0.0 109.54 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.5 tptm -63.37 -30.69 71.78 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.304 -0.873 . . . . 0.0 109.083 179.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.18 -32.58 83.02 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 107.825 -2.11 . . . . 0.0 107.825 178.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.532 ' O ' ' CD ' ' A' ' 50' ' ' PRO . 2.9 mt -90.54 21.56 3.9 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.59 -0.947 . . . . 0.0 109.106 178.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.517 ' HB3' ' O ' ' A' ' 30' ' ' LEU . 13.0 tttm 65.25 20.32 11.88 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.815 -0.553 . . . . 0.0 110.78 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.842 ' HB2' HD22 ' A' ' 49' ' ' LEU . . . -91.97 89.9 7.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.028 -1.045 . . . . 0.0 110.039 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -49.79 -79.66 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.371 -0.831 . . . . 0.0 110.667 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.419 ' O ' ' HA ' ' A' ' 46' ' ' CYS . 75.2 m -71.04 91.4 0.89 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.215 -0.928 . . . . 0.0 110.438 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.521 ' CA ' ' SG ' ' A' ' 46' ' ' CYS . . . -131.56 123.72 3.81 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.418 ' CD1' ' C ' ' A' ' 36' ' ' TYR . 5.0 p90 -142.81 -175.29 4.44 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.177 -1.19 . . . . 0.0 110.594 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 6.2 t -115.91 136.35 53.12 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.217 -0.927 . . . . 0.0 110.406 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.617 ' CD1' ' HB2' ' A' ' 42' ' ' LEU . 1.9 t-105 -79.92 150.94 30.38 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.146 -0.971 . . . . 0.0 109.674 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -98.1 -13.81 41.37 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 -179.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 1.059 ' CD1' HG22 ' A' ' 41' ' ' THR . 40.8 t-105 -84.06 -73.05 0.44 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.216 -1.167 . . . . 0.0 109.936 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 1.059 HG22 ' CD1' ' A' ' 40' ' ' TRP . 7.5 t -179.66 50.52 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.554 -0.716 . . . . 0.0 109.748 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.786 HD22 ' CE2' ' A' ' 5' ' ' TYR . 0.5 OUTLIER -120.84 21.32 11.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.315 -0.866 . . . . 0.0 110.638 -179.554 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.841 ' OG ' HG22 ' A' ' 15' ' ' ILE . 28.2 t 50.99 -168.57 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.116 -0.99 . . . . 0.0 110.406 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.555 ' CA ' ' SG ' ' A' ' 16' ' ' CYS . 3.0 t -77.25 135.0 38.43 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.201 -0.937 . . . . 0.0 109.67 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.628 ' CD1' ' CE2' ' A' ' 5' ' ' TYR . 8.1 t80 -122.05 109.56 14.71 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.199 -0.938 . . . . 0.0 110.234 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.627 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . 24.2 m -125.52 149.13 48.57 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.471 -0.768 . . . . 0.0 109.732 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.429 ' OE1' ' HB2' ' A' ' 3' ' ' ASP . 24.8 mt-30 -130.03 137.96 50.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.267 -0.895 . . . . 0.0 110.333 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 31' ' ' LYS . . . 112.32 22.84 5.69 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.92 HD12 ' CB ' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -99.85 170.26 6.99 Favored Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.128 -1.219 . . . . 0.0 109.999 179.645 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.532 ' CD ' ' O ' ' A' ' 30' ' ' LEU . 41.5 Cg_endo -67.31 155.06 72.1 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.978 1.515 . . . . 0.0 110.457 -179.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -56.94 -23.06 42.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.324 -0.86 . . . . 0.0 110.162 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -87.56 13.61 9.9 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.276 -0.89 . . . . 0.0 110.237 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.92 ' CB ' HD12 ' A' ' 49' ' ' LEU . . . -62.32 115.41 4.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.282 -0.887 . . . . 0.0 110.074 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.464 ' O ' ' HA ' ' A' ' 6' ' ' PRO . 0.1 OUTLIER -72.29 133.8 45.21 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.228 -0.92 . . . . 0.0 110.551 -179.811 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.76 HG22 ' C ' ' A' ' 5' ' ' TYR . 1.3 pp -142.98 -167.52 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.426 -0.796 . . . . 0.0 110.209 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.431 ' HG3' HD13 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -41.05 91.74 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.342 -0.849 . . . . 0.0 111.007 -179.386 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.566 ' O ' ' C ' ' A' ' 58' ' ' SER . 10.3 mtp85 -120.48 21.81 11.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.199 -0.938 . . . . 0.0 109.323 179.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.566 ' C ' ' O ' ' A' ' 57' ' ' ARG . 0.2 OUTLIER -7.45 122.93 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.255 0 CA-C-O 121.475 0.655 . . . . 0.0 112.432 -179.571 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -142.43 -103.41 0.48 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.457 ' O ' ' O ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER -132.64 48.05 2.45 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.241 -1.153 . . . . 0.0 110.253 179.973 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.457 ' O ' ' O ' ' A' ' 60' ' ' ARG . 0.8 OUTLIER 40.24 91.46 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.505 -0.747 . . . . 0.0 109.933 179.938 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.562 ' O ' ' CD1' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -81.31 47.41 1.03 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.106 -0.997 . . . . 0.0 110.479 -179.666 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.642 ' HB2' ' CG ' ' A' ' 10' ' ' TRP . . . . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.171 -0.955 . . . . 0.0 110.332 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 12.4 ptmt . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.255 0.55 . . . . 0.0 110.279 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.457 ' O ' ' OD1' ' A' ' 3' ' ' ASP . 10.3 tt -125.02 163.16 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.326 -0.859 . . . . 0.0 110.159 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.457 ' OD1' ' O ' ' A' ' 2' ' ' ILE . 85.2 m-20 -135.91 136.12 40.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.343 -0.848 . . . . 0.0 109.979 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -178.39 -159.52 23.08 Favored Glycine 0 N--CA 1.492 2.388 0 C-N-CA 119.608 -1.282 . . . . 0.0 109.977 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.638 ' CD1' ' N ' ' A' ' 5' ' ' TYR . 5.4 m-85 -120.14 111.27 35.51 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.41 -1.053 . . . . 0.0 109.774 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.438 ' HD2' ' HB3' ' A' ' 44' ' ' CYS . 45.4 Cg_endo -72.22 144.79 42.44 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.949 1.499 . . . . 0.0 110.877 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.9 HG12 HG23 ' A' ' 15' ' ' ILE . 15.7 m -99.71 -168.07 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.324 -0.86 . . . . 0.0 110.392 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -72.87 -128.04 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.4 -0.813 . . . . 0.0 110.105 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -115.55 -33.04 5.36 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.915 -1.115 . . . . 0.0 110.327 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.528 ' O ' ' HB2' ' A' ' 11' ' ' ASN . 4.1 m-90 -112.7 13.38 19.86 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.178 -0.952 . . . . 0.0 110.301 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.528 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 3.0 m-20 62.23 6.61 1.9 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.548 -0.72 . . . . 0.0 110.705 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 16.9 m -76.92 -67.02 0.75 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.062 -1.024 . . . . 0.0 110.358 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.432 ' O ' ' O ' ' A' ' 14' ' ' ARG . 2.9 mptm? -58.63 173.53 0.4 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.497 -0.752 . . . . 0.0 110.506 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.432 ' O ' ' O ' ' A' ' 13' ' ' LYS . 5.0 ttp180 -50.78 -178.54 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.352 -0.842 . . . . 0.0 110.139 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.9 HG23 HG12 ' A' ' 7' ' ' VAL . 4.0 mt -95.95 26.04 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.238 -0.914 . . . . 0.0 109.794 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.551 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 8.7 t -151.94 159.41 43.8 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.463 -0.773 . . . . 0.0 110.044 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.96 ' CZ3' HD13 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -85.75 -152.68 0.17 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.223 -0.923 . . . . 0.0 110.266 -179.967 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -120.33 44.43 2.45 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.289 -0.882 . . . . 0.0 110.357 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -176.84 158.78 1.67 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.151 -0.968 . . . . 0.0 110.321 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 34.8 t30 -82.9 -7.18 59.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.263 -0.898 . . . . 0.0 110.239 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.6 tptt -110.1 -31.32 7.4 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.256 -0.902 . . . . 0.0 109.971 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -54.64 -31.23 57.09 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.327 -0.858 . . . . 0.0 110.269 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 27' ' ' CYS . 0.1 OUTLIER -91.38 -32.77 15.53 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.223 -0.923 . . . . 0.0 110.481 -179.663 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.513 ' CB ' ' O ' ' A' ' 35' ' ' GLY . 25.1 t30 -70.63 -44.32 67.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.106 -0.996 . . . . 0.0 110.133 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -56.27 -45.57 80.07 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.232 -0.918 . . . . 0.0 110.468 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.96 HD13 ' CZ3' ' A' ' 17' ' ' TRP . 0.2 OUTLIER -78.1 -40.33 38.65 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.208 -0.932 . . . . 0.0 110.332 -179.9 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 23' ' ' CYS . 1.6 m -57.45 -37.8 73.43 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.146 -0.971 . . . . 0.0 109.522 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.99 -28.12 69.88 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.427 -0.796 . . . . 0.0 109.524 179.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.62 -34.97 90.4 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 107.873 -2.091 . . . . 0.0 107.873 178.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.532 ' O ' ' HD3' ' A' ' 50' ' ' PRO . 1.3 mt -89.16 17.8 5.62 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.707 -0.878 . . . . 0.0 109.325 178.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.528 ' CB ' ' O ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER 72.54 14.79 5.16 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.64 -0.662 . . . . 0.0 111.161 179.688 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.687 ' HB1' ' HB3' ' A' ' 46' ' ' CYS . . . -85.3 81.0 8.96 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.786 -1.196 . . . . 0.0 109.633 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 32' ' ' ALA . 0.1 OUTLIER -39.89 -80.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.373 -0.83 . . . . 0.0 110.842 -179.32 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.497 ' O ' ' HA ' ' A' ' 46' ' ' CYS . 57.9 m -69.85 90.16 0.6 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.33 -0.856 . . . . 0.0 110.514 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.513 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -122.26 89.18 0.42 Allowed Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 29.6 p90 -118.25 153.82 33.28 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.244 -1.151 . . . . 0.0 109.964 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.507 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.1 OUTLIER -107.31 134.59 50.16 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.148 -0.97 . . . . 0.0 110.632 -179.567 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.575 ' CD1' ' HB2' ' A' ' 42' ' ' LEU . 14.6 t-105 -83.67 125.57 31.99 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.396 -0.815 . . . . 0.0 109.908 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -89.15 64.25 3.33 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.568 ' HB3' ' CD1' ' A' ' 38' ' ' TRP . 0.1 OUTLIER -155.84 -80.4 0.08 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.299 -1.118 . . . . 0.0 109.648 179.816 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.615 HG23 ' O ' ' A' ' 41' ' ' THR . 2.6 t -162.68 33.64 0.1 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.361 -0.837 . . . . 0.0 109.869 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.575 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 0.4 OUTLIER -117.9 4.92 12.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.333 -0.854 . . . . 0.0 110.363 -179.753 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.551 ' HA ' ' HB2' ' A' ' 16' ' ' CYS . 13.0 m 59.96 -170.93 0.13 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.218 -0.927 . . . . 0.0 110.456 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.507 ' HA ' ' HA ' ' A' ' 37' ' ' CYS . 19.3 t -75.57 156.45 34.99 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.297 -0.877 . . . . 0.0 109.977 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -140.82 99.54 3.63 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.016 -1.053 . . . . 0.0 110.917 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.687 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . 65.6 m -120.51 139.77 52.41 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.241 -0.912 . . . . 0.0 109.551 178.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.44 ' HA ' ' OD1' ' A' ' 3' ' ' ASP . 58.8 mt-30 -126.24 138.96 53.67 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.201 -0.937 . . . . 0.0 110.201 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.55 ' N ' HD23 ' A' ' 49' ' ' LEU . . . 103.8 32.61 4.38 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 -179.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.961 HD12 ' CB ' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -110.2 172.34 3.67 Favored Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 121.276 -1.132 . . . . 0.0 109.506 179.843 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.532 ' HD3' ' O ' ' A' ' 30' ' ' LEU . 42.5 Cg_endo -67.78 162.17 40.68 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 O-C-N 123.514 1.271 . . . . 0.0 110.7 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -64.58 -19.78 65.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.354 -0.841 . . . . 0.0 110.134 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -92.68 15.57 14.14 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.265 -0.897 . . . . 0.0 109.997 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.961 ' CB ' HD12 ' A' ' 49' ' ' LEU . . . -62.29 141.79 58.08 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.183 -0.948 . . . . 0.0 110.205 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.774 ' O ' HD13 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -66.24 139.7 58.11 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.304 -0.873 . . . . 0.0 109.764 179.722 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.774 HD13 ' O ' ' A' ' 54' ' ' ARG . 5.3 mm -139.1 -177.76 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.029 -1.045 . . . . 0.0 110.862 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.672 ' H ' HG22 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -59.76 77.78 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.512 -0.742 . . . . 0.0 110.963 -179.528 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.487 ' N ' ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -107.0 17.47 23.02 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.208 -0.932 . . . . 0.0 109.539 179.117 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.438 ' C ' ' O ' ' A' ' 57' ' ' ARG . 0.8 OUTLIER -39.41 136.09 0.98 Allowed 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.25 0.548 . . . . 0.0 110.5 -179.776 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.472 ' O ' ' HD3' ' A' ' 60' ' ' ARG . . . 158.31 -34.45 0.51 Allowed Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.472 ' HD3' ' O ' ' A' ' 59' ' ' GLY . 14.8 mmt85 -114.93 68.92 0.71 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.325 -1.103 . . . . 0.0 110.348 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.423 ' C ' ' O ' ' A' ' 60' ' ' ARG . 0.1 OUTLIER -42.35 100.41 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.32 -0.862 . . . . 0.0 110.098 179.653 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.426 ' C ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -83.84 45.89 1.12 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.132 -0.98 . . . . 0.0 110.246 -179.969 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.196 -0.94 . . . . 0.0 110.313 -179.931 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.283 0.563 . . . . 0.0 110.156 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.564 HG22 ' O ' ' A' ' 49' ' ' LEU . 4.4 tt -140.21 157.51 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.321 -0.862 . . . . 0.0 110.094 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.574 ' OD1' ' CE1' ' A' ' 45' ' ' TYR . 33.4 t0 -125.42 128.01 47.44 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.632 -0.667 . . . . 0.0 109.863 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -174.68 -160.23 22.36 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.691 ' CE2' ' CD1' ' A' ' 45' ' ' TYR . 3.6 m-85 -126.56 99.64 29.81 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.444 -1.033 . . . . 0.0 110.258 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.535 ' HD2' ' O ' ' A' ' 44' ' ' CYS . 43.4 Cg_endo -69.79 125.61 12.33 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 O-C-N 123.917 1.483 . . . . 0.0 110.659 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.572 ' CG1' ' HA ' ' A' ' 56' ' ' LYS . 17.2 m -79.65 175.49 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.418 -0.801 . . . . 0.0 110.31 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -51.35 167.85 0.08 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.272 -0.892 . . . . 0.0 110.145 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.541 ' HB3' ' CE2' ' A' ' 10' ' ' TRP . 0.3 OUTLIER -66.43 -8.48 26.22 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.244 -0.91 . . . . 0.0 110.287 179.976 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.541 ' CE2' ' HB3' ' A' ' 9' ' ' TYR . 1.7 m-90 -139.59 11.28 2.5 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.28 -0.887 . . . . 0.0 109.993 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.417 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 2.8 m120 55.54 19.06 3.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.205 -0.934 . . . . 0.0 109.572 -179.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 3.5 t -81.78 -38.64 25.29 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.55 -0.719 . . . . 0.0 110.74 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.405 ' O ' ' CB ' ' A' ' 14' ' ' ARG . 2.5 mttp -93.04 53.38 1.97 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.273 -0.892 . . . . 0.0 110.603 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.405 ' CB ' ' O ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER 62.57 -143.85 0.39 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.233 -0.917 . . . . 0.0 110.409 179.694 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.834 HD12 ' HB2' ' A' ' 43' ' ' SER . 31.8 pt -109.4 4.06 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.165 -0.959 . . . . 0.0 110.277 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.601 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 0.9 OUTLIER -151.36 -174.23 4.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.18 -0.95 . . . . 0.0 109.708 179.436 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.689 ' CE3' ' CG ' ' A' ' 22' ' ' TYR . 0.0 OUTLIER -118.02 -171.92 2.16 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.121 -0.987 . . . . 0.0 110.156 179.839 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -91.28 -36.59 13.79 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.11 -0.994 . . . . 0.0 110.294 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.519 ' HB2' ' HB2' ' A' ' 22' ' ' TYR . 20.8 m120 -78.87 148.58 32.73 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.326 -0.859 . . . . 0.0 110.302 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -88.66 -16.68 31.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.342 -0.849 . . . . 0.0 110.121 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.28 -14.11 24.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.287 -0.883 . . . . 0.0 110.318 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.689 ' CG ' ' CE3' ' A' ' 17' ' ' TRP . 2.8 t80 -72.62 -40.11 66.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.085 -1.009 . . . . 0.0 109.913 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.46 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 1.3 t -63.3 -34.4 77.6 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.328 -0.857 . . . . 0.0 109.659 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.538 ' CB ' ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -78.0 -51.82 9.76 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.279 -0.888 . . . . 0.0 109.776 179.76 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.476 ' N ' ' CG ' ' A' ' 24' ' ' ASN . 5.7 m-20 -51.54 -49.08 62.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.197 -0.94 . . . . 0.0 110.173 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.7 mt -71.04 -37.59 72.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.242 -0.911 . . . . 0.0 110.282 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 23' ' ' CYS . 1.8 m -62.3 -38.66 90.25 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.159 -0.963 . . . . 0.0 109.616 179.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.556 ' CD ' ' HA ' ' A' ' 33' ' ' ASP . 8.7 mmmt -61.55 -27.07 68.36 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.291 -0.881 . . . . 0.0 109.145 179.277 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.61 -33.46 86.68 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 107.189 -2.364 . . . . 0.0 107.189 178.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.549 ' O ' ' HD3' ' A' ' 50' ' ' PRO . 12.8 mt -90.29 21.65 3.72 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.872 -0.781 . . . . 0.0 108.95 178.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.515 ' CB ' ' O ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER 71.81 8.54 6.09 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.452 -0.78 . . . . 0.0 110.81 179.875 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.618 ' HB2' HD22 ' A' ' 49' ' ' LEU . . . -87.06 103.76 15.68 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.95 -1.094 . . . . 0.0 109.877 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.556 ' HA ' ' CD ' ' A' ' 28' ' ' LYS . 9.2 m-20 -67.05 -76.49 0.08 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -0.912 . . . . 0.0 110.723 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.508 ' O ' ' HA ' ' A' ' 46' ' ' CYS . 0.5 OUTLIER -66.28 93.68 0.23 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.361 -0.837 . . . . 0.0 110.791 -179.514 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.538 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -133.05 126.2 4.32 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.421 ' C ' ' SG ' ' A' ' 23' ' ' CYS . 40.4 p90 -145.48 151.56 38.38 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.152 -1.204 . . . . 0.0 110.261 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 42.0 t -97.1 133.16 42.12 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.185 -0.947 . . . . 0.0 110.913 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.61 ' CD1' HD22 ' A' ' 42' ' ' LEU . 0.7 OUTLIER -97.49 138.62 34.64 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.266 -0.896 . . . . 0.0 109.935 179.535 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -89.06 8.74 79.15 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.829 ' CD1' HG22 ' A' ' 41' ' ' THR . 20.6 t-105 -99.57 -76.46 0.54 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.166 -1.196 . . . . 0.0 110.104 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.829 HG22 ' CD1' ' A' ' 40' ' ' TRP . 11.6 t -169.08 31.63 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.393 -0.817 . . . . 0.0 109.888 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.61 HD22 ' CD1' ' A' ' 38' ' ' TRP . 10.9 mp -107.0 14.23 26.66 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.442 -0.786 . . . . 0.0 110.215 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.834 ' HB2' HD12 ' A' ' 15' ' ' ILE . 8.2 t 47.56 -169.1 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.185 -0.947 . . . . 0.0 110.239 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.535 ' O ' ' HD2' ' A' ' 6' ' ' PRO . 1.8 t -81.41 97.12 7.59 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.691 ' CD1' ' CE2' ' A' ' 5' ' ' TYR . 4.8 t80 -79.81 130.54 35.41 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.12 -0.988 . . . . 0.0 111.251 -178.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.574 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . 83.3 m -145.15 145.94 31.58 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.366 -0.834 . . . . 0.0 109.376 179.104 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.469 ' HG2' ' OD1' ' A' ' 3' ' ' ASP . 3.9 mt-30 -127.57 142.23 51.42 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.086 -1.008 . . . . 0.0 110.244 -179.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' A' ' 31' ' ' LYS . . . 101.94 31.03 5.54 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 179.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.851 HD12 ' CB ' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -108.58 171.75 4.26 Favored Pre-proline 0 N--CA 1.497 1.896 0 O-C-N 121.132 -1.216 . . . . 0.0 109.658 179.456 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.549 ' HD3' ' O ' ' A' ' 30' ' ' LEU . 44.1 Cg_endo -69.41 159.42 53.73 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 123.621 1.327 . . . . 0.0 110.738 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -61.15 -24.04 65.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.32 -0.863 . . . . 0.0 109.822 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -88.05 9.69 21.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.335 -0.853 . . . . 0.0 109.854 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.851 ' CB ' HD12 ' A' ' 49' ' ' LEU . . . -59.16 126.09 26.26 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.374 -0.829 . . . . 0.0 110.233 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.924 ' O ' HD13 ' A' ' 55' ' ' ILE . 14.1 ttm-85 -53.82 150.08 7.94 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.317 -0.864 . . . . 0.0 110.351 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.924 HD13 ' O ' ' A' ' 54' ' ' ARG . 5.8 mm -146.87 175.03 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.443 -0.786 . . . . 0.0 110.013 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.572 ' HA ' ' CG1' ' A' ' 7' ' ' VAL . 0.1 OUTLIER -46.44 94.63 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.35 -0.844 . . . . 0.0 110.211 179.31 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.475 ' N ' ' O ' ' A' ' 55' ' ' ILE . 0.1 OUTLIER -116.29 -13.93 11.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.184 -0.948 . . . . 0.0 110.364 -179.904 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.0 t 49.86 -172.14 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.201 -0.937 . . . . 0.0 110.177 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 133.08 -129.43 5.43 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.33 138.47 53.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.328 -1.101 . . . . 0.0 110.265 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 32.5 t -43.61 113.75 0.55 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.233 -0.917 . . . . 0.0 110.179 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.514 ' CA ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -86.88 35.1 0.68 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.178 -0.951 . . . . 0.0 110.356 -179.961 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.654 0 O-C-N 121.281 -0.887 . . . . 0.0 110.105 179.978 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 2.8 ptmt . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.23 0.538 . . . . 0.0 110.184 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.502 HG22 ' HG ' ' A' ' 49' ' ' LEU . 3.3 tt -120.52 163.53 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.269 -0.894 . . . . 0.0 110.313 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.509 ' CB ' ' HG2' ' A' ' 47' ' ' GLN . 35.1 p-10 -125.26 117.19 23.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.589 -0.694 . . . . 0.0 109.675 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -153.37 -165.03 13.1 Favored Glycine 0 N--CA 1.493 2.455 0 C-N-CA 119.529 -1.32 . . . . 0.0 110.285 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.688 ' CZ ' ' CD1' ' A' ' 45' ' ' TYR . 21.4 m-85 -124.9 97.84 37.66 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.424 -1.045 . . . . 0.0 110.523 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.894 ' CA ' HG22 ' A' ' 55' ' ' ILE . 44.2 Cg_endo -70.68 130.31 18.01 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.865 1.455 . . . . 0.0 110.691 179.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.589 HG12 HG22 ' A' ' 15' ' ' ILE . 15.6 m -80.51 -162.53 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.303 -0.873 . . . . 0.0 110.523 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.424 ' O ' ' NH1' ' A' ' 54' ' ' ARG . 1.0 OUTLIER -74.63 -88.59 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.439 -0.788 . . . . 0.0 110.553 -179.544 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.473 ' O ' ' NH1' ' A' ' 62' ' ' ARG . 0.2 OUTLIER -142.35 -66.79 0.39 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.295 -0.878 . . . . 0.0 110.066 -179.888 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.5 ' O ' ' HB2' ' A' ' 11' ' ' ASN . 4.0 m-90 -90.2 10.38 24.8 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.307 -0.87 . . . . 0.0 109.823 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.5 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 6.2 m-20 65.75 5.44 3.36 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.627 -0.67 . . . . 0.0 110.655 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 2.7 t -73.65 -36.8 65.43 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.047 -1.033 . . . . 0.0 109.617 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.464 ' O ' ' O ' ' A' ' 14' ' ' ARG . 5.8 tttt -86.72 152.3 22.65 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.42 -0.8 . . . . 0.0 109.333 179.092 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.464 ' O ' ' O ' ' A' ' 13' ' ' LYS . 1.1 ptp180 -38.31 160.25 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.419 -0.801 . . . . 0.0 110.983 -179.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.598 HD12 ' CB ' ' A' ' 43' ' ' SER . 30.3 pt -70.5 0.71 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.383 -0.823 . . . . 0.0 110.84 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.596 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 1.7 t -141.74 121.86 13.8 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.174 -0.954 . . . . 0.0 109.406 179.192 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.66 ' CD2' ' CD2' ' A' ' 22' ' ' TYR . 1.1 t90 -60.94 -137.28 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.14 -0.975 . . . . 0.0 110.111 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -142.6 30.6 1.51 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.159 -0.963 . . . . 0.0 110.468 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.555 ' HB2' ' CE3' ' A' ' 17' ' ' TRP . 0.1 OUTLIER -143.63 134.47 25.27 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.152 -0.967 . . . . 0.0 110.235 179.759 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -69.17 -6.81 31.11 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.313 -0.867 . . . . 0.0 110.119 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.84 -21.84 12.89 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.32 -0.863 . . . . 0.0 110.224 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.66 ' CD2' ' CD2' ' A' ' 17' ' ' TRP . 8.5 t80 -72.53 -56.74 4.9 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.243 -0.911 . . . . 0.0 109.579 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.475 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 1.6 t -56.3 -30.25 62.27 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.435 -0.791 . . . . 0.0 109.51 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.488 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 10.0 t-20 -81.14 -36.04 30.76 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.134 -0.979 . . . . 0.0 109.99 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -64.06 -48.77 74.95 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.197 -0.939 . . . . 0.0 109.711 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.64 -40.02 73.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.372 -0.83 . . . . 0.0 109.867 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.475 ' SG ' ' O ' ' A' ' 23' ' ' CYS . 9.7 m -62.74 -41.01 98.99 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.314 -0.867 . . . . 0.0 109.747 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 24' ' ' ASN . 0.0 OUTLIER -63.79 -24.4 67.74 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.204 -0.935 . . . . 0.0 109.347 179.302 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.83 -37.03 91.89 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 107.638 -2.185 . . . . 0.0 107.638 178.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.509 ' O ' ' HB3' ' A' ' 31' ' ' LYS . 1.1 mt -93.67 20.19 7.76 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.815 -0.815 . . . . 0.0 109.245 178.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.509 ' HB3' ' O ' ' A' ' 30' ' ' LEU . 0.1 OUTLIER 69.61 15.78 8.12 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.851 -0.53 . . . . 0.0 111.365 179.557 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.667 ' HB1' ' HB3' ' A' ' 46' ' ' CYS . . . -78.36 86.04 4.45 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.744 -1.222 . . . . 0.0 109.26 179.273 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.416 ' C ' ' O ' ' A' ' 32' ' ' ALA . 2.2 m-20 -39.38 -90.3 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.621 -0.675 . . . . 0.0 111.488 -178.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.53 ' O ' ' HA ' ' A' ' 46' ' ' CYS . 12.5 p -67.01 92.34 0.24 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.31 -0.869 . . . . 0.0 111.109 -178.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.508 ' CA ' ' SG ' ' A' ' 46' ' ' CYS . . . -122.31 108.79 1.32 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 108.91 -1.676 . . . . 0.0 108.91 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.411 ' CD1' ' C ' ' A' ' 36' ' ' TYR . 30.4 p90 -135.8 165.57 25.3 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.178 -1.19 . . . . 0.0 110.651 -179.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.495 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.0 OUTLIER -107.59 128.99 55.03 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.317 -0.864 . . . . 0.0 109.94 179.608 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.601 ' CD1' ' HB2' ' A' ' 42' ' ' LEU . 35.5 t-105 -79.6 166.87 21.43 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.091 -1.006 . . . . 0.0 110.005 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -98.25 -27.35 8.77 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 120.003 -1.094 . . . . 0.0 110.369 -179.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.577 ' HB3' ' CD1' ' A' ' 38' ' ' TRP . 48.6 t-105 -79.51 -91.8 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.994 -1.298 . . . . 0.0 110.074 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.527 HG23 ' C ' ' A' ' 40' ' ' TRP . 41.6 p -150.54 34.9 0.63 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.074 -1.016 . . . . 0.0 110.346 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.601 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 0.2 OUTLIER -89.53 0.29 57.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.303 -0.873 . . . . 0.0 110.074 179.809 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.598 ' CB ' HD12 ' A' ' 15' ' ' ILE . 0.9 OUTLIER 60.77 -176.4 0.11 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.227 -0.921 . . . . 0.0 110.201 -179.897 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.517 ' O ' ' HD2' ' A' ' 6' ' ' PRO . 0.9 OUTLIER -80.19 94.48 6.05 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.991 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.688 ' CD1' ' CZ ' ' A' ' 5' ' ' TYR . 9.3 t80 -79.98 138.97 37.18 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.117 -0.989 . . . . 0.0 110.682 -179.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.667 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . 74.2 m -149.3 144.44 26.47 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.343 -0.848 . . . . 0.0 110.228 179.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.509 ' HG2' ' CB ' ' A' ' 3' ' ' ASP . 39.1 mt-30 -126.64 149.39 49.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.387 -0.821 . . . . 0.0 110.069 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.486 ' O ' ' O ' ' A' ' 31' ' ' LYS . . . 99.59 21.73 13.97 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.844 HD12 ' CB ' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -101.48 169.29 7.91 Favored Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 121.072 -1.252 . . . . 0.0 109.898 179.626 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.519 ' HD2' ' HB2' ' A' ' 49' ' ' LEU . 44.6 Cg_endo -71.56 159.02 52.4 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 123.717 1.377 . . . . 0.0 110.342 -179.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.464 ' HA ' HD12 ' A' ' 2' ' ' ILE . 18.9 t70 -60.47 -23.66 64.64 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.157 -0.964 . . . . 0.0 109.723 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -92.87 17.24 10.88 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.466 -0.771 . . . . 0.0 109.609 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.844 ' CB ' HD12 ' A' ' 49' ' ' LEU . . . -47.72 143.67 3.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.372 -0.83 . . . . 0.0 110.104 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.48 ' O ' ' HA ' ' A' ' 6' ' ' PRO . 41.8 ttp85 -85.24 91.7 8.22 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.344 -0.848 . . . . 0.0 110.334 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.894 HG22 ' CA ' ' A' ' 6' ' ' PRO . 0.2 OUTLIER -140.3 166.81 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.324 -0.86 . . . . 0.0 109.965 179.69 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 6.1 mttt 45.25 67.12 0.77 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.135 -0.978 . . . . 0.0 109.759 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.494 ' HG2' ' O ' ' A' ' 55' ' ' ILE . 34.2 mmm-85 -125.44 17.25 8.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.247 -0.908 . . . . 0.0 110.458 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 57' ' ' ARG . 0.7 OUTLIER -42.23 138.99 1.52 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.334 -0.854 . . . . 0.0 109.941 179.884 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -164.25 -128.28 0.94 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.492 ' O ' ' O ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER -117.32 46.67 1.65 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.394 -1.063 . . . . 0.0 110.242 -179.97 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.492 ' O ' ' O ' ' A' ' 60' ' ' ARG . 52.2 m 56.06 121.46 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.476 0.655 . . . . 0.0 110.643 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.497 ' NH1' ' HA ' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -87.66 39.18 0.87 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.024 -1.048 . . . . 0.0 110.235 179.747 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.234 -0.917 . . . . 0.0 110.264 -179.938 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 7.5 mttt . . . . . 0 N--CA 1.494 1.749 0 CA-C-O 121.158 0.504 . . . . 0.0 110.025 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.72 HG22 ' O ' ' A' ' 49' ' ' LEU . 13.5 tt -118.98 161.81 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.143 -0.973 . . . . 0.0 110.337 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -131.34 131.46 43.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.259 -0.901 . . . . 0.0 110.032 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.449 ' O ' ' CD1' ' A' ' 45' ' ' TYR . . . -169.95 -176.17 39.43 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.702 -1.237 . . . . 0.0 110.011 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.681 ' CE1' ' CE1' ' A' ' 45' ' ' TYR . 66.8 m-85 -106.27 100.85 31.62 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.381 -1.07 . . . . 0.0 110.15 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.49 ' O ' ' HB3' ' A' ' 44' ' ' CYS . 43.3 Cg_endo -70.59 140.98 40.76 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.845 1.445 . . . . 0.0 110.478 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.915 ' CG1' HG22 ' A' ' 15' ' ' ILE . 5.1 m -110.12 -170.99 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.194 -0.941 . . . . 0.0 110.168 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -63.99 -145.04 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.24 -0.913 . . . . 0.0 110.686 -179.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -85.97 -47.57 9.49 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.427 -0.796 . . . . 0.0 110.648 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.476 ' HB3' ' CB ' ' A' ' 62' ' ' ARG . 3.3 m-90 -120.36 21.35 11.7 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.098 -1.001 . . . . 0.0 110.546 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.49 ' N ' ' OD1' ' A' ' 11' ' ' ASN . 1.8 m-20 57.7 15.12 2.74 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.118 -0.989 . . . . 0.0 110.154 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.8 t -84.94 -52.8 5.73 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.244 -0.91 . . . . 0.0 110.46 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.426 ' O ' ' CG ' ' A' ' 14' ' ' ARG . 5.6 tptt -61.49 -51.91 66.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.33 -0.856 . . . . 0.0 110.326 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.426 ' CG ' ' O ' ' A' ' 13' ' ' LYS . 0.1 OUTLIER 176.66 -158.71 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.204 -0.935 . . . . 0.0 110.511 -179.963 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.915 HG22 ' CG1' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -119.33 -18.04 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.368 -0.832 . . . . 0.0 109.491 179.558 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.623 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 1.8 t -132.64 111.99 11.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.469 -0.769 . . . . 0.0 110.22 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.464 ' CD2' ' HB3' ' A' ' 22' ' ' TYR . 0.0 OUTLIER -50.27 163.55 0.16 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.24 -0.913 . . . . 0.0 110.157 179.868 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -79.88 -24.75 40.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.305 -0.872 . . . . 0.0 109.983 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -83.88 145.72 28.46 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.272 -0.892 . . . . 0.0 110.047 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 16.0 p30 -80.46 7.6 9.47 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.212 -0.93 . . . . 0.0 110.416 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -131.23 -18.42 2.91 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.137 -0.977 . . . . 0.0 110.954 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.464 ' HB3' ' CD2' ' A' ' 17' ' ' TRP . 0.1 OUTLIER -60.36 -14.07 16.66 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.926 -1.109 . . . . 0.0 110.286 -179.753 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.449 ' O ' ' HB2' ' A' ' 27' ' ' CYS . 0.1 OUTLIER -103.58 -29.85 10.86 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.152 -0.967 . . . . 0.0 110.204 179.926 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.469 ' O ' ' HG2' ' A' ' 28' ' ' LYS . 55.1 t-20 -72.81 -52.58 14.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.192 -0.943 . . . . 0.0 109.582 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -54.75 -42.34 71.51 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.257 -0.902 . . . . 0.0 109.91 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.692 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -72.89 -41.64 64.45 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.279 -0.888 . . . . 0.0 109.431 179.749 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.478 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 1.5 m -60.61 -39.75 89.34 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.4 -0.813 . . . . 0.0 109.638 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.469 ' HG2' ' O ' ' A' ' 24' ' ' ASN . 1.7 mmmp? -61.73 -30.17 70.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.362 -0.837 . . . . 0.0 109.6 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.82 -34.01 80.74 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 108.149 -1.981 . . . . 0.0 108.149 179.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.55 ' O ' ' CB ' ' A' ' 31' ' ' LYS . 62.4 mt -93.06 18.56 9.07 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.605 -0.938 . . . . 0.0 109.785 179.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.55 ' CB ' ' O ' ' A' ' 30' ' ' LEU . 0.1 OUTLIER 76.11 12.76 2.75 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.618 -0.676 . . . . 0.0 111.133 179.717 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.815 ' HB2' HD22 ' A' ' 49' ' ' LEU . . . -88.52 82.1 7.0 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.845 -1.159 . . . . 0.0 109.734 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.417 ' O ' ' HD3' ' A' ' 28' ' ' LYS . 72.1 m-20 -46.25 -74.91 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.576 -0.702 . . . . 0.0 111.151 -179.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.409 ' O ' ' HA ' ' A' ' 46' ' ' CYS . 11.0 t -69.76 90.38 0.59 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.424 -0.798 . . . . 0.0 110.983 -179.16 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.486 ' HA2' ' SG ' ' A' ' 46' ' ' CYS . . . -122.04 113.89 2.37 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 108.976 -1.65 . . . . 0.0 108.976 179.212 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.572 ' CE1' ' HB3' ' A' ' 45' ' ' TYR . 27.4 p90 -133.28 154.6 50.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.123 -1.222 . . . . 0.0 110.485 -179.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.487 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.5 OUTLIER -107.73 118.08 35.81 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.332 -0.855 . . . . 0.0 110.151 179.775 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.616 ' CD1' ' HB3' ' A' ' 40' ' ' TRP . 25.0 t-105 -85.71 99.37 11.28 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.157 -0.965 . . . . 0.0 110.248 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.71 68.03 1.02 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.616 ' HB3' ' CD1' ' A' ' 38' ' ' TRP . 57.3 t-105 -157.94 -88.61 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.251 -1.147 . . . . 0.0 110.254 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 67.0 p -144.74 23.12 1.59 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.114 -0.991 . . . . 0.0 110.281 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.591 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 0.4 OUTLIER -121.01 11.17 10.94 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.168 -0.958 . . . . 0.0 110.537 -179.82 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.623 ' HA ' ' HB2' ' A' ' 16' ' ' CYS . 25.7 m 46.81 -170.23 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.919 -1.113 . . . . 0.0 109.973 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.49 ' HB3' ' O ' ' A' ' 6' ' ' PRO . 51.2 t -77.65 151.65 34.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.101 -1.0 . . . . 0.0 109.139 179.224 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.681 ' CE1' ' CE1' ' A' ' 5' ' ' TYR . 6.1 t80 -147.85 123.86 10.72 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.836 -1.165 . . . . 0.0 111.299 -179.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.637 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . 80.0 m -130.63 142.73 50.45 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.444 -0.785 . . . . 0.0 109.453 178.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 13.2 mp0 -116.98 131.17 57.02 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.082 -1.011 . . . . 0.0 110.22 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.598 ' C ' HD23 ' A' ' 49' ' ' LEU . . . 105.35 42.04 1.81 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.815 HD22 ' HB2' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -103.51 -174.79 0.35 Allowed Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.1 -1.236 . . . . 0.0 109.466 179.744 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.692 ' HD2' ' HB2' ' A' ' 53' ' ' ALA . 49.9 Cg_endo -86.23 160.33 9.88 Favored 'Trans proline' 0 C--N 1.303 -1.842 0 O-C-N 123.938 1.493 . . . . 0.0 109.764 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -59.91 -19.54 52.19 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.051 -1.031 . . . . 0.0 109.756 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -99.54 22.01 11.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.331 -0.856 . . . . 0.0 109.645 179.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.692 ' HB2' ' HD2' ' A' ' 50' ' ' PRO . . . -60.1 137.9 58.0 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.374 -0.828 . . . . 0.0 110.244 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.671 ' O ' HD13 ' A' ' 55' ' ' ILE . 12.2 ttp-105 -77.69 129.61 35.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.267 -0.896 . . . . 0.0 110.03 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.671 HD13 ' O ' ' A' ' 54' ' ' ARG . 12.9 mm -134.5 177.15 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.182 -0.949 . . . . 0.0 109.616 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.496 ' H ' HG22 ' A' ' 55' ' ' ILE . 2.4 ptmt -67.14 61.77 0.05 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.121 -0.987 . . . . 0.0 109.191 179.446 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.53 ' N ' ' O ' ' A' ' 55' ' ' ILE . 20.0 ttm-85 -86.86 -25.17 24.63 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.598 -0.689 . . . . 0.0 110.665 -179.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.8 m -123.19 162.0 23.4 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.14 -0.975 . . . . 0.0 110.119 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -145.17 13.97 1.88 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.515 ' O ' ' O ' ' A' ' 61' ' ' CYS . 2.4 mpp_? -106.55 41.86 1.37 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.096 -1.238 . . . . 0.0 110.211 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.515 ' O ' ' O ' ' A' ' 60' ' ' ARG . 42.7 t 42.42 104.25 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.501 0.667 . . . . 0.0 111.285 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.476 ' CB ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -81.53 45.39 0.87 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.087 -1.008 . . . . 0.0 110.412 179.588 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.069 -1.019 . . . . 0.0 110.183 179.873 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 4.0 pttp . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.265 0.555 . . . . 0.0 110.248 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.503 ' CG2' ' HG ' ' A' ' 49' ' ' LEU . 15.2 tt -131.68 161.1 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.266 -0.896 . . . . 0.0 110.136 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.443 ' OD1' ' HA ' ' A' ' 47' ' ' GLN . 48.8 m-20 -127.46 147.57 50.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.379 -0.826 . . . . 0.0 110.133 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 164.21 -179.93 38.78 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.668 ' CZ ' ' CD2' ' A' ' 45' ' ' TYR . 23.8 m-85 -98.22 109.82 53.68 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.331 -1.1 . . . . 0.0 110.241 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.521 ' CA ' HG22 ' A' ' 55' ' ' ILE . 48.8 Cg_endo -74.8 130.53 13.58 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 123.972 1.512 . . . . 0.0 110.576 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.593 HG12 ' HA ' ' A' ' 15' ' ' ILE . 16.4 m -119.66 -168.22 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.23 -0.919 . . . . 0.0 109.767 179.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.512 ' HB2' ' HB2' ' A' ' 14' ' ' ARG . 0.7 OUTLIER -66.58 -176.84 0.51 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.332 -0.855 . . . . 0.0 110.139 179.712 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.506 ' HB3' ' CE2' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -79.1 -5.85 55.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.326 -0.859 . . . . 0.0 109.9 179.723 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.528 ' HA ' ' HB2' ' A' ' 62' ' ' ARG . 4.5 m-90 -137.98 3.62 2.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.282 -0.886 . . . . 0.0 110.513 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.47 ' N ' ' OD1' ' A' ' 11' ' ' ASN . 2.2 m-20 59.73 12.21 2.83 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.283 -0.886 . . . . 0.0 110.524 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 4.2 t -77.78 -62.85 1.54 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.097 -1.002 . . . . 0.0 111.186 -178.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.516 ' O ' ' CB ' ' A' ' 14' ' ' ARG . 1.5 tmtt? -136.39 98.98 3.97 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.059 -1.026 . . . . 0.0 111.313 -179.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.566 ' O ' ' N ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER 168.04 -88.74 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.361 -0.837 . . . . 0.0 110.222 179.098 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.657 HG23 ' CB ' ' A' ' 43' ' ' SER . 5.0 mt 55.57 -81.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.142 -0.974 . . . . 0.0 110.087 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.629 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 37.5 t -122.77 127.91 49.78 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.428 -0.795 . . . . 0.0 109.946 179.238 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.64 ' CZ3' ' CD2' ' A' ' 22' ' ' TYR . 0.1 OUTLIER -69.8 -145.5 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.051 -1.03 . . . . 0.0 109.92 179.609 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -118.02 -9.73 10.5 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.239 -0.913 . . . . 0.0 110.21 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.443 ' CB ' ' HB2' ' A' ' 22' ' ' TYR . 0.7 OUTLIER -117.8 166.65 12.2 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.318 -0.864 . . . . 0.0 110.296 -179.896 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -88.68 -59.47 2.22 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.254 -0.904 . . . . 0.0 110.308 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.28 -26.98 66.9 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.208 -0.932 . . . . 0.0 110.24 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.64 ' CD2' ' CZ3' ' A' ' 17' ' ' TRP . 0.4 OUTLIER -58.86 -53.65 56.01 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.316 -0.865 . . . . 0.0 110.506 -179.818 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -66.77 -27.18 67.38 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.17 -0.956 . . . . 0.0 110.337 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.439 ' OD1' ' O ' ' A' ' 33' ' ' ASP . 25.0 t-20 -66.71 -55.61 14.32 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.276 -0.89 . . . . 0.0 110.272 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -44.09 -49.86 8.7 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.347 -0.846 . . . . 0.0 110.417 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.53 -42.1 95.96 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.201 -0.937 . . . . 0.0 110.154 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.411 ' SG ' ' HG3' ' A' ' 6' ' ' PRO . 0.8 OUTLIER -59.54 -39.87 85.38 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.243 -0.911 . . . . 0.0 109.419 179.474 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.1 mtmt -62.91 -33.9 76.3 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.258 -0.901 . . . . 0.0 109.154 179.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -50.87 -39.42 39.84 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.766 -1.734 . . . . 0.0 108.766 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.655 ' O ' ' CB ' ' A' ' 31' ' ' LYS . 6.9 mt -79.94 -34.07 39.14 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.248 -1.148 . . . . 0.0 109.609 179.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.655 ' CB ' ' O ' ' A' ' 30' ' ' LEU . 1.8 tttp 141.14 0.35 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.658 0 C-N-CA 123.015 0.526 . . . . 0.0 110.126 179.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.498 ' HB1' ' HB3' ' A' ' 46' ' ' CYS . . . -85.44 117.12 24.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.95 -1.094 . . . . 0.0 110.511 -179.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.439 ' O ' ' OD1' ' A' ' 24' ' ' ASN . 11.3 t0 -83.32 -59.15 2.55 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.272 -0.893 . . . . 0.0 110.309 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.93 88.04 2.9 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.388 -0.82 . . . . 0.0 110.117 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.482 ' CA ' ' SG ' ' A' ' 46' ' ' CYS . . . -124.03 109.68 1.33 Allowed Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -127.27 147.44 50.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.279 -1.13 . . . . 0.0 109.861 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.1 OUTLIER -91.66 140.64 29.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.284 -0.885 . . . . 0.0 110.815 -179.282 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.602 ' CD1' ' HB3' ' A' ' 40' ' ' TRP . 45.5 t-105 -79.78 104.11 10.14 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.276 -0.89 . . . . 0.0 109.407 179.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -76.4 76.09 1.53 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -179.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.811 ' CD1' HG22 ' A' ' 41' ' ' THR . 5.8 t-105 -160.5 -72.21 0.07 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.41 -1.053 . . . . 0.0 109.583 179.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.811 HG22 ' CD1' ' A' ' 40' ' ' TRP . 12.7 t -179.11 35.3 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.569 -0.707 . . . . 0.0 109.79 179.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.578 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 1.7 mt -113.12 -84.3 0.59 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.244 -0.91 . . . . 0.0 110.866 -179.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.657 ' CB ' HG23 ' A' ' 15' ' ' ILE . 3.2 t 170.36 175.76 0.06 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.411 -0.806 . . . . 0.0 109.59 -179.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.497 ' O ' ' CD2' ' A' ' 5' ' ' TYR . 10.3 t -63.49 159.96 17.43 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.003 -1.06 . . . . 0.0 108.923 179.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.668 ' CD2' ' CZ ' ' A' ' 5' ' ' TYR . 1.0 OUTLIER -147.99 116.41 6.59 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.877 -1.14 . . . . 0.0 110.935 -179.755 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.498 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . 71.6 m -128.46 149.38 50.6 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.28 -0.887 . . . . 0.0 109.686 179.238 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.443 ' HA ' ' OD1' ' A' ' 3' ' ' ASP . 0.2 OUTLIER -127.96 104.51 7.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.163 -0.96 . . . . 0.0 110.074 -179.853 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.51 ' C ' HD23 ' A' ' 49' ' ' LEU . . . 131.51 49.86 0.1 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.869 HD12 ' CB ' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -120.37 173.47 3.69 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.351 -1.087 . . . . 0.0 110.106 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.515 ' HD2' ' HB2' ' A' ' 49' ' ' LEU . 43.0 Cg_endo -70.38 157.7 58.4 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.944 1.497 . . . . 0.0 110.362 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -60.39 -18.0 47.62 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.285 -0.884 . . . . 0.0 110.033 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -89.83 9.18 28.45 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.34 -0.85 . . . . 0.0 109.968 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.869 ' CB ' HD12 ' A' ' 49' ' ' LEU . . . -58.42 122.01 12.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.388 -0.82 . . . . 0.0 110.275 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.03 130.88 37.01 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.181 -0.949 . . . . 0.0 110.297 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.709 HD12 ' C ' ' A' ' 55' ' ' ILE . 2.3 pp -145.0 -179.56 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.317 -0.865 . . . . 0.0 110.074 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.403 ' O ' ' HG3' ' A' ' 56' ' ' LYS . 4.1 ptpt -51.35 88.2 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.323 -0.861 . . . . 0.0 110.479 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.523 ' N ' ' O ' ' A' ' 55' ' ' ILE . 0.3 OUTLIER -110.25 -28.85 8.42 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.408 -0.808 . . . . 0.0 109.382 179.526 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -125.48 170.84 11.01 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.67 -0.644 . . . . 0.0 110.222 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -124.71 -3.8 7.61 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.14 131.64 54.43 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.272 -1.134 . . . . 0.0 110.041 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 33.5 m -44.31 126.57 5.27 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.196 -0.94 . . . . 0.0 109.813 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.528 ' HB2' ' HA ' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -86.68 50.31 1.98 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.131 -0.98 . . . . 0.0 110.127 179.879 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.187 -0.946 . . . . 0.0 110.246 179.96 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 38.1 pttt . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.298 0.57 . . . . 0.0 110.219 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.721 HG22 ' O ' ' A' ' 49' ' ' LEU . 2.8 tt -154.36 166.07 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.261 -0.899 . . . . 0.0 110.056 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.508 ' N ' HG12 ' A' ' 2' ' ' ILE . 2.4 p-10 -147.87 166.04 28.81 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.369 -0.832 . . . . 0.0 109.965 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 157.36 -152.12 23.41 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.456 ' HA ' ' O ' ' A' ' 44' ' ' CYS . 6.9 m-85 -110.58 99.22 40.41 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.276 -1.131 . . . . 0.0 110.393 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.818 ' HA ' HG22 ' A' ' 55' ' ' ILE . 46.7 Cg_endo -73.85 126.76 10.94 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 124.066 1.561 . . . . 0.0 110.146 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.707 HG12 HG23 ' A' ' 15' ' ' ILE . 16.0 m -79.59 -172.29 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.243 -0.911 . . . . 0.0 110.256 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.451 ' O ' ' HB2' ' A' ' 9' ' ' TYR . 6.9 p-10 -77.28 -44.63 29.06 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.155 -0.966 . . . . 0.0 109.87 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.581 ' HB3' ' CE3' ' A' ' 10' ' ' TRP . 1.7 t80 178.98 -66.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.675 -0.641 . . . . 0.0 109.444 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.581 ' CE3' ' HB3' ' A' ' 9' ' ' TYR . 2.6 m-90 -107.27 21.68 17.14 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.35 -0.844 . . . . 0.0 109.37 179.272 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 2.3 m120 59.11 14.07 3.29 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.46 -0.775 . . . . 0.0 110.307 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.9 m -68.9 -36.26 77.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.259 -0.901 . . . . 0.0 109.969 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.1 44.7 1.01 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.423 -0.798 . . . . 0.0 109.773 179.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 62.32 -179.8 0.13 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.332 -0.855 . . . . 0.0 110.081 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.707 HG23 HG12 ' A' ' 7' ' ' VAL . 3.3 mt -82.11 -6.56 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.211 -0.931 . . . . 0.0 110.548 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.525 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 46.3 t -132.12 162.56 30.54 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.286 -0.884 . . . . 0.0 110.37 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.669 ' CE3' ' CG ' ' A' ' 22' ' ' TYR . 0.3 OUTLIER -105.77 -153.66 0.5 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.274 -0.891 . . . . 0.0 109.889 179.605 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -105.48 -20.27 13.53 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.184 -0.948 . . . . 0.0 110.113 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.503 ' HB3' ' HB2' ' A' ' 22' ' ' TYR . 0.3 OUTLIER -100.98 149.7 23.65 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.262 -0.899 . . . . 0.0 110.137 179.963 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -84.32 -25.56 29.16 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.215 -0.928 . . . . 0.0 110.276 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -90.22 -28.61 18.74 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.23 -0.919 . . . . 0.0 110.355 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.669 ' CG ' ' CE3' ' A' ' 17' ' ' TRP . 28.4 t80 -57.54 -46.36 83.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.262 -0.899 . . . . 0.0 110.179 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -64.45 -43.41 94.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.193 -0.942 . . . . 0.0 109.792 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.507 ' O ' ' HG2' ' A' ' 28' ' ' LYS . 50.0 t30 -57.92 -40.9 81.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.222 -0.924 . . . . 0.0 109.675 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.57 -56.82 17.0 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.222 -0.923 . . . . 0.0 110.066 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.72 -36.87 82.19 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.238 -0.914 . . . . 0.0 109.966 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.48 ' SG ' ' HG3' ' A' ' 6' ' ' PRO . 5.2 m -63.02 -43.06 99.77 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.173 -0.955 . . . . 0.0 109.469 179.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.507 ' HG2' ' O ' ' A' ' 24' ' ' ASN . 0.3 OUTLIER -58.36 -27.78 64.52 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.294 -0.879 . . . . 0.0 109.257 179.027 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.14 -38.34 94.26 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 107.956 -2.057 . . . . 0.0 107.956 179.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.529 ' O ' ' HD3' ' A' ' 50' ' ' PRO . 5.0 mt -89.78 21.47 3.54 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.65 -0.912 . . . . 0.0 109.14 178.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.504 ' HB3' ' O ' ' A' ' 30' ' ' LEU . 0.4 OUTLIER 69.65 15.92 8.06 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.647 -0.658 . . . . 0.0 110.798 179.922 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.623 ' HB1' ' HB3' ' A' ' 46' ' ' CYS . . . -88.38 73.6 8.76 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.933 -1.105 . . . . 0.0 109.383 179.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.425 ' C ' ' O ' ' A' ' 32' ' ' ALA . 0.1 OUTLIER -39.82 -76.94 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.565 -0.709 . . . . 0.0 110.848 -179.289 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.495 ' O ' ' HA ' ' A' ' 46' ' ' CYS . 1.8 t -65.88 93.65 0.19 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.443 -0.786 . . . . 0.0 110.454 -179.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.522 ' CA ' ' SG ' ' A' ' 46' ' ' CYS . . . -128.52 93.64 0.36 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.523 ' CD1' ' C ' ' A' ' 36' ' ' TYR . 9.4 p90 -113.47 153.35 28.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.294 -1.121 . . . . 0.0 109.859 179.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.511 ' HA ' ' HA ' ' A' ' 44' ' ' CYS . 0.1 OUTLIER -108.8 139.99 42.86 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.097 -1.002 . . . . 0.0 110.428 -179.863 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.639 ' CD1' ' CD1' ' A' ' 42' ' ' LEU . 49.1 t-105 -79.54 86.85 5.16 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.292 -0.88 . . . . 0.0 109.848 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -62.38 80.77 0.03 OUTLIER Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -179.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.825 ' CD1' HG22 ' A' ' 41' ' ' THR . 14.0 t-105 -160.53 -73.16 0.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.435 -1.038 . . . . 0.0 109.6 179.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.825 HG22 ' CD1' ' A' ' 40' ' ' TRP . 15.0 t -179.07 40.1 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.634 -0.666 . . . . 0.0 109.588 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.639 ' CD1' ' CD1' ' A' ' 38' ' ' TRP . 0.3 OUTLIER -123.25 -80.65 0.63 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.281 -0.887 . . . . 0.0 110.818 -179.485 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.525 ' HA ' ' HB2' ' A' ' 16' ' ' CYS . 1.2 p 170.01 176.09 0.05 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.263 -0.898 . . . . 0.0 109.901 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.511 ' HA ' ' HA ' ' A' ' 37' ' ' CYS . 6.8 t -74.6 166.54 23.39 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.23 -0.919 . . . . 0.0 110.176 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.467 ' CE1' ' OE1' ' A' ' 47' ' ' GLN . 0.8 OUTLIER -148.98 108.47 3.98 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.191 -0.943 . . . . 0.0 110.35 -179.973 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.623 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . 64.9 m -129.23 137.71 51.26 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.375 -0.828 . . . . 0.0 109.729 179.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.467 ' OE1' ' CE1' ' A' ' 45' ' ' TYR . 2.2 mt-30 -124.18 128.4 49.17 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.086 -1.009 . . . . 0.0 110.314 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.488 ' O ' ' O ' ' A' ' 31' ' ' LYS . . . 121.25 28.9 1.56 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.892 HD12 ' CB ' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -106.2 169.5 6.84 Favored Pre-proline 0 N--CA 1.497 1.883 0 O-C-N 121.135 -1.215 . . . . 0.0 109.993 179.6 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.671 ' O ' HG21 ' A' ' 2' ' ' ILE . 42.4 Cg_endo -67.23 157.62 60.85 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 O-C-N 123.87 1.458 . . . . 0.0 111.126 -179.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -58.46 -27.86 64.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.488 -0.758 . . . . 0.0 109.883 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.4 ' O ' ' OD1' ' A' ' 52' ' ' ASN . 15.8 t-20 -90.75 20.42 4.74 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.393 -0.817 . . . . 0.0 109.457 179.437 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.892 ' CB ' HD12 ' A' ' 49' ' ' LEU . . . -62.84 110.83 1.89 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.665 -0.647 . . . . 0.0 110.592 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.509 ' NH1' ' O ' ' A' ' 9' ' ' TYR . 1.3 tmm_? -65.02 129.36 39.43 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.324 -0.86 . . . . 0.0 110.307 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.818 HG22 ' HA ' ' A' ' 6' ' ' PRO . 2.7 pt -152.55 -163.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.543 -0.723 . . . . 0.0 109.907 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.488 ' O ' ' HG3' ' A' ' 56' ' ' LYS . 2.5 ptmm? -40.72 93.43 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.569 -0.707 . . . . 0.0 110.498 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.526 ' N ' ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -135.17 2.95 3.1 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.294 -0.879 . . . . 0.0 110.113 -179.935 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -153.46 -173.63 4.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.239 -0.913 . . . . 0.0 109.864 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -166.73 23.93 0.13 Allowed Glycine 0 N--CA 1.49 2.272 0 C-N-CA 119.674 -1.25 . . . . 0.0 110.049 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.485 ' O ' ' O ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER -137.16 47.47 2.11 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.959 -1.318 . . . . 0.0 110.411 179.802 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.485 ' O ' ' O ' ' A' ' 60' ' ' ARG . 0.5 OUTLIER 47.36 103.07 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.619 -0.676 . . . . 0.0 110.742 179.885 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.501 ' N ' ' HB3' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -79.9 54.68 1.92 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.382 -0.824 . . . . 0.0 110.171 179.811 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.165 -0.959 . . . . 0.0 110.263 -179.962 . . . . . . . . 0 0 . 1 stop_ save_